Citrus Sinensis ID: 000535
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1437 | 2.2.26 [Sep-21-2011] | |||||||
| Q8T2I8 | 1167 | Serine/threonine-protein | yes | no | 0.180 | 0.221 | 0.670 | 1e-100 | |
| Q5B4Z3 | 1346 | Cytokinesis protein sepH | yes | no | 0.216 | 0.231 | 0.553 | 3e-99 | |
| A2QHV0 | 1336 | Cytokinesis protein sepH | yes | no | 0.178 | 0.192 | 0.643 | 9e-97 | |
| Q0CL79 | 1342 | Cytokinesis protein sepH | N/A | no | 0.190 | 0.204 | 0.6 | 2e-95 | |
| P41892 | 1062 | Cell division control pro | yes | no | 0.173 | 0.234 | 0.620 | 6e-89 | |
| Q55CA6 | 635 | Probable serine/threonine | no | no | 0.199 | 0.450 | 0.498 | 7e-83 | |
| Q54PX0 | 496 | Probable serine/threonine | no | no | 0.196 | 0.570 | 0.508 | 1e-80 | |
| Q54XJ4 | 1495 | Probable serine/threonine | no | no | 0.197 | 0.189 | 0.481 | 9e-76 | |
| Q54QI2 | 941 | Serine/threonine-protein | no | no | 0.176 | 0.269 | 0.519 | 5e-71 | |
| O22042 | 651 | Mitogen-activated protein | no | no | 0.187 | 0.414 | 0.450 | 1e-63 |
| >sp|Q8T2I8|SEPA_DICDI Serine/threonine-protein kinase sepA OS=Dictyostelium discoideum GN=sepA PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 368 bits (944), Expect = e-100, Method: Compositional matrix adjust.
Identities = 177/264 (67%), Positives = 210/264 (79%), Gaps = 5/264 (1%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
K+ T+ N Y LG IGKG +G VY+GLD+E+GDFVAIKQ++L I ++ L IM EIDLL
Sbjct: 11 KNVTVGN-YNLGVVIGKGGFGTVYQGLDIEDGDFVAIKQINLTKIPKDQLQGIMNEIDLL 69
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
KNLNH NIVKY+ +KT+ +L+I+LEYVENGSL+ IIK KFG FPE+LV VYI QVLEG
Sbjct: 70 KNLNHANIVKYIKYVKTKDNLYIVLEYVENGSLSGIIK--KFGKFPETLVCVYIRQVLEG 127
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI 191
LVYLHEQGV+HRDIKGANILTTKEG +KLADFGVATK D + +VVGTPYWMAPE+I
Sbjct: 128 LVYLHEQGVVHRDIKGANILTTKEGKIKLADFGVATKFD--DTSAAAVVGTPYWMAPEII 185
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFL 251
E++G SDIWSVGCTVIELLT PPYY+L MPALFRIVQD+ PP+PE +SP + D+L
Sbjct: 186 ELNGATTKSDIWSVGCTVIELLTGSPPYYDLGQMPALFRIVQDDCPPLPEGISPPLKDWL 245
Query: 252 RQCFKKDARQRPDAKTLLSHPWIQ 275
QCF+KD R A+ LL H WIQ
Sbjct: 246 MQCFQKDPNLRISAQKLLKHKWIQ 269
|
Serine/threonine-protein kinase involved in the spatial and temporal control system organizing cortical activities in mitotic and postmitotic cells. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5B4Z3|SEPH_EMENI Cytokinesis protein sepH OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) GN=sepH PE=3 SV=2 | Back alignment and function description |
|---|
Score = 364 bits (934), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 182/329 (55%), Positives = 229/329 (69%), Gaps = 18/329 (5%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y LGD +G+GA+G VY+ L+ G+ VA+KQ+ L ++ + +L +IM EIDLLKNL+H NI
Sbjct: 60 YQLGDCLGRGAFGSVYRALNWNTGETVAVKQIKLADLPKSELRVIMLEIDLLKNLDHPNI 119
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
VKY G +K+ L+IILEY ENGSL +I K FG FPE+LV VY++QVL GL+YLH+QG
Sbjct: 120 VKYQGFVKSAETLNIILEYCENGSLHSIAK--NFGRFPETLVGVYMSQVLHGLLYLHDQG 177
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
VIHRDIKGANILTTKEGLVKLADFGVA++ T ++ SVVGTPYWMAPEVIE+SG A
Sbjct: 178 VIHRDIKGANILTTKEGLVKLADFGVASRTT--GLSESSVVGTPYWMAPEVIELSGATTA 235
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
SDIWS+GCTVIELL PPYY LQPMPALFRIV D+ PP+P+ SP + DFL QCF+KD
Sbjct: 236 SDIWSLGCTVIELLEGKPPYYNLQPMPALFRIVNDDHPPLPQGASPAVKDFLMQCFQKDP 295
Query: 260 RQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSEDNQSAGESLSAP 319
R A+ LL HPWI N RR+ +V S + E + Q E+L +P
Sbjct: 296 NLRVSARKLLKHPWIVNARRS-----------DSVVPKKSTEYEEAVKSVQEWNEALRSP 344
Query: 320 KAEAFETGSRKELLSPAATHLSKSDKEHS 348
++ A G+R E +P + L D H+
Sbjct: 345 ESNALRRGTRNENQNPPSLRL---DTRHT 370
|
Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring. Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (taxid: 227321) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2QHV0|SEPH_ASPNC Cytokinesis protein sepH OS=Aspergillus niger (strain CBS 513.88 / FGSC A1513) GN=sepH PE=3 SV=1 | Back alignment and function description |
|---|
Score = 356 bits (913), Expect = 9e-97, Method: Compositional matrix adjust.
Identities = 168/261 (64%), Positives = 203/261 (77%), Gaps = 4/261 (1%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y LGD +GKGA+G VY+ L+ G+ VA+KQ+ L ++ + +L +IM EIDLLKNL+H NI
Sbjct: 59 YQLGDCLGKGAFGSVYRALNWNTGETVAVKQIKLVDLPKSELRVIMLEIDLLKNLDHPNI 118
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
VKY G +K+ L+IILEY ENGSL +I K FG FPE+LV +Y++QVL GL+YLHEQG
Sbjct: 119 VKYQGFVKSAETLNIILEYCENGSLHSIAK--NFGRFPENLVGLYMSQVLHGLLYLHEQG 176
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
VIHRDIKGANILTTKEGLVKLADFGVA++ T ++ SVVGTPYWMAPEVIE+SG A
Sbjct: 177 VIHRDIKGANILTTKEGLVKLADFGVASRTT--GLSESSVVGTPYWMAPEVIELSGATTA 234
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
SDIWS+GCTVIELL PPYY LQPMPALFRIV D+ PP+P+ SP + DFL QCF+KD
Sbjct: 235 SDIWSLGCTVIELLEGKPPYYNLQPMPALFRIVNDDHPPLPQGASPAVKDFLMQCFQKDP 294
Query: 260 RQRPDAKTLLSHPWIQNCRRA 280
R A+ LL HPWI N RR+
Sbjct: 295 NLRVSARKLLKHPWIVNARRS 315
|
Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring. Aspergillus niger (strain CBS 513.88 / FGSC A1513) (taxid: 425011) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0CL79|SEPH_ASPTN Cytokinesis protein sepH OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=sepH PE=3 SV=2 | Back alignment and function description |
|---|
Score = 351 bits (901), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 171/285 (60%), Positives = 212/285 (74%), Gaps = 11/285 (3%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y LGD +GKGA+G VY+ L+ G+ VA+KQ+ L ++ + +L + EIDLLKNL+H NI
Sbjct: 61 YQLGDCLGKGAFGSVYRALNWNTGETVAVKQIKLADLPKSELRL---EIDLLKNLDHPNI 117
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
VKY G +K+ L+IILEY ENGSL +I K FG FPE+LV +Y++QVL GL+YLHEQG
Sbjct: 118 VKYQGFVKSAETLNIILEYCENGSLHSIAK--NFGRFPENLVGLYMSQVLHGLLYLHEQG 175
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
VIHRDIKGANILTTKEGLVKLADFGVA++ T ++ SVVGTPYWMAPEVIE+SG A
Sbjct: 176 VIHRDIKGANILTTKEGLVKLADFGVASRTT--GLSESSVVGTPYWMAPEVIELSGATTA 233
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
SDIWS+GCTVIELL PPYY +QPMPALFRIV D+ PP+P+ SP + DFL QCF+KD
Sbjct: 234 SDIWSLGCTVIELLEGKPPYYNMQPMPALFRIVNDDHPPLPQGASPAVKDFLMQCFQKDP 293
Query: 260 RQRPDAKTLLSHPWIQNCRRA----LQSSLRHSGTMRNVEENGSA 300
R A+ LL HPWI N RR+ +SS + +R+V+E A
Sbjct: 294 NLRVSARKLLKHPWIVNARRSDSVVPKSSTEYEEAVRSVQEWNEA 338
|
Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring. Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P41892|CDC7_SCHPO Cell division control protein 7 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cdc7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (846), Expect = 6e-89, Method: Compositional matrix adjust.
Identities = 157/253 (62%), Positives = 192/253 (75%), Gaps = 4/253 (1%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
LGD +GKGA+G VY+GL+++NG+ VA+K+V L + + DL++I EIDLLKNL+H NIVK
Sbjct: 11 LGDCLGKGAFGAVYRGLNIKNGETVAVKKVKLSKMLKSDLSVIKMEIDLLKNLDHPNIVK 70
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
Y GS +T L IILEY ENGSL +I K FG PE+LVA+Y QVL+GL+YLH QGVI
Sbjct: 71 YRGSYQTNDSLCIILEYCENGSLRSICK--NFGKIPENLVALYTFQVLQGLLYLHNQGVI 128
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASD 201
HRDIKGANILTTK+G +KLADFGVATK+ + HSVVG+PYWMAPEVIE+ G ASD
Sbjct: 129 HRDIKGANILTTKDGTIKLADFGVATKINA--LEDHSVVGSPYWMAPEVIELVGATTASD 186
Query: 202 IWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261
IWSVGCTVIELL PPYY+L P ALFR+V+DE PP+P ++S FL QCF+KD
Sbjct: 187 IWSVGCTVIELLDGNPPYYDLDPTSALFRMVKDEHPPLPSNISSAAKSFLMQCFQKDPNL 246
Query: 262 RPDAKTLLSHPWI 274
R + LL HPW+
Sbjct: 247 RIKTRKLLKHPWV 259
|
Protein kinase essential for cell division. Plays a key role in initiation of septum formation and cytokinesis. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55CA6|Y0146_DICDI Probable serine/threonine-protein kinase DDB_G0270146 OS=Dictyostelium discoideum GN=DDB_G0270146 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 7e-83, Method: Compositional matrix adjust.
Identities = 146/293 (49%), Positives = 202/293 (68%), Gaps = 7/293 (2%)
Query: 1 MSRQTTTSAFHKSKTLDNK----YMLGD-EIGKGAYGRVYKGLDLENGDFVAIKQVSLEN 55
++ +T S F +S K +++ D IGKGA+ V+KGL+ +GDFVAIK+
Sbjct: 53 INNKTDRSHFRESMVASKKTIGAFVISDIAIGKGAFATVFKGLNTLSGDFVAIKRFEKSK 112
Query: 56 IAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGP 115
I+ E + + E D+L+ LNH+NIV+ LG + ++++I LEY+ENGSL+ I+ N FG
Sbjct: 113 ISNEQHSSVSTEFDILQRLNHENIVRILGREENENYIYIFLEYMENGSLSTIL--NNFGT 170
Query: 116 FPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175
FPESL+ Y+ VL+GLVYLH++GVIHRDIK ANIL K G KL+DFG A ++ +
Sbjct: 171 FPESLICNYVENVLKGLVYLHQEGVIHRDIKAANILINKAGEAKLSDFGTAGEIIKESDK 230
Query: 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE 235
+SVVGTPYWMAPEVIE+SG C SDIWS+GCT+IEL T PPY++L P+ A++RI QD+
Sbjct: 231 RYSVVGTPYWMAPEVIEISGHCQVSDIWSLGCTIIELFTSYPPYFDLNPLGAMYRICQDD 290
Query: 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHS 288
RPP+P+ +S ++ +FL +CF K +R AK LLSHPWI R L + R+S
Sbjct: 291 RPPLPDDISSELANFLERCFCKSTEERATAKELLSHPWITKNRTNLINHQRNS 343
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54PX0|Y4251_DICDI Probable serine/threonine-protein kinase DDB_G0284251 OS=Dictyostelium discoideum GN=DDB_G0284251 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 148/291 (50%), Positives = 198/291 (68%), Gaps = 8/291 (2%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL 61
S Q + KS +Y LG++IG+GA+G+V+KGL+ + G+FVAIKQ+ I + L
Sbjct: 18 SSQIMPDSKKKSIVKIGEYTLGEKIGRGAFGQVFKGLNGKTGEFVAIKQIDSNKIDESSL 77
Query: 62 NIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLV 121
+ E+++L L H NIVK LG ++ ++ L+ ILEYVENGSL ++I+ KFGP E L
Sbjct: 78 QSVKGEVEILHKLRHNNIVKVLGVVEVQAQLNFILEYVENGSLRDVIE--KFGPLSEELC 135
Query: 122 AVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181
+Y+ Q+L+GL YLH VIHRDIK +NIL TKEG++KLADFGVA+++ SVVG
Sbjct: 136 IIYLYQMLQGLAYLHSNKVIHRDIKASNILITKEGVIKLADFGVASQIDSESQLRFSVVG 195
Query: 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE 241
TPYWMAPE IE+SG +ASDIWS+G T+IELLT PPYY LQPM A+FRIV D+ PP P
Sbjct: 196 TPYWMAPESIEISGCSSASDIWSLGSTMIELLTGNPPYYTLQPMAAMFRIVSDQHPPFPT 255
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA------LQSSLR 286
+S + D+ +Q FKKD QRP A+ LL HP ++ LQS+L+
Sbjct: 256 DISKEFLDYFQQSFKKDPTQRPTAQELLQHPIFFTLQKVPPTLSELQSTLK 306
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XJ4|Y8901_DICDI Probable serine/threonine-protein kinase DDB_G0278901 OS=Dictyostelium discoideum GN=DDB_G0278901 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 9e-76, Method: Compositional matrix adjust.
Identities = 145/301 (48%), Positives = 199/301 (66%), Gaps = 17/301 (5%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLEN---IAQEDLNIIMQEIDLLKNLNH 76
Y+L D IGKG +G VYKGL G F AIK++ + + E +M EI+LLK L+H
Sbjct: 22 YLLIDIIGKGGFGVVYKGLHKTKGYFSAIKKIKIMKKKKLQSESQISLMAEINLLKVLSH 81
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
NIV+Y + + SH +I++E++ENGSL IIK + G PESLV VYIAQVL GL YLH
Sbjct: 82 HNIVRYYEHIPSSSHSYIVMEFIENGSLEKIIK--RHGLLPESLVTVYIAQVLNGLEYLH 139
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE--ADVNTHSVVGTPYWMAPEVIEMS 194
QGVIHRDIK AN+L + +G +KLADFGVATK+++ +D + GTPYWMAPEVI+M
Sbjct: 140 RQGVIHRDIKAANLLISTDGSIKLADFGVATKVSDLSSDNPDDTFAGTPYWMAPEVIQMQ 199
Query: 195 GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
G+ A D+WS+GCT+IELLT PPY+ L P AL++IVQ++ PPIP +S + DFL C
Sbjct: 200 GISTACDVWSLGCTIIELLTGTPPYFGLAPAAALYKIVQEDHPPIPPGISAALKDFLLNC 259
Query: 255 FKKDARQRPDAKTLLSHPWIQNC----------RRALQSSLRHSGTMRNVEENGSADAEI 304
FKKD R AK LL HPW+++ + A Q L ++ ++++ ++ +++
Sbjct: 260 FKKDENIRSSAKQLLHHPWVKSVQIRNPETQAPKNARQEILSYNAQLQDIIQDNNSNITR 319
Query: 305 P 305
P
Sbjct: 320 P 320
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54QI2|Y9877_DICDI Serine/threonine-protein kinase DDB_G0283821 OS=Dictyostelium discoideum GN=DDB_G0283821 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 5e-71, Method: Compositional matrix adjust.
Identities = 135/260 (51%), Positives = 184/260 (70%), Gaps = 6/260 (2%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+KY +G+ +GKGA+G+V+K L+ E GDF AIKQ+ I+++ L I+QEI LL+ L H
Sbjct: 11 SKYQIGEAVGKGAFGKVFKALNAETGDFCAIKQIEKTIISEKQLPSIIQEIKLLQTLQHP 70
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NIVK++ S +T +L+ LE++E GSLA I K ++G F E L++ Y +QVL+GL YLHE
Sbjct: 71 NIVKFIESYETSRYLYFALEFIEGGSLAKIAK--RYGCFQEPLLSRYFSQVLKGLAYLHE 128
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM--SG 195
+GVIHRDIK NIL TKEG++KLADFG T A +VVGTP+WMAPEVI+M +
Sbjct: 129 KGVIHRDIKSDNILITKEGVIKLADFGSCT--YSAIDRKLTVVGTPFWMAPEVIQMDMNA 186
Query: 196 VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255
A DIWS+GCT++E+LT PPY++L MPA+F +V + PPIP ++S D+ FL CF
Sbjct: 187 RSTACDIWSLGCTLLEMLTGNPPYWDLGTMPAMFAMVNNPHPPIPNNISADLKHFLLACF 246
Query: 256 KKDARQRPDAKTLLSHPWIQ 275
+D +RP A LL HPWI+
Sbjct: 247 VRDINKRPTASQLLEHPWIK 266
|
May play a role in responding to changes in cAMP levels. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (628), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 127/282 (45%), Positives = 186/282 (65%), Gaps = 12/282 (4%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSL------ENIAQEDLNIIMQEIDLLK 72
++ G+ IG GA+GRVY G++L++G+ +AIKQV + + Q + + +E+ LLK
Sbjct: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLK 126
Query: 73 NLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGL 132
NL+H NIV+YLG+++ L+I++E+V GS++++++ KFG FPE ++ +Y Q+L GL
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLE--KFGSFPEPVIIMYTKQLLLGL 184
Query: 133 VYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE-ADVN-THSVVGTPYWMAPEV 190
YLH G++HRDIKGANIL +G ++LADFG + K+ E A VN S+ GTPYWMAPEV
Sbjct: 185 EYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEV 244
Query: 191 IEMSGVCAASDIWSVGCTVIELLTCVPPYYE-LQPMPALFRIVQDE-RPPIPESLSPDIT 248
I +G ++DIWSVGCTVIE+ T PP+ E Q A+ I + + PPIPE LSP+
Sbjct: 245 ILQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAK 304
Query: 249 DFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGT 290
DFL +C K+ R A LL HP++ R+ + R+S T
Sbjct: 305 DFLMKCLHKEPSLRLSATELLQHPFVTGKRQEPYPAYRNSLT 346
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1437 | ||||||
| 359473030 | 1425 | PREDICTED: serine/threonine-protein kina | 0.984 | 0.992 | 0.798 | 0.0 | |
| 297737926 | 1396 | unnamed protein product [Vitis vinifera] | 0.965 | 0.993 | 0.789 | 0.0 | |
| 449508416 | 1422 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.992 | 0.786 | 0.0 | |
| 449461725 | 1402 | PREDICTED: serine/threonine-protein kina | 0.968 | 0.992 | 0.786 | 0.0 | |
| 255559776 | 1354 | cell division control protein 15 , cdc15 | 0.934 | 0.991 | 0.791 | 0.0 | |
| 356540990 | 1392 | PREDICTED: serine/threonine-protein kina | 0.963 | 0.994 | 0.764 | 0.0 | |
| 350536833 | 1401 | MAP3K epsilon protein kinase [Solanum ly | 0.966 | 0.991 | 0.749 | 0.0 | |
| 402169215 | 1395 | protein kinase [Nicotiana benthamiana] | 0.966 | 0.995 | 0.749 | 0.0 | |
| 356544399 | 1380 | PREDICTED: serine/threonine-protein kina | 0.953 | 0.992 | 0.753 | 0.0 | |
| 297834176 | 1365 | MAPKKK7 [Arabidopsis lyrata subsp. lyrat | 0.945 | 0.994 | 0.748 | 0.0 |
| >gi|359473030|ref|XP_002277322.2| PREDICTED: serine/threonine-protein kinase sepA-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 2310 bits (5985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1156/1447 (79%), Positives = 1252/1447 (86%), Gaps = 32/1447 (2%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MSRQ TS FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED
Sbjct: 1 MSRQVATSHFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL
Sbjct: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
VAVYI+QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV
Sbjct: 121 VAVYISQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY+LQPMPALFRIVQD+ PPIP
Sbjct: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDDHPPIP 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA 300
+ LS DITDFLRQCFKKDARQRPDAKTLLSHPWI+NCRRALQSSLRHSGT+RN++E+ S
Sbjct: 241 DGLSTDITDFLRQCFKKDARQRPDAKTLLSHPWIRNCRRALQSSLRHSGTLRNIQEDASV 300
Query: 301 DAEIPSEDNQSAGESLSAPKAEA----FETGSRKELLSPAATHLSKSDKEHSSNGNLAEE 356
DAEI + D+QS GES S KAE FE SRKE L KS + SNG+L E+
Sbjct: 301 DAEISNGDDQSIGESPSDEKAEVIASEFENDSRKECLPTEVVDTGKSYTD--SNGDLIED 358
Query: 357 RVENPEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLI 416
V+NPE+ SDQVPTLAIHE S + T SG LP+NK A + E+ + D+DE L+
Sbjct: 359 EVDNPEEYVQSDQVPTLAIHEKSSLPTTSGILPANKDVAPPSPTDSNEVLDMGDQDEALM 418
Query: 417 NGETQSPESRRKN-LDSKHGGKGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGNELS 475
NG+ SP+SR+ N L K GKG+S +DN+ FGF PR+ NS +KA K GGNELS
Sbjct: 419 NGKVGSPKSRKNNVLYKKSEGKGSSTQLDNRLFGFVPRSQENSSRKAAKAPVISGGNELS 478
Query: 476 RFSDTPGDASLDDLFHPLEKSLEDRAAEASTSASASSSHVNQSHAAVADTGKNDLATKLR 535
+FSDTPGDASL+DLFHPL K+ ED+A A S SASSSHV Q +A + D GKNDLATKLR
Sbjct: 479 KFSDTPGDASLEDLFHPLHKNPEDQA--AEASTSASSSHVVQGNAFINDAGKNDLATKLR 536
Query: 536 ATIAQKQMENEMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFS 595
ATIAQKQMENE+GQTN GDLF LM+ VLK+DV+DIDGLVFD+K+P ENLFPLQAVEFS
Sbjct: 537 ATIAQKQMENEIGQTN---GDLFSLMLDVLKEDVMDIDGLVFDDKMPGENLFPLQAVEFS 593
Query: 596 RLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSI 655
RLVGSLRP E ED IVSAC KLI+IFHQRP QK FVTQHGLLPLMELLE+ +TRVICS+
Sbjct: 594 RLVGSLRPQEPEDVIVSACLKLISIFHQRPEQKGVFVTQHGLLPLMELLEVSRTRVICSV 653
Query: 656 LQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQM 715
LQ++NQI+KDN+DFQENACLVGLIPVVM FAVPD PREVRMEAAYF QQLCQSSSLTLQM
Sbjct: 654 LQIVNQIIKDNTDFQENACLVGLIPVVMSFAVPDHPREVRMEAAYFSQQLCQSSSLTLQM 713
Query: 716 FIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRL 775
FIAC GIPVLVGFLEADY +YREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGIL RL
Sbjct: 714 FIACGGIPVLVGFLEADYVRYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILPRL 773
Query: 776 INTLYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVK 835
INTLYSLNEA RLASI+ G GF +GLA RPRSG LD S PIF Q E LT D D +K
Sbjct: 774 INTLYSLNEAARLASIAGGSGFTIEGLAPRPRSGSLDPSSPIFIQGEISLTGIDHPDLLK 833
Query: 836 VRHGMIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVASKL 895
VRHG+IDH LST TQEPSR S SH QRSD NQ + R+ + D DR ++A+VASKL
Sbjct: 834 VRHGLIDHSLSTATQEPSRVSASHPQRSDANQPDSRYFSLDTDRP-----AMEASVASKL 888
Query: 896 SDSTLLEKNANLATKEPSVAMSKERD-LDRWKFDPSRTEIDLRQQRIASAVNRTSIDKPP 954
D EK AN+ TKE S + KER+ LDRWK DP QR+ ++ NRTS+D+P
Sbjct: 889 QDLAFSEKVANMQTKESSGTILKERENLDRWKIDP---------QRVPNSANRTSVDRPS 939
Query: 955 KSPEGASNGFPTTT-TQSDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLL 1013
K EG SNGFP+T TQ +QVRPLLSLL+KEPPSRHFSGQL+YVRH+ G+ERHESILPLL
Sbjct: 940 KLVEGVSNGFPSTIGTQQEQVRPLLSLLDKEPPSRHFSGQLEYVRHLSGLERHESILPLL 999
Query: 1014 HASNDKKTNGELDFLMAEFAEVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAASMS 1073
HA+N+KKTNGELDFLMAEFAEVSGRGRENGNLDS P++S+KT KK+ L+SNEGAAS S
Sbjct: 1000 HATNEKKTNGELDFLMAEFAEVSGRGRENGNLDSAPRISNKTVNKKI-PLASNEGAASTS 1058
Query: 1074 GIVSQTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQAD 1133
GI SQTASGVLSGSGVLNARPGSATSSGLLSHMVS+LNADVA+EYLEKVADLLLEFAQAD
Sbjct: 1059 GIASQTASGVLSGSGVLNARPGSATSSGLLSHMVSSLNADVAKEYLEKVADLLLEFAQAD 1118
Query: 1134 TTVKSYMCSQSLLSRLFQMFNRIEPPIL---LKCVNHLSTDPNCLENLQRADAIKYLIPN 1190
TTVKSYMCSQSLLSRLFQMFNRIEPPIL LKC+NHLSTDPNCLENLQRADAIKYLIPN
Sbjct: 1119 TTVKSYMCSQSLLSRLFQMFNRIEPPILLKILKCINHLSTDPNCLENLQRADAIKYLIPN 1178
Query: 1191 LDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPL 1250
L+LK+G LV IH EVL+ALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQ+ALPL
Sbjct: 1179 LELKEGPLVFQIHYEVLYALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQHALPL 1238
Query: 1251 LCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLK 1310
LCDMAHASRNSREQLRAH GLDVYL+LLE+E+WSVTALDSIAVCLAHDNDNRKVEQALLK
Sbjct: 1239 LCDMAHASRNSREQLRAHDGLDVYLSLLEDELWSVTALDSIAVCLAHDNDNRKVEQALLK 1298
Query: 1311 KDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIA 1370
KDA+QKLVKFFQ CPE HFVHILEPFLKIITKSSRINTTLA+NGLTPLLIARLDHQDAIA
Sbjct: 1299 KDAIQKLVKFFQCCPEQHFVHILEPFLKIITKSSRINTTLAINGLTPLLIARLDHQDAIA 1358
Query: 1371 RLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKA 1430
RLNLLKLIK+VYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKA
Sbjct: 1359 RLNLLKLIKSVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKA 1418
Query: 1431 LHINTVL 1437
LHINTVL
Sbjct: 1419 LHINTVL 1425
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737926|emb|CBI27127.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 2273 bits (5891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1141/1446 (78%), Positives = 1235/1446 (85%), Gaps = 59/1446 (4%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MSRQ TS FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED
Sbjct: 1 MSRQVATSHFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL
Sbjct: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
VAVYI+QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV
Sbjct: 121 VAVYISQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY+LQPMPALFRIVQD+ PPIP
Sbjct: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDDHPPIP 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA 300
+ LS DITDFLRQCFKKDARQRPDAKTLLSHPWI+NCRRALQSSLRHSGT+RN++E+ S
Sbjct: 241 DGLSTDITDFLRQCFKKDARQRPDAKTLLSHPWIRNCRRALQSSLRHSGTLRNIQEDASV 300
Query: 301 DAEIPSEDNQSAGESLSAPKAEA----FETGSRKELLSPAATHLSKSDKEHSSNGNLAEE 356
DAEI + D+QS GES S KAE FE SRKE L KS + SNG+L E+
Sbjct: 301 DAEISNGDDQSIGESPSDEKAEVIASEFENDSRKECLPTEVVDTGKSYTD--SNGDLIED 358
Query: 357 RVENPEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLI 416
V+NPE+ SDQVPTLAIHE S + T SG LP+NK A + E+ + D+DE L+
Sbjct: 359 EVDNPEEYVQSDQVPTLAIHEKSSLPTTSGILPANKDVAPPSPTDSNEVLDMGDQDEALM 418
Query: 417 NGETQSPESRRKN-LDSKHGGKGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGNELS 475
NG+ SP+SR+ N L K GKG+S +DN+ FGF PR+ NS +KA K GGNELS
Sbjct: 419 NGKVGSPKSRKNNVLYKKSEGKGSSTQLDNRLFGFVPRSQENSSRKAAKAPVISGGNELS 478
Query: 476 RFSDTPGDASLDDLFHPLEKSLEDRAAEASTSASASSSHVNQSHAAVADTGKNDLATKLR 535
+FSDTPGDASL+DLFHPL K+ ED+AA S SASSSHV Q +A + D GKNDLATKLR
Sbjct: 479 KFSDTPGDASLEDLFHPLHKNPEDQAA--EASTSASSSHVVQGNAFINDAGKNDLATKLR 536
Query: 536 ATIAQKQMENEMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFS 595
ATIAQKQMENE+GQTNG DLF LM+ VLK+DV+DIDGLVFD+K+P ENLFPLQAVEFS
Sbjct: 537 ATIAQKQMENEIGQTNG---DLFSLMLDVLKEDVMDIDGLVFDDKMPGENLFPLQAVEFS 593
Query: 596 RLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSI 655
RLVGSLRP E ED IVSAC KLI+IFHQRP QK FVTQHGLLPLMELLE+ +TRVICS+
Sbjct: 594 RLVGSLRPQEPEDVIVSACLKLISIFHQRPEQKGVFVTQHGLLPLMELLEVSRTRVICSV 653
Query: 656 LQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQM 715
LQ++NQI+KDN+DFQENACLVGLIPVVM FAVPD PREVRMEAAYF QQLCQSSSLTLQM
Sbjct: 654 LQIVNQIIKDNTDFQENACLVGLIPVVMSFAVPDHPREVRMEAAYFSQQLCQSSSLTLQM 713
Query: 716 FIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRL 775
FIAC GIPVLVGFLEADY +YREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGIL RL
Sbjct: 714 FIACGGIPVLVGFLEADYVRYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILPRL 773
Query: 776 INTLYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVK 835
INTLYSLNEA RLASI+ G GF +GLA RPRSG LD S PIF Q E LT D D +K
Sbjct: 774 INTLYSLNEAARLASIAGGSGFTIEGLAPRPRSGSLDPSSPIFIQGEISLTGIDHPDLLK 833
Query: 836 VRHGMIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVASKL 895
VRHG+IDH LST TQEPSR S SH QRSD NQ + R+ + D DR
Sbjct: 834 VRHGLIDHSLSTATQEPSRVSASHPQRSDANQPDSRYFSLDTDR---------------- 877
Query: 896 SDSTLLEKNANLATKEPSVAMSKERDLDRWKFDPSRTEIDLRQQRIASAVNRTSIDKPPK 955
P++ S+E +LDRWK DP QR+ ++ NRTS+D+P K
Sbjct: 878 ----------------PAMEASRE-NLDRWKIDP---------QRVPNSANRTSVDRPSK 911
Query: 956 SPEGASNGFPTTT-TQSDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLLH 1014
EG SNGFP+T TQ +QVRPLLSLL+KEPPSRHFSGQL+YVRH+ G+ERHESILPLLH
Sbjct: 912 LVEGVSNGFPSTIGTQQEQVRPLLSLLDKEPPSRHFSGQLEYVRHLSGLERHESILPLLH 971
Query: 1015 ASNDKKTNGELDFLMAEFAEVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAASMSG 1074
A+N+KKTNGELDFLMAEFAEVSGRGRENGNLDS P++S+KT KK+ L+SNEGAAS SG
Sbjct: 972 ATNEKKTNGELDFLMAEFAEVSGRGRENGNLDSAPRISNKTVNKKI-PLASNEGAASTSG 1030
Query: 1075 IVSQTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADT 1134
I SQTASGVLSGSGVLNARPGSATSSGLLSHMVS+LNADVA+EYLEKVADLLLEFAQADT
Sbjct: 1031 IASQTASGVLSGSGVLNARPGSATSSGLLSHMVSSLNADVAKEYLEKVADLLLEFAQADT 1090
Query: 1135 TVKSYMCSQSLLSRLFQMFNRIEPPILLK---CVNHLSTDPNCLENLQRADAIKYLIPNL 1191
TVKSYMCSQSLLSRLFQMFNRIEPPILLK C+NHLSTDPNCLENLQRADAIKYLIPNL
Sbjct: 1091 TVKSYMCSQSLLSRLFQMFNRIEPPILLKILKCINHLSTDPNCLENLQRADAIKYLIPNL 1150
Query: 1192 DLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPLL 1251
+LK+G LV IH EVL+ALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQ+ALPLL
Sbjct: 1151 ELKEGPLVFQIHYEVLYALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQHALPLL 1210
Query: 1252 CDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKK 1311
CDMAHASRNSREQLRAH GLDVYL+LLE+E+WSVTALDSIAVCLAHDNDNRKVEQALLKK
Sbjct: 1211 CDMAHASRNSREQLRAHDGLDVYLSLLEDELWSVTALDSIAVCLAHDNDNRKVEQALLKK 1270
Query: 1312 DAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIAR 1371
DA+QKLVKFFQ CPE HFVHILEPFLKIITKSSRINTTLA+NGLTPLLIARLDHQDAIAR
Sbjct: 1271 DAIQKLVKFFQCCPEQHFVHILEPFLKIITKSSRINTTLAINGLTPLLIARLDHQDAIAR 1330
Query: 1372 LNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKAL 1431
LNLLKLIK+VYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKAL
Sbjct: 1331 LNLLKLIKSVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKAL 1390
Query: 1432 HINTVL 1437
HINTVL
Sbjct: 1391 HINTVL 1396
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449508416|ref|XP_004163307.1| PREDICTED: serine/threonine-protein kinase sepA-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 2267 bits (5874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1138/1447 (78%), Positives = 1240/1447 (85%), Gaps = 35/1447 (2%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MSRQ T+AFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFV IKQVSLENIAQED
Sbjct: 1 MSRQVPTTAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVVIKQVSLENIAQED 60
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
LNIIMQEIDLLKNLNHKNIVKYLGSLKT++HLHIILEYVENGSLANIIKPNKFGPFPESL
Sbjct: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTKTHLHIILEYVENGSLANIIKPNKFGPFPESL 120
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
VAVYI+QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV
Sbjct: 121 VAVYISQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY+LQPMPALFRIVQD+ PPIP
Sbjct: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDKHPPIP 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA 300
+SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRAL SSLRHSGT+RN +++GS
Sbjct: 241 DSLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALHSSLRHSGTLRNSQQDGSI 300
Query: 301 DAEIPSEDNQSAGESLSAPKAEA----FETGSRKELLSPAATHLSKSDKEHSSNGNLAEE 356
+AEI + DNQ++ ES SA K E F+ SRKEL S AT SKS K +S N EE
Sbjct: 301 EAEISNGDNQNSCESPSAEKNEVADSDFKADSRKELSSDVATDASKSQKHFASGPNFVEE 360
Query: 357 RVENPEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLI 416
E+ E++ L DQVPTL+IHE S + T SGRL AT+ ++ E ++ DE+++
Sbjct: 361 G-ESLEEDTLLDQVPTLSIHENSSLLTSSGRL------ATSGPTEFHE-SHGRAHDEVIM 412
Query: 417 NGETQSPESRRKNLDSKHGGKGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGNELSR 476
NGE E RK+ K G + TS + +SFGF P + +NS QK K S +GG+ELS+
Sbjct: 413 NGEVPLTE-LRKDASRKQGEQETSTTSGRRSFGFEPESQDNSFQKVSKMSVALGGDELSK 471
Query: 477 FSDTPGDASLDDLFHPLEKSLEDRAAEASTSASASSSHVNQSHAAVADTGKNDLATKLRA 536
FSDTPGDASLDDLF PL+K D+A ASTS S S N + V D GKNDLATKLRA
Sbjct: 472 FSDTPGDASLDDLFQPLDKHSGDQATGASTSLSILQS--NMGNVPVNDVGKNDLATKLRA 529
Query: 537 TIAQKQMENEMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFSR 596
TIAQKQMENEMGQ +G GGDL RL++GVLKDD IDIDGLVFDEKLP E LFPLQAVEF R
Sbjct: 530 TIAQKQMENEMGQASG-GGDLIRLVMGVLKDDDIDIDGLVFDEKLPGETLFPLQAVEFGR 588
Query: 597 LVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSIL 656
LVGSLRPDE ED IVSACQKLIAIFHQRP QK +VTQHGLLPL ELLE+P+TR+ICS+L
Sbjct: 589 LVGSLRPDEPEDVIVSACQKLIAIFHQRPEQKIVYVTQHGLLPLTELLEVPKTRIICSVL 648
Query: 657 QLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMF 716
QLINQIVKDN DFQENACLVG+IP+VMGFAVPDRPREVRMEAAYF QQLCQSSSLTLQMF
Sbjct: 649 QLINQIVKDNVDFQENACLVGMIPLVMGFAVPDRPREVRMEAAYFFQQLCQSSSLTLQMF 708
Query: 717 IACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLI 776
+ACRGIPVLV FLEADYAKYR+MVHLAIDGMWQ+FKLQRST RN FCRIAAK+GILLRLI
Sbjct: 709 VACRGIPVLVSFLEADYAKYRDMVHLAIDGMWQIFKLQRSTLRNGFCRIAAKSGILLRLI 768
Query: 777 NTLYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVKV 836
NTLYSLNEATRLASI+VG G+P DGL RPRSGQLD SHPIF+Q E + DQ D +KV
Sbjct: 769 NTLYSLNEATRLASITVGAGYPVDGLTPRPRSGQLDPSHPIFSQYEASFPMPDQPDLLKV 828
Query: 837 RHGMIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVASKLS 896
RHG++DH STG EPSRASTSHSQRSD NQS+ R D DR QS N +A + SK S
Sbjct: 829 RHGIVDHHSSTGPPEPSRASTSHSQRSDTNQSDYRHFPMDTDRPQSSNATNEA-LGSKPS 887
Query: 897 DSTLLEKNANLATKEPSVAMSKERD-LDRWKFDPSRTEIDLRQQRIASAVNRTSIDKPPK 955
+ L+K +LA+KEPS + SKE + DRW R +R+A++ NRTS D+PPK
Sbjct: 888 ELASLDKVLHLASKEPSGSASKEHENADRW-----------RTERMANS-NRTSTDRPPK 935
Query: 956 SPEGASNGFPTTT--TQSDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLL 1013
E ASNGF TT+ TQ +QVRPLLSLL+KEPPSRHFSGQL+Y+R + G+ERHE+I+PLL
Sbjct: 936 FVEPASNGFSTTSAATQQEQVRPLLSLLDKEPPSRHFSGQLEYMRQLSGLERHETIMPLL 995
Query: 1014 HASNDKKTNGELDFLMAEFAEVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAASMS 1073
HASN+KK NGE DFLMAEFAEVS RG++N NLD K+S KTA KK+G L SNEGAAS S
Sbjct: 996 HASNEKKINGEPDFLMAEFAEVSQRGKDNANLDPASKVSLKTAAKKVGPLISNEGAASTS 1055
Query: 1074 GIVSQTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQAD 1133
GI SQTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYL KVADLLLEFAQAD
Sbjct: 1056 GIASQTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLAKVADLLLEFAQAD 1115
Query: 1134 TTVKSYMCSQSLLSRLFQMFNRIEPPIL---LKCVNHLSTDPNCLENLQRADAIKYLIPN 1190
TTVKSYMCSQSLL+RLFQMFNR+EP IL LKC+NHLSTDPNCLENLQRADAIKYLIPN
Sbjct: 1116 TTVKSYMCSQSLLNRLFQMFNRVEPSILLKILKCINHLSTDPNCLENLQRADAIKYLIPN 1175
Query: 1191 LDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPL 1250
L+LK+G LVS IH+EVL ALFNLCKINKRRQE AAENGIIPHLMHFI+SDSPLKQYALPL
Sbjct: 1176 LELKEGSLVSQIHTEVLSALFNLCKINKRRQEYAAENGIIPHLMHFIISDSPLKQYALPL 1235
Query: 1251 LCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLK 1310
LCDMAHASRNSREQLRAHGGLDVYL+LLE+++WSVTALDSIAVCLAHDNDNRKVEQALLK
Sbjct: 1236 LCDMAHASRNSREQLRAHGGLDVYLSLLEDDLWSVTALDSIAVCLAHDNDNRKVEQALLK 1295
Query: 1311 KDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIA 1370
KDAVQKLVKFFQ CPE HFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIA
Sbjct: 1296 KDAVQKLVKFFQCCPEQHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIA 1355
Query: 1371 RLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKA 1430
RLNLLKLIKAVYEHHPRPKQLIVENDLP KLQNLIEERRDGQRSGGQVLVKQMATSLLKA
Sbjct: 1356 RLNLLKLIKAVYEHHPRPKQLIVENDLPHKLQNLIEERRDGQRSGGQVLVKQMATSLLKA 1415
Query: 1431 LHINTVL 1437
LHINTVL
Sbjct: 1416 LHINTVL 1422
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449461725|ref|XP_004148592.1| PREDICTED: serine/threonine-protein kinase sepA-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 2232 bits (5784), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1122/1427 (78%), Positives = 1223/1427 (85%), Gaps = 35/1427 (2%)
Query: 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV
Sbjct: 1 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 60
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
KYLGSLKT++HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI+QVLEGLVYLHEQGV
Sbjct: 61 KYLGSLKTKTHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYISQVLEGLVYLHEQGV 120
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS 200
IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS
Sbjct: 121 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS 180
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260
DIWSVGCTVIELLTCVPPYY+LQPMPALFRIVQD+ PPIP+SLSPDITDFLRQCFKKDAR
Sbjct: 181 DIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDKHPPIPDSLSPDITDFLRQCFKKDAR 240
Query: 261 QRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSEDNQSAGESLSAPK 320
QRPDAKTLLSHPWIQNCRRAL SSLRHSGT+RN +++GS +AEI + DNQ++ ES SA K
Sbjct: 241 QRPDAKTLLSHPWIQNCRRALHSSLRHSGTLRNSQQDGSIEAEISNGDNQNSCESPSAEK 300
Query: 321 AEA----FETGSRKELLSPAATHLSKSDKEHSSNGNLAEERVENPEDEPLSDQVPTLAIH 376
E F+ SRKEL S AT SKS K +S N EE E+ E++ L DQVPTL+IH
Sbjct: 301 NEVADSDFKADSRKELSSDVATDASKSQKHFASGPNFVEEG-ESLEEDTLLDQVPTLSIH 359
Query: 377 EMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLINGETQSPESRRKNLDSKHGG 436
E S + T SGRL AT+ ++ E ++ DE+++NGE E RK+ K G
Sbjct: 360 ENSSLLTSSGRL------ATSGPTEFHE-SHGRAHDEVIMNGEVPLTE-LRKDASRKQGE 411
Query: 437 KGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGNELSRFSDTPGDASLDDLFHPLEKS 496
+ TS + +SFGF P + +NS QK K S +GG+ELS+FSDTPGDASLDDLF PL+K
Sbjct: 412 QETSTTSGRRSFGFEPESQDNSFQKVSKMSVALGGDELSKFSDTPGDASLDDLFQPLDKH 471
Query: 497 LEDRAAEASTSASASSSHVNQSHAAVADTGKNDLATKLRATIAQKQMENEMGQTNGSGGD 556
D+A ASTS S S N + V D GKNDLATKLRATIAQKQMENEMGQ +G GGD
Sbjct: 472 SGDQATGASTSLSILQS--NMGNVPVNDVGKNDLATKLRATIAQKQMENEMGQASG-GGD 528
Query: 557 LFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFSRLVGSLRPDESEDAIVSACQK 616
L RL++GVLKDD IDIDGLVFDEKLP E LFPLQAVEF RLVGSLRPDE ED IVSACQK
Sbjct: 529 LIRLVMGVLKDDDIDIDGLVFDEKLPGETLFPLQAVEFGRLVGSLRPDEPEDVIVSACQK 588
Query: 617 LIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSILQLINQIVKDNSDFQENACLV 676
LIAIFHQRP QK +VTQHGLLPL ELLE+P+TR+ICS+LQLINQIVKDN DFQENACLV
Sbjct: 589 LIAIFHQRPEQKIVYVTQHGLLPLTELLEVPKTRIICSVLQLINQIVKDNVDFQENACLV 648
Query: 677 GLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFIACRGIPVLVGFLEADYAKY 736
G+IP+VMGFAVPDRPREVRMEAAYF QQLCQSSSLTLQMF+ACRGIPVLV FLEADYAKY
Sbjct: 649 GMIPLVMGFAVPDRPREVRMEAAYFFQQLCQSSSLTLQMFVACRGIPVLVSFLEADYAKY 708
Query: 737 REMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLINTLYSLNEATRLASISVGGG 796
R+MVHLAIDGMWQ+FKLQRST RN FCRIAAK+GILLRLINTLYSLNEATRLASI+VG G
Sbjct: 709 RDMVHLAIDGMWQIFKLQRSTLRNGFCRIAAKSGILLRLINTLYSLNEATRLASITVGAG 768
Query: 797 FPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVKVRHGMIDHPLSTGTQEPSRAS 856
+P DGL RPRSGQLD SHPIF+Q E + DQ D +KVRHG++DH STG EPSRAS
Sbjct: 769 YPVDGLTPRPRSGQLDPSHPIFSQYEASFPMPDQPDLLKVRHGIVDHHSSTGPPEPSRAS 828
Query: 857 TSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVASKLSDSTLLEKNANLATKEPSVAM 916
TSHSQRSD NQS+ R D DR QS N +A + SK S+ L+K +LA+KEPS +
Sbjct: 829 TSHSQRSDTNQSDYRHFPMDTDRPQSSNATNEA-LGSKPSELASLDKVLHLASKEPSGSA 887
Query: 917 SKERD-LDRWKFDPSRTEIDLRQQRIASAVNRTSIDKPPKSPEGASNGFPTTT--TQSDQ 973
SKE + DRW R +R+A++ NRTS D+PPK E ASNGF TT+ TQ +Q
Sbjct: 888 SKEHENADRW-----------RTERMANS-NRTSTDRPPKFVEPASNGFSTTSAATQQEQ 935
Query: 974 VRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLLHASNDKKTNGELDFLMAEFA 1033
VRPLLSLL+KEPPSRHFSGQL+Y+R + G+ERHE+I+PLLHASN+KK NGE DFLMAEFA
Sbjct: 936 VRPLLSLLDKEPPSRHFSGQLEYMRQLSGLERHETIMPLLHASNEKKINGEPDFLMAEFA 995
Query: 1034 EVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAASMSGIVSQTASGVLSGSGVLNAR 1093
EVS RG++N NLD K+S KTA KK+G L SNEGAAS SGI SQTASGVLSGSGVLNAR
Sbjct: 996 EVSQRGKDNANLDPASKVSLKTAAKKVGPLISNEGAASTSGIASQTASGVLSGSGVLNAR 1055
Query: 1094 PGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMF 1153
PGSATSSGLLSHMVSTLNADVAREYL KVADLLLEFAQADTTVKSYMCSQSLL+RLFQMF
Sbjct: 1056 PGSATSSGLLSHMVSTLNADVAREYLAKVADLLLEFAQADTTVKSYMCSQSLLNRLFQMF 1115
Query: 1154 NRIEPPIL---LKCVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHAL 1210
NR+EP IL LKC+NHLSTDPNCLENLQRADAIKYLIPNL+LK+G LVS IH+EVL AL
Sbjct: 1116 NRVEPSILLKILKCINHLSTDPNCLENLQRADAIKYLIPNLELKEGSLVSQIHTEVLSAL 1175
Query: 1211 FNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPLLCDMAHASRNSREQLRAHGG 1270
FNLCKINKRRQE AAENGIIPHLMHFI+SDSPLKQYALPLLCDMAHASRNSREQLRAHGG
Sbjct: 1176 FNLCKINKRRQEYAAENGIIPHLMHFIISDSPLKQYALPLLCDMAHASRNSREQLRAHGG 1235
Query: 1271 LDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFV 1330
LDVYL+LLE+++WSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQ CPE HFV
Sbjct: 1236 LDVYLSLLEDDLWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQCCPEQHFV 1295
Query: 1331 HILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQ 1390
HILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQ
Sbjct: 1296 HILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQ 1355
Query: 1391 LIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHINTVL 1437
LIVENDLP KLQNLIEERRDGQRSGGQVLVKQMATSLLKALHINTVL
Sbjct: 1356 LIVENDLPHKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHINTVL 1402
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559776|ref|XP_002520907.1| cell division control protein 15 , cdc15, putative [Ricinus communis] gi|223539873|gb|EEF41452.1| cell division control protein 15 , cdc15, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 2211 bits (5729), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1098/1387 (79%), Positives = 1205/1387 (86%), Gaps = 44/1387 (3%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED
Sbjct: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
LNIIMQEIDLLKNLNHKNIVKYLGS KT++HLHIILEYVENGSLANIIKPNKFGPFPESL
Sbjct: 61 LNIIMQEIDLLKNLNHKNIVKYLGSSKTKTHLHIILEYVENGSLANIIKPNKFGPFPESL 120
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV
Sbjct: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY+LQPMPALFRIVQD+ PPIP
Sbjct: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDDHPPIP 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA 300
+SLS DITDFLRQCFKKDARQRPDAKTLLSHPWIQN RRAL +S RH+G++R+++E+GSA
Sbjct: 241 DSLSLDITDFLRQCFKKDARQRPDAKTLLSHPWIQNSRRAL-NSFRHNGSIRSIQEDGSA 299
Query: 301 DAEIPSEDNQSAGESLSAPKAEAF----ETGSRKELLSPAATHLSKSDKEHSSNGNLAEE 356
D+EI + DNQS + S+ KA+ ET SRKELL+ A + KSDK+H SN EE
Sbjct: 300 DSEILNGDNQSTDQIHSSEKADVATADSETDSRKELLNETA--VIKSDKDHFSNCETVEE 357
Query: 357 RVENPEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLI 416
R++ ED+ SDQVPTL+I E + +Q+G RL +NK+ A + + T+ D+DE L
Sbjct: 358 RIDKLEDDLQSDQVPTLSIREKTSLQSGFNRLSANKVIAA--YASVHGSTHLHDQDESLA 415
Query: 417 NGETQSPESRRKNLDSKHGGKGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGNELSR 476
G+ S E+RR ++D KHGGKG+S +N+SFGF PR+ +N +KAVK S +GGNELSR
Sbjct: 416 KGDVDSSEARRISVDRKHGGKGSSAPPENRSFGFLPRSQDNGHEKAVKMSVPLGGNELSR 475
Query: 477 FSDTPGDASLDDLFHPLEKSLEDRAAEASTSASASSSHVNQSHAAVADTGKNDLATKLRA 536
FSD PGDASLDDLFHPL+KSL+DRA EASTSAS SH+N+ +A++ D GKNDLATKLRA
Sbjct: 476 FSDPPGDASLDDLFHPLDKSLDDRATEASTSAS--KSHMNEGNASLTDAGKNDLATKLRA 533
Query: 537 TIAQKQMENEMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFSR 596
TIAQKQME E+GQ NG GDLFRLM+GV+KDDVIDIDGLVFDEKLPAENLFPLQAVEF R
Sbjct: 534 TIAQKQMEGEIGQPNG--GDLFRLMLGVIKDDVIDIDGLVFDEKLPAENLFPLQAVEFGR 591
Query: 597 LVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSIL 656
LVGSLRP+ESED IVSACQKLIAIFHQRP QK FVTQHGLLPL ELLE+P+TRVICS+L
Sbjct: 592 LVGSLRPEESEDVIVSACQKLIAIFHQRPEQKIVFVTQHGLLPLTELLEVPKTRVICSVL 651
Query: 657 QLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMF 716
QLINQIVKDN+DFQENACLVGLIPVVM FA PDRPREVRMEAAYFLQQLCQSS LTLQMF
Sbjct: 652 QLINQIVKDNTDFQENACLVGLIPVVMSFAGPDRPREVRMEAAYFLQQLCQSSPLTLQMF 711
Query: 717 IACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLI 776
IACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLI
Sbjct: 712 IACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLI 771
Query: 777 NTLYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVKV 836
NTLYSLNEATRLASISVG GFP +G +RPRSGQLD SHPI QSE L+ +DQ + +KV
Sbjct: 772 NTLYSLNEATRLASISVGTGFPLEGSIQRPRSGQLDSSHPILVQSEATLSASDQPEILKV 831
Query: 837 RHGMIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVASKLS 896
RHG+++HPLSTG+QEPSRASTSHSQR D Q + R+L TD DR+ S + ++ +VA
Sbjct: 832 RHGVVEHPLSTGSQEPSRASTSHSQRLDPLQPDARYLVTDADRNHSSSVAIETSVA---- 887
Query: 897 DSTLLEKNANLATKEPSVAMSKERDLDRWKFDPSRTEIDLRQQRIASAVNRTSIDKPPKS 956
LEK N+A KE SR EID R QR+ ++NRTS D+PPK
Sbjct: 888 ----LEKAGNIAAKE------------------SRAEIDGRPQRVTGSINRTSTDRPPKL 925
Query: 957 PEGASNGFPTTT-TQSDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLLHA 1015
E ASNG P TQ +QVRPLLSLLEKEPPSRHFSGQL+YVRH+ G+ERHESILPLLHA
Sbjct: 926 IESASNGLPAIMYTQPEQVRPLLSLLEKEPPSRHFSGQLEYVRHISGLERHESILPLLHA 985
Query: 1016 SNDKKTNGELDFLMAEFAEVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAASMSGI 1075
S +KKTNGELDFLMAEFAEV+GRGRENGNLDSTP++SHK KK+G L SN+GAAS SG+
Sbjct: 986 S-EKKTNGELDFLMAEFAEVTGRGRENGNLDSTPRVSHKMVNKKVGALGSNDGAASTSGL 1044
Query: 1076 VSQTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTT 1135
SQT SGVLSGSGVLNARPGSATSSGLLSHMVST+NA+ AR+YLEKVADLLLEF+QADTT
Sbjct: 1045 ASQTTSGVLSGSGVLNARPGSATSSGLLSHMVSTMNAEAARDYLEKVADLLLEFSQADTT 1104
Query: 1136 VKSYMCSQSLLSRLFQMFNRIEPPIL---LKCVNHLSTDPNCLENLQRADAIKYLIPNLD 1192
VKSYMCSQSLLSRLFQMFNRIEPPIL LKC+NHLSTDPNCLENLQRADAIK+LIPNL+
Sbjct: 1105 VKSYMCSQSLLSRLFQMFNRIEPPILLKILKCINHLSTDPNCLENLQRADAIKFLIPNLE 1164
Query: 1193 LKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPLLC 1252
LKDG LV IH EVL+ALFNLCKINKRRQEQAAENGIIPHLM+ IM+DS LKQYALPLLC
Sbjct: 1165 LKDGPLVEQIHHEVLNALFNLCKINKRRQEQAAENGIIPHLMNIIMTDSDLKQYALPLLC 1224
Query: 1253 DMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKKD 1312
DMAHASRNSREQLRAHGGLDVYL+LL++ WSVTALDSIAVCLAHDND+RKVEQALLKKD
Sbjct: 1225 DMAHASRNSREQLRAHGGLDVYLSLLDDVFWSVTALDSIAVCLAHDNDSRKVEQALLKKD 1284
Query: 1313 AVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARL 1372
AVQKLVKFFQSCPE FVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARL
Sbjct: 1285 AVQKLVKFFQSCPEQQFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARL 1344
Query: 1373 NLLKLIK 1379
NLLKLIK
Sbjct: 1345 NLLKLIK 1351
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356540990|ref|XP_003538967.1| PREDICTED: serine/threonine-protein kinase sepA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 2165 bits (5609), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1105/1445 (76%), Positives = 1217/1445 (84%), Gaps = 61/1445 (4%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MSRQTT+SAF KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED
Sbjct: 1 MSRQTTSSAFTKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
LNIIMQEIDLLKNLNHKNIVKYLGS KT+SHLHI+LEYVENGSLANIIKPNKFGPFPESL
Sbjct: 61 LNIIMQEIDLLKNLNHKNIVKYLGSSKTKSHLHIVLEYVENGSLANIIKPNKFGPFPESL 120
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV
Sbjct: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GTPYWMAPEVIEM+GVCAASDIWSVGCTVIELLTCVPPYY+LQPMPALFRIVQDE PPIP
Sbjct: 181 GTPYWMAPEVIEMAGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDEHPPIP 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA 300
+SLSPDITDFL QCFKKDARQRPDAKTLLSHPWIQNCRR LQSSLRHSGT+RN+EE+ SA
Sbjct: 241 DSLSPDITDFLLQCFKKDARQRPDAKTLLSHPWIQNCRRVLQSSLRHSGTLRNIEEDDSA 300
Query: 301 DAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAATHLSKSDKEHSSNGNLAEERVEN 360
DAE+ ++SA E+ S K + S KE + AA SK+ ++++++ N + E+ E
Sbjct: 301 DAEVSGGYHKSAYENSSVEKED-----SAKEHTTMAADG-SKAHEDNAADSNFSNEQTEK 354
Query: 361 PEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLINGET 420
+D P SDQV TLAIHE S +Q GS +L SN+ ++ + EI+N D E+++NGE
Sbjct: 355 ADDAP-SDQVLTLAIHEKSFLQAGSSKLTSNREVVNSESTGNHEISNAKDLHEVVMNGEG 413
Query: 421 QSPESRRKNLDSKHGGKGTSISVDNKSFGFSPR-TDNNSLQKAVKTSATVGGNELSRFSD 479
SP+SR + SK GGK +S++ NKSF F PR DN L+KA+K TV GNELSRFSD
Sbjct: 414 GSPQSR--GMASKVGGKDSSVNNGNKSFAFGPRGQDNGPLKKAMKMPITVEGNELSRFSD 471
Query: 480 TPGDASLDDLFHPLEKSLEDRAAEASTSASASSSHVNQSHAAVADTGKNDLATKLRATIA 539
PGDA LDDLFHPL+K + AEASTS S SH+ + +A+ D KNDLA +LRATIA
Sbjct: 472 PPGDAYLDDLFHPLDKQPGEVVAEASTSTST--SHMTKGNASAIDGVKNDLAKELRATIA 529
Query: 540 QKQM--ENEMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFSRL 597
+KQ E+E+GQ N G L R+MIGVLKDDVIDIDGLVFDEKLP ENLFPLQAVEFS+L
Sbjct: 530 RKQWEKESEIGQANNGGNLLHRVMIGVLKDDVIDIDGLVFDEKLPGENLFPLQAVEFSKL 589
Query: 598 VGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSILQ 657
VGSL+P+ESED IVSACQKLI IFHQRP QK FVTQHGLLPL +LLE+P+TR+ICS+LQ
Sbjct: 590 VGSLKPEESEDMIVSACQKLIGIFHQRPEQKIVFVTQHGLLPLTDLLEVPKTRIICSVLQ 649
Query: 658 LINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFI 717
LINQIVKDN+DFQENACLVGLIP V FAVPDRPRE+RMEAAYFLQQLCQSSSLTLQMFI
Sbjct: 650 LINQIVKDNTDFQENACLVGLIPAVTSFAVPDRPREIRMEAAYFLQQLCQSSSLTLQMFI 709
Query: 718 ACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLIN 777
ACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQ+STPRNDFCRIAAKNGILLRLIN
Sbjct: 710 ACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQQSTPRNDFCRIAAKNGILLRLIN 769
Query: 778 TLYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVKVR 837
TLYSLNE+TRLAS S GGGF DG A+RPRSG LD +HP Q+ET L+ DQ D KVR
Sbjct: 770 TLYSLNESTRLASSSAGGGFSVDGSAQRPRSGILDPNHPYINQNETMLSSVDQQDPPKVR 829
Query: 838 HGMIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVASKLSD 897
+ DH L EP S+S+ +RSD N D DR QS N D
Sbjct: 830 RAVPDHHL-----EP---SSSNPRRSDAN------YPVDVDRPQSSNATAD--------- 866
Query: 898 STLLEKNANLATKEPSVAMSKERD-LDRWKFDPSRTEIDLRQQRIASAVNRTSIDKPPKS 956
EK+ N A++E S KER+ +DRWK DPS Q RI++ NRTS D+PPKS
Sbjct: 867 ----EKSLNQASRESSAGALKERENMDRWKTDPS-------QPRISN--NRTSTDRPPKS 913
Query: 957 PEGASNGFPTT-TTQSDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLLHA 1015
E +SNG T T +QVRPLLSLL+KEPPS FSGQL+Y+R G+ERHES+LPLLHA
Sbjct: 914 TEPSSNGLSVTGTMHQEQVRPLLSLLDKEPPSGRFSGQLEYMRQFSGLERHESVLPLLHA 973
Query: 1016 SNDKKTNGELDFLMAEFAEVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAASMSGI 1075
+ +KKTNGELDFLMAEFA+VS RGRENGNLDS+ ++SHK KK+GTL S+EGAAS SGI
Sbjct: 974 T-EKKTNGELDFLMAEFADVSQRGRENGNLDSSARVSHKVTPKKLGTLGSSEGAASTSGI 1032
Query: 1076 VSQTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTT 1135
SQTASGVLSGSGVLNARPGSATSSGLLSHMVS+LNA+VAREYLEKVADLLLEFAQADTT
Sbjct: 1033 ASQTASGVLSGSGVLNARPGSATSSGLLSHMVSSLNAEVAREYLEKVADLLLEFAQADTT 1092
Query: 1136 VKSYMCSQSLLSRLFQMFNRIEPPILLK---CVNHLSTDPNCLENLQRADAIKYLIPNLD 1192
VKSYMCSQSLLSRLFQMFNR+EPPILLK C+NHLSTDPNCLENLQRA+AIKYLIPNL+
Sbjct: 1093 VKSYMCSQSLLSRLFQMFNRVEPPILLKILRCINHLSTDPNCLENLQRAEAIKYLIPNLE 1152
Query: 1193 LKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPLLC 1252
LK+G LVS IH EVL+ALFNLCKINKRRQEQAAENGIIPHLM FI S+SPLKQYALPLLC
Sbjct: 1153 LKEGSLVSEIHHEVLNALFNLCKINKRRQEQAAENGIIPHLMLFITSNSPLKQYALPLLC 1212
Query: 1253 DMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKKD 1312
DMAHASRNSREQLRAHGGLDVYLNLLE+E+WSVTALDSIAVCLAHDNDNRKVEQALLKKD
Sbjct: 1213 DMAHASRNSREQLRAHGGLDVYLNLLEDELWSVTALDSIAVCLAHDNDNRKVEQALLKKD 1272
Query: 1313 AVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARL 1372
AVQKLVKFFQ CPE HFVHILEPFLKIITKS+RINTTLAVNGLTPLLIARLDHQDAIARL
Sbjct: 1273 AVQKLVKFFQGCPEQHFVHILEPFLKIITKSARINTTLAVNGLTPLLIARLDHQDAIARL 1332
Query: 1373 NLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALH 1432
NLL+LIKAVYEHHP+PK+LIVENDLP+KLQNLI ERRD GQVLVKQMATSLLKALH
Sbjct: 1333 NLLRLIKAVYEHHPQPKKLIVENDLPEKLQNLIGERRD-----GQVLVKQMATSLLKALH 1387
Query: 1433 INTVL 1437
INTVL
Sbjct: 1388 INTVL 1392
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350536833|ref|NP_001234779.1| MAP3K epsilon protein kinase [Solanum lycopersicum] gi|300827400|gb|ADK36642.1| MAPKKKe [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 2129 bits (5517), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1086/1449 (74%), Positives = 1200/1449 (82%), Gaps = 60/1449 (4%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MSRQ +AFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED
Sbjct: 1 MSRQMANAAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
LN+IMQEIDLLKNLNHKNIVKYLGSLKT+SHL IILEYVENGSLANI+KPNKFGPFPESL
Sbjct: 61 LNVIMQEIDLLKNLNHKNIVKYLGSLKTKSHLFIILEYVENGSLANIVKPNKFGPFPESL 120
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
VAVYI+QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV
Sbjct: 121 VAVYISQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC+PPYY+LQPMPALFRIVQD+ PPIP
Sbjct: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCLPPYYDLQPMPALFRIVQDDHPPIP 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA 300
+SLSP ITDFLRQCFKKDARQRPDAKTLLSHPWIQN RRALQSSLRHSGT+R++EE+GSA
Sbjct: 241 DSLSPAITDFLRQCFKKDARQRPDAKTLLSHPWIQNSRRALQSSLRHSGTIRDIEEDGSA 300
Query: 301 DAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAATHLSKSDKEHSSNGNLAEERVEN 360
E +E+++ A S S+ KA+ T L SP SKS++ ++ E R +
Sbjct: 301 IREASNEEDKGAAGSSSSDKAKESST----TLASPEVLETSKSEEVDGASSIRIEGRTDK 356
Query: 361 PEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLINGET 420
ED+ +SD VPTLAIHE S +Q + L A N +S LQ T+ S+ D++ NGE
Sbjct: 357 IEDQFMSDPVPTLAIHEKSPIQNNTDGL------AVNKESALQSSTDLSEPDKVFANGEL 410
Query: 421 QSPESRRKNL------DSKHG--GKGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGN 472
+S ESR +N D HG S S K+ +SPR KAVKTS GN
Sbjct: 411 ESSESRGRNTVGRKVEDKGHGVNAYSASSSSGQKNTDYSPR-------KAVKTSVVPQGN 463
Query: 473 ELSRFSDTPGDASLDDLFHPLEKSLEDRAAEASTSASASSSHVNQSHAAVADTGKNDLAT 532
ELSRFSD PGDASLDDLFHPLEK+LE+RAAE S SASSS + Q++ A+A+TGKNDLAT
Sbjct: 464 ELSRFSDPPGDASLDDLFHPLEKNLENRAAEVSL--SASSSQIAQNN-AIAETGKNDLAT 520
Query: 533 KLRATIAQKQMENEMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAV 592
KLRATIA+KQME+E G N GGDL +M+GVLK+DVID+DGL FD+KLP ENLF LQAV
Sbjct: 521 KLRATIAKKQMESESGPPN--GGDLLSIMMGVLKEDVIDMDGLGFDDKLPTENLFHLQAV 578
Query: 593 EFSRLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVI 652
EFS+LV SLR DESED IVSACQKLIA FHQRP QK FVTQHGLLPLMELLE+P+TRV+
Sbjct: 579 EFSKLVSSLRTDESEDVIVSACQKLIAFFHQRPDQKLVFVTQHGLLPLMELLEVPKTRVM 638
Query: 653 CSILQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLT 712
CS+LQ++N IV+DN+D QENACLVGLIPVVM FA PDRPRE+RMEAAYF QQLCQSS LT
Sbjct: 639 CSVLQVLNLIVQDNTDSQENACLVGLIPVVMSFAAPDRPREIRMEAAYFFQQLCQSSPLT 698
Query: 713 LQMFIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGIL 772
LQMFIA RGIPVLVGFLEADY KYREMVH+AIDGMWQVFKLQRST RNDFCRIAAKNGIL
Sbjct: 699 LQMFIANRGIPVLVGFLEADYTKYREMVHMAIDGMWQVFKLQRSTSRNDFCRIAAKNGIL 758
Query: 773 LRLINTLYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQAD 832
LRLINTLYSLNEA RLAS S GGGFP DGLA RPRSG LD + F Q+E P TDQ D
Sbjct: 759 LRLINTLYSLNEAARLASASGGGGFPPDGLAPRPRSGPLDHGNSSFMQTEVPPYGTDQPD 818
Query: 833 GVKVRHGMIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVA 892
+K+++G D L +G QEPSR S SHS S F D +R +S N ++A+
Sbjct: 819 MLKIKNG--DRVLPSGMQEPSRNSASHSPDSP-------FFRQDGERPRSSNATMEASGL 869
Query: 893 SKLSDSTLLEKNANLATKEPSVAMSKERDLDRWKFDPSRTEIDLRQQRIASAVNRTSIDK 952
S+L D NL TK+ LDR+K D R EIDLRQQR +R S DK
Sbjct: 870 SRLPD-------GNLVTKD-------RESLDRYKNDLFRAEIDLRQQR-GGNTSRISTDK 914
Query: 953 PPKSPEGASNGFP-TTTTQSDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILP 1011
K EGAS GFP +T +Q + VRPLLSLLEKEPPSRHFSGQL+Y ++PG+E+HESILP
Sbjct: 915 GSKQMEGASYGFPASTASQQENVRPLLSLLEKEPPSRHFSGQLEY-HNLPGLEKHESILP 973
Query: 1012 LLHASNDKKTNGELDFLMAEFAEVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAAS 1071
LLHASN+KKTNG LDFLMAEFAEVSGRGREN NL+S P+ HK ATKK+G +S +G AS
Sbjct: 974 LLHASNEKKTNG-LDFLMAEFAEVSGRGRENTNLESLPRSPHKAATKKVGGAASTDGIAS 1032
Query: 1072 MSGIVSQTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQ 1131
SG SQTASGVLSGSGVLNARPGSA SSG+LSH+ NADVAREYLEKVADLLLEFA
Sbjct: 1033 TSGFASQTASGVLSGSGVLNARPGSAASSGILSHVAPPWNADVAREYLEKVADLLLEFAA 1092
Query: 1132 ADTTVKSYMCSQSLLSRLFQMFNRIEPPI---LLKCVNHLSTDPNCLENLQRADAIKYLI 1188
ADTTVKS+MCSQSLLSRLFQMFN+IEPPI LLKC+NHLSTDP+CLE+LQRADAIKYLI
Sbjct: 1093 ADTTVKSFMCSQSLLSRLFQMFNKIEPPILLKLLKCINHLSTDPHCLEHLQRADAIKYLI 1152
Query: 1189 PNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYAL 1248
PNLDLK+G LVS IH EVL+ALFNLCKINKRRQEQAAENGIIPHLMHFIM+ SPLKQYAL
Sbjct: 1153 PNLDLKEGPLVSQIHHEVLNALFNLCKINKRRQEQAAENGIIPHLMHFIMTSSPLKQYAL 1212
Query: 1249 PLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQAL 1308
PLLCDMAHASRNSREQLRAHGGLDVYL+LLE+E+WSVTALDSIAVCLAHDN++RKVEQAL
Sbjct: 1213 PLLCDMAHASRNSREQLRAHGGLDVYLSLLEDELWSVTALDSIAVCLAHDNESRKVEQAL 1272
Query: 1309 LKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDA 1368
LKKDA+QK+VKFF+ CPE HF+HILEPFLKIITKSSRINTTLAVNGLTPLL++RLDH+DA
Sbjct: 1273 LKKDAIQKMVKFFECCPEQHFLHILEPFLKIITKSSRINTTLAVNGLTPLLVSRLDHRDA 1332
Query: 1369 IARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLL 1428
IARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQ SGGQVLVKQMATSLL
Sbjct: 1333 IARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQTSGGQVLVKQMATSLL 1392
Query: 1429 KALHINTVL 1437
KALHINTVL
Sbjct: 1393 KALHINTVL 1401
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|402169215|dbj|BAM36969.1| protein kinase [Nicotiana benthamiana] | Back alignment and taxonomy information |
|---|
Score = 2127 bits (5512), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1082/1443 (74%), Positives = 1210/1443 (83%), Gaps = 54/1443 (3%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MSRQ SAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED
Sbjct: 1 MSRQMANSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
LN+IMQEIDLLKNLNHKNIVKYLGSLKT++HL IILEYVENGSLANI+KPNKFGPFPESL
Sbjct: 61 LNVIMQEIDLLKNLNHKNIVKYLGSLKTKTHLFIILEYVENGSLANIVKPNKFGPFPESL 120
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
VAVYI+QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV
Sbjct: 121 VAVYISQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY+LQPMPALFRIVQD+ PPIP
Sbjct: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDDHPPIP 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA 300
+SLSP ITDFLRQCFKKDARQRPDAKTLLSHPWIQN RRALQSSLRHSGT+RN+EE+GSA
Sbjct: 241 DSLSPAITDFLRQCFKKDARQRPDAKTLLSHPWIQNSRRALQSSLRHSGTLRNIEEDGSA 300
Query: 301 DAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAATHLSKSDKEHSSNGNLAEERVEN 360
D + +ED++ A S S+ KA+ S L SP + +SKS++ S + E R +N
Sbjct: 301 DTDASNEDDKGAAGSSSSDKAKE----SCSVLASPEVSEISKSEEFDGSTSSHLEGRTDN 356
Query: 361 PEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLINGET 420
ED+ SDQVPTLAIHE SL+Q+ + L A N++S LQ T+ + +++L NGE
Sbjct: 357 IEDQFTSDQVPTLAIHEKSLIQSCADGL------AVNNESTLQSSTDLVEPEKVLANGEL 410
Query: 421 QSPESR-RKNLDSKHGGKGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGNELSRFSD 479
+S +S+ N+ K +G I+ + S + ++S +KAVKTS GNELSRFSD
Sbjct: 411 ESSQSKGGNNVGKKVEEQGRGINAYSASSSSGQKNPDHSPRKAVKTSVVPRGNELSRFSD 470
Query: 480 TPGDASLDDLFHPLEKSLEDRAAEASTSASASSSHVNQSHAAVADTGKNDLATKLRATIA 539
PGDASLDDLFHPLEK+LE+RAAE S S+SSS + QS+ AV++TGKNDLATKLRATIA
Sbjct: 471 PPGDASLDDLFHPLEKNLENRAAE--VSLSSSSSQIAQSN-AVSETGKNDLATKLRATIA 527
Query: 540 QKQMENEMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFSRLVG 599
+KQME+E G N GGDL +M+GVLK+DVID+DGL FD+KLP ENLF LQAVEFS+LV
Sbjct: 528 KKQMESESGPAN--GGDLLSIMMGVLKEDVIDMDGLGFDDKLPTENLFHLQAVEFSKLVS 585
Query: 600 SLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSILQLI 659
SLR DESED IVSACQKLIA FHQRP QK FVTQHGLLPLMELLE+P+TRVICS+LQ++
Sbjct: 586 SLRTDESEDVIVSACQKLIAFFHQRPDQKLVFVTQHGLLPLMELLEVPKTRVICSVLQVL 645
Query: 660 NQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFIAC 719
N IV+DN+D QENACLVGLIPVVM F+ PDRPRE+RMEAA F QQLCQSSSLTLQMFIA
Sbjct: 646 NLIVQDNTDSQENACLVGLIPVVMSFSAPDRPREIRMEAACFFQQLCQSSSLTLQMFIAN 705
Query: 720 RGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLINTL 779
RGIPVLVGFLEADYAKYREMVH+AIDGMWQVFKLQRSTPRNDFCRIAA NGILLRLINTL
Sbjct: 706 RGIPVLVGFLEADYAKYREMVHMAIDGMWQVFKLQRSTPRNDFCRIAATNGILLRLINTL 765
Query: 780 YSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVKVRHG 839
YSLNEA RLA S GGGFP DGLA RPRSG LD + F Q+E P TDQ D +K+++G
Sbjct: 766 YSLNEAARLAFASGGGGFPPDGLASRPRSGPLDPGNSSFMQTEMPPYGTDQPDMLKIKNG 825
Query: 840 MIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVASKLSDST 899
+ L G QEPSR S SHS S F D +R +S N ++A+ S+L D T
Sbjct: 826 --ERVLPAGMQEPSRTSASHSPDSP-------FFRQDFERLRSSNATVEASGPSRLPDGT 876
Query: 900 LLEKNANLATKEPSVAMSKERD-LDRWKFDPSRTEIDLRQQRIASAVNRTSIDKPPKSPE 958
++S++R+ LDR+K D SR EID RQQR + +R S D+
Sbjct: 877 ---------------SVSRDRESLDRYKNDLSRAEIDFRQQR-GGSTSRISTDR------ 914
Query: 959 GASNGFP-TTTTQSDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLLHASN 1017
AS GFP +T T + VRPLLSLLEKEPPSRHFSGQL+YV ++PG+E+HESILPLLHASN
Sbjct: 915 -ASYGFPASTATPQENVRPLLSLLEKEPPSRHFSGQLEYVHNLPGLEKHESILPLLHASN 973
Query: 1018 DKKTNGELDFLMAEFAEVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAASMSGIVS 1077
+KKTNG LDFLMAEFAEVSGRGREN NL+S P+ HK ATKK+G +S +G AS SG+ S
Sbjct: 974 EKKTNG-LDFLMAEFAEVSGRGRENTNLESLPRSPHKAATKKVGGAASTDGIASTSGLAS 1032
Query: 1078 QTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVK 1137
QTASGVLSGSGVLNARPGSA SSG+LSHMVS NAD AREYLEKVADLLLEF+ ADTTVK
Sbjct: 1033 QTASGVLSGSGVLNARPGSAASSGILSHMVSPWNADAAREYLEKVADLLLEFSAADTTVK 1092
Query: 1138 SYMCSQSLLSRLFQMFNRIEPPI---LLKCVNHLSTDPNCLENLQRADAIKYLIPNLDLK 1194
S+MCSQSLLSRLFQMFN+IEPPI LLKC+NHLSTDP+CLE+LQRADAIKYLIPNLDLK
Sbjct: 1093 SFMCSQSLLSRLFQMFNKIEPPILLKLLKCINHLSTDPHCLEHLQRADAIKYLIPNLDLK 1152
Query: 1195 DGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPLLCDM 1254
+G LVS IH EVLHALFNLCKINKRRQEQAAENGIIPHLMHFIM+ SPLKQYALPLLCDM
Sbjct: 1153 EGPLVSQIHHEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMTSSPLKQYALPLLCDM 1212
Query: 1255 AHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKKDAV 1314
AHASRNSREQLRAHGGLDVYL+LLE+++WSVTALDSIAVCLAHDN++RKVEQALLKKDA+
Sbjct: 1213 AHASRNSREQLRAHGGLDVYLSLLEDDLWSVTALDSIAVCLAHDNESRKVEQALLKKDAI 1272
Query: 1315 QKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNL 1374
QK+VKFF+ CPE HF+HILEPFLKIITKSSRINTTLAVNGLTPLL++RLDH+DAIARLNL
Sbjct: 1273 QKMVKFFECCPEQHFLHILEPFLKIITKSSRINTTLAVNGLTPLLVSRLDHRDAIARLNL 1332
Query: 1375 LKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHIN 1434
LKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQ SGGQVLVKQMATSLLKALHIN
Sbjct: 1333 LKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQSSGGQVLVKQMATSLLKALHIN 1392
Query: 1435 TVL 1437
TVL
Sbjct: 1393 TVL 1395
|
Source: Nicotiana benthamiana Species: Nicotiana benthamiana Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356544399|ref|XP_003540639.1| PREDICTED: serine/threonine-protein kinase sepA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 2123 bits (5500), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1090/1447 (75%), Positives = 1196/1447 (82%), Gaps = 77/1447 (5%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MSRQTT+SAF KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED
Sbjct: 1 MSRQTTSSAFTKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
LNIIMQEIDLLKNLNHKNIVKYLGS KT+SHLHI+LEYVENGSLAN IKPNKFGPFPESL
Sbjct: 61 LNIIMQEIDLLKNLNHKNIVKYLGSSKTKSHLHIVLEYVENGSLANNIKPNKFGPFPESL 120
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
VA+YIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV
Sbjct: 121 VALYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GTPYWMAPEVIEM+GVCAASDIWSVGCTVIELLTCVPPYY+LQPMPALFRIVQDE PPIP
Sbjct: 181 GTPYWMAPEVIEMAGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDEHPPIP 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA 300
+SLSPDITDFL QCFKKDARQRPDAKTLLSHPWIQN RRALQSSLRHSGT+RN+E++ SA
Sbjct: 241 DSLSPDITDFLLQCFKKDARQRPDAKTLLSHPWIQNFRRALQSSLRHSGTLRNIEDD-SA 299
Query: 301 DAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAATHLSKSDKEHSS---NGNLAEER 357
DAE+ ++SA E+ S K E S KEH+S +G+ A E
Sbjct: 300 DAEVSGGYHKSAYENSSVEKEE--------------------SAKEHTSVAADGSKAHE- 338
Query: 358 VENPEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLIN 417
+N D+ DQV TLAI E S +Q GS R N + N EI+N D E++ N
Sbjct: 339 -DNAADDVPPDQVLTLAIREKSFLQAGSNREVVNSESTGN-----HEISNAKDLHEVVKN 392
Query: 418 GETQSPESRRKNLDSKHGGKGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGNELSRF 477
GE SP+SR + +K GGK S++ NKSF F PR +N KA+K TV GNELSRF
Sbjct: 393 GEVGSPQSR--GMANKFGGKDNSVNNGNKSFAFGPRGQDNDFLKAMKMPTTVEGNELSRF 450
Query: 478 SDTPGDASLDDLFHPLEKSLEDRAAEASTSASASSSHVNQSHAAVADTGKNDLATKLRAT 537
SD PGDA LDDLFHPL+K + AEASTS S SH+ + +A+ D GKNDLA +LRAT
Sbjct: 451 SDPPGDAYLDDLFHPLDKQPGEVVAEASTSTST--SHMTKGYASAIDGGKNDLAKELRAT 508
Query: 538 IAQKQM--ENEMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFS 595
IA+KQ E E+GQ N G L R+MIGVLKD+VIDIDGLVFDEKLP ENLFPLQAVEFS
Sbjct: 509 IARKQWEKETEIGQANNGGNLLHRVMIGVLKDEVIDIDGLVFDEKLPGENLFPLQAVEFS 568
Query: 596 RLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSI 655
+LV SL+P+ESED IVSACQKLI IFHQRP QK FVTQHGLLPL +LLE+P+T VICS+
Sbjct: 569 KLVSSLKPEESEDVIVSACQKLIGIFHQRPEQKIVFVTQHGLLPLTDLLEVPKTHVICSV 628
Query: 656 LQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQM 715
LQLINQIVKDN+DF ENACLVGLIP V FAVPDRPRE+RMEAAYFLQQLCQSSSLTLQM
Sbjct: 629 LQLINQIVKDNTDFLENACLVGLIPAVTSFAVPDRPREIRMEAAYFLQQLCQSSSLTLQM 688
Query: 716 FIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRL 775
FIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQ+STPRNDFCRIAAKNGILLRL
Sbjct: 689 FIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQQSTPRNDFCRIAAKNGILLRL 748
Query: 776 INTLYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVK 835
INTLYSLNE+TRLAS S G GF DG A+RPRSG LD +HP Q+ET L+ DQ + K
Sbjct: 749 INTLYSLNESTRLASSSAGDGFSVDGSAQRPRSGILDPNHPSINQNETVLSSVDQQEPPK 808
Query: 836 VRHGMIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVASKL 895
VRH + DH L EP S+S+ +RSD N D DR QS N D
Sbjct: 809 VRHAVPDHHL-----EP---SSSNPRRSDAN------YPVDVDRPQSSNATAD------- 847
Query: 896 SDSTLLEKNANLATKEPSVAMSKER-DLDRWKFDPSRTEIDLRQQRIASAVNRTSIDKPP 954
EK++ ++E S + KER ++DRWK DPSR +++ RQ I++ NRTS D+ P
Sbjct: 848 ------EKSSTQTSRESSASALKERGNMDRWKTDPSRADVESRQPCIST--NRTSTDRLP 899
Query: 955 KSPEGASNGFPTT-TTQSDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLL 1013
KS E +SNG T T +QVRPLLSLL+KEPPS FSGQL+YVR G+ERHES+LPLL
Sbjct: 900 KSTEPSSNGLSVTGATHQEQVRPLLSLLDKEPPSGRFSGQLEYVRQFSGLERHESVLPLL 959
Query: 1014 HASNDKKTNGELDFLMAEFAEVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAASMS 1073
HA+ +KKTNGELDFLMAEFA+VS RGRENGN DS+ ++SHK KK+G L S+EGAAS S
Sbjct: 960 HAT-EKKTNGELDFLMAEFADVSQRGRENGNFDSSARVSHKVTPKKLGALGSSEGAASTS 1018
Query: 1074 GIVSQTASGVLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQAD 1133
GI SQTASGVLSGSGVLNARPGSATSSGLLSHMVS+LNA+VAREYLEKVADLLLEFAQAD
Sbjct: 1019 GIASQTASGVLSGSGVLNARPGSATSSGLLSHMVSSLNAEVAREYLEKVADLLLEFAQAD 1078
Query: 1134 TTVKSYMCSQSLLSRLFQMFNRIEPPIL---LKCVNHLSTDPNCLENLQRADAIKYLIPN 1190
TTVKSYMCSQSLLSRLFQMFNR+EPPIL LKC+NHLSTDPNCLENLQRA+AIKYLIPN
Sbjct: 1079 TTVKSYMCSQSLLSRLFQMFNRVEPPILLKILKCINHLSTDPNCLENLQRAEAIKYLIPN 1138
Query: 1191 LDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPL 1250
L+LK+G LVS IH EVL+ALFNLCKINKRRQEQAAENGIIPHLM FI S+SPLKQYALPL
Sbjct: 1139 LELKEGSLVSEIHHEVLNALFNLCKINKRRQEQAAENGIIPHLMQFITSNSPLKQYALPL 1198
Query: 1251 LCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLK 1310
LCDMAHASRNSREQLRAHGGLDVYLNLLE+E+WSVTALDSIAVCLAHDNDNRKVEQALLK
Sbjct: 1199 LCDMAHASRNSREQLRAHGGLDVYLNLLEDELWSVTALDSIAVCLAHDNDNRKVEQALLK 1258
Query: 1311 KDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIA 1370
KDAVQKLVKFFQ CPE HFVHILEPFLKIITKS+RINTTLAVNGLTPLLIARLDHQDAIA
Sbjct: 1259 KDAVQKLVKFFQGCPEQHFVHILEPFLKIITKSARINTTLAVNGLTPLLIARLDHQDAIA 1318
Query: 1371 RLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKA 1430
RLNLL+LIKAVYEHHP+PK+LIVENDLP+KLQNLI ERRD GQVLVKQMATSLLKA
Sbjct: 1319 RLNLLRLIKAVYEHHPQPKKLIVENDLPEKLQNLIGERRD-----GQVLVKQMATSLLKA 1373
Query: 1431 LHINTVL 1437
LHINTVL
Sbjct: 1374 LHINTVL 1380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297834176|ref|XP_002884970.1| MAPKKK7 [Arabidopsis lyrata subsp. lyrata] gi|297330810|gb|EFH61229.1| MAPKKK7 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 2113 bits (5476), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1076/1438 (74%), Positives = 1187/1438 (82%), Gaps = 80/1438 (5%)
Query: 6 TTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIM 65
T+S FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI QEDLN IM
Sbjct: 2 TSSQFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIVQEDLNTIM 61
Query: 66 QEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI 125
QEIDLLKNLNHKNIVKYLGS KT++HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI
Sbjct: 62 QEIDLLKNLNHKNIVKYLGSSKTKTHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI 121
Query: 126 AQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYW 185
AQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL EADVNTHSVVGTPYW
Sbjct: 122 AQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLNEADVNTHSVVGTPYW 181
Query: 186 MAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSP 245
MAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY+LQPMPALFRIVQD+ PPIP+SLSP
Sbjct: 182 MAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDDNPPIPDSLSP 241
Query: 246 DITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIP 305
DITDFLRQCFKKD+RQRPDAKTLLSHPWI+N RRALQSSLRHSGT++ ++E +A +E
Sbjct: 242 DITDFLRQCFKKDSRQRPDAKTLLSHPWIRNSRRALQSSLRHSGTIKYMKE-ATASSEKD 300
Query: 306 SEDNQSAGESLSAPKAEAFETGSRKELLSPAATHLSKSDKEHSSNGNLAEERVENPEDEP 365
E +Q A ESLSA ++ S+ +L + +S+K+ S+ +L EE +N ED+
Sbjct: 301 DEGSQDAAESLSAENVGMSKSDSKSKLPLLGVSSF-RSEKDQSTPSDLGEEGTDNSEDDI 359
Query: 366 LSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLINGETQSPES 425
+SDQVPTL+IHE S G+ P + + E S++ E N ET++ E+
Sbjct: 360 MSDQVPTLSIHEKSSDAKGT---PED----------VSEFHGKSERVETRENLETETSEA 406
Query: 426 RRKNLDSKHGGKGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGNELSRFSDTPGDAS 485
R+ K GK SI VD S F + + ++KAVKT ++V GNEL+RFSD PGDAS
Sbjct: 407 RKNTSAKKQVGKELSIPVDQTSHSFGQKGEERGIRKAVKTPSSVSGNELARFSDPPGDAS 466
Query: 486 LDDLFHPLEKSLEDRAAEASTSASASSSHVNQSHAAVADTGKNDLATKLRATIAQKQMEN 545
L DLFHPL+K E + EAST S +S+VNQ + VAD GKNDLATKLRATIAQKQME
Sbjct: 467 LHDLFHPLDKVSEGKPNEAST--SMPTSNVNQGDSPVADGGKNDLATKLRATIAQKQMEG 524
Query: 546 EMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFSRLVGSLRPDE 605
E G +N GGDLFRLM+GVLKDDVIDIDGLVFDEK+PAENLFPLQAVEFSRLV SLRPDE
Sbjct: 525 ETGHSN-DGGDLFRLMMGVLKDDVIDIDGLVFDEKVPAENLFPLQAVEFSRLVSSLRPDE 583
Query: 606 SEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSILQLINQIVKD 665
SEDAIVS+CQKL+A+F QRP QK FVTQHG LPLM+LL++P++RVIC++LQLIN+I+KD
Sbjct: 584 SEDAIVSSCQKLVAMFRQRPEQKAVFVTQHGFLPLMDLLDIPKSRVICTVLQLINEIIKD 643
Query: 666 NSDFQENACLVGLIPVVMGFAVP--DRPREVRMEAAYFLQQLCQSSSLTLQMFIACRGIP 723
N+DFQENACLVGLIPVVM FA P DR RE+R EAAYFLQQLCQS LTLQMFIACRGIP
Sbjct: 644 NTDFQENACLVGLIPVVMSFAGPERDRSREIRKEAAYFLQQLCQSRILTLQMFIACRGIP 703
Query: 724 VLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLINTLYSLN 783
VLVGFLEADYAKYREMVHLAIDGMWQVFKL+RSTPRNDFCRIAAKNGILLRLINTLYSLN
Sbjct: 704 VLVGFLEADYAKYREMVHLAIDGMWQVFKLKRSTPRNDFCRIAAKNGILLRLINTLYSLN 763
Query: 784 EATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVKVRHGMIDH 843
EATRLASIS GG DG A R RSGQLD ++PIF Q+ET L++ DQ D +K RHG+
Sbjct: 764 EATRLASIS--GGAIVDGQAPRARSGQLDPNNPIFGQNETSLSMIDQPDVLKTRHGV--- 818
Query: 844 PLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDATVASKLSDSTLLEK 903
+EPS ASTS+SQRSDV+Q P L D DR + + DA+
Sbjct: 819 -----GEEPSHASTSNSQRSDVHQ--PDALHPDGDRPRVSSVAPDAST------------ 859
Query: 904 NANLATKEPSVAMSKERDLDRWKFDPSRTEIDLRQQ-RIASAVNRTSIDKPPKSPEGASN 962
S TE D+RQQ RI+ + NRTS DK K EG SN
Sbjct: 860 --------------------------SGTE-DIRQQHRISLSANRTSTDKLQKLAEGTSN 892
Query: 963 GFPTTTTQSDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLLHASNDKKTN 1022
GFP +Q++QVRPLLSLLEKEPPSRH+SGQLDYV+H+ G+ERHES LPLLH SN+KK N
Sbjct: 893 GFP--VSQTEQVRPLLSLLEKEPPSRHYSGQLDYVKHITGIERHESRLPLLHGSNEKKNN 950
Query: 1023 GELDFLMAEFAEVSGRGRENGNLDSTPKLSHKTATKKMGTLSSNEGAASMSGIVSQTASG 1082
G+LDFLMAEFAEVSGRG+ENGNLD+T + KT TKK+ + EG AS SGI SQTASG
Sbjct: 951 GDLDFLMAEFAEVSGRGKENGNLDTTTRYPSKTMTKKVLAI---EGVASTSGIASQTASG 1007
Query: 1083 VLSGSGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCS 1142
VLSGSGVLNARPGSATSSGLL+HMVSTL+ADVAREYLEKVADLLLEFA+ADTTVKSYMCS
Sbjct: 1008 VLSGSGVLNARPGSATSSGLLAHMVSTLSADVAREYLEKVADLLLEFARADTTVKSYMCS 1067
Query: 1143 QSLLSRLFQMFNRIEPPILLK---CVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLV 1199
QSLLSRLFQMFNR+EPPILLK C NHLSTDPNCLENLQRADAIK+LIPNL+LKDGHLV
Sbjct: 1068 QSLLSRLFQMFNRVEPPILLKILECTNHLSTDPNCLENLQRADAIKHLIPNLELKDGHLV 1127
Query: 1200 SLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPLLCDMAHASR 1259
IH EVL ALFNLCKINKRRQEQAAENGIIPHLM FIMSDSPLKQYALPLLCDMAHASR
Sbjct: 1128 YQIHHEVLSALFNLCKINKRRQEQAAENGIIPHLMLFIMSDSPLKQYALPLLCDMAHASR 1187
Query: 1260 NSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVK 1319
NSREQLRAHGGLDVYL+LL++E WSV ALDSIAVCLA DNDNRKVEQALLK+DA+QKLV
Sbjct: 1188 NSREQLRAHGGLDVYLSLLDDEYWSVIALDSIAVCLAQDNDNRKVEQALLKQDAIQKLVD 1247
Query: 1320 FFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIK 1379
FFQSCPE HFVHILEPFLKIITKS RIN TLAVNGLTPLLI+RLDHQDAIARLNLLKLIK
Sbjct: 1248 FFQSCPERHFVHILEPFLKIITKSYRINKTLAVNGLTPLLISRLDHQDAIARLNLLKLIK 1307
Query: 1380 AVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHINTVL 1437
AVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHINT+L
Sbjct: 1308 AVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHINTIL 1365
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1437 | ||||||
| TAIR|locus:2077417 | 1367 | MAPKKK6 "mitogen-activated pro | 0.601 | 0.632 | 0.665 | 0.0 | |
| TAIR|locus:2092890 | 1368 | MAPKKK7 "mitogen-activated pro | 0.349 | 0.366 | 0.828 | 0.0 | |
| DICTYBASE|DDB_G0276465 | 1167 | sepA "septase" [Dictyostelium | 0.180 | 0.221 | 0.670 | 9.8e-190 | |
| ASPGD|ASPL0000071911 | 1346 | sepH [Emericella nidulans (tax | 0.328 | 0.350 | 0.440 | 8.9e-157 | |
| UNIPROTKB|G4NGK7 | 1484 | MGG_04100 "STE/STE11/CDC15 pro | 0.192 | 0.185 | 0.581 | 5.4e-144 | |
| POMBASE|SPBC21.06c | 1062 | cdc7 "serine/threonine protein | 0.173 | 0.234 | 0.620 | 1.8e-131 | |
| DICTYBASE|DDB_G0278901 | 1495 | DDB_G0278901 "protein kinase, | 0.306 | 0.294 | 0.387 | 1.3e-104 | |
| CGD|CAL0005910 | 1126 | orf19.3545 [Candida albicans ( | 0.253 | 0.323 | 0.405 | 2.2e-92 | |
| DICTYBASE|DDB_G0270146 | 635 | DDB_G0270146 "protein kinase, | 0.199 | 0.450 | 0.498 | 1.4e-76 | |
| DICTYBASE|DDB_G0284251 | 496 | DDB_G0284251 "protein kinase, | 0.283 | 0.820 | 0.399 | 2.9e-74 |
| TAIR|locus:2077417 MAPKKK6 "mitogen-activated protein kinase kinase kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2827 (1000.2 bits), Expect = 0., Sum P(2) = 0.
Identities = 594/893 (66%), Positives = 684/893 (76%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
M+RQ T+S FHKSKTLDNKYMLGDEIGKGAYGRVY GLDLENGDFVAIKQVSLENI QED
Sbjct: 1 MARQMTSSQFHKSKTLDNKYMLGDEIGKGAYGRVYIGLDLENGDFVAIKQVSLENIGQED 60
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
LN IMQEIDLLKNLNHKNIVKYLGSLKT++HLHIILEYVENGSLANIIKPNKFGPFPESL
Sbjct: 61 LNTIMQEIDLLKNLNHKNIVKYLGSLKTKTHLHIILEYVENGSLANIIKPNKFGPFPESL 120
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
V VYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL EAD NTHSVV
Sbjct: 121 VTVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLNEADFNTHSVV 180
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GTPYWMAPEVIE+SGVCAASDIWSVGCT+IELLTCVPPYY+LQPMPAL+RIVQD+ PPIP
Sbjct: 181 GTPYWMAPEVIELSGVCAASDIWSVGCTIIELLTCVPPYYDLQPMPALYRIVQDDTPPIP 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA 300
+SLSPDITDFLR CFKKD+RQRPDAKTLLSHPWI+N RRAL+SSLRHSGT+R ++E S+
Sbjct: 241 DSLSPDITDFLRLCFKKDSRQRPDAKTLLSHPWIRNSRRALRSSLRHSGTIRYMKETDSS 300
Query: 301 DAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAATHLS-KSDKEHSSNGNLAEERVE 359
+E +E +Q ES+SA K E +T S+ +L P S +S+K+ SS +L EE +
Sbjct: 301 -SEKDAEGSQEVVESVSAEKVEVTKTNSKSKL--PVIGGASFRSEKDQSSPSDLGEEGTD 357
Query: 360 NPEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATNDQSQLQEITNTSDKDEMLINGE 419
+ ED+ SDQ PTL++H+ S Q+G+ + S+ + D + E D+DE+ N E
Sbjct: 358 S-EDDINSDQGPTLSMHDKSSRQSGTCSISSDAKGTSQDVLENHE---KYDRDEIPGNLE 413
Query: 420 TQSPESRRKNLDSKHGGKGTSISVDNKSFGFSPRTDNNSLQKAVKTSATVGGNELSRFSD 479
T++ E RR L +K GK SI S FS + ++ L+KAVKT ++ GGNEL+RFSD
Sbjct: 414 TEASEGRRNTLATKLVGKEYSIQ---SSHSFSQKGEDG-LRKAVKTPSSFGGNELTRFSD 469
Query: 480 TPGDASLDDLFHPLEKSLEDRXXXXXXXXXXXXXXXXXXXXXXXDTGKNDLATKLRATIA 539
PGDASL DLFHPL+K E + D GKNDLATKLRA IA
Sbjct: 470 PPGDASLHDLFHPLDKVPEGKTNEASTSTPTANVNQGDSPVA--DGGKNDLATKLRARIA 527
Query: 540 QKQMENEMGQTNGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAENLFPLQAVEFSRLVG 599
QKQME E G + GGDLFRLM+GVLKDDV++ID LVFDEK+P ENLFPLQAVEFSRLV
Sbjct: 528 QKQMEGETGHSQ-DGGDLFRLMMGVLKDDVLNIDDLVFDEKVPPENLFPLQAVEFSRLVS 586
Query: 600 SLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGXXXXXXXXXXXQTRVICSILQLI 659
SLRPDESEDAIV++ KL+A+F QRPGQK FVTQ+G ++RVIC++LQLI
Sbjct: 587 SLRPDESEDAIVTSSLKLVAMFRQRPGQKAVFVTQNGFLPLMDLLDIPKSRVICAVLQLI 646
Query: 660 NQIVKDNSDFQENACLVGLIPVVMGFA--VPDRPREVRMEAAYFXXXXXXXXXXXXXMFI 717
N+IVKDN+DF ENACLVGLIP+VM FA DR RE+R EAAYF MFI
Sbjct: 647 NEIVKDNTDFLENACLVGLIPLVMSFAGFERDRSREIRKEAAYFLQQLCQSSPLTLQMFI 706
Query: 718 ACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLIN 777
+CRGIPVLVGFLEADYAK+REMVHLAIDGMWQVFKL++ST RNDFCRIAAKNGILLRL+N
Sbjct: 707 SCRGIPVLVGFLEADYAKHREMVHLAIDGMWQVFKLKKSTSRNDFCRIAAKNGILLRLVN 766
Query: 778 TLYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVKVR 837
TLYSL+EATRLASIS G DG R RSGQLD ++PIF+Q ET ++ D DG+K R
Sbjct: 767 TLYSLSEATRLASIS-GDALILDGQTPRARSGQLDPNNPIFSQRETSPSVIDHPDGLKTR 825
Query: 838 HGMIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLDAT 890
+G G +EPS A TS+SQ SDV+Q P L D DR + + V DAT
Sbjct: 826 NG--------GGEEPSHALTSNSQSSDVHQ--PDALHPDGDRPRLSSVVADAT 868
|
|
| TAIR|locus:2092890 MAPKKK7 "mitogen-activated protein kinase kinase kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2095 (742.5 bits), Expect = 0., Sum P(2) = 0.
Identities = 424/512 (82%), Positives = 454/512 (88%)
Query: 930 SRTEIDLRQQ-RIASAVNRTSIDKPPKSPEGASNGFPTTTTQSDQVRXXXXXXXXXXXXR 988
S TE D+RQQ RI+ + NRTS DK K EGASNGFP T Q++QVR R
Sbjct: 863 SGTE-DVRQQHRISLSANRTSTDKLQKLAEGASNGFPVT--QTEQVRPLLSLLDKEPPSR 919
Query: 989 HFSGQLDYVRHVPGMERHESILPLLHASNDKKTNGELDFLMAEFAEVSGRGRENGNLDST 1048
H+SGQLDYV+H+ G+ERHES LPLLH SN+KK NG+LDFLMAEFAEVSGRG+ENG+LD+T
Sbjct: 920 HYSGQLDYVKHITGIERHESRLPLLHGSNEKKNNGDLDFLMAEFAEVSGRGKENGSLDTT 979
Query: 1049 PKLSHKTATKKMGTLSSNEGAASMSGIVSQTASGVLSGSGVLNARPGSATSSGLLSHMVS 1108
+ KT TKK+ + EG AS SGI SQTASGVLSGSGVLNARPGSATSSGLL+HMVS
Sbjct: 980 TRYPSKTMTKKVLAI---EGVASTSGIASQTASGVLSGSGVLNARPGSATSSGLLAHMVS 1036
Query: 1109 TLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPILLK---CV 1165
TL+ADVAREYLEKVADLLLEFA+ADTTVKSYMCSQSLLSRLFQMFNR+EPPILLK C
Sbjct: 1037 TLSADVAREYLEKVADLLLEFARADTTVKSYMCSQSLLSRLFQMFNRVEPPILLKILECT 1096
Query: 1166 NHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAA 1225
NHLSTDPNCLENLQRADAIK+LIPNL+LKDGHLV IH EVL ALFNLCKINKRRQEQAA
Sbjct: 1097 NHLSTDPNCLENLQRADAIKHLIPNLELKDGHLVYQIHHEVLSALFNLCKINKRRQEQAA 1156
Query: 1226 ENGIIPHLMHFIMSDSPLKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSV 1285
ENGIIPHLM FIMSDSPLKQYALPLLCDMAHASRNSREQLRAHGGLDVYL+LL++E WSV
Sbjct: 1157 ENGIIPHLMLFIMSDSPLKQYALPLLCDMAHASRNSREQLRAHGGLDVYLSLLDDEYWSV 1216
Query: 1286 TALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSR 1345
ALDSIAVCLA DNDNRKVEQALLK+DA+QKLV FFQSCPE HFVHILEPFLKIITKS R
Sbjct: 1217 IALDSIAVCLAQDNDNRKVEQALLKQDAIQKLVDFFQSCPERHFVHILEPFLKIITKSYR 1276
Query: 1346 INTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLI 1405
IN TLAVNGLTPLLI+RLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLI
Sbjct: 1277 INKTLAVNGLTPLLISRLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLI 1336
Query: 1406 EERRDGQRSGGQVLVKQMATSLLKALHINTVL 1437
EERRDGQRSGGQVLVKQMATSLLKALHINT+L
Sbjct: 1337 EERRDGQRSGGQVLVKQMATSLLKALHINTIL 1368
|
|
| DICTYBASE|DDB_G0276465 sepA "septase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 905 (323.6 bits), Expect = 9.8e-190, Sum P(3) = 9.8e-190
Identities = 177/264 (67%), Positives = 210/264 (79%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
K+ T+ N Y LG IGKG +G VY+GLD+E+GDFVAIKQ++L I ++ L IM EIDLL
Sbjct: 11 KNVTVGN-YNLGVVIGKGGFGTVYQGLDIEDGDFVAIKQINLTKIPKDQLQGIMNEIDLL 69
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
KNLNH NIVKY+ +KT+ +L+I+LEYVENGSL+ IIK KFG FPE+LV VYI QVLEG
Sbjct: 70 KNLNHANIVKYIKYVKTKDNLYIVLEYVENGSLSGIIK--KFGKFPETLVCVYIRQVLEG 127
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI 191
LVYLHEQGV+HRDIKGANILTTKEG +KLADFGVATK D + +VVGTPYWMAPE+I
Sbjct: 128 LVYLHEQGVVHRDIKGANILTTKEGKIKLADFGVATKFD--DTSAAAVVGTPYWMAPEII 185
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFL 251
E++G SDIWSVGCTVIELLT PPYY+L MPALFRIVQD+ PP+PE +SP + D+L
Sbjct: 186 ELNGATTKSDIWSVGCTVIELLTGSPPYYDLGQMPALFRIVQDDCPPLPEGISPPLKDWL 245
Query: 252 RQCFKKDARQRPDAKTLLSHPWIQ 275
QCF+KD R A+ LL H WIQ
Sbjct: 246 MQCFQKDPNLRISAQKLLKHKWIQ 269
|
|
| ASPGD|ASPL0000071911 sepH [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 8.9e-157, Sum P(3) = 8.9e-157
Identities = 228/518 (44%), Positives = 307/518 (59%)
Query: 3 RQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLN 62
R TSA ++ D Y LGD +G+GA+G VY+ L+ G+ VA+KQ+ L ++ + +L
Sbjct: 45 RMGKTSAKDVAELKD--YQLGDCLGRGAFGSVYRALNWNTGETVAVKQIKLADLPKSELR 102
Query: 63 IIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVA 122
+IM EIDLLKNL+H NIVKY G +K+ L+IILEY ENGSL +I K FG FPE+LV
Sbjct: 103 VIMLEIDLLKNLDHPNIVKYQGFVKSAETLNIILEYCENGSLHSIAK--NFGRFPETLVG 160
Query: 123 VYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT 182
VY++QVL GL+YLH+QGVIHRDIKGANILTTKEGLVKLADFGVA++ T ++ SVVGT
Sbjct: 161 VYMSQVLHGLLYLHDQGVIHRDIKGANILTTKEGLVKLADFGVASRTT--GLSESSVVGT 218
Query: 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES 242
PYWMAPEVIE+SG ASDIWS+GCTVIELL PPYY LQPMPALFRIV D+ PP+P+
Sbjct: 219 PYWMAPEVIELSGATTASDIWSLGCTVIELLEGKPPYYNLQPMPALFRIVNDDHPPLPQG 278
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA----LQSSLRHSGTMRNVEENG 298
SP + DFL QCF+KD R A+ LL HPWI N RR+ + S + +++V+E
Sbjct: 279 ASPAVKDFLMQCFQKDPNLRVSARKLLKHPWIVNARRSDSVVPKKSTEYEEAVKSVQEWN 338
Query: 299 SADAEIPSEDNQSAG---ESLSAP--KAEAFETGSRKELLSPAATHLSKSDKEHSSNGNL 353
A P + G E+ + P + + T ++ L SP + ++ DK S +
Sbjct: 339 EA-LRSPESNALRRGTRNENQNPPSLRLDTRHTPTKVTLPSPVSRIVA--DKFSSPSSG- 394
Query: 354 AEERVENPEDE------PLSDQVPTLAIHEMSLVQTGSGRLPSNKITA--TNDQSQLQEI 405
EE +N +D+ P + Q+P L H+ G L S K+ A + D + L+
Sbjct: 395 -EE--DNWDDDFATAISPSALQLPHLRPHD-----NFGGMLSSEKLKAFASLDGTVLKSD 446
Query: 406 TNTSDKDE----MLINGETQSPESRRKNLDSKHGGKGTSISVDNKSFGFSPRTDNNSLQK 461
+ + D+ L+ GE P + S+ GTS S N +G R L
Sbjct: 447 ESFEESDDPFKGSLLAGE-HDPLKTIRPPPSQQANSGTSQS-QNGPYGAHMRR-GPPLNT 503
Query: 462 AVKTSATVGGNELSRFSDTPGDASLDDLFHPLEKSLED 499
A+ V G ++ + S +P LF+ E S+ED
Sbjct: 504 AI---TPVYGGQMLQNSSSPIRQQRPPLFYK-ENSVED 537
|
|
| UNIPROTKB|G4NGK7 MGG_04100 "STE/STE11/CDC15 protein kinase" [Magnaporthe oryzae 70-15 (taxid:242507)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 5.4e-144, Sum P(5) = 5.4e-144
Identities = 164/282 (58%), Positives = 201/282 (71%)
Query: 3 RQTTTSAFHKSKTLDNK----YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ 58
R+ +T+ + K L + Y LGD IGKGA+G VYK + G+ VA+KQ+ L ++ +
Sbjct: 38 RKNSTANLAREKALQDPGLRDYRLGDCIGKGAFGSVYKAFNWGTGEAVAVKQIKLVDVPR 97
Query: 59 EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPE 118
+L +I EIDLLKNL+H NIVKY+G +KT L+IILEY ENGSL +I K +G FPE
Sbjct: 98 SELRMIEAEIDLLKNLHHDNIVKYIGFVKTSDCLNIILEYCENGSLHSICKA--YGKFPE 155
Query: 119 SLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178
+LV VY+ QVL+GL YLH+QGVIHRDIKGANILTTK+G VKLADFGV+T
Sbjct: 156 NLVGVYMTQVLQGLQYLHDQGVIHRDIKGANILTTKDGKVKLADFGVSTSTLAGPDKEAQ 215
Query: 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP 238
VVGTPYWMAPE+I++SG +ASDIWSVGCTVIELL PPY+ L PMPALF IV D+ PP
Sbjct: 216 VVGTPYWMAPEIIQLSGATSASDIWSVGCTVIELLQGKPPYHNLAPMPALFAIVNDDHPP 275
Query: 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA 280
+PE +SP DFL QCF+KD R AK L HPWI RR+
Sbjct: 276 LPEGVSPAARDFLMQCFQKDPNLRVSAKKLQRHPWIVGSRRS 317
|
|
| POMBASE|SPBC21.06c cdc7 "serine/threonine protein kinase Cdc7" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 1.8e-131, Sum P(4) = 1.8e-131
Identities = 157/253 (62%), Positives = 192/253 (75%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
LGD +GKGA+G VY+GL+++NG+ VA+K+V L + + DL++I EIDLLKNL+H NIVK
Sbjct: 11 LGDCLGKGAFGAVYRGLNIKNGETVAVKKVKLSKMLKSDLSVIKMEIDLLKNLDHPNIVK 70
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
Y GS +T L IILEY ENGSL +I K FG PE+LVA+Y QVL+GL+YLH QGVI
Sbjct: 71 YRGSYQTNDSLCIILEYCENGSLRSICK--NFGKIPENLVALYTFQVLQGLLYLHNQGVI 128
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASD 201
HRDIKGANILTTK+G +KLADFGVATK+ + HSVVG+PYWMAPEVIE+ G ASD
Sbjct: 129 HRDIKGANILTTKDGTIKLADFGVATKINALE--DHSVVGSPYWMAPEVIELVGATTASD 186
Query: 202 IWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261
IWSVGCTVIELL PPYY+L P ALFR+V+DE PP+P ++S FL QCF+KD
Sbjct: 187 IWSVGCTVIELLDGNPPYYDLDPTSALFRMVKDEHPPLPSNISSAAKSFLMQCFQKDPNL 246
Query: 262 RPDAKTLLSHPWI 274
R + LL HPW+
Sbjct: 247 RIKTRKLLKHPWV 259
|
|
| DICTYBASE|DDB_G0278901 DDB_G0278901 "protein kinase, STE group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 1.3e-104, Sum P(6) = 1.3e-104
Identities = 180/465 (38%), Positives = 259/465 (55%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSL---ENIAQEDLNIIMQEIDLLKNLNH 76
Y+L D IGKG +G VYKGL G F AIK++ + + + E +M EI+LLK L+H
Sbjct: 22 YLLIDIIGKGGFGVVYKGLHKTKGYFSAIKKIKIMKKKKLQSESQISLMAEINLLKVLSH 81
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
NIV+Y + + SH +I++E++ENGSL IIK + G PESLV VYIAQVL GL YLH
Sbjct: 82 HNIVRYYEHIPSSSHSYIVMEFIENGSLEKIIK--RHGLLPESLVTVYIAQVLNGLEYLH 139
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE--ADVNTHSVVGTPYWMAPEVIEMS 194
QGVIHRDIK AN+L + +G +KLADFGVATK+++ +D + GTPYWMAPEVI+M
Sbjct: 140 RQGVIHRDIKAANLLISTDGSIKLADFGVATKVSDLSSDNPDDTFAGTPYWMAPEVIQMQ 199
Query: 195 GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
G+ A D+WS+GCT+IELLT PPY+ L P AL++IVQ++ PPIP +S + DFL C
Sbjct: 200 GISTACDVWSLGCTIIELLTGTPPYFGLAPAAALYKIVQEDHPPIPPGISAALKDFLLNC 259
Query: 255 FKKDARQRPDAKTLLSHPWIQNCR-RALQSSLRHSGTMRNVEENGSADAEIPSEDNQSAG 313
FKKD R AK LL HPW+++ + R ++ + + N I +DN S
Sbjct: 260 FKKDENIRSSAKQLLHHPWVKSVQIRNPETQAPKNARQEILSYNAQLQDII--QDNNS-- 315
Query: 314 ESLSAPKAEAFETGSRKELLSPAATHL---SKSDKEHSSNGNLAEERVENPEDEPLSDQV 370
+++ P++ A L P T++ S +D +++N + A N +
Sbjct: 316 -NITRPRSSAVVQPPSPSQLVPPLTNMNISSSNDNNNNNNNSSATNNSPNISSTTTKNNS 374
Query: 371 PTLAIHEMSLVQTG--SGRLPSNKI-TATNDQSQLQEITNTSDKDEMLINGETQSPESRR 427
T + L S LP T+T +Q++ N+S + N +Q+ S
Sbjct: 375 STTNNNNNKLTSPSLSSSLLPIPATSTSTVNQNKASPTLNSS-WSAVPSNKISQTVNSID 433
Query: 428 KN-LDSKHGGKGTSISVDNK---SFGFSPRTDNNSLQKAVKTSAT 468
K+ L+ + G G + + + S G N + A T+ T
Sbjct: 434 KSSLNKINNGSGQHVQIASPRKLSAGQKQSIQPNIIAAAATTTTT 478
|
|
| CGD|CAL0005910 orf19.3545 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 2.2e-92, Sum P(3) = 2.2e-92
Identities = 155/382 (40%), Positives = 225/382 (58%)
Query: 3 RQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLN 62
++T+T + H + LDN + L +G GA+ VY+ ++L+ +AIKQ+ +E +D+
Sbjct: 198 KRTSTRS-HNA--LDN-FELTTLVGNGAFASVYRAVNLKTNQVIAIKQIRIEK--DQDVG 251
Query: 63 IIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVA 122
++M EIDLLK L H+NIVKY G +KT + L+++LEY E GSL + K K G PE +
Sbjct: 252 VLMGEIDLLKILKHRNIVKYHGFVKTATSLNVLLEYCEGGSLRQLYKKLKKG-LPEYQII 310
Query: 123 VYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT 182
Y+ Q+LEGL YLHEQGV+HRD+K AN+L T +G VKLADFGVATK+T + +VVGT
Sbjct: 311 NYVRQILEGLNYLHEQGVVHRDVKAANVLLTDKGDVKLADFGVATKVTSQHL---TVVGT 367
Query: 183 PYWMAPE-VIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE 241
P WMAPE V+ G+C ASDIWS+G T+IEL T PPY++L M L I DE PP+P+
Sbjct: 368 PNWMAPETVLGGEGICTASDIWSLGATIIELFTTNPPYHDLNAMATLHAIGTDEHPPLPK 427
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSAD 301
++S DFL +CF+K A R AK LL H W+ A ++S+ T+
Sbjct: 428 NMSTLAKDFLLECFQKQANLRISAKLLLKHKWLNQTATA-KTSM---ATLLRQPSRELRS 483
Query: 302 AEIPSEDN-QSAGESLSAPKAEAFETGSRKEL-LSPAATHLSKSDKEHSSNGNLAEERVE 359
+I SE N ++ E K F+ + + L P T E+S +L +
Sbjct: 484 IKIYSESNDENWDEDFEEIKVSKFQNSTSSIIELKPDNTEKQFKLTEYSKK-DLLTLFAD 542
Query: 360 NPEDEPLSDQVPTLAIHEMSLV 381
ED + + T+ +++++V
Sbjct: 543 EKEDTSGNFEFETIGPNKLAVV 564
|
|
| DICTYBASE|DDB_G0270146 DDB_G0270146 "protein kinase, STE group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 1.4e-76, Sum P(2) = 1.4e-76
Identities = 146/293 (49%), Positives = 202/293 (68%)
Query: 1 MSRQTTTSAFHKSKTLDNK----YMLGD-EIGKGAYGRVYKGLDLENGDFVAIKQVSLEN 55
++ +T S F +S K +++ D IGKGA+ V+KGL+ +GDFVAIK+
Sbjct: 53 INNKTDRSHFRESMVASKKTIGAFVISDIAIGKGAFATVFKGLNTLSGDFVAIKRFEKSK 112
Query: 56 IAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGP 115
I+ E + + E D+L+ LNH+NIV+ LG + ++++I LEY+ENGSL+ I+ N FG
Sbjct: 113 ISNEQHSSVSTEFDILQRLNHENIVRILGREENENYIYIFLEYMENGSLSTIL--NNFGT 170
Query: 116 FPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175
FPESL+ Y+ VL+GLVYLH++GVIHRDIK ANIL K G KL+DFG A ++ +
Sbjct: 171 FPESLICNYVENVLKGLVYLHQEGVIHRDIKAANILINKAGEAKLSDFGTAGEIIKESDK 230
Query: 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE 235
+SVVGTPYWMAPEVIE+SG C SDIWS+GCT+IEL T PPY++L P+ A++RI QD+
Sbjct: 231 RYSVVGTPYWMAPEVIEISGHCQVSDIWSLGCTIIELFTSYPPYFDLNPLGAMYRICQDD 290
Query: 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHS 288
RPP+P+ +S ++ +FL +CF K +R AK LLSHPWI R L + R+S
Sbjct: 291 RPPLPDDISSELANFLERCFCKSTEERATAKELLSHPWITKNRTNLINHQRNS 343
|
|
| DICTYBASE|DDB_G0284251 DDB_G0284251 "protein kinase, STE group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 2.9e-74, P = 2.9e-74
Identities = 167/418 (39%), Positives = 248/418 (59%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL 61
S Q + KS +Y LG++IG+GA+G+V+KGL+ + G+FVAIKQ+ I + L
Sbjct: 18 SSQIMPDSKKKSIVKIGEYTLGEKIGRGAFGQVFKGLNGKTGEFVAIKQIDSNKIDESSL 77
Query: 62 NIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLV 121
+ E+++L L H NIVK LG ++ ++ L+ ILEYVENGSL ++I+ KFGP E L
Sbjct: 78 QSVKGEVEILHKLRHNNIVKVLGVVEVQAQLNFILEYVENGSLRDVIE--KFGPLSEELC 135
Query: 122 AVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181
+Y+ Q+L+GL YLH VIHRDIK +NIL TKEG++KLADFGVA+++ SVVG
Sbjct: 136 IIYLYQMLQGLAYLHSNKVIHRDIKASNILITKEGVIKLADFGVASQIDSESQLRFSVVG 195
Query: 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE 241
TPYWMAPE IE+SG +ASDIWS+G T+IELLT PPYY LQPM A+FRIV D+ PP P
Sbjct: 196 TPYWMAPESIEISGCSSASDIWSLGSTMIELLTGNPPYYTLQPMAAMFRIVSDQHPPFPT 255
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSA- 300
+S + D+ +Q FKKD QRP A+ LL HP ++ + T++ + S
Sbjct: 256 DISKEFLDYFQQSFKKDPTQRPTAQELLQHPIFFTLQKVPPTLSELQSTLKTLNGGRSRL 315
Query: 301 DAEIPSED--NQSAGESLSAPKAEAFETGSRKELLSPAATH-LSKSDKEHSSN-GNLAEE 356
+ S D + S+ S P + + + + K ++S + L + K+ + NL+EE
Sbjct: 316 RTSVNSIDWGSSSSTSGSSTPLSSSSSSSNIKSIVSDEDFNKLQTTIKQQAQTISNLSEE 375
Query: 357 RV---ENPEDEPLSDQVPTLAIHEMSL-VQTGSGRLPSNKITATNDQSQLQEITNTSD 410
+ + +++P ++ + M+L + + +K D QL E+ + +
Sbjct: 376 ILILKKELKEKPKLEEQQFYKEYFMALAISVKVNQCYQDKTCEPKDMQQLYEMARSQE 433
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00030218001 | SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (1393 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1437 | |||
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-170 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-117 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-96 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-95 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-93 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-90 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-86 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-83 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-83 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-83 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-77 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-76 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-73 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-71 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-71 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-71 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-70 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-69 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-65 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-65 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-64 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-64 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-63 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-61 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-61 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-61 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-60 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-60 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-60 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-59 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-59 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-58 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-58 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-55 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-55 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-55 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-55 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-53 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-53 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-53 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-53 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-53 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-52 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-52 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-51 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-51 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-51 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-50 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-50 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-50 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-49 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-48 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-48 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-48 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-48 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-47 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-46 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-45 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-44 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-43 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-43 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-43 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-43 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-42 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-42 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-42 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-42 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-42 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-42 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-42 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-41 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-41 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-41 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-41 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-41 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-40 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-40 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-40 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-39 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-39 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-38 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-38 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-37 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-37 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-37 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-36 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-36 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-35 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-35 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-35 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-34 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-34 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-34 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-33 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-33 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-33 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-33 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-33 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-33 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-32 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-32 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-32 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-32 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-32 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-31 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-31 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-30 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-30 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-29 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-29 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-29 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-29 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-28 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-28 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-28 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-27 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-27 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-27 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-27 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-27 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-27 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-27 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-27 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-27 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-26 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-26 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-26 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-26 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-26 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-26 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-26 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-26 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-26 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-25 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-25 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-25 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-25 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-25 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-24 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-24 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-24 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-24 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-23 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-23 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-23 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-23 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-23 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-22 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-22 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-22 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-22 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-21 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-20 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-19 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-19 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-19 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-19 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-18 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-18 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-18 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-18 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-18 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-17 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-17 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-15 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-13 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-05 | |
| cd00020 | 120 | cd00020, ARM, Armadillo/beta-catenin-like repeats | 9e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 509 bits (1312), Expect = e-170
Identities = 187/256 (73%), Positives = 210/256 (82%), Gaps = 2/256 (0%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
Y LGD IG+GA+G VYKGL+LE GDFVAIKQ+SLE I +E L IMQEIDLLKNL H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IVKY+GS++T L+IILEY ENGSL IIK KFGPFPESLVAVY+ QVL+GL YLHEQ
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
GVIHRDIK ANILTTK+G+VKLADFGVATKL + + SVVGTPYWMAPEVIEMSG
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
ASDIWS+GCTVIELLT PPYY+L PM ALFRIVQD+ PP+PE +SP++ DFL QCF+KD
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238
Query: 259 ARQRPDAKTLLSHPWI 274
RP AK LL HPWI
Sbjct: 239 PNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 366 bits (941), Expect = e-117
Identities = 126/262 (48%), Positives = 176/262 (67%), Gaps = 8/262 (3%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
++ G+ +G+G++G VY LD + G+ +A+K V L ++E+L + +EI +L +L H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 79 IVKYLGSLKTR--SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
IV+Y GS + + L+I LEYV GSL++++K KFG PE ++ Y Q+LEGL YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN--THSVVGTPYWMAPEVIEMS 194
G++HRDIKGANIL +G+VKLADFG A +L + + T SV GTPYWMAPEVI
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 195 GVCAASDIWSVGCTVIELLTCVPPYYEL-QPMPALFRIV-QDERPPIPESLSPDITDFLR 252
A+DIWS+GCTVIE+ T PP+ EL PM AL++I E P IPE LS + DFLR
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 253 QCFKKDARQRPDAKTLLSHPWI 274
+C ++D ++RP A LL HP++
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 309 bits (795), Expect = 2e-96
Identities = 97/258 (37%), Positives = 148/258 (57%), Gaps = 7/258 (2%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y + +++G+G++G+VY D + G VAIK + + I +D I++EI +LK L H NI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
V+ + L++++EY E G L +++K K G E Y+ Q+L L YLH +G
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
++HRD+K NIL ++G VKLADFG+A +L + VGTP +MAPEV+ G A
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE---SLSPDITDFLRQCFK 256
DIWS+G + ELLT PP+ + LF+ + +PP P +SP+ D +R+
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 257 KDARQRPDAKTLLSHPWI 274
KD +R A+ L HP+
Sbjct: 237 KDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 308 bits (790), Expect = 2e-95
Identities = 116/264 (43%), Positives = 157/264 (59%), Gaps = 5/264 (1%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ L + IGKG++G VYK +D VAIK + LE A++++ I QEI L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSP 59
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
I KY GS S L II+EY GS +++KP G E+ +A + +VL GL YLHE
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHE 116
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC 197
+G IHRDIK ANIL ++EG VKLADFGV+ +LT ++ VGTP+WMAPEVI+ SG
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 198 AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL-SPDITDFLRQCFK 256
+DIWS+G T IEL PP +L PM LF I ++ P + + S DF+ C
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236
Query: 257 KDARQRPDAKTLLSHPWIQNCRRA 280
KD ++RP AK LL H +I+ ++
Sbjct: 237 KDPKERPSAKELLKHKFIKKAKKT 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 301 bits (772), Expect = 3e-93
Identities = 122/257 (47%), Positives = 174/257 (67%), Gaps = 8/257 (3%)
Query: 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLEN---IAQEDLNIIMQEIDLLKNLNHKNI 79
G+ +G G++G VY+GL+L++GDF A+K+VSL + QE + + QEI LL L H NI
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
V+YLG+ + +L+I LE V GSLA ++K K+G FPE ++ +Y Q+L GL YLH++
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA- 198
+HRDIKGANIL G+VKLADFG+A ++ E S G+PYWMAPEVI G
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF-AKSFKGSPYWMAPEVIAQQGGYGL 181
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-ERPPIPESLSPDITDFLRQCFKK 257
A+DIWS+GCTV+E+ T PP+ +L+ + A+F+I + E PPIP+ LS + DF+ +C ++
Sbjct: 182 AADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQR 241
Query: 258 DARQRPDAKTLLSHPWI 274
D RP A LL HP++
Sbjct: 242 DPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 292 bits (750), Expect = 3e-90
Identities = 111/257 (43%), Positives = 156/257 (60%), Gaps = 6/257 (2%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ + ++IGKG +G VYK G VAIK + LE+ +E I+ EI +LK H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPN 58
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IVKY GS + L I++E+ GSL +++K + ES +A ++L+GL YLH
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLK-STNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
G+IHRDIK ANIL T +G VKL DFG++ +L++ +++VGTPYWMAPEVI
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMVGTPYWMAPEVINGKPYDY 176
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES--LSPDITDFLRQCFK 256
+DIWS+G T IEL PPY EL PM ALF+I + P + S + DFL++C +
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236
Query: 257 KDARQRPDAKTLLSHPW 273
K+ +RP A+ LL HP+
Sbjct: 237 KNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 281 bits (720), Expect = 5e-86
Identities = 123/261 (47%), Positives = 151/261 (57%), Gaps = 10/261 (3%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
Y L IG G YG VYK D+ G+ VAIK + LE +D II QEI +LK H N
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPN 61
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV Y GS R L I++EY GSL +I + + GP E +A + L+GL YLHE
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET 120
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIE---MSG 195
G IHRDIKGANIL T++G VKLADFGV+ +LT S +GTPYWMAPEV G
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 196 VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI----PESLSPDITDFL 251
DIW++G T IEL PP ++L PM ALF I + PP E SP DF+
Sbjct: 181 YDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240
Query: 252 RQCFKKDARQRPDAKTLLSHP 272
++C KD ++RP A LL HP
Sbjct: 241 KKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 1e-83
Identities = 115/254 (45%), Positives = 156/254 (61%), Gaps = 13/254 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+G+G+YG VYK + E G VAIK V +E EDL I++EI +LK + IVKY GS
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 86 LKTRSHLHIILEYVENGSLANIIK-PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ L I++EY GS+++I+K NK E +A + Q L+GL YLH IHRD
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
IK NIL +EG KLADFGV+ +LT+ ++V+GTP+WMAPEVI+ G +DIWS
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPP----IPESLSPDITDFLRQCFKKDAR 260
+G T IE+ PPY ++ PM A+F I +PP PE SP+ DF+++C KD
Sbjct: 185 LGITAIEMAEGKPPYSDIHPMRAIFMIPN--KPPPTLSDPEKWSPEFNDFVKKCLVKDPE 242
Query: 261 QRPDAKTLLSHPWI 274
+RP A LL HP+I
Sbjct: 243 ERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 274 bits (704), Expect = 2e-83
Identities = 115/263 (43%), Positives = 153/263 (58%), Gaps = 6/263 (2%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
Y ++IG+GA G VYK D G VAIK++ L ++ +I+ EI ++K+ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK---QNKELIINEILIMKDCKH 74
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
NIV Y S L +++EY++ GSL +II N E +A +VL+GL YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV-RMNEPQIAYVCREVLQGLEYLH 133
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
Q VIHRDIK NIL +K+G VKLADFG A +LT+ +SVVGTPYWMAPEVI+
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQC 254
DIWS+G IE+ PPY P+ ALF I PP+ PE SP+ DFL +C
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253
Query: 255 FKKDARQRPDAKTLLSHPWIQNC 277
KD +RP A+ LL HP+++
Sbjct: 254 LVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 271 bits (696), Expect = 8e-83
Identities = 93/262 (35%), Positives = 144/262 (54%), Gaps = 9/262 (3%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y L ++G G++G VYK G VA+K + + + +EI +L+ L+H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
V+ + + + + HL++++EY E G L + + GP E Q+L GL YLH G
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMS-GVCA 198
+IHRD+K NIL + G+VK+ADFG+A KL ++ + + VGTP++MAPEV+ G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE------SLSPDITDFLR 252
D+WS+G + ELLT PP+ + L I + PP+ S S + D ++
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK 238
Query: 253 QCFKKDARQRPDAKTLLSHPWI 274
+C KD +RP A+ +L HPW
Sbjct: 239 KCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 256 bits (657), Expect = 1e-77
Identities = 92/259 (35%), Positives = 149/259 (57%), Gaps = 4/259 (1%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
KY + +IGKG++G+VY +G +K++ L N+++++ + E+ +LK LNH N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIK--PNKFGPFPESLVAVYIAQVLEGLVYLH 136
I+KY S + + L I++EY + G L+ IK + PFPE + + Q+ L YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
+ ++HRDIK NI T GLVKL DFG++ L+ +VVGTPY+++PE+ +
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALF-RIVQDERPPIPESLSPDITDFLRQCF 255
SDIWS+GC + EL T P +E + + L +I++ + PPIP S ++ + +
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP-FEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239
Query: 256 KKDARQRPDAKTLLSHPWI 274
+KD +RP +L P+I
Sbjct: 240 QKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 7e-76
Identities = 112/264 (42%), Positives = 163/264 (61%), Gaps = 9/264 (3%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE---DLNIIMQEIDLLKNL 74
+ G +G+GA+GRVY D++ G +A+KQV + + E ++N + EI LLKNL
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
H+ IV+Y G L+ L I +EY+ GS+ + +K +G E++ Y Q+LEG+ Y
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEY 119
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT---HSVVGTPYWMAPEVI 191
LH ++HRDIKGANIL G VKL DFG + +L + SV GTPYWM+PEVI
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV-QDERPPIPESLSPDITDF 250
G +D+WSVGCTV+E+LT PP+ E + M A+F+I Q P +P +SPD +F
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
Query: 251 LRQCFKKDARQRPDAKTLLSHPWI 274
LR+ F ++A++RP A+ LL H ++
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 243 bits (621), Expect = 9e-73
Identities = 112/264 (42%), Positives = 160/264 (60%), Gaps = 15/264 (5%)
Query: 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLEN----IAQEDLNIIMQEIDLLKNLNHKN 78
G+ +GKGAYG VY GL G +A+KQV L+ A+++ + +E+DLLK+L H N
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV+YLG+ + + I +E+V GS+++I+ N+FGP PE + Y Q+L+G+ YLH
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN-TH-----SVVGTPYWMAPEVIE 192
V+HRDIKG N++ G++KL DFG A +L ++ TH S+ GTPYWMAPEVI
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 193 MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER--PPIPESLSPDITDF 250
SG SDIWS+GCTV E+ T PP + + A+F I P +P+S S DF
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDF 241
Query: 251 LRQCFKKDARQRPDAKTLLSHPWI 274
+ C +D +RP A LL H ++
Sbjct: 242 VTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 2e-71
Identities = 113/270 (41%), Positives = 175/270 (64%), Gaps = 17/270 (6%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-------LNIIMQEIDLL 71
K++ G IG G++G VY G++ +G+ +A+KQV L +++ L+ + +EI LL
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
K L H+NIV+YLGS HL+I LEYV GS+A ++ N +G F E+LV ++ Q+L+G
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKG 118
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-----NTH--SVVGTPY 184
L YLH +G+IHRDIKGANIL +G +K++DFG++ KL EA+ N S+ G+ +
Sbjct: 119 LNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVF 177
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLS 244
WMAPEV++ + +DIWS+GC V+E+LT P+ + + A+F+I ++ P IP ++S
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS 237
Query: 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWI 274
+ DFL + F+ D +RP A LL HP++
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 5e-71
Identities = 101/266 (37%), Positives = 158/266 (59%), Gaps = 12/266 (4%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
++ G++IG G +G+VY ++L+ G+ +A+K++ +++ + + I E+ +L+ L H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+VKY G R ++I +EY G+L +++ + E ++ VY Q+LEGL YLH
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLHSH 118
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH----SVVGTPYWMAPEVI--- 191
G++HRDIK ANI G++KL DFG A KL S+ GTP +MAPEVI
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPAL-FRIVQDERPPIPES--LSPDIT 248
+ G A+DIWS+GC V+E+ T P+ EL + F + +PPIP+S LSP+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238
Query: 249 DFLRQCFKKDARQRPDAKTLLSHPWI 274
DFL +C + D ++RP A LL HP++
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 238 bits (608), Expect = 8e-71
Identities = 108/273 (39%), Positives = 163/273 (59%), Gaps = 19/273 (6%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSL-ENIAQED-------LNIIMQEIDL 70
K++ G+ IGKG YGRVY L++ G+ +A+KQV L IA + + EI+
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
LK+L+H NIV+YLG T +L I LEYV GS+ + ++ +G F E LV + QVLE
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVLE 119
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA--DVNTHSVVGTPYWMAP 188
GL YLH +G++HRD+K N+L +G+ K++DFG++ K + + S+ G+ +WMAP
Sbjct: 120 GLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 189 EVIEMS--GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI-VQDERPPIPESLSP 245
EVI G A DIWS+GC V+E+ P+ + + + A+F++ + PPIP +S
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239
Query: 246 DIT----DFLRQCFKKDARQRPDAKTLLSHPWI 274
+++ DFL CF + RP A+ LL HP+I
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 1e-70
Identities = 105/277 (37%), Positives = 151/277 (54%), Gaps = 27/277 (9%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NH 76
+ L + IG+G YG+VYK + G VAIK + + +E+ I +E ++L+ NH
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSNH 62
Query: 77 KNIVKYLGSLKTRSH------LHIILEYVENGSLANIIKP--NKFGPFPESLVAVYIAQV 128
NI + G+ ++ L +++E GS+ +++K K E +A + +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
L GL YLHE VIHRDIKG NIL TK VKL DFGV+ +L ++ +GTPYWMAP
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 189 EVIEMSGVC---------AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI 239
EVI C A SD+WS+G T IEL PP ++ PM ALF+I ++ P +
Sbjct: 183 EVI----ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238
Query: 240 --PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274
PE+ S DF+ +C K+ QRP + LL HP+I
Sbjct: 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 230 bits (590), Expect = 4e-69
Identities = 92/249 (36%), Positives = 134/249 (53%), Gaps = 36/249 (14%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+G+G +G VY D + G VAIK + E+ + L +++EI++LK LNH NIVK G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED-SSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDI 145
+ +HL++++EY E GSL +++K G E + + Q+LEGL YLH G+IHRD+
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 146 KGANIL-TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC-AASDIW 203
K NIL + G VKLADFG++ LT ++VGTP +MAPEV+ G SDIW
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
S+G + EL P++ D +R+ +KD +RP
Sbjct: 179 SLGVILYEL--------------------------------PELKDLIRKMLQKDPEKRP 206
Query: 264 DAKTLLSHP 272
AK +L H
Sbjct: 207 SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 5e-65
Identities = 103/263 (39%), Positives = 144/263 (54%), Gaps = 18/263 (6%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
E+G GA+G+VYK E G F A K + +E ++E+L M EID+L H NIV
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ + L I++E+ + G+L +I+ + E + Q+LE L +LH VIHRD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA----- 199
+K NIL T +G VKLADFGV+ K + +GTPYWMAPEV+ C
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV----ACETFKDNP 184
Query: 200 ----SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQ 253
+DIWS+G T+IEL PP++EL PM L +I++ E P + P S DFL+
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKS 244
Query: 254 CFKKDARQRPDAKTLLSHPWIQN 276
C KD RP A LL HP++ +
Sbjct: 245 CLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 5e-65
Identities = 101/268 (37%), Positives = 145/268 (54%), Gaps = 12/268 (4%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ Y L + IG GA VY + L N + VAIK++ LE Q ++ + +E+ + NH
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHP 59
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIK-PNKFGPFPESLVAVYIAQVLEGLVYLH 136
N+VKY S L +++ Y+ GSL +I+K G E+++A + +VL+GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT----HSVVGTPYWMAPEVIE 192
G IHRDIK NIL ++G VK+ADFGV+ L + T + VGTP WMAPEV+E
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 193 -MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES-----LSPD 246
+ G +DIWS G T IEL T PY + PM L +Q++ P + S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239
Query: 247 ITDFLRQCFKKDARQRPDAKTLLSHPWI 274
+ C +KD +RP A+ LL H +
Sbjct: 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 3e-64
Identities = 110/251 (43%), Positives = 156/251 (62%), Gaps = 4/251 (1%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
+ IGKG++G VYKG+D + VAIK + LE A++++ I QEI +L + I +Y
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
GS + L II+EY+ GS +++KP GP E+ +A + ++L+GL YLH + IHR
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
DIK AN+L +++G VKLADFGVA +LT+ + ++ VGTP+WMAPEVI+ S +DIW
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
S+G T IEL PP +L PM LF I ++ P + S +F+ C KD R RP
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245
Query: 264 DAKTLLSHPWI 274
AK LL H +I
Sbjct: 246 TAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 218 bits (556), Expect = 7e-64
Identities = 102/256 (39%), Positives = 152/256 (59%), Gaps = 10/256 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+GKG YG VY DL +AIK++ + + + +EI L L H+NIV+YLGS
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFP--ESLVAVYIAQVLEGLVYLHEQGVIHR 143
I +E V GSL+ +++ +K+GP E + Y Q+LEGL YLH+ ++HR
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 144 DIKGANIL-TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIE--MSGVCAAS 200
DIKG N+L T G+VK++DFG + +L + T + GT +MAPEVI+ G A +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA 192
Query: 201 DIWSVGCTVIELLTCVPPYYELQ-PMPALFRI-VQDERPPIPESLSPDITDFLRQCFKKD 258
DIWS+GCT++E+ T PP+ EL P A+F++ + P IPESLS + +F+ +CF+ D
Sbjct: 193 DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPD 252
Query: 259 ARQRPDAKTLLSHPWI 274
+R A LL P++
Sbjct: 253 PDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 2e-63
Identities = 87/264 (32%), Positives = 142/264 (53%), Gaps = 12/264 (4%)
Query: 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
+G+G+ G VYK G A+K++ + + +E +++E+ L++ +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-G 139
K G+ + I+LEY++ GSLA+++K K G PE ++A Q+L+GL YLH +
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLK--KVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI--EMSGVC 197
+IHRDIK +N+L +G VK+ADFG++ L ++ VGT +M+PE I E
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY- 179
Query: 198 AASDIWSVGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIPESL-SPDITDFLRQ 253
A+DIWS+G T++E P+ + + I P +P SP+ DF+
Sbjct: 180 -AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA 238
Query: 254 CFKKDARQRPDAKTLLSHPWIQNC 277
C +KD ++RP A LL HP+I+
Sbjct: 239 CLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 1e-61
Identities = 106/266 (39%), Positives = 151/266 (56%), Gaps = 9/266 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH---KNIVKY 82
IG+GAYG VY+G + G VA+K ++L+ +D++ I +E+ LL L NI KY
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
GS L II+EY E GS+ ++K GP E ++V I +VL L Y+H+ GVIH
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIH 124
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI-EMSGVCAASD 201
RDIK ANIL T G VKL DFGVA L + + VGTPYWMAPEVI E +D
Sbjct: 125 RDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKAD 184
Query: 202 IWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE-SLSPDITDFLRQCFKKDAR 260
IWS+G T+ E+ T PPY ++ A+ I + + P + + S + +F+ C ++ +
Sbjct: 185 IWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPK 244
Query: 261 QRPDAKTLLSHPWIQNCRRALQSSLR 286
+R A+ LL WI+ + S L+
Sbjct: 245 ERLSAEELLKSKWIKAHSKTPVSILK 270
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 1e-61
Identities = 107/257 (41%), Positives = 158/257 (61%), Gaps = 5/257 (1%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
+ IGKG++G V+KG+D VAIK + LE A++++ I QEI +L + + KY
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
GS + L II+EY+ GS ++++ GPF E +A + ++L+GL YLH + IHR
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHR 125
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
DIK AN+L +++G VKLADFGVA +LT+ + ++ VGTP+WMAPEVI+ S + +DIW
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
S+G T IEL PP ++ PM LF I ++ P + S +F+ C KD RP
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRP 245
Query: 264 DAKTLLSHPWI-QNCRR 279
AK LL H +I +N ++
Sbjct: 246 TAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 2e-61
Identities = 113/262 (43%), Positives = 158/262 (60%), Gaps = 12/262 (4%)
Query: 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE---DLNIIMQEIDLLKNLNHKNI 79
G +G+GA+GRVY D++ G +A KQV + + E +++ + EI LLKNL H+ I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 80 VKYLGSLKTRSH--LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
V+Y G L+ R+ L I +EY+ GS+ + +K +G ES+ Y Q+LEG+ YLH
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYLHS 124
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTE---ADVNTHSVVGTPYWMAPEVIEMS 194
++HRDIKGANIL G VKL DFG + +L + SV GTPYWM+PEVI
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 195 GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI-VQDERPPIPESLSPDITDFLRQ 253
G +D+WS+GCTV+E+LT PP+ E + M A+F+I Q P +P +S DFL
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGC 244
Query: 254 CFKKDARQRPDAKTLLSHPWIQ 275
F +AR RP A+ LL HP+ Q
Sbjct: 245 IF-VEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 207 bits (527), Expect = 5e-60
Identities = 94/268 (35%), Positives = 149/268 (55%), Gaps = 25/268 (9%)
Query: 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSL-ENIAQEDLNI---IMQEIDLLKNLNHKN 78
G ++G GA+ Y+ D++ G +A+KQV+ N + E + + +EI L+ LNH +
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
I++ LG+ SH ++ +E++ GS+++++ K+G F E+++ Y Q+L GL YLHE
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 139 GVIHRDIKGANILTTKEG-LVKLADFGVA----TKLTEADVNTHSVVGTPYWMAPEVIEM 193
+IHRD+KGAN+L G +++ADFG A K T A ++GT +MAPEV+
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPY--------YELQPMPALFRIVQ-DERPPIPESLS 244
+ D+WSVGC +IE+ T PP+ L +F+I P IPE LS
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-----IFKIASATTAPSIPEHLS 237
Query: 245 PDITDFLRQCFKKDARQRPDAKTLLSHP 272
P + D +C + RP ++ LL HP
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 5e-60
Identities = 110/264 (41%), Positives = 160/264 (60%), Gaps = 12/264 (4%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE---DLNIIMQEIDLLKNLNH 76
+ LG +G+GA+G VY D + G +A+KQV + +QE ++N + EI LLKNL H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 77 KNIVKYLGSLK--TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
IV+Y G L+ L I +EY+ GS+ + +K +G E++ Y Q+L+G+ Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSY 121
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE---ADVNTHSVVGTPYWMAPEVI 191
LH ++HRDIKGANIL G VKL DFG + ++ + SV GTPYWM+PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI-VQDERPPIPESLSPDITDF 250
G +D+WSV CTV+E+LT PP+ E + M A+F+I Q +P +P+ +S DF
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241
Query: 251 LRQCFKKDARQRPDAKTLLSHPWI 274
L+Q F ++ R RP A+ LL HP++
Sbjct: 242 LKQIFVEEKR-RPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 7e-60
Identities = 107/251 (42%), Positives = 158/251 (62%), Gaps = 4/251 (1%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
++IGKG++G V+KG+D VAIK + LE A++++ I QEI +L + + KY
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
GS + L II+EY+ GS ++++P GP E+ +A + ++L+GL YLH + IHR
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
DIK AN+L ++ G VKLADFGVA +LT+ + ++ VGTP+WMAPEVI+ S + +DIW
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 185
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
S+G T IEL PP+ EL PM LF I ++ P + + S + +F+ C K+ RP
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
Query: 264 DAKTLLSHPWI 274
AK LL H +I
Sbjct: 246 TAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 3e-59
Identities = 112/262 (42%), Positives = 151/262 (57%), Gaps = 17/262 (6%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y L +G G YG VYK +L G+ A+K + LE +D ++I QEI ++K H NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNI 68
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
V Y GS +R L I +EY GSL +I GP E +A + L+GL YLH +G
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV--IEMSG-- 195
+HRDIKGANIL T G VKLADFGVA K+T S +GTPYWMAPEV +E +G
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 196 --VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD--ERPPIPESL--SPDITD 249
+C DIW+VG T IEL PP ++L PM ALF + + + P + + S +
Sbjct: 187 NQLC---DIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243
Query: 250 FLRQCFKKDARQRPDAKTLLSH 271
F++ K+ ++RP A+ LL+H
Sbjct: 244 FVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 204 bits (519), Expect = 5e-59
Identities = 111/265 (41%), Positives = 158/265 (59%), Gaps = 12/265 (4%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE---DLNIIMQEIDLLKNLNH 76
+ LG +G+GA+GRVY D + G +A+KQV + + E ++N + EI LLKNL H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 77 KNIVKYLGSLK--TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
+ IV+Y G L+ L I +E++ GS+ + +K +G E++ Y Q+LEG+ Y
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSY 121
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE---ADVNTHSVVGTPYWMAPEVI 191
LH ++HRDIKGANIL G VKL DFG + +L + SV GTPYWM+PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI-VQDERPPIPESLSPDITDF 250
G +DIWSVGCTV+E+LT PP+ E + M A+F+I Q P +P +S DF
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241
Query: 251 LRQCFKKDARQRPDAKTLLSHPWIQ 275
L++ F +A+ RP A LL H ++
Sbjct: 242 LKRIF-VEAKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 4e-58
Identities = 81/252 (32%), Positives = 136/252 (53%), Gaps = 7/252 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG++G+V + G A+K + + I + + + E ++L +NH IVK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ +T L+++LEY G L + + +K G F E Y A+++ L YLH G+I+RD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K NIL +G +KL DFG+A +L+ T++ GTP ++APEV+ G A D WS
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWS 178
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR-- 262
+G + E+LT PP+Y + ++ + + PE LSP+ D + +KD +R
Sbjct: 179 LGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 263 -PDAKTLLSHPW 273
A+ + +HP+
Sbjct: 238 SGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 8e-58
Identities = 109/261 (41%), Positives = 148/261 (56%), Gaps = 11/261 (4%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
+ L IG G YG VYK ++ G+ AIK + LE ED ++ QEI ++K+ H NI
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNI 68
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
V Y GS R L I +E+ GSL +I GP ES +A + L+GL YLH +G
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMS---GV 196
+HRDIKGANIL T G VKLADFGV+ ++T S +GTPYWMAPEV + G
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD--ERPPIPESL--SPDITDFLR 252
DIW+VG T IEL PP ++L PM ALF + + + P + + + S F++
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246
Query: 253 QCFKKDARQRPDAKTLLSHPW 273
K+ ++RP A+ LL HP+
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-56
Identities = 101/259 (38%), Positives = 142/259 (54%), Gaps = 11/259 (4%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
E+G G G V K L G +A+K + LE I + I++E+D+L N IV +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIH 142
G+ + I +EY++ GSL I+K + G PE ++ VL+GL YLHE+ +IH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RD+K +NIL G +KL DFGV+ +L + T VGT +MAPE I+ + SDI
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF--VGTSSYMAPERIQGNDYSVKSDI 182
Query: 203 WSVGCTVIELLTCVPPY-YELQPMPALF----RIVQDERPPIPES-LSPDITDFLRQCFK 256
WS+G ++IEL T PY E P +F IV + P +P SPD DF+ C
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLI 242
Query: 257 KDARQRPDAKTLLSHPWIQ 275
KD R+RP K LL HP+I+
Sbjct: 243 KDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 2e-56
Identities = 75/255 (29%), Positives = 123/255 (48%), Gaps = 9/255 (3%)
Query: 22 LGDEIGKGAYGRVYKG----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
LG ++G+GA+G VYKG VA+K + + Q+ ++E +++ L+H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF-LREARIMRKLDHP 61
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NIVK LG L I++EY+ G L + ++ N+ S + + Q+ G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGV 196
+ IHRD+ N L + +VK++DFG++ L + D P WMAPE + G
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL-KEGK 180
Query: 197 CA-ASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
SD+WS G + E+ T PY + L + + R P P + P++ + QC
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQC 240
Query: 255 FKKDARQRPDAKTLL 269
+ +D RP L+
Sbjct: 241 WAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 1e-55
Identities = 78/256 (30%), Positives = 128/256 (50%), Gaps = 10/256 (3%)
Query: 22 LGDEIGKGAYGRVYKG-LDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
LG ++G+GA+G VYKG L + G VA+K + + Q+ ++E +++ L+H
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF-LREARIMRKLDHP 61
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
N+VK LG L+I++EY+E G L + ++ N+ S + + Q+ G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLES 120
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGV 196
+ IHRD+ N L + +VK++DFG++ L + D P WMAPE + G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL-KEGK 179
Query: 197 CA-ASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
SD+WS G + E+ T PY + L + R P P + P++ D + QC
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQC 239
Query: 255 FKKDARQRPDAKTLLS 270
+ +D RP L+
Sbjct: 240 WAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-55
Identities = 83/270 (30%), Positives = 133/270 (49%), Gaps = 19/270 (7%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
Y + + IGKG++G V K +G + K++ N+ +++ ++ E+++L+ L H N
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 79 IVKYLGSLKTRSH--LHIILEYVENGSLANIIKPNK--FGPFPESLVAVYIAQVLEGLVY 134
IV+Y + RS+ L+I++EY E G LA +I+ K E + + Q+L L
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 135 LH-----EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
H V+HRD+K ANI VKL DFG+A L + VGTPY+M+PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 190 VIEMSGVCAASDIWSVGCTVIELLTCVPPYY-----ELQPMPALFRIVQDERPPIPESLS 244
+ SDIWS+GC + EL PP+ +L +I + + IP S
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS-----KIKEGKFRRIPYRYS 235
Query: 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWI 274
++ + ++ D +RP + LL P I
Sbjct: 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 5e-55
Identities = 82/254 (32%), Positives = 138/254 (54%), Gaps = 2/254 (0%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
+ + ++IGKG++G V+K + + A+KQ+ L + + + + E +L L+ I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
++Y S + L+I++EY ENG L ++K + P PE V + Q+L GL +LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
++HRDIK N+ VK+ D GVA L++ +++VGTPY+++PE+ E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEK 181
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFR-IVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+W++G + E T P ++ AL I++ PP+ + S + + QC KD
Sbjct: 182 SDVWALGVVLYECCTGKHP-FDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 259 ARQRPDAKTLLSHP 272
RQRPD LL +P
Sbjct: 241 YRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 9e-55
Identities = 102/269 (37%), Positives = 148/269 (55%), Gaps = 8/269 (2%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
KY ++IG+GA G VY +D+ G VAIKQ++L+ +++L I+ EI +++ H
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKH 75
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
NIV YL S L +++EY+ GSL +++ E +A + L+ L +LH
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLH 132
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
VIHRDIK NIL +G VKL DFG ++T ++VGTPYWMAPEV+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQC 254
DIWS+G IE++ PPY P+ AL+ I + P + PE LS DFL +C
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252
Query: 255 FKKDARQRPDAKTLLSHPWIQNCRRALQS 283
+ D +R AK LL HP+++ + L S
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK-IAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 4e-54
Identities = 96/259 (37%), Positives = 142/259 (54%), Gaps = 11/259 (4%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLE-NIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
EIG G++G VY D+ + VAIK++S + E I++E+ L+ L H N ++Y
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
G +++EY GS ++I++ +K P E +A L+GL YLH IHR
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI---EMSGVCAAS 200
DIK NIL T+ G VKLADFG A+ ++ A+ S VGTPYWMAPEVI +
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVSPAN----SFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES-LSPDITDFLRQCFKKDA 259
D+WS+G T IEL PP + + M AL+ I Q++ P + + S +F+ C +K
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIP 255
Query: 260 RQRPDAKTLLSHPWIQNCR 278
+ RP ++ LL H ++ R
Sbjct: 256 QDRPSSEELLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 1e-53
Identities = 76/258 (29%), Positives = 127/258 (49%), Gaps = 11/258 (4%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDF----VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
LG ++G+GA+G VYKG +G+ VA+K + E ++E+ ++E ++K L+H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK-EGASEEEREEFLEEASIMKKLSHP 61
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NIV+ LG L+I+ EY+ G L + ++ + + Q+ +G+ YL
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLES 120
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG-TPY-WMAPEVIEMSG 195
+ +HRD+ N L T+ +VK++DFG++ + E D G P WMAPE + G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL-KDG 179
Query: 196 VCA-ASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
SD+WS G + E+ T PY + L + R P PE+ ++ + + Q
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQ 239
Query: 254 CFKKDARQRPDAKTLLSH 271
C+ D RP L+
Sbjct: 240 CWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 1e-53
Identities = 101/261 (38%), Positives = 149/261 (57%), Gaps = 18/261 (6%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
E+G GA+G+VYK + E G A K + + ++E+L M EID+L + +H NIVK L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ ++L I++E+ G++ ++ + P E + V Q LE L YLHE +IHRD
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS---- 200
+K NIL T +G +KLADFGV+ K T S +GTPYWMAPEV+ +C S
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV----MCETSKDRP 184
Query: 201 -----DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQ 253
D+WS+G T+IE+ PP++EL PM L +I + E P + P S + DFL++
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244
Query: 254 CFKKDARQRPDAKTLLSHPWI 274
C +K+ R LL HP++
Sbjct: 245 CLEKNVDARWTTTQLLQHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 1e-53
Identities = 90/259 (34%), Positives = 144/259 (55%), Gaps = 6/259 (2%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSL-ENIAQEDLNIIMQEIDLLKNLNH 76
+ + +IGKG + VYK + L +G VA+K+V + E + + ++EIDLLK L+H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFG--PFPESLVAVYIAQVLEGLVY 134
N++KYL S + L+I+LE + G L+ +IK K PE + Y Q+ L +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMS 194
+H + ++HRDIK AN+ T G+VKL D G+ + HS+VGTPY+M+PE I +
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 195 GVCAASDIWSVGCTVIELLTCVPPYY--ELQPMPALFRIVQDERPPIP-ESLSPDITDFL 251
G SDIWS+GC + E+ P+Y ++ +I + + PP+P + S ++ D +
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241
Query: 252 RQCFKKDARQRPDAKTLLS 270
+C D +RPD +L
Sbjct: 242 SRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 4e-53
Identities = 95/267 (35%), Positives = 146/267 (54%), Gaps = 11/267 (4%)
Query: 17 DNKYMLGD--EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
D + L + +IG+G+ G V D G VA+K++ L Q+ ++ E+ ++++
Sbjct: 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDY 73
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
H NIV+ S L +++E++E G+L +I+ + E +A VL+ L +
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN---EEQIATVCLAVLKALSF 130
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMS 194
LH QGVIHRDIK +IL T +G VKL+DFG ++++ S+VGTPYWMAPEVI
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 195 GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI---PESLSPDITDFL 251
DIWS+G VIE++ PPY+ P+ A+ RI +D PP +SP + FL
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPPKLKNLHKVSPRLRSFL 249
Query: 252 RQCFKKDARQRPDAKTLLSHPWIQNCR 278
+ +D QR A LL+HP++
Sbjct: 250 DRMLVRDPAQRATAAELLNHPFLAKAG 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 8e-53
Identities = 101/267 (37%), Positives = 145/267 (54%), Gaps = 12/267 (4%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
E+G GA+G+VYK + E G A K + ++ +E+L M EI++L NH IVK LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ L I++E+ G++ I+ G E + V Q+LE L YLH +IHRD
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA----- 199
+K N+L T +G +KLADFGV+ K + S +GTPYWMAPEV+ +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK 195
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQCFKK 257
+DIWS+G T+IE+ PP++EL PM L +I + E P + P S + DFL+ K
Sbjct: 196 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDK 255
Query: 258 DARQRPDAKTLLSHPWIQ--NCRRALQ 282
RP A LL HP++ R L+
Sbjct: 256 HPETRPSAAQLLEHPFVSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 77/285 (27%), Positives = 127/285 (44%), Gaps = 35/285 (12%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLN- 75
+ + G IG+G++ V + E AIK + + +E + + E ++L LN
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
H I+K + + +L+ +LEY NG L I+ K+G E Y A++L L YL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR--KYGSLDEKCTRFYAAEILLALEYL 118
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH------------------ 177
H +G+IHRD+K NIL K+ +K+ DFG A L
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 178 --SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY---ELQPMPALFRIV 232
S VGT +++PE++ +SD+W++GC + ++LT PP+ E F+ +
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----TFQKI 234
Query: 233 QDERPPIPESLSPDITDFLRQCFKKDARQRP----DAKTLLSHPW 273
P + PD D + + D + R L +HP+
Sbjct: 235 LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 6e-52
Identities = 82/247 (33%), Positives = 131/247 (53%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+GKGA+G E+ V K+V+L +++++ + EI +L L H NI+ Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDI 145
+ L I +EY G+L + I K F E +V Y+ Q++ + Y+H+ G++HRDI
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127
Query: 146 KGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSV 205
K NI TK GL+KL DFG++ L +VVGTPY+M+PE+ + SDIW++
Sbjct: 128 KTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWAL 187
Query: 206 GCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDA 265
GC + ELLT + P+ + +IVQ P+ S ++ + ++D +RP A
Sbjct: 188 GCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTA 247
Query: 266 KTLLSHP 272
+L P
Sbjct: 248 DEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-51
Identities = 79/264 (29%), Positives = 135/264 (51%), Gaps = 15/264 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
I KGAYGRV+ GD AIK + ++ +++ ++ ++ E D+L +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S + + +L++++EY+ G LA++++ G E + +YIA+++ L YLH G+IHRD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 145 IKGANILTTKEGLVKLADFGV--------ATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
+K NIL G +KL DFG+ L + + +VGTP ++APEVI G
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP-ESLSPDITDFLRQCF 255
D WS+GC + E L +PP++ P I+ + +S + D + +
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL 238
Query: 256 KKDARQRPDAKT---LLSHPWIQN 276
D +R AK+ + +HP+ +
Sbjct: 239 VPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-51
Identities = 93/286 (32%), Positives = 142/286 (49%), Gaps = 43/286 (15%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNHKNIVKY 82
+++G+G YG VYK D + G+ VA+K++ L+N +E + ++EI LLK L H NIVK
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKL 63
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
L + T L+++ EY + L + + GP +L+ + Q+L GL Y H ++H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVN-THSVVGTPYWMAPEVI-EMSGVCAAS 200
RD+K NIL ++G++KLADFG+A TH VV T ++ APE++ A
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYSTAV 180
Query: 201 DIWSVGCTVIELLTCVPPYY---EL-QPMPALFRIVQ----------------------- 233
DIWSVGC E++T P + E+ Q LF+I Q
Sbjct: 181 DIWSVGCIFAEMITGKPLFPGDSEIDQ----LFKIFQILGTPTEESWPGVTKLPDYKPTF 236
Query: 234 DERPPIP-----ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274
+ PP L P+ D L + + + +R AK L HP+
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 3e-51
Identities = 99/259 (38%), Positives = 148/259 (57%), Gaps = 7/259 (2%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
KY ++IG+GA G V+ +D+ G VAIKQ++L+ +++L I+ EI ++K L + N
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPN 77
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV +L S L +++EY+ GSL +++ E+ +A + L+ L +LH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN 134
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
VIHRDIK N+L +G VKL DFG ++T ++VGTPYWMAPEV+
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQCFK 256
DIWS+G IE++ PPY P+ AL+ I + P + PE LSP DFL +C +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254
Query: 257 KDARQRPDAKTLLSHPWIQ 275
D +R AK LL HP+++
Sbjct: 255 MDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 7e-51
Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 22/265 (8%)
Query: 24 DEIGKGAYGRVYKG--LDLENGDF-VAIKQV--SLENIAQEDLNIIMQEIDLLKNLNHKN 78
++G+GA+G VYKG + VA+K + ++D ++E ++K L H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF---LKEARVMKKLGHPN 57
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSL-------ANIIKPNKFGPFPESLVAVYIAQVLEG 131
+V+ LG L+++LEY+E G L + + + + Q+ +G
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTP---YWMAP 188
+ YL + +HRD+ N L ++ +VK++DFG++ + + D G WMAP
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-TGGKLPIRWMAP 176
Query: 189 EVIEMSGVC-AASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPD 246
E ++ G+ + SD+WS G + E+ T PY L L + + R P PE +
Sbjct: 177 ESLK-DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDE 235
Query: 247 ITDFLRQCFKKDARQRPDAKTLLSH 271
+ + + C++ D RP L+
Sbjct: 236 LYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 1e-50
Identities = 106/267 (39%), Positives = 153/267 (57%), Gaps = 20/267 (7%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVS-LENIAQEDLNIIMQEIDLLKNL-NHKNIVK 81
+ IGKG YG+V+K L+ +NG A+K + + +I +E I E ++LK L +H N+VK
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILKALSDHPNVVK 79
Query: 82 YLG-----SLKTRSHLHIILEYVENGSLANIIKP--NKFGPFPESLVAVYIAQVLEGLVY 134
+ G +K L ++LE GS+ +++K + E ++A + + L GL +
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM- 193
LH IHRD+KG NIL T EG VKL DFGV+ +LT + ++ VGTP+WMAPEVI
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 194 ----SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDI 247
S A D+WS+G T IEL PP +L PM ALF+I ++ P + PE S +
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEF 259
Query: 248 TDFLRQCFKKDARQRPDAKTLLSHPWI 274
DF+R+C KD +RP LL H +I
Sbjct: 260 NDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 96/262 (36%), Positives = 144/262 (54%), Gaps = 16/262 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH-KNIVKYLG 84
+G G YG+VYKG ++ G AIK + ++ +++ I EI++LK +H +NI Y G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK---VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 85 SLKTRS------HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+ +S L +++E+ GS+ +++K K E +A ++L GL +LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM----- 193
VIHRDIKG N+L T+ VKL DFGV+ +L ++ +GTPYWMAPEVI
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-PESLSPDITDFLR 252
+ SDIWS+G T IE+ PP ++ PM ALF I ++ P + + S DF+
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIE 260
Query: 253 QCFKKDARQRPDAKTLLSHPWI 274
C K+ RP + LL HP+I
Sbjct: 261 GCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 4e-50
Identities = 90/252 (35%), Positives = 142/252 (56%), Gaps = 6/252 (2%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
++GKG+YG VYK L + F A+K+V L +++Q++ + EI +L ++NH NI+ Y
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFG--PFPESLVAVYIAQVLEGLVYLHEQGVI 141
+ + L I++EY G L+ I K PE + Q+L GL LHEQ ++
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASD 201
HRD+K ANIL LVK+ D G++ L + T +GTP++MAPEV + SD
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT--QIGTPHYMAPEVWKGRPYSYKSD 183
Query: 202 IWSVGCTVIELLTCVPPYYELQPMPAL-FRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260
IWS+GC + E+ T PP +E + M L +++ + + PPIP S D+ +F+R + +
Sbjct: 184 IWSLGCLLYEMATFAPP-FEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPK 242
Query: 261 QRPDAKTLLSHP 272
RP+ +L+ P
Sbjct: 243 LRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 8e-50
Identities = 99/259 (38%), Positives = 145/259 (55%), Gaps = 7/259 (2%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
KY ++IG+GA G VY +D+ G VAIKQ++L+ +++L I+ EI +++ + N
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPN 77
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV YL S L +++EY+ GSL +++ E +A + L+ L +LH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN 134
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
VIHRDIK NIL +G VKL DFG ++T ++VGTPYWMAPEV+
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQCFK 256
DIWS+G IE++ PPY P+ AL+ I + P + PE LS DFL +C +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE 254
Query: 257 KDARQRPDAKTLLSHPWIQ 275
D +R AK LL HP+++
Sbjct: 255 MDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 4e-49
Identities = 98/350 (28%), Positives = 168/350 (48%), Gaps = 28/350 (8%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNH- 76
Y + ++G+G++G VY D + VA+K ++ + ++ ++EI +L +LNH
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKF-GPFPESLVAVYIAQVLEGLVYL 135
NIVK + L++++EYV+ GSL +++K GP ES +AQ+L L YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 136 HEQGVIHRDIKGANILTTKEG-LVKLADFGVATKLTEADVNTH------SVVGTPYWMAP 188
H +G+IHRDIK NIL ++G +VKL DFG+A L + + + VGTP +MAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 189 EVIEMSG---VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ------------ 233
EV+ ++SDIWS+G T+ ELLT +PP+ + A + ++
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 234 DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRN 293
P PE +S +D L++ KD + R + + LSH + + + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 294 VEENGSADAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAATHLSKS 343
S + + + ++S + ++ KEL + +
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHN 347
|
Length = 384 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 98/268 (36%), Positives = 148/268 (55%), Gaps = 16/268 (5%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH-KN 78
+ L + +G G YG+VYKG ++ G AIK + + +E+ I QEI++LK +H +N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---IKQEINMLKKYSHHRN 64
Query: 79 IVKYLGSLKTRS------HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGL 132
I Y G+ ++ L +++E+ GS+ ++IK K E +A ++L GL
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 133 VYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIE 192
+LH+ VIHRDIKG N+L T+ VKL DFGV+ +L ++ +GTPYWMAPEVI
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 193 MSGVCAA-----SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-PESLSPD 246
A SD+WS+G T IE+ PP ++ PM ALF I ++ P + + S
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244
Query: 247 ITDFLRQCFKKDARQRPDAKTLLSHPWI 274
F+ C K+ QRP + L+ HP+I
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 3e-48
Identities = 99/267 (37%), Positives = 145/267 (54%), Gaps = 18/267 (6%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKY 82
+ IGKG YG+VYK + ++G A+K L+ I+ D I E ++L++L NH N+VK+
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVK--ILDPISDVDEEI-EAEYNILQSLPNHPNVVKF 84
Query: 83 LGSLKTRSH-----LHIILEYVENGSLANIIKP--NKFGPFPESLVAVYIAQVLEGLVYL 135
G L ++LE GS+ ++K E++++ + L GL +L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM-- 193
H +IHRD+KG NIL T EG VKL DFGV+ +LT + ++ VGTP+WMAPEVI
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 194 ---SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDIT 248
A D+WS+G T IEL PP +++ P+ LF+I ++ P + PE
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFN 264
Query: 249 DFLRQCFKKDARQRPDAKTLLSHPWIQ 275
F+ QC KD RP LL HP+I+
Sbjct: 265 HFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-48
Identities = 95/282 (33%), Positives = 142/282 (50%), Gaps = 34/282 (12%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
+IG+G YG VYK D G+ VAIK++ L ++ ++EI LLK LNH NI+K L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ + L+++ E+++ L +IK + PESL+ Y+ Q+L+GL + H G++HR
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDRQR-GLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 144 DIKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVI-EMSGVCAASD 201
D+K N+L EG++KLADFG+A + TH VV T ++ APE++ G D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTPVD 181
Query: 202 IWSVGCTVIELLTCVP--------------------PYYELQP------MPALFRIVQDE 235
IWSVGC ELL+ P P E+ P F +
Sbjct: 182 IWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKA 241
Query: 236 RPPIPE---SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274
P+P+ + SP D L Q D +R A+ L+HP+
Sbjct: 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 5e-48
Identities = 97/259 (37%), Positives = 143/259 (55%), Gaps = 7/259 (2%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
KY ++IG+GA G VY +D+ G VAI+Q++L+ +++L I+ EI +++ + N
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPN 78
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV YL S L +++EY+ GSL +++ E +A + L+ L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN 135
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
VIHRDIK NIL +G VKL DFG ++T ++VGTPYWMAPEV+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQCFK 256
DIWS+G IE++ PPY P+ AL+ I + P + PE LS DFL +C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 257 KDARQRPDAKTLLSHPWIQ 275
D +R AK LL H +++
Sbjct: 256 MDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 4e-47
Identities = 80/257 (31%), Positives = 143/257 (55%), Gaps = 2/257 (0%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
KY+ +IG+G++G+ E+G IK++++ ++ ++ +E+ +L N+ H N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV+Y S + +L+I+++Y E G L I + FPE + + Q+ L ++H++
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
++HRDIK NI TK+G +KL DFG+A L + +GTPY+++PE+ E
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPAL-FRIVQDERPPIPESLSPDITDFLRQCFKK 257
SDIW++GC + E+ T + +E M L +I++ PP+ S D+ + + Q FK+
Sbjct: 181 KSDIWALGCVLYEMCT-LKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239
Query: 258 DARQRPDAKTLLSHPWI 274
+ R RP ++L +I
Sbjct: 240 NPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 89/256 (34%), Positives = 148/256 (57%), Gaps = 9/256 (3%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
+IG+G+ G V + +G VA+K + L Q+ ++ E+ ++++ H+N+V+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S L +++E+++ G+L +I+ + E +A VL+ L YLH QGVIHRD
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLN---EEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
IK +IL T +G VKL+DFG ++++ S+VGTPYWMAPEVI + DIWS
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES---LSPDITDFLRQCFKKDARQ 261
+G VIE++ PPY+ P+ A+ R+ +D PP ++ +SP + DFL + ++ ++
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPPKLKNAHKISPVLRDFLERMLTREPQE 261
Query: 262 RPDAKTLLSHPWIQNC 277
R A+ LL HP++
Sbjct: 262 RATAQELLDHPFLLQT 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-45
Identities = 90/254 (35%), Positives = 140/254 (55%), Gaps = 12/254 (4%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS----LENIAQEDLNIIMQEIDLLKNLN 75
+ + +IG+G + VY+ L + VA+K+V ++ A++D ++EIDLLK LN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQD---CVKEIDLLKQLN 60
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK--PNKFGPFPESLVAVYIAQVLEGLV 133
H N++KYL S + L+I+LE + G L+ +IK + PE V Y Q+ +
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
++H + V+HRDIK AN+ T G+VKL D G+ + HS+VGTPY+M+PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPYY--ELQPMPALFRIVQDERPPIP-ESLSPDITDF 250
+G SDIWS+GC + E+ P+Y ++ +I Q + PP+P E S + +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240
Query: 251 LRQCFKKDARQRPD 264
+ C D QRPD
Sbjct: 241 VSMCIYPDPDQRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 6e-44
Identities = 94/259 (36%), Positives = 141/259 (54%), Gaps = 11/259 (4%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLE-NIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
EIG G++G VY D+ N + VAIK++S + E I++E+ L+ L H N ++Y
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
G +++EY GS +++++ +K P E +A L+GL YLH +IHR
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI---EMSGVCAAS 200
D+K NIL ++ GLVKL DFG A+ + A+ VGTPYWMAPEVI +
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPAN----XFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES-LSPDITDFLRQCFKKDA 259
D+WS+G T IEL PP + + M AL+ I Q+E P + S +F+ C +K
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255
Query: 260 RQRPDAKTLLSHPWIQNCR 278
+ RP ++ LL H ++ R
Sbjct: 256 QDRPTSEVLLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 90/291 (30%), Positives = 139/291 (47%), Gaps = 39/291 (13%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
NKY + +G+GAYG V K + G+ VAIK+ ++ ++E+ +L+ L H+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NIV + + + L+++ EYVE +L +++ + G P V YI Q+L+ + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHS 118
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTE-ADVNTHSVVGTPYWMAPEVI---EM 193
+IHRDIK NIL ++ G++KL DFG A L V T ++ APE++
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPY---------YELQ----PMP----------ALFR 230
G D+W++GC + ELL P + Y +Q P+P F
Sbjct: 179 YG--KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 231 IVQDERPPIPESL--------SPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
V P PESL S DFL+ C + D ++R LL HP+
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 95/266 (35%), Positives = 140/266 (52%), Gaps = 18/266 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+G+GA G V K G A+K ++ + + I++E+++ K+ IVKY G+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 86 --LKTRSHLHIILEYVENGSLANIIKP-NKFGPFPESLVAVYIAQ-VLEGLVYLHEQGVI 141
++ S + I +EY E GSL +I K K G V IA+ VL+GL YLH + +I
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKII 127
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASD 201
HRDIK +NIL T++G VKL DFGV+ +L + T GT ++MAPE I+ SD
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT--FTGTSFYMAPERIQGKPYSITSD 185
Query: 202 IWSVGCTVIELLTC---VPPYYELQPMP--ALFRIVQDERPPIPESLSPDIT------DF 250
+WS+G T++E+ PP E P L IV P + + I DF
Sbjct: 186 VWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDF 245
Query: 251 LRQCFKKDARQRPDAKTLLSHPWIQN 276
++QC +KD +RP +L HPWI+
Sbjct: 246 IKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 90/254 (35%), Positives = 140/254 (55%), Gaps = 12/254 (4%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI----AQEDLNIIMQEIDLLKNLN 75
+ + +IG+G + VY+ L +G VA+K+V + ++ A+ D ++EIDLLK LN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD---CIKEIDLLKQLN 60
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGP--FPESLVAVYIAQVLEGLV 133
H N++KY S + L+I+LE + G L+ +IK K PE V Y Q+ L
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
++H + V+HRDIK AN+ T G+VKL D G+ + HS+VGTPY+M+PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPYY--ELQPMPALFRIVQDERPPIP-ESLSPDITDF 250
+G SDIWS+GC + E+ P+Y ++ +I Q + PP+P + S ++
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240
Query: 251 LRQCFKKDARQRPD 264
+ C D +RPD
Sbjct: 241 VNMCINPDPEKRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 4e-43
Identities = 89/253 (35%), Positives = 144/253 (56%), Gaps = 9/253 (3%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
+IG+G+ G V +G VA+K++ L Q+ ++ E+ ++++ H+N+V+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S L +++E++E G+L +I+ + E +A VL+ L LH QGVIHRD
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMN---EEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
IK +IL T +G VKL+DFG ++++ S+VGTPYWMAPE+I DIWS
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL---SPDITDFLRQCFKKDARQ 261
+G VIE++ PPY+ P+ A+ ++++D PP ++L SP + FL + +D Q
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 262 RPDAKTLLSHPWI 274
R A LL HP++
Sbjct: 261 RATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 88/294 (29%), Positives = 143/294 (48%), Gaps = 52/294 (17%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQV-----SLENIAQEDLNIIMQEIDLLKNL 74
Y + ++G G +G VY + E G+ VAIK++ S E E +N ++E+ L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE----ECMN--LREVKSLRKL 54
Query: 75 N-HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
N H NIVK + L+ + EY+E G+L ++K K PF ES++ I Q+L+GL
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
++H+ G HRD+K N+L + +VK+ADFG+A ++ T V T ++ APE++
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-DYVSTRWYRAPEILLR 172
Query: 194 SGV-CAASDIWSVGCTVIELLTCVPPYYELQP----MPALFRIVQ--------------- 233
S + DIW++GC + EL T P L P + L++I
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRP----LFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228
Query: 234 ---------DERPPIPE-----SLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
+ P + SP+ D ++ + D ++RP A L HP+
Sbjct: 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 2e-42
Identities = 94/259 (36%), Positives = 141/259 (54%), Gaps = 11/259 (4%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLE-NIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
EIG G++G VY + + VA+K++S E I++E+ L+ L H N ++Y
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
G +++EY GS +++++ +K P E +A L+GL YLH +IHR
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI---EMSGVCAAS 200
DIK NIL T+ G VKLADFG A+K + A+ S VGTPYWMAPEVI +
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSSPAN----SFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPD-ITDFLRQCFKKDA 259
D+WS+G T IEL PP + + M AL+ I Q++ P + + D F+ C +K
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIP 261
Query: 260 RQRPDAKTLLSHPWIQNCR 278
++RP + LL H +++ R
Sbjct: 262 QERPASAELLRHDFVRRDR 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 88/268 (32%), Positives = 135/268 (50%), Gaps = 14/268 (5%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
DE+GKG YG VYK L G +A+K++ LE + + N I+ E+D+L IV +
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 84 GSLKTRSHLHIILEYVENGSLANII-KPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVI 141
G+ +++ +EY++ GSL + PE ++ V++GL +L E+ +I
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA-- 199
HRD+K N+L G VKL DFGV+ L + T+ +G +MAPE I+ G
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQNPT 183
Query: 200 ----SDIWSVGCTVIEL-LTCVP--PYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252
SD+WS+G +++E+ L P P L IV + P +P S D DF+
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA 243
Query: 253 QCFKKDARQRPDAKTLLSHPWIQNCRRA 280
+C K +RP LL HPW+ + A
Sbjct: 244 KCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 2e-42
Identities = 78/262 (29%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA---QEDLNIIMQEIDLLKNLNH 76
+ +G G++GRV +G + A+K +S I Q + ++ E +L+++ H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH--VLNEKRILQSIRH 60
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
+V GS + S+L++++EYV G L + ++ K G FPE + Y AQV+ L YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPVARFYAAQVVLALEYLH 118
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
+++RD+K N+L +G +K+ DFG A ++ T+++ GTP ++APE+I G
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLCGTPEYLAPEIILSKGY 175
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
A D W++G + E+L PP+++ P+ +I++ + P SPD D +R +
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIRNLLQ 234
Query: 257 KDARQR-----PDAKTLLSHPW 273
D +R + +HPW
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 78/260 (30%), Positives = 124/260 (47%), Gaps = 12/260 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL-NIIMQEIDLLKNLNHKNIVKYLG 84
+G G +GRV A+K V +I + I E ++L+ NH IVK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ K + ++++++EY G L I++ G F E YIA V+ YLH +G+I+RD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR--DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K N+L G VKL DFG A KL ++ T + GTP ++APE+I G + D WS
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKL-KSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177
Query: 205 VGCTVIELLTCVPPYYELQPMP-ALFRIVQDERPPI--PESLSPDITDFLRQCFKKDARQ 261
+G + ELLT PP+ E P ++ + + P + D ++Q +++ +
Sbjct: 178 LGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
Query: 262 R-----PDAKTLLSHPWIQN 276
R K + H W
Sbjct: 238 RLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 3e-42
Identities = 91/292 (31%), Positives = 141/292 (48%), Gaps = 39/292 (13%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI--AQEDLNI-IMQEIDLLKNLN 75
+Y G ++G+G Y VYK D E G VAIK++ L A++ +N ++EI LL+ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
H NI+ L +S+++++ E++E L +IK +K + + Y+ L GL YL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIK-DKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN-THSVVGTPYWMAPEVI--- 191
H ++HRD+K N+L +G++KLADFG+A + TH VV T ++ APE++
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGA 177
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYY---------------------ELQPMPALFR 230
GV D+WSVGC ELL VP + +L
Sbjct: 178 RHYGV--GVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235
Query: 231 IVQ-DERPPIP-----ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
V+ PP P + S D D L++ + +R A+ L HP+ N
Sbjct: 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 88/253 (34%), Positives = 142/253 (56%), Gaps = 7/253 (2%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
+IG+G+ G V + G VA+K++ L Q+ ++ E+ ++++ +H+N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S L +++E++E G+L +I+ + E +A VL L YLH QGVIHRD
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMN---EEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
IK +IL T +G +KL+DFG ++++ S+VGTPYWMAPEVI DIWS
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES--LSPDITDFLRQCFKKDARQR 262
+G VIE++ PPY+ P+ A+ RI + P + +S +S + FL ++ QR
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR 263
Query: 263 PDAKTLLSHPWIQ 275
A+ LL HP+++
Sbjct: 264 ATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 90/290 (31%), Positives = 147/290 (50%), Gaps = 41/290 (14%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+Y + IG+GA+G V+K D E G+ VA+K+V+L + N ++EI L+ H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+VK L S +++EY+ L+ +++ ++ P PE+ V Y+ +L+G+ Y+H
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS-VVGTPYWMAPEVIEMS--- 194
G++HRD+K AN+L + +G++K+ADFG+A +E + +S V T ++ APE++ +
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 195 --GVCAASDIWSVGCTVIELLTCVP--------------------PYYELQP----MPAL 228
GV D+W+VGC ELL P P E P +P
Sbjct: 179 DPGV----DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234
Query: 229 FRIVQDERPPIP-ESLSPDIT----DFLRQCFKKDARQRPDAKTLLSHPW 273
+I E PIP E + PD + D L+ D +R A L HP+
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 84/252 (33%), Positives = 133/252 (52%), Gaps = 1/252 (0%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+Y + +G+G++GR + + A+K++ L + + +E LL + H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP-KSSSAVEDSRKEAVLLAKMKHPN 59
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV + S + HL+I++EY + G L IK + FPE + + Q+ G+ ++HE+
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
V+HRDIK NI T+ G VKL DFG A LT + VGTPY++ PE+ E
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SDIWS+GC + EL T P+ + ++ Q P+P S ++ ++Q FK++
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239
Query: 259 ARQRPDAKTLLS 270
R RP A T+LS
Sbjct: 240 PRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 7e-42
Identities = 94/255 (36%), Positives = 141/255 (55%), Gaps = 11/255 (4%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLE-NIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
EIG G++G VY D+ + VAIK++S + E I++E+ L+ + H N ++Y
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
G +++EY GS +++++ +K P E +A L+GL YLH +IHR
Sbjct: 92 GCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI---EMSGVCAAS 200
DIK NIL T+ G VKLADFG A+ + A+ S VGTPYWMAPEVI +
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPAN----SFVGTPYWMAPEVILAMDEGQYDGKV 205
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPD-ITDFLRQCFKKDA 259
D+WS+G T IEL PP + + M AL+ I Q+E P + + D +F+ C +K
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265
Query: 260 RQRPDAKTLLSHPWI 274
+ RP ++ LL H ++
Sbjct: 266 QDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 88/295 (29%), Positives = 142/295 (48%), Gaps = 56/295 (18%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNHKNIVKY 82
+IG+G YG+VYK + + G+ VA+K++ +EN +E I ++EI LL+ L H NIV+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 83 LGSL--KTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+ K + ++++ EY+++ L ++ + F ES + Y+ Q+LEGL YLH G+
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLD-SPEVKFTESQIKCYMKQLLEGLQYLHSNGI 121
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLT--EADVNTHSVVGTPYWMAPEVI---EMSG 195
+HRDIKG+NIL +G++KLADFG+A T + T+ V+ T ++ PE++ G
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYG 180
Query: 196 VCAASDIWSVGCTVIELLTCVP--------------------------------PYYEL- 222
D+WSVGC + EL P P++E
Sbjct: 181 --PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238
Query: 223 ---QPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274
+P R P +L D L + D ++R A L H +
Sbjct: 239 KPKKPYKRRLREFFKHLID-PSAL-----DLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-41
Identities = 81/257 (31%), Positives = 138/257 (53%), Gaps = 3/257 (1%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y +GKG+YG V +G IK+++L N ++ + QE LL L H NI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 80 VKYLGSLKTRS-HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
V Y S + L+I++ + E G L + +K K PE+ V + Q+ L YLHE+
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
++HRD+K N+ T+ ++K+ D G+A L +++GTPY+M+PE+
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPAL-FRIVQDERPPIPESLSPDITDFLRQCFKK 257
SD+W++GC V E+ T + + + M +L +RI++ + PP+P+ SP++ + + K
Sbjct: 182 KSDVWALGCCVYEMAT-LKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK 240
Query: 258 DARQRPDAKTLLSHPWI 274
+RP K++L P+I
Sbjct: 241 RPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 84/261 (32%), Positives = 133/261 (50%), Gaps = 16/261 (6%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLEN-IAQEDL-NIIMQEIDLLKNLNHKNIVKY 82
I KGA+G VY GD+ AIK + + IA+ + N+ + ++ + K
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
S +++ +L++++EY+ G A++IK G PE YIA+V+ G+ LH++G+IH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RDIK N+L + G +KL DFG L+ + VGTP ++APE I G SD
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFG----LSRNGLENKKFVGTPDYLAPETILGVGDDKMSDW 176
Query: 203 WSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP----ESLSPDITDFLRQCFKKD 258
WS+GC + E L PP++ P A+F + R P E SP+ D + + D
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETP-DAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 259 ARQRPDAK---TLLSHPWIQN 276
+R A + SHP+ ++
Sbjct: 236 PAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 5e-41
Identities = 78/257 (30%), Positives = 137/257 (53%), Gaps = 1/257 (0%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+Y + +IG+G++G++Y + + IK++ L + ++ +E+ LL + H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV + S + L I++EY + G L I + F E + + Q+ GL ++H++
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 139 GVIHRDIKGANILTTKEGLV-KLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC 197
++HRDIK NI +K G+V KL DFG+A +L ++ ++ VGTPY+++PE+ +
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 198 AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257
+DIWS+GC + EL T P+ + +I Q PI + S D+ + Q FK
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV 240
Query: 258 DARQRPDAKTLLSHPWI 274
R RP ++L P++
Sbjct: 241 SPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-41
Identities = 91/292 (31%), Positives = 135/292 (46%), Gaps = 44/292 (15%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIM-QEIDLLKNL---N 75
Y EIG+GAYG VYK DL G FVA+K+V + ++E + + +EI LLK L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFE 59
Query: 76 HKNIVKYL----GSLKTRS-HLHIILEYVE---NGSLANIIKPNKFGPFPESLVAVYIAQ 127
H NIV+ L G R L ++ E+V+ L+ KP P + + Q
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG----LPPETIKDLMRQ 115
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
+L G+ +LH ++HRD+K NIL T +G VK+ADFG+A + T SVV T ++ A
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT-SVVVTLWYRA 174
Query: 188 PEVIEMSGVCAASDIWSVGCTVIELLTCVP---PYYELQPMPALFRIV----QDE----- 235
PEV+ S D+WSVGC EL P E + +F ++ ++E
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234
Query: 236 ---------RPPIPE-----SLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
P + + D L++ + +R A L HP+
Sbjct: 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 2e-40
Identities = 75/249 (30%), Positives = 133/249 (53%), Gaps = 4/249 (1%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+G+GA+G V+ + V IKQ+ +E + +++ E +LK L+H NI++Y +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDI 145
L I++EY G+LA I+ E + + Q+L L ++H + ++HRD+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 146 KGANILTTK-EGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
K NIL K + +VK+ DFG+ +K+ + ++VVGTP +++PE+ E SDIW+
Sbjct: 128 KTQNILLDKHKMVVKIGDFGI-SKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWA 186
Query: 205 VGCTVIELLTCVPPYYELQPMPAL-FRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
+GC + EL + + +E +PAL +I+ PI + SPD+ + D +RP
Sbjct: 187 LGCVLYELAS-LKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRP 245
Query: 264 DAKTLLSHP 272
+++ P
Sbjct: 246 QLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 75/254 (29%), Positives = 129/254 (50%), Gaps = 8/254 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLEN-IAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IGKGA+G+V + A+K ++ + + + + ++ E +L+ LNH +V
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S + +++++++ + G L + ++ F E V +I +++ L YLH +G+IHRD
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRD 125
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
IK NIL ++G V + DF +ATK+T D T S GTP +MAPEV+ G A D WS
Sbjct: 126 IKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWS 184
Query: 205 VGCTVIELLTCVPPYY--ELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262
+G T E L PY + + P + S + D + + ++D ++R
Sbjct: 185 LGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244
Query: 263 --PDAKTLLSHPWI 274
+ K L +HP+
Sbjct: 245 LGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 93/269 (34%), Positives = 142/269 (52%), Gaps = 12/269 (4%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
L++ LG EIG G G+VYK + G +A+KQ+ +E+ I+M +LK+
Sbjct: 13 DLNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH 71
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
+ IVK G T S + I +E + + + + GP PE ++ +++ L Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 135 LHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
L E GVIHRD+K +NIL G VKL DFG++ +L ++ T S G +MAPE I+
Sbjct: 130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPERIDP 188
Query: 194 SGVCAA----SDIWSVGCTVIELLTCVPPYYELQ-PMPALFRIVQDERPPIP--ESLSPD 246
+D+WS+G +++EL T PY + L +I+Q+E P +P E SPD
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248
Query: 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
F+ C KD R+RP + LL HP+I+
Sbjct: 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 87/289 (30%), Positives = 141/289 (48%), Gaps = 39/289 (13%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLN---IIMQEIDLLKNLN 75
KY +IG+G+YG V+K + E G VAIK+ +E +++D I ++EI +LK L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF-VE--SEDDPVIKKIALREIRMLKQLK 58
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
H N+V + + + LH++ EY ++ ++ N ++ N G PE L+ I Q L+ + +
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFC 116
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
H+ IHRD+K NIL TK+G +KL DFG A LT + V T ++ APE++
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 196 VCAAS-DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ--------------------- 233
D+W++GC ELLT P + + L+ I +
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236
Query: 234 ------DERPPIPE---SLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
+ R P+ ++S FL+ C + D +R + LL HP+
Sbjct: 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 85/264 (32%), Positives = 142/264 (53%), Gaps = 17/264 (6%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL-LKNLNHKNIVKY 82
+E+G+GAYG V K + G +A+K++ +QE ++M ++D+ +++++ V +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLM-DLDISMRSVDCPYTVTF 65
Query: 83 LGSLKTRSHLHIILEYVENGSL----ANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
G+L + I +E V + SL + PE ++ +++ L YLH +
Sbjct: 66 YGALFREGDVWICME-VMDTSLDKFYKKVYDKGLT--IPEDILGKIAVSIVKALEYLHSK 122
Query: 139 -GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI----EM 193
VIHRD+K +N+L + G VKL DFG++ L ++ T PY MAPE I
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPY-MAPERINPELNQ 181
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPYYELQ-PMPALFRIVQDERPPIP-ESLSPDITDFL 251
G SD+WS+G T+IEL T PY + P L ++V++ P +P E SP+ DF+
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFV 241
Query: 252 RQCFKKDARQRPDAKTLLSHPWIQ 275
+C KK+ ++RP+ LL HP+ +
Sbjct: 242 NKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 86/270 (31%), Positives = 137/270 (50%), Gaps = 21/270 (7%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL-NIIMQEIDLLKNLNHKNIVKYL 83
++G G G V K + G +A K V + A+ + I++E+ ++ IV +
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH-EQGVIH 142
G+ +++ + +E+++ GSL I K K GP P ++ V+EGL YL+ ++H
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RDIK +NIL G +KL DFGV+ +L + +T VGT +M+PE I+ SD+
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--FVGTSTYMSPERIQGGKYTVKSDV 185
Query: 203 WSVGCTVIELLTCVPPY--------YELQPMPA---LFRIVQDERPPIPES-LSPDITDF 250
WS+G ++IEL P+ + PM L +IVQ+ P +P S D+ DF
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF 245
Query: 251 LRQCFKKDARQRPDAKTLL-SHPWIQNCRR 279
+ C KD +RP + L P+IQ R
Sbjct: 246 VDACLLKDPTERPTPQQLCAMPPFIQALRA 275
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 76/303 (25%), Positives = 132/303 (43%), Gaps = 44/303 (14%)
Query: 22 LGDEIGKGAYGR--VYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
L IGK V+ VA+K+++L++ ++EDL ++ QEI + L H NI
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
+ Y+ S S L+++ + GS +++K + PE +A + VL L Y+H +G
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTP-------YWMAPEVIE 192
IHR +K ++IL + +G V L+ + + + V P W++PEV++
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 193 --MSGVCAASDIWSVGCTVIELLTCVPPYYELQP-----------MPAL-----FRIVQD 234
+ G SDI+SVG T EL P+ ++ +P L + + +D
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241
Query: 235 ERPPIPE-----------------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277
+ S F+ C ++D RP A LL+H + + C
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301
Query: 278 RRA 280
+R
Sbjct: 302 KRR 304
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 90/280 (32%), Positives = 140/280 (50%), Gaps = 32/280 (11%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
++IG+G YG VYK + G+ VA+K++ L+ + + ++EI LLK LNH NIVK L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ T + L+++ E++ + L + + P L+ Y+ Q+L+GL + H V+HR
Sbjct: 66 DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 144 DIKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVIEMSGVCA-ASD 201
D+K N+L EG +KLADFG+A TH VV T ++ APE++ + A D
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVD 183
Query: 202 IWSVGCTVIELLT---CVPPYYELQPMPALFRIV--------------QDERPPIPE--- 241
IWS+GC E++T P E+ + +FR + D +P P+
Sbjct: 184 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR 243
Query: 242 --------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
L D D L Q D +R AK L+HP+
Sbjct: 244 QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 1e-37
Identities = 82/259 (31%), Positives = 133/259 (51%), Gaps = 17/259 (6%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
+ +G G G VYK L +A+K + L+ I E IM E+++L + I+ +
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
G+ + + I E+++ GSL + + PE ++ V++GL YL ++HR
Sbjct: 66 GAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHR 119
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K +N+L G VKL DFGV+T+L + T+ VGT +MAPE I SD+W
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY--VGTNAYMAPERISGEQYGIHSDVW 177
Query: 204 SVGCTVIELLTCVPPYYELQ-------PMPALFRIVQDERPPIPESL-SPDITDFLRQCF 255
S+G + +EL PY ++Q P+ L IV ++ P +P S F+ QC
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCM 237
Query: 256 KKDARQRPDAKTLLSHPWI 274
+K ++RP + L+ HP+I
Sbjct: 238 RKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 96/290 (33%), Positives = 146/290 (50%), Gaps = 39/290 (13%)
Query: 18 NKY-MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLN-IIMQEIDLLKNLN 75
KY LG +G+G+YG V K E G VAIK+ LE+ + + I M+EI +LK L
Sbjct: 1 EKYENLG-LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLR 58
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK-PNKFGPFPESLVAVYIAQVLEGLVY 134
H+N+V + + + L+++ E+V++ L ++ K PN ES V Y+ Q+L G+ +
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLD---ESRVRKYLFQILRGIEF 115
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE-VIEM 193
H +IHRDIK NIL ++ G+VKL DFG A L V T ++ APE ++
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 194 SGVCAASDIWSVGCTVIELLT-------------------CV----PPYYEL---QPMPA 227
+ A DIW+VGC V E+LT C+ P + E+ P+ A
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235
Query: 228 LFRIVQ-DERPPIPE---SLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
R+ + E P+ + LS + D +QC + D RP + LL H +
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-37
Identities = 89/291 (30%), Positives = 143/291 (49%), Gaps = 45/291 (15%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
E+G G G V K L +G +A K + LE I N I++E+ +L N IV + G
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHR 143
+ + + I +E+++ GSL ++K K G PE+++ VL GL YL E+ ++HR
Sbjct: 67 AFYSDGEISICMEHMDGGSLDQVLK--KAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K +NIL G +KL DFGV+ +L ++ N S VGT +M+PE ++ + SDIW
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYTVQSDIW 182
Query: 204 SVGCTVIELLTCV------------------------------PPYY---ELQPMPALFR 230
S+G +++E+ + +PM A+F
Sbjct: 183 SLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM-AIFE 241
Query: 231 ----IVQDERPPIPES-LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
IV + P +P S + DF+ +C KK+ ++R D K L HP+I+
Sbjct: 242 LLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 39/286 (13%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLEN-IAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V+ D + G A+K + + I + + + E D+L + + IVK
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S + HL++++EY+ G L N++ + FPE YIA+++ L +H+ G IHRD
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFYIAELVLALDSVHKLGFIHRD 126
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEAD-----------------------------VN 175
IK NIL +G +KLADFG+ K+ +A V
Sbjct: 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186
Query: 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE 235
+S VGTP ++APEV+ + D WS+G + E+L PP+Y +I+ +
Sbjct: 187 ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWK 246
Query: 236 R----PPIPESLSPDITDFLRQCFKKDARQRPD-AKTLLSHPWIQN 276
PP P +SP+ D + + D R + + SHP+ +
Sbjct: 247 ESLRFPPDPP-VSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 85/273 (31%), Positives = 138/273 (50%), Gaps = 36/273 (13%)
Query: 25 EIGKGAYGRVYKG-LDLEN---GDFVAIK--QVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
++G+G +G+V D G+ VA+K S E + D +EI++L+ L+H+N
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE---REIEILRTLDHEN 67
Query: 79 IVKYLG---SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
IVKY G RS +I+EY+ +GSL + ++ ++ + L+ ++ +Q+ +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLR-LIMEYLPSGSLRDYLQRHRDQINLKRLL-LFSSQICKGMDYL 125
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTP-----YWMAPEV 190
Q IHRD+ NIL E LVK++DFG+A L E + V P +W APE
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK--DYYYVKEPGESPIFWYAPEC 183
Query: 191 IEMSGVCAASDIWSVGCTVIELLT-----CVPP------YYELQPMPALFRIVQ----DE 235
+ S +ASD+WS G T+ EL T PP Q + R+++ E
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTL 268
R P P S ++ D ++ C++ + + RP L
Sbjct: 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 82/264 (31%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID-LLKNLNHKNIVKYL 83
EIG+GA+G V K L +G +A+K++ +E ++M ++D ++++ + IVK+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLM-DLDVVMRSSDCPYIVKFY 69
Query: 84 GSLKTRSHLHIILEYVENGSLAN---IIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-G 139
G+L I +E ++ SL + PE ++ ++ L YL E+
Sbjct: 70 GALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA- 198
+IHRD+K +NIL + G +KL DFG++ +L ++ T PY MAPE I+ S
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPSARDGY 187
Query: 199 --ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-----PESLSPDITDFL 251
SD+WS+G T+ E+ T PY + + V PPI SP +F+
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247
Query: 252 RQCFKKDARQRPDAKTLLSHPWIQ 275
C KD +RP K LL HP+I+
Sbjct: 248 NLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 88/282 (31%), Positives = 141/282 (50%), Gaps = 35/282 (12%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
++IG+G YG VYKG + + G VA+K++ LE+ + + ++EI LLK L H NIV
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 84 GSLKTRSHLHIILEYV--ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
L S L++I E++ + + + ++ LV Y+ Q+L+G+++ H + V+
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGILFCHSRRVL 123
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVIEMSGVCAAS 200
HRD+K N+L +G++KLADFG+A V TH VV T ++ APEV+ S +
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTP 182
Query: 201 -DIWSVGCTVIELLTCVPPYYELQPMPALFRI-----------------VQDERPPIP-- 240
DIWS+G E+ T P ++ + LFRI + D + P
Sbjct: 183 VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKW 242
Query: 241 ---------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
++L D D L + D +R AK L+HP+
Sbjct: 243 KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 92/300 (30%), Positives = 137/300 (45%), Gaps = 44/300 (14%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+Y L IG GAYG V +D G VAIK++S D I++EI LL++L H+N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 79 IVKYL-----GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
I+ L S + + ++I+ E +E L +IK + P + + ++ Q+L GL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLK 117
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVA----TKLTEADVNTHSVVGTPYWMAPE 189
YLH VIHRD+K +NIL +K+ DFG+A E T VV T ++ APE
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPE 176
Query: 190 VIEMSGVC-AASDIWSVGCTVIELLT---------------------CVPPYYELQPMP- 226
++ S A DIWSVGC ELLT P +L+ +
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236
Query: 227 --ALFRIVQD-ERPPIP-ESLSPDIT----DFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278
A + ++P P L P + D L + D ++R A L+HP++
Sbjct: 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 91/286 (31%), Positives = 136/286 (47%), Gaps = 48/286 (16%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI---IMQEIDLLKNLNHKNIVKY 82
IG+G YG VYK D G+ VA+K++ LE ED + ++EI LLK LNH NIV+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE---TEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
L + + + L+++ E++ + L + + L+ Y+ Q+L+G+ Y H V+H
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLH 122
Query: 143 RDIKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVIEMS-----GV 196
RD+K N+L +EG +KLADFG+A TH VV T ++ APE++ S V
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPV 181
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV------------------------ 232
DIWS+GC E++ P + + LFRI
Sbjct: 182 ----DIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237
Query: 233 -----QDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
QD +P +L D D L + D +R AK L HP+
Sbjct: 238 PKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 85/263 (32%), Positives = 137/263 (52%), Gaps = 10/263 (3%)
Query: 19 KYMLGDEIGKGAYGRVYKGLD---LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
+Y+L +GKG++G VY D + +K++ + + + QE LL L+
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFG--PFPESLVAVYIAQVLEGLV 133
H IVK+ S R II EY E L ++ K E+ V + Q+L G+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT-EADVNTHSVVGTPYWMAPEVIE 192
Y+H++ ++HRD+K NI K L+K+ DFGV+ L D+ T + GTPY+M+PE ++
Sbjct: 121 YMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLAT-TFTGTPYYMSPEALK 178
Query: 193 MSGVCAASDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQDERPPIPESLSPDITDFL 251
G + SDIWS+GC + E + C+ +E Q + + RIV+ P +PE+ S + +
Sbjct: 179 HQGYDSKSDIWSLGCILYE-MCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237
Query: 252 RQCFKKDARQRPDAKTLLSHPWI 274
+ KD RP A +L +P+I
Sbjct: 238 QSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 79/259 (30%), Positives = 134/259 (51%), Gaps = 15/259 (5%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENG-DFVAIKQVSLENIA------QEDLNI--IMQEIDL 70
Y + + +G GA+G VYK NG + +A+K++++ N A + D +I I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 71 LK-NLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKP--NKFGPFPESLVAVYIAQ 127
+K L H NIV+Y + L+I+++ +E L K F E + Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 128 VLEGLVYLH-EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWM 186
++ L YLH E+ ++HRD+ NI+ ++ V + DFG+A + T SVVGT +
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLT-SVVGTILYS 180
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL-SP 245
PE+++ +D+W+ GC + ++ T PP+Y + +IV+ P+PE + S
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 246 DITDFLRQCFKKDARQRPD 264
D+TD + C DA RPD
Sbjct: 241 DVTDVITSCLTPDAEARPD 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 88/283 (31%), Positives = 139/283 (49%), Gaps = 38/283 (13%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL-NIIMQEIDLLKNLNHKNIVKY 82
+++G+G Y VYKG + G+ VA+K++ L+ A+E + ++EI L+K L H+NIV+
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELKHENIVRL 63
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
+ T + L ++ EY++ + G + V + Q+L+G+ + HE V+H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV-VGTPYWMAPEVIEMSGVCAAS- 200
RD+K N+L K G +KLADFG+A VNT S V T ++ AP+V+ S + S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFG-IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182
Query: 201 DIWSVGCTVIELLTCVPPYY----ELQPMPALFRIV------------------------ 232
DIWSVGC + E++T P + E Q + +FRI+
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEYKPTFPRY 241
Query: 233 --QDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
QD + P P D L + + + R A L HPW
Sbjct: 242 PPQDLQQLFP-HADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 77/252 (30%), Positives = 124/252 (49%), Gaps = 8/252 (3%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
LG IG+G +G VY+G+ EN VA+K + +QE +++ +H +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IVK +G + T + + I++E G L + ++ NK+ SL+ +Y Q+ L YL +
Sbjct: 69 IVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLI-LYSYQLSTALAYLESK 126
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVC 197
+HRDI N+L + VKL DFG++ L + S P WMAPE I
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 198 AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
+ASD+W G + E+L V P+ ++ + RI ER P+P + P + + +C+
Sbjct: 187 SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 246
Query: 257 KDARQRPDAKTL 268
D +RP L
Sbjct: 247 YDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 11/254 (4%)
Query: 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
E+G G +G V+ G VAIK + ++++D ++E ++ L+H N+V
Sbjct: 7 TFLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDF---IEEAKVMMKLSHPNLV 62
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+ G + + I+ EY+ NG L N ++ K G + + V E + YL G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY---WMAPEVIEMSGVC 197
IHRD+ N L ++ +VK++DFG+A + + D T S GT + W PEV + S
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSS-QGTKFPVKWAPPEVFDYSRFS 179
Query: 198 AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
+ SD+WS G + E+ + PY + + R P+ ++ + C+
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWH 239
Query: 257 KDARQRPDAKTLLS 270
+ RP K LLS
Sbjct: 240 EKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 65/205 (31%), Positives = 113/205 (55%), Gaps = 6/205 (2%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIV 80
+G+ +G G++GRV G++ AIK + I + + + + QE +L L+H IV
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+ S + + ++ +LE+V G L ++ K G FP + Y A+++ YLH + +
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS 200
I+RD+K N+L +G VK+ DFG A K+ + T ++ GTP ++APEVI+ G A
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---RTFTLCGTPEYLAPEVIQSKGHGKAV 196
Query: 201 DIWSVGCTVIELLTCVPPYYELQPM 225
D W++G + E + PP+++ P
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTPF 221
|
Length = 329 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 77/197 (39%), Positives = 116/197 (58%), Gaps = 9/197 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII-MQEIDLLKNLNHKNIVKYLG 84
IG+G YG VY+ D +G+ VA+K+V ++N ++ + I ++EI LL NL H NIV+ L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNLRHPNIVE-LK 72
Query: 85 SLKTRSHLH---IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
+ HL +++EY E LA+++ N PF ES V + Q+L GL YLHE +I
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLD-NMPTPFSESQVKCLMLQLLRGLQYLHENFII 130
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI-EMSGVCAAS 200
HRD+K +N+L T +G +K+ADFG+A V T ++ APE++ + A
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190
Query: 201 DIWSVGCTVIELLTCVP 217
D+W+VGC + ELL P
Sbjct: 191 DMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 79/257 (30%), Positives = 124/257 (48%), Gaps = 24/257 (9%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQ---EIDLLKNLNHKNIVKY 82
I GAYG VY E A+K+++ +N+ N I Q E D+L + +V
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILR--NQIQQVFVERDILTFAENPFVVSM 66
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
S +T+ HL +++EYVE G A ++K G P + +Y A+ + L YLH G++H
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLALEYLHNYGIVH 124
Query: 143 RDIKGANILTTKEGLVKLADFGV--------ATKLTEADVNTHS-------VVGTPYWMA 187
RD+K N+L T G +KL DFG+ T L E + + V GTP ++A
Sbjct: 125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIA 184
Query: 188 PEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD--ERPPIPESLSP 245
PEVI G D W++G + E L P++ P +++ D E P E+L
Sbjct: 185 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPA 244
Query: 246 DITDFLRQCFKKDARQR 262
D D + + +++ +R
Sbjct: 245 DAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-33
Identities = 87/319 (27%), Positives = 140/319 (43%), Gaps = 64/319 (20%)
Query: 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII-MQEI 68
F+ L + Y + ++G+G +G VYK ++ G VA+K++ + N ++ I ++EI
Sbjct: 1 FYGCSKLRD-YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREI 58
Query: 69 DLLKNLNHKNIVKYL--------GSLKTRSHLHIILEYVE---NGSLANIIKPNKFGPFP 117
+LK L H N+V + S + R ++++ Y++ +G L N P+
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN---PSV--KLT 113
Query: 118 ESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA----------- 166
ES + Y+ Q+LEG+ YLHE ++HRDIK ANIL +G++K+ADFG+A
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 167 TKLTEADVNTHSVVGTPYWMAPEVIEMSGVC---AASDIWSVGCTVIELLT--------- 214
++V T ++ PE++ G A DIW +GC E+ T
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELL--LGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231
Query: 215 -----------CVPPYYELQP----MP-ALFRIVQDERPPIPE----SLSPDITDFLRQC 254
C P E P +P P E L P+ D L +
Sbjct: 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKL 291
Query: 255 FKKDARQRPDAKTLLSHPW 273
D +R A L HP+
Sbjct: 292 LSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 81/258 (31%), Positives = 135/258 (52%), Gaps = 13/258 (5%)
Query: 26 IGKGAYGRVY---KGLDLENGDFVAIKQVSLENIA--QEDLNIIMQEIDLLKNLNHKNIV 80
+GKG YG+V+ K + G A+K + I Q+D E ++L+ + H IV
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+ + +T L++ILEY+ G L + + G F E Y++++ L +LH+QG+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS 200
I+RD+K NIL +G VKL DFG+ + TH+ GT +MAPE++ SG A
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAV 181
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260
D WS+G + ++LT PP+ + +I++ + +P L+P+ D L++ K++
Sbjct: 182 DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-KLNLPPYLTPEARDLLKKLLKRNPS 240
Query: 261 QR-----PDAKTLLSHPW 273
R DA + SHP+
Sbjct: 241 SRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 71/238 (29%), Positives = 127/238 (53%), Gaps = 7/238 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSL-ENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
+G G +GRV+ D + + A+K +++ E I + + E +LK ++H I++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ + L++++EYV G L + ++ + G F S Y ++++ L YLH + +++RD
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K NIL KEG +KL DFG A KL + T ++ GTP ++APEVI+ G A D W+
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWA 183
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262
+G + E+L PP+++ P +I+ + P L D +++ D +R
Sbjct: 184 LGILIYEMLVGYPPFFDDNPFGIYEKILAG-KLEFPRHLDLYAKDLIKKLLVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 7e-33
Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 34/272 (12%)
Query: 25 EIGKGAYGRV----YKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
+G+G +G+V Y + G+ VA+K + E Q +EI++LK L H+NIV
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK-KEINILKTLYHENIV 69
Query: 81 KYLG--SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
KY G S + L +I+EYV GSL + + +K + + ++ Q+ EG+ YLH Q
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN---LAQLLLFAQQICEGMAYLHSQ 126
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV------NTHSVVGTPYWMAPEVIE 192
IHRD+ N+L + LVK+ DFG+A + E + S V +W A E ++
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FWYAVECLK 183
Query: 193 MSGVCAASDIWSVGCTVIELLTCVPPYYE--------LQPMPALFRIV-------QDERP 237
+ ASD+WS G T+ ELLT + P +V + R
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243
Query: 238 PIPESLSPDITDFLRQCFKKDARQRPDAKTLL 269
P P++ ++ ++ C++ +A+ RP ++L+
Sbjct: 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 8e-33
Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 17/265 (6%)
Query: 26 IGKGAYGRVY---KGLDLENGDFVAIKQVSLENIAQ--EDLNIIMQEIDLLKNLNHKN-I 79
+G GAYG+V+ K + G A+K + I Q + E +L+ + +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
V + +T + LH+IL+YV G L + F ES V VYIA+++ L +LH+ G
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG 125
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATK-LTEADVNTHSVVGTPYWMAPEVIEM--SGV 196
+I+RDIK NIL EG V L DFG++ + L E + +S GT +MAPEVI G
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 197 CAASDIWSVGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
A D WS+G ELLT P+ E + R + +PP P+++S + DF+++
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQK 245
Query: 254 CFKKDARQR---PDAKTLLSHPWIQ 275
+KD ++R A + +HP+ Q
Sbjct: 246 LLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 75/262 (28%), Positives = 129/262 (49%), Gaps = 18/262 (6%)
Query: 26 IGKGAYGRV----YKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNL-NHKNI 79
+GKG++G+V KG D + A+K + + I Q +D+ M E +L H +
Sbjct: 3 LGKGSFGKVLLAELKGTD----ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
+ +T+ L ++EYV G L I+ + G F E Y A+++ GL +LHE+G
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHERG 116
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
+I+RD+K N+L EG +K+ADFG+ + V T + GTP ++APE++ A
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA 176
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
D W++G + E+L P +E LF+ + ++ P LS + L+ K+
Sbjct: 177 VDWWALGVLLYEMLAGQSP-FEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP 235
Query: 260 RQR-----PDAKTLLSHPWIQN 276
+R + + HP+ +
Sbjct: 236 EKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 65/197 (32%), Positives = 108/197 (54%), Gaps = 8/197 (4%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYL 83
++G+G YG+V+ + G+ VA+K++ + + + + ++ E D+L + +VK L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ + +L++ +EYV G ++ N G E Y+A++ E + LHE G IHR
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALHELGYIHR 125
Query: 144 DIKGANILTTKEGLVKLADFGVATK-LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
D+K N L G +KL DFG++ +T A +SVVG+P +MAPEV+ G D
Sbjct: 126 DLKPENFLIDASGHIKLTDFGLSKGIVTYA----NSVVGSPDYMAPEVLRGKGYDFTVDY 181
Query: 203 WSVGCTVIELLTCVPPY 219
WS+GC + E L PP+
Sbjct: 182 WSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 77/259 (29%), Positives = 135/259 (52%), Gaps = 15/259 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDF--VAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKY 82
+G G++GRV +N DF VAIK+ I Q+ ++ + E +L +NH V
Sbjct: 38 LGTGSFGRVILA-TYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
GS K S+L+++LE+V G ++ NK FP + Y AQ++ YL +++
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RD+K N+L K+G +K+ DFG A + D T+++ GTP ++APE++ G A+D
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVGHGKAADW 211
Query: 203 WSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262
W++G + E+L PP+Y +P+ +++ + + P+ L + +++ D +R
Sbjct: 212 WTLGIFIYEILVGCPPFYANEPL-LIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKR 270
Query: 263 -----PDAKTLLSHPWIQN 276
A+ + HPW N
Sbjct: 271 YGNLKKGAQNVKEHPWFGN 289
|
Length = 340 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-32
Identities = 98/303 (32%), Positives = 144/303 (47%), Gaps = 57/303 (18%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQV--SLENIAQEDLNIIMQEIDLLKNL-N 75
KY + ++GKGAYG V+K +D + VA+K++ + N D +EI L+ L +
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGD 65
Query: 76 HKNIVKYLGSLKTRSHLHIIL--EYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGL 132
H NIVK L +K + I L EY+E L +I+ N E + YI Q+L+ L
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANIL----EDVHKRYIMYQLLKAL 120
Query: 133 VYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY----WM-A 187
Y+H VIHRD+K +NIL + VKLADFG+A L+E + N + V T Y W A
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 188 PEVIEMS-----GVCAASDIWSVGCTVIELLTCVPPY------------YELQPMPA--- 227
PE++ S GV D+WSVGC + E+L P + E+ P+
Sbjct: 181 PEILLGSTRYTKGV----DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 228 ------------LFRIVQDERPPIPESL---SPDITDFLRQCFKKDARQRPDAKTLLSHP 272
L + R P+ E L S D D L++ + +R A+ L HP
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296
Query: 273 WIQ 275
++
Sbjct: 297 YVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 86/290 (29%), Positives = 142/290 (48%), Gaps = 43/290 (14%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN-IVKY 82
++IG+G YG+VYK D G VA+K+ LE + ++EI LL+ L+ IV+
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 83 LGSLKT-----RSHLHIILEYVENGSLANIIKPNKFG---PFPESLVAVYIAQVLEGLVY 134
L + L+++ EY+++ L + N G P P + ++ Q+L+G+ +
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 135 LHEQGVIHRDIKGANILTTKE-GLVKLADFGVATKLT-EADVNTHSVVGTPYWMAPEV-I 191
H+ GV+HRD+K N+L K+ GL+K+AD G+ + TH +V T ++ APEV +
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEVLL 184
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPY---YELQPMPALFRIV---------------- 232
+ DIWSVGC E+ P + ELQ + +F+++
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRD 244
Query: 233 ---------QDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
QD +P LSP+ D L++ + D +R AK L+HP+
Sbjct: 245 WHEFPQWKPQDLSRAVP-DLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 9e-32
Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 32/270 (11%)
Query: 26 IGKGAYGRV----YKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+GKG +G V Y L G+ VA+K+ L++ E L +EI++LK+L H NIVK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKK--LQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 82 YLGSLKT--RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
Y G + R +L +++EY+ GSL + ++ ++ L+ +Y +Q+ +G+ YL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEYLGSKR 128
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTP-----YWMAPEVIEMS 194
+HRD+ NIL E VK+ DFG+ TK+ D + V P +W APE + S
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGL-TKVLPQD-KEYYKVREPGESPIFWYAPESLTES 186
Query: 195 GVCAASDIWSVGCTVIELLT-----CVPPYYELQPM-------PALFRIV----QDERPP 238
ASD+WS G + EL T C PP ++ M ++ ++ + R P
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP 246
Query: 239 IPESLSPDITDFLRQCFKKDARQRPDAKTL 268
P +I +++C+ D QRP L
Sbjct: 247 APPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 91/322 (28%), Positives = 138/322 (42%), Gaps = 74/322 (22%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLEN--GDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLN 75
KY + IG+G YGRVYK G AIK+ + ++ +EI LL+ L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 76 HKNIVKYLGSL---KTRSHLHIILEYVENGSLANIIK---PNKFGPFPESLVAVYIAQVL 129
H+N+V + +S ++++ +Y E+ L IIK K P S+V + Q+L
Sbjct: 61 HENVVSLVEVFLEHADKS-VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKE----GLVKLADFGVATKLTE-----ADVNTHSVV 180
G+ YLH V+HRD+K ANIL E G+VK+ D G+A AD++ VV
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD--PVV 176
Query: 181 GTPYWMAPEVIEMSGV---CAASDIWSVGCTVIELLTCVP-------------PYYELQP 224
T ++ APE+ + G A DIW++GC ELLT P P+ Q
Sbjct: 177 VTIWYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ- 233
Query: 225 MPALFRI---VQDERPP----IPE--------------------------SLSPDITDFL 251
+ +F + ++ P +PE D L
Sbjct: 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLL 293
Query: 252 RQCFKKDARQRPDAKTLLSHPW 273
R+ + D +R A+ L HP+
Sbjct: 294 RKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 92/303 (30%), Positives = 152/303 (50%), Gaps = 53/303 (17%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII-MQEIDLLKNLNH 76
+K+ + +IG+G YG+VYK D + G+ VA+K+V L+N +E I ++EI +L+ LNH
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNH 65
Query: 77 KNIVKY----------LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA 126
+NIV L K + +++ EY+++ L +++ + F E + ++
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLE-SGLVHFSEDHIKSFMK 123
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN---THSVVGTP 183
Q+LEGL Y H++ +HRDIK +NIL +G +KLADFG+A +L ++ + T+ V+ T
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA-RLYNSEESRPYTNKVI-TL 181
Query: 184 YWMAPEVI---EMSGVCAASDIWSVGCTVIELLTCVPPY--------YEL------QPMP 226
++ PE++ E G A D+WS GC + EL T P + EL P P
Sbjct: 182 WYRPPELLLGEERYG--PAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 227 AL------------FRIVQDERPPIPESLS---PDITDFLRQCFKKDARQRPDAKTLLSH 271
A+ + + R + E S D L D +R A+ L+
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 272 PWI 274
PW+
Sbjct: 300 PWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 84/305 (27%), Positives = 144/305 (47%), Gaps = 54/305 (17%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII-MQEIDLLKNLN 75
+KY +IG+G +G V+K + VA+K+V +EN +E I ++EI +L+ L
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLK 69
Query: 76 HKNIV--------KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
H+N+V K + + +++ E+ E+ LA ++ NK F S + +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS-NKNVKFTLSEIKKVMKM 127
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA-----TKLTEADVNTHSVVGT 182
+L GL Y+H ++HRD+K ANIL TK+G++KLADFG+A +K ++ + T+ VV T
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 183 PYWMAPEVI---EMSGVCAASDIWSVGCTVIEL---------------LTC--------- 215
++ PE++ G D+W GC + E+ LT
Sbjct: 187 LWYRPPELLLGERDYG--PPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244
Query: 216 --VPPYYELQPMPALFRIVQDERPPIPESLSPDIT-----DFLRQCFKKDARQRPDAKTL 268
V P + + + Q ++ + E L P + D + + D +R DA T
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304
Query: 269 LSHPW 273
L+H +
Sbjct: 305 LNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 69/197 (35%), Positives = 115/197 (58%), Gaps = 15/197 (7%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII-MQEIDLLKNLNHKNIVKY-- 82
I +G YG VY+ D + G+ VA+K++ +E +E I ++EI++L L H NIV
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 83 --LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+GS +++++EYVE+ L ++++ K PF +S V + Q+L G+ +LH+ +
Sbjct: 72 VVVGS--NLDKIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWI 127
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTE-ADVNTHSVVGTPYWMAPEVIEMSGVC-- 197
+HRD+K +N+L G++K+ DFG+A + T VV T ++ APE++ +
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELL-LGAKEYS 185
Query: 198 AASDIWSVGCTVIELLT 214
A D+WSVGC ELLT
Sbjct: 186 TAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 5e-30
Identities = 75/244 (30%), Positives = 121/244 (49%), Gaps = 5/244 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI--AQEDLNIIMQEIDLLKNLNHKNIVKYL 83
IGKG++G+V +G F A+K + + I +E +I+ + LLKNL H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
S +T L+ +L+YV G L ++ + F E Y A+V + YLH +I+R
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K NIL +G V L DFG+ + E + T + GTP ++APEV+ D W
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
+G + E+L +PP+Y + + ++ + + +P + D L KD R+R
Sbjct: 181 CLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239
Query: 264 DAKT 267
AK
Sbjct: 240 GAKA 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 66/251 (26%), Positives = 122/251 (48%), Gaps = 17/251 (6%)
Query: 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
+ ++G G YG VY+G+ + VA+K + + + E+ ++E ++K + H N+V
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLV 65
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQG 139
+ LG +II E++ G+L + ++ ++V +Y+A Q+ + YL ++
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN-AVVLLYMATQISSAMEYLEKKN 124
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCA 198
IHRD+ N L + LVK+ADFG++ +T H+ P W APE + +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPAL------FRIVQDERPPIPESLSPDITDFLR 252
SD+W+ G + E+ T Y + P P + + + R PE P + + +R
Sbjct: 185 KSDVWAFGVLLWEIAT-----YGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239
Query: 253 QCFKKDARQRP 263
C++ + RP
Sbjct: 240 ACWQWNPSDRP 250
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 78/254 (30%), Positives = 122/254 (48%), Gaps = 12/254 (4%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLEN-IAQEDLNIIMQEIDLLKNLNHKN 78
+ L ++G G +G V++GL +N VAIK + ++ + Q+D +E+ LK L HK+
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDF---QKEVQALKRLRHKH 63
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
++ ++II E +E GSL ++ + P + + QV EG+ YL EQ
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVC 197
IHRD+ NIL ++ + K+ADFG+A +L + DV S PY W APE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLA-RLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 198 AASDIWSVGCTVIELLT---CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
SD+WS G + E+ T PY + +I R P P +I + +C
Sbjct: 183 TKSDVWSFGILLYEMFTYGQV--PYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240
Query: 255 FKKDARQRPDAKTL 268
+ + RP K L
Sbjct: 241 WAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 88/285 (30%), Positives = 143/285 (50%), Gaps = 39/285 (13%)
Query: 25 EIGKGAYGRVYKGLDLENGD-FVAIKQVSLENIAQEDLNI-IMQEIDLLKNLN---HKNI 79
EIG+GAYG+V+K DL+NG FVA+K+V ++ +E + + ++E+ +L++L H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 80 VKY-----LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
V+ + + L ++ E+V+ + K + G E++ + + Q+L GL +
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM-MFQLLRGLDF 125
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMS 194
LH V+HRD+K NIL T G +KLADFG+A ++ + SVV T ++ APEV+ S
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVLLQS 184
Query: 195 GVCAASDIWSVGCTVIELLTCVPPY------------YELQPMP---------ALFRIVQ 233
D+WSVGC E+ P + ++ +P AL R
Sbjct: 185 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244
Query: 234 DERPPIP-ESLSPDI----TDFLRQCFKKDARQRPDAKTLLSHPW 273
+ P E DI D L +C + +R A + LSHP+
Sbjct: 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 34/273 (12%)
Query: 25 EIGKGAYGRVYKGLDLENGD------FVAIKQV--SLENIAQEDLNIIMQEIDLLKNLNH 76
E+G+GA+G+V+ G + + + VA+K + + N A++D +E +LL N H
Sbjct: 12 ELGEGAFGKVFLG-ECYHLEPENDKELVAVKTLKETASNDARKDF---EREAELLTNFQH 67
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIK------------PNKFGPFPESLVAVY 124
+NIVK+ G ++ EY+E+G L ++ + G S +
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVG 181
Q+ G+VYL Q +HRD+ N L + +VK+ DFG++ + D V H+++
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML- 186
Query: 182 TPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPI 239
P WM PE I SD+WS G + E+ T P+Y L + I Q
Sbjct: 187 -PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245
Query: 240 PESLSPDITDFLRQCFKKDARQR---PDAKTLL 269
P + ++ D + C+K+D +QR D L
Sbjct: 246 PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 76/259 (29%), Positives = 122/259 (47%), Gaps = 22/259 (8%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
L ++G G +G V+ G NG VA+K + ++ E +QE ++K L H +V
Sbjct: 10 LERKLGAGQFGEVWMGT--WNGTTKVAVKTLKPGTMSPEAF---LQEAQIMKKLRHDKLV 64
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIK--PNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+ ++I+ EY+ GSL + +K K P+ LV + AQ+ EG+ YL +
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQ-LVDM-AAQIAEGMAYLESR 122
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVC 197
IHRD+ NIL + + K+ADFG+A + + + P W APE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 198 AASDIWSVGCTVIELLTCVPPYYELQPMPA------LFRIVQDERPPIPESLSPDITDFL 251
SD+WS G + E++T Y P P L ++ + R P P + ++ D +
Sbjct: 183 IKSDVWSFGILLTEIVT-----YGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM 237
Query: 252 RQCFKKDARQRPDAKTLLS 270
QC+ KD +RP + L S
Sbjct: 238 LQCWDKDPEERPTFEYLQS 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 66/241 (27%), Positives = 122/241 (50%), Gaps = 6/241 (2%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
++G G +G V+ G N VA+K + ++ + ++E +L+K L H +V+
Sbjct: 13 KLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAF---LEEANLMKTLQHDKLVRLYA 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ ++II EY+ GSL + +K ++ G + + AQ+ EG+ Y+ + IHRD
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAASDIW 203
++ AN+L ++ + K+ADFG+A + + + P W APE I SD+W
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 204 SVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262
S G + E++T PY + + + + R P E+ ++ D ++ C+K+ A +R
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEER 248
Query: 263 P 263
P
Sbjct: 249 P 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 78/270 (28%), Positives = 138/270 (51%), Gaps = 28/270 (10%)
Query: 25 EIGKGAYGRV----YKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
++G+G +G+V Y G+ VA+K + E+ + + +EI++L+NL H+NIV
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIV 69
Query: 81 KYLG--SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
KY G + + + +I+E++ +GSL + NK + + Y Q+ +G+ YL +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKGMDYLGSR 128
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV---VGTP-YWMAPEVIEMS 194
+HRD+ N+L E VK+ DFG+ TK E D ++V + +P +W APE + S
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGL-TKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 195 GVCAASDIWSVGCTVIELLT-----CVP---------PYYELQPMPALFRIVQDE-RPPI 239
ASD+WS G T+ ELLT P P + + L R++++ R P
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247
Query: 240 PESLSPDITDFLRQCFKKDARQRPDAKTLL 269
P + ++ +R+C++ +R + L+
Sbjct: 248 PPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 82/277 (29%), Positives = 127/277 (45%), Gaps = 35/277 (12%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
IG GA G VYK + G A+K V N I +EI++L+++NH N+VK
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 86 LKTRSHLHIILEYVENGSL--ANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ ++LE+++ GSL +I E +A Q+L G+ YLH + ++HR
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIAD--------EQFLADVARQILSGIAYLHRRHIVHR 192
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM-------SGV 196
DIK +N+L VK+ADFGV+ L + +S VGT +M+PE I G
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPA---------LFRIVQDERPPIPESLSPDI 247
A DIWS+G +++E Y P + I + P P + S +
Sbjct: 253 --AGDIWSLGVSILEF------YLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304
Query: 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSS 284
F+ C +++ +R A LL HP+I +
Sbjct: 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQG 341
|
Length = 353 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 71/252 (28%), Positives = 123/252 (48%), Gaps = 18/252 (7%)
Query: 24 DEIGKGAYGRVYKG-LDLENGDF--VAIKQVSLENI--AQEDLNIIMQEIDLLKNLNHKN 78
++G G++G V +G G VA+K + + + +D ++E ++ +L+H+N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDF---LKEAAIMHSLDHEN 57
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+++ G + T L ++ E GSL + ++ + G F S + Y Q+ G+ YL +
Sbjct: 58 LIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD----VNTHSVVGTPY-WMAPEVIEM 193
IHRD+ NIL + VK+ DFG+ L + + + H V P+ W APE +
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRT 174
Query: 194 SGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQD-ERPPIPESLSPDITDFL 251
ASD+W G T+ E+ T P+ L L +I ++ ER PE+ DI + +
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234
Query: 252 RQCFKKDARQRP 263
QC+ + RP
Sbjct: 235 LQCWAHNPADRP 246
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 78/251 (31%), Positives = 126/251 (50%), Gaps = 12/251 (4%)
Query: 26 IGKGAYGRVYKGL---DLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+G GA+G VYKG+ + E VAIK V E + + I+ E ++ +++H ++V+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIK-VLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
LG + +I + + G L + ++ +K + L+ + Q+ +G+ YL E+ ++
Sbjct: 74 LLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLN-WCVQIAKGMSYLEEKRLV 131
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG--TPY-WMAPEVIEMSGVCA 198
HRD+ N+L VK+ DFG+A KL + D + G P WMA E I
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-ERPPIPESLSPDITDFLRQCFKK 257
SD+WS G TV EL+T YE P + +++ ER P P + D+ L +C+
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMI 250
Query: 258 DARQRPDAKTL 268
DA RP K L
Sbjct: 251 DAESRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 74/254 (29%), Positives = 125/254 (49%), Gaps = 9/254 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G+V + G + A+K + E I A++++ + E +L+N H +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S +T L ++EY G L ++ F E Y A+++ L YLH V++RD
Sbjct: 63 SFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K N++ K+G +K+ DFG+ + + GTP ++APEV+E + A D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR-- 262
+G + E++ P+Y Q LF ++ E P +LSP+ L KKD +QR
Sbjct: 181 LGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 263 ---PDAKTLLSHPW 273
DAK ++ H +
Sbjct: 240 GGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 73/243 (30%), Positives = 121/243 (49%), Gaps = 5/243 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ--EDLNIIMQEIDLLKNLNHKNIVKYL 83
IGKG++G+V +G F A+K + + I + E +I+ + LLKN+ H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
S +T L+ +L+YV G L ++ + FPE Y A++ L YLH +I+R
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K NIL +G V L DFG+ + E T + GTP ++APEV+ D W
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
+G + E+L +PP+Y + ++ + ++ + ++S L +KD +R
Sbjct: 181 CLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239
Query: 264 DAK 266
AK
Sbjct: 240 GAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 19/263 (7%)
Query: 18 NKYMLGDEIGKGAYGRVYKGL--DLENGDF---VAIKQVSLENIAQEDLNIIMQEIDLLK 72
K L E+G+G++G VY+GL + G+ VAIK V+ EN + + + E ++K
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNEASVMK 64
Query: 73 NLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK--------PNKFGPFPESLVAVY 124
N ++V+ LG + T +++E + G L + ++ GP
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-P 183
A++ +G+ YL + +HRD+ N + ++ VK+ DFG+ + E D G P
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 184 Y-WMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIP 240
WMAPE + GV SD+WS G + E+ T PY L L ++ +P
Sbjct: 185 VRWMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP 243
Query: 241 ESLSPDITDFLRQCFKKDARQRP 263
E+ + + +R C++ + + RP
Sbjct: 244 ENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 4e-28
Identities = 88/306 (28%), Positives = 146/306 (47%), Gaps = 51/306 (16%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
D+ + E+G G G V+K +G +A K + LE I N I++E+ +L N
Sbjct: 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNS 62
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
IV + G+ + + I +E+++ GSL ++K K G PE ++ V++GL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 137 EQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
E+ ++HRD+K +NIL G +KL DFGV+ +L ++ N S VGT +M+PE ++ +
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTH 178
Query: 196 VCAASDIWSVGCTVIELLTC---VPP-------------------YYELQPMP------- 226
SDIWS+G +++E+ +PP E P P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238
Query: 227 -----------ALFR----IVQDERPPIPESL-SPDITDFLRQCFKKDARQRPDAKTLLS 270
A+F IV + P +P + + DF+ +C K+ +R D K L+
Sbjct: 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298
Query: 271 HPWIQN 276
H +I+
Sbjct: 299 HAFIKR 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 15/201 (7%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
KY ++IG+G YG V+K + E + VA+K+V L++ + + ++EI LLK L HKN
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKF-----GPFPESLVAVYIAQVLEGLV 133
IV+ L + L ++ EY + +K K+ G +V ++ Q+L+GL
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQD-----LK--KYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVIE 192
+ H V+HRD+K N+L K G +KLADFG+A + VV T ++ P+V+
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 172
Query: 193 MSGVCAAS-DIWSVGCTVIEL 212
+ + + S D+WS GC EL
Sbjct: 173 GAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 70/244 (28%), Positives = 125/244 (51%), Gaps = 7/244 (2%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L ++G G +G V+ G VAIK + +++ E + E +L+K L H +V+
Sbjct: 10 LVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAF---LAEANLMKQLQHPRLVR 65
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
L ++ T+ ++II EY+ENGSL + +K + + + AQ+ EG+ ++ + I
Sbjct: 66 -LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAAS 200
HRD++ ANIL ++ K+ADFG+A + + + P W APE I S
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFR-IVQDERPPIPESLSPDITDFLRQCFKKDA 259
D+WS G + E++T Y P + + + + R P P++ ++ + +R C+K+
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKP 244
Query: 260 RQRP 263
+RP
Sbjct: 245 EERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-28
Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 50/305 (16%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYL 83
+GKG GRV+ G A+K + + + + + + ++ E ++L L+H +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
S +T ++L ++++Y G L +++ E + Y A+VL L YLH G+++R
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYR 127
Query: 144 DIKGANILTTKEGLVKLADF------GVATKLT-----------------------EADV 174
D+K NIL + G + L+DF V E
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187
Query: 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP-----MPALF 229
++S VGT ++APEVI G +A D W++G + E+L Y P F
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML------YGTTPFKGSNRDETF 241
Query: 230 RIVQDERPPIPES--LSPDITDFLRQCFKKDARQRPDAKT----LLSHPWIQNCRRALQS 283
+ + P S +S D +R+ KD +R +K + HP+ + AL
Sbjct: 242 SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL-- 299
Query: 284 SLRHS 288
+RH+
Sbjct: 300 -IRHT 303
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 6e-28
Identities = 88/285 (30%), Positives = 136/285 (47%), Gaps = 38/285 (13%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNL---NHKNIV 80
EIG GAYG VYK D +G FVA+K V ++ ++ L + ++E+ LLK L +H NIV
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQT-NEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 81 KYL---GSLKTRSHLHIIL--EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
+ + + +T + L E+V+ + K G P + + Q L GL +L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFL 124
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
H ++HRD+K NIL T G VKLADFG+A ++ + VV T ++ APEV+ S
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLA-RIYSCQMALTPVVVTLWYRAPEVLLQST 183
Query: 196 VCAASDIWSVGCTVIELLTCVPPY---YELQPMPALFRIV----QDERP----------- 237
D+WSVGC E+ P + E + +F ++ +D+ P
Sbjct: 184 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFS 243
Query: 238 ---PIP-ESLSPDIT----DFLRQCFKKDARQRPDAKTLLSHPWI 274
P P +S+ P+I L + + +R A L HP+
Sbjct: 244 PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 74/257 (28%), Positives = 127/257 (49%), Gaps = 9/257 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G+V + G + A+K + E I A++++ + E +L+N H +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ +T L ++EY G L + + F E Y A+++ L YLH + V++RD
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
IK N++ K+G +K+ DFG+ + + GTP ++APEV+E + A D W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR-- 262
+G + E++ P+Y Q LF ++ E P +LSP+ L KKD +QR
Sbjct: 181 LGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 263 ---PDAKTLLSHPWIQN 276
DAK ++ H + +
Sbjct: 240 GGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-28
Identities = 86/299 (28%), Positives = 142/299 (47%), Gaps = 18/299 (6%)
Query: 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLK 72
+K KY + +G GA G V + +G+ A+K V +E +++ D N E+ L
Sbjct: 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLL 86
Query: 73 NLNHKNIVKYLGSLKTR--------SHLHIILEYVENGSLANIIKPN-KFG-PFPESLVA 122
N + +IVK + + ++L+Y G L IK K F E
Sbjct: 87 NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 123 VYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT---HSV 179
+ QVL + ++H + +IHRDIK ANIL GLVKL DFG +K+ A V+ +
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF-SKMYAATVSDDVGRTF 205
Query: 180 VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI 239
GTPY++APE+ +D++S+G + ELLT P+ + + + P+
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265
Query: 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSHP----WIQNCRRALQSSLRHSGTMRNV 294
P S+SP++ + + D ++RP + LL+ P +I +Q+ SG +R+
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDT 324
|
Length = 496 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 71/258 (27%), Positives = 118/258 (45%), Gaps = 25/258 (9%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
LG IGKG +G V G G VA+K + ++ A + + E ++ L H N+V+
Sbjct: 10 LGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAF---LAEASVMTTLRHPNLVQ 64
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
LG + + L+I+ EY+ GSL + ++ + + V EG+ YL E+ +
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFV 124
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASD 201
HRD+ N+L +++ + K++DFG+A EA S W APE + SD
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 202 IWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---------RPPIPESLSPDITDFLR 252
+WS G + E+ + + P P RI + R PE P++ ++
Sbjct: 182 VWSFGILLWEIYS-----FGRVPYP---RIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233
Query: 253 QCFKKDARQRPDAKTLLS 270
C++ D +RP K L
Sbjct: 234 DCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 74/240 (30%), Positives = 126/240 (52%), Gaps = 6/240 (2%)
Query: 26 IGKGAYGRVY---KGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82
+G+G++G+V+ K + G A+K + + D E D+L +NH IVK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
+ +T L++IL+++ G L + +K F E V Y+A++ L +LH G+I+
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RD+K NIL +EG +KL DFG++ + + + +S GT +MAPEV+ G ++D
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 181
Query: 203 WSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262
WS G + E+LT P+ + I++ + +P+ LSP+ LR FK++ R
Sbjct: 182 WSFGVLMFEMLTGSLPFQGKDRKETMTMILK-AKLGMPQFLSPEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 77/303 (25%), Positives = 143/303 (47%), Gaps = 50/303 (16%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS----LENIAQEDLNIIMQEIDLL 71
+ ++Y + IG GAYG V +D +G VAIK++ + +A+ L +E+ +L
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKIL 58
Query: 72 KNLNHKNIVKYLGSLKTRS----HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
++ H NI+ L+ ++++++ +E+ L +II + P E + ++ Q
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD--QPLTEEHIRYFLYQ 115
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA--DVNTH--SVVGTP 183
+L GL Y+H VIHRD+K +N+L ++ +++ DFG+A L+ + + V T
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 184 YWMAPEVI-EMSGVCAASDIWSVGCTVIELL---------------------TCVPPYYE 221
++ APE++ + A D+WSVGC E+L P
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235
Query: 222 LQPMPA--LFRIVQD--ERPPIPES-----LSPDITDFLRQCFKKDARQRPDAKTLLSHP 272
L + + + + +Q+ + P+P S SP+ D L Q + D +R + L HP
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295
Query: 273 WIQ 275
++
Sbjct: 296 FLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 12/244 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
IGKG +G VYKG+ L+ VA+K + + +QE ++LK +H NIVK +G
Sbjct: 3 IGKGNFGDVYKGV-LKGNTEVAVKTCR-STLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDI 145
+ ++I++E V GSL ++ K + L+ + + G+ YL + IHRD+
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL-DAAAGMEYLESKNCIHRDL 119
Query: 146 KGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG----TPY-WMAPEVIEMSGVCAAS 200
N L + ++K++DFG++ E + ++V P W APE + + S
Sbjct: 120 AARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 201 DIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
D+WS G + E + PY + RI R P P+ +I + QC+ D
Sbjct: 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236
Query: 260 RQRP 263
RP
Sbjct: 237 ENRP 240
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 51/299 (17%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQV-SLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG GA+G V ++ A+K + + + + + E D+L +++ +VK
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S + + +L+ +++Y+ G + +++ + G F E L YIA++ + +H+ G IHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 145 IKGANILTTKEGLVKLADFGVAT--------------------------KLTEAD----- 173
IK NIL ++G +KL DFG+ T + +E D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 174 ------------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYE 221
HS+VGTP ++APEV+ +G D WSVG + E+L PP+
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246
Query: 222 LQPMPALFRIVQDE---RPPIPESLSPDITDFLRQ-CFKKDAR-QRPDAKTLLSHPWIQ 275
P +++ E P LS + +D + + C + R + A + +HP+ +
Sbjct: 247 DTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 72/242 (29%), Positives = 127/242 (52%), Gaps = 11/242 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIK----QVSLENIAQEDLNIIMQEIDLLK-NLNHKNIV 80
+GKG++G+V +F AIK V LE+ +D+ M E +L H +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DDVECTMVERRVLALAWEHPFLT 59
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+ +T+ HL ++EY+ G L I+ G F E+ Y A+++ GL +LH++G+
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS 200
I+RD+K N+L K+G +K+ADFG+ + + + GTP ++APE+++ +
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260
D WS G + E+L P++ + LF + ++RP P +S + D L + F++D
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236
Query: 261 QR 262
+R
Sbjct: 237 KR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 76/271 (28%), Positives = 139/271 (51%), Gaps = 24/271 (8%)
Query: 22 LGDEIGKGAYGRVYKG--LDLENGDF---VAIKQVSLENIAQEDLNIIMQEIDLLKNL-N 75
LG +G+GA+G+V K + L+N + VA+K + ++ ++DL+ ++ E++++K +
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGK 74
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVA------------- 122
HKNI+ LG L++++EY +G+L + ++ + S
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 123 VYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181
V A QV G+ +L + IHRD+ N+L T++ ++K+ADFG+A + D + G
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 182 -TPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV-QDERPP 238
P WMAPE + SD+WS G + E+ T Y P+ LF+++ + R
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRME 254
Query: 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLL 269
P++ + ++ +R C+ + QRP K L+
Sbjct: 255 KPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 73/260 (28%), Positives = 124/260 (47%), Gaps = 13/260 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLN---HKNIVK 81
+G+G +G+V + G+ AIK + +I A++++ +M E + + N H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
+T H+ ++EY G L I + F E Y A V+ GL YLHE ++
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVFYAACVVLGLQYLHENKIV 123
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASD 201
+RD+K N+L EG VK+ADFG+ + T + GTP ++APEV+ + A D
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVD 183
Query: 202 IWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261
W +G + E+L P+ IV DE P LS + +R+ +++ +
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSREAISIMRRLLRRNPER 242
Query: 262 R-----PDAKTLLSHPWIQN 276
R DA+ + P+ ++
Sbjct: 243 RLGSGEKDAEDVKKQPFFRD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 3/227 (1%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
NK+ + +G+GAYG V K E + VAIK+ +E ++E+ +L+ L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NIV+ + + R L+++ EYVE L +++ G PE V YI Q+++ + + H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEK-VRSYIYQLIKAIHWCHK 118
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA-DVNTHSVVGTPYWMAPEVIEMSGV 196
++HRDIK N+L + ++KL DFG A L+E + N V T ++ +PE++ +
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL 243
A D+WSVGC + EL P + + LF I + P E +
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-27
Identities = 75/253 (29%), Positives = 127/253 (50%), Gaps = 10/253 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G+V + G + A+K + E I A++++ + E +L+N H +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH-EQGVIHR 143
S +T L ++EY G L + + F E Y A+++ L YLH E+ V++R
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N++ K+G +K+ DFG+ + + + GTP ++APEV+E + A D W
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR- 262
+G + E++ P+Y Q LF ++ E P +LSP+ L KKD +QR
Sbjct: 181 GLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
Query: 263 ----PDAKTLLSH 271
DAK ++ H
Sbjct: 240 GGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-27
Identities = 88/299 (29%), Positives = 144/299 (48%), Gaps = 53/299 (17%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
E+G G G V K +G +A K + LE I N I++E+ +L N IV + G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHR 143
+ + + I +E+++ GSL ++K K PE ++ VL GL YL E+ ++HR
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHR 128
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K +NIL G +KL DFGV+ +L ++ N S VGT +M+PE ++ + SDIW
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 204 SVGCTVIELLTC---VPPY---------------------YELQPMP------------- 226
S+G +++EL +PP + + P P
Sbjct: 187 SMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMD 246
Query: 227 -----ALFR----IVQDERPPIPESL-SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
A+F IV + P +P + +PD +F+ +C K+ +R D K L++H +I+
Sbjct: 247 SRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-27
Identities = 80/267 (29%), Positives = 131/267 (49%), Gaps = 18/267 (6%)
Query: 26 IGKGAYGRVY---KGLDLENGDFVAIKQVSLENIAQEDLNI--IMQEIDLLKNLNHKNIV 80
+G GAYG+V+ K + G A+K + + Q+ + E ++L+++ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 81 KYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
L + +T + LH+IL+YV G + + F E V Y +++ L +LH+ G
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLG 125
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATK-LTEADVNTHSVVGTPYWMAPEVIE-MSGVC 197
+++RDIK NIL EG V L DFG++ + L+E T+S GT +MAPE+I G
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 198 AASDIWSVGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
A D WS+G + ELLT P+ E + R + PP P + P+ D L +
Sbjct: 186 KAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKL 245
Query: 255 FKKDARQR-----PDAKTLLSHPWIQN 276
+KD ++R A + HP+ +
Sbjct: 246 LRKDPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 69/256 (26%), Positives = 125/256 (48%), Gaps = 21/256 (8%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
K LG+ IG+G +G V +G G VA+K + + AQ ++E ++ L+HKN
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKN 60
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+V+ LG + + L+I++E + G+L N ++ + + V EG+ YL +
Sbjct: 61 LVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
++HRD+ NIL +++G+ K++DFG+A + N+ V W APE ++ +
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEALKHKKFSS 176
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALF------RIVQDERPPIPESLSPDITDFLR 252
SD+WS G + E+ + Y P P + + + R PE D+ +
Sbjct: 177 KSDVWSYGVLLWEVFS-----YGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT 231
Query: 253 QCFKKDARQRPDAKTL 268
C++ + ++RP L
Sbjct: 232 SCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 86/299 (28%), Positives = 140/299 (46%), Gaps = 43/299 (14%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI---IMQEIDLLKNL 74
++Y ++IG+G YG VYK D + +A+K++ LE QED + ++EI LLK +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEM 58
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
H NIV+ + + L+++ EY++ ++ F P L+ Y+ Q+L G+ Y
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR-LIKTYLYQILRGIAY 117
Query: 135 LHEQGVIHRDIKGANILTTKE-GLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVIE 192
H V+HRD+K N+L + +KLADFG+A TH VV T ++ APE+
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEI-- 174
Query: 193 MSGVCAAS---DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ---------------- 233
+ G S DIWSVGC E++ P + + LF+I +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234
Query: 234 -DERPPIPE-----------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA 280
D + P+ +L P D L + + D +R A+ L H + ++ A
Sbjct: 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293
|
Length = 294 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 73/254 (28%), Positives = 125/254 (49%), Gaps = 9/254 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G+V + +G + A+K + E I A++++ + E +LKN H +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S +T+ L ++EYV G L + + F E Y A+++ L YLH +++RD
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K N++ K+G +K+ DFG+ + + GTP ++APEV+E + A D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR-- 262
+G + E++ P+Y Q LF ++ E P +LS D L KD +R
Sbjct: 181 LGVVMYEMMCGRLPFYN-QDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239
Query: 263 ---PDAKTLLSHPW 273
DAK ++ H +
Sbjct: 240 GGPDDAKEIMRHSF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 68/248 (27%), Positives = 114/248 (45%), Gaps = 12/248 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+G G +G V++GL N VA+K + + +D + E ++K L H +++
Sbjct: 14 LGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDF---LAEAQIMKKLRHPKLIQLYAV 69
Query: 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFP-ESLVAVYIAQVLEGLVYLHEQGVIHRD 144
++I+ E ++ GSL ++ L+ + AQV G+ YL Q IHRD
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM-AAQVASGMAYLEAQNYIHRD 128
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY---WMAPEVIEMSGVCAASD 201
+ N+L + + K+ADFG+A + E G + W APE + SD
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAR--EGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 202 IWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260
+WS G + E++T PY + L ++ Q R P P ++ D + C+K+D
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPD 246
Query: 261 QRPDAKTL 268
RP +TL
Sbjct: 247 DRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII-MQEIDLLKNLNHKNIVKY 82
D++G+G+Y VYKG G VA+K++ LE +E ++E LLK+L H NIV
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 83 LGSLKTRSHLHIILEYVENG------SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
+ T+ L ++ EY++ + + V +++ Q+L GL Y H
Sbjct: 69 HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHN--------VRLFLFQLLRGLAYCH 120
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
++ V+HRD+K N+L ++ G +KLADFG+A K + ++ VV T ++ P+V+ S
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGST 179
Query: 196 VCAAS-DIWSVGCTVIELLTCVP 217
+ S D+W VGC E+ T P
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 70/225 (31%), Positives = 115/225 (51%), Gaps = 13/225 (5%)
Query: 26 IGKGAYGRVY----KGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIV 80
+GKG++G+V KG D + AIK + + I Q +D+ M E +L +
Sbjct: 8 LGKGSFGKVMLAERKGTD----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 81 KYLGS-LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
L S +T L+ ++EYV G L I+ + G F E Y A++ GL +LH +G
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
+I+RD+K N++ EG +K+ADFG+ + T + GTP ++APE+I +
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLS 244
D W+ G + E+L PP ++ + LF+ + + P+SLS
Sbjct: 182 VDWWAFGVLLYEMLAGQPP-FDGEDEDELFQSIMEHNVSYPKSLS 225
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 78/293 (26%), Positives = 146/293 (49%), Gaps = 17/293 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IGKG++G+V + + A+K + +I ++ ++ + E +L +N IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S ++ L+++L ++ G L + ++ + G F S Y A++L L LH+ VI+RD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ--REGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVN-THSVVGTPYWMAPEVIEMSGVCAASDIW 203
+K NIL +G + L DFG+ KL D + T++ GTP ++APE++ G A D W
Sbjct: 119 LKPENILLDYQGHIALCDFGLC-KLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR- 262
++G + E+LT +PP+Y+ + + ++R + E P+ D D L +D +R
Sbjct: 178 TLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRL 236
Query: 263 --PDAKTLLSHP------WIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSE 307
A+ + +HP W + + +Q + + + + + + D E E
Sbjct: 237 GYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPA--VSSAIDTSNFDEEFTRE 287
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 70/251 (27%), Positives = 110/251 (43%), Gaps = 11/251 (4%)
Query: 25 EIGKGAYGRVYKGLDLENGDF---VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
E+G G +G V KG+ L VA+K + E+IA ++E ++ L+H IV+
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEF-LREASVMAQLDHPCIVR 60
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
+G K L +++E G L +K K P S + QV G+ YL + +
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY---WMAPEVIEMSGVCA 198
HRD+ N+L K++DFG++ L + + W APE I +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 199 ASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257
SD+WS G T+ E + PY E++ + + ER P PE +I + C+K
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKY 237
Query: 258 DARQRPDAKTL 268
RP L
Sbjct: 238 RPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 85/295 (28%), Positives = 133/295 (45%), Gaps = 52/295 (17%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII-MQEIDLLKNLNHKN 78
Y+ +++G+G+Y VYKG+ NG VA+K +S++ +E + ++E LLK L H N
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHAN 64
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV + T+ L + EY+ LA + + G P + V +++ Q+L GL Y+H Q
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYIHGQ 122
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI-EMSGVC 197
++HRD+K N+L + G +KLADFG+A + S V T ++ P+V+ +
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 198 AASDIWSVGCTVIELLTCVP-------------------------------------PYY 220
+A DIW GC IE+L P P +
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242
Query: 221 ELQPMPALFRIVQDE--RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
L P R+V RPP E L+ Q + R A+ L HP+
Sbjct: 243 FLPCKPQQLRVVWKRLSRPPKAEDLA-------SQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 83/297 (27%), Positives = 144/297 (48%), Gaps = 19/297 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLK-NLNHKNIVKYL 83
+GKG++G+V E+G A+K + + I Q+D + M E +L NH + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+T L ++E+V G L I+ ++ F E+ Y A++ L++LH++G+I+R
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N+L EG KLADFG+ + T + GTP ++APE+++ + D W
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWW 180
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
++G + E+L P +E + LF + ++ P LS D D L+ K+ R
Sbjct: 181 AMGVLLYEMLCGHAP-FEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239
Query: 264 DAKTL------LSHP------WIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSED 308
+ TL L HP W + RR ++ R +++ E+ + D + ED
Sbjct: 240 GSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPR--IKSREDVSNFDPDFIKED 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 67/209 (32%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS--LENIAQEDLNIIMQEIDLLK 72
+D KY+ IG+GAYG V + E + VAIK+++ +N D ++EI LL+
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI--DAKRTLREIKLLR 59
Query: 73 NLNHKNIVKYLGSLK-----TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
+L+H+N++ + + ++I+ E ++ L II+ ++ + ++ Q
Sbjct: 60 HLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQ--TLSDDHCQYFLYQ 116
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPYWM 186
+L GL Y+H V+HRD+K +N+L +K+ DFG+A T + D T VV T ++
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYR 175
Query: 187 APEVI-EMSGVCAASDIWSVGCTVIELLT 214
APE++ S A D+WSVGC ELL
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 86/298 (28%), Positives = 134/298 (44%), Gaps = 61/298 (20%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQ-----VSLENIAQEDLNIIMQEIDLLKNL 74
Y + +IG+G + V K + G + AIK SLE + N ++EI L+ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNN--LREIQALRRL 54
Query: 75 N-HKNIVKYLGSLKTRSH--LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
+ H NI++ + L R L ++ E ++ +L +IK K P PE V Y+ Q+L+
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKR-PLPEKRVKSYMYQLLKS 112
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFG----VATKL--TEADVNTHSVVGTPYW 185
L ++H G+ HRDIK NIL K+ ++KLADFG + +K TE + T ++
Sbjct: 113 LDHMHRNGIFHRDIKPENIL-IKDDILKLADFGSCRGIYSKPPYTE-------YISTRWY 164
Query: 186 MAPEVIEMSGV-CAASDIWSVGCTVIELLTCVPPY---YELQ-----------PMPAL-- 228
APE + G DIW+VGC E+L+ P + EL P +
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224
Query: 229 -------------FRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
+ R +P + S + D L++ D +R AK L HP+
Sbjct: 225 KFRKSRHMNYNFPSKKGTGLRKLLP-NASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 64/205 (31%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
+G+G +G V + GD A+K + + AQE ++ +E D+L N I +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKF-GPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ + + +L++++EY G L +++ N++ F E + Y+A+++ + +H+ G +HR
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126
Query: 144 DIKGANILTTKEGLVKLADFGVATKLT-EADVNTHSVVGTPYWMAPEVIE-MSGVCAAS- 200
DIK N+L + G +KLADFG A +LT VN+ VGTP ++APEV+ M+G +
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 201 ----DIWSVGCTVIELLTCVPPYYE 221
D WS+G E++ P++E
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 72/255 (28%), Positives = 125/255 (49%), Gaps = 13/255 (5%)
Query: 26 IGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVK 81
IGKG +G VY G +++ A+K SL I E++ ++E ++K+ +H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVK--SLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 82 YLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
LG L + ++L Y+++G L N I+ P + L+ + QV +G+ YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAKGMEYLASKKF 119
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPY-WMAPEVIEMSGV 196
+HRD+ N + + VK+ADFG+A + + + V+ H+ P WMA E ++
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 197 CAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255
SD+WS G + EL+T PPY ++ ++Q R PE + + + C+
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW 239
Query: 256 KKDARQRPDAKTLLS 270
RP L+S
Sbjct: 240 HPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 6e-26
Identities = 68/253 (26%), Positives = 126/253 (49%), Gaps = 6/253 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLK-NLNHKNIVKYL 83
+GKG++G+V+ F AIK + + + +D+ M E +L H +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ +T+ +L ++EY+ G L I+ P + Y A+++ GL +LH +G+++R
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA--TFYAAEIICGLQFLHSKGIVYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K NIL +G +K+ADFG+ + D T + GTP ++APE++ + D W
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
S G + E+L P++ LF+ ++ + P P L+ + D L + F ++ +R
Sbjct: 181 SFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239
Query: 264 DAK-TLLSHPWIQ 275
K + HP+ +
Sbjct: 240 GVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 79/278 (28%), Positives = 138/278 (49%), Gaps = 30/278 (10%)
Query: 18 NKYMLGDEIGKGAYGRVYK----GLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDL 70
++ +LG +G+G +G+V + G+D D VA+K + +N +DL ++ E++L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMEL 70
Query: 71 LKNLN-HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK----------------PNKF 113
+K + HKNI+ LG L++I+EY G+L ++ P +
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 114 GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173
F + + Y QV G+ YL + IHRD+ N+L T++ ++K+ADFG+A + + D
Sbjct: 131 LSFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 174 VNTHSVVG-TPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI 231
+ G P WMAPE + SD+WS G + E+ T Y P+ LF++
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 232 VQD-ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTL 268
+++ R P + + ++ +R+C+ QRP K L
Sbjct: 249 LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 46/292 (15%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQV-SLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V + G A+K++ E + +E + + E D+L ++ +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S + ++L++I+EY+ G + ++ K F E YIA+ + + +H+ G IHRD
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKLGYIHRD 126
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTH--------------------------- 177
IK N+L +G +KL+DFG+ T L ++
Sbjct: 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186
Query: 178 -----------SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMP 226
S VGTP ++APEV +G D WS+G + E+L PP+ P
Sbjct: 187 TWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE 246
Query: 227 ALFRIVQ-DERPPIPES--LSPDITDF-LRQCFKKDAR-QRPDAKTLLSHPW 273
+I+ E P+ LSP+ D R C + + R + SHP+
Sbjct: 247 TYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 75/255 (29%), Positives = 127/255 (49%), Gaps = 23/255 (9%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
EIG G +G V+ G LE VAIK + +++ED ++E ++ L+H +V+ G
Sbjct: 11 EIGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDF---IEEAQVMMKLSHPKLVQLYG 66
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
RS + ++ E++E+G L++ ++ + G F + + V EG+ YL VIHRD
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY---WMAPEVIEMSGVCAASD 201
+ N L + +VK++DFG+ T+ D T S GT + W +PEV S + SD
Sbjct: 126 LAARNCLVGENQVVKVSDFGM-TRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 202 IWSVGCTVIELLTCVPPYYE-------LQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
+WS G + E+ + YE ++ + A FR+ + P S + + ++ C
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK------PRLASQSVYELMQHC 237
Query: 255 FKKDARQRPDAKTLL 269
+K+ RP LL
Sbjct: 238 WKERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 79/268 (29%), Positives = 131/268 (48%), Gaps = 19/268 (7%)
Query: 26 IGKGAYGRVY---KGLDLENGDFVAIKQVSLENIAQEDLNI--IMQEIDLLKNLNHKNIV 80
+G GAYG+V+ K ++G A+K + I Q+ E +L+++ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 81 KYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
L + +T + LH+IL+Y+ G L + + F E V +Y +++ L +LH+ G
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG 125
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN-THSVVGTPYWMAPEVIE--MSGV 196
+I+RDIK NIL G V L DFG++ + E +V +S GT +MAP+++ G
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 197 CAASDIWSVGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
A D WS+G + ELLT P+ E + R + PP P+ +S D +++
Sbjct: 186 DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQR 245
Query: 254 CFKKDARQR-----PDAKTLLSHPWIQN 276
KD ++R DA + HP+ Q
Sbjct: 246 LLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 68/251 (27%), Positives = 130/251 (51%), Gaps = 7/251 (2%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L ++G G +G V+ ++ VA+K + +++ E + E +++K L H +VK
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAF---LAEANVMKTLQHDKLVK 65
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
L ++ T+ ++II E++ GSL + +K ++ P + + AQ+ EG+ ++ ++ I
Sbjct: 66 -LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAAS 200
HRD++ ANIL + + K+ADFG+A + + + P W APE I S
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ-DERPPIPESLSPDITDFLRQCFKKDA 259
D+WS G ++E++T Y P + R ++ R P PE+ ++ + + +C+K
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 244
Query: 260 RQRPDAKTLLS 270
+RP + + S
Sbjct: 245 EERPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 62/241 (25%), Positives = 114/241 (47%), Gaps = 5/241 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G V G A K++ + + + + + E +L+ ++ + IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ +T+ L +++ + G L I FPE+ Y AQ++ GL +LH++ +++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K N+L G V+++D G+A +L GTP +MAPEV++ + D ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRAGTPGYMAPEVLQGEVYDFSVDWFA 179
Query: 205 VGCTVIELLTCVPP---YYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261
+GCT+ E++ P E L R + P+ SP+ D +KD +
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239
Query: 262 R 262
R
Sbjct: 240 R 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 70/250 (28%), Positives = 124/250 (49%), Gaps = 11/250 (4%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
E+G G +G V G D VAIK + ++++++ ++E ++ L+H+ +V+ G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEF---IEEAKVMMKLSHEKLVQLYG 66
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ ++I+ EY+ NG L N ++ + P L+ + V EG+ YL + IHRD
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM-CKDVCEGMAYLESKQFIHRD 125
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY---WMAPEVIEMSGVCAASD 201
+ N L +G VK++DFG+ ++ D T S VG+ + W PEV+ S + SD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGL-SRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 202 IWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260
+W+ G + E+ + PY + ++ Q R P S + + C+ + A
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAE 243
Query: 261 QRPDAKTLLS 270
+RP + LLS
Sbjct: 244 ERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 81/263 (30%), Positives = 121/263 (46%), Gaps = 32/263 (12%)
Query: 26 IGKGAYGRVYKG-----LDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
+G GA+G VY+G L +G VA+K + QE ++E L+ N NH NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEF-LKEAHLMSNFNHPNI 61
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAV-----YIAQVLEGLVY 134
VK LG +II+E +E G L + ++ + F L+ + V +G VY
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 135 LHEQGVIHRDIKGANILTTKEG-----LVKLADFGVATKLTEADVNTHSVVG--TPYWMA 187
L + IHRD+ N L +++G +VK+ DFG+A + ++D G WMA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 188 PEVIEMSGV-CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI-----VQDE-RPPIP 240
PE + + G SD+WS G + E+LT QP PAL V R P
Sbjct: 182 PESL-LDGKFTTQSDVWSFGVLMWEILT-----LGQQPYPALNNQEVLQHVTAGGRLQKP 235
Query: 241 ESLSPDITDFLRQCFKKDARQRP 263
E+ I + C+ +D +RP
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 65/245 (26%), Positives = 114/245 (46%), Gaps = 9/245 (3%)
Query: 26 IGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82
IG G +G V++G+ G VAIK + ++ + E ++ +H NI++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
G + II EY+ENG+L ++ + G F + + + G+ YL + +H
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY---WMAPEVIEMSGVCAA 199
RD+ NIL K++DFG++ L + T++ G W APE I +A
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190
Query: 200 SDIWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G + E+++ PY+++ + I R P P + + QC+++D
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQD 250
Query: 259 ARQRP 263
+RP
Sbjct: 251 RARRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 74/254 (29%), Positives = 130/254 (51%), Gaps = 14/254 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI----AQEDLNIIMQEIDLLKNLNHKNIVK 81
+G G +G V+KG+ + GD + I V+++ I ++ I + + +L+H IV+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIP-VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
LG + + L ++ + GSL + ++ ++ P+ L+ + Q+ +G+ YL E ++
Sbjct: 74 LLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN-WCVQIAKGMYYLEEHRMV 131
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVN-THSVVGTPY-WMAPEVIEMSGVCAA 199
HR++ NIL + +V++ADFGVA L D +S TP WMA E I
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191
Query: 200 SDIWSVGCTVIELLTC-VPPYYELQP--MPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
SD+WS G TV E+++ PY ++P +P L + ER P+ + D+ + +C+
Sbjct: 192 SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE--KGERLAQPQICTIDVYMVMVKCWM 249
Query: 257 KDARQRPDAKTLLS 270
D RP K L +
Sbjct: 250 IDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 76/279 (27%), Positives = 138/279 (49%), Gaps = 30/279 (10%)
Query: 18 NKYMLGDEIGKGAYGRVYK----GLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDL 70
+ LG +G+G +G+V G+D + + VA+K + ++ +DL+ ++ E+++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-DDATDKDLSDLVSEMEM 70
Query: 71 LKNL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK----------------PNKF 113
+K + HKNI+ LG+ L++++EY G+L ++ P +
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 114 GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173
F + + Y QV G+ YL Q IHRD+ N+L T++ ++K+ADFG+A + D
Sbjct: 131 LTFKDLVSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188
Query: 174 VNTHSVVGT-PY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI 231
+ G P WMAPE + SD+WS G + E+ T Y P+ LF++
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248
Query: 232 VQD-ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLL 269
+++ R P + + ++ +R+C+ QRP K L+
Sbjct: 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 5e-25
Identities = 78/277 (28%), Positives = 140/277 (50%), Gaps = 26/277 (9%)
Query: 18 NKYMLGDEIGKGAYGRVYK----GLDLENGDF---VAIKQVSLENIAQEDLNIIMQEIDL 70
++ +LG +G+G +G+V GLD E + VA+K + + ++DL+ ++ E+++
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-SDATEKDLSDLISEMEM 76
Query: 71 LKNL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNK-------FGP--FPESL 120
+K + HKNI+ LG+ L++I+EY G+L ++ + + P PE
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 121 VAVY-----IAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175
++ QV G+ YL + IHRD+ N+L T++ ++K+ADFG+A + D
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 176 THSVVGT-PY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ 233
+ G P WMAPE + SD+WS G + E+ T Y P+ LF++++
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256
Query: 234 D-ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLL 269
+ R P + + ++ +R C+ QRP K L+
Sbjct: 257 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 73/247 (29%), Positives = 119/247 (48%), Gaps = 13/247 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI--AQEDLNIIMQEIDLLKNLNHKNIVKYL 83
IGKG++G+V F A+K + + I +E+ +I+ + LLKN+ H +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
S +T L+ +L+Y+ G L ++ + F E Y A++ L YLH +++R
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K NIL +G + L DFG+ + E + T + GTP ++APEV+ D W
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITD----FLRQCFKKDA 259
+G + E+L +PP+Y I+ P L P+IT+ L +KD
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----PLQLKPNITNSARHLLEGLLQKDR 235
Query: 260 RQRPDAK 266
+R AK
Sbjct: 236 TKRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 79/320 (24%), Positives = 137/320 (42%), Gaps = 60/320 (18%)
Query: 13 SKTLDNKYM-LGDEIGKGAYGRVYKGLDLENGDFVAIKQV-----------SLENIAQED 60
S ++ +Y+ G +G+G YG+V K D G VAIK+V + +
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 61 LN-IIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPES 119
++ ++E+ ++ + H+NI+ + ++++++ + L ++ ES
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTES 119
Query: 120 LVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL---------- 169
V + Q+L GL LH+ +HRD+ ANI +G+ K+ADFG+A +
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 170 ----TEADVNTHSVVGTPYWMAPEVIEMSGVC--AASDIWSVGCTVIELLTCVPPY---- 219
+ S V T ++ APE++ M A D+WSVGC ELLT P +
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELL-MGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 220 --------YELQPMPALFRIVQDERPPI--------PESL-------SPDITDFLRQCFK 256
+EL P Q ++ P+ P+ L S D D L+ K
Sbjct: 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298
Query: 257 KDARQRPDAKTLLSHPWIQN 276
+ +R AK L H + ++
Sbjct: 299 LNPLERISAKEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 63/198 (31%), Positives = 105/198 (53%), Gaps = 6/198 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI--AQEDLNIIMQEIDLLKNLNHKNIVKYL 83
IGKG++G+V +G A+K + + + +E +I+ + LLKN+ H +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
S +T L+ +L++V G L ++ + FPE Y A++ L YLH +++R
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATK-LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
D+K NIL +G V L DFG+ + + ++D T + GTP ++APEVI D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT-TFCGTPEYLAPEVIRKQPYDNTVDW 179
Query: 203 WSVGCTVIELLTCVPPYY 220
W +G + E+L +PP+Y
Sbjct: 180 WCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 11/264 (4%)
Query: 16 LDNKY-MLGDEIGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLL 71
+D Y + IG G +G V +G G VAIK + + ++ L+ + E ++
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF-LTEASIM 59
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPF-PESLVAVYIAQVLE 130
+H NI++ G + + II EY+ENGSL ++ N G F LV + + +
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGM-LRGIAS 117
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL--TEADVNTHSVVGTPYWMAP 188
G+ YL E +HRD+ NIL + K++DFG++ +L +EA T W AP
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 189 EVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDI 247
E I +ASD+WS G + E+++ PY+++ + + R P P +
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL 237
Query: 248 TDFLRQCFKKDARQRPDAKTLLSH 271
+ C++KD +RP ++S
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS-LEN--IAQEDLNIIMQEIDLLK 72
+ +Y IG+GAYG V G VAIK++S E+ Q L +EI +L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILR 58
Query: 73 NLNHKNIVKYLGSLKTRS-----HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
H+NI+ L ++ S ++I+ E +E L +IK + ++ Q
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLS---NDHIQYFLYQ 114
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV---VGTPY 184
+L GL Y+H V+HRD+K +N+L +K+ DFG+A +T + V T +
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 185 WMAPEV-IEMSGVCAASDIWSVGCTVIELLTCVP 217
+ APE+ + G A DIWSVGC + E+L+ P
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 77/279 (27%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 18 NKYMLGDEIGKGAYGRVYK----GLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDL 70
+K LG +G+G +G+V G+D + VA+K + ++ ++DL+ ++ E+++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEM 73
Query: 71 LKNL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK----------------PNKF 113
+K + HKNI+ LG+ L++I+EY G+L ++ P++
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 114 GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173
F + + Y QV G+ YL Q IHRD+ N+L T+ ++K+ADFG+A + D
Sbjct: 134 MTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 174 VNTHSVVGT-PY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI 231
+ G P WMAPE + SD+WS G + E+ T Y P+ LF++
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 232 VQD-ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLL 269
+++ R P + + ++ +R C+ RP K L+
Sbjct: 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 69/239 (28%), Positives = 119/239 (49%), Gaps = 5/239 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG++G+V + AIK + + + Q+D + M E +L + + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 85 S-LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
S +T L+ ++EYV G L I+ + G F E Y A++ GL +LH +G+I+R
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N++ EG +K+ADFG+ + V T + GTP ++APE+I + D W
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262
+ G + E+L PP ++ + LF+ + + P+SLS + + K +R
Sbjct: 186 AYGVLLYEMLAGQPP-FDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 72/252 (28%), Positives = 122/252 (48%), Gaps = 9/252 (3%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
L ++G G +G V+ G NG+ VA+K + ++ E ++E ++K L H +V
Sbjct: 10 LIKKLGNGQFGEVWMGT--WNGNTKVAVKTLKPGTMSPESF---LEEAQIMKKLRHDKLV 64
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+ L ++ + ++I+ EY+ GSL + +K + + AQV G+ Y+
Sbjct: 65 Q-LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAA 199
IHRD++ ANIL + K+ADFG+A + + + P W APE
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 200 SDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G + EL+T PY + L ++ + R P P+ + + + QC+KKD
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD 243
Query: 259 ARQRPDAKTLLS 270
+RP + L S
Sbjct: 244 PEERPTFEYLQS 255
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 6/230 (2%)
Query: 67 EIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKP--NKFGPFPESLVAVY 124
E+ L +H IVK+ K+ L +I+EY G L IK + PF E V +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA---DVNTHSVVG 181
Q++ L +H + ++HRD+K ANI G++KL DFG + + +++ DV + S G
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS-SFCG 233
Query: 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE 241
TPY++APE+ E +D+WS+G + ELLT P+ + +++ + P P
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPC 293
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTM 291
+S + L K+ RP + LL +++ Q +RHS T+
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETI 343
|
Length = 478 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 76/263 (28%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 26 IGKGAYGRVY----KGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLK-NLNHKNI 79
+GKG++G+V KG D + AIK + + I Q+D ++ M E +L H +
Sbjct: 3 LGKGSFGKVMLAELKGTD----EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
+T+ L ++EYV G L I+ ++ F E Y A+V L++LH G
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
VI+RD+K NIL EG KLADFG+ + V T + GTP ++APE+++ +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS 176
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
D W++G + E++ PP +E LF + + P LS + L+ K+
Sbjct: 177 VDWWALGVLMYEMMAGQPP-FEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP 235
Query: 260 RQR-------PDAKTLLSHPWIQ 275
+R + HP+ +
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 92/383 (24%), Positives = 156/383 (40%), Gaps = 79/383 (20%)
Query: 8 SAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQ 66
S F K KTL G GA+G V ++ A+K + +++ + + +
Sbjct: 1 SMFVKIKTL----------GIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKA 50
Query: 67 EIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA 126
E D+L +++ +VK S + + +L+ +++Y+ G + +++ + FPE L YIA
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYIA 108
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA-------------- 172
++ + +H+ G IHRDIK NIL +G +KL DFG+ T
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168
Query: 173 ----------DVN-----------------------THSVVGTPYWMAPEVIEMSGVCAA 199
DV+ HS+VGTP ++APEV+ G
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP---PIPESLSPDITDFLRQ--C 254
D WSVG + E+L PP+ P +++ E P LSP+ D + + C
Sbjct: 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCC 288
Query: 255 FKKDARQRPDAKTLLSHPWIQ------NCRRA---LQSSLRHSGTMRN---VEENGSADA 302
++ R A + +HP+ + R + H N VEE +
Sbjct: 289 SAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWND 348
Query: 303 EIPSEDNQSAGESLSAPKAEAFE 325
S D+ ++L +P + E
Sbjct: 349 A--SGDSTRTWDTLCSPNGKHPE 369
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 9/201 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVS-LENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V + A+K +S E I + D +E D++ N +V+
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ + +L++++EY+ G L N++ PE Y A+V+ L +H G+IHRD
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDV---PEKWAKFYTAEVVLALDAIHSMGLIHRD 167
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEAD-VNTHSVVGTPYWMAPEVIEMSG----VCAA 199
+K N+L K G +KLADFG K+ E V + VGTP +++PEV++ G
Sbjct: 168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 200 SDIWSVGCTVIELLTCVPPYY 220
D WSVG + E+L P+Y
Sbjct: 228 CDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 31/282 (10%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSL----ENIAQEDLNIIMQEIDLLKNL 74
+LG +G+G +G+V K V++ EN + +L ++ E +LLK +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNK------------------FGPF 116
NH +++K G+ L +I+EY + GSL + ++ ++ P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 117 PESL----VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172
+L + + Q+ G+ YL E ++HRD+ N+L + +K++DFG++ + E
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 173 DVNTHSVVG-TPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALF 229
D G P WMA E + SD+WS G + E++T PY + P LF
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERLF 239
Query: 230 RIVQD-ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
+++ R PE+ S ++ + + C+K++ +RP +
Sbjct: 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 9e-24
Identities = 70/244 (28%), Positives = 121/244 (49%), Gaps = 13/244 (5%)
Query: 25 EIGKGAYGRVYKGLDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
++G+G +G V+ G NG VAIK + ++ E +QE ++K L H+ +V+ L
Sbjct: 13 KLGQGCFGEVWMGT--WNGTTRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQ-L 66
Query: 84 GSLKTRSHLHIILEYVENGSLANIIK--PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
++ + ++I+ EY+ GSL + +K K+ P+ + AQ+ G+ Y+ +
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ--LVDMAAQIASGMAYVERMNYV 124
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAAS 200
HRD++ ANIL + + K+ADFG+A + + + P W APE S
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 201 DIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
D+WS G + EL T PY + L ++ + R P P + D + QC++K+
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 244
Query: 260 RQRP 263
+RP
Sbjct: 245 EERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 83/304 (27%), Positives = 138/304 (45%), Gaps = 55/304 (18%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS--LENIAQEDLNIIMQEIDLLKNLNH 76
+Y + + IGKG+YG V +D G+ VAIK+++ E+++ D I++EI LL+ L H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS--DATRILREIKLLRLLRH 58
Query: 77 KNIVKYLG-----SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVA----VYIAQ 127
+IV+ S + ++++ E +E+ L +IK N + L ++ Q
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHHQFFLYQ 111
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFG---VATKLTEADVNTHSVVGTPY 184
+L L Y+H V HRD+K NIL + +K+ DFG VA T + V T +
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 185 WMAPEVIE--MSGVCAASDIWSVGCTVIELLTCVPPY------YELQ---------PMPA 227
+ APE+ S A DIWS+GC E+LT P + ++L
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231
Query: 228 LFRIVQDE----------RPPIPES-----LSPDITDFLRQCFKKDARQRPDAKTLLSHP 272
+ R+ ++ + P+P S P L + D + RP A+ L+ P
Sbjct: 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291
Query: 273 WIQN 276
+ +
Sbjct: 292 YFKG 295
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 72/244 (29%), Positives = 122/244 (50%), Gaps = 13/244 (5%)
Query: 25 EIGKGAYGRVYKGLDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
++G+G +G V+ G NG VAIK + + E +QE ++K L H +V L
Sbjct: 13 KLGQGCFGEVWMGT--WNGTTKVAIKTLKPGTMMPEAF---LQEAQIMKKLRHDKLVP-L 66
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
++ + ++I+ E++ GSL + +K K+ P+ LV + AQ+ +G+ Y+ I
Sbjct: 67 YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ-LVDM-AAQIADGMAYIERMNYI 124
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAAS 200
HRD++ ANIL + K+ADFG+A + + + P W APE S
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 201 DIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
D+WS G + EL+T PY + L ++ + R P P+ + + ++ C+KKD
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDP 244
Query: 260 RQRP 263
+RP
Sbjct: 245 DERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 63/239 (26%), Positives = 123/239 (51%), Gaps = 5/239 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYL- 83
+GKG++G+V G++ A+K + + + +D+ M E +L + +L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ +T+ HL ++E++ G L I+ G F Y A+++ GL +LH +G+I+R
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N++ ++G +K+ADFG+ + D + GTP ++APE+++ + D W
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWW 180
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262
S G + E+L P++ LF ++ + P P ++ + D L + F++D +R
Sbjct: 181 SFGVLLYEMLIGQSPFHG-DDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 9/201 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVS-LENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V + A+K +S E I + D +E D++ + N + IV+
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ + +L++++EY+ G L N++ PE Y A+V+ L +H G IHRD
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDI---PEKWARFYTAEVVLALDAIHSMGFIHRD 167
Query: 145 IKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVIEMSGVCA----A 199
+K N+L K G +KLADFG K+ V + VGTP +++PEV++ G
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 200 SDIWSVGCTVIELLTCVPPYY 220
D WSVG + E+L P+Y
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 85/322 (26%), Positives = 129/322 (40%), Gaps = 65/322 (20%)
Query: 25 EIGKG--AYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82
EIG+G VY G V ++ LEN +E L + E+ L H NI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL----EGLVYLHEQ 138
T S L +I ++ GS +++K FPE + I +L GL YLH+
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTY----FPEGMSEALIGNILFGALRGLNYLHQN 120
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-------WMAPEVI 191
G IHR+IK ++IL + +GLV L+ L V P W++PE++
Sbjct: 121 GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180
Query: 192 --EMSGVCAASDIWSVGCTVIELLTCV------------------PPYYEL--------- 222
++ G SDI+SVG T EL T PPY L
Sbjct: 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240
Query: 223 QPM-----------------PALFRIVQDER--PPIPESLSPDITDFLRQCFKKDARQRP 263
M + + + ER P ++ SP + + C ++D +RP
Sbjct: 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300
Query: 264 DAKTLLSHPWIQNCRRALQSSL 285
A +LLSH + + + Q S+
Sbjct: 301 SASSLLSHAFFKQVKEQTQGSI 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-23
Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 4/197 (2%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
+++G+G+Y VYKG NG VA+K + L+ I +E LLK L H NIV
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLLH 69
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ T+ L ++ EYV L + + G PE+ V +++ Q+L GL Y+H++ ++HR
Sbjct: 70 DIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPEN-VKLFLFQLLRGLSYIHQRYILHR 127
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS-DI 202
D+K N+L + G +KLADFG+A + + V T ++ P+V+ S + D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 203 WSVGCTVIELLTCVPPY 219
W VGC +E++ V +
Sbjct: 188 WGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 46/286 (16%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG- 84
+G GAYG+V D + G VAIK++S + +E+ LLK+++H+N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 85 -----SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
SL+ ++++ + L NI+K K + + + Q+L GL Y+H G
Sbjct: 83 FTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLS---DDHIQFLVYQILRGLKYIHSAG 138
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI--EMSGVC 197
+IHRD+K +NI ++ +K+ DFG+A + T+ ++ + V T ++ APE++ M
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLA-RHTDDEMTGY--VATRWYRAPEIMLNWMHYNQ 195
Query: 198 AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL-------------- 243
DIWSVGC + ELLT + + L RI+ P E L
Sbjct: 196 TV-DIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQS 254
Query: 244 ----------------SPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
+P D L + D +R A L+HP+
Sbjct: 255 LPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-23
Identities = 78/287 (27%), Positives = 135/287 (47%), Gaps = 24/287 (8%)
Query: 26 IGKGAYGRVY----KGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIV 80
+GKG++G+V KG D + AIK + + + Q+D + M E +L +
Sbjct: 8 LGKGSFGKVMLAERKGTD----ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 81 KYLGS-LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
L S +T L+ ++EYV G L I+ + G F E Y A++ GL +LH +G
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
+I+RD+K N++ EG +K+ADFG+ + V T + GTP ++APE+I +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
D W+ G + E+L P +E + LF+ + + P+S+S + + K
Sbjct: 182 VDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240
Query: 260 RQR----PDA-KTLLSHP------WIQNCRRALQSSLRHSGTMRNVE 295
+R P+ + + H W + R+ +Q + R+ E
Sbjct: 241 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDAE 287
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 16/198 (8%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI--IMQEIDLLKNLNHKNIVKYL 83
IG GA+G V+ D +G VA+K+ + N+ Q ++ + +E+ +L H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKK--MPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 84 GSLKTR-----SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
L+ ++++ E +++ L II + P V V++ Q+L GL YLH
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA 122
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATK--LTEADVNTHSVVGTPYWMAPEVIEMSG- 195
G++HRDIK N+L ++K+ DFG+A E+ T VV T Y+ APE++ S
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEILMGSRH 181
Query: 196 VCAASDIWSVGCTVIELL 213
+A DIWSVGC ELL
Sbjct: 182 YTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 71/254 (27%), Positives = 120/254 (47%), Gaps = 17/254 (6%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
+ IG+G +G V+ G + VA+K E + + +QE +LK +H NIV+ +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE----GLVYLHEQG 139
G + ++I++E V+ G ++ GP L + Q++E G+ YL +
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTE--GP---RLKVKELIQMVENAAAGMEYLESKH 114
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPY-WMAPEVIEMSG 195
IHRD+ N L T++ ++K++DFG++ + E D +T + P W APE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 196 VCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
+ SD+WS G + E + PY L I Q R P PE + + +C
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERC 232
Query: 255 FKKDARQRPDAKTL 268
++ D QRP T+
Sbjct: 233 WEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 76/274 (27%), Positives = 131/274 (47%), Gaps = 32/274 (11%)
Query: 21 MLGDEIGKGAYGRV-----YKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNL 74
+L E+G+GA+G+V Y ++ VA+K + + A++D +E +LL NL
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ---REAELLTNL 64
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLV------------- 121
H++IVK+ G L ++ EY+++G L ++ + GP LV
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH--GPDAMILVDGQPRQAKGELGL 122
Query: 122 --AVYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VN 175
++IA Q+ G+VYL Q +HRD+ N L LVK+ DFG++ + D V
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182
Query: 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQD 234
H+++ WM PE I SD+WS G + E+ T P+++L + I Q
Sbjct: 183 GHTMLPI-RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241
Query: 235 ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTL 268
P ++ D + C++++ +QR + K +
Sbjct: 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 79/280 (28%), Positives = 137/280 (48%), Gaps = 25/280 (8%)
Query: 21 MLGDEIGKGAYGRV-----YKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
+L E+G+GA+G+V Y ++ VA+K +L++ + +E +LL NL
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKDFHREAELLTNLQ 65
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK---PNKF----GPFPESLVA---VYI 125
H++IVK+ G L ++ EY+++G L ++ P+ G P L ++I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 126 AQ-VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVG 181
AQ + G+VYL Q +HRD+ N L + LVK+ DFG++ + D V H+++
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIP 240
WM PE I SD+WS+G + E+ T P+Y+L + I Q P
Sbjct: 186 I-RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA 280
+ ++ D + C++++ R + K + H +QN +A
Sbjct: 245 RTCPKEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 6e-23
Identities = 70/247 (28%), Positives = 116/247 (46%), Gaps = 11/247 (4%)
Query: 26 IGKGAYGRVYKGLDLENG---DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82
IG G +G V +G G FVAIK + ++ + E ++ +H NI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
G + + II E++ENG+L + ++ N G F + + + G+ YL E +H
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTE--ADVNTHSVVGTPY---WMAPEVIEMSGVC 197
RD+ NIL + K++DFG++ L + +D S +G W APE I
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT 189
Query: 198 AASDIWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
+ASD+WS G + E+++ PY+++ + I QD R P P + + C++
Sbjct: 190 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQ 249
Query: 257 KDARQRP 263
KD RP
Sbjct: 250 KDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-22
Identities = 63/207 (30%), Positives = 110/207 (53%), Gaps = 16/207 (7%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y+ D++G+G Y V+KG + VA+K++ LE+ I +E+ LLKNL H NI
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHANI 65
Query: 80 VKYLGSLKTRSHLHIILEYVENG------SLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
V + T L ++ EY+++ + N++ + V +++ Q+L GL
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--------VKIFMFQLLRGLS 117
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
Y H++ ++HRD+K N+L ++G +KLADFG+A + + V T ++ P+V+
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 194 SGVCAAS-DIWSVGCTVIELLTCVPPY 219
S + D+W VGC + E+ T P +
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 5/240 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+GKG +G V+KG L++ VA+K E++ QE + E +LK +H NIVK +G
Sbjct: 3 LGKGNFGEVFKG-TLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDI 145
R ++I++E V G + ++ K + LV + G+ YL + IHRD+
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK-FALDAAAGMAYLESKNCIHRDL 119
Query: 146 KGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAASDIWS 204
N L + ++K++DFG++ + + ++ + P W APE + + SD+WS
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179
Query: 205 VGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
G + E + V PY + A ++ + R P+ D+ +++C+ RP
Sbjct: 180 YGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 21/268 (7%)
Query: 18 NKYMLGDEIGKGAYGRVYK----GLDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLK 72
N G +G GA+G+V + GL + VA+K + + E +M E+ ++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER-EALMSELKIMS 93
Query: 73 NL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNK--FGPFPESLVAVYIAQVL 129
+L NH+NIV LG+ + +I EY G L N ++ + F + L Y QV
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY--QVA 151
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY----W 185
+G+ +L + IHRD+ N+L T +VK+ DFG+A + D N + V G W
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN-DSN-YVVKGNARLPVKW 209
Query: 186 MAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALF-RIVQDE-RPPIPES 242
MAPE I SD+WS G + E+ + PY + P+ + F +++++ R PE
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLIKEGYRMAQPEH 268
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLS 270
+I D ++ C+ D +RP K ++
Sbjct: 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 57/191 (29%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
E+G G +G V+ G VAIK ++ +++ED ++E ++ L+H +V+ G
Sbjct: 11 ELGSGQFGVVHLG-KWRAQIKVAIKAINEGAMSEEDF---IEEAKVMMKLSHPKLVQLYG 66
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ L+I+ E++ENG L N ++ + G + ++ V EG+ YL IHRD
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAASDIW 203
+ N L + G+VK++DFG+ + + + + S P W PEV S + SD+W
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 204 SVGCTVIELLT 214
S G + E+ T
Sbjct: 186 SFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 69/261 (26%), Positives = 121/261 (46%), Gaps = 27/261 (10%)
Query: 25 EIGKGAYGRVYKG-----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
E+G+GA+G+V+ L ++ VA+K +L+ ++ +E +LL L H++I
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQREAELLTVLQHQHI 69
Query: 80 VKYLGSLKTRSHLHIILEYVENGSL----------ANIIKPNK---FGPFPESLVAVYIA 126
V++ G L ++ EY+ +G L A I+ + G + +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-- 184
Q+ G+VYL +HRD+ N L + +VK+ DFG++ + D + V G
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY--YRVGGRTMLP 187
Query: 185 --WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPE 241
WM PE I SDIWS G + E+ T P+Y+L A+ I Q P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPR 247
Query: 242 SLSPDITDFLRQCFKKDARQR 262
+ P++ ++ C++++ +QR
Sbjct: 248 TCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 3e-22
Identities = 73/268 (27%), Positives = 130/268 (48%), Gaps = 20/268 (7%)
Query: 26 IGKGAYGRVYKGLDLENGDFV-AIKQVSLENIAQ-EDLNIIMQEIDLLKNL-NHKNIVKY 82
IG+G+Y +V + L+ + + A+K V E + ED++ + E + + NH +V
Sbjct: 3 IGRGSYAKVLL-VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
+T S L ++EYV G L ++ + PE Y A++ L YLHE+G+I+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RD+K N+L EG +KL D+G+ + T + GTP ++APE++ + D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 203 WSVGCTVIELLTCVPPY--------YELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
W++G + E++ P+ + LF+++ +++ IP SLS L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239
Query: 255 FKKDARQR----PDA--KTLLSHPWIQN 276
KD ++R P + HP+ +N
Sbjct: 240 LNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 3e-22
Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y+ D++G+G Y VYKG + VA+K++ LE+ I +E+ LLK+L H NI
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANI 66
Query: 80 VKYLGSLKTRSHLHIILEYVENG------SLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
V + T L ++ EY++ N I + V +++ Q+L GL
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--------VKLFLFQLLRGLN 118
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
Y H + V+HRD+K N+L + G +KLADFG+A + T+S W P I +
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVVTLWYRPPDILL 177
Query: 194 SGVCAAS--DIWSVGCTVIELLTCVP 217
++ D+W VGC E+ T P
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-22
Identities = 84/302 (27%), Positives = 132/302 (43%), Gaps = 45/302 (14%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
L +Y ++G GAYG V +D G+ VAIK++S ++ +E+ LLK++
Sbjct: 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 76 HKNIVKYLGSLKTRSHLH------IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
H+N++ L + +++ Y++ L I+ P E V + Q+L
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGH----PLSEDKVQYLVYQML 127
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
GL Y+H G+IHRD+K N+ ++ +K+ DFG+A AD V T ++ APE
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPE 184
Query: 190 VI-EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE------- 241
VI DIWSVGC + E+LT + + L +I++ P PE
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 242 --------SL---------------SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278
SL SP D L + + D +R A L HP+ + R
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 279 RA 280
A
Sbjct: 305 DA 306
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-22
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVS-LENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V A+K +S E I + D +E D++ N +V+
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ + +L++++EY+ G L N++ PE Y A+V+ L +H G IHRD
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDV---PEKWARFYTAEVVLALDAIHSMGFIHRD 167
Query: 145 IKGANILTTKEGLVKLADFGVATKLT-EADVNTHSVVGTPYWMAPEVIEMSG----VCAA 199
+K N+L K G +KLADFG K+ E V + VGTP +++PEV++ G
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 200 SDIWSVGCTVIELLTCVPPYY 220
D WSVG + E+L P+Y
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 4e-22
Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 14/252 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVS--LENIAQEDLNI-IMQEIDLLKNLNHKNIVKY 82
+G GA+G VYKG+ + G+ V I L N+ M E ++ +++H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
LG + + + ++ + + +G L + + +K L+ + Q+ +G++YL E+ ++H
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVH 132
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY---WMAPEVIEMSGVCAA 199
RD+ N+L VK+ DFG+A +L E D ++ G WMA E I
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 200 SDIWSVGCTVIELLTCVPPYYELQP---MPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
SD+WS G T+ EL+T Y+ P +P L + ER P P + D+ + +C+
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE--KGERLPQPPICTIDVYMVMVKCWM 249
Query: 257 KDARQRPDAKTL 268
DA RP K L
Sbjct: 250 IDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-22
Identities = 74/263 (28%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ--EDLNIIMQEIDLLKNLNHKN--IVK 81
IGKG +G+VY+ + A+K +S + I E + I + L++ L ++ IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
S +T S L+++ +Y+ G L K G F E YIA+++ L +LH+ ++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV-IEMSGVCAAS 200
+RD+K NIL G + L DFG++ + T++ GT ++APEV ++ G
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 201 DIWSVGCTVIELLTCVPPYY--ELQPMPALFRIVQDERPPIPES-LSPDITDFLRQCFKK 257
D WS+G V E+ P+Y + Q M +R + + P++ LS + F++ +
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQM---YRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235
Query: 258 DARQR----PDAKTLLSHPWIQN 276
+ + R DA L HP+ +
Sbjct: 236 NPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 69/251 (27%), Positives = 117/251 (46%), Gaps = 23/251 (9%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
IGKG +G V G G+ VA+K + + AQ + E ++ L H N+V+ LG
Sbjct: 14 IGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGV 67
Query: 86 L-KTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ + + L+I+ EY+ GSL + ++ + + V E + YL +HRD
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAASDIW 203
+ N+L +++ + K++DFG LT+ +T P W APE + SD+W
Sbjct: 128 LAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 204 SVGCTVIELLTC--VP----PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257
S G + E+ + VP P ++ P R+ + + P+ P + D ++QC+
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVP-----RVEKGYKMDAPDGCPPVVYDVMKQCWHL 238
Query: 258 DARQRPDAKTL 268
DA RP L
Sbjct: 239 DAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 9e-22
Identities = 66/245 (26%), Positives = 121/245 (49%), Gaps = 10/245 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+G+Y +V +N A+K V E + ED++ + E + + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 85 S-LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
S +T S L +++EYV G L ++ + PE Y A++ L +LHE+G+I+R
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N+L +G +KL D+G+ + T + GTP ++APE++ + D W
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWW 180
Query: 204 SVGCTVIELLTCVPPYYELQPMPA------LFRIVQDERPPIPESLSPDITDFLRQCFKK 257
++G + E++ P+ + P LF+++ ++ IP LS + L+ K
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK 240
Query: 258 DARQR 262
D ++R
Sbjct: 241 DPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 66/260 (25%), Positives = 116/260 (44%), Gaps = 10/260 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G V G A K++ + I + + ++ + E +L+ +N + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ +T+ L ++L + G L I F E Y A++L GL LH + ++RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K NIL G ++++D G+A K+ E + VGT +MAPEV+ + D W
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRVGTVGYMAPEVLNNQRYTLSPDYWG 186
Query: 205 VGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261
+GC + E++ P+ E + R V + S + + KD +Q
Sbjct: 187 LGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQ 246
Query: 262 R-----PDAKTLLSHPWIQN 276
R A + HP+ +N
Sbjct: 247 RLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-21
Identities = 76/290 (26%), Positives = 138/290 (47%), Gaps = 33/290 (11%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
N+Y + +IG G +G V+ +F K +S + + + + ++ E+++++ L HK
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 78 NIVKYLGSL--KTRSHLHIILEYVENGSLA-NIIKPNK-FGPFPESLVAVYIAQVLEGLV 133
NIV+Y+ K L+I++E+ + G L+ NI K K FG E + Q+L L
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 134 YLHE-------QGVIHRDIKGANILTTK-----------------EGLVKLADFGVATKL 169
Y H + V+HRD+K NI + + K+ DFG++ +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 170 TEADVNTHSVVGTPYWMAPEVI--EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPA 227
+ HS VGTPY+ +PE++ E SD+W++GC + EL + P+++
Sbjct: 193 G-IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251
Query: 228 LFRIVQDERPPIP-ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
L ++ P +P + S ++ ++ A++RP A L + I+N
Sbjct: 252 LISELK-RGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-21
Identities = 75/251 (29%), Positives = 129/251 (51%), Gaps = 10/251 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDF----VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+G GA+G VYKGL + G+ VAIK++ E + + I+ E ++ ++++ ++ +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
LG T S + +I + + G L + ++ +K + L+ + Q+ +G+ YL E+ ++
Sbjct: 74 LLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGMNYLEERRLV 131
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG-TPY-WMAPEVIEMSGVCAA 199
HRD+ N+L VK+ DFG+A L + H+ G P WMA E I
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-ERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G TV EL+T Y+ P + I++ ER P P + D+ + +C+ D
Sbjct: 192 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 251
Query: 259 ARQRPDAKTLL 269
A RP + L+
Sbjct: 252 ADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-21
Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 25/268 (9%)
Query: 24 DEIGKGAYGRVYKGL----DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
+E+G+ A+G++YKG +++ VAIK + N Q+ QE L+ L+H NI
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ-WGEFQQEASLMAELHHPNI 69
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANII-----------KPNKFGPFPESLVA---VYI 125
V LG + + ++ EY+ G L + ++ G SL ++I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 126 A-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVG 181
A Q+ G+ YL +H+D+ NIL ++ VK++D G++ ++ AD V S++
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIP 240
WM PE I + SDIWS G + E+ + + PYY + + + + P
Sbjct: 190 I-RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS 248
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTL 268
E P + + +C+++ +RP K +
Sbjct: 249 EDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-21
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
Y+ +++G+G Y V+KG + VA+K++ LE+ I +E+ LLK+L H NI
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANI 66
Query: 80 VKYLGSLKTRSHLHIILEYVENG------SLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
V + T L ++ EY++ NI+ + V +++ Q+L GL
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN--------VKIFLYQILRGLA 118
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
Y H + V+HRD+K N+L + G +KLADFG+A + + V T ++ P+V+
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178
Query: 194 SGVCAAS-DIWSVGCTVIELLTCVP 217
S + D+W VGC E+ + P
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 5e-21
Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 16/267 (5%)
Query: 20 YMLGDEIGKGAYGRVYKG-LDLENGDF--VAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
+ LG +GKG +G V + L E+G F VA+K + + + D+ ++E +K +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 77 KNIVKYLG-SLKTRSHLH-----IILEYVENGSLANIIKPNKFG--PF--PESLVAVYIA 126
N++K +G SL++R+ +IL ++++G L + ++ G PF P + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-PY- 184
+ G+ YL + IHRD+ N + + V +ADFG++ K+ D P
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESL 243
W+A E + + SD+W+ G T+ E++T PY ++ +++ R P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240
Query: 244 SPDITDFLRQCFKKDARQRPDAKTLLS 270
D+ + + QC+ + + RP + L
Sbjct: 241 LEDVYELMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-21
Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 58/294 (19%)
Query: 42 NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101
G++V +++++LE E + + E+ + K NH NIV Y + + L ++ ++
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83
Query: 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLA 161
GS ++I + E +A + VL+ L Y+H G +HR +K ++IL + +G V L+
Sbjct: 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 143
Query: 162 ---------DFGVATKLTEADVNTHSVVGTPYWMAPEVIE--MSGVCAASDIWSVGCTVI 210
+ G ++ D +SV P W++PEV++ + G A SDI+SVG T
Sbjct: 144 GLRSNLSMINHGQRLRVVH-DFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITAC 201
Query: 211 ELLTCVPPYYELQP-----------MPALFRI--------------------------VQ 233
EL P+ ++ +P L V
Sbjct: 202 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVS 261
Query: 234 DERPPIPES--------LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279
RP ES SP F+ QC +++ RP A TLL+H + + +R
Sbjct: 262 TPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 22 LGDEIGKGAYGRVYKGLDL-ENGDF----VAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
L +G GA+G VY+GL +GD VA+K + Q++ + +M E ++ NH
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-EALIMSKFNH 68
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIK---PNKFGPFPESLV-AVYIAQ-VLEG 131
+NIV+ +G R I+LE + G L + ++ P P ++ ++ A+ V +G
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 132 LVYLHEQGVIHRDIKGANILTTKEG---LVKLADFGVATKLTEAD---VNTHSVVGTPYW 185
YL E IHRDI N L T +G + K+ADFG+A + A +++ W
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-W 187
Query: 186 MAPEVIEMSGV-CAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESL 243
M PE + G+ + +D+WS G + E+ + PY + + R P+
Sbjct: 188 MPPEAF-LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGC 246
Query: 244 SPDITDFLRQCFKKDARQRPDAKTLLSH 271
+ + C++ RP+ T+L
Sbjct: 247 PGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 74/253 (29%), Positives = 124/253 (49%), Gaps = 12/253 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIK---QVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82
+G GA+G VYKG+ + +G+ V I +V EN + + I+ E ++ + + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
LG T S + ++ + + G L + ++ NK + L+ + Q+ +G+ YL E ++H
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCVQIAKGMSYLEEVRLVH 132
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG-TPY-WMAPEVIEMSGVCAAS 200
RD+ N+L VK+ DFG+A L + H+ G P WMA E I S
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS 192
Query: 201 DIWSVGCTVIELLTC-VPPYYELQP--MPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257
D+WS G TV EL+T PY + +P L + ER P P + D+ + +C+
Sbjct: 193 DVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE--KGERLPQPPICTIDVYMIMVKCWMI 250
Query: 258 DARQRPDAKTLLS 270
D+ RP + L+
Sbjct: 251 DSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 68/262 (25%), Positives = 120/262 (45%), Gaps = 20/262 (7%)
Query: 26 IGKGAYGRVY----KGLDLENGD-FVAIK--QVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+G+G +G V+ KG++ E G+ V +K Q + + Q + +E+D+ + L+HKN
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR---RELDMFRKLSHKN 69
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSL-----ANIIKPNKFGPFPESLVAV--YIAQVLEG 131
+V+ LG + ++ILEY + G L A K K P P S Q+ G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEV 190
+ +L +HRD+ N L + + VK++ ++ + ++ P W+APE
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 191 IEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRI-VQDERPPIPESLSPDIT 248
++ SD+WS G + E+ T P+Y L L R+ P+PE +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249
Query: 249 DFLRQCFKKDARQRPDAKTLLS 270
+ +C+ + + RP L+S
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-20
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL--NIIMQEIDLLKNLNHKNIVKY 82
++G GAYG V LD G VAIK+ L Q +L +E+ LLK++ H+N++
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79
Query: 83 LG------SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
L SL ++++ ++ L ++K K E + + Q+L+GL Y+H
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLS---EDRIQFLVYQMLKGLKYIH 135
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI-EMSG 195
G+IHRD+K N+ ++ +K+ DFG+A + D V T ++ APEVI
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAPEVILNWMH 192
Query: 196 VCAASDIWSVGCTVIELLTCVP 217
DIWSVGC + E+LT P
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 64/194 (32%), Positives = 103/194 (53%), Gaps = 12/194 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG- 84
IG GA G V D G VAIK++S +E+ L+K +NHKNI+ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 85 -----SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
SL+ +++++E ++ +L +I+ + ++ + Q+L G+ +LH G
Sbjct: 84 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG 138
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
+IHRD+K +NI+ + +K+ DFG+A + + T VV T Y+ APEVI G
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKEN 197
Query: 200 SDIWSVGCTVIELL 213
DIWSVGC + E++
Sbjct: 198 VDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 75/273 (27%), Positives = 121/273 (44%), Gaps = 29/273 (10%)
Query: 24 DEIGKGAYGRVYKG--LDLENGDF---VAIKQVSLENIAQEDL-NIIMQEIDLLKNLNHK 77
+E+G+GA+G+VYKG VAIK +L+ A+ + QE +L+ +L H
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIK--TLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANII---KPNKFGPFPESLVAV----------Y 124
NIV LG ++ EY+ +G L + P+ V +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 125 IA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVV 180
IA Q+ G+ YL +HRD+ N L + VK++DFG++ + AD V + S++
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 181 GTPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPP 238
P WM PE I SDIWS G + E+ + + PYY + I + P
Sbjct: 189 --PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
PE + + +C+ + +RP K + +
Sbjct: 247 CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 61/241 (25%), Positives = 116/241 (48%), Gaps = 5/241 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G V G A K++ + I + + ++ + E +L+ +N + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ +T+ L ++L + G L I F E Y A++ GL LH++ +++RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K NIL G ++++D G+A + E VGT +MAPEV++ + D W+
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186
Query: 205 VGCTVIELLTCVPPYYELQ---PMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261
+GC + E++ P+ + + + R+V++ + E SPD + KD ++
Sbjct: 187 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKE 246
Query: 262 R 262
R
Sbjct: 247 R 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 84/310 (27%), Positives = 148/310 (47%), Gaps = 58/310 (18%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
L ++YM +G G+ G V+ +D + VA+K++ L + + + ++EI +++ L+
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLD 60
Query: 76 HKNIVK--------------YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLV 121
H NIVK +GSL + ++I+ EY+E LAN+++ GP E
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ---GPLSEEHA 116
Query: 122 AVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLV-KLADFGVATKLTEADVNTHS-- 178
+++ Q+L GL Y+H V+HRD+K AN+ E LV K+ DFG+A ++ + +H
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA-RIVDPHY-SHKGY 174
Query: 179 ---VVGTPYWMAPE-VIEMSGVCAASDIWSVGCTVIELLTCVPPY---YELQPMPALFRI 231
+ T ++ +P ++ + A D+W+ GC E+LT P + +EL+ M +
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234
Query: 232 VQ-----DE------------------RPPIPESL---SPDITDFLRQCFKKDARQRPDA 265
V D R P+ + L +P+ DFL Q + R A
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
Query: 266 KTLLSHPWIQ 275
+ L HP++
Sbjct: 295 EEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-20
Identities = 78/259 (30%), Positives = 116/259 (44%), Gaps = 28/259 (10%)
Query: 41 ENGDFVAIKQVSLENIAQEDLNIIMQ-EIDLLKNLNHKNIVKYLGSLKTRSH-LHIILEY 98
G VAIK + + +E + E L L H NIV L S + L + EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGL- 157
V +L ++ + G P + QVL+ L H QG++HRD+K NI+ ++ G+
Sbjct: 61 VPGRTLREVLAAD--GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 158 --VKLADFGVATKLT---EADVN----THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCT 208
K+ DFG+ T L +ADV T V+GTP + APE + V SD+++ G
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 209 VIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDIT-----DFLRQCFKKDARQRP 263
+E LT + ++ I+ + P+ SL P I LR+ KD RQR
Sbjct: 179 FLECLTGQR----VVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRA 234
Query: 264 DAKTLLSHPWIQNCRRALQ 282
S P + RAL+
Sbjct: 235 -----ASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 9/246 (3%)
Query: 25 EIGKGAYGRVYKGL-DLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82
E+G G +G V KG+ + VAIK + EN + + +M+E +++ L++ IV+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
+G + + L +++E G L + K S V + QV G+ YL + +H
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY---WMAPEVIEMSGVCAA 199
RD+ N+L + K++DFG++ L D + + W APE I +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 200 SDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G T+ E + PY +++ + I Q +R P P++ ++ C+
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYK 238
Query: 259 ARQRPD 264
RP+
Sbjct: 239 WEDRPN 244
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-20
Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 9/245 (3%)
Query: 26 IGKGAYGRVYKG---LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82
IG G +G V G L + VAIK + ++ + + E ++ +H NI+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDF-LSEASIMGQFDHPNIIHL 70
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
G + + I+ EY+ENGSL ++ + G F + + + G+ YL + G +H
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVH 129
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY---WMAPEVIEMSGVCAA 199
RD+ NIL + K++DFG++ L + ++ G W APE I +A
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 200 SDIWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G + E+++ PY+E+ + I + R P P + + C++KD
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKD 249
Query: 259 ARQRP 263
+RP
Sbjct: 250 RNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-20
Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 55/301 (18%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQ-VSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IGKGA+G V + G A+K + E ++ L + E D+L + +V
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S + +L++I+E++ G L ++ K+ F E + Y+A+ + + +H+ G IHRD
Sbjct: 69 SFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 145 IKGANILTTKEGLVKLADFGVAT------------KLTEADVNT---------------- 176
IK NIL + G +KL+DFG++T KL + N
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 177 -------------------HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVP 217
+S VGTP ++APE+ G D WS+G + E L P
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWP 246
Query: 218 PYYELQPMPALFRIVQ-DERPPIPE--SLSPDITDFLRQ--CFKKDARQRPDAKTLLSHP 272
P+ +I+ E P+ LS + D +R+ ++ R A + SHP
Sbjct: 247 PFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHP 306
Query: 273 W 273
+
Sbjct: 307 F 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-20
Identities = 63/243 (25%), Positives = 121/243 (49%), Gaps = 6/243 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G V G A K+++ + + + + M E +L ++ + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 85 SLKTRSHLHIILEYVENGSLA-NIIKPNKFGP-FPESLVAVYIAQVLEGLVYLHEQGVIH 142
+ +T++ L +++ + G L +I ++ P FPE Y AQ++ GL +LH++ +I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RD+K N+L +G V+++D G+A +L + T GTP +MAPE+++ + D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180
Query: 203 WSVGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
+++G T+ E++ P+ E L + + ++ P+ SP F KD
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240
Query: 260 RQR 262
+R
Sbjct: 241 EKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 7e-20
Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 43/276 (15%)
Query: 25 EIGKGAYGRVYKG-----LDLENGDFVAIKQVSLENIAQEDLNIIMQ-----EIDLLKNL 74
+IG+GA+GRV++ L E VA+K + +E+ + MQ E L+
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVK------MLKEEASADMQADFQREAALMAEF 65
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPN----------------KFGPFPE 118
+H NIVK LG + ++ EY+ G L ++ K G P
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 119 SL---VAVYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD- 173
L + IA QV G+ YL E+ +HRD+ N L + +VK+ADFG++ + AD
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 174 --VNTHSVVGTPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALF 229
+ + + P WM PE I + SD+W+ G + E+ + + PYY + ++
Sbjct: 186 YKASENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
Query: 230 RIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDA 265
+ P++ ++ + +R C+ K RP
Sbjct: 244 YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-20
Identities = 71/267 (26%), Positives = 130/267 (48%), Gaps = 18/267 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNL-NHKNIVKYL 83
IG+G+Y +V + A+K + E + ED++ + E + + NH +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+T S L ++E+V G L ++ + PE Y A++ L +LHE+G+I+R
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N+L EG +KL D+G+ + T + GTP ++APE++ + D W
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180
Query: 204 SVGCTVIELLTCVPPY--YELQPMPA------LFRIVQDERPPIPESLSPDITDFLRQCF 255
++G + E++ P+ + P LF+++ +++ IP SLS + L+
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL 240
Query: 256 KKDARQR----PDA--KTLLSHPWIQN 276
KD ++R P + + SHP+ +N
Sbjct: 241 NKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 65/246 (26%), Positives = 117/246 (47%), Gaps = 11/246 (4%)
Query: 25 EIGKGAYGRVYKGL--DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82
E+G G +G V KG+ ++ VA+K + +N + +++E ++++ L++ IV+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
+G + S +++E E G L ++ NK E + + QV G+ YL E +H
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT---PY-WMAPEVIEMSGVCA 198
RD+ N+L + K++DFG++ L AD N + P W APE + +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALG-ADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 199 ASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257
SD+WS G + E + PY ++ I ER P+ P++ D ++ C+
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237
Query: 258 DARQRP 263
+RP
Sbjct: 238 GVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-19
Identities = 72/218 (33%), Positives = 109/218 (50%), Gaps = 16/218 (7%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL 61
S Q S F T+ +Y IG GA G V D G VA+K++S Q
Sbjct: 9 SVQVADSTF----TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 64
Query: 62 NIIMQEIDLLKNLNHKNIVKYLG------SLKTRSHLHIILEYVENGSLANIIKPNKFGP 115
+E+ LLK +NHKNI+ L SL+ +++++E ++ +L +I
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME---- 119
Query: 116 FPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175
++ + Q+L G+ +LH G+IHRD+K +NI+ + +K+ DFG+A +
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 179
Query: 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELL 213
T VV T Y+ APEVI G DIWSVGC + EL+
Sbjct: 180 TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 70/247 (28%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ---EDLNI---IMQEIDLLKNLNHKNI 79
IG+G +G VY + G A+K + + I E L + IM + L+ + I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--LSLVSTGDCPFI 59
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
V + T L IL+ + G L + ++ G F E+ + Y A+++ GL ++H +
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC-- 197
V++RD+K ANIL + G V+++D G+A ++ H+ VGT +MAPEV++ GV
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ-KGVAYD 174
Query: 198 AASDIWSVGCTVIELLTCVPPYYELQPMPALF--RIVQDERPPIPESLSPDITDFLRQCF 255
+++D +S+GC + +LL P+ + + R+ +P+S SP++ L
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234
Query: 256 KKDARQR 262
++D +R
Sbjct: 235 QRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-19
Identities = 79/294 (26%), Positives = 133/294 (45%), Gaps = 49/294 (16%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLEN-IAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V + G A+K + + + +E + I E D+L + +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S + + +L++I+E++ G + ++ K E YIA+ + + +H+ G IHRD
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEA--------------------DVNT-------- 176
IK N+L +G VKL+DFG+ T L +A ++N+
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186
Query: 177 -------HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALF 229
+S VGTP ++APEV +G D WS+G + E+L PP+ P +
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET-Y 245
Query: 230 RIVQDER------PPIPESLSPDITDF-LRQCFKKDAR-QRPDAKTLLSHPWIQ 275
R V + + P +P +S D LR C + R + + SHP+ +
Sbjct: 246 RKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 75/251 (29%), Positives = 124/251 (49%), Gaps = 21/251 (8%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGD--FVAIKQVSLENIAQEDLNI--IMQEIDLLKNL- 74
Y L E+G+GAYG V + E + VAIK+++ N+ + + ++E+ LL++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKIT--NVFSKKILAKRALRELKLLRHFR 59
Query: 75 NHKNIVK-YLGSLKTRSHLHIILEYVE--NGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
HKNI Y + + + + Y E L II+ + P ++ +I Q+L G
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCG 117
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE-ADVNTHSV---VGTPYWMA 187
L Y+H V+HRD+K N+L + +K+ DFG+A +E N + V T ++ A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 188 PEV-IEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL--- 243
PE+ + A D+WSVGC + ELL P + + L +I+Q P E+L
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 244 -SPDITDFLRQ 253
SP +++R
Sbjct: 238 GSPKAQNYIRS 248
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 51/295 (17%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQV----SLENIAQEDLNIIMQEIDLLKN 73
N+Y+ +G GA+G V D G VAIK++ S +A+ +E+ LLK+
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR----TYRELKLLKH 65
Query: 74 LNHKNIVKYLGS-LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGL 132
L H+NI+ + ++ + E + L ++ P + + ++ Q+L GL
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTS---RPLEKQFIQYFLYQILRGL 121
Query: 133 VYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI- 191
Y+H GV+HRD+K +NIL + +K+ DFG+A D V T Y+ APE++
Sbjct: 122 KYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAPEIML 178
Query: 192 --EMSGVCAASDIWSVGCTVIELLTCVPPY------------YELQPMPA---------- 227
+ V DIWS GC E+L P + +L P
Sbjct: 179 TWQKYDV--EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236
Query: 228 -LFRIVQD--ERPPIP-----ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274
R VQ +R P+P ++ P D L + D ++R A L+HP++
Sbjct: 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 67/262 (25%), Positives = 128/262 (48%), Gaps = 16/262 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVS-LENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V G A+K ++ E + + + +E D+L N + + I
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGP-FPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ + ++L+++++Y G L ++ +KF PE + Y+A+++ + +H+ G +HR
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126
Query: 144 DIKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVIEMSGVCAAS-- 200
DIK N+L K G ++LADFG +L + V ++ VGTP +++PE+++
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYG 186
Query: 201 ---DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER----PPIPESLSPDITDFLRQ 253
D WS+G + E+L P+Y + +I+ + PP +S + D +R+
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR 246
Query: 254 --CFKKDARQRPDAKTLLSHPW 273
C + R + HP+
Sbjct: 247 LICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 64/258 (24%), Positives = 121/258 (46%), Gaps = 16/258 (6%)
Query: 22 LGDEIGKGAYGRVYKG-LDLENGDF--VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
LG +G+G +G V +G L ++G VA+K + L+ ++ + E +K+ +H N
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 79 IVKYLGSLKTRSHLH------IILEYVENGSLANIIKPNKFGPFPESL----VAVYIAQV 128
++K +G S L +IL ++++G L + + ++ G PE L + ++ +
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV--NTHSVVGTPYWM 186
G+ YL + IHRD+ N + ++ V +ADFG++ K+ D W+
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSP 245
A E + + SD+W+ G T+ E+ T PY ++ + R PE
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD 242
Query: 246 DITDFLRQCFKKDARQRP 263
++ D + C++ D + RP
Sbjct: 243 ELYDLMYSCWRADPKDRP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-19
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG- 84
+G GAYG V D + G VA+K++S + +E+ LLK++ H+N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 85 -----SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
SL+ + ++++ ++ L NI+K K + V I Q+L GL Y+H
Sbjct: 85 FTPARSLEEFNDVYLV-THLMGADLNNIVKCQKL---TDDHVQFLIYQILRGLKYIHSAD 140
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV-IEMSGVCA 198
+IHRD+K +N+ ++ +K+ DFG+A D V T ++ APE+ +
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 197
Query: 199 ASDIWSVGCTVIELLT 214
DIWSVGC + ELLT
Sbjct: 198 TVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-19
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 28/219 (12%)
Query: 23 GDEIGKGAYGRVYKGL--DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
G ++G+G YG VYK D ++ A+KQ+ I+ +EI LL+ L H N++
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS----ACREIALLRELKHPNVI 61
Query: 81 KYLGSLKTRS--HLHIILEYVENGSLANIIKPNKFGP-------FPESLVAVYIAQVLEG 131
+ S + ++ +Y E+ L +IIK ++ P S+V + Q+L+G
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 132 LVYLHEQGVIHRDIKGANILTTKE----GLVKLADFGVATKLTE-----ADVNTHSVVGT 182
+ YLH V+HRD+K ANIL E G VK+AD G A AD++ VV T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD--PVVVT 178
Query: 183 PYWMAPE-VIEMSGVCAASDIWSVGCTVIELLTCVPPYY 220
++ APE ++ A DIW++GC ELLT P ++
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-19
Identities = 73/277 (26%), Positives = 134/277 (48%), Gaps = 43/277 (15%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFV--AIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIV 80
D IG+G +G+V K ++G + AIK++ E +++D E+++L L H NI+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKF--------------GPFPESLVAVYIA 126
LG+ + R +L++ +EY +G+L + ++ ++ + + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-PY- 184
V G+ YL ++ IHRD+ NIL + + K+ADFG++ +V +G P
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPVR 188
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIEL----------LTCVPPYYELQPMPALFRIVQD 234
WMA E + S SD+WS G + E+ +TC Y + +P +R+ +
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKLPQGYRLEK- 244
Query: 235 ERPPIPESLSPDITDFLRQCFKKDARQRPD-AKTLLS 270
P + ++ D +RQC+++ +RP A+ L+S
Sbjct: 245 -----PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-19
Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 38/235 (16%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQV-SLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V + G A+K + + + +E + I E D+L + +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S + + +L++I+E++ G + ++ K E YIA+ + + +H+ G IHRD
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEA--------------------DVNTH------- 177
IK N+L +G VKL+DFG+ T L +A ++N+
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186
Query: 178 --------SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP 224
S VGTP ++APEV +G D WS+G + E+L PP+ P
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-19
Identities = 91/330 (27%), Positives = 139/330 (42%), Gaps = 65/330 (19%)
Query: 1 MSRQTTTSAFHKSKTLDN------KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLE 54
MSR + F+ + D+ +Y IG GA G V D VAIK++S
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 55 NIAQEDLNIIMQEIDLLKNLNHKNIVKYLG------SLKTRSHLHIILEYVENGSLANII 108
Q +E+ L+K +NHKNI+ L SL+ ++I++E ++ +L +I
Sbjct: 61 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI 119
Query: 109 KPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168
+ ++ + Q+L G+ +LH G+IHRD+K +NI+ + +K+ DFG+A
Sbjct: 120 QME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-------------- 214
+ + T VV T Y+ APEVI G DIWSVGC + E++
Sbjct: 176 AGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 215 ----------CVPPYYELQPMPALFRIVQDERPPIP----ESLSPDI------------- 247
C +LQP R + RP E L PD+
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPT---VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 291
Query: 248 ---TDFLRQCFKKDARQRPDAKTLLSHPWI 274
D L + DA +R L HP+I
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 65/260 (25%), Positives = 117/260 (45%), Gaps = 10/260 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII-MQEIDLLKNLNHKNIVKYLG 84
+GKG +G V G A K++ + I + + + E +L+ +N + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ +T+ L ++L + G L I F E Y A++ GL LH + +++RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K NIL G ++++D G+A ++ E + VGT +MAPEV++ + D W
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRVGTVGYMAPEVVKNERYTFSPDWWG 186
Query: 205 VGCTVIELLTCVPP---YYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261
+GC + E++ P E + R V++++ E S RQ KD
Sbjct: 187 LGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGF 246
Query: 262 R-----PDAKTLLSHPWIQN 276
R A+ + +HP+ +
Sbjct: 247 RLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 70/246 (28%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 46 VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLA 105
VA+K V + + ++E+ +L L+ NI + LG L +I+EY+ENG L
Sbjct: 49 VAVK-VLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 106 NIIKPNKFGPFPESLVA----------VYIA-QVLEGLVYLHEQGVIHRDIKGANILTTK 154
++ K L +Y+A Q+ G+ YL +HRD+ N L K
Sbjct: 108 QFLQ--KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 155 EGLVKLADFGVATKLTEADVNTHSVVGTP----YWMAPEVIEMSGVCAASDIWSVGCTVI 210
+K+ADFG++ L +D + V G WMA E + + SD+W+ G T+
Sbjct: 166 NYTIKIADFGMSRNLYSSDY--YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 211 ELLT-C-VPPYYEL---QPMPALFRIVQDE-------RPPI-PESLSPDITDFLRQCFKK 257
E+LT C PY L Q + +D+ RPP P+ DI + + +C+++
Sbjct: 224 EILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPK----DIYELMLECWRR 279
Query: 258 DARQRP 263
D RP
Sbjct: 280 DEEDRP 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 65/244 (26%), Positives = 122/244 (50%), Gaps = 11/244 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQE---IDLLKNLNHKNIVK 81
IG+G +G VY + G A+K + + I ++ + + E + L+ + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
+ T L IL+ + G L + ++ G F E + Y +++ GL ++H + V+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASD 201
+RD+K ANIL + G V+++D G+A ++ H+ VGT +MAPEV++ +S
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSA 177
Query: 202 IW-SVGCTVIELLTCVPPY--YELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
W S+GC + +LL P+ ++ + + R+ +P+S SP++ L ++D
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237
Query: 259 ARQR 262
+R
Sbjct: 238 VSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-18
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 23 GDEIGKGAYGRVYKGL--DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
G ++G+G YG VYK D ++ A+KQ+ I+ +EI LL+ L H N++
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS----ACREIALLRELKHPNVI 61
Query: 81 KYLGSLKTRS--HLHIILEYVENGSLANIIKPNKFGP-------FPESLVAVYIAQVLEG 131
+ + + ++ +Y E+ L +IIK ++ P +V + Q+L+G
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 132 LVYLHEQGVIHRDIKGANILTTKE----GLVKLADFGVATKLTE-----ADVNTHSVVGT 182
+ YLH V+HRD+K ANIL E G VK+AD G A AD++ VV T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD--PVVVT 178
Query: 183 PYWMAPE-VIEMSGVCAASDIWSVGCTVIELLTCVPPYY 220
++ APE ++ A DIW++GC ELLT P ++
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-18
Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 26/275 (9%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQV--SLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
IG+GA+G V + L+N D V ++ E + + + +E D+L N +++ I
Sbjct: 9 IGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKF-GPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
+ + ++L+++++Y G L ++ +KF PE + Y+A+++ + +H+ +H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTE-ADVNTHSVVGTPYWMAPEVIEM-----SGV 196
RDIK NIL G ++LADFG KL E V + VGTP +++PE+++
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV-QDERPPIPES---LSPDITDFLR 252
D WS+G + E+L P+Y + +I+ ER P +S D D +R
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245
Query: 253 Q--CFKKDARQRPDAKTLLSHPW--------IQNC 277
+ C ++ + + HP+ I+NC
Sbjct: 246 RLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNC 280
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 23/158 (14%)
Query: 67 EIDLLKNLNHKNIVKYLGSLKTRS--------HLHIILEYVENGSLANIIKPNKFGPFPE 118
EID+LK ++H+ I+ + + + +S + + YV+ + GP P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVD-----------RSGPLPL 184
Query: 119 SLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT-- 176
++LE L YLH +G+IHRD+K NI + L DFG A KL +T
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP-DTPQ 243
Query: 177 -HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELL 213
+ GT +PE++ + CA +DIWS G + E+
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 3e-18
Identities = 65/255 (25%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 25 EIGKGAYGRVYKGL--DLENGDF---VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
E+G+G++G VY+G D+ G+ VA+K V+ +E + + E ++K ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF-LNEASVMKGFTCHHV 71
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKP------NKFGPFPESLVAV--YIAQVLEG 131
V+ LG + +++E + +G L + ++ N G P +L + A++ +G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG-TPY-WMAPE 189
+ YL+ + +HRD+ N + + VK+ DFG+ + E D G P WMAPE
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191
Query: 190 VIEMSGVCAASDIWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPESLSPDIT 248
++ +SD+WS G + E+ + PY L L ++ P++ +T
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 251
Query: 249 DFLRQCFKKDARQRP 263
D +R C++ + + RP
Sbjct: 252 DLMRMCWQFNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 71/287 (24%), Positives = 133/287 (46%), Gaps = 43/287 (14%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFV--AIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIV 80
D IG+G +G+V + + ++G + AIK + E ++ D E+++L L +H NI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKF--------------GPFPESLVAVYIA 126
LG+ + R +L+I +EY G+L + ++ ++ + + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-PY- 184
V G+ YL E+ IHRD+ N+L + K+ADFG++ +V +G P
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG---EEVYVKKTMGRLPVR 183
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIEL----------LTCVPPYYELQPMPALFRIVQD 234
WMA E + S SD+WS G + E+ +TC Y + +P +R+ +
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY---EKLPQGYRMEK- 239
Query: 235 ERPPIPESLSPDITDFLRQCFKKDARQRPD-AKTLLSHPWIQNCRRA 280
P + ++ + +RQC++ +RP A+ + + R+A
Sbjct: 240 -----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-18
Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 44/285 (15%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL-- 83
+G GAYG V D VA+K++S + +E+ LLK++ H+N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 84 ----GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
S++ + ++++ + L NI+K K + V I Q+L GL Y+H G
Sbjct: 83 FTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLS---DEHVQFLIYQLLRGLKYIHSAG 138
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV-IEMSGVCA 198
+IHRD+K +N+ ++ +++ DFG+A +AD V T ++ APE+ +
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEIMLNWMHYNQ 195
Query: 199 ASDIWSVGCTVIELLTCVPPY----YELQ----------PMPALFRIVQDER-------- 236
DIWSVGC + ELL + Y Q P P + + + E
Sbjct: 196 TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSL 255
Query: 237 PPIPES--------LSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
P +P+ +P D L + D+ +R A L+HP+
Sbjct: 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-18
Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 5/241 (2%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G V G A K++ + I + + + + E +L+ +N + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ +T+ L ++L + G L I F E Y A++ GL L + +++RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K NIL G ++++D G+A ++ E + VGT +MAPEVI + D W
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWG 186
Query: 205 VGCTVIELLTCVPP---YYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261
+GC + E++ P E + R V++++ E S D R K+ ++
Sbjct: 187 LGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKE 246
Query: 262 R 262
R
Sbjct: 247 R 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-18
Identities = 69/253 (27%), Positives = 125/253 (49%), Gaps = 25/253 (9%)
Query: 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLK 72
+++ + Y LG+ IG G++G VY+ + ++ + VAIK+V +D +E+ ++K
Sbjct: 61 NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMK 114
Query: 73 NLNHKNIV-----KYLGSLKTRSH---LHIILEYVE---NGSLANIIKPNKFGPFPESLV 121
NLNH NI+ Y K L++++E++ + + + + N P LV
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH--ALPLFLV 172
Query: 122 AVYIAQVLEGLVYLHEQGVIHRDIKGANILTT-KEGLVKLADFGVATKLTEADVNTHSVV 180
+Y Q+ L Y+H + + HRD+K N+L +KL DFG A L A + S +
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL-AGQRSVSYI 231
Query: 181 GTPYWMAPEV-IEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI 239
+ ++ APE+ + + D+WS+GC + E++ P + + L RI+Q P
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291
Query: 240 PESL---SPDITD 249
+ L +P+ D
Sbjct: 292 EDQLKEMNPNYAD 304
|
Length = 440 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-17
Identities = 69/260 (26%), Positives = 128/260 (49%), Gaps = 24/260 (9%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFV--AIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIV 80
D IG+G +G+V K ++G + AIK++ E +++D E+++L L +H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKF--------------GPFPESLVAVYIA 126
LG+ + R +L++ +EY +G+L + ++ ++ + + A
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-PY- 184
V G+ YL ++ IHRD+ NIL + + K+ADFG++ +V +G P
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPVR 176
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESL 243
WMA E + S SD+WS G + E+++ PY + ++ Q R P +
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 236
Query: 244 SPDITDFLRQCFKKDARQRP 263
++ D +RQC+++ +RP
Sbjct: 237 DDEVYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-17
Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 12/205 (5%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
T+ +Y IG GA G V D VAIK++S Q +E+ L+K +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 75 NHKNIVKYLG------SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQV 128
NHKNI+ L SL+ +++++E ++ +L +I+ ++ + Q+
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQME----LDHERMSYLLYQM 128
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
L G+ +LH G+IHRD+K +NI+ + +K+ DFG+A + + T VV T Y+ AP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAP 187
Query: 189 EVIEMSGVCAASDIWSVGCTVIELL 213
EVI G DIWSVGC + E++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 54/186 (29%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLA 161
SLA+I++ P E + Q L L LH Q K NIL T +GL+KL
Sbjct: 1 VSLADILEVRG-RPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL- 52
Query: 162 DFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYE 221
G T PY+MAPEVI+ +DI+S+G T+ E L PY E
Sbjct: 53 -DGSVAFKTPEQSR-----PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106
Query: 222 LQPMPALFRIVQDERPP-------IPESLS--PDITDFLRQCFKKDARQRPDAKTLLSHP 272
+ + A+ I+ + P E +S DF+R C + ++R A L+H
Sbjct: 107 ERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166
Query: 273 WIQNCR 278
Sbjct: 167 RALFAE 172
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 47/281 (16%)
Query: 24 DEIGKGAYGRVY----KGL-DLENGDF-----------VAIKQVSLENIAQEDLNIIMQE 67
+++G+G +G V+ +G+ + DF VA+K + E+ + N ++E
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDANKNARNDFLKE 69
Query: 68 IDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI-- 125
I ++ L NI++ L T L +I EY+ENG L + ++ E V I
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 126 -------AQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VN 175
Q+ G+ YL +HRD+ N L K +K+ADFG++ L D +
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVP--PYYEL---QPMPALFR 230
+V+ WM+ E I + ASD+W+ G T+ E+LT PY +L Q +
Sbjct: 190 GRAVLPI-RWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248
Query: 231 IVQDE-------RPPI-PESLSPDITDFLRQCFKKDARQRP 263
+D+ +P + P+SL + C++++A++RP
Sbjct: 249 FFRDQGRQVYLPKPALCPDSLY----KLMLSCWRRNAKERP 285
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-17
Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 38/235 (16%)
Query: 62 NIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL----------------A 105
N ++E+ +L L NI++ LG L +I EY+ENG L
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 106 NIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFG 164
+ + P P +++A Q+ G+ YL +HRD+ N L + +K+ADFG
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 165 VATKLTEAD---VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCV--PPY 219
++ L D + +V+ WMA E I M ASD+W+ G T+ E+L PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 220 YEL---QPMPALFRIVQDE-------RPPI-PESLSPDITDFLRQCFKKDARQRP 263
EL Q + +D+ RPP P+ L + + QC+ +D R+RP
Sbjct: 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGL----YELMLQCWSRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-17
Identities = 53/204 (25%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQV--SLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
IG+GA+G V + +++ + + ++ E + + + +E ++L N + + I
Sbjct: 9 IGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKF-GPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
+ + ++L+++++Y G L ++ +KF PE + YIA+++ + +H+ +H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLT-EADVNTHSVVGTPYWMAPEVIE-----MSGV 196
RDIK N+L G ++LADFG K+ + V + VGTP +++PE+++ M
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 185
Query: 197 CAASDIWSVGCTVIELLTCVPPYY 220
D WS+G + E+L P+Y
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 76/272 (27%), Positives = 129/272 (47%), Gaps = 27/272 (9%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVA---IKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
DEIG G +G+V G + G A +K++ E L + +QE+ + LNH N++
Sbjct: 1 DEIGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQL-LFLQEVQPYRELNHPNVL 58
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNK--FGPFPESLVAVYIA-QVLEGLVYLHE 137
+ LG ++LE+ G L N ++ N+ + V +A +V GL++LH+
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPY-WMAPEVIEMSG 195
IH D+ N T + VK+ D+G+A + E T P W+APE++E+ G
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 196 -------VCAASDIWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDE-----RPPIPES 242
S+IWS+G T+ EL T PY +L L ++V+++ +P +
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238
Query: 243 LSPDITDFLRQCFKKDARQRPDAKT---LLSH 271
S + ++ C+ D RP A+ LL++
Sbjct: 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-17
Identities = 61/246 (24%), Positives = 122/246 (49%), Gaps = 14/246 (5%)
Query: 26 IGKGAYGRVYKGLDLEN-GDFVAIKQVS---LENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+GKG +G V + ++N G A K++ L+ + E + ++ +EI L+ +N IV
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVN 57
Query: 82 YLGSLKTRSHLHIILEYVENGSLA-NIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+ ++++HL +++ + G L +I + G V Y AQ+ G+++LH +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHSMDI 116
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS 200
++RD+K N+L +G +L+D G+A +L + T GT +MAPE+++
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR-AGTNGYMAPEILKEEPYSYPV 175
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPA----LFRIVQDERPPIPESLSPDITDFLRQCFK 256
D +++GC++ E++ P+ + + A R ++DE ++ + + D R
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235
Query: 257 KDARQR 262
K R
Sbjct: 236 KKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 62/268 (23%), Positives = 121/268 (45%), Gaps = 17/268 (6%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKN 73
K + E+G+G++G VY+G+ E VAIK V+ +E + + E ++K
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEF-LNEASVMKE 65
Query: 74 LNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNK--------FGPFPESLVAVYI 125
N ++V+ LG + +I+E + G L + ++ + P +
Sbjct: 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 126 AQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG-TPY 184
++ +G+ YL+ +HRD+ N + ++ VK+ DFG+ + E D G P
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 185 -WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPES 242
WM+PE ++ SD+WS G + E+ T PY + L +++ P++
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDN 245
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLS 270
+ + +R C++ + + RP ++S
Sbjct: 246 CPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 18 NKYMLGDEIGKGAYGRVY----KGLD--LENG--------DFVAIKQVSLENIAQEDLNI 63
+ L +++G+G +G V+ +GL L G VA+K + ++ + N
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR-ADVTKTARND 63
Query: 64 IMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL----------ANIIKPNKF 113
++EI ++ L + NI++ LG + L +I EY+ENG L + N
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 114 GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173
+ + Q+ G+ YL +HRD+ N L +K+ADFG++ L D
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 174 ---VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYEL------- 222
+ +V+ WMA E I + ASD+W+ G T+ E+ T C Y L
Sbjct: 184 YYRIQGRAVLPI-RWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242
Query: 223 QPMPALFR-----IVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTL 268
+ FR I + P P + + +C+ +D + RP +
Sbjct: 243 ENTGEFFRNQGRQIYLSQTPLCPSPV----FKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 60/262 (22%), Positives = 111/262 (42%), Gaps = 25/262 (9%)
Query: 26 IGKGAYGRVYKGLDLENGDF-VAIKQVSLEN---IAQEDLNIIM---QEIDLLKNLNHKN 78
+G+G + +YKG+ D + + + D + + L+ L+HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+VK G ++ ++ EYV+ G L + K Q+ L YL ++
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNV-SLHWKLDVAKQLASALHYLEDK 120
Query: 139 GVIHRDIKGANILTTKEGL-------VKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI 191
++H ++ G NIL + GL +KL+D G+ + + V P W+APE I
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE---ERVERIP-WIAPECI 176
Query: 192 E--MSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDIT 248
+ + A+D WS G T++E+ + P L R P+P+ ++
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD--CAELA 234
Query: 249 DFLRQCFKKDARQRPDAKTLLS 270
+ + QC+ D +RP + +L
Sbjct: 235 NLINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-16
Identities = 51/164 (31%), Positives = 91/164 (55%), Gaps = 3/164 (1%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQ-EIDLLKNLNHKNIVKYLG 84
I +GA+G+VY G N A+K V ++ +++ +Q E D L IV
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
SL++ +++++++EY+ G + +++ + +G F E + YI++V L YLH G+IHRD
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDYLHRHGIIHRD 129
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
+K N+L + EG +KL DFG++ ++N ++ TP P
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 56 IAQEDLNIIMQEI---DLLKNLNHKNIVKYLGSLKT-RSHLHIILEYVENGSLANIIKPN 111
I ++ N I E L+K+ + N +K S+ T + H+ +I++Y+++G L +++K
Sbjct: 49 IKAKNFNAI--EPMVHQLMKD--NPNFIKLYYSVTTLKGHV-LIMDYIKDGDLFDLLKKE 103
Query: 112 KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL-TTKEGLVKLADFGVATKLT 170
G E+ V I Q++E L LH+ +IH DIK N+L + + L D+G+
Sbjct: 104 --GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-- 159
Query: 171 EADVNTHSVV-GTPYWMAPEVIEMSGVCAAS-DIWSVGCTVIELLTCVPPYY-----ELQ 223
+ T S GT + +PE I+ S D W+VG ELLT P+ EL
Sbjct: 160 ---IGTPSCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215
Query: 224 PMPALFRIVQDERPPIPESLSPDITDFLRQ--CFKKDAR 260
L R Q ++ P +++S + DF++ + + R
Sbjct: 216 LESLLKR--QQKKLPFIKNVSKNANDFVQSMLKYNINYR 252
|
Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 54/185 (29%), Positives = 86/185 (46%), Gaps = 11/185 (5%)
Query: 29 GAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT 88
G+ GRV+ D V +K I Q+ +I E LL+N+NH ++++ +L +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK------IGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVS 128
Query: 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGA 148
+ ++L + + L + + P P + Q+LEGL YLH Q +IHRD+K
Sbjct: 129 GAITCMVLPHY-SSDLYTYLT-KRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTE 186
Query: 149 NILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCT 208
NI V + D G A + + GT APEV+ + +DIWS G
Sbjct: 187 NIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIV 245
Query: 209 VIELL 213
+ E+L
Sbjct: 246 LFEML 250
|
Length = 357 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 60/263 (22%), Positives = 115/263 (43%), Gaps = 17/263 (6%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDF---VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
LG +G+G +G V +G L D VA+K + + + ++ + E +K +H N
Sbjct: 3 LGKTLGEGEFGSVMEGQ-LNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 79 IVKYLGSLKTRSHLH------IILEYVENGSLANIIKPNKFGP----FPESLVAVYIAQV 128
+++ +G +IL ++++G L + + ++ G P ++ ++ +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS-VVGTPY-WM 186
G+ YL + IHRD+ N + + V +ADFG++ K+ D + P W+
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSP 245
A E + SD+WS G T+ E+ T PY ++ + Q R P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLD 241
Query: 246 DITDFLRQCFKKDARQRPDAKTL 268
+ + C+ + + RP +TL
Sbjct: 242 GLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 65/258 (25%), Positives = 120/258 (46%), Gaps = 16/258 (6%)
Query: 16 LDNKYM-LGDEIGKGAYGRVYKG-LDLENGD--FVAIKQVSLENIAQEDLNIIMQEIDLL 71
LDNK + + +G G +G + +G L L + VAI + ++ + E L
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGF-LAEALTL 60
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
+H NIV+ G + + + I+ EY+ NG+L + ++ ++ LVA + +L G
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPG 115
Query: 132 LV----YLHEQGVIHRDIKGANILTTKEGLVKLADFG-VATKLTEADVNTHSVVGTPYWM 186
L YL E G +H+ + +L + + K++ F + +EA T S W
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPESLSP 245
APE I+ +ASD+WS G + E+++ PY+++ + + R P P +
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPN 235
Query: 246 DITDFLRQCFKKDARQRP 263
+ + C++K+ +RP
Sbjct: 236 LLHQLMLDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 73/272 (26%), Positives = 131/272 (48%), Gaps = 33/272 (12%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDF-----VAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
L D + +G +GR++ G+ L + V +K V ++ ++ + +++QE LL L+H
Sbjct: 10 LSDLLQEGTFGRIFYGI-LIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSH 67
Query: 77 KNIVKYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPF--PESLVA---VYIA-QVL 129
+NI+ L ++ ++ Y+ G+L ++ + G P++L V++A Q+
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY----W 185
G+ YLH++GVIH+DI N + +E VK+ D ++ L D H + W
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY--HCLGDNENRPVKW 185
Query: 186 MAPEVIEMSGVCAASDIWSVGCTVIELLTCVP-PYYELQP--MPAL----FRIVQDERPP 238
MA E + +ASD+WS G + EL+T PY E+ P M A +R+ Q
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ----- 240
Query: 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
P + ++ + C+ D +RP L+
Sbjct: 241 -PINCPDELFAVMACCWALDPEERPSFSQLVQ 271
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-15
Identities = 47/161 (29%), Positives = 86/161 (53%), Gaps = 13/161 (8%)
Query: 8 SAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQ 66
S F K KTL G GA+G V ++ A+K + +++ + + +
Sbjct: 1 SMFVKIKTL----------GIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKA 50
Query: 67 EIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA 126
E D+L +++ +V+ S + + +L+ +++Y+ G + +++ + G FPE L YIA
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFPEDLARFYIA 108
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167
++ + +H+ G IHRDIK NIL ++G +KL DFG+ T
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 35/273 (12%)
Query: 24 DEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDL-NIIMQEIDLLKNLNHK 77
+E+G+ +G+VYKG E VAIK +L++ A+ L E + L H
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIK--TLKDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANII---------------KPNKFGPFPESLVA 122
NIV LG + L +I Y + L + K K P V
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 123 VYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT 182
+ + Q+ G+ +L V+H+D+ N+L + VK++D G+ ++ AD + ++G
Sbjct: 129 I-VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY--YKLMGN 185
Query: 183 PY----WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPY--YELQPMPALFRIVQDE 235
WM+PE I SDIWS G + E+ + + PY Y Q + + R Q
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ-- 243
Query: 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTL 268
P P+ + + +C+ + +RP K +
Sbjct: 244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-12
Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--PY 184
QV G+ +L + +HRD+ N+L + LVK+ DFG+A + D N S T P
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGSTFLPL 305
Query: 185 -WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALF--RIVQDERPPIP 240
WMAPE I + SD+WS G + E+ T PY EL PM F I + R P
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL-PMNEQFYNAIKRGYRMAKP 364
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLL 269
S +I + +++C+++ RPD L+
Sbjct: 365 AHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGL 157
Y++ + I++ ++ E L++ + QV +G+ +L + IHRD+ NIL T +
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLS-FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI 252
Query: 158 VKLADFGVATKLTEADVNTHS---VVGTPY----WMAPEVIEMSGVCAASDIWSVGCTVI 210
K+ DFG+A D+ S V G WMAPE I SD+WS G +
Sbjct: 253 TKICDFGLAR-----DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 307
Query: 211 ELLTCVPPYYELQPMPALF--RIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTL 268
E+ + Y P+ + F I + R PE ++ D ++ C+ D +RP K +
Sbjct: 308 EIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
Query: 269 L 269
+
Sbjct: 368 V 368
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-12
Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 5/150 (3%)
Query: 118 ESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL-TEADVNT 176
E L+ Y QV G+ +L + IHRD+ NIL ++ +VK+ DFG+A + + D
Sbjct: 174 EDLIC-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232
Query: 177 HSVVGTPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQD 234
P WMAPE I SD+WS G + E+ + PY +Q + ++D
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292
Query: 235 -ERPPIPESLSPDITDFLRQCFKKDARQRP 263
R PE+ +P+I + C++ D ++RP
Sbjct: 293 GTRMRAPENATPEIYRIMLACWQGDPKERP 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-12
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 4/152 (2%)
Query: 124 YIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGT 182
Y QV +G+ +L + IHRD+ NIL ++ +VK+ DFG+A + + D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 183 PY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALF--RIVQDERPPI 239
P WMAPE I SD+WS G + E+ + Y + F R+ + R
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303
Query: 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
P+ +P++ + C+ + QRP L+ H
Sbjct: 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-11
Identities = 67/274 (24%), Positives = 119/274 (43%), Gaps = 44/274 (16%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL--NIIMQEIDLLKNLNHKNIVKYL 83
IGKG G VY D VA+K++ E++++ L ++E + +L H IV
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 84 GSLKTRSHLHIILEYVENGSLANIIK----------PNKFGPFPESLVAVYIAQVLEGLV 133
++ + Y+E +L +++K + ++++ ++ +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH-KICATIE 127
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADV----------NTHS---- 178
Y+H +GV+HRD+K NIL G V + D+G A K E + +S
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 179 ---VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFR-IVQD 234
+VGTP +MAPE + ++DI+++G + ++LT PY + R I
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK-----GRKISYR 242
Query: 235 ERPPIPESLSP--DITDFLRQCFKK----DARQR 262
+ P ++P +I FL Q K D +R
Sbjct: 243 DVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-11
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 67 EIDLLKNLNHKNIVKYLGSL-----------KTRSHLHIILEYVENGSLANIIKPNKFGP 115
E +L+ +NH +I++ G+ + ++ L+ L N ++ +I+ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIER--- 189
Query: 116 FPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175
VL + YLHE +IHRDIK NI G V L DFG A + + N
Sbjct: 190 -----------SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238
Query: 176 T-HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYE 221
+ GT APE++ A DIWS G + E+ TC +E
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 18/186 (9%)
Query: 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTT 153
++ E+VE+G L ++ K G P + Q+ L YL ++ ++H ++ NIL
Sbjct: 93 MVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151
Query: 154 KEGL-------VKLADFGVA-TKLTEADVNTHSVVGTPYWMAPEVIE-MSGVCAASDIWS 204
+ GL +KL+D GV+ T L+ + V P W+APE + + + A+D WS
Sbjct: 152 RLGLAEGTSPFIKLSDPGVSFTALSREE----RVERIP-WIAPECVPGGNSLSTAADKWS 206
Query: 205 VGCTVIELLTCVPPYYELQP-MPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
G T++E+ C L+ P+ +++ +PE ++ + QC + QRP
Sbjct: 207 FGTTLLEI--CFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRP 264
Query: 264 DAKTLL 269
+T+L
Sbjct: 265 SFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 40/137 (29%), Positives = 68/137 (49%), Gaps = 5/137 (3%)
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
N+V + + + ++L++ E G L + I +KF PE V + A+++ L LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI--SKFLNIPEECVKRWAAEMVVALDALHR 103
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC 197
+G++ RD+ NIL G ++L F + +E + + + APEV +S
Sbjct: 104 EGIVCRDLNPNNILLDDRGHIQLTYFS---RWSEVEDSCDGEAVENMYCAPEVGGISEET 160
Query: 198 AASDIWSVGCTVIELLT 214
A D WS+G + ELLT
Sbjct: 161 EACDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 55/232 (23%), Positives = 106/232 (45%), Gaps = 17/232 (7%)
Query: 25 EIGKGAYGRVYKGLDLENGDFVA---IKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
EIG G +G+V ++ VA +K++ N + ++ N +Q+ D + L H NI++
Sbjct: 2 EIGNGWFGKVLLS-EIYTDTGVARVVVKELK-ANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQG 139
LG ++ EY E G L + + L+ ++ G+ ++H+
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPY-WMAPEVIE--MSG 195
+H D+ N T + VK+ D+G+ ++ E + T P W+APE++ G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 196 VCAA-----SDIWSVGCTVIELLTCVP-PYYELQPMPALFRIVQDERPPIPE 241
+ A S++W++G T+ EL PY L L +++D++ + +
Sbjct: 180 LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 124 YIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGT 182
Y QV G+ +L + IHRD+ NIL ++ +VK+ DFG+A + + D
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 183 PY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALF--RIVQDERPP 238
P WMAPE I SD+WS G + E+ + PY +Q + F R+ + R
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-IDEEFCRRLKEGTRMR 296
Query: 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
PE +P+I + C+ + RP L+
Sbjct: 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-10
Identities = 46/157 (29%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 67 EIDLLKNLNHKNIVKYLGSLKTRSHLHIILE--------YVENGSLANIIKPNKFGPFPE 118
EI L LNH+NI+K L++ ++ ++I + ++ + + K P +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-----KDRPLLK 267
Query: 119 SLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL-TEADVNTH 177
A+ + Q+L + Y+H++ +IHRDIK NI +G + L DFG A E + +
Sbjct: 268 QTRAI-MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT 214
VGT +PE++ G C +DIWS G ++++L+
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-10
Identities = 52/236 (22%), Positives = 96/236 (40%), Gaps = 19/236 (8%)
Query: 33 RVYKGLDLEN-GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91
R Y L EN GD++ +KQ Q + +L+ S R
Sbjct: 164 RSYVILSFENKGDYMDMKQAD-----------TTQYVPMLEIKEASKYSDIQRSNYDRPA 212
Query: 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL 151
+ + + + N++ + + + QV G+ +L + +HRD+ N+L
Sbjct: 213 SY---KGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269
Query: 152 TTKEGLVKLADFGVATKLTEAD--VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTV 209
+ +VK+ DFG+A + V+ S WMAPE I + SD+WS G +
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329
Query: 210 IELLTCVPPYYELQPMPALF--RIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
E+ + Y + + F +I R P+ + ++ D + +C+ + +RP
Sbjct: 330 WEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 60/264 (22%), Positives = 122/264 (46%), Gaps = 28/264 (10%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQ--VSLENIAQEDLNI---IMQEIDLLKNLNHKN 78
+ +G+G + +++KG+ E GD+ + + V L+ + + N + ++ L+HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+V G ++ EYV+ GSL +K NK S Q+ L +L ++
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK 119
Query: 139 GVIHRDIKGANILTTKEG--------LVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV 190
G+ H ++ N+L +E +KL+D G++ + ++ + P W+ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---P-WVPPEC 175
Query: 191 IEMSGVCA-ASDIWSVGCTVIELLTCVPPYYELQPMPAL--FRIVQ--DERPPIPESLSP 245
IE + A+D WS G T+ E+ + +P+ AL + +Q ++R +P
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGD-----KPLSALDSQKKLQFYEDRHQLPAPKWT 230
Query: 246 DITDFLRQCFKKDARQRPDAKTLL 269
++ + + QC + RP + ++
Sbjct: 231 ELANLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 66/265 (24%), Positives = 123/265 (46%), Gaps = 24/265 (9%)
Query: 25 EIGKGAYGRVYKG---LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
EIG G +G+V G V +K++ + QE + ++E ++L H N+++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQ-VVVKELRVSASVQEQMKF-LEEAQPYRSLQHSNLLQ 59
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPF--PESLVAVYIA-QVLEGLVYLHEQ 138
LG + +++E+ G L ++ + P+ +A ++ GL++LH+
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPY-WMAPEVI-EMSG 195
IH D+ N L T + VK+ D+G++ K E T + P W+APE++ E+ G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 196 ------VCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPE-----SL 243
S++WS+G T+ EL PY L L V++++ +P+ L
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239
Query: 244 SPDITDFLRQCFKKDARQRPDAKTL 268
S + ++ C+ + QRP A+ +
Sbjct: 240 SDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-09
Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-- 184
QV +G+ +L + IHRD+ N+L T + K+ DFG+A + D N + V G
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSN-YVVKGNARLP 277
Query: 185 --WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQD-ERPPIP 240
WMAPE I SD+WS G + E+ + PY + +++V+ + P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP 337
Query: 241 ESLSPDITDFLRQCFKKDARQRP 263
+ P+I ++ C+ + +RP
Sbjct: 338 DFAPPEIYSIMKMCWNLEPTERP 360
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 5/105 (4%)
Query: 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER 236
HS+VGTP ++APEV+ +G D WSVG + E+L PP+ P+ +++ +
Sbjct: 206 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT 265
Query: 237 P---PIPESLSPDITDF-LRQCFKKDAR-QRPDAKTLLSHPWIQN 276
P LSP+ +D ++ C + R + A + +HP+ +
Sbjct: 266 SLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-08
Identities = 42/143 (29%), Positives = 62/143 (43%), Gaps = 15/143 (10%)
Query: 115 PFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA--TKLTEA 172
P + V Q+L + Y+H +G+IHRDIK N+L + L DFG A + + +
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315
Query: 173 DVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIEL------LTCVPPYYELQPMP 226
+ + GT APEV+ + DIWS G + E L E +P
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375
Query: 227 A-LFRIVQ------DERPPIPES 242
A + RI++ DE P S
Sbjct: 376 AQILRIIRQAQVHVDEFPQHAGS 398
|
Length = 461 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-07
Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 68/251 (27%)
Query: 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDF----------------VAIKQVSLE-- 54
S+ + + L D++G G +G ++GL L+ D V +K+V+++
Sbjct: 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ 199
Query: 55 ----------NIAQEDLNIIMQEIDLLKNLNHKNIV-----KYLGSLK--------TRSH 91
+A+ M E + + I +YLG T+
Sbjct: 200 GVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGS 259
Query: 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-----------------------QV 128
++ ++ + +L + + K GPFP L +A QV
Sbjct: 260 QWLVWKFESDATLGDALD-GKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV 318
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--PYWM 186
L GL LH G++HRDIK N+L T +G VK+ DFG A + +N + + G P +
Sbjct: 319 LTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYS 377
Query: 187 APEVIEMSGVC 197
PE + M C
Sbjct: 378 PPEELVMPQSC 388
|
Length = 507 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILE-YVENGSLANIIKPNKFGPFPESLVAVYIAQV 128
+++ ++HK+IV L + R +I++E +VE G L ++ K Q+
Sbjct: 57 MMRQVSHKHIV-LLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQL 114
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGL-------VKLADFGVA-TKLTEADVNTHSVV 180
L YL ++ ++H ++ NIL +EG+ +KL+D G+ T L+ + V
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE----CVE 170
Query: 181 GTPYWMAPEVIEMSGVCA-ASDIWSVGCTVIEL------------LTCVPPYYELQPMPA 227
P W+APE +E S + A+D WS G T+ E+ L +YE Q M
Sbjct: 171 RIP-WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLV 229
Query: 228 LFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263
P E + D + C D QRP
Sbjct: 230 --------TPSCKE-----LADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-05
Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 36/189 (19%)
Query: 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGL----DLENGDFVAIKQVSLENIAQEDLNIIM 65
F S D+ ++LG ++G+GA+G VYK + +K+ + E A E I M
Sbjct: 125 FRPSFKKDD-FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT-EYGAVE---IWM 179
Query: 66 QEIDLLKNLNHKNIVKYLG------SLKTRSHLHIILEYVENGSLANIIKPNKF------ 113
E ++ + ++ S K ++ Y +LA++++ +F
Sbjct: 180 NE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEP 237
Query: 114 -----------GPFPES-LVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL-TTKEGLVKL 160
G E+ ++ + Q+L L LH G++HRD+K NI+ + G K+
Sbjct: 238 YLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKI 297
Query: 161 ADFGVATKL 169
D G A L
Sbjct: 298 IDLGAAADL 306
|
Length = 566 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 44/160 (27%), Positives = 67/160 (41%), Gaps = 23/160 (14%)
Query: 26 IGKGAYGRVYKGLDLENGDF---VAIKQVSLEN--IAQEDLNI-IMQEIDLL------KN 73
IG G +G VY+ + K +LEN I E L + +ID + N
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 74 LNHKNIVKYLG--SLK--TRSHLHIILE--YVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
++H I KY G S K + I+LE + IK + L+ +
Sbjct: 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC-----KNKKLIKNIMKD 134
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167
+L L Y+HE G+ H DIK NI+ + D+G+A+
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-05
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 41/217 (18%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+G+G +G+V + D + ++ A+K V D I +Q ++ ++
Sbjct: 137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR----------QAD 186
Query: 86 LKTRSHLHIILEYVENGS-LANIIKPN----------KFGPFPESLVAVYIAQVLEGLVY 134
R L I Y +N + I+ P K GPF +A I Q L Y
Sbjct: 187 PADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDY 246
Query: 135 LH-EQGVIHRDIKGANIL----------TTKEGL------VKLADFGVATKLTEADVNTH 177
H E ++H D+K NIL T L V++ D G E T
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD--ERHSRT- 303
Query: 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT 214
++V T ++ +PEV+ G ++D+WS+GC + EL T
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340
|
Length = 467 |
| >gnl|CDD|237987 cd00020, ARM, Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 25/99 (25%), Positives = 44/99 (44%), Gaps = 8/99 (8%)
Query: 1197 HLVSLIHS-------EVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYAL 1248
LVSL+ S E AL NL N + E G +P L+ + S+ + + AL
Sbjct: 11 ALVSLLSSSDENVQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQLLKSEDEEVVKAAL 70
Query: 1249 PLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTA 1287
L ++A +++ + GG+ +NLL++ +
Sbjct: 71 WALRNLAAGPEDNKLIVLEAGGVPKLVNLLDSSNEDIQK 109
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. Length = 120 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-04
Identities = 33/106 (31%), Positives = 60/106 (56%), Gaps = 10/106 (9%)
Query: 22 LGDEIGKGAYGRVYK----GLDLENG-DFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-N 75
LG +G GA+G+V + G+D ++ + VA+K + A E +M E+ +L ++ N
Sbjct: 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH-KALMSELKILIHIGN 69
Query: 76 HKNIVKYLGS-LKTRSHLHIILEYVENGSLANIIKPNK--FGPFPE 118
H N+V LG+ K L +I+E+ + G+L+N ++ + F P+ E
Sbjct: 70 HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE 115
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 18 NKYMLGDEIGKGAYGRVYK----GLDLENGDF-VAIKQVSLENIAQED-LNIIMQEIDLL 71
+ G +G GA+G+V + GL E+ VA+K L+ A D +M E+ +L
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKM--LKASAHTDEREALMSELKIL 95
Query: 72 KNL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK 109
+L HKNIV LG+ + +I EY G L N ++
Sbjct: 96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 0.001
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 8 SAFHKSKTLDNKYMLGDE---IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII 64
S KS T+++ E I +G G YKG ++NG +K+++ N +I
Sbjct: 677 SKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN------SIP 730
Query: 65 MQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVY 124
EI + L H NIVK +G ++ ++I EY+E +L+ ++ +A+
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RNLSWERRRKIAIG 788
Query: 125 IAQVLEGLVYLH---EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181
IA + L +LH V+ ++ I+ + L + L +T +
Sbjct: 789 IA---KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---TDTKCFIS 841
Query: 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT 214
+ Y +APE E + SDI+ G +IELLT
Sbjct: 842 SAY-VAPETRETKDITEKSDIYGFGLILIELLT 873
|
Length = 968 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1437 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.52 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.42 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.27 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.25 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.17 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| PLN03200 | 2102 | cellulose synthase-interactive protein; Provisiona | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.03 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.94 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.81 | |
| PF05804 | 708 | KAP: Kinesin-associated protein (KAP) | 97.64 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.53 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.46 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.43 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.29 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.28 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.28 | |
| PF05804 | 708 | KAP: Kinesin-associated protein (KAP) | 97.16 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.13 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.01 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.98 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.95 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.83 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.82 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.76 | |
| PLN03200 | 2102 | cellulose synthase-interactive protein; Provisiona | 96.65 | |
| PF10508 | 503 | Proteasom_PSMB: Proteasome non-ATPase 26S subunit; | 96.4 | |
| cd00020 | 120 | ARM Armadillo/beta-catenin-like repeats. An approx | 96.13 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.09 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.98 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.85 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.82 | |
| cd00020 | 120 | ARM Armadillo/beta-catenin-like repeats. An approx | 95.77 | |
| PLN02236 | 344 | choline kinase | 95.43 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.39 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.23 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.82 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.41 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.23 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.22 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.81 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.01 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.94 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=467.41 Aligned_cols=263 Identities=31% Similarity=0.613 Sum_probs=240.9
Q ss_pred cccccccCC----ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEE
Q 000535 10 FHKSKTLDN----KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLG 84 (1437)
Q Consensus 10 F~~gktLgg----RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLig 84 (1437)
++.+..|.+ +|+.++.||+|||+.||++++..+|..||+|++.+..+. ....+.+.+||+|.++|+|||||++++
T Consensus 6 ~~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~ 85 (592)
T KOG0575|consen 6 PEIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYH 85 (592)
T ss_pred CCCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeee
Confidence 345555555 799999999999999999999999999999999886544 456788999999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecc
Q 000535 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFG 164 (1437)
Q Consensus 85 Vfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFG 164 (1437)
+|++..++|||+|+|+.++|.++++ +.++++|.+++.|++||+.||.|||+++|+|||||..|+|++++.+|||+|||
T Consensus 86 ~FEDs~nVYivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 86 FFEDSNNVYIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred EeecCCceEEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccc
Confidence 9999999999999999999999999 44789999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCC
Q 000535 165 VATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLS 244 (1437)
Q Consensus 165 LAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~IS 244 (1437)
+|..+..+.....+.||||.|.|||++...+++..+||||+|||||.||+|+|||...+-. ..++.++......|..+|
T Consensus 164 LAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-ety~~Ik~~~Y~~P~~ls 242 (592)
T KOG0575|consen 164 LATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-ETYNKIKLNEYSMPSHLS 242 (592)
T ss_pred eeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-HHHHHHHhcCcccccccC
Confidence 9999988777888999999999999999999999999999999999999999999875544 445555566667888999
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 245 pELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
.++++||.+||++||.+|||++++|.|+||.
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 9999999999999999999999999999993
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=455.79 Aligned_cols=263 Identities=33% Similarity=0.571 Sum_probs=231.7
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEE
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE-----DLNIIMQEIDLLKNLNHKNIVKYLGSL 86 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee-----die~L~REIkILrrLnHPNIVKLigVf 86 (1437)
.-+.+.+.|.+.+.||+|+||.|-+|.++.+|+.||||++.+...... ....+.+|+++|++|+|||||+++++|
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 345688999999999999999999999999999999999987654431 223467999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC---CcEEEEec
Q 000535 87 KTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE---GLVKLADF 163 (1437)
Q Consensus 87 edd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden---G~VKLiDF 163 (1437)
+..++.||||||++||+|.+.+-.+ +.+.|.....+++|++.|+.|||++||+||||||+|||+..+ ..+||+||
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999999999855 579999999999999999999999999999999999999876 68999999
Q ss_pred ccccccccCCcccccccCCCccCChhhhhcCC---CCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHH-HhhcC---C
Q 000535 164 GVATKLTEADVNTHSVVGTPYWMAPEVIEMSG---VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFR-IVQDE---R 236 (1437)
Q Consensus 164 GLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~---yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~k-Iiq~~---r 236 (1437)
|+|+..++.. ...+.||||.|.|||++...+ +..++|||||||+||-+|+|++||.+....+.+.+ |.++. .
T Consensus 324 GlAK~~g~~s-fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 324 GLAKVSGEGS-FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred chhhccccce-ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 9999987543 567899999999999997765 34578999999999999999999988777764444 44443 3
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 237 ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
++.+..+|.+..+||+.||..||++|||+.|+|+||||+..
T Consensus 403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 45567899999999999999999999999999999999843
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-49 Score=438.89 Aligned_cols=259 Identities=32% Similarity=0.570 Sum_probs=242.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
.+.|++++.||+|+||+||.++.+++++.||+|++++....+ .+.+....|..||.+++||.||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 578999999999999999999999999999999999877654 4778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
+||+.||.|+..|++. +.|+|..++.|+..|+.||.|||++|||||||||+|||++..|+++|+|||+|+........
T Consensus 104 ld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 9999999999999854 68999999999999999999999999999999999999999999999999999977777667
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
+.++|||+.|||||++.+.+|+..+|+||||+++|+|++|.+||+..+......++.....+..|..++.+++++|+++|
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLL 261 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHh
Confidence 78899999999999999999999999999999999999999999998888888888777767777779999999999999
Q ss_pred hhcccCCC----CHHHHhcCHHHHHH
Q 000535 256 KKDARQRP----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 256 qkDPeKRP----SAeELLkHPWFQe~ 277 (1437)
.+||++|. ++.+|-+||||...
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccC
Confidence 99999995 79999999999765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=434.76 Aligned_cols=255 Identities=35% Similarity=0.610 Sum_probs=235.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-eEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS-HLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~-~LYLVM 96 (1437)
++.+.++.||+|..|+||+|+|+.+++.||+|+|. ........+.+.+|+++++..+|||||.+|+.|..++ .++|+|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 46788899999999999999999999999999994 4456677788999999999999999999999999998 599999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+||+|.++++.. ++++|.....|+.++++||.|||+ ++|+||||||+||||+..|.|||||||.+..+... .
T Consensus 158 EYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I 233 (364)
T ss_pred hhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence 999999999999855 679999999999999999999996 89999999999999999999999999999988766 4
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCC-----CChhHHHHHhhcCCCCCCCC-CCHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYEL-----QPMPALFRIVQDERPPIPES-LSPDITD 249 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~-----d~~eqL~kIiq~~rppiP~~-ISpELkD 249 (1437)
..+++||..|||||.+.+..|+.++||||||++++|+.+|+.||... ...+.+..|+....+.+|.. +|+++++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 56799999999999999999999999999999999999999999774 45667777888888889987 9999999
Q ss_pred HHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
||..||++||.+||++.++++|||+++.
T Consensus 314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 9999999999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=433.56 Aligned_cols=258 Identities=31% Similarity=0.607 Sum_probs=237.3
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
.-++|.+.+.||+|+||+||+|+++.++..||||.|.+..+.....+.+..|+++|+.++|||||.++++++.++++|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 45789999999999999999999999999999999999988888999999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC------CcEEEEeccccccc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE------GLVKLADFGVATKL 169 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden------G~VKLiDFGLAr~L 169 (1437)
||||.||+|.++|+.. +.++|..++.++.||+.||++||+++||||||||+||||+.+ -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999855 589999999999999999999999999999999999999875 36999999999999
Q ss_pred ccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC--CCCCCCCCCHHH
Q 000535 170 TEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE--RPPIPESLSPDI 247 (1437)
Q Consensus 170 ~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~--rppiP~~ISpEL 247 (1437)
.+.. ...+.||+|.|||||+++...|+.|+|+||+|+|+|+|++|++||...+..+.+..+-++. .+.++..+++.+
T Consensus 166 ~~~~-~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGS-MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred Cchh-HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 8654 4568999999999999999999999999999999999999999999888877777655443 345566788889
Q ss_pred HHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 248 kDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.+|+...|..+|..|.+..+.+.|+++..
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 99999999999999999999999988864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=440.44 Aligned_cols=261 Identities=28% Similarity=0.511 Sum_probs=234.6
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-e
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRS-H 91 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd~-~ 91 (1437)
..+.++|.++++||.|+||+||+|+...++..||||.+++.....++..++ ||++.|++|+ |||||++.+++.+.+ .
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nL-REvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHH-HHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 457789999999999999999999999999999999999888776666554 8999999998 999999999998877 9
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e 171 (1437)
+|+|||||+. +|+++++.+ ...|+|..++.|++||++||+|+|.+|++|||+||+||||..+..|||+|||+|+.+..
T Consensus 85 L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 9999999975 999999977 67999999999999999999999999999999999999999999999999999999876
Q ss_pred CCcccccccCCCccCChhhhh-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC------------
Q 000535 172 ADVNTHSVVGTPYWMAPEVIE-MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP------------ 238 (1437)
Q Consensus 172 sd~kt~t~~GTp~YmAPEVL~-g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp------------ 238 (1437)
... ...++.|.+|+|||++. ...|+.++|||++|||++|+.+-++.|.+.++.+++++|..--..|
T Consensus 163 kpP-YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KPP-YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CCC-cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 653 44689999999999875 4568999999999999999999999999999999999986521110
Q ss_pred -----------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 239 -----------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 239 -----------------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
+-+.+++++.++|.+||.+||.+||||.++|+||||+...
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1134789999999999999999999999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=431.06 Aligned_cols=260 Identities=31% Similarity=0.559 Sum_probs=233.8
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC---HHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA---QEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTR 89 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS---eedie~L~REIkILrrLn-HPNIVKLigVfedd 89 (1437)
....++|++++.||+|+||.||.|.+..++..||+|++.+.... ....+.+.+|+.+++++. ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 45678999999999999999999999999999999988765322 134556779999999998 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC-CcEEEEecccccc
Q 000535 90 SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE-GLVKLADFGVATK 168 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden-G~VKLiDFGLAr~ 168 (1437)
..+|+|||||.||+|++++.. .+++.|..++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999999999986 4789999999999999999999999999999999999999999 9999999999998
Q ss_pred cccCCcccccccCCCccCChhhhhcCC-CC-ccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCC-CH
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSG-VC-AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL-SP 245 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g~~-yS-~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~I-Sp 245 (1437)
.........+.|||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||...+. ..+++.+......+|..+ |+
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~l~~ki~~~~~~~p~~~~S~ 249 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PNLYRKIRKGEFKIPSYLLSP 249 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HHHHHHHhcCCccCCCCcCCH
Confidence 743334667899999999999999987 85 789999999999999999999988554 444555666777888888 99
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
++.+|+.+||..||.+|+++.+|+.||||+.
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=426.88 Aligned_cols=274 Identities=36% Similarity=0.631 Sum_probs=243.6
Q ss_pred CCCCcc-CcccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCc
Q 000535 1 MSRQTT-TSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79 (1437)
Q Consensus 1 MSrQtt-as~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNI 79 (1437)
|+++.. ...+.+++--...|+|+++||+|+||+||++++..+|+.+|.|.|....++....+.+..|+.+|++|+||||
T Consensus 1 M~~~~~~~~~~~~~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNI 80 (375)
T KOG0591|consen 1 MDKQSSAMMDFSPPQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNI 80 (375)
T ss_pred CCcccccccCCCCCcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchH
Confidence 565543 3333344445567999999999999999999999999999999999888888889999999999999999999
Q ss_pred ceEEE-EE-EeCCeEEEEEeecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHH--CC--cccccccCCceE
Q 000535 80 VKYLG-SL-KTRSHLHIILEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHE--QG--VIHRDIKGANIL 151 (1437)
Q Consensus 80 VKLig-Vf-edd~~LYLVMEYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHS--nG--IVHRDLKPENIL 151 (1437)
|++++ .| ++...++||||||.+|+|..+|+.. ....++|..+|.++.|++.||+++|+ .. |+||||||.||+
T Consensus 81 VqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIF 160 (375)
T KOG0591|consen 81 VQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIF 160 (375)
T ss_pred HHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheE
Confidence 99998 34 4445599999999999999999742 34679999999999999999999999 44 999999999999
Q ss_pred eccCCcEEEEecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHH
Q 000535 152 TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI 231 (1437)
Q Consensus 152 LdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kI 231 (1437)
|+.+|.|||+|||+++.+.......++++|||+||+||.+...+|+.++|||||||++|||+.-.+||++.+-.....+|
T Consensus 161 l~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI 240 (375)
T KOG0591|consen 161 LTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI 240 (375)
T ss_pred EcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH
Confidence 99999999999999999988887888999999999999999999999999999999999999999999999777777788
Q ss_pred hhcCCCCCC-CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHHH
Q 000535 232 VQDERPPIP-ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279 (1437)
Q Consensus 232 iq~~rppiP-~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~rr 279 (1437)
.++..+++| ..+|.++..||..|+..||+.||+. +|+++..+.
T Consensus 241 ~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 241 EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 888888899 7899999999999999999999986 566665543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=401.74 Aligned_cols=259 Identities=28% Similarity=0.547 Sum_probs=229.4
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~ 90 (1437)
....-.++|.+.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 3444457899999999999999999999999999999999765432 244567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
.+|+|||||.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999999999754 579999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHH
Q 000535 171 EADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 171 esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDL 250 (1437)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+. .....+|..++..+.+|
T Consensus 170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~l 245 (329)
T PTZ00263 170 DR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-AGRLKFPNWFDGRARDL 245 (329)
T ss_pred CC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCCcCCCCCCCHHHHHH
Confidence 43 234689999999999999999999999999999999999999998766655544444 44566778899999999
Q ss_pred HHHHhhhcccCCCC-----HHHHhcCHHHHH
Q 000535 251 LRQCFKKDARQRPD-----AKTLLSHPWIQN 276 (1437)
Q Consensus 251 IrkCLqkDPeKRPS-----AeELLkHPWFQe 276 (1437)
|.+||..||.+||+ +.++++||||..
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999999997 799999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=413.37 Aligned_cols=261 Identities=32% Similarity=0.563 Sum_probs=232.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|+.+.++|+|+||+||+|+++.||+.||||++.-...++.-.+...|||++|++|+|||+|.++++|...+.+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 57999999999999999999999999999999987655555556678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
||+. ++.+.++..+.| +++..+..|++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+...+....
T Consensus 82 ~~dh-TvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred ecch-HHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 9987 777777777654 89999999999999999999999999999999999999999999999999999986555666
Q ss_pred cccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--------------------
Q 000535 178 SVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------------------- 236 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-------------------- 236 (1437)
.++.|.+|+|||.+.+ .+|+..+|||++||++.||++|.+-|++.++.++++.|...-.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 7899999999999876 6899999999999999999999999999999999998764210
Q ss_pred CCCC----------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHHHH
Q 000535 237 PPIP----------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA 280 (1437)
Q Consensus 237 ppiP----------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~rrs 280 (1437)
.|.| +.++.-+.+|+++||..||++|++.++++.||||......
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence 1111 3456779999999999999999999999999999776543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=431.85 Aligned_cols=259 Identities=30% Similarity=0.580 Sum_probs=236.6
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrL-nHPNIVKLigVfedd~~LY 93 (1437)
=..+|++++.||.|+|++||+|++..+++.||||++.+..+-. ..++.+.+|-.+|.+| +||.|++|+..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3467999999999999999999999999999999998876544 4567889999999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+|+||+++|+|.++|+. .|.|+|..++.|+.||+.||+|||++|||||||||+|||++.+++++|+|||.|+.+.+..
T Consensus 151 FvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999984 4889999999999999999999999999999999999999999999999999998875432
Q ss_pred cc-------------cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCC
Q 000535 174 VN-------------THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240 (1437)
Q Consensus 174 ~k-------------t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP 240 (1437)
.. ..+++||..|.+||++.+...+..+|||+||||||+|+.|.+||.+.+++-...+|+... ..+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~-y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD-YEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc-ccCC
Confidence 11 145899999999999999999999999999999999999999999999888777776554 5788
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 241 ~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+++++.+.+||+++|..||.+|+++.+|-+||||...
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 8999999999999999999999999999999999653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=428.44 Aligned_cols=259 Identities=29% Similarity=0.518 Sum_probs=232.1
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
=.++|+++++||+|+||.||+|+.+.||..||+|++++..+- ..+++.+..|-.+|..-.+|+||+|+..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457899999999999999999999999999999999987654 4678889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc---
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE--- 171 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e--- 171 (1437)
||||++||++.++|... +.|+|..++.|+.+++.|++.||+.||+||||||+|+||+..|++||+|||||..+..
T Consensus 219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999844 7899999999999999999999999999999999999999999999999999954321
Q ss_pred -------------------CCcc-------------------------cccccCCCccCChhhhhcCCCCccchhhhHHH
Q 000535 172 -------------------ADVN-------------------------THSVVGTPYWMAPEVIEMSGVCAASDIWSVGC 207 (1437)
Q Consensus 172 -------------------sd~k-------------------------t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ 207 (1437)
.+.. ..+.+|||.|||||++.+.+|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0000 11368999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCChhHHHHHhhcC---CCCCCCCCCHHHHHHHHHHhhhcccCCC---CHHHHhcCHHHHHH
Q 000535 208 TVIELLTCVPPYYELQPMPALFRIVQDE---RPPIPESLSPDITDFLRQCFKKDARQRP---DAKTLLSHPWIQNC 277 (1437)
Q Consensus 208 ILYELLTGkpPF~g~d~~eqL~kIiq~~---rppiP~~ISpELkDLIrkCLqkDPeKRP---SAeELLkHPWFQe~ 277 (1437)
||||||.|+|||...++.+...+|+... ..|-...+++++++||.+||. ||++|. +++||-+||||+..
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 9999999999999999999988887654 223335688999999999999 999997 59999999999764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=435.60 Aligned_cols=259 Identities=29% Similarity=0.511 Sum_probs=237.0
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecc-ccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLE-NIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke-~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
.--|.|++++.||.|+-|.|-+|+|..||+.+|||+|.+. ...+.....+.+||-+|+-+.||||+.++++++++.++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 3457899999999999999999999999999999999887 556667778999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+|.||++||.|++++... |+|+|.+++++++||+.|+.|+|..+|+||||||+|+|++..+++||+|||+|....++.
T Consensus 89 lvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999999844 789999999999999999999999999999999999999999999999999998766544
Q ss_pred cccccccCCCccCChhhhhcCCC-CccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 000535 174 VNTHSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g~~y-S~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIr 252 (1437)
-..+.||+|.|.+||++.+..| +.++||||+|||||.||+|+.||.+. ....+...++.+....|..+|+++++||+
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-Nir~LLlKV~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-NIRVLLLKVQRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence 4567899999999999999988 57899999999999999999999864 45555555666667888999999999999
Q ss_pred HHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 253 QCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+||..||++|.|.+||++|||+..+
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcC
Confidence 9999999999999999999999764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=392.14 Aligned_cols=254 Identities=28% Similarity=0.525 Sum_probs=225.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4799999999999999999999999999999999764432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---T 155 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---c
Confidence 999999999999754 57999999999999999999999999999999999999999999999999999876432 2
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .....++..+++.+.+||.+||.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL-AGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCcCCCccCCHHHHHHHHHHcC
Confidence 34679999999999999999999999999999999999999998876555444444 44556778889999999999999
Q ss_pred hcccCCCC-----HHHHhcCHHHHHH
Q 000535 257 KDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 257 kDPeKRPS-----AeELLkHPWFQe~ 277 (1437)
.||.+||+ +.++++||||+..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccCC
Confidence 99999995 9999999999653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=425.44 Aligned_cols=257 Identities=34% Similarity=0.589 Sum_probs=239.0
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|.+.+.||+|+||+||||+.+.+.+.||||.+.+....+.+...+.+|++|+++|+|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57999999999999999999999999999999999998888999999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
||.| +|++++... +.++|+.++.|.+|++.||.|||+++|.|||+||.|||+..+|.+|+||||+|+.+.....-..
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 9987 999999854 6899999999999999999999999999999999999999999999999999999888776667
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqk 257 (1437)
...|||.|||||++.+..|+..+|+||||||+|||+.|+|||+..... .+.+.+.......|..++..+.+|+..+|.+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-QLVKSILKDPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-HHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence 789999999999999999999999999999999999999999876544 4445555566677789999999999999999
Q ss_pred cccCCCCHHHHhcCHHHHHHH
Q 000535 258 DARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 258 DPeKRPSAeELLkHPWFQe~r 278 (1437)
||.+|.+..+++.|||++...
T Consensus 238 dP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred ChhhcccHHHHhcChHHhhhh
Confidence 999999999999999998653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=385.97 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=223.5
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
|++.+.||+|+||+||+|.+..+++.||+|.+.+..... .....+.+|+.++++++|+||+++++++.+++.+|+||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 889999999999999999999999999999987654332 2334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
|++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....... ....
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 160 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRG 160 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-eecC
Confidence 999999988865545579999999999999999999999999999999999999999999999999998764332 2335
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChh---HHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMP---ALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~e---qL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+..........++..+++++.+||++||
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 240 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence 679999999999999999999999999999999999999998755432 23333334445667789999999999999
Q ss_pred hhcccCCCC-----HHHHhcCHHHHHH
Q 000535 256 KKDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 256 qkDPeKRPS-----AeELLkHPWFQe~ 277 (1437)
++||.+||+ ++++++||||...
T Consensus 241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 241 TKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred hcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=397.09 Aligned_cols=251 Identities=29% Similarity=0.511 Sum_probs=221.6
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.++++++||||+++++++..++.+|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999986543 2345567789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCC
Q 000535 103 SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT 182 (1437)
Q Consensus 103 SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GT 182 (1437)
+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 999999744 579999999999999999999999999999999999999999999999999998654333344567899
Q ss_pred CccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCC
Q 000535 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262 (1437)
Q Consensus 183 p~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKR 262 (1437)
+.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+......+|..+++++.+||.+||.+||++|
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999999999999999999999999999999998755444 33444445567788899999999999999999999
Q ss_pred C-----CHHHHhcCHHHHHH
Q 000535 263 P-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 263 P-----SAeELLkHPWFQe~ 277 (1437)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=383.71 Aligned_cols=255 Identities=30% Similarity=0.468 Sum_probs=217.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||+|+||.||+|++..++..||+|++..........+.+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999998765545556678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-cc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NT 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-kt 176 (1437)
|++++.+..+... .+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..+..... ..
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 9998766655442 35699999999999999999999999999999999999999999999999999987654321 22
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--------------------
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------------------- 236 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-------------------- 236 (1437)
....|++.|+|||++.+..++.++|||||||++|+|++|++||......+.+..+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 346789999999999988899999999999999999999999987665544433221100
Q ss_pred -C----------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 -P----------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 -p----------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
+ .....+|.++.+||.+||++||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0112368889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=403.36 Aligned_cols=256 Identities=29% Similarity=0.585 Sum_probs=236.3
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
--++|++++.||.|+||.|.+++++.+|..||+|++.+.... -.+++....|..+|+.+.||.++++++.+.+.+++||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 356799999999999999999999999999999999877654 3567888999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||++||.|+.++++. ++|+|..++.|+.||+.||+|||+++|++|||||+|||++.+|.+||+|||+|+.+..
T Consensus 122 vmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred EEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 99999999999999854 6899999999999999999999999999999999999999999999999999998764
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
.+.+.||||.|+|||++...+|+.++|+|+||+++|||+.|++||+..++...+.+|+.. ...+|..+++++++||+++
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-~v~fP~~fs~~~kdLl~~L 275 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-KVKFPSYFSSDAKDLLKKL 275 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-cccCCcccCHHHHHHHHHH
Confidence 367899999999999999999999999999999999999999999999887766666554 5678899999999999999
Q ss_pred hhhcccCC-----CCHHHHhcCHHHHHH
Q 000535 255 FKKDARQR-----PDAKTLLSHPWIQNC 277 (1437)
Q Consensus 255 LqkDPeKR-----PSAeELLkHPWFQe~ 277 (1437)
|+.|-.+| ....+|.+||||+..
T Consensus 276 L~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 276 LQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HhhhhHhhhcCcCCCccccccCcccccc
Confidence 99999999 468899999999754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=410.66 Aligned_cols=258 Identities=45% Similarity=0.770 Sum_probs=225.3
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--eEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS--HLHI 94 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~--~LYL 94 (1437)
..+|..++.||+|+||.||++.+.++|..+|||.+..... ...+.+.+|+.+|++|+|||||++++...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4569999999999999999999999999999999887632 22777999999999999999999999754444 7999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-CCcEEEEeccccccccc--
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-EGLVKLADFGVATKLTE-- 171 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-nG~VKLiDFGLAr~L~e-- 171 (1437)
+|||+++|+|.++++...+ +|+|..++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999997755 8999999999999999999999999999999999999999 79999999999987763
Q ss_pred -CCcccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCC-CCChhHHHHHhhcC-CCCCCCCCCHHH
Q 000535 172 -ADVNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYE-LQPMPALFRIVQDE-RPPIPESLSPDI 247 (1437)
Q Consensus 172 -sd~kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g-~d~~eqL~kIiq~~-rppiP~~ISpEL 247 (1437)
.........||+.|||||++... ....++|||||||++.||+||++||.. ......+..+.... .|.+|..+|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 11223467899999999999863 233599999999999999999999987 45555566665444 568899999999
Q ss_pred HHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 248 kDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
++||.+|+.+||++|||+.++|+|||.++.
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=393.53 Aligned_cols=257 Identities=32% Similarity=0.545 Sum_probs=225.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|.+.+.||+|+||+||+|++..+++.||||++.+..... .....+.+|+.+++.++||||+++++++.+++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998654333 45567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC---
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--- 173 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd--- 173 (1437)
|||++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999999755 679999999999999999999999999999999999999999999999999998765433
Q ss_pred --------------------------cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhH
Q 000535 174 --------------------------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPA 227 (1437)
Q Consensus 174 --------------------------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eq 227 (1437)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 123346799999999999999999999999999999999999999988776666
Q ss_pred HHHHhhc---CCCCCCCCCCHHHHHHHHHHhhhcccCCCC-HHHHhcCHHHHHH
Q 000535 228 LFRIVQD---ERPPIPESLSPDITDFLRQCFKKDARQRPD-AKTLLSHPWIQNC 277 (1437)
Q Consensus 228 L~kIiq~---~rppiP~~ISpELkDLIrkCLqkDPeKRPS-AeELLkHPWFQe~ 277 (1437)
..++... ...+....+++++.+||.+||. +|.+||+ +.++++||||+..
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 6665542 1222233479999999999997 9999999 9999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=377.69 Aligned_cols=255 Identities=32% Similarity=0.513 Sum_probs=215.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcC-CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----e
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLE-NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL---NHKNIVKYLGSLK-----T 88 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrk-TGk~VAIKVIkke~lSeedie~L~REIkILrrL---nHPNIVKLigVfe-----d 88 (1437)
.+|++.+.||+|+||+||+|++.. ++..||+|.+............+.+|+.+++.+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999865 578899999876544433344566777777766 6999999999885 3
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 89 d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
...+++||||+. ++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 467999999997 5999999866656799999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC----------
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---------- 238 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp---------- 238 (1437)
..... ......||+.|+|||++....++.++|||||||++|+|++|.+||.+....+.+.++......+
T Consensus 160 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 160 YSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred ccCCc-ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 65432 3345679999999999998899999999999999999999999999877766666654321111
Q ss_pred ----------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 239 ----------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 239 ----------------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
+.+.+++.+.+||.+||+.||++|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=382.00 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=215.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|.+.+.||.|+||.||+|++..++..||+|++...... .....+.+|+.++++++||||+++++++..++..|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 5699999999999999999999999999999998754322 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+.+ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 84 ~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 84 YLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred CCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 9985 999988644 24689999999999999999999999999999999999999999999999999987554333334
Q ss_pred cccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC-------------------
Q 000535 178 SVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP------------------- 237 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp------------------- 237 (1437)
...|++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 5678999999999865 56889999999999999999999999876665554443321100
Q ss_pred ----------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 ----------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 ----------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.....+++++.+||.+||.+||.+|||+.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0113568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=384.94 Aligned_cols=256 Identities=30% Similarity=0.469 Sum_probs=212.4
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CeEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR-----SHLH 93 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd-----~~LY 93 (1437)
+|++.+.||+|+||.||+|++..++..||||++............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999875443444556788999999999999999999988543 3589
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+|||||. ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 9999995 6999998744 469999999999999999999999999999999999999999999999999998653322
Q ss_pred c---ccccccCCCccCChhhhhc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhh---------------
Q 000535 174 V---NTHSVVGTPYWMAPEVIEM--SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ--------------- 233 (1437)
Q Consensus 174 ~---kt~t~~GTp~YmAPEVL~g--~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq--------------- 233 (1437)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1 1234679999999999876 5789999999999999999999999977554332211110
Q ss_pred ------------cCCCC---CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 234 ------------DERPP---IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 234 ------------~~rpp---iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
....+ ..+.+++++.++|.+||..||++||++.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00001 113568889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=387.68 Aligned_cols=249 Identities=28% Similarity=0.490 Sum_probs=219.7
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCH
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL 104 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL 104 (1437)
||+|+||.||+|++..+++.||+|++..... .......+.+|+.++++++||||+++++++...+.+|+|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999999999999999976432 334566788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCCCc
Q 000535 105 ANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY 184 (1437)
Q Consensus 105 ~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~ 184 (1437)
.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+.
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 9999753 57999999999999999999999999999999999999999999999999999865443334445789999
Q ss_pred cCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCC-
Q 000535 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP- 263 (1437)
Q Consensus 185 YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRP- 263 (1437)
|+|||++.+..++.++|||||||++|+|++|.+||........... +......++..+++++.+||.+||.+||.+||
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK-ILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH-HHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999999999999999999999999999999987655444444 34445667888999999999999999999997
Q ss_pred --CHHHHhcCHHHHHH
Q 000535 264 --DAKTLLSHPWIQNC 277 (1437)
Q Consensus 264 --SAeELLkHPWFQe~ 277 (1437)
++.++++||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 58999999999753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=392.77 Aligned_cols=257 Identities=29% Similarity=0.510 Sum_probs=222.2
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++.++.++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999999999999999999865432 344566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-- 174 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-- 174 (1437)
|||++|+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999999754 5799999999999999999999999999999999999999999999999999876432110
Q ss_pred ------------------------------------ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCC
Q 000535 175 ------------------------------------NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPP 218 (1437)
Q Consensus 175 ------------------------------------kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpP 218 (1437)
...+.+||+.|+|||++....++.++|||||||++|+|++|.+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 11135799999999999999999999999999999999999999
Q ss_pred CCCCCChhHHHHHhhcCC-CCCC--CCCCHHHHHHHHHHhhhcccCCCC---HHHHhcCHHHHHH
Q 000535 219 YYELQPMPALFRIVQDER-PPIP--ESLSPDITDFLRQCFKKDARQRPD---AKTLLSHPWIQNC 277 (1437)
Q Consensus 219 F~g~d~~eqL~kIiq~~r-ppiP--~~ISpELkDLIrkCLqkDPeKRPS---AeELLkHPWFQe~ 277 (1437)
|...+..+....+..... ..++ ..+++++.+||.+||. +|.+|++ +.+++.||||...
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 988776666665554321 2222 3579999999999997 9999998 9999999999654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=386.82 Aligned_cols=254 Identities=27% Similarity=0.487 Sum_probs=221.3
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCeEEEE
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLL---KNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkIL---rrLnHPNIVKLigVfedd~~LYLV 95 (1437)
|++.+.||+|+||.||+|.+..+++.||||++++.... ....+.+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999865422 23456677777665 466899999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
||||++|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 999999999998863 46999999999999999999999999999999999999999999999999998765433333
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
....+|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. .....|..+++++.++|.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-DEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHHh
Confidence 4467899999999999999999999999999999999999999987666555555443 345577789999999999999
Q ss_pred hhcccCCC-----CHHHHhcCHHHHHH
Q 000535 256 KKDARQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 256 qkDPeKRP-----SAeELLkHPWFQe~ 277 (1437)
.+||.+|| ++.++++||||+..
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999 79999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=388.42 Aligned_cols=254 Identities=28% Similarity=0.525 Sum_probs=222.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||.||+|++..+++.||+|++.+..... .....+.+|+.+++.++||||+++++++...++.|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654332 34566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YA 155 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---cc
Confidence 999999999999744 5799999999999999999999999999999999999999999999999999987644 23
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC---CCCC----CCCCHHHHH
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER---PPIP----ESLSPDITD 249 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r---ppiP----~~ISpELkD 249 (1437)
...+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+..... .+.. ..+++++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 456899999999999999999999999999999999999999988766555544433211 1111 256899999
Q ss_pred HHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
||.+||..+|.+||++.++++||||..
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=395.08 Aligned_cols=258 Identities=28% Similarity=0.531 Sum_probs=219.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
..|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+++|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 368999999999999999999999999999999986543 3345677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC---
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--- 173 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd--- 173 (1437)
|||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999999754 579999999999999999999999999999999999999999999999999986431100
Q ss_pred --------------------------------------------cccccccCCCccCChhhhhcCCCCccchhhhHHHHH
Q 000535 174 --------------------------------------------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTV 209 (1437)
Q Consensus 174 --------------------------------------------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~IL 209 (1437)
....+.+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001245799999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCChhHHHHHhhcC-CCCCC--CCCCHHHHHHHHHHhh--hcccCCCCHHHHhcCHHHHHH
Q 000535 210 IELLTCVPPYYELQPMPALFRIVQDE-RPPIP--ESLSPDITDFLRQCFK--KDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 210 YELLTGkpPF~g~d~~eqL~kIiq~~-rppiP--~~ISpELkDLIrkCLq--kDPeKRPSAeELLkHPWFQe~ 277 (1437)
|+|++|.+||...+..+...++.... ...++ ..+++++.+||.+|+. .+|..||++.++++||||++.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999998877666555554322 22233 3689999999999664 455559999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=380.40 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=213.5
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|++.+.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.++...|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999998754322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+. ++|.+++... .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 83 EYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred ECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 9996 5888887654 3569999999999999999999999999999999999999999999999999997654333333
Q ss_pred ccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhH-HHHHhhcCCCC----------------
Q 000535 177 HSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPA-LFRIVQDERPP---------------- 238 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eq-L~kIiq~~rpp---------------- 238 (1437)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...... +..+......+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 45678999999999865 4578899999999999999999999987554322 22221100000
Q ss_pred ------CC---------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 239 ------IP---------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 239 ------iP---------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
.+ ..+++.+.+||.+||++||.+|||+.++++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 1245788999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=394.19 Aligned_cols=257 Identities=28% Similarity=0.513 Sum_probs=220.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
+.|++.+.||+|+||.||+|++..+++.||+|++.+.... ......+.+|+.+|++++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999998754332 234566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC----
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA---- 172 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es---- 172 (1437)
|||++|+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999999754 57999999999999999999999999999999999999999999999999998533100
Q ss_pred ---------------------------------------CcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHH
Q 000535 173 ---------------------------------------DVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELL 213 (1437)
Q Consensus 173 ---------------------------------------d~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELL 213 (1437)
.......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00012357999999999999999999999999999999999
Q ss_pred hCCCCCCCCCChhHHHHHhhcC---CCCCCCCCCHHHHHHHHHHhhhcccCCC---CHHHHhcCHHHHHH
Q 000535 214 TCVPPYYELQPMPALFRIVQDE---RPPIPESLSPDITDFLRQCFKKDARQRP---DAKTLLSHPWIQNC 277 (1437)
Q Consensus 214 TGkpPF~g~d~~eqL~kIiq~~---rppiP~~ISpELkDLIrkCLqkDPeKRP---SAeELLkHPWFQe~ 277 (1437)
+|++||......+...++.... ..+....+++++.++|.+|+ .+|.+|+ ++.++++||||+..
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999998877666555554322 12233468999999999987 5999999 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=393.27 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=220.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||+||+|++..+++.||+|++.+.... ......+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999999999999999999765432 344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-- 174 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-- 174 (1437)
|||+||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999999754 5799999999999999999999999999999999999999999999999999976532110
Q ss_pred ---------------------------------ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 000535 175 ---------------------------------NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYE 221 (1437)
Q Consensus 175 ---------------------------------kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g 221 (1437)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 01246899999999999999999999999999999999999999988
Q ss_pred CCChhHHHHHhhcC-CCCCC--CCCCHHHHHHHHHHhhhccc---CCCCHHHHhcCHHHHHH
Q 000535 222 LQPMPALFRIVQDE-RPPIP--ESLSPDITDFLRQCFKKDAR---QRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 222 ~d~~eqL~kIiq~~-rppiP--~~ISpELkDLIrkCLqkDPe---KRPSAeELLkHPWFQe~ 277 (1437)
....+...++.... ...+| ..++++++++|.+|+. +|. .||+++++++||||+..
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 77766666665432 22233 3478999999999775 444 46899999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=386.12 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=220.2
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
+.||+|+||.||+|++..+|..||+|++..... .......+.+|+.+++.++||||+++++++..++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 468999999999999999999999999986543 2345566788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCC
Q 000535 103 SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT 182 (1437)
Q Consensus 103 SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GT 182 (1437)
+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 999988744 579999999999999999999999999999999999999999999999999997644333334457899
Q ss_pred CccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCC
Q 000535 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262 (1437)
Q Consensus 183 p~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKR 262 (1437)
+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+ ......+|..+++++.++|.+||.+||.+|
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 9999999999889999999999999999999999999876655444443 334456778899999999999999999999
Q ss_pred C-----CHHHHhcCHHHHHH
Q 000535 263 P-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 263 P-----SAeELLkHPWFQe~ 277 (1437)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 8 89999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=362.04 Aligned_cols=256 Identities=31% Similarity=0.585 Sum_probs=233.0
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|.+.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 48899999999999999999999999999999987666667778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+++++|.+++.......+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..+.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 99999999998765678999999999999999999999999999999999999999999999999999877654434445
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhc
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkD 258 (1437)
..|++.|+|||++....++.++|+|||||++|+|++|..||...+.......+.....++++..++.++.++|.+||..+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCC
Confidence 67899999999999989999999999999999999999999887766666666666667777789999999999999999
Q ss_pred ccCCCCHHHHhcCHHH
Q 000535 259 ARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 259 PeKRPSAeELLkHPWF 274 (1437)
|++||++.+++.|||+
T Consensus 241 p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 241 YRQRPDTFQLLRNPSL 256 (256)
T ss_pred cccCcCHHHHhhCCCC
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=420.77 Aligned_cols=255 Identities=39% Similarity=0.733 Sum_probs=238.6
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
...|...+.||+|+-|.||.|+...+++.||||.+.+.... ..+.+..|+.+|+.++|+|||++++.|.-.+.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 35688999999999999999999999999999999876543 3456889999999999999999999998889999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||++||+|.+++... .++|.+++.|++.+++||+|||.+||+|||||.+|||++.+|.+||+|||+|.++.....+.
T Consensus 350 Eym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred eecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 999999999999754 49999999999999999999999999999999999999999999999999999999888788
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCC--CCCCCHHHHHHHHHH
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQC 254 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppi--P~~ISpELkDLIrkC 254 (1437)
.+.+|||+|||||++....|+.++||||||++.+||+.|.+||...++...++.|.....+.+ +..+|+++++|+.+|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 899999999999999999999999999999999999999999999999999999988887664 578999999999999
Q ss_pred hhhcccCCCCHHHHhcCHHHHH
Q 000535 255 FKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 255 LqkDPeKRPSAeELLkHPWFQe 276 (1437)
|+.|+++|+++.|||.||||+.
T Consensus 507 L~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred hhcchhcCCCHHHHhcChhhhh
Confidence 9999999999999999999964
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=393.24 Aligned_cols=256 Identities=28% Similarity=0.476 Sum_probs=218.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|.+++.||+|+||+||+|.+..+++.||||++.+... .....+.+.+|+.++++++||||+++++++.+..++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999999999999999999876432 2345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-- 174 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-- 174 (1437)
|||+||+|.+++... +.+++..++.|+.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999999743 5799999999999999999999999999999999999999999999999999964321100
Q ss_pred ---------------------------------------------ccccccCCCccCChhhhhcCCCCccchhhhHHHHH
Q 000535 175 ---------------------------------------------NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTV 209 (1437)
Q Consensus 175 ---------------------------------------------kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~IL 209 (1437)
.....+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00125799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCChhHHHHHhhcC-CCCCC--CCCCHHHHHHHHHHhhhcccCC---CCHHHHhcCHHHHH
Q 000535 210 IELLTCVPPYYELQPMPALFRIVQDE-RPPIP--ESLSPDITDFLRQCFKKDARQR---PDAKTLLSHPWIQN 276 (1437)
Q Consensus 210 YELLTGkpPF~g~d~~eqL~kIiq~~-rppiP--~~ISpELkDLIrkCLqkDPeKR---PSAeELLkHPWFQe 276 (1437)
|+|++|.+||......+....+.... ...+| ..++.++.+||.+||. +|.+| +++.+++.||||+.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999999998877666555554322 22233 3589999999999998 66665 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=385.57 Aligned_cols=258 Identities=27% Similarity=0.467 Sum_probs=223.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|.+.+.||+|+||+||+|.+..+++.||+|+++.... .......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 469999999999999999999999999999999986544 2345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-c
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-N 175 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-k 175 (1437)
|||++|+|.+++... .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+..... .
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 999999999999754 25799999999999999999999999999999999999999999999999999987654332 2
Q ss_pred cccccCCCccCChhhhh------cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC---CCCCCCCCHH
Q 000535 176 THSVVGTPYWMAPEVIE------MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER---PPIPESLSPD 246 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~------g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r---ppiP~~ISpE 246 (1437)
.....||+.|+|||++. ...++.++|||||||++|+|++|..||........+.++..... .+....++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 23357999999999986 45678899999999999999999999988776666666554322 1223468999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+.+||.+||. +|.+||++.++++||||...
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999999998 99999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=401.09 Aligned_cols=261 Identities=35% Similarity=0.622 Sum_probs=235.1
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
...|++.++||.|.-++||+|++..++..||||++..+..... .+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 5689999999999999999999999999999999998765544 889999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc-
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN- 175 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k- 175 (1437)
.||.+||+.++++..-...|+|..+..|++++++||.|||++|.+|||||+.||||+.+|.|||+|||....+...+..
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 9999999999998765556999999999999999999999999999999999999999999999999998665443321
Q ss_pred --c-ccccCCCccCChhhhh--cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC-----CC----C
Q 000535 176 --T-HSVVGTPYWMAPEVIE--MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP-----IP----E 241 (1437)
Q Consensus 176 --t-~t~~GTp~YmAPEVL~--g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp-----iP----~ 241 (1437)
. .+++||++|||||++. ..+|+.|+||||||++..||.+|..||....+.+.+...+++..+. ++ +
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k 263 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDK 263 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhh
Confidence 1 4679999999999964 4579999999999999999999999999999999998888877652 11 3
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 242 ~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
.++..+..+|..||.+||.+|||+.++|+|+||++.+
T Consensus 264 ~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 264 KFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 4678899999999999999999999999999998764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=387.98 Aligned_cols=250 Identities=28% Similarity=0.487 Sum_probs=220.1
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.+.||||+++++++..++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999986543 2345667889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCC
Q 000535 103 SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT 182 (1437)
Q Consensus 103 SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GT 182 (1437)
+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 999998744 579999999999999999999999999999999999999999999999999997644333334456899
Q ss_pred CccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCC
Q 000535 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262 (1437)
Q Consensus 183 p~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKR 262 (1437)
+.|+|||++.+..++.++|||||||++|+|++|..||...+...... .+......+|..+++++.+||.+||.+||.+|
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-LILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH-HhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999998899999999999999999999999998765544433 33444556788899999999999999999999
Q ss_pred C-----CHHHHhcCHHHHH
Q 000535 263 P-----DAKTLLSHPWIQN 276 (1437)
Q Consensus 263 P-----SAeELLkHPWFQe 276 (1437)
| ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=393.88 Aligned_cols=257 Identities=28% Similarity=0.549 Sum_probs=221.0
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.+|.+++.||+|+||+||+|++..+++.||+|++.+... .......+.+|+.++++++||||+++++++.+++++|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 369999999999999999999999999999999976433 2345667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC---
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--- 173 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd--- 173 (1437)
|||++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999999754 579999999999999999999999999999999999999999999999999975331000
Q ss_pred --------------------------------------------cccccccCCCccCChhhhhcCCCCccchhhhHHHHH
Q 000535 174 --------------------------------------------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTV 209 (1437)
Q Consensus 174 --------------------------------------------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~IL 209 (1437)
....+.+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCChhHHHHHhhcC-C--CCCCCCCCHHHHHHHHHHhhhcccCCCC---HHHHhcCHHHHHH
Q 000535 210 IELLTCVPPYYELQPMPALFRIVQDE-R--PPIPESLSPDITDFLRQCFKKDARQRPD---AKTLLSHPWIQNC 277 (1437)
Q Consensus 210 YELLTGkpPF~g~d~~eqL~kIiq~~-r--ppiP~~ISpELkDLIrkCLqkDPeKRPS---AeELLkHPWFQe~ 277 (1437)
|+|++|++||...+..+...++.... . .+....+++++.++|.+|+ .+|.+|++ +.++++||||+..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999998877766666655432 1 2233568999999999987 59999997 9999999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=409.83 Aligned_cols=262 Identities=34% Similarity=0.593 Sum_probs=250.8
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe-EEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH-LHII 95 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~-LYLV 95 (1437)
.++|..++.+|+|+||.++.++++.+++.|++|.|......+........|+.+++++.|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999999999999999999999888888899999999999999999999999988877 9999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|+||+||+|.+.|+..++..|+|+.+..|+.|++.|+.|||++.|+|||||+.|||++.++.|+|+|||+|+.+.+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 99999999999999888889999999999999999999999999999999999999999999999999999999887756
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
..+++|||.||+||++.+.+|+.++|||||||++|||++-+++|...+......++......|+|..++.+++.+|+.||
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l 242 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSML 242 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHh
Confidence 77899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCHHHHhcCHHHHHHH
Q 000535 256 KKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 256 qkDPeKRPSAeELLkHPWFQe~r 278 (1437)
.++|+.||++.++|.+|.++...
T Consensus 243 ~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 243 RKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred hcCCccCCCHHHHhhChhhhhHH
Confidence 99999999999999999998655
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=361.55 Aligned_cols=256 Identities=31% Similarity=0.579 Sum_probs=228.1
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCeEEEEEe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT-RSHLHIILE 97 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed-d~~LYLVME 97 (1437)
.|++.+.||+|+||.||++.+..+++.||+|.+..........+.+.+|+.++++++|||++++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4999999999999999999999999999999998766666667778999999999999999999998864 557899999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++++|.+++.......+++..++.++.|++.+|.|||++||+||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999999876566799999999999999999999999999999999999999999999999999987654333334
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqk 257 (1437)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.....+..+..+++++.++|.+||..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSK 240 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhcc
Confidence 56789999999999998899999999999999999999999987665555556656556667778999999999999999
Q ss_pred cccCCCCHHHHhcCHHH
Q 000535 258 DARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 258 DPeKRPSAeELLkHPWF 274 (1437)
+|++||++.++++||||
T Consensus 241 ~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 241 RPEKRPSVKSILRQPYI 257 (257)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=386.41 Aligned_cols=251 Identities=27% Similarity=0.492 Sum_probs=219.4
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||.||+|++..+++.||+|++++.... ....+.+.+|+.+++.+ +||||+++++++.++..+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999875443 34456788999999998 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... +++++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 9999988644 57999999999999999999999999999999999999999999999999999754333333446789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------ChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQ--------PMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d--------~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+.+.+.+......+|..++.++.++|.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 238 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKG 238 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999996321 223345555566667888899999999999
Q ss_pred HhhhcccCCCC------HHHHhcCHHHHH
Q 000535 254 CFKKDARQRPD------AKTLLSHPWIQN 276 (1437)
Q Consensus 254 CLqkDPeKRPS------AeELLkHPWFQe 276 (1437)
||.+||.+|++ +.++++||||..
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 239 FLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999987 799999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=383.47 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=223.0
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCeEEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHK-NIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHP-NIVKLigVfedd~~LYLVM 96 (1437)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+..|+.++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986543 234556788899999999765 5888999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 999999999999744 579999999999999999999999999999999999999999999999999987543333334
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
...+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+. .....+|..+++++.++|.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-EHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCHHHHHHHHHHhh
Confidence 45689999999999999999999999999999999999999998776655555444 44556778899999999999999
Q ss_pred hcccCCCCH-----HHHhcCHHHHH
Q 000535 257 KDARQRPDA-----KTLLSHPWIQN 276 (1437)
Q Consensus 257 kDPeKRPSA-----eELLkHPWFQe 276 (1437)
+||.+|++. .++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999976 89999999965
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=389.87 Aligned_cols=258 Identities=29% Similarity=0.530 Sum_probs=226.4
Q ss_pred ccccCCceEEEeEecccCcEEEEEEEEcCCC-eEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 000535 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENG-DFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 13 gktLggRYeIlEvLGrGgFGtVYKArDrkTG-k~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~ 90 (1437)
.+.-.++|.+.+.||+|+||.||+|.+..++ ..||+|++.+... .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3344568999999999999999999876654 7899999875443 2345567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
.+|+|||||.+|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999999999754 579999999999999999999999999999999999999999999999999998764
Q ss_pred cCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHH
Q 000535 171 EADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 171 esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDL 250 (1437)
.. ..+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+......++. .....+|..+++++.++
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL-EGIIYFPKFLDNNCKHL 258 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCHHHHHH
Confidence 32 345689999999999999889999999999999999999999998876655545544 34456778899999999
Q ss_pred HHHHhhhcccCCC-----CHHHHhcCHHHHH
Q 000535 251 LRQCFKKDARQRP-----DAKTLLSHPWIQN 276 (1437)
Q Consensus 251 IrkCLqkDPeKRP-----SAeELLkHPWFQe 276 (1437)
|++||+.||++|+ +++++++||||++
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999995 8999999999975
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=385.55 Aligned_cols=250 Identities=28% Similarity=0.509 Sum_probs=219.4
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
+.||+|+||.||+|.+..+++.||+|++.+.... ......+..|+.+++.++||||+++++++..++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999999999999999999865432 334566788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 103 SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 103 SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
+|.+++... +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 999988743 579999999999999999999997 79999999999999999999999999999765433333445689
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.... .+.+......+|..+++++.+||.+||++||++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999999999999999999999987655443 344444556677889999999999999999999
Q ss_pred CC-----CHHHHhcCHHHHH
Q 000535 262 RP-----DAKTLLSHPWIQN 276 (1437)
Q Consensus 262 RP-----SAeELLkHPWFQe 276 (1437)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 9999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=372.50 Aligned_cols=252 Identities=25% Similarity=0.451 Sum_probs=216.3
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCH
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL 104 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL 104 (1437)
||+|+||+||+|.+..+++.||+|++....... ...+.+..|+.+++.++||||+++.+++..+..+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999999999999999987654332 2345678899999999999999999999999999999999999999
Q ss_pred HHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCC
Q 000535 105 ANIIKP--NKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT 182 (1437)
Q Consensus 105 ~DLLKs--sr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GT 182 (1437)
.+++.. .....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+...........||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 988743 233569999999999999999999999999999999999999999999999999998766544444456899
Q ss_pred CccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChh---HHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcc
Q 000535 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMP---ALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259 (1437)
Q Consensus 183 p~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~e---qL~kIiq~~rppiP~~ISpELkDLIrkCLqkDP 259 (1437)
+.|+|||++.+..++.++|||||||++|+|++|+.||....... ............++..+++++.+++.+||+.||
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 240 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence 99999999999999999999999999999999999997644322 222222233445667899999999999999999
Q ss_pred cCCC-----CHHHHhcCHHHHHH
Q 000535 260 RQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 260 eKRP-----SAeELLkHPWFQe~ 277 (1437)
++|| +++++++||||+..
T Consensus 241 ~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 241 EKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHhcCCCCCCHHHHhcChhhhcC
Confidence 9999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=382.49 Aligned_cols=256 Identities=30% Similarity=0.517 Sum_probs=219.4
Q ss_pred ceEEEeEecccCcEEEEEEEEc---CCCeEEEEEEeeccccC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDL---ENGDFVAIKQVSLENIA--QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDr---kTGk~VAIKVIkke~lS--eedie~L~REIkILrrL-nHPNIVKLigVfedd~~L 92 (1437)
+|++.+.||+|+||.||+|++. .+++.||+|++.+.... ....+.+..|+.+++.+ .||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999999754322 23345678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
|+|||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999999754 56999999999999999999999999999999999999999999999999999865433
Q ss_pred C-cccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCC---ChhHHHHHhhcCCCCCCCCCCHHH
Q 000535 173 D-VNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQ---PMPALFRIVQDERPPIPESLSPDI 247 (1437)
Q Consensus 173 d-~kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d---~~eqL~kIiq~~rppiP~~ISpEL 247 (1437)
. ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ....+.+.+....++++..+++.+
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence 2 223356899999999999865 47889999999999999999999996432 233344444455667788899999
Q ss_pred HHHHHHHhhhcccCCC-----CHHHHhcCHHHHH
Q 000535 248 TDFLRQCFKKDARQRP-----DAKTLLSHPWIQN 276 (1437)
Q Consensus 248 kDLIrkCLqkDPeKRP-----SAeELLkHPWFQe 276 (1437)
.++|.+||..||++|| ++.++++||||+.
T Consensus 239 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=379.52 Aligned_cols=257 Identities=32% Similarity=0.530 Sum_probs=219.5
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
..++|++.+.||+|+||.||+|++..++..||+|++.... .....+.+.+|+.+|++++||||+++++++..++.+|+|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3578999999999999999999999999999999987543 344556789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSn-GIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred eecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999999754 4699999999999999999999986 6999999999999999999999999999876443
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHH------------------------
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFR------------------------ 230 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~k------------------------ 230 (1437)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 23346799999999999988999999999999999999999999965443221110
Q ss_pred ----------------------HhhcCCCCCC-CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 231 ----------------------IVQDERPPIP-ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 231 ----------------------Iiq~~rppiP-~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+.....+..+ ..+++++.+||.+||.+||++|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 1111111221 2478899999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=369.82 Aligned_cols=254 Identities=31% Similarity=0.471 Sum_probs=212.5
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----CC
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL---NHKNIVKYLGSLKT-----RS 90 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL---nHPNIVKLigVfed-----d~ 90 (1437)
+|++.+.||+|+||+||+|++..+++.||+|.+..............+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999999876543332233455677777665 79999999998864 35
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
.+++||||+.+ +|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 68999999985 89999876655669999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--------------
Q 000535 171 EADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------------- 236 (1437)
Q Consensus 171 esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-------------- 236 (1437)
... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||......+.+.++.....
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 160 CQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred Ccc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 432 23346789999999999988999999999999999999999999987766555554432110
Q ss_pred ------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 ------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 ------------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
....+.++.++.++|.+||.+||++|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00123577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=383.52 Aligned_cols=250 Identities=32% Similarity=0.564 Sum_probs=219.3
Q ss_pred eEecccCcEEEEEEEEc---CCCeEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 24 DEIGKGAYGRVYKGLDL---ENGDFVAIKQVSLENIA--QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDr---kTGk~VAIKVIkke~lS--eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+.||+|+||.||+|++. .+++.||+|++...... ......+..|+.+|++++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999864 46899999999864332 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence 9999999999754 57899999999999999999999999999999999999999999999999999765444434455
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhc
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkD 258 (1437)
.+||+.|+|||++.+..++.++|||||||++|+|++|++||...+......++.. ....++..+++++.+||.+||.++
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-GKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHcccC
Confidence 7899999999999988899999999999999999999999988766655555544 345677889999999999999999
Q ss_pred ccCCC-----CHHHHhcCHHHHH
Q 000535 259 ARQRP-----DAKTLLSHPWIQN 276 (1437)
Q Consensus 259 PeKRP-----SAeELLkHPWFQe 276 (1437)
|++|| ++.++++||||..
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCC
Confidence 99999 8999999999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=382.12 Aligned_cols=250 Identities=28% Similarity=0.462 Sum_probs=219.4
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||.||+|++..+++.||+|++.+.... ......+..|+.++..+ +||||+++++++..++.+|+|||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999865432 34456677899998876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|...+... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 9999998744 57999999999999999999999999999999999999999999999999999865444334455789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|++||...+..+.+..+.. .....|..+++++.++|.+||.+||++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-DDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999998999999999999999999999999988776665555544 344566778999999999999999999
Q ss_pred CC-------CHHHHhcCHHHHH
Q 000535 262 RP-------DAKTLLSHPWIQN 276 (1437)
Q Consensus 262 RP-------SAeELLkHPWFQe 276 (1437)
|| ++.++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=411.35 Aligned_cols=256 Identities=32% Similarity=0.567 Sum_probs=228.7
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--SHLHII 95 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd--~~LYLV 95 (1437)
+.|+.++.||+|+||.||+|++..+|+.||+|++......+.......|||.||++|+||||++|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 458889999999999999999999999999999998887777777889999999999999999999988776 799999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
+|||+. +|.-++.. +.-.|++.++..|++||+.||+|||++||+|||||.+||||+.+|.+||+|||+|+++......
T Consensus 197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 999987 89888864 4467999999999999999999999999999999999999999999999999999987765533
Q ss_pred -cccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC---------CC----
Q 000535 176 -THSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---------IP---- 240 (1437)
Q Consensus 176 -t~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp---------iP---- 240 (1437)
....+-|.+|+|||.+.+. .|+.++|+||+||||.||+.|++.|.+.++.+++..|.+....| +|
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 3456789999999998765 69999999999999999999999999999999999887632111 11
Q ss_pred ---------------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 241 ---------------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 241 ---------------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
..+++...+|+..||..||.+|.|+.++|.++||.
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 24578899999999999999999999999999994
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=402.51 Aligned_cols=261 Identities=33% Similarity=0.578 Sum_probs=238.0
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTR 89 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLn-HPNIVKLigVfedd 89 (1437)
....+...|.+.+.||+|.||.||+|+++.+|+.||+|++.+..... ...+.+.+|+.+|+++. |||||.++++|++.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 34567788999999999999999999999999999999998876543 35678999999999998 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC----CcEEEEeccc
Q 000535 90 SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE----GLVKLADFGV 165 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden----G~VKLiDFGL 165 (1437)
..+|+|||+|.||+|++.+... .++|..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++|||+
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 9999999999999999999865 39999999999999999999999999999999999999643 4799999999
Q ss_pred ccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC---CCCCCCC
Q 000535 166 ATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RPPIPES 242 (1437)
Q Consensus 166 Ar~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~---rppiP~~ 242 (1437)
+..... .....+.|||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+......++.... ..+.+..
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 999887 556778999999999999999999999999999999999999999999998888888777664 3455678
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
++..++++|+.||..||.+|+|+.++|+|||++.
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 8999999999999999999999999999999864
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=383.32 Aligned_cols=251 Identities=28% Similarity=0.474 Sum_probs=219.4
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||+||+|++..+++.||+|++.+... .....+.+..|+.++..+ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999976532 234456677888888877 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 9999998754 57999999999999999999999999999999999999999999999999999865433334455789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+ ......++..++.++.++|.+||.+||.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-LNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 99999999999999999999999999999999999999876655544444 44455667789999999999999999999
Q ss_pred CCCH------HHHhcCHHHHHH
Q 000535 262 RPDA------KTLLSHPWIQNC 277 (1437)
Q Consensus 262 RPSA------eELLkHPWFQe~ 277 (1437)
||++ +++++||||...
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCCC
Confidence 9998 999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=396.59 Aligned_cols=261 Identities=28% Similarity=0.512 Sum_probs=239.4
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
.-|.++|.+-++||+|.|+.||++.+..+|..+|+|+|....++..+.+.+.+|+.|-+.|+|||||++++.+.+.++.|
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 35678899999999999999999999999999999999988888889999999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC---cEEEEecccccccc
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG---LVKLADFGVATKLT 170 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG---~VKLiDFGLAr~L~ 170 (1437)
||+|++.|++|..-|..+ ..++|..+-.+++||+++|.|+|.+||||||+||+|+++-... .+||+|||+|..+.
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999998777644 4689999999999999999999999999999999999996432 69999999999988
Q ss_pred cCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC---CCCCCCCCCHHH
Q 000535 171 EADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RPPIPESLSPDI 247 (1437)
Q Consensus 171 esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~---rppiP~~ISpEL 247 (1437)
++....+.+|||.|||||+++..+|+..+|||+.|+|||-|+.|++||++.+....+.+|.++. .++.++.+++++
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 5556678899999999999999999999999999999999999999999988777777777654 445778999999
Q ss_pred HHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 248 kDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
++||++||..||.+|.|+.|+|+|||+.+.
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999764
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=380.87 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=223.0
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVM 96 (1437)
+|.+.+.||+|+||.||+|++..+++.||+|++.+.... ....+.+..|..++..+ .||+|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999865432 23445567788888877 5899999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++|+|.+.+... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 999999999998744 579999999999999999999999999999999999999999999999999998654433344
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..++.++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-EHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCCcCCHHHHHHHHHHcc
Confidence 56789999999999999999999999999999999999999998876655555444 44456778899999999999999
Q ss_pred hcccCCCC-----HHHHhcCHHHHH
Q 000535 257 KDARQRPD-----AKTLLSHPWIQN 276 (1437)
Q Consensus 257 kDPeKRPS-----AeELLkHPWFQe 276 (1437)
++|.+|++ ..++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999997 489999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=379.45 Aligned_cols=251 Identities=27% Similarity=0.525 Sum_probs=217.1
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||.||+|++..+++.||+|+++..... ....+.+..|..++..+ +||||+++++++..++++|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999865432 23445566677777654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... +.+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 9999999754 57999999999999999999999999999999999999999999999999999865443334445789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.... +....+.++..++.++.+||.+||..+|.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS-ILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999998999999999999999999999999988665544444 444566778889999999999999999999
Q ss_pred CCCH-HHHhcCHHHHHH
Q 000535 262 RPDA-KTLLSHPWIQNC 277 (1437)
Q Consensus 262 RPSA-eELLkHPWFQe~ 277 (1437)
||++ .++++||||...
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 238 RLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 9986 589999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=362.49 Aligned_cols=253 Identities=38% Similarity=0.639 Sum_probs=217.1
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999987655555555667999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccc
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV 179 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~ 179 (1437)
.+++|.+++. ..+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+.............
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999998 33579999999999999999999999999999999999999999999999999998653333344567
Q ss_pred cCCCccCChhhhh-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHH---hhcC---CCCCCCCCCHHHHHHHH
Q 000535 180 VGTPYWMAPEVIE-MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI---VQDE---RPPIPESLSPDITDFLR 252 (1437)
Q Consensus 180 ~GTp~YmAPEVL~-g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kI---iq~~---rppiP~~ISpELkDLIr 252 (1437)
.+++.|+|||++. ...++.++||||||+++|+|++|..||...........+ .... ........+.++.++|.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 238 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK 238 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence 8899999999998 788999999999999999999999999876322222222 1111 01111223489999999
Q ss_pred HHhhhcccCCCCHHHHhcCHHH
Q 000535 253 QCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkHPWF 274 (1437)
+||..||++||++.++++||||
T Consensus 239 ~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 239 KMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=382.38 Aligned_cols=252 Identities=28% Similarity=0.497 Sum_probs=218.9
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||.||+|++..+++.||+|++.+.... ......+.+|+.++.++ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876433 34556788899998877 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|..++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 9999988644 57999999999999999999999999999999999999999999999999999764433333445789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCC--------CChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYEL--------QPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~--------d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|..||... .....+.+.+......+|..++.++.++|.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~ 238 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS 238 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999531 1223344555556667888999999999999
Q ss_pred HhhhcccCCCC------HHHHhcCHHHHHH
Q 000535 254 CFKKDARQRPD------AKTLLSHPWIQNC 277 (1437)
Q Consensus 254 CLqkDPeKRPS------AeELLkHPWFQe~ 277 (1437)
||.+||.+||+ +.++++||||++.
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 239 FLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999998 5899999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=370.58 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=222.6
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH-HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE-DLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee-die~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.|++.+.||+|+||+||++.+..+++.||+|++........ ....+.+|+.+++.++||||+++++++..++++|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976543322 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++|+|.+++.......+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccc
Confidence 9999999998875545679999999999999999999999999999999999999999999999999998764332 223
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHH---HHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPAL---FRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL---~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
..+|++.|+|||++.+..++.++||||+||++|+|++|..||.+....... ...+......++..++..+.+||.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 457999999999999888999999999999999999999999875543322 22233344456677999999999999
Q ss_pred hhhcccCCC-----CHHHHhcCHHHHH
Q 000535 255 FKKDARQRP-----DAKTLLSHPWIQN 276 (1437)
Q Consensus 255 LqkDPeKRP-----SAeELLkHPWFQe 276 (1437)
|..||.+|| +++++++||||..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=382.16 Aligned_cols=250 Identities=30% Similarity=0.507 Sum_probs=220.4
Q ss_pred eEecccCcEEEEEEEEc---CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecC
Q 000535 24 DEIGKGAYGRVYKGLDL---ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDr---kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYce 100 (1437)
+.||+|+||.||++.+. .+|+.||+|++........+...+..|+.++++++||||+++++++.+++.+|+|||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 67999999999999863 578999999998765444455667889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccccc
Q 000535 101 NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180 (1437)
Q Consensus 101 GGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~ 180 (1437)
+|+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence 99999998643 5799999999999999999999999999999999999999999999999999987654433445678
Q ss_pred CCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhccc
Q 000535 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260 (1437)
Q Consensus 181 GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPe 260 (1437)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ....+|..+++++.+||.+||++||+
T Consensus 160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-AKLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 99999999999988899999999999999999999999987666555554443 34567778999999999999999999
Q ss_pred CCCC-----HHHHhcCHHHHH
Q 000535 261 QRPD-----AKTLLSHPWIQN 276 (1437)
Q Consensus 261 KRPS-----AeELLkHPWFQe 276 (1437)
+||+ +.++++||||+.
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCC
Confidence 9999 788999999965
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=381.82 Aligned_cols=256 Identities=29% Similarity=0.425 Sum_probs=215.7
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR----- 89 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd----- 89 (1437)
.+.++|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 577899999999999999999999999999999999976655555667788999999999999999999998654
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 90 -SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 90 -~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
..+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 357999999975 6777664 3489999999999999999999999999999999999999999999999999986
Q ss_pred cccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-------------
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE------------- 235 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~------------- 235 (1437)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 173 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 54332 2344678999999999999999999999999999999999999998765543332221110
Q ss_pred --------CCC--------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 236 --------RPP--------------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 236 --------rpp--------------------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.+. .....++++.+||.+||..||++|||+.|+++||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 11224678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.73 Aligned_cols=256 Identities=30% Similarity=0.580 Sum_probs=231.9
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||+|+||.||++.+..+++.|++|.+............+.+|+.++++++||||+++++++...++.|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 59999999999999999999999999999999987655556667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+.+++|.+.+.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 99999999997655557899999999999999999999999999999999999999999999999999876554333334
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhc
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkD 258 (1437)
..|++.|+|||++.+..++.++|+|||||++|+|++|..||......+...++.....++.+..++.++.++|.+||+.+
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCC
Confidence 56899999999998888999999999999999999999999877776667777777777778889999999999999999
Q ss_pred ccCCCCHHHHhcCHHH
Q 000535 259 ARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 259 PeKRPSAeELLkHPWF 274 (1437)
|.+||++.++++||||
T Consensus 241 p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 241 PRDRPSVNSILEKNFI 256 (256)
T ss_pred hhhCcCHHHHhhCcCC
Confidence 9999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=415.99 Aligned_cols=258 Identities=28% Similarity=0.497 Sum_probs=233.7
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrL-nHPNIVKLigVfedd~~LY 93 (1437)
=.++|.++++||+|.||+|++|..+.+++.||||++++... ...+++..+.|..|+... +||.++.++..|+.+.++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 34679999999999999999999999999999999998764 456788899999999888 5999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+.||++..+.+ .+.|+|..++.|+..|+.||+|||++||||||||.+|||+|.+|++||+|||+|+...-.+
T Consensus 446 fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999999655544 3579999999999999999999999999999999999999999999999999999766555
Q ss_pred cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 174 VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
..+.++||||.|||||++.+..|+.++|+|||||+|||||.|.+||.+.+..+. ..-+....+.+|..+|.++.+++++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-FdsI~~d~~~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-FDSIVNDEVRYPRFLSKEAIAIMRR 601 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHhcCCCCCCCcccHHHHHHHHH
Confidence 578899999999999999999999999999999999999999999998665554 4445556678889999999999999
Q ss_pred HhhhcccCCCC-----HHHHhcCHHHHHH
Q 000535 254 CFKKDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 254 CLqkDPeKRPS-----AeELLkHPWFQe~ 277 (1437)
+|+++|++|.. +++|..||||+..
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999985 6899999999875
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.68 Aligned_cols=256 Identities=32% Similarity=0.576 Sum_probs=233.1
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||.|+||.||.+++..++..+++|.+............+.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 69999999999999999999999999999999987776677777889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
|++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 99999999998665567999999999999999999999999999999999999999999999999999877554433345
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhc
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkD 258 (1437)
..|++.|+|||++.+..++.++|+|||||++|+|++|..||......+....+......+.+..++.++.++|.+||.++
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccC
Confidence 67899999999998888899999999999999999999999887777777777766666667788999999999999999
Q ss_pred ccCCCCHHHHhcCHHH
Q 000535 259 ARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 259 PeKRPSAeELLkHPWF 274 (1437)
|.+||++.++++|||+
T Consensus 241 p~~R~s~~~ll~~~~l 256 (256)
T cd08221 241 PEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCCCHHHHhhCcCC
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=379.03 Aligned_cols=251 Identities=25% Similarity=0.502 Sum_probs=217.1
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||.||+|++..+++.||+|++++.... .........|+.++..+ .||||+++++++.+++++|+|||||.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999865422 23445667788888765 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 9999998753 57999999999999999999999999999999999999999999999999999754333333445789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+... +.+.+....+.++..++.++.+||.+||..||++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-LFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999999999999999999999998765443 4444445556677789999999999999999999
Q ss_pred CCCH-HHHhcCHHHHHH
Q 000535 262 RPDA-KTLLSHPWIQNC 277 (1437)
Q Consensus 262 RPSA-eELLkHPWFQe~ 277 (1437)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9997 589999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=411.20 Aligned_cols=257 Identities=42% Similarity=0.708 Sum_probs=241.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
..|...+.||+|+||.||+|.+..+++.||||++..+.. +.+++.+.+|+.+|.+++++||.++|+.+..+..+|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 458888999999999999999999999999999987754 3567889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
||.||++.++++.. ..++|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+.++........
T Consensus 92 y~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999999999844 4569999999999999999999999999999999999999999999999999999988777778
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqk 257 (1437)
+++|||.|||||+++..+|+.++||||||++.|||.+|.|||....++..++-|.+..+|.+...+|+.+++||..||.+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k 249 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDK 249 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999999999999999999999888888888888888889999999999999999
Q ss_pred cccCCCCHHHHhcCHHHHHH
Q 000535 258 DARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 258 DPeKRPSAeELLkHPWFQe~ 277 (1437)
||+.||+|.++|+|+|++..
T Consensus 250 ~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 250 NPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred CcccCcCHHHHhhhHHHHhc
Confidence 99999999999999999863
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=388.62 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=224.8
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~ 90 (1437)
....-.++|++.+.||+|+||.||+|++..+++.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 3334457899999999999999999999999999999999764332 234456788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
++|+|||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999999998643 58999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc-ccccccCCCccCChhhhhcC----CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CCCCC--CC
Q 000535 171 EADV-NTHSVVGTPYWMAPEVIEMS----GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RPPIP--ES 242 (1437)
Q Consensus 171 esd~-kt~t~~GTp~YmAPEVL~g~----~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rppiP--~~ 242 (1437)
.... .....+||+.|+|||++... .++.++|||||||++|+|++|.+||..........++.... ...+| ..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 4322 23356899999999998654 37889999999999999999999998877666666665432 22233 35
Q ss_pred CCHHHHHHHHHHhhhcccC--CCCHHHHhcCHHHHH
Q 000535 243 LSPDITDFLRQCFKKDARQ--RPDAKTLLSHPWIQN 276 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeK--RPSAeELLkHPWFQe 276 (1437)
+|.++.+||.+||..+|.+ |+++.++++||||++
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 8999999999999999998 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=379.31 Aligned_cols=250 Identities=30% Similarity=0.501 Sum_probs=214.6
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEID-LLKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIk-ILrrLnHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||+||+|++..+++.||+|++.+.... ......+..|.. +++.++||||+++++++...+.+|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4689999999999999999999999999765432 223344555554 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 9999998754 57999999999999999999999999999999999999999999999999999765433333445689
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+. .....+++.+++++.++|.+||++||.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL-NKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 999999999999999999999999999999999999998766554444444 3444566778999999999999999999
Q ss_pred CCCH----HHHhcCHHHHH
Q 000535 262 RPDA----KTLLSHPWIQN 276 (1437)
Q Consensus 262 RPSA----eELLkHPWFQe 276 (1437)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9987 69999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=385.60 Aligned_cols=257 Identities=28% Similarity=0.489 Sum_probs=221.5
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
+.|++.+.||+|+||.||+|++..+++.||+|++..... .......+..|+.++.+++||||+++++++.+++++|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 469999999999999999999999999999999975432 2345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC---
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--- 173 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd--- 173 (1437)
|||+||+|.+++... +.+++..++.|+.|++.||+|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999999754 579999999999999999999999999999999999999999999999999987543211
Q ss_pred --------------------------------cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 000535 174 --------------------------------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYE 221 (1437)
Q Consensus 174 --------------------------------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g 221 (1437)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001245799999999999999999999999999999999999999988
Q ss_pred CCChhHHHHHhhcC-CCCCCC--CCCHHHHHHHHHHhhhcccCCC---CHHHHhcCHHHHHH
Q 000535 222 LQPMPALFRIVQDE-RPPIPE--SLSPDITDFLRQCFKKDARQRP---DAKTLLSHPWIQNC 277 (1437)
Q Consensus 222 ~d~~eqL~kIiq~~-rppiP~--~ISpELkDLIrkCLqkDPeKRP---SAeELLkHPWFQe~ 277 (1437)
........++.... ...+|+ .+++++++||.+|+. +|.+|+ ++.++++||||+..
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 77776666665422 222332 478999999999874 999998 58999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=382.90 Aligned_cols=256 Identities=29% Similarity=0.408 Sum_probs=217.2
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR----- 89 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd----- 89 (1437)
.+.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 467899999999999999999999999999999999986655555667788999999999999999999987543
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 90 -SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 90 -~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
..+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 468999999975 7888775 2488999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC----------
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---------- 238 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp---------- 238 (1437)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.+++.....+
T Consensus 176 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 65432 2345679999999999999999999999999999999999999998776655554443311110
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 239 -------------------------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 239 -------------------------------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.....+.++.+||.+||..||.+|||+.++|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 01123467899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=356.77 Aligned_cols=255 Identities=43% Similarity=0.803 Sum_probs=223.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ---EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe---edie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
+.|.+.+.||+|+||.||+|.+..++..||+|.+....... .....+.+|+.++++++||||+++++++..+..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987654332 234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+++++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.......
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999999754 5699999999999999999999999999999999999999999999999999986643221
Q ss_pred cc---ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhc-CCCCCCCCCCHHHHHH
Q 000535 175 NT---HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-ERPPIPESLSPDITDF 250 (1437)
Q Consensus 175 kt---~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~-~rppiP~~ISpELkDL 250 (1437)
.. ....|+..|+|||++.+..++.++||||||+++|+|++|+.||..........++... ....++..++.++.++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence 11 2356889999999999988999999999999999999999999877666555554433 3445677899999999
Q ss_pred HHHHhhhcccCCCCHHHHhcCHHH
Q 000535 251 LRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
|.+||.++|.+||++.++++||||
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=376.63 Aligned_cols=250 Identities=31% Similarity=0.492 Sum_probs=214.1
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEID-LLKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIk-ILrrLnHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||+||+|++..+++.||+|++.+.... ......+..|+. +++.++||||+++++++.+.+.+|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999765432 223344555554 67889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|...+... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 9999988743 56999999999999999999999999999999999999999999999999999764333333445689
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++....++.++|||||||++|+|++|.+||...+..... ..+......++...+.++.++|.+||+++|.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY-DNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH-HHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 99999999999889999999999999999999999999876544433 44444556677889999999999999999999
Q ss_pred CCCH----HHHhcCHHHHH
Q 000535 262 RPDA----KTLLSHPWIQN 276 (1437)
Q Consensus 262 RPSA----eELLkHPWFQe 276 (1437)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9875 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=401.83 Aligned_cols=269 Identities=29% Similarity=0.466 Sum_probs=237.4
Q ss_pred ccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 000535 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 11 ~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~ 90 (1437)
...+...++|.+.+.||+|+||+||+|++..+++.||||++........+...+.+|+.++..++|+||+++++.+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34456678999999999999999999999999999999999887777777788899999999999999999988774322
Q ss_pred --------eEEEEEeecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEE
Q 000535 91 --------HLHIILEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKL 160 (1437)
Q Consensus 91 --------~LYLVMEYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKL 160 (1437)
.+++||||+++|+|.++++.. ...++++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 478999999999999998643 2357999999999999999999999999999999999999999999999
Q ss_pred EecccccccccCC--cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC
Q 000535 161 ADFGVATKLTEAD--VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP 238 (1437)
Q Consensus 161 iDFGLAr~L~esd--~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp 238 (1437)
+|||+++.+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+..+......+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 9999998764321 12345689999999999999999999999999999999999999998877666667777777777
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHHH
Q 000535 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279 (1437)
Q Consensus 239 iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~rr 279 (1437)
++..+++++.++|.+||..||.+||++.++++|||++....
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 88899999999999999999999999999999999987543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=394.45 Aligned_cols=250 Identities=33% Similarity=0.590 Sum_probs=224.1
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeE-EEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-eEEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS-HLHIIL 96 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~-VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~-~LYLVM 96 (1437)
...+.+.||.|+||+||++.+ .|.. ||+|++..........+.+.+|+.+|.+|+|||||+++|++.+.. .++|||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 345667799999999999987 4555 999999887766666788999999999999999999999998887 799999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccccCCceEeccCC-cEEEEecccccccccCCc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG-VIHRDIKGANILTTKEG-LVKLADFGVATKLTEADV 174 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnG-IVHRDLKPENILLdenG-~VKLiDFGLAr~L~esd~ 174 (1437)
||+++|+|.+++.......++...+..|+.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++.......
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 9999999999998644578999999999999999999999999 99999999999999998 999999999988765433
Q ss_pred ccccccCCCccCChhhhh--cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHh-hcCCCCCCCCCCHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIE--MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV-QDERPPIPESLSPDITDFL 251 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~--g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIi-q~~rppiP~~ISpELkDLI 251 (1437)
......||+.|||||++. ...|+.++||||||+++|||+||..||.+.........+. ...++++|..+++.+..||
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~ 279 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLM 279 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence 344478999999999999 5699999999999999999999999999988877777765 5667788888999999999
Q ss_pred HHHhhhcccCCCCHHHHhc
Q 000535 252 RQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLk 270 (1437)
..||..||.+||++.+++.
T Consensus 280 ~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 280 ERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999964
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=396.66 Aligned_cols=265 Identities=26% Similarity=0.453 Sum_probs=232.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCC-CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLEN-GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkT-Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+++.++||||+++++++..++.+|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 34599999999999999999998877 788999987543 234456778899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 96 LEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 96 MEYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
||||+||+|.++++.. ...++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999988542 34579999999999999999999999999999999999999999999999999998765432
Q ss_pred c--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHH
Q 000535 174 V--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFL 251 (1437)
Q Consensus 174 ~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLI 251 (1437)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+......+.+..+++++.+||
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 1 23356799999999999999999999999999999999999999988777777777777777777888999999999
Q ss_pred HHHhhhcccCCCCHHHHhcCHHHHHHHHHhhh
Q 000535 252 RQCFKKDARQRPDAKTLLSHPWIQNCRRALQS 283 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLkHPWFQe~rrsLqs 283 (1437)
.+||.++|++||++.+++.|||++.....+..
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~~~~~~~~~~~~~ 335 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335 (478)
T ss_pred HHHhccChhhCcCHHHHHhCHHHHHHHHHHHH
Confidence 99999999999999999999999876554443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=383.85 Aligned_cols=253 Identities=30% Similarity=0.491 Sum_probs=214.4
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|++.+.||+|+||.||+|++..+++.||||++.... .......+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 457899999999999999999999999999999986543 3344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|||++|+|.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 152 e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 152 EFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred ecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 99999998653 246788899999999999999999999999999999999999999999999998765443333
Q ss_pred ccccCCCccCChhhhhc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCChh---HHHHHhhcCCCCCCCCCCHHHH
Q 000535 177 HSVVGTPYWMAPEVIEM-----SGVCAASDIWSVGCTVIELLTCVPPYYELQPMP---ALFRIVQDERPPIPESLSPDIT 248 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g-----~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~e---qL~kIiq~~rppiP~~ISpELk 248 (1437)
....||..|+|||++.. ..++.++|||||||++|+|++|+.||......+ ....+........+..++.++.
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR 305 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence 45689999999998843 234568999999999999999999997433222 1222333444556678999999
Q ss_pred HHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 249 DFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 249 DLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+||.+||..||++||++.++++||||..
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccc
Confidence 9999999999999999999999999965
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=388.87 Aligned_cols=262 Identities=27% Similarity=0.473 Sum_probs=223.8
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~ 90 (1437)
......++|++.+.||+|+||.||+|++..+++.||+|++.+.... ......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3444567899999999999999999999999999999999754332 234556789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
++|+|||||++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999999643 58999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc-ccccccCCCccCChhhhhcCC----CCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CCCCC--CC
Q 000535 171 EADV-NTHSVVGTPYWMAPEVIEMSG----VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RPPIP--ES 242 (1437)
Q Consensus 171 esd~-kt~t~~GTp~YmAPEVL~g~~----yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rppiP--~~ 242 (1437)
.... ...+.+||+.|+|||++.... ++.++|||||||++|+|++|.+||...+......++.... ...+| ..
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 4322 234578999999999997643 7889999999999999999999998877666666665433 22333 35
Q ss_pred CCHHHHHHHHHHhhhcccC--CCCHHHHhcCHHHHH
Q 000535 243 LSPDITDFLRQCFKKDARQ--RPDAKTLLSHPWIQN 276 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeK--RPSAeELLkHPWFQe 276 (1437)
++..++++|..||..++.+ |+++.++++||||+.
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 7999999999999866654 899999999999965
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.66 Aligned_cols=255 Identities=33% Similarity=0.498 Sum_probs=215.3
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||.|+||.||+|.+..++..||+|++............+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999999876554444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 99 VENGSLANIIKPNK-FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 99 ceGGSL~DLLKssr-~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 97 58988886543 36799999999999999999999999999999999999999999999999999976543322223
Q ss_pred cccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--------------------
Q 000535 178 SVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------------------- 236 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-------------------- 236 (1437)
...+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+.....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 34678999999998654 478899999999999999999999987655444433221100
Q ss_pred --------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 --------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 --------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
......+++++.++|.+||..||.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.58 Aligned_cols=251 Identities=27% Similarity=0.489 Sum_probs=219.6
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||+||+|.+..++..||||++.+.... ......+.+|+.+++.+ +||||+++++++...+++|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999865432 34456678899999888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+.+... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 9999998754 57999999999999999999999999999999999999999999999999999764333334445689
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+...... .+......++..++.++.+||.+||.+||.+
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ-SILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH-HHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999999999999999999999998765544433 3444455677789999999999999999999
Q ss_pred CCCH-----HHHhcCHHHHHH
Q 000535 262 RPDA-----KTLLSHPWIQNC 277 (1437)
Q Consensus 262 RPSA-----eELLkHPWFQe~ 277 (1437)
||++ .++++||||...
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=380.61 Aligned_cols=257 Identities=30% Similarity=0.518 Sum_probs=230.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.+|...++||+|.||+||+|++..+|+.||||+|+.....+.-.....|||+.|+.++||||+.++++|-..+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57899999999999999999999999999999999887665556678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|++. +|...|+.. ...|+...+..|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+........
T Consensus 82 fm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred eccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 9985 999999855 46899999999999999999999999999999999999999999999999999999987765555
Q ss_pred cccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC------------------
Q 000535 178 SVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP------------------ 238 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp------------------ 238 (1437)
..+-|.+|+|||.+.+. .|+..+||||.|||+.||+-|.|.|.+.++.+++..+......|
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 55889999999988765 69999999999999999999999999999999998886532111
Q ss_pred ---------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 239 ---------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 239 ---------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+-+.++.++.+|+.+||.+||.+|+++.++|+|+||.+
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 11234678899999999999999999999999999975
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=369.78 Aligned_cols=257 Identities=26% Similarity=0.464 Sum_probs=216.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|.+.+.||+|+||.||+|++..++..||+|.+...... .....+.+|+.++++++||||+++++++..++..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 6799999999999999999999999999999998755422 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+.+ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 85 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 85 YLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred CCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 9975 888887644 24689999999999999999999999999999999999999999999999999986544333333
Q ss_pred cccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--------------------
Q 000535 178 SVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------------------- 236 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-------------------- 236 (1437)
...+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+.....
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 4578999999999865 4588999999999999999999999987665444433322100
Q ss_pred -C--------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 237 -P--------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 237 -p--------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+ ...+.+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0 0113578899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=375.68 Aligned_cols=259 Identities=24% Similarity=0.454 Sum_probs=219.0
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||+||+|++..+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 479999999999999999999999999999999975332 2345566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-c
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-N 175 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-k 175 (1437)
||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... .
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999999743 35699999999999999999999999999999999999999999999999999977654332 1
Q ss_pred cccccCCCccCChhhhhc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC----CCCCCCCCCHH
Q 000535 176 THSVVGTPYWMAPEVIEM-----SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE----RPPIPESLSPD 246 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g-----~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~----rppiP~~ISpE 246 (1437)
....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+....+.... .++....++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999963 457889999999999999999999998876666655554322 12233458999
Q ss_pred HHHHHHHHhhhcccC--CCCHHHHhcCHHHHHH
Q 000535 247 ITDFLRQCFKKDARQ--RPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 247 LkDLIrkCLqkDPeK--RPSAeELLkHPWFQe~ 277 (1437)
+.++|.+||..++.+ |+++.++++||||...
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999764444 7899999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=377.41 Aligned_cols=252 Identities=26% Similarity=0.467 Sum_probs=220.5
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||+||+|.+..+++.||+|++.+.... ....+.+.+|+.++.++ .||||+++++++...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999875433 34566788999999988 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 9999988744 57999999999999999999999999999999999999999999999999999764333333456789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCC------CChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYEL------QPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~------d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|..||... ...+.+.+........+|..++..+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L 238 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFL 238 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999532 233445555666666788889999999999999
Q ss_pred hhcccCCCC------HHHHhcCHHHHHH
Q 000535 256 KKDARQRPD------AKTLLSHPWIQNC 277 (1437)
Q Consensus 256 qkDPeKRPS------AeELLkHPWFQe~ 277 (1437)
.+||.+|++ +.++++||||...
T Consensus 239 ~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 239 NKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred ccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999999997 5799999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=376.33 Aligned_cols=256 Identities=26% Similarity=0.457 Sum_probs=222.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLn-HPNIVKLigVfedd~~LYLVM 96 (1437)
.|.+.+.||+|+||+||+|++..+++.||+|++.+... .....+.+..|+.+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47889999999999999999999999999999986533 2334566778999998886 577888999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|||+||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 999999999999744 579999999999999999999999999999999999999999999999999998654443344
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
...+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+.. ....+|..++.++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-HNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCccCCHHHHHHHHHHcc
Confidence 557799999999999988999999999999999999999999988766555555443 4456777899999999999999
Q ss_pred hcccCCCC-----HHHHhcCHHHHHH
Q 000535 257 KDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 257 kDPeKRPS-----AeELLkHPWFQe~ 277 (1437)
++|.+|++ ..++++||||+..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99999997 5899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=377.15 Aligned_cols=251 Identities=26% Similarity=0.486 Sum_probs=216.8
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||+||+|++..+++.||||+++..... .........|..++..+ +||||+++++++.+++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999865422 23345566788888764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 9999999753 56999999999999999999999999999999999999999999999999999764333333445789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.... +....+.++..++.++.++|.+||.+||++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS-IRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999998999999999999999999999999987665444433 344445667779999999999999999999
Q ss_pred CCCHH-HHhcCHHHHHH
Q 000535 262 RPDAK-TLLSHPWIQNC 277 (1437)
Q Consensus 262 RPSAe-ELLkHPWFQe~ 277 (1437)
||++. +++.||||+..
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 89999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=351.80 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=229.9
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||+|+||.||+|.+..++..||+|.+............+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 59999999999999999999999999999999987766666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-cEEEEecccccccccCCcccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-~VKLiDFGLAr~L~esd~kt~ 177 (1437)
+++++|.+++.......+++..+..++.|++.+|.|||++||+|+||||+||+++.++ .++|+|||++....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence 9999999999865556799999999999999999999999999999999999998654 68999999998775443 233
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqk 257 (1437)
...|+..|+|||.+....++.++|+||||+++|+|++|+.||...+......++......+++..+++++.+++.+||..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence 46789999999999988899999999999999999999999988776666666666666677888999999999999999
Q ss_pred cccCCCCHHHHhcCHHH
Q 000535 258 DARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 258 DPeKRPSAeELLkHPWF 274 (1437)
+|.+|||+.++++||||
T Consensus 240 ~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 240 DPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ChhhCCCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=378.39 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=216.0
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR----- 89 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd----- 89 (1437)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 467899999999999999999999999999999999986655556667788999999999999999999988643
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 90 -SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 90 -~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
...|+||||+++ +|.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999975 7777775 2489999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC------------
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER------------ 236 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r------------ 236 (1437)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....++....
T Consensus 169 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 64432 23456899999999999999999999999999999999999999987664443332221100
Q ss_pred -----------------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 237 -----------------------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 237 -----------------------------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
...+...+.++.+||.+||..||++|||+.++++||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0011224567899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=375.26 Aligned_cols=257 Identities=31% Similarity=0.540 Sum_probs=218.3
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|++++++++||||+++++++.+++++|+|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 4678999999999999999999999999999999987643 344556788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSn-GIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
|||+.+|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999999754 5699999999999999999999985 7999999999999999999999999999766432
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHH-------------------------
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALF------------------------- 229 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~------------------------- 229 (1437)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 2234579999999999998889999999999999999999999997543221110
Q ss_pred -------------------HHhhcCCCCCC-CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 230 -------------------RIVQDERPPIP-ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 230 -------------------kIiq~~rppiP-~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
.+.....+.++ ..++.++.+||.+||.+||++||++.+++.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 01111112222 2367899999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=394.26 Aligned_cols=255 Identities=28% Similarity=0.500 Sum_probs=213.1
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR------ 89 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd------ 89 (1437)
...+|.+++.||+|+||.||+|.+..++..||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3568999999999999999999999999999999885432 2345799999999999999999877432
Q ss_pred --CeEEEEEeecCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-cEEEEecc
Q 000535 90 --SHLHIILEYVENGSLANIIKP--NKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKLADFG 164 (1437)
Q Consensus 90 --~~LYLVMEYceGGSL~DLLKs--sr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-~VKLiDFG 164 (1437)
.++++|||||++ +|.+++.. .....+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 357899999975 78777653 2345799999999999999999999999999999999999999765 79999999
Q ss_pred cccccccCCcccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC-------
Q 000535 165 VATKLTEADVNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER------- 236 (1437)
Q Consensus 165 LAr~L~esd~kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r------- 236 (1437)
+++.+.... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+....+.+.+++....
T Consensus 217 la~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 217 SAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred cchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 998765433 33456889999999998654 689999999999999999999999998777666665543110
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 237 ---------------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 237 ---------------------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
..+|...++++.+||.+||.+||.+|||+.++++||||+..+
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 012345788999999999999999999999999999998754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=365.10 Aligned_cols=258 Identities=25% Similarity=0.440 Sum_probs=221.7
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.++++++|+||+++++.+.+++.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3788899999999999999999999999999987654332 233556789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-ccc
Confidence 9999999999875555579999999999999999999999999999999999999999999999999997654332 223
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---hHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM---PALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~---eqL~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
...|++.|+|||++....++.++||||+||++|+|++|.+||...... ..............+..+++++.+|+.+|
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 457999999999999889999999999999999999999999764432 22233333333445677899999999999
Q ss_pred hhhcccCCCC-----HHHHhcCHHHHHH
Q 000535 255 FKKDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 255 LqkDPeKRPS-----AeELLkHPWFQe~ 277 (1437)
|+.||++||| +.++++||||.+.
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999999 9999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=376.25 Aligned_cols=250 Identities=28% Similarity=0.466 Sum_probs=213.7
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHH-HHHHhCCCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEI-DLLKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REI-kILrrLnHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||+||+|++..+++.||+|++.+..... .....+..|. .+++.++||||+++++++...+.+|+|||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997644321 2233444444 456788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 9999999753 56899999999999999999999999999999999999999999999999999865443334456789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+..+.. ....+++.+++++.++|.+||+++|.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-KPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh-CCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999999999999999999999999999999988766555555443 344566789999999999999999999
Q ss_pred CCCHH----HHhcCHHHHH
Q 000535 262 RPDAK----TLLSHPWIQN 276 (1437)
Q Consensus 262 RPSAe----ELLkHPWFQe 276 (1437)
||++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99865 8999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=385.52 Aligned_cols=264 Identities=26% Similarity=0.448 Sum_probs=224.2
Q ss_pred cccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 000535 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT 88 (1437)
Q Consensus 10 F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfed 88 (1437)
+.....-.++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44455556899999999999999999999999999999999875432 23345567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 89 d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
+.++|+|||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999999999999643 589999999999999999999999999999999999999999999999999987
Q ss_pred cccCCc-ccccccCCCccCChhhhhcCC----CCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CC--CCC
Q 000535 169 LTEADV-NTHSVVGTPYWMAPEVIEMSG----VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RP--PIP 240 (1437)
Q Consensus 169 L~esd~-kt~t~~GTp~YmAPEVL~g~~----yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rp--piP 240 (1437)
+..... .....+||+.|+|||++.... ++.++|||||||++|+|++|.+||...+......++.... .. +.+
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 654322 233568999999999997543 7889999999999999999999998877666666655432 12 333
Q ss_pred CCCCHHHHHHHHHHhhhcccC--CCCHHHHhcCHHHHH
Q 000535 241 ESLSPDITDFLRQCFKKDARQ--RPDAKTLLSHPWIQN 276 (1437)
Q Consensus 241 ~~ISpELkDLIrkCLqkDPeK--RPSAeELLkHPWFQe 276 (1437)
..++.+++++|.+||..++.+ |+++.++++||||++
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 478999999999999854443 789999999999965
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=358.70 Aligned_cols=256 Identities=45% Similarity=0.764 Sum_probs=228.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.++..+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 47999999999999999999999999999999987653 33455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++++|.+++... ++++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++.+........
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 80 YCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred eeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 99999999999754 799999999999999999999999999999999999999999999999999988765433344
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCC-CCHHHHHHHHHHhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES-LSPDITDFLRQCFK 256 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~-ISpELkDLIrkCLq 256 (1437)
...|++.|+|||.+.+..++.++|||||||++|+|++|.+||...+.......+.....+..+.. +++++.+++.+||.
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 56789999999999988899999999999999999999999987776666655555555555555 89999999999999
Q ss_pred hcccCCCCHHHHhcCHHHHHH
Q 000535 257 KDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 257 kDPeKRPSAeELLkHPWFQe~ 277 (1437)
.+|++||++.++++||||+..
T Consensus 237 ~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 237 KDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred CChhhCcCHHHHhhChhhcCC
Confidence 999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=376.58 Aligned_cols=250 Identities=29% Similarity=0.469 Sum_probs=214.4
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEID-LLKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIk-ILrrLnHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||+||+|.+..+|+.||+|++.+.... ......+..|.. +++.++||||+++++++..++.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999999999999999999765332 233445556655 46778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... +++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 9999988743 57999999999999999999999999999999999999999999999999999764333333445789
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+.. .....++.++.++.++|.+||+++|.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-KPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc-CCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999999999999999999999999999999988665555444443 344556678999999999999999999
Q ss_pred CCCH----HHHhcCHHHHH
Q 000535 262 RPDA----KTLLSHPWIQN 276 (1437)
Q Consensus 262 RPSA----eELLkHPWFQe 276 (1437)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9976 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.09 Aligned_cols=251 Identities=33% Similarity=0.565 Sum_probs=225.4
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||.|+||.||++.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+.+++.+|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 58999999999999999999999999999999875432 34567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+++++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++............
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 99999999987655667999999999999999999999999999999999999999999999999999877554433445
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhc
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkD 258 (1437)
..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......+.+..++..+.+||.+||+.|
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCC
Confidence 67899999999999888999999999999999999999999887666666666666677778889999999999999999
Q ss_pred ccCCCCHHHHhc
Q 000535 259 ARQRPDAKTLLS 270 (1437)
Q Consensus 259 PeKRPSAeELLk 270 (1437)
|++||++.+++.
T Consensus 240 P~~Rp~~~~il~ 251 (255)
T cd08219 240 PRSRPSATTILS 251 (255)
T ss_pred cccCCCHHHHhh
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=363.22 Aligned_cols=251 Identities=22% Similarity=0.382 Sum_probs=211.8
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCH
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL 104 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL 104 (1437)
||+|+||.||++++..+|+.||+|.+....... .....+..|+.++++++||||++++++++.+.++|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999987544332 2234456799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCCCc
Q 000535 105 ANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY 184 (1437)
Q Consensus 105 ~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~ 184 (1437)
.+++.......+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence 998876555579999999999999999999999999999999999999999999999999998765432 2234578999
Q ss_pred cCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh----hHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhccc
Q 000535 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM----PALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260 (1437)
Q Consensus 185 YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~----eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPe 260 (1437)
|+|||++.+..++.++|||||||++|+|++|..||...... .................+++++.+||.+||++||+
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 99999999888999999999999999999999999764332 12222222222222346899999999999999999
Q ss_pred CCCCH----HHHhcCHHHHHH
Q 000535 261 QRPDA----KTLLSHPWIQNC 277 (1437)
Q Consensus 261 KRPSA----eELLkHPWFQe~ 277 (1437)
+||++ .+++.||||+..
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hCCCCccchhhhhcChhhcCC
Confidence 99999 778899999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=351.65 Aligned_cols=256 Identities=39% Similarity=0.678 Sum_probs=224.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||.|+||+||+|.+..++..+++|++....... ..+.+.+|+.+++.++|+||+++++.+..+...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47999999999999999999998899999999987655443 66789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc-
Q 000535 98 YVENGSLANIIKPNKF-GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN- 175 (1437)
Q Consensus 98 YceGGSL~DLLKssr~-GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k- 175 (1437)
|+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||++++++.++|+|||++..+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9999999999975432 57999999999999999999999999999999999999999999999999999876554322
Q ss_pred ---cccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCC-----CCCCHH
Q 000535 176 ---THSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP-----ESLSPD 246 (1437)
Q Consensus 176 ---t~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP-----~~ISpE 246 (1437)
.....|+..|+|||++... .++.++|+|||||++|+|++|+.||..........+......+.++ ..++++
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence 1345789999999998776 7899999999999999999999999887766666666555433332 257899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
+.+++.+||.+||++||++.+++.||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=357.25 Aligned_cols=256 Identities=37% Similarity=0.677 Sum_probs=218.2
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe------
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT------ 88 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfed------ 88 (1437)
..++|.+.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++++ +||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4678999999999999999999999999999999987543 2335678899999998 79999999999865
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 89 d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
+..+|+||||+.+++|.+++.......+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 35689999999999999999876556799999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccCCCccCChhhhh-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CCCCCCC
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RPPIPES 242 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~-----g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rppiP~~ 242 (1437)
............|++.|+|||++. ...++.++||||+||++|+|++|..||................ ....+..
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 654333334567999999999986 3457889999999999999999999997665544444333322 2223456
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
++.++.+||.+||..+|.+||++.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 88999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=377.62 Aligned_cols=248 Identities=28% Similarity=0.467 Sum_probs=211.1
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL---NHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL---nHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
||+|+||+||+|++..+++.||||++.+.... ..+......|..++..+ .||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999754332 23344556677777665 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence 9999998743 57999999999999999999999999999999999999999999999999999765443334456789
Q ss_pred CCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCC-CCCCHHHHHHHHHHhhhcc
Q 000535 182 TPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP-ESLSPDITDFLRQCFKKDA 259 (1437)
Q Consensus 182 Tp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP-~~ISpELkDLIrkCLqkDP 259 (1437)
|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.... ..++ ..+++++.+||.+||.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK-VRFPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCCH
Confidence 9999999998754 58899999999999999999999998866555544444333 3333 4579999999999999999
Q ss_pred cCCC----CHHHHhcCHHHHH
Q 000535 260 RQRP----DAKTLLSHPWIQN 276 (1437)
Q Consensus 260 eKRP----SAeELLkHPWFQe 276 (1437)
.+|| ++.++++||||..
T Consensus 238 ~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 238 QHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HHCCCCCCCHHHHhcCccccC
Confidence 9998 7999999999964
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=349.64 Aligned_cols=256 Identities=31% Similarity=0.550 Sum_probs=227.4
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--RSHLHIIL 96 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed--d~~LYLVM 96 (1437)
+|++.+.||.|+||.||+|.+..++..||+|.+..........+.+..|+.++++++||||+++++++.. ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999998776677777889999999999999999999997753 46789999
Q ss_pred eecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCcccccccCCceEeccCCcEEEEeccccccc
Q 000535 97 EYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLH-----EQGVIHRDIKGANILTTKEGLVKLADFGVATKL 169 (1437)
Q Consensus 97 EYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLH-----SnGIVHRDLKPENILLdenG~VKLiDFGLAr~L 169 (1437)
||+++++|.+++... ...++++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999653 2467999999999999999999999 899999999999999999999999999999887
Q ss_pred ccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHH
Q 000535 170 TEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249 (1437)
Q Consensus 170 ~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkD 249 (1437)
...........|++.|+|||++....++.++|+||||+++|+|++|..||...........+.....+.++..++..+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNE 240 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 65543344567899999999999888999999999999999999999999887655545555555556677889999999
Q ss_pred HHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
++.+||..+|.+||++.++++|||+
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=371.94 Aligned_cols=253 Identities=28% Similarity=0.521 Sum_probs=211.1
Q ss_pred CCceEEEeEecccCcEEEEEEEEc-----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTR- 89 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDr-----kTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd- 89 (1437)
.++|++.+.||+|+||.||+|.+. .++..||+|++... ........+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 468999999999999999999752 34578999998743 2344556788999999999 899999999988654
Q ss_pred CeEEEEEeecCCCCHHHHhccCC---------------------------------------------------------
Q 000535 90 SHLHIILEYVENGSLANIIKPNK--------------------------------------------------------- 112 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKssr--------------------------------------------------------- 112 (1437)
..+|+|||||++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 56899999999999999986432
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC--cccccccCCCccCC
Q 000535 113 ---FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--VNTHSVVGTPYWMA 187 (1437)
Q Consensus 113 ---~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd--~kt~t~~GTp~YmA 187 (1437)
..++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.... .......+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 1348888999999999999999999999999999999999999999999999998754322 11223456788999
Q ss_pred hhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHh-hcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCH
Q 000535 188 PEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIV-QDERPPIPESLSPDITDFLRQCFKKDARQRPDA 265 (1437)
Q Consensus 188 PEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIi-q~~rppiP~~ISpELkDLIrkCLqkDPeKRPSA 265 (1437)
||++.+..++.++|||||||++|+|++ |.+||......+...... .......+..+++++.++|.+||..||.+|||+
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 324 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTF 324 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999999999999999999997 999998766544444433 334455667889999999999999999999999
Q ss_pred HHHhc
Q 000535 266 KTLLS 270 (1437)
Q Consensus 266 eELLk 270 (1437)
.++++
T Consensus 325 ~el~~ 329 (338)
T cd05102 325 SALVE 329 (338)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=353.98 Aligned_cols=254 Identities=43% Similarity=0.826 Sum_probs=224.0
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-------HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-------EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-------edie~L~REIkILrrLnHPNIVKLigVfedd~~ 91 (1437)
+|.+.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.++++++||||+++++++...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999998899999999887543321 234568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e 171 (1437)
.++||||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++.+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999754 5799999999999999999999999999999999999999999999999999987753
Q ss_pred CCc------ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCH
Q 000535 172 ADV------NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSP 245 (1437)
Q Consensus 172 sd~------kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISp 245 (1437)
... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+....+.++.....+..+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS 238 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence 211 11234688999999999988899999999999999999999999988776666666666666677788999
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
++.++|.+||..||.+||++.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=376.03 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=215.3
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR----- 89 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd----- 89 (1437)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 467899999999999999999999999999999999876544444556678999999999999999999987543
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 90 -SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 90 -~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
..+|++|+++ +++|.++++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 4579999998 6799988863 4699999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC-----------
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER----------- 236 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r----------- 236 (1437)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.++.....
T Consensus 168 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 168 ADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred cCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 6432 345679999999999876 5688999999999999999999999987655444443322110
Q ss_pred -----------CC--------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 237 -----------PP--------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 237 -----------pp--------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+. ....+++.+.+||.+||..||.+|||+.+++.||||.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 00 11245678899999999999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.59 Aligned_cols=255 Identities=33% Similarity=0.546 Sum_probs=217.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.....+|+|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999999999999999999987554333334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|++++.|..++... ..+++..++.++.|++.+|.|||++||+||||||+||+++.++.++|+|||++..+........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 99998888877533 4699999999999999999999999999999999999999999999999999988765443334
Q ss_pred cccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC--------------------C
Q 000535 178 SVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE--------------------R 236 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~--------------------r 236 (1437)
...++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+.... .
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 4568899999999876 457889999999999999999999998777655554432210 0
Q ss_pred CCC----------CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 PPI----------PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 ppi----------P~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.+. ...++..+.+||.+||..+|++||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 13568889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=350.76 Aligned_cols=256 Identities=30% Similarity=0.593 Sum_probs=228.4
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|.+.+.||+|+||.||++.+..++..||+|.+........+.+.+.+|+.+++.++||||+++++.+......|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58999999999999999999999999999999987655555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-cEEEEecccccccccCCcccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-~VKLiDFGLAr~L~esd~kt~ 177 (1437)
+++++|.+++.......+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 9999999999766555789999999999999999999999999999999999999886 579999999987755433333
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqk 257 (1437)
...|++.|+|||++....++.++|+||||+++|+|++|..||...+..+....+......+.++.++.++.++|.+||..
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 240 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV 240 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhcc
Confidence 45689999999999888899999999999999999999999987766666666666666667778899999999999999
Q ss_pred cccCCCCHHHHhcCHHH
Q 000535 258 DARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 258 DPeKRPSAeELLkHPWF 274 (1437)
+|++||++.++++||||
T Consensus 241 ~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 241 SPRDRPSITSILKRPFL 257 (257)
T ss_pred ChhhCcCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=369.91 Aligned_cols=257 Identities=27% Similarity=0.478 Sum_probs=213.4
Q ss_pred EEeEeccc--CcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 22 LGDEIGKG--AYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 22 IlEvLGrG--gFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
++++||+| +|++||++.+..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56889999 7899999999999999999999876555556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-----
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV----- 174 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~----- 174 (1437)
++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999765555699999999999999999999999999999999999999999999999987654322111
Q ss_pred --ccccccCCCccCChhhhhc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--------------
Q 000535 175 --NTHSVVGTPYWMAPEVIEM--SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------------- 236 (1437)
Q Consensus 175 --kt~t~~GTp~YmAPEVL~g--~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-------------- 236 (1437)
......++..|+|||++.. ..++.++|||||||++|+|++|..||.................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 1122356788999999976 4689999999999999999999999976543332222221110
Q ss_pred -------------------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 237 -------------------------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 237 -------------------------------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
.+....+++++.+||.+||++||++|||+.++++||||++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 011224578899999999999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.28 Aligned_cols=256 Identities=36% Similarity=0.675 Sum_probs=231.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|.+.+.||.|+||.||++.+..++..|++|++............+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58999999999999999999998999999999987776667778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 99 VENGSLANIIKPNK--FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 99 ceGGSL~DLLKssr--~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999999997643 4679999999999999999999999999999999999999999999999999998776554333
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
....|++.|+|||.+....++.++|+||+|+++|+|++|..||..................+++..++.++.+++.+||.
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQ 240 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 45678999999999988889999999999999999999999998776655555666666677778899999999999999
Q ss_pred hcccCCCCHHHHhcCHHH
Q 000535 257 KDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 257 kDPeKRPSAeELLkHPWF 274 (1437)
.+|++||++.++++||||
T Consensus 241 ~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 241 KDPEERPSIAQILQSPFI 258 (258)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=371.48 Aligned_cols=258 Identities=22% Similarity=0.419 Sum_probs=219.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||+||++++..+++.||+|++.+... .......+.+|+.++..+.|+||+++++++.++++.|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999875332 2334556788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-c
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-N 175 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-k 175 (1437)
|||+||+|.+++... .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+..... .
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 999999999999753 25799999999999999999999999999999999999999999999999999987654332 1
Q ss_pred cccccCCCccCChhhhhc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CCCCC---CCCCHH
Q 000535 176 THSVVGTPYWMAPEVIEM-----SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RPPIP---ESLSPD 246 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g-----~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rppiP---~~ISpE 246 (1437)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...++.... ..++| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 223579999999999875 457889999999999999999999998877666665555432 22233 457899
Q ss_pred HHHHHHHHhhhcccC--CCCHHHHhcCHHHHH
Q 000535 247 ITDFLRQCFKKDARQ--RPDAKTLLSHPWIQN 276 (1437)
Q Consensus 247 LkDLIrkCLqkDPeK--RPSAeELLkHPWFQe 276 (1437)
+.++|.+||..++.+ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 579999999999965
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.65 Aligned_cols=260 Identities=26% Similarity=0.456 Sum_probs=226.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.+|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+..|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765443 45667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-- 174 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-- 174 (1437)
||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999999866667899999999999999999999999999999999999999999999999999876532211
Q ss_pred ---------------------------ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhH
Q 000535 175 ---------------------------NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPA 227 (1437)
Q Consensus 175 ---------------------------kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eq 227 (1437)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 11134689999999999988899999999999999999999999988777666
Q ss_pred HHHHhhcCCCCCCC--CCCHHHHHHHHHHhhhcccCCCC----HHHHhcCHHHHHHH
Q 000535 228 LFRIVQDERPPIPE--SLSPDITDFLRQCFKKDARQRPD----AKTLLSHPWIQNCR 278 (1437)
Q Consensus 228 L~kIiq~~rppiP~--~ISpELkDLIrkCLqkDPeKRPS----AeELLkHPWFQe~r 278 (1437)
..++.... ..++. .++.++.++|.+||..+|++||+ +++++.||||+...
T Consensus 241 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 241 FSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 66655332 22332 37999999999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=359.41 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=222.7
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH-HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE-DLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee-die~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.|+..+.||+|+||+||+|.+..+++.||+|.+........ ....+.+|+.+++.++|+||+.+++++..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876544332 33457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-ccc
Confidence 9999999998875545579999999999999999999999999999999999999999999999999997654322 223
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHH---hhcCCCCCCCCCCHHHHHHHHHH
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI---VQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kI---iq~~rppiP~~ISpELkDLIrkC 254 (1437)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+ .......++..+++++.+|+..|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 467999999999999888999999999999999999999999876543332222 23333456677899999999999
Q ss_pred hhhcccCCCC-----HHHHhcCHHHHHH
Q 000535 255 FKKDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 255 LqkDPeKRPS-----AeELLkHPWFQe~ 277 (1437)
|..||++||+ +.+++.||||+..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=371.31 Aligned_cols=259 Identities=24% Similarity=0.426 Sum_probs=219.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||+||++++..+++.||+|++.+... .......+..|+.++..++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999875432 2234455788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-c
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-N 175 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-k 175 (1437)
||+++|+|.+++... .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 999999999999753 24699999999999999999999999999999999999999999999999999976543322 2
Q ss_pred cccccCCCccCChhhhh-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC----CCCCCCCCHH
Q 000535 176 THSVVGTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER----PPIPESLSPD 246 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~-----g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r----ppiP~~ISpE 246 (1437)
....+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+...++..... +.....++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 23457999999999986 34578899999999999999999999988777666666654321 2223468999
Q ss_pred HHHHHHHHhhhcccC--CCCHHHHhcCHHHHHH
Q 000535 247 ITDFLRQCFKKDARQ--RPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 247 LkDLIrkCLqkDPeK--RPSAeELLkHPWFQe~ 277 (1437)
+.+||.+||..++.+ |+++.++++||||+..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 999999999765554 6899999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.68 Aligned_cols=259 Identities=28% Similarity=0.462 Sum_probs=216.1
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
-++|.+.+.||.|+||.||+|.+..++..||+|.+...... .....+.+|+.++++++||||+++++++..++.+|+||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 35799999999999999999999999999999998754322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+. ++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 84 e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 84 EYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred eccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 9997 5899888654 3468999999999999999999999999999999999999999999999999997654433233
Q ss_pred ccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC-------------------
Q 000535 177 HSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER------------------- 236 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r------------------- 236 (1437)
....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+.....
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 345678999999998654 578899999999999999999999987665444333221100
Q ss_pred --C--------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 237 --P--------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 237 --p--------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
+ .....+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 01135788999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=377.39 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=216.2
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----eEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS-----HLH 93 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~-----~LY 93 (1437)
+|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999998755444455667889999999999999999999998776 899
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9999996 5888888643 579999999999999999999999999999999999999999999999999998654332
Q ss_pred c-ccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhc-----------------
Q 000535 174 V-NTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD----------------- 234 (1437)
Q Consensus 174 ~-kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~----------------- 234 (1437)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 1 12235689999999998764 4789999999999999999999999877665554433221
Q ss_pred -------CCC-------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 235 -------ERP-------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 235 -------~rp-------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
..+ .+....++++.+||.+||..||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 001 1234568899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=376.11 Aligned_cols=259 Identities=27% Similarity=0.505 Sum_probs=237.1
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHH-HHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL-NIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedi-e~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
.--++|++++.||+|-||.||.|+.++++..||+|++.+..+..... ..+.+|++|...|+||||++++++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 33567999999999999999999999999999999999877554443 46889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+++||...|+|+..++..+.++++|..++.|++|++.||.|+|.++|+||||||+|+|++..|.+||+|||++..-. .
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~ 176 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--S 176 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--C
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999997754 3
Q ss_pred cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 174 VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...... ..++.+......+|..++.++.++|.+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkrI~k~~~~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKRIRKVDLKFPSTISGGAADLISR 255 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHHHHHccccCCcccChhHHHHHHH
Confidence 3567899999999999999999999999999999999999999999887744 445555556667889999999999999
Q ss_pred HhhhcccCCCCHHHHhcCHHHHH
Q 000535 254 CFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLkHPWFQe 276 (1437)
||.++|.+|.+..+++.|||+..
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999964
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=359.95 Aligned_cols=254 Identities=31% Similarity=0.496 Sum_probs=211.3
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||+|+||.||+|++..+|+.||+|.+............+.+|+.++++++||||+++++++.+...+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 59999999999999999999999999999999976544433445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+.+ +|.+++... .+++++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 81 CDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 974 888887643 357999999999999999999999999999999999999999999999999999876543323334
Q ss_pred ccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCC-hhHHHHHhhcC-------------------CC
Q 000535 179 VVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQDE-------------------RP 237 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-~eqL~kIiq~~-------------------rp 237 (1437)
..+++.|+|||++.+. .++.++|||||||++|+|++|..||..... .+.+..+.... .+
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 5678999999998765 478899999999999999999888654333 22222221100 00
Q ss_pred ---------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 ---------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 ---------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
...+.+++++.+||.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.22 Aligned_cols=257 Identities=40% Similarity=0.678 Sum_probs=223.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||.|+||.||+|.+..++..||+|.+... .....+.+.+|+.++++++||||+++++++..+...|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 5699999999999999999999889999999998754 34455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++++|.+++.... .++++..++.++.|++.+|.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus 83 ~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 83 FCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred ccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999999999987542 4699999999999999999999999999999999999999999999999999877654433344
Q ss_pred cccCCCccCChhhhhc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC--CCCCCCCHHHHHH
Q 000535 178 SVVGTPYWMAPEVIEM-----SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPESLSPDITDF 250 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g-----~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--piP~~ISpELkDL 250 (1437)
...|++.|+|||++.. ..++.++|+|||||++|+|++|.+||..........++.....+ ..+..++.++.++
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence 5678999999999853 34678999999999999999999999887666655555544333 2355789999999
Q ss_pred HHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 251 LRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
|.+||..+|.+||++.++++||||.+.
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=395.57 Aligned_cols=262 Identities=33% Similarity=0.562 Sum_probs=222.4
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH------------HHHHHHHHHHHHHhCCCCCc
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE------------DLNIIMQEIDLLKNLNHKNI 79 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee------------die~L~REIkILrrLnHPNI 79 (1437)
.+...-++|++.+.||+|.||.|-+|++..+++.||||++.+...... ..+.+.+||.+|++|.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 345556889999999999999999999999999999999987643321 24678999999999999999
Q ss_pred ceEEEEEEeC--CeEEEEEeecCCCCHHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC
Q 000535 80 VKYLGSLKTR--SHLHIILEYVENGSLANIIKPNKFGP-FPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG 156 (1437)
Q Consensus 80 VKLigVfedd--~~LYLVMEYceGGSL~DLLKssr~Gp-LSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG 156 (1437)
|+|+++..+. +.+|||+|||..|.+...- ..++ +++.+++.|+++++.||+|||.+||+||||||+|+||+.+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 9999999874 6899999999998876543 2345 99999999999999999999999999999999999999999
Q ss_pred cEEEEecccccccccC-----CcccccccCCCccCChhhhhcC---C-CCccchhhhHHHHHHHHHhCCCCCCCCCChhH
Q 000535 157 LVKLADFGVATKLTEA-----DVNTHSVVGTPYWMAPEVIEMS---G-VCAASDIWSVGCTVIELLTCVPPYYELQPMPA 227 (1437)
Q Consensus 157 ~VKLiDFGLAr~L~es-----d~kt~t~~GTp~YmAPEVL~g~---~-yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eq 227 (1437)
+|||+|||.+...... +......+|||.|+|||...+. . .+.+.||||||++||.|+.|..||.+....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999999866322 1122346899999999988663 2 35678999999999999999999999888777
Q ss_pred HHHHhhcCC-CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 228 LFRIVQDER-PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 228 L~kIiq~~r-ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
..+|+.... .|..+.+.+.+++||.+||.+||++|.+..+|..|||...
T Consensus 328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 777765432 2333468999999999999999999999999999999954
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=354.48 Aligned_cols=253 Identities=43% Similarity=0.768 Sum_probs=217.1
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 458999999999999999999999999999999987553 234456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++++|.+++... +.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..........
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 86 EFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 999999999998744 579999999999999999999999999999999999999999999999999998765433333
Q ss_pred ccccCCCccCChhhhh---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC-C-C--CCCCCHHHHH
Q 000535 177 HSVVGTPYWMAPEVIE---MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP-P-I--PESLSPDITD 249 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~---g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp-p-i--P~~ISpELkD 249 (1437)
....|++.|+|||++. ...++.++|+|||||++|+|++|.+||.................. + . ...++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 4567999999999984 445888999999999999999999999776655444433322211 1 1 1257889999
Q ss_pred HHHHHhhhcccCCCCHHHHhcCHH
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPW 273 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkHPW 273 (1437)
+|.+||..+|++||++.++++|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.86 Aligned_cols=255 Identities=40% Similarity=0.722 Sum_probs=218.6
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC-----
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRS----- 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~----- 90 (1437)
.++|++.+.||+|+||.||+|.+..++..|++|++.... ...+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999999899999999987543 2345688999999999 7999999999996544
Q ss_pred -eEEEEEeecCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 91 -HLHIILEYVENGSLANIIKPNK--FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 91 -~LYLVMEYceGGSL~DLLKssr--~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
.+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 5899999999999999987533 4679999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccccccCCCccCChhhhhc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCC--C
Q 000535 168 KLTEADVNTHSVVGTPYWMAPEVIEM-----SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--P 240 (1437)
Q Consensus 168 ~L~esd~kt~t~~GTp~YmAPEVL~g-----~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppi--P 240 (1437)
.............|++.|+|||++.. ..++.++|||||||++|+|++|.+||........+.++.....+.. +
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence 76544333445678999999999854 3467889999999999999999999987666666666554433222 2
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 241 ~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
..++.++.+||.+||..||++|||+.++++|||+
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 3478899999999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=342.15 Aligned_cols=254 Identities=73% Similarity=1.191 Sum_probs=232.7
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|.+.+.||+|+||.||+|.+..+++.|++|.+..........+.+.+|++++++++|||++++++++.+....|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999999999999999988776666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+++++|.+++... +++++..++.++.|++.+|.|||++||+||||||+||+++.++.++|+|||++............
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 9999999999754 67999999999999999999999999999999999999999999999999999887665443345
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhc
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkD 258 (1437)
..++..|+|||.+.+..++.++||||||+++|+|++|..||..........+......+..+..++..+.++|.+||..+
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 67899999999998888899999999999999999999999887777777777666777788889999999999999999
Q ss_pred ccCCCCHHHHhcCHHH
Q 000535 259 ARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 259 PeKRPSAeELLkHPWF 274 (1437)
|++||++.+++.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999996
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=357.45 Aligned_cols=254 Identities=30% Similarity=0.610 Sum_probs=226.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+++++++.||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999999999999999998765432 345577889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---T 155 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---C
Confidence 999999999999754 57999999999999999999999999999999999999999999999999999876544 3
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
...+|++.|+|||.+....++.++||||||+++|+|++|..||..........++. ....+++..++..+.++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCccCCccCCHHHHHHHHHHcc
Confidence 34578999999999988888999999999999999999999998766444444443 45567788899999999999999
Q ss_pred hcccCCC-----CHHHHhcCHHHHHH
Q 000535 257 KDARQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 257 kDPeKRP-----SAeELLkHPWFQe~ 277 (1437)
.+|.+|+ +++++++||||+..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccC
Confidence 9999999 99999999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=347.28 Aligned_cols=253 Identities=48% Similarity=0.823 Sum_probs=220.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||.|+||.||+|.+..+++.+++|++..... ...+.+.+|+.++++++||||+++++++.+...+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 679999999999999999999999999999999976542 356788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+.+++|.+++... ..++++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..+........
T Consensus 81 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 81 YCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 99999999998754 25799999999999999999999999999999999999999999999999999987654332334
Q ss_pred cccCCCccCChhhhhcC---CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC----CCCCCCCHHHHHH
Q 000535 178 SVVGTPYWMAPEVIEMS---GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP----PIPESLSPDITDF 250 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~---~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp----piP~~ISpELkDL 250 (1437)
...++..|+|||.+... .++.++|+|||||++|+|++|.+||...........+...... ..+..++.++.++
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence 46789999999999776 7889999999999999999999999887766655554443211 1234567899999
Q ss_pred HHHHhhhcccCCCCHHHHhcCHH
Q 000535 251 LRQCFKKDARQRPDAKTLLSHPW 273 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkHPW 273 (1437)
|.+||..+|..||++.+++.|||
T Consensus 240 i~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.05 Aligned_cols=261 Identities=38% Similarity=0.643 Sum_probs=224.0
Q ss_pred ccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 13 gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
.-...+.|++++.||.|+||.||+|.+..++..|++|.+... .....+.+.+|+.+++.++||||+++++++..++.+
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 334557899999999999999999999999999999998754 345567788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
|+||||+++++|..++.... ..+++..+..++.|++.+|.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999999988876433 56999999999999999999999999999999999999999999999999998765443
Q ss_pred CcccccccCCCccCChhhhh-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC--CCCCCCCH
Q 000535 173 DVNTHSVVGTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPESLSP 245 (1437)
Q Consensus 173 d~kt~t~~GTp~YmAPEVL~-----g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--piP~~ISp 245 (1437)
........+++.|+|||++. ...++.++|+|||||++|+|++|.+||..........++.....+ ..+..++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 33334567899999999984 345788999999999999999999999876665555555443332 23567889
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
++.++|.+||..+|++||++.++++||||..
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 9999999999999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.97 Aligned_cols=257 Identities=37% Similarity=0.679 Sum_probs=218.7
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE------
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLK------ 87 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfe------ 87 (1437)
.-.++|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 34578999999999999999999999999999999986542 3445678899999998 7999999999884
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 88 TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 88 dd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
....+|++|||+.+|+|.+++.......+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 35689999999999999999987666679999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccccccCCCccCChhhhh-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC-CCCC
Q 000535 168 KLTEADVNTHSVVGTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP-PIPE 241 (1437)
Q Consensus 168 ~L~esd~kt~t~~GTp~YmAPEVL~-----g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp-piP~ 241 (1437)
.............|++.|+|||++. ...++.++|+|||||++|+|++|.+||....+......+...... ....
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 7654332334567899999999985 345788999999999999999999999776655444443333222 2334
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 242 ~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.++.++.+||.+||..||.+||++.++++||||
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 689999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=344.91 Aligned_cols=257 Identities=33% Similarity=0.597 Sum_probs=226.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||.|+||.||+|.+..+++.|++|++...... .....+.+|+.++.+++||||+++++++......|+|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4699999999999999999999999999999998765432 445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|+++++|.+++... .++++..++.++.|++.+|.|||+ .|++||||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 99999999999754 679999999999999999999999 999999999999999999999999999998876554433
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCC--C-hhHHHHHhhcCCCCCCCC-CCHHHHHHHH
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQ--P-MPALFRIVQDERPPIPES-LSPDITDFLR 252 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d--~-~eqL~kIiq~~rppiP~~-ISpELkDLIr 252 (1437)
....++..|+|||.+....++.++|+||||+++|+|++|..||.... . .+....+.....+..+.. ++..+.++|.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 35678999999999998889999999999999999999999997764 2 333334444445556666 8999999999
Q ss_pred HHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 253 QCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+||..+|++||++.++++|||+++.
T Consensus 238 ~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.38 Aligned_cols=254 Identities=31% Similarity=0.556 Sum_probs=218.3
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||.|+||.||+|.+..+++.|++|++............+.+|+.++++++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 59999999999999999999999999999999987665555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-ccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NTH 177 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-kt~ 177 (1437)
+ +++|.+++.... .++++..++.++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 9 999999987543 6799999999999999999999999999999999999999999999999999987654331 123
Q ss_pred cccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC-------------------
Q 000535 178 SVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP------------------- 237 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp------------------- 237 (1437)
...|+..|+|||++... .++.++|||||||++|+|++|.+||........+..+......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 45789999999998654 4688999999999999999999888776655554443321110
Q ss_pred ----------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 ----------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 ----------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
...+.++.++.++|.+||.++|.+||+++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 0113567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=382.16 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=207.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++|+||||+++++++..+...++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 467999999999999999999999999999999643 234678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC-cc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD-VN 175 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd-~k 175 (1437)
||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 163 e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 163 PRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred ecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 9995 6899888644 468999999999999999999999999999999999999999999999999997543221 12
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-------hhHHHHHhhc--------------
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP-------MPALFRIVQD-------------- 234 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-------~eqL~kIiq~-------------- 234 (1437)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+..++..
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 3356899999999999988999999999999999999999988764321 1111111100
Q ss_pred -----------CCCCCC---------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 235 -----------ERPPIP---------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 235 -----------~rppiP---------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.....+ ..++.++.+||.+||.+||.+|||+.++|+||||+.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000000 134678999999999999999999999999999975
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=389.08 Aligned_cols=270 Identities=28% Similarity=0.413 Sum_probs=240.6
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
...|++++.||.|.-|+||+|+...++..+|+|++.+..+. .....++..|-+||+.++||.++.||..|+.+++.|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 34688999999999999999999999999999999988766 45567788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc----
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE---- 171 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e---- 171 (1437)
||||+||+|..++++++.+.|++..++.|+..++.||+|||-.|||+|||||+||||.++|+|.|+||.++....-
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998753210
Q ss_pred -------------------------------C---------------------CcccccccCCCccCChhhhhcCCCCcc
Q 000535 172 -------------------------------A---------------------DVNTHSVVGTPYWMAPEVIEMSGVCAA 199 (1437)
Q Consensus 172 -------------------------------s---------------------d~kt~t~~GTp~YmAPEVL~g~~yS~K 199 (1437)
. +....+++||-.|.|||++.+.+++.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 011224689999999999999999999
Q ss_pred chhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC-CCCCCCCCHHHHHHHHHHhhhcccCCCC----HHHHhcCHHH
Q 000535 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-PPIPESLSPDITDFLRQCFKKDARQRPD----AKTLLSHPWI 274 (1437)
Q Consensus 200 SDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-ppiP~~ISpELkDLIrkCLqkDPeKRPS----AeELLkHPWF 274 (1437)
+|+|+||+++|||+.|..||.+.+..+.+.+++.... .+-.+.++.+++|||+++|.+||.+|.. +.||-+||||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccc
Confidence 9999999999999999999999999999999876542 2233478899999999999999999998 9999999999
Q ss_pred HHHHHHhhhhcc
Q 000535 275 QNCRRALQSSLR 286 (1437)
Q Consensus 275 Qe~rrsLqssL~ 286 (1437)
+.....+.....
T Consensus 396 ~gVnWaLir~~~ 407 (459)
T KOG0610|consen 396 EGVNWALIRCAR 407 (459)
T ss_pred cCCChhheeccC
Confidence 987766555444
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=383.25 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=225.1
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--RSHLHIIL 96 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed--d~~LYLVM 96 (1437)
.|+.+.+|++|+||.||+|+|+.+++.||+|.++.+.-...-.=...|||.+|.+++|||||.+-++... -+.+||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 6899999999999999999999999999999998765222112235699999999999999999998764 46799999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|||+. +|..++...+ .+|...++..++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+...-...
T Consensus 157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 99987 9999998765 689999999999999999999999999999999999999999999999999999998876555
Q ss_pred ccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC-----------------
Q 000535 177 HSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP----------------- 238 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp----------------- 238 (1437)
...+-|.+|+|||.+.+. .|+.++|+||+|||+.||++++|-|.+....+++.+|...-..|
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 667889999999998765 69999999999999999999999999999999999887632111
Q ss_pred -------------CCC-CCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 239 -------------IPE-SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 239 -------------iP~-~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
++. .++....+|++.+|.+||.+|.|+.+.|+|+||.+.
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 111 145788999999999999999999999999999764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=358.29 Aligned_cols=258 Identities=37% Similarity=0.666 Sum_probs=224.5
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
....+|.+.+.||+|+||.||+|.+..++..|++|.+...... ..+.+.+|+.+++.+.||||+++++.+....+.|+
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 3456899999999999999999999999999999998765432 34668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred eecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999999999864 3589999999999999999999999999999999999999999999999999987654433
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC--CCCCCCCHHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPESLSPDITDFLR 252 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--piP~~ISpELkDLIr 252 (1437)
......|++.|+|||.+.+..++.++|||||||++|+|++|++||.................+ ..+..++..+.++|.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 334457899999999999888999999999999999999999999876665554444333322 235678899999999
Q ss_pred HHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 253 QCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+||.++|++||++.++++||||...
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.68 Aligned_cols=255 Identities=33% Similarity=0.556 Sum_probs=217.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||.|+||.||+|++..++..||||.+............+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48999999999999999999999999999999876554444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+. ++|.+++.......+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++............
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 96 58999987666678999999999999999999999999999999999999999999999999999876543323334
Q ss_pred ccCCCccCChhhhhcCC-CCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC--------------------
Q 000535 179 VVGTPYWMAPEVIEMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP-------------------- 237 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~-yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp-------------------- 237 (1437)
..+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...+......++......
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 56788999999886644 588899999999999999999999876665555444321111
Q ss_pred --------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 --------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 --------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.+.+.+++++.++|.+||..||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=351.15 Aligned_cols=254 Identities=44% Similarity=0.756 Sum_probs=215.3
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
-.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.++++++||||+++++++..++.+|+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 35679999999999999999999999999999999875432 3345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+++++|.+++... +++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 9999999999998743 57999999999999999999999999999999999999999999999999999876543323
Q ss_pred cccccCCCccCChhhhh---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CCC---CCCCCCHHHH
Q 000535 176 THSVVGTPYWMAPEVIE---MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RPP---IPESLSPDIT 248 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~---g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rpp---iP~~ISpELk 248 (1437)
.....|++.|+|||.+. ...++.++|+||+||++|+|++|.+||...........+.... .++ ....++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 34567899999999884 3457889999999999999999999997655444333322221 111 1235789999
Q ss_pred HHHHHHhhhcccCCCCHHHHhcCHH
Q 000535 249 DFLRQCFKKDARQRPDAKTLLSHPW 273 (1437)
Q Consensus 249 DLIrkCLqkDPeKRPSAeELLkHPW 273 (1437)
+||++||..+|++||+++++++|+|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=343.95 Aligned_cols=253 Identities=48% Similarity=0.890 Sum_probs=222.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI---AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l---Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
+|+..+.||+|+||.||+|.+..++..|++|.+..... ..+....+.+|+.++++++||||+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58888999999999999999988999999999875432 234567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+++++|.+++... +++++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-F 157 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-c
Confidence 9999999999999754 568999999999999999999999999999999999999999999999999998765433 2
Q ss_pred cccccCCCccCChhhhhcCC-CCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhh-cCCCCCCCCCCHHHHHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ-DERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~-yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq-~~rppiP~~ISpELkDLIrk 253 (1437)
.....|++.|++||.+.... ++.++|+|||||++|+|++|.+||..........++.. ...+.++..+++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999997776 89999999999999999999999987665555555544 34456677889999999999
Q ss_pred HhhhcccCCCCHHHHhcCHHH
Q 000535 254 CFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLkHPWF 274 (1437)
||..+|.+||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999995
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.07 Aligned_cols=259 Identities=42% Similarity=0.755 Sum_probs=226.5
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
...|...+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.++++++||||+++++++..+...|+||
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 3457788899999999999999999999999999875432 345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++++|.+++.. +++++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+.......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 99999999999863 468999999999999999999999999999999999999999999999999998765443333
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.....+..+..++.++.++|.+||.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 34568999999999998889999999999999999999999998766655555554444555666788999999999999
Q ss_pred hcccCCCCHHHHhcCHHHHHHHH
Q 000535 257 KDARQRPDAKTLLSHPWIQNCRR 279 (1437)
Q Consensus 257 kDPeKRPSAeELLkHPWFQe~rr 279 (1437)
.+|++||++.++++||||+....
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHHhh
Confidence 99999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.43 Aligned_cols=256 Identities=38% Similarity=0.637 Sum_probs=222.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||.|+||.||+|.+..+++.|++|.+..... ......+.+|+.+++++.||||+++++++..+..+|+|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 468889999999999999999999999999999876543 3455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|+.+++|.+++.... .++++..+..++.|++.+|+|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999999998653 679999999999999999999999 9999999999999999999999999999977644321
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCC-----ChhHHHHHhhcCCCCCCCC-CCHHHHHH
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQ-----PMPALFRIVQDERPPIPES-LSPDITDF 250 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d-----~~eqL~kIiq~~rppiP~~-ISpELkDL 250 (1437)
....++..|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+.....+..+.. +++++.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 22678999999999998899999999999999999999999997542 2223333444444455554 89999999
Q ss_pred HHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 251 LRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
|.+||..+|++||++.+++.||||++.
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=350.72 Aligned_cols=253 Identities=30% Similarity=0.483 Sum_probs=224.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
+|++.+.||.|+||.||+|.+..+++.||+|++.+..... ...+.+.+|+.++++++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999899999999998654433 456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+.|++|.+.+... .++++..+..|+.|++++|.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTT 157 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccc
Confidence 99999999999754 579999999999999999999999999999999999999999999999999998765543 233
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--hhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP--MPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~--~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
...|+..|+|||++....++.++|+||||+++|+|++|..||..... ...+...........+..++.++.++|.+||
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHc
Confidence 46788999999999988899999999999999999999999987664 3333344443556677889999999999999
Q ss_pred hhcccCCCCH--HHHhcCHHH
Q 000535 256 KKDARQRPDA--KTLLSHPWI 274 (1437)
Q Consensus 256 qkDPeKRPSA--eELLkHPWF 274 (1437)
..||.+||++ .|+++||||
T Consensus 238 ~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 238 ERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cCChhHcCCccHHHHhcCCCC
Confidence 9999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=353.16 Aligned_cols=258 Identities=41% Similarity=0.736 Sum_probs=227.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
...|...+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++++.||||+++++++.++...|+||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4568889999999999999999999999999999875432 345678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++++|.+++.. +++++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+.......
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 99999999999864 468999999999999999999999999999999999999999999999999998775544333
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
....++..|+|||++.+..++.++|+|||||++|+|++|.+||...........+.....+..+..++..+.++|.+||.
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 44578899999999988889999999999999999999999998776665555554444555666788999999999999
Q ss_pred hcccCCCCHHHHhcCHHHHHHH
Q 000535 257 KDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 257 kDPeKRPSAeELLkHPWFQe~r 278 (1437)
.+|++||++.+++.||||.+..
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred cCcccCcCHHHHHhChHhhhcc
Confidence 9999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=353.62 Aligned_cols=255 Identities=39% Similarity=0.664 Sum_probs=221.0
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
.|++.+.||+|+||.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 4788999999999999999999999999999986432 44566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+++++|..++... ..++++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++............
T Consensus 84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 9999999887643 357999999999999999999999999999999999999999999999999999776443323345
Q ss_pred ccCCCccCChhhhh-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC--CCCCCCCHHHHHHH
Q 000535 179 VVGTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPESLSPDITDFL 251 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~-----g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--piP~~ISpELkDLI 251 (1437)
..|++.|+|||++. ...++.++||||+||++|+|++|.+||...+.......+.....+ ..+..++.++.+||
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 67899999999984 345778999999999999999999999887766666665544332 34567899999999
Q ss_pred HHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 252 RQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.+||..+|.+||++.++++||||..
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHccCChhhCcCHHHHhcCCCEec
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=351.65 Aligned_cols=260 Identities=40% Similarity=0.665 Sum_probs=218.2
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE---
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLK--- 87 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfe--- 87 (1437)
......++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34456789999999999999999999999999999999876432 2234577899999999 7999999999873
Q ss_pred --eCCeEEEEEeecCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEec
Q 000535 88 --TRSHLHIILEYVENGSLANIIKP--NKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADF 163 (1437)
Q Consensus 88 --dd~~LYLVMEYceGGSL~DLLKs--sr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDF 163 (1437)
.+..+|+||||+++++|.+++.. .....+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 45679999999999999998753 23357899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccccCCCccCChhhhhc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC-
Q 000535 164 GVATKLTEADVNTHSVVGTPYWMAPEVIEM-----SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP- 237 (1437)
Q Consensus 164 GLAr~L~esd~kt~t~~GTp~YmAPEVL~g-----~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp- 237 (1437)
|+++.+...........|++.|+|||++.. ..++.++|||||||++|+|++|..||........+.+......+
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 999877554434445679999999999853 44788999999999999999999999877665555444333222
Q ss_pred -CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 -PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 -piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
..+..++.++.++|.+||..+|++||++.++++|+||
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2345578899999999999999999999999999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=347.74 Aligned_cols=253 Identities=42% Similarity=0.806 Sum_probs=218.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA----QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS----eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
+|++.+.||+|+||+||+|.+ .++..+|+|.+...... ......+.+|+.++++++|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 57889999998754322 2345668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC-
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD- 173 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd- 173 (1437)
||||+++++|.+++... +++++..++.++.|++.+|+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999754 578999999999999999999999999999999999999999999999999997653211
Q ss_pred -----cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhc--CCCCCCCCCCHH
Q 000535 174 -----VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD--ERPPIPESLSPD 246 (1437)
Q Consensus 174 -----~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~--~rppiP~~ISpE 246 (1437)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+... ..+..+..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 1122456899999999999888999999999999999999999999876655544444332 344577789999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
+.++|.+||..+|.+||++.++++||||
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.55 Aligned_cols=258 Identities=32% Similarity=0.580 Sum_probs=214.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL-LKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkI-LrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|.+.+.||+|+||.||+|++..+|+.||+|.+........+. .+..|+.+ ++.++||||+++++++..++..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 47999999999999999999999999999999998665444433 34455554 66779999999999999999999999
Q ss_pred eecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 97 EYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 97 EYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSn-GIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
||++ |+|.+++... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..+....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9997 5888877542 235799999999999999999999998 99999999999999999999999999998765432
Q ss_pred cccccccCCCccCChhhhhc----CCCCccchhhhHHHHHHHHHhCCCCCCCC-CChhHHHHHhhcCCCCCC-CCCCHHH
Q 000535 174 VNTHSVVGTPYWMAPEVIEM----SGVCAASDIWSVGCTVIELLTCVPPYYEL-QPMPALFRIVQDERPPIP-ESLSPDI 247 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g----~~yS~KSDIWSLG~ILYELLTGkpPF~g~-d~~eqL~kIiq~~rppiP-~~ISpEL 247 (1437)
......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||... ...+.+..+.....+.++ ..+|.++
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 2223568899999998864 45688999999999999999999999653 334455555554444444 3589999
Q ss_pred HHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 248 kDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
.++|.+||..+|++||++.+++.||||+...
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=360.20 Aligned_cols=258 Identities=38% Similarity=0.675 Sum_probs=223.9
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
....+|.+.+.||.|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...++.|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 345789999999999999999999999999999999875443 234567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+++++|.+++.. ..+++..+..++.|++.+|.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred eecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999999999864 3589999999999999999999999999999999999999999999999999987655443
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC--CCCCCCCHHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPESLSPDITDFLR 252 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--piP~~ISpELkDLIr 252 (1437)
......+++.|+|||.+.+..++.++|+|||||++|+|++|.+||...+....+..+.....+ ..+..++..+.+||.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 334567899999999999888999999999999999999999999876654444333332222 245668899999999
Q ss_pred HHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 253 QCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+||..+|++||++.++++||||+..
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=344.56 Aligned_cols=253 Identities=44% Similarity=0.780 Sum_probs=220.4
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|.+.+.||.|+||.||+|.+..++..|++|.+.... ..+.+.+|+.++++++||||+++++++..+..+|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 367999999999999999999998889999999987542 2667899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+.+++|.+++... ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..........
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 999999999999643 3579999999999999999999999999999999999999999999999999998876543333
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC--CCCCCCCHHHHHHHHHH
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPESLSPDITDFLRQC 254 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--piP~~ISpELkDLIrkC 254 (1437)
....|+..|+|||++.+..++.++||||||+++|+|++|++||...........+...... ..+..++.++.++|.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 3456889999999999889999999999999999999999999876655444333222221 23456788999999999
Q ss_pred hhhcccCCCCHHHHhcCHHH
Q 000535 255 FKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 255 LqkDPeKRPSAeELLkHPWF 274 (1437)
|..+|++||++.+++.||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.35 Aligned_cols=258 Identities=37% Similarity=0.665 Sum_probs=218.8
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTR---- 89 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd---- 89 (1437)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 35688999999999999999999999999999999986542 2234567899999999 899999999998643
Q ss_pred -CeEEEEEeecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccc
Q 000535 90 -SHLHIILEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA 166 (1437)
Q Consensus 90 -~~LYLVMEYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLA 166 (1437)
..+|+||||+++++|.++++.. ...++++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 4689999999999999988632 3457999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccccCCCccCChhhhhcC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC--C
Q 000535 167 TKLTEADVNTHSVVGTPYWMAPEVIEMS-----GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--I 239 (1437)
Q Consensus 167 r~L~esd~kt~t~~GTp~YmAPEVL~g~-----~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp--i 239 (1437)
..+...........|+..|+|||++... .++.++|||||||++|+|++|++||........+.++.....+. .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence 8765444333456789999999998643 36789999999999999999999998776666665554443332 2
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 240 P~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
+..++..+.++|.+||.++|++||++.+++.||||+
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 446778999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=353.27 Aligned_cols=258 Identities=32% Similarity=0.585 Sum_probs=221.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++++.||+|+||.||+|.+..++..||+|.+... ......+.+.+|+.++++++||||+++++++..++.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4789999999999999999999999999999998754 344556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 98 YVENGSLANIIKPNK-FGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 98 YceGGSL~DLLKssr-~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
||++++|.+++.... ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++..+... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--L 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--c
Confidence 999999999987531 3479999999999999999999997 59999999999999999999999999999876433 2
Q ss_pred cccccCCCccCChhhhhcC------CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHH---HHHhhcCCCCCCCCCCHH
Q 000535 176 THSVVGTPYWMAPEVIEMS------GVCAASDIWSVGCTVIELLTCVPPYYELQPMPAL---FRIVQDERPPIPESLSPD 246 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~------~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL---~kIiq~~rppiP~~ISpE 246 (1437)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|..||......... ..+.....+.++..++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 3345788999999998544 3578999999999999999999999764443322 223344556677789999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
+.+||.+||..+|++||++.+++.||||...+
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.18 Aligned_cols=251 Identities=31% Similarity=0.550 Sum_probs=213.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 36889999999999999999999999999999987543 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..+... ...
T Consensus 80 ~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~ 151 (279)
T cd06619 80 FMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAK 151 (279)
T ss_pred cCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--ccc
Confidence 9999998654 35789999999999999999999999999999999999999999999999999876543 233
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-------hHHHHHhhcCCCCC-CCCCCHHHHH
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM-------PALFRIVQDERPPI-PESLSPDITD 249 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~-------eqL~kIiq~~rppi-P~~ISpELkD 249 (1437)
..+|+..|+|||++.+..++.++|+|||||++|+|++|..||...... .....+.....+.. ...+++++.+
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 468999999999999888999999999999999999999999653221 11111222222222 2457899999
Q ss_pred HHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+|.+||..+|++||++.++++||||+..
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=380.44 Aligned_cols=267 Identities=31% Similarity=0.489 Sum_probs=232.6
Q ss_pred cccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 000535 8 SAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK 87 (1437)
Q Consensus 8 s~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfe 87 (1437)
..|.....+..+|...+.||+|+||.|..|.+..+|+.||||++.......-..++..||+++|+.++|+||+.+++++.
T Consensus 12 ~~~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 12 EVFGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred EeeeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 34556667788888899999999999999999999999999999866666778889999999999999999999999986
Q ss_pred e-----CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEe
Q 000535 88 T-----RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLAD 162 (1437)
Q Consensus 88 d-----d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiD 162 (1437)
. -+.+|+|+|+|+ -+|..+++.+ ..|++..+..+++|++.||+|+|+.+|+||||||+|+|++.++.+||+|
T Consensus 92 p~~~~~f~DvYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cccccccceeEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecc
Confidence 5 357999999995 5999999865 3599999999999999999999999999999999999999999999999
Q ss_pred cccccccccC--CcccccccCCCccCChhhhh-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC---
Q 000535 163 FGVATKLTEA--DVNTHSVVGTPYWMAPEVIE-MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER--- 236 (1437)
Q Consensus 163 FGLAr~L~es--d~kt~t~~GTp~YmAPEVL~-g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r--- 236 (1437)
||+|+..... ......++.|.+|.|||++. ...|+.++||||+|||+.||++|++-|.+.+...++..+...-.
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 9999988642 22345688999999999874 56799999999999999999999999999888777776543111
Q ss_pred ----------------------CC-----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 237 ----------------------PP-----IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 237 ----------------------pp-----iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
++ +-++.++.+.+|+.+||..||.+|+|++|+|.|||+...
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11 114678999999999999999999999999999999764
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.42 Aligned_cols=254 Identities=39% Similarity=0.785 Sum_probs=221.3
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|.+.+.||+|+||.||+|.+..++..|++|.+..........+.+..|+.++++++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999988999999999987766556778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc--
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT-- 176 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt-- 176 (1437)
+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999999754 458999999999999999999999999999999999999999999999999998765433221
Q ss_pred --ccccCCCccCChhhhhcCC---CCccchhhhHHHHHHHHHhCCCCCCCCC-ChhHHHHHhhcCCCCCCCC--CCHHHH
Q 000535 177 --HSVVGTPYWMAPEVIEMSG---VCAASDIWSVGCTVIELLTCVPPYYELQ-PMPALFRIVQDERPPIPES--LSPDIT 248 (1437)
Q Consensus 177 --~t~~GTp~YmAPEVL~g~~---yS~KSDIWSLG~ILYELLTGkpPF~g~d-~~eqL~kIiq~~rppiP~~--ISpELk 248 (1437)
....+++.|+|||++.... ++.++||||||+++|+|++|..||.... .......+.....+.+|.. +++.+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHH
Confidence 1356889999999998766 8899999999999999999999997653 3333334443444445544 489999
Q ss_pred HHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 249 DFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 249 DLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
++|.+||..+|.+||++.+++.|||+
T Consensus 239 ~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 239 DFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.00 Aligned_cols=256 Identities=38% Similarity=0.705 Sum_probs=224.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.+|.+.+.||.|+||.||+|.+..+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++.....+|+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 579999999999999999999999999999999875433 334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus 97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 97 YLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred ecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 9999999999864 3589999999999999999999999999999999999999999999999999987655443334
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC--CCCCCCCHHHHHHHHHHh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--piP~~ISpELkDLIrkCL 255 (1437)
...|++.|+|||.+....++.++|+|||||++|+|++|..||...+.......+.....+ ..+..+++.+.++|.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence 467899999999999888999999999999999999999999887766555554433322 245678999999999999
Q ss_pred hhcccCCCCHHHHhcCHHHHHHH
Q 000535 256 KKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 256 qkDPeKRPSAeELLkHPWFQe~r 278 (1437)
..+|.+||++.+++.||||+...
T Consensus 254 ~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 254 EMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=353.85 Aligned_cols=256 Identities=32% Similarity=0.528 Sum_probs=217.6
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA---QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS---eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
+|.+.+.||+|+||.||+|.+..+++.|++|.+...... ......+..|+.++++++|+||+++++++.+....|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999866544 33345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+ +++|.+++.... ..+++..++.++.||++||.|||++||+|+||||+||+++.++.++|+|||+++........
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 9999 889999997543 47999999999999999999999999999999999999999999999999999887654333
Q ss_pred cccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC-----------------
Q 000535 176 THSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP----------------- 237 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp----------------- 237 (1437)
.....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||......+.+.++......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 334467889999998854 45788999999999999999999888876665554444321100
Q ss_pred -----C-----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 238 -----P-----IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 238 -----p-----iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+ ....++.++.++|.+||.++|++|||+.+++.||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 0 11345788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=350.60 Aligned_cols=253 Identities=27% Similarity=0.446 Sum_probs=218.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCC-----eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENG-----DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTG-----k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
++|++.+.||+|+||.||+|.+...+ ..|++|.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 47899999999999999999876554 789999986443 334456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcE
Q 000535 93 HIILEYVENGSLANIIKPNKF--------------GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLV 158 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~--------------GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~V 158 (1437)
|++|||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 999999999999999975321 468899999999999999999999999999999999999999999
Q ss_pred EEEecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC
Q 000535 159 KLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE 235 (1437)
Q Consensus 159 KLiDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~ 235 (1437)
+|+|||++........ ......+++.|+|||.+....++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999986543321 1223466889999999988889999999999999999998 999998877766666666666
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 236 rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
..+.+..+++++.+|+.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 244 LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 667788899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=346.65 Aligned_cols=255 Identities=35% Similarity=0.685 Sum_probs=217.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA----QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS----eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
+|+..+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999999999999999998754422 1235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-cEEEEecccccccccCC
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKLADFGVATKLTEAD 173 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-~VKLiDFGLAr~L~esd 173 (1437)
||||+++++|.+++... +++++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999753 5799999999999999999999999999999999999998776 69999999998765432
Q ss_pred c----ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHH---h-hcCCCCCCCCCCH
Q 000535 174 V----NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI---V-QDERPPIPESLSP 245 (1437)
Q Consensus 174 ~----kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kI---i-q~~rppiP~~ISp 245 (1437)
. ......|+..|+|||.+....++.++|+|||||++|+|++|..||...........+ . ....+..+..+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 1 112356889999999998888999999999999999999999999754433222222 1 1233456677899
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
++.+++.+||..+|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.27 Aligned_cols=254 Identities=32% Similarity=0.557 Sum_probs=216.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|++++++++||||+++++++..++.+|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 46999999999999999999999999999999987542 34455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|+++++|.++++.. +++++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++....... .
T Consensus 80 y~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~ 155 (308)
T cd06615 80 HMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A 155 (308)
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--c
Confidence 99999999999754 679999999999999999999997 599999999999999999999999999997664332 3
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhh-----------------------
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ----------------------- 233 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq----------------------- 233 (1437)
...+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+... ......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCCCcc
Confidence 45678999999999988889999999999999999999999996544222 111111
Q ss_pred --------------cCCCCCC-CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 234 --------------DERPPIP-ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 234 --------------~~rppiP-~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
...+..| ..++.++.+||.+||..+|++||++.++++||||.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111111 1368899999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=351.92 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=213.7
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCe-----
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSH----- 91 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd~~----- 91 (1437)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++++. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998765433334456788999999995 6999999999877655
Q ss_pred EEEEEeecCCCCHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-CCcEEEEeccccc
Q 000535 92 LHIILEYVENGSLANIIKPNK---FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-EGLVKLADFGVAT 167 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr---~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-nG~VKLiDFGLAr 167 (1437)
.|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 8988886432 246899999999999999999999999999999999999998 8899999999998
Q ss_pred ccccCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC---------
Q 000535 168 KLTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--------- 237 (1437)
Q Consensus 168 ~L~esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--------- 237 (1437)
.+...........+++.|+|||++.+ ..++.++||||||+++|+|++|.+||......+.+.++......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 66443222233467889999998865 45789999999999999999999999887766655544331100
Q ss_pred ------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 238 ------------------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 238 ------------------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
...+.+++++.+||.+||.++|.+||++.+++.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01135789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.59 Aligned_cols=260 Identities=29% Similarity=0.495 Sum_probs=218.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+.++++++||||+++++++.+..+.|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999999999999999987655444445668889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-CCcEEEEecccccccccCCccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-EGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-nG~VKLiDFGLAr~L~esd~kt 176 (1437)
|+. ++|.+.+.......+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++..........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 996 58888887655556789999999999999999999999999999999999985 4579999999998764432222
Q ss_pred ccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC-----------------
Q 000535 177 HSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP----------------- 238 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp----------------- 238 (1437)
....+++.|+|||++.+. .++.++|||||||++|+|++|.+||......+.+.++......+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 345678999999998764 57889999999999999999999998766655555443211000
Q ss_pred -----------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 239 -----------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 239 -----------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
..+.+++++.++|.+||..+|++||++.++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1235788999999999999999999999999999998754
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.80 Aligned_cols=255 Identities=43% Similarity=0.789 Sum_probs=217.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA---QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--RSHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS---eedie~L~REIkILrrLnHPNIVKLigVfed--d~~L 92 (1437)
..|.+.+.||+|+||.||+|.+..++..|++|.+...... ......+.+|+.++++++||||+++++++.. +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4699999999999999999999999999999998755332 2345678899999999999999999998865 4688
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
|++|||+++++|.+++... +.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999999754 46899999999999999999999999999999999999999999999999999765432
Q ss_pred C---cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhc-CCCCCCCCCCHHHH
Q 000535 173 D---VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-ERPPIPESLSPDIT 248 (1437)
Q Consensus 173 d---~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~-~rppiP~~ISpELk 248 (1437)
. .......++..|+|||++.+..++.++|+||+||++|+|++|.+||............... ..+.++..+++.+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence 1 1122356889999999999888999999999999999999999999876655555444332 23455667889999
Q ss_pred HHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 249 DFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 249 DLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
++| +||..+|++||+++++++||||+
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999 67778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=348.03 Aligned_cols=252 Identities=21% Similarity=0.414 Sum_probs=216.8
Q ss_pred CCceEEEeEecccCcEEEEEEEEc---CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL---ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDr---kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.++++++||||+++++++..++..|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 457999999999999999999765 346789999987543 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+++|+|.+++... .+.+++..++.++.|++.||+|||++|++||||||+|||++.++.++++|||.+.......
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999999754 3579999999999999999999999999999999999999999999999999886643222
Q ss_pred c-ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHH
Q 000535 174 V-NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFL 251 (1437)
Q Consensus 174 ~-kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLI 251 (1437)
. ......++..|+|||++.+..++.++|||||||++|++++ |.+||......+.+..+......+.+..++..+.+++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLM 241 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 1 1112345678999999999999999999999999999775 9999988777666666666666677888999999999
Q ss_pred HHHhhhcccCCCCHHHHhc
Q 000535 252 RQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLk 270 (1437)
.+||.++|.+||++.+|++
T Consensus 242 ~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 242 LDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHcCCCchhCCCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=333.95 Aligned_cols=254 Identities=48% Similarity=0.886 Sum_probs=224.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--SHLHIIL 96 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd--~~LYLVM 96 (1437)
+|.+.+.||+|+||.||+|.+..+++.|++|++..........+.+.+|+.++++++||||+++++++... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999998999999999987765556778899999999999999999999999988 8999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-- 174 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-- 174 (1437)
||+++++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999999998553 799999999999999999999999999999999999999999999999999988766542
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-hhHHHHHhh-cCCCCCCCCCCHHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQ-DERPPIPESLSPDITDFLR 252 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-~eqL~kIiq-~~rppiP~~ISpELkDLIr 252 (1437)
......++..|+|||.+....++.++|+||||+++|+|++|..||..... ......+.. .....++..++..+.++|.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 13346789999999999888899999999999999999999999977652 222333322 3445667788999999999
Q ss_pred HHhhhcccCCCCHHHHhcCHHH
Q 000535 253 QCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkHPWF 274 (1437)
+||..+|++||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=357.88 Aligned_cols=247 Identities=30% Similarity=0.467 Sum_probs=195.7
Q ss_pred EeEecccCcEEEEEEEEc--CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEEEEee
Q 000535 23 GDEIGKGAYGRVYKGLDL--ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--RSHLHIILEY 98 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDr--kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed--d~~LYLVMEY 98 (1437)
+.+||+|+||+||+|++. .+++.||+|.+...... ..+.+|+.+|++++||||+++++++.. +..+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999965 46789999998754332 346789999999999999999998854 5678999999
Q ss_pred cCCCCHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEe----ccCCcEEEEeccccc
Q 000535 99 VENGSLANIIKPN-------KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILT----TKEGLVKLADFGVAT 167 (1437)
Q Consensus 99 ceGGSL~DLLKss-------r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILL----denG~VKLiDFGLAr 167 (1437)
+.+ +|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 964 898887532 12358999999999999999999999999999999999999 455789999999998
Q ss_pred ccccCCc---ccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCC---------hhHHHHHhhc
Q 000535 168 KLTEADV---NTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQP---------MPALFRIVQD 234 (1437)
Q Consensus 168 ~L~esd~---kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~---------~eqL~kIiq~ 234 (1437)
.+..... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||..... ...+.++...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 7643221 2234678999999999876 4588999999999999999999999964332 1112111110
Q ss_pred CCC-------------------------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 235 ERP-------------------------------------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 235 ~rp-------------------------------------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
... ......+.++.+||.+||.+||.+|||++++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 0001235678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=375.80 Aligned_cols=264 Identities=26% Similarity=0.473 Sum_probs=234.8
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC------HHHHHHHHHHHHHHHhC-CCCCcceEEE
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA------QEDLNIIMQEIDLLKNL-NHKNIVKYLG 84 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS------eedie~L~REIkILrrL-nHPNIVKLig 84 (1437)
..+.+.+.|.-.+.||+|.-++|.++.++.+|+.+|+|+|...... .+-.+.-.+|+.||+++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 3456677899999999999999999999999999999999754321 12234556799999998 7999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecc
Q 000535 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFG 164 (1437)
Q Consensus 85 Vfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFG 164 (1437)
+|+++..+++|+|.|+.|.|+|++.+. -.++|+..+.|++|++.|++|||.++||||||||+|||++++.++||+|||
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999999999854 579999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccccccCCCccCChhhhhc------CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC---
Q 000535 165 VATKLTEADVNTHSVVGTPYWMAPEVIEM------SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE--- 235 (1437)
Q Consensus 165 LAr~L~esd~kt~t~~GTp~YmAPEVL~g------~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~--- 235 (1437)
+++.+.++. +....||||+|+|||.+.. .+|+..+|+|++|+|||.|+.|.+||+.....-.+.-|+.+.
T Consensus 169 Fa~~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF 247 (411)
T KOG0599|consen 169 FACQLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF 247 (411)
T ss_pred eeeccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence 999997765 6678999999999999854 368899999999999999999999999877666666666654
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 236 rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
..+.+.++|.+.++||.+||+.||.+|.|++|+|.||||++..
T Consensus 248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 4567789999999999999999999999999999999998764
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=337.25 Aligned_cols=247 Identities=27% Similarity=0.490 Sum_probs=218.9
Q ss_pred eEecccCcEEEEEEEEcCC---CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecC
Q 000535 24 DEIGKGAYGRVYKGLDLEN---GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkT---Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYce 100 (1437)
+.||+|+||.||+|.+... +..|++|.+....... ..+.+.+|+.+++.++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 4689999999999999866 8999999998665433 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 101 NGSLANIIKPNK-------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 101 GGSL~DLLKssr-------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 999999998642 3679999999999999999999999999999999999999999999999999998876543
Q ss_pred --cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHH
Q 000535 174 --VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 174 --~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDL 250 (1437)
.......+++.|+|||.+....++.++|||||||++|+|++ |..||......+....+........+..+++++.++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL 239 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence 22334567889999999988889999999999999999999 699998887666666666666677788899999999
Q ss_pred HHHHhhhcccCCCCHHHHhcC
Q 000535 251 LRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkH 271 (1437)
+.+||..+|++||++.+++++
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.50 Aligned_cols=255 Identities=32% Similarity=0.559 Sum_probs=217.5
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||+|+||.||+|.+..+++.|++|.+..........+.+.+|+++++++.||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999999999999999987655545556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-cc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NT 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-kt 176 (1437)
|++++.+..++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99987666655432 4689999999999999999999999999999999999999999999999999988765432 23
Q ss_pred ccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC--------------------
Q 000535 177 HSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-------------------- 235 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-------------------- 235 (1437)
....++..|+|||++... .++.++|+||||+++|+|++|.+||......+.+..+....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 346788999999999888 78999999999999999999999998765544433321100
Q ss_pred -C----------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 236 -R----------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 236 -r----------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
. ...+..+++++.+||.+||..+|++||++.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01233458999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=383.40 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=204.1
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC------CCcceEEEEEEeC-
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH------KNIVKYLGSLKTR- 89 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnH------PNIVKLigVfedd- 89 (1437)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.+.| ++++++++++..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 578999999999999999999999999999999986432 223345567777777654 4588999988764
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCC------------
Q 000535 90 SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEG------------ 156 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG------------ 156 (1437)
.++|+|||++ |++|.+++... +.+++..++.|+.||+.||.|||+ .||+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 6789999998 67999988744 579999999999999999999998 5999999999999998765
Q ss_pred ----cEEEEecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHh
Q 000535 157 ----LVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV 232 (1437)
Q Consensus 157 ----~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIi 232 (1437)
.+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.
T Consensus 282 ~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 499999999865332 2345789999999999999999999999999999999999999998766655443332
Q ss_pred hcCC--------------------------CCC-C--------------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 233 QDER--------------------------PPI-P--------------ESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 233 q~~r--------------------------ppi-P--------------~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
.... +.. + ...++.+.+||.+||.+||.+|||+.++|+|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 2100 000 0 0113567899999999999999999999999
Q ss_pred HHHHH
Q 000535 272 PWIQN 276 (1437)
Q Consensus 272 PWFQe 276 (1437)
|||++
T Consensus 439 p~~~~ 443 (467)
T PTZ00284 439 PYVLK 443 (467)
T ss_pred ccccc
Confidence 99975
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=350.69 Aligned_cols=255 Identities=34% Similarity=0.543 Sum_probs=216.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999998899999999987654444445668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++++|.++.... ..+++..+..++.|++.+|.|||+.||+|+||+|+||+++.++.++|+|||++..+........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 99999888877533 4589999999999999999999999999999999999999999999999999987655443334
Q ss_pred cccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--------------------
Q 000535 178 SVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------------------- 236 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-------------------- 236 (1437)
...++..|+|||++.+. .++.++|||||||++|+|++|.+||......+...++.....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 46788999999998753 477889999999999999999999976665444333321000
Q ss_pred -C---------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 -P---------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 -p---------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
+ ...+.++..+.+|+.+||..+|++||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 0124678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.73 Aligned_cols=255 Identities=41% Similarity=0.725 Sum_probs=220.1
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCeEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN---HKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn---HPNIVKLigVfedd~~LYLV 95 (1437)
.|++.+.||.|+||.||+|.+..+++.||+|.+.... .....+.+.+|+.+++++. |||++++++++..+...|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 5888999999999999999999999999999987543 3345567889999999996 99999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+++++|.++++. +++++..++.++.|++.+|.|||+.||+|+||+|+||+++.++.++|+|||++..+......
T Consensus 81 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 81 MEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 999999999999864 37999999999999999999999999999999999999999999999999999887655434
Q ss_pred cccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCC-CCCHHHHHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE-SLSPDITDFLRQ 253 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~-~ISpELkDLIrk 253 (1437)
.....|+..|+|||.+.. ..++.++|+|||||++|+|++|.+||...........+.....+.++. .++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 445678999999999865 457889999999999999999999998766544443333333334444 388999999999
Q ss_pred HhhhcccCCCCHHHHhcCHHHHHH
Q 000535 254 CFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
||..||++||++.+++.||||++.
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhcc
Confidence 999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=384.50 Aligned_cols=263 Identities=25% Similarity=0.490 Sum_probs=236.8
Q ss_pred CcccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEE
Q 000535 7 TSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGS 85 (1437)
Q Consensus 7 as~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigV 85 (1437)
.+..+....+..+|++.+.||+|+||.|-+|.+...|+.||||.|++..... .+.-.+.+||+||..|+||||+.++++
T Consensus 42 vkrhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV 121 (668)
T KOG0611|consen 42 VKRHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV 121 (668)
T ss_pred ccccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence 5666777889999999999999999999999999999999999999877654 567789999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccc
Q 000535 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGV 165 (1437)
Q Consensus 86 fedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGL 165 (1437)
|++.+.+.|||||..+|.|++++.+. +.|+|.+++.+++||..|+.|+|.++++|||||.+|||++.|+++||+|||+
T Consensus 122 FENkdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 122 FENKDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred hcCCceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccch
Confidence 99999999999999999999999754 6899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccCCCccCChhhhhcCCC-CccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCC
Q 000535 166 ATKLTEADVNTHSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLS 244 (1437)
Q Consensus 166 Ar~L~esd~kt~t~~GTp~YmAPEVL~g~~y-S~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~IS 244 (1437)
+..+.... ...++||+|.|.+||++++.+| ++.+|-||||++||.|+.|.+||.+.+....+.+|..+.+. .+.-+
T Consensus 200 SNly~~~k-fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--EP~~P 276 (668)
T KOG0611|consen 200 SNLYADKK-FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--EPETP 276 (668)
T ss_pred hhhhcccc-HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--CCCCC
Confidence 98887654 5668999999999999999988 57899999999999999999999998877666666555432 23356
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 245 pELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
..+.-||+.||..+|++|.|+.+|..|=|+
T Consensus 277 SdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 277 SDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred chHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 678899999999999999999999999444
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.24 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=221.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.+|.+.+.||.|+||.||+|.+.. +..+++|++.... ....+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 469999999999999999999877 8999999987543 2345568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 99999999999876667799999999999999999999999999999999999999999999999999987654433333
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
...++..|+|||.+....++.++||||||+++|+|++ |..||......+.+..+......+.+..+++++.++|.+||.
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 242 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWA 242 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcC
Confidence 4456778999999988889999999999999999998 899998877666666666666667778899999999999999
Q ss_pred hcccCCCCHHHHhc
Q 000535 257 KDARQRPDAKTLLS 270 (1437)
Q Consensus 257 kDPeKRPSAeELLk 270 (1437)
.+|.+|||+.++++
T Consensus 243 ~~p~~Rpt~~~l~~ 256 (261)
T cd05148 243 AEPEDRPSFKALRE 256 (261)
T ss_pred CCchhCcCHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=346.17 Aligned_cols=256 Identities=41% Similarity=0.745 Sum_probs=225.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
+-|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.++++++||||+++++++..+...|+|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 458889999999999999999988999999998865432 3455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++++|.+++.. +.+++..+..++.|++.++.|||++|++|+||||+||+++.++.++|+|||++..+........
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 9999999999864 4689999999999999999999999999999999999999999999999999987654433333
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqk 257 (1437)
...++..|+|||.+....++.++|+|||||++|+|++|..||...........+.....+.++..++.++.++|.+||..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 45789999999999888889999999999999999999999987666555555555555566678899999999999999
Q ss_pred cccCCCCHHHHhcCHHHHHH
Q 000535 258 DARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 258 DPeKRPSAeELLkHPWFQe~ 277 (1437)
+|.+||++.++++||||.+.
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=330.19 Aligned_cols=251 Identities=44% Similarity=0.784 Sum_probs=221.1
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
.|.+.+.||+|+||.||++.+..+++.|++|++..... .....+.+|+.++++++||||+++++++..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 48899999999999999999988999999999876543 3556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+++++|.+++.... .++++..+..++.|++.+|.|||++|++||||+|+||+++.++.++|+|||.+........ ...
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 156 (253)
T cd05122 79 CSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNT 156 (253)
T ss_pred CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccc
Confidence 99999999997543 5799999999999999999999999999999999999999999999999999988765432 345
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCC--CCHHHHHHHHHHhh
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES--LSPDITDFLRQCFK 256 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~--ISpELkDLIrkCLq 256 (1437)
..++..|+|||.+....++.++|+||||+++|+|++|..||...+.............+..+.. ++..+.++|.+||.
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 6789999999999888899999999999999999999999987765555555444433334333 48999999999999
Q ss_pred hcccCCCCHHHHhcCHH
Q 000535 257 KDARQRPDAKTLLSHPW 273 (1437)
Q Consensus 257 kDPeKRPSAeELLkHPW 273 (1437)
.||++|||+.++++|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=353.84 Aligned_cols=258 Identities=32% Similarity=0.490 Sum_probs=215.5
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--SHLHI 94 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd--~~LYL 94 (1437)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.++++++|+||+++++++.+. +.+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4579999999999999999999999999999999876543333334466899999999999999999998754 57899
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999975 8988887543 5799999999999999999999999999999999999999999999999999987754432
Q ss_pred ccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC----------------
Q 000535 175 NTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP---------------- 237 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp---------------- 237 (1437)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+......
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 2233456888999999865 45789999999999999999999999887766655554431110
Q ss_pred --CCC-----------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 238 --PIP-----------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 238 --piP-----------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.++ ..+++++.+||.+||..||++|||+.+++.||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 125889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=341.60 Aligned_cols=254 Identities=43% Similarity=0.776 Sum_probs=217.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI---AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--RSHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l---Seedie~L~REIkILrrLnHPNIVKLigVfed--d~~L 92 (1437)
.+|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+.+|+.+++++.||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999865432 23456788899999999999999999998866 3578
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
|+||||+++++|.+++... +++++..+..++.|++.+|.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999999744 46899999999999999999999999999999999999999999999999999865432
Q ss_pred Cc---ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CCCCCCCCCHHHH
Q 000535 173 DV---NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RPPIPESLSPDIT 248 (1437)
Q Consensus 173 d~---kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rppiP~~ISpELk 248 (1437)
.. ......|+..|+|||++.+..++.++|+|||||++|+|++|..||..........+..... .+..|..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 11 1233568999999999988889999999999999999999999998765555554443322 3446677889999
Q ss_pred HHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 249 DFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 249 DLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
++|.+||. +|.+||++++++.|||+
T Consensus 240 ~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 240 DFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 99999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=340.80 Aligned_cols=253 Identities=35% Similarity=0.605 Sum_probs=215.7
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||.||+|++..+++.||||.+..... .......+.+|+.++++++||||+++++++...+..|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 689999999999999999999999999999998875433 3444567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 97 EYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 97 EYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||+++|+|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999999999988532 234689999999999999999999999999999999999999999999999999987755433
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--hhHHHHHhhcCCCCCC-CCCCHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP--MPALFRIVQDERPPIP-ESLSPDITDFL 251 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~--~eqL~kIiq~~rppiP-~~ISpELkDLI 251 (1437)
......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......+.....++.+ ..++..+.++|
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV 241 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 33456789999999999988899999999999999999999999965432 2222333333333433 46788999999
Q ss_pred HHHhhhcccCCCCHHHHhc
Q 000535 252 RQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLk 270 (1437)
.+||..+|++||++.++++
T Consensus 242 ~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 242 SMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHCCCCcccCcCHHHHHH
Confidence 9999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=346.73 Aligned_cols=251 Identities=25% Similarity=0.449 Sum_probs=215.7
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCH
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL 104 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL 104 (1437)
||+|+||+||+|.+..+++.||+|++....... .....+..|+.++++++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999999999999999997654332 2344567899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCCCc
Q 000535 105 ANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY 184 (1437)
Q Consensus 105 ~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~ 184 (1437)
.+++.......+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .......++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence 99997655457999999999999999999999999999999999999999999999999999876542 22334568889
Q ss_pred cCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---hhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP---MPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 185 YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~---~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|+|||++.+..++.++|||||||++|+|++|+.||..... ...+.+.........+..+++.+.++|.+||..+|.+
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 9999999888899999999999999999999999976544 2223333333445567788999999999999999999
Q ss_pred CC-----CHHHHhcCHHHHHH
Q 000535 262 RP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 262 RP-----SAeELLkHPWFQe~ 277 (1437)
|| ++.++++||||...
T Consensus 240 R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCCCcccHHHHHhChhhhcC
Confidence 99 89999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=341.86 Aligned_cols=251 Identities=24% Similarity=0.439 Sum_probs=218.3
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
...|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++..+..+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 456999999999999999999999999999999987432 34566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++++|.+++.......+++..++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 99999999999976655679999999999999999999999999999999999999999999999999998765433211
Q ss_pred -ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 177 -HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 177 -~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+........+..++.++.++|.+|
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 241 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRAC 241 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 12234567999999998899999999999999999998 9999987665554445544456677788999999999999
Q ss_pred hhhcccCCCCHHHHhc
Q 000535 255 FKKDARQRPDAKTLLS 270 (1437)
Q Consensus 255 LqkDPeKRPSAeELLk 270 (1437)
|..+|++||++.++++
T Consensus 242 l~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 242 WQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ccCCcccCCCHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.73 Aligned_cols=254 Identities=33% Similarity=0.555 Sum_probs=216.1
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
|++.+.||.|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999999999999999866544444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccc
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV 179 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~ 179 (1437)
. ++|.+++.......+++..++.++.|++.||+|||+++++||||+|+||+++.++.++|+|||++.............
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 5 699999976654579999999999999999999999999999999999999999999999999998764433222334
Q ss_pred cCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC----------------------
Q 000535 180 VGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER---------------------- 236 (1437)
Q Consensus 180 ~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r---------------------- 236 (1437)
.+++.|+|||++.+. .++.++||||||+++|+|++|.+||...+....+.++.....
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 678899999988654 578899999999999999999999987766555444332110
Q ss_pred ------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 ------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 ------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
....+.++.++.++|.+||+.+|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01234677899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=340.69 Aligned_cols=248 Identities=32% Similarity=0.544 Sum_probs=217.9
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCH
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL 104 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL 104 (1437)
||.|+||.||+|.+..+++.|++|++.+.... ....+.+.+|+.++++++||||+++++++.++..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999989999999999865443 34456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCCCc
Q 000535 105 ANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY 184 (1437)
Q Consensus 105 ~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~ 184 (1437)
.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPE 157 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcC
Confidence 9999754 468999999999999999999999999999999999999999999999999998876543 2334578999
Q ss_pred cCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCC--ChhHHHHHhh-cCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQ--PMPALFRIVQ-DERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 185 YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d--~~eqL~kIiq-~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
|++||.+....++.++|+||||+++|+|++|..||.... ......++.. ......|..+++++.++|.+||..+|++
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 237 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence 999999988889999999999999999999999998766 3334444442 3455667777999999999999999999
Q ss_pred CCC-----HHHHhcCHHHHH
Q 000535 262 RPD-----AKTLLSHPWIQN 276 (1437)
Q Consensus 262 RPS-----AeELLkHPWFQe 276 (1437)
||+ +.|+++||||..
T Consensus 238 R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 238 RLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred CcCCcccCHHHHhcChhhhC
Confidence 999 999999999964
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=337.63 Aligned_cols=253 Identities=35% Similarity=0.640 Sum_probs=217.2
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|.+.+.||+|+||.||+|.+..+++.||+|.++..... ....+.+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5899999999999999999999989999999998754433 344678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 97 EYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 97 EYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||+++++|.+++... ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999998642 235689999999999999999999999999999999999999999999999999987655433
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--hhHHHHHhhcCCCCCCC-CCCHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP--MPALFRIVQDERPPIPE-SLSPDITDFL 251 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~--~eqL~kIiq~~rppiP~-~ISpELkDLI 251 (1437)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||..... ......+.....++.+. .++.++.++|
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 241 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV 241 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence 33456789999999999988899999999999999999999999965432 12222333334445554 7889999999
Q ss_pred HHHhhhcccCCCCHHHHhc
Q 000535 252 RQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLk 270 (1437)
.+||..+|++||++.++++
T Consensus 242 ~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 242 SRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHcCCCcccCCCHHHHHH
Confidence 9999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=340.47 Aligned_cols=252 Identities=23% Similarity=0.419 Sum_probs=216.4
Q ss_pred eEEEeEecccCcEEEEEEEEcCC---CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLEN---GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS------ 90 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkT---Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~------ 90 (1437)
|.+++.||+|+||.||+|.+..+ +..||+|.++.........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987653 478999999876666667788999999999999999999999886544
Q ss_pred eEEEEEeecCCCCHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccc
Q 000535 91 HLHIILEYVENGSLANIIKPNK----FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA 166 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr----~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLA 166 (1437)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 3899999999999999885432 246899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccc--ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCC
Q 000535 167 TKLTEADVNT--HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESL 243 (1437)
Q Consensus 167 r~L~esd~kt--~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~I 243 (1437)
+.+....... ....++..|+|||.+....++.++|||||||++|+|++ |.+||.+....+....+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence 8765433211 12235678999999988889999999999999999999 99999887766666666666667778889
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 244 SpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
+.++.+++.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 241 LDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=349.58 Aligned_cols=252 Identities=26% Similarity=0.430 Sum_probs=207.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEcC----------------CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcc
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLE----------------NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrk----------------TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIV 80 (1437)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 5689999999999999999997532 34579999987543 344556788999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 000535 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNK-----------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143 (1437)
Q Consensus 81 KLigVfedd~~LYLVMEYceGGSL~DLLKssr-----------------~GpLSEs~I~rILrQILsALaYLHSnGIVHR 143 (1437)
++++++.+.+..|+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999999999999986432 1246788899999999999999999999999
Q ss_pred cccCCceEeccCCcEEEEecccccccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh--CCCCC
Q 000535 144 DIKGANILTTKEGLVKLADFGVATKLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT--CVPPY 219 (1437)
Q Consensus 144 DLKPENILLdenG~VKLiDFGLAr~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT--GkpPF 219 (1437)
||||+|||++.++.+||+|||+++.+...... .....++..|+|||++....++.++|||||||++|+|++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999876443211 123456788999999998889999999999999999986 56788
Q ss_pred CCCCChhHHHHHhh-------cCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHh
Q 000535 220 YELQPMPALFRIVQ-------DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLL 269 (1437)
Q Consensus 220 ~g~d~~eqL~kIiq-------~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELL 269 (1437)
......+.+..+.. ......++.++..+.+||.+||..+|.+|||+.++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 76655444333221 112234567899999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=368.93 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=213.7
Q ss_pred cccccccCCceEEEeEecccCcEEEEEEEEc--CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 000535 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDL--ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK 87 (1437)
Q Consensus 10 F~~gktLggRYeIlEvLGrGgFGtVYKArDr--kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfe 87 (1437)
......+..+|.+++.||+|+||.||+|... .++..|++|.+.... ...+|+.+|++++||||+++++++.
T Consensus 84 ~~~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~ 156 (392)
T PHA03207 84 SDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYR 156 (392)
T ss_pred CCcchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEe
Confidence 3445567788999999999999999999764 356889999876432 3458999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 88 TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 88 dd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
....+|+||||+. ++|.+++. ..+++++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 157 ~~~~~~lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 157 WKSTVCMVMPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred eCCEEEEEehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 9999999999996 58999885 33679999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---hHHHHHhhc--------
Q 000535 168 KLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM---PALFRIVQD-------- 234 (1437)
Q Consensus 168 ~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~---eqL~kIiq~-------- 234 (1437)
.+..... ......||+.|+|||++....|+.++|||||||++|+|++|..||.+.... ..+..+...
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 7654322 223467999999999999999999999999999999999999999765431 112111110
Q ss_pred ------------------CCCC--CC-----CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 235 ------------------ERPP--IP-----ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 235 ------------------~rpp--iP-----~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
..++ .+ ..++.++.++|.+||..||++||++.++|.||||....
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 0111 11 23567899999999999999999999999999997643
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=336.64 Aligned_cols=254 Identities=34% Similarity=0.609 Sum_probs=227.7
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||.|+||.||++.+..+++.|++|.+........+...+.+|+.++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58999999999999999999999999999999987766666677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 99 VENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 99 ceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence 9999999998652 2356899999999999999999999999999999999999999999999999999877654 22
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
....+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....++.+..++.++.+++.+||.
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence 34568999999999998889999999999999999999999998877655555666666667777899999999999999
Q ss_pred hcccCCCCHHHHhcCHHH
Q 000535 257 KDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 257 kDPeKRPSAeELLkHPWF 274 (1437)
.+|++||++.++++||++
T Consensus 239 ~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 239 VKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=372.18 Aligned_cols=261 Identities=33% Similarity=0.563 Sum_probs=225.5
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC-----
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN-IVKYLGSLKTRS----- 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPN-IVKLigVfedd~----- 90 (1437)
...|..+++||+|+||+||+|++..+|+.||+|++......+.-.....+|+.+|+.|+|+| ||.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577888999999999999999999999999999877543333456789999999999999 999999998876
Q ss_pred -eEEEEEeecCCCCHHHHhccCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 91 -HLHIILEYVENGSLANIIKPNKF--GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 91 -~LYLVMEYceGGSL~DLLKssr~--GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
.+|+|+||++. +|..++..... ..++...+..+++||+.||+|||+++|+||||||+||||++.|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 89999999975 99999986543 358889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC--------
Q 000535 168 KLTEADVNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP-------- 238 (1437)
Q Consensus 168 ~L~esd~kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp-------- 238 (1437)
.+.-+.......++|.+|+|||++.+. .|+..+||||+|||++||+++.+-|.+..+.+++.+|...-..|
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 776544445567899999999999877 68999999999999999999999999999999998886532111
Q ss_pred ---------CC------------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 239 ---------IP------------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 239 ---------iP------------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
++ +..+++..+++.+||+++|.+|.|+..++.||||+...
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 11 12235899999999999999999999999999998653
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=346.53 Aligned_cols=255 Identities=28% Similarity=0.486 Sum_probs=209.0
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.++++++||||+++++++.++...|+||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 36899999999999999999999989999999998754322 12234568999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+.+ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 83 e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 83 EYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred ecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 99985 9999887543 478999999999999999999999999999999999999999999999999997654332222
Q ss_pred ccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCC-hhHHHHHhhcCC------------------
Q 000535 177 HSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQDER------------------ 236 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-~eqL~kIiq~~r------------------ 236 (1437)
....++..|+|||++.+ ..++.++||||+||++|+|++|.+||..... .+.+..+.....
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 33457889999999875 4588899999999999999999999976552 222221111000
Q ss_pred --------C---CCCCCCC--HHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 --------P---PIPESLS--PDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 --------p---piP~~IS--pELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
. .....++ .++.++|.+||+++|++||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0001334 788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=359.27 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=215.7
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR----- 89 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd----- 89 (1437)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 467899999999999999999999999999999999876554555566788999999999999999999988643
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 90 -SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 90 -~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
...|+|||||.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 357999999964 89888863 289999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC----------
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---------- 238 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp---------- 238 (1437)
..... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+......++......+
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 168 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 65432 2334578999999999999999999999999999999999999998765444333322110000
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 239 --------------------------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 239 --------------------------------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.+...++.+.+||.+||..||++|||+.++|.||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 01234667899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=339.48 Aligned_cols=250 Identities=27% Similarity=0.500 Sum_probs=216.8
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|++.+.||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 46799999999999999999986 456789999876543 23467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc-
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN- 175 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k- 175 (1437)
||+++++|.++++......+++..++.++.|++.||+|||+++++||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 9999999999998666667999999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
.....++..|+|||++....++.++|||||||++|+|++ |..||...........+......+.+..++.++.+++.+|
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 240 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 122345678999999988889999999999999999998 9999988776666666655555566677899999999999
Q ss_pred hhhcccCCCCHHHHhc
Q 000535 255 FKKDARQRPDAKTLLS 270 (1437)
Q Consensus 255 LqkDPeKRPSAeELLk 270 (1437)
|..+|++||+++++++
T Consensus 241 l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 241 WKEKAEERPTFDYLQS 256 (261)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=392.17 Aligned_cols=260 Identities=32% Similarity=0.511 Sum_probs=227.3
Q ss_pred ccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-C-----CCcceEEE
Q 000535 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-H-----KNIVKYLG 84 (1437)
Q Consensus 11 ~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-H-----PNIVKLig 84 (1437)
-....+..+|.+.+.||+|+||.|.+|.+..+++.||||+++... .-......|+.+|..|+ | -|+|++++
T Consensus 179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 345667779999999999999999999999999999999998543 44556678999999996 4 47999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC--cEEEEe
Q 000535 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG--LVKLAD 162 (1437)
Q Consensus 85 Vfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG--~VKLiD 162 (1437)
+|...+++|||+|.+.. +|+++++.+++..|+...++.++.||+.||.+||+.||||+|||||||||...+ .|||+|
T Consensus 256 ~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred ccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEe
Confidence 99999999999999964 999999999999999999999999999999999999999999999999998654 799999
Q ss_pred cccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC----
Q 000535 163 FGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---- 238 (1437)
Q Consensus 163 FGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp---- 238 (1437)
||.++..... ..+++-+..|+|||++.+.+|+.+.||||||||++||++|.|.|.+.+..+++.+|+.....|
T Consensus 335 FGSSc~~~q~---vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 335 FGSSCFESQR---VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccccccCCc---ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999987653 337899999999999999999999999999999999999999999999999988876411000
Q ss_pred -----------------------------------------------CCC-----------CCCHHHHHHHHHHhhhccc
Q 000535 239 -----------------------------------------------IPE-----------SLSPDITDFLRQCFKKDAR 260 (1437)
Q Consensus 239 -----------------------------------------------iP~-----------~ISpELkDLIrkCLqkDPe 260 (1437)
.|. .-...+.+||++||.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 010 0124589999999999999
Q ss_pred CCCCHHHHhcCHHHHHH
Q 000535 261 QRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 261 KRPSAeELLkHPWFQe~ 277 (1437)
+|+|+.++|+||||...
T Consensus 492 ~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGT 508 (586)
T ss_pred hcCCHHHHhcCcccccc
Confidence 99999999999999753
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=340.17 Aligned_cols=253 Identities=26% Similarity=0.475 Sum_probs=217.8
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCC---CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLEN---GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkT---Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
.++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.++++++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 35799999999999999999988644 4689999886543 3344567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+++++|.+++.... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+....
T Consensus 82 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 82 IITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999997543 479999999999999999999999999999999999999999999999999998875221
Q ss_pred --cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHH
Q 000535 174 --VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 174 --~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDL 250 (1437)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+......+.+..++..+.++
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 12222345678999999998899999999999999999998 999998776666555565555666777899999999
Q ss_pred HHHHhhhcccCCCCHHHHhcC
Q 000535 251 LRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkH 271 (1437)
+.+||+.+|++||++.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=343.48 Aligned_cols=254 Identities=30% Similarity=0.530 Sum_probs=213.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+|++.+.||.|++|.||+|++..++..||||++..... ......+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 58999999999999999999999999999999876542 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 99 VENGSLANIIKPNK-FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 99 ceGGSL~DLLKssr-~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
+++ +|.+++.... ..++++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 985 8988886433 34699999999999999999999999999999999999999999999999999986644322223
Q ss_pred cccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC-----------------C-
Q 000535 178 SVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP-----------------P- 238 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp-----------------p- 238 (1437)
...+++.|++||++.+. .++.++|||||||++|+|++|.+||...+..+...++...... .
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 45678999999998654 5788999999999999999999999877665554443321100 0
Q ss_pred ----------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 239 ----------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 239 ----------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
+.+.++..+.++|.+||+.||.+||++.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=343.57 Aligned_cols=252 Identities=28% Similarity=0.503 Sum_probs=217.0
Q ss_pred CceEEEeEecccCcEEEEEEEEcC-----CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLE-----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrk-----TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+..+.+.+|+++++.+.||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 468899999999999999998743 36889999986543 233457789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEE
Q 000535 93 HIILEYVENGSLANIIKPNK------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKL 160 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKL 160 (1437)
|+||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 99999999999999997532 245889999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCC
Q 000535 161 ADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERP 237 (1437)
Q Consensus 161 iDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rp 237 (1437)
+|||++..+..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+......
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999976543221 1123456788999999999999999999999999999998 99999887776666666655555
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 238 PIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 238 piP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
..+..++.++.+++.+||..||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 667789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=341.39 Aligned_cols=254 Identities=42% Similarity=0.801 Sum_probs=214.9
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC--------HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA--------QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS--------eedie~L~REIkILrrLnHPNIVKLigVfedd~ 90 (1437)
+|.+.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+..|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 699999999999999999999889999999988643211 112456788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
.+++||||+.+++|.+++... +++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999754 679999999999999999999999999999999999999999999999999997654
Q ss_pred cCC--cccccccCCCccCChhhhhcCC--CCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CCCCC----C
Q 000535 171 EAD--VNTHSVVGTPYWMAPEVIEMSG--VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RPPIP----E 241 (1437)
Q Consensus 171 esd--~kt~t~~GTp~YmAPEVL~g~~--yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rppiP----~ 241 (1437)
... .......|+..|+|||.+.... ++.++|+||||+++|++++|..||........+.++.... ...++ .
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 321 1122356889999999987654 8899999999999999999999997655554444433221 22222 3
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 242 ~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.++.++.++|.+||.++|++||++.++++|||+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 568999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.01 Aligned_cols=255 Identities=31% Similarity=0.504 Sum_probs=215.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--SHLHII 95 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd--~~LYLV 95 (1437)
++|++.+.||.|+||.||+|.+..+++.|++|.++...........+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 479999999999999999999999999999999986654433344567899999999999999999998877 899999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+.+ +|.+++.... ..+++..++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 999975 9999987543 36999999999999999999999999999999999999999999999999999877654333
Q ss_pred cccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC------------------
Q 000535 176 THSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER------------------ 236 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r------------------ 236 (1437)
.....+++.|+|||.+.+. .++.++||||||+++|+|++|.+||......+...++.....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 3445688999999998754 468899999999999999999999987766555444322110
Q ss_pred ------------CCCCCC-CCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 ------------PPIPES-LSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 ------------ppiP~~-ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
..++.. +++.+.++|.+||..+|++|||+.|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 58889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=401.87 Aligned_cols=269 Identities=26% Similarity=0.499 Sum_probs=230.9
Q ss_pred cccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 000535 8 SAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK 87 (1437)
Q Consensus 8 s~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfe 87 (1437)
..|..+..+.++|.+++.||+|+||+||+|.+..++..||+|++............+..|+.++++|.|||||+++++|.
T Consensus 3 ~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 35677888889999999999999999999999999999999999877767777788999999999999999999999885
Q ss_pred e--CCeEEEEEeecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CcccccccCCceEeccC-
Q 000535 88 T--RSHLHIILEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQ-------GVIHRDIKGANILTTKE- 155 (1437)
Q Consensus 88 d--d~~LYLVMEYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSn-------GIVHRDLKPENILLden- 155 (1437)
+ ...+|||||||++|+|.++|... ..+.+++..++.|+.||+.||.|||+. +|+||||||+||||+..
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 4 46799999999999999999642 235799999999999999999999985 49999999999999642
Q ss_pred ----------------CcEEEEecccccccccCCcccccccCCCccCChhhhhc--CCCCccchhhhHHHHHHHHHhCCC
Q 000535 156 ----------------GLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM--SGVCAASDIWSVGCTVIELLTCVP 217 (1437)
Q Consensus 156 ----------------G~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g--~~yS~KSDIWSLG~ILYELLTGkp 217 (1437)
+.+||+|||++..+.... .....+||+.|+|||++.. ..++.++||||||||||+|++|..
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 358999999998765432 2345679999999999864 458899999999999999999999
Q ss_pred CCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 218 PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 218 PF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
||........+...+..........++.++.+||..||..+|.+||++.++|.|||+...
T Consensus 242 PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 998777666666555544333335679999999999999999999999999999999764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=343.07 Aligned_cols=256 Identities=23% Similarity=0.440 Sum_probs=216.0
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEc-----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR 89 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDr-----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd 89 (1437)
+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35678999999999999999999864 245789999886432 233455688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEE
Q 000535 90 SHLHIILEYVENGSLANIIKPNK--------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLA 161 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKssr--------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLi 161 (1437)
...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999986432 1246788899999999999999999999999999999999999999999
Q ss_pred ecccccccccCCccc--ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCC
Q 000535 162 DFGVATKLTEADVNT--HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPP 238 (1437)
Q Consensus 162 DFGLAr~L~esd~kt--~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rpp 238 (1437)
|||+++.+....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999998654332211 12345778999999998889999999999999999999 789998776655555555555667
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 239 iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
.+..++..+.+++.+||+.+|++||++.+++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 778899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=365.13 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=203.8
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
...|++.+.||+|+||.||+|.+..++..||+|+.... ....|+.++++++||||+++++++......|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34699999999999999999999999999999985432 2346899999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+. ++|.+++... ..++++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 137 e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 213 (357)
T PHA03209 137 PHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-AF 213 (357)
T ss_pred EccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-cc
Confidence 9996 5888888643 3579999999999999999999999999999999999999999999999999997543322 23
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-h---------hHHHHHhhc---CCCCCC---
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP-M---------PALFRIVQD---ERPPIP--- 240 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-~---------eqL~kIiq~---~rppiP--- 240 (1437)
....||+.|+|||++.+..++.++|||||||++|+|+++..|+..... . ..+.+++.. ....++
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 456799999999999998999999999999999999985544432211 1 111111110 000011
Q ss_pred ---------------------------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 241 ---------------------------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 241 ---------------------------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
..++.++.+||.+||+.||.+|||+.++|+||||++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 245677888999999999999999999999999974
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.76 Aligned_cols=258 Identities=29% Similarity=0.499 Sum_probs=219.7
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||.||++.+..+++.|++|.+...... ....+.+.+|+.+++.++||||+++++.+..++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4699999999999999999999999999999998765432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC---
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--- 173 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd--- 173 (1437)
||++|++|.++++.. +++++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999754 579999999999999999999999999999999999999999999999999986421100
Q ss_pred ------------cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--CCC
Q 000535 174 ------------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER--PPI 239 (1437)
Q Consensus 174 ------------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r--ppi 239 (1437)
.......|+..|+|||.+....++.++|+|||||++|+|++|..||.+....+...++..... +..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG 238 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc
Confidence 011124678899999999888899999999999999999999999987665555555443321 222
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCC---HHHHhcCHHHHHH
Q 000535 240 PESLSPDITDFLRQCFKKDARQRPD---AKTLLSHPWIQNC 277 (1437)
Q Consensus 240 P~~ISpELkDLIrkCLqkDPeKRPS---AeELLkHPWFQe~ 277 (1437)
...++.++.++|.+||.++|++||+ +.++++||||...
T Consensus 239 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 2368999999999999999999998 7999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=341.78 Aligned_cols=254 Identities=29% Similarity=0.545 Sum_probs=222.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLn-HPNIVKLigVfedd~~LYLV 95 (1437)
++|.+.+.||+|+||.||+|.+..++..|++|++.+.... ......+.+|+.+++++. ||||+++++++.+++..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999999999999999998764432 344567889999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV- 174 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~- 174 (1437)
|||+++++|.+++... +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999999754 4799999999999999999999999999999999999999999999999999987654321
Q ss_pred -------------------ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC
Q 000535 175 -------------------NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE 235 (1437)
Q Consensus 175 -------------------kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~ 235 (1437)
......++..|+|||++....++.++|+||||+++|++++|..||...........+. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-KL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hc
Confidence 1223467899999999988889999999999999999999999998776544444443 34
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCH----HHHhcCHHH
Q 000535 236 RPPIPESLSPDITDFLRQCFKKDARQRPDA----KTLLSHPWI 274 (1437)
Q Consensus 236 rppiP~~ISpELkDLIrkCLqkDPeKRPSA----eELLkHPWF 274 (1437)
...++..+++.+.++|.+||..+|.+||++ .++++||||
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 446677889999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=393.72 Aligned_cols=256 Identities=38% Similarity=0.675 Sum_probs=233.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
+-|.|+..||.|+||.||+|.++.++-..|.|+|... +.++.+.+.-||.||..+.||+||+|++.|..++.+||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 4599999999999999999999999999999998643 46788889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
||.||-...++-.-. ..|.|.++..+++|++.||.|||+++|+|||||..|||++-+|.|+|+|||.+...........
T Consensus 110 FC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred ecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 999998888776543 5799999999999999999999999999999999999999999999999999876554444566
Q ss_pred cccCCCccCChhhhh-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCC--CCCCCHHHHHH
Q 000535 178 SVVGTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDF 250 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~-----g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppi--P~~ISpELkDL 250 (1437)
+++|||+|||||+.. +.+|++++||||||++|.+|..+.||....+++..+.++.+..+|.+ |..++..+.+|
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 899999999999874 56799999999999999999999999999999999999988877654 67899999999
Q ss_pred HHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 251 LRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+.+||.+||..||++.++|+|||+++
T Consensus 269 Lk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999999999999999999984
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.25 Aligned_cols=252 Identities=22% Similarity=0.405 Sum_probs=212.5
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCe--EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCe
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGD--FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT------RSH 91 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk--~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed------d~~ 91 (1437)
|.+++.||+|+||.||+|.+..++. .||+|.++.......+.+.+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3577899999999999999877665 69999988766666777889999999999999999999997643 235
Q ss_pred EEEEEeecCCCCHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 92 LHIILEYVENGSLANIIKPN----KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKss----r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
.++||||+.+|+|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999999999887422 22458999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCC
Q 000535 168 KLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLS 244 (1437)
Q Consensus 168 ~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~IS 244 (1437)
.+...... .....+++.|++||++....++.++|||||||++|+|++ |.+||...........+......+.+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL 240 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 76543211 122346778999999998899999999999999999999 899998766655555555555556677899
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 245 PDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 245 pELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
..+.++|.+||..+|++|||+.++++.
T Consensus 241 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 241 DGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=353.25 Aligned_cols=263 Identities=33% Similarity=0.577 Sum_probs=223.9
Q ss_pred ccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 000535 9 AFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT 88 (1437)
Q Consensus 9 ~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed 88 (1437)
.........+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+..
T Consensus 13 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~ 90 (292)
T cd06658 13 LVVSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV 90 (292)
T ss_pred EEeccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec
Confidence 33344455667787889999999999999999999999999986432 3445668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 89 d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
.++.|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 91 GDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred CCeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 9999999999999999998853 3589999999999999999999999999999999999999999999999999986
Q ss_pred cccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC--CCCCCCHH
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--IPESLSPD 246 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp--iP~~ISpE 246 (1437)
............|++.|+|||.+....++.++|+||||+++|+|++|..||........+..+....... ....++..
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSV 247 (292)
T ss_pred cccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHH
Confidence 6443333345678999999999988889999999999999999999999998766655444433322222 22357899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+.++|.+||..+|.+|||+.++++||||+.
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 999999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.19 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=214.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||+|+||.||++.+. .+..+|+|.+...... .+.+.+|+.++++++||||+++++++..+...|+|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 46899999999999999999764 4568999988754433 2457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc-
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT- 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt- 176 (1437)
|+++|+|.+++.... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++.........
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 80 FMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999999997543 468999999999999999999999999999999999999999999999999998764332211
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
....++..|+|||++....++.++|+||||+++|+|++ |++||...+..+.+..+........+...+.++.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~ 238 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCW 238 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 22345668999999988889999999999999999999 99999887777677777666666667778999999999999
Q ss_pred hhcccCCCCHHHHhc
Q 000535 256 KKDARQRPDAKTLLS 270 (1437)
Q Consensus 256 qkDPeKRPSAeELLk 270 (1437)
..+|++||++.++++
T Consensus 239 ~~~p~~Rps~~~l~~ 253 (256)
T cd05114 239 HEKPEGRPTFAELLR 253 (256)
T ss_pred cCCcccCcCHHHHHH
Confidence 999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.76 Aligned_cols=245 Identities=25% Similarity=0.445 Sum_probs=209.0
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGS 103 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGS 103 (1437)
+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+.++++++||||+++++++......|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4689999999999999999999999987643 334455678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc--cccC
Q 000535 104 LANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH--SVVG 181 (1437)
Q Consensus 104 L~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~--t~~G 181 (1437)
|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........... ...+
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999743 34689999999999999999999999999999999999999999999999999976543221111 1123
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhccc
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPe 260 (1437)
+..|+|||.+....++.++|||||||++|+|++ |.+||...........+......+.+..++..+.+|+.+||..+|+
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence 456999999998889999999999999999998 8999977665554455555555677778899999999999999999
Q ss_pred CCCCHHHHhc
Q 000535 261 QRPDAKTLLS 270 (1437)
Q Consensus 261 KRPSAeELLk 270 (1437)
+||++.++++
T Consensus 239 ~Rps~~~~~~ 248 (252)
T cd05084 239 QRPSFSTVHQ 248 (252)
T ss_pred hCcCHHHHHH
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.80 Aligned_cols=254 Identities=26% Similarity=0.476 Sum_probs=217.6
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCC-----CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLEN-----GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkT-----Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~ 90 (1437)
..++|.+.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 357899999999999999999987643 4889999986443 3344566889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEe
Q 000535 91 HLHIILEYVENGSLANIIKPNK--------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLAD 162 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr--------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiD 162 (1437)
..|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999999996432 23478899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCC
Q 000535 163 FGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPI 239 (1437)
Q Consensus 163 FGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppi 239 (1437)
||+++.+..... ......++..|+|||.+....++.++|||||||++|++++ |.+||...+.......+......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL 242 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCC
Confidence 999987654332 1223456788999999988889999999999999999998 9999987766655555555556677
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 240 P~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
+..++.++.++|.+||..+|++|||+.++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=346.60 Aligned_cols=255 Identities=31% Similarity=0.530 Sum_probs=218.7
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 57999999999999999999999999999999987543 23445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|+++++|.+++... +++++..+..++.|++.+|.|||+ ++++||||||+||+++.++.++|+|||++...... ..
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~ 159 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IA 159 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--cc
Confidence 99999999998753 579999999999999999999997 69999999999999999999999999998765332 22
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-----------hHHHHHhhcCCCCCCCC-CC
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM-----------PALFRIVQDERPPIPES-LS 244 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~-----------eqL~kIiq~~rppiP~~-IS 244 (1437)
...+|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.....+.++.. ++
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 3467899999999998888999999999999999999999999764432 22233333333344433 88
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 245 pELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
.++.+||.+||.+||++||++.++++||||.+.
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 899999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.36 Aligned_cols=250 Identities=30% Similarity=0.495 Sum_probs=207.5
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CeEEEEE
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTR--SHLHIIL 96 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd--~~LYLVM 96 (1437)
|++.+.||+|+||.||+|.+..+++.||+|.++......... ...+|+.+++++. ||||+++++++.+. +.+|+||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 788999999999999999999999999999987654333332 3457889999985 99999999999887 8999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+. |+|.+.+.... +.+++..++.++.|++.||.|||+.|++||||||+||+++. +.+||+|||++..+..... .
T Consensus 80 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~ 155 (282)
T cd07831 80 ELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-Y 155 (282)
T ss_pred ecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-c
Confidence 9997 48888886543 57999999999999999999999999999999999999999 9999999999987654332 2
Q ss_pred ccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-----------------CC-
Q 000535 177 HSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-----------------RP- 237 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-----------------rp- 237 (1437)
....+++.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+....+.... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence 34568999999998754 457889999999999999999999998766544433332100 00
Q ss_pred ----------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 ----------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 ----------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.+...++.++.++|.+||.++|++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0123568999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.45 Aligned_cols=253 Identities=25% Similarity=0.465 Sum_probs=215.7
Q ss_pred CceEEEeEecccCcEEEEEEEEc----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDL----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDr----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
..|++.+.||+|+||.||+|.+. .++..|++|.+.... .......+.+|+.+++++.||||+++++++......|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 46899999999999999999853 456889999987533 3445577889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcE
Q 000535 94 IILEYVENGSLANIIKPNK---------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLV 158 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr---------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~V 158 (1437)
+||||+.+++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 9999999999999985321 1348899999999999999999999999999999999999999999
Q ss_pred EEEecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC
Q 000535 159 KLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE 235 (1437)
Q Consensus 159 KLiDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~ 235 (1437)
||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 243 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987643321 1223456778999999988889999999999999999998 999998876655555555555
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 236 rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
..+.+..+++++.+++.+||..+|.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 244 LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 566778899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.84 Aligned_cols=249 Identities=40% Similarity=0.732 Sum_probs=211.3
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
...||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+.++++++||||+++++++..++..|+|+||++++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 357999999999999999999999999886543 345567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-CCcEEEEecccccccccCCcccccc
Q 000535 103 SLANIIKPNKFGPF--PESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-EGLVKLADFGVATKLTEADVNTHSV 179 (1437)
Q Consensus 103 SL~DLLKssr~GpL--SEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-nG~VKLiDFGLAr~L~esd~kt~t~ 179 (1437)
+|.+++.... .++ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++..+..........
T Consensus 91 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 169 (268)
T cd06624 91 SLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF 169 (268)
T ss_pred CHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccC
Confidence 9999997532 345 88899999999999999999999999999999999986 6799999999998765433333345
Q ss_pred cCCCccCChhhhhcC--CCCccchhhhHHHHHHHHHhCCCCCCCCCChhH-HHHH-hhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 180 VGTPYWMAPEVIEMS--GVCAASDIWSVGCTVIELLTCVPPYYELQPMPA-LFRI-VQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 180 ~GTp~YmAPEVL~g~--~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eq-L~kI-iq~~rppiP~~ISpELkDLIrkCL 255 (1437)
.|++.|+|||++... .++.++|+||||+++|+|++|.+||........ .... .....+.++..+++++.+++.+||
T Consensus 170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 249 (268)
T cd06624 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249 (268)
T ss_pred CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHc
Confidence 689999999998654 378899999999999999999999976543222 2221 223345567789999999999999
Q ss_pred hhcccCCCCHHHHhcCHHH
Q 000535 256 KKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 256 qkDPeKRPSAeELLkHPWF 274 (1437)
..+|.+||++.+++.||||
T Consensus 250 ~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 250 EPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCCchhCCCHHHHHhCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.89 Aligned_cols=254 Identities=27% Similarity=0.490 Sum_probs=217.0
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCC-----CeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLEN-----GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkT-----Gk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~ 90 (1437)
.++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++ +||||+++++++..++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 46899999999999999999987643 3789999987543 344556788999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC
Q 000535 91 HLHIILEYVENGSLANIIKPN--------------KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG 156 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKss--------------r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG 156 (1437)
.+|+||||+++|+|.+++... ..+.+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 999999999999999999642 245799999999999999999999999999999999999999999
Q ss_pred cEEEEecccccccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhh
Q 000535 157 LVKLADFGVATKLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQ 233 (1437)
Q Consensus 157 ~VKLiDFGLAr~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq 233 (1437)
.+||+|||+++.+...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 249 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999999876543221 112334677999999988899999999999999999997 9999987665555555555
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 234 DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 234 ~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
......+..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 250 GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 55556677889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.67 Aligned_cols=253 Identities=34% Similarity=0.619 Sum_probs=214.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|.+.+.||+|+||.||+|++..++..|+||.+..... .......+.+|+.+++.++||||+++++++..++..|++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 578999999999999999999999999999998875433 3344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 97 EYVENGSLANIIKP--NKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 97 EYceGGSL~DLLKs--sr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||+++++|.+++.. .....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 2235689999999999999999999999999999999999999999999999999987655443
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh--hHHHHHhhcCCCCCC-CCCCHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM--PALFRIVQDERPPIP-ESLSPDITDFL 251 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~--eqL~kIiq~~rppiP-~~ISpELkDLI 251 (1437)
......|+..|+|||++....++.++|+||||+++|+|++|..||...... .....+.....++.+ ..+++++.++|
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence 334567899999999999888999999999999999999999999754332 222222222333333 45889999999
Q ss_pred HHHhhhcccCCCCHHHHhc
Q 000535 252 RQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLk 270 (1437)
.+||..+|++|||+.++++
T Consensus 242 ~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 242 NMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHhcCCCcccCCCHHHHHH
Confidence 9999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=387.60 Aligned_cols=252 Identities=38% Similarity=0.670 Sum_probs=230.4
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLEN-IAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~-lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.|.=+..||.|+||-||.|++..+...||||++.... -+.+.++.+.+||..|+++.|||++.+.++|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3666788999999999999999999999999987553 335678999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
||-| +-.|++.-.+ +++-|..+..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|....+. .
T Consensus 107 YClG-SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----n 180 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----N 180 (948)
T ss_pred HHhc-cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch----h
Confidence 9965 8888887554 68999999999999999999999999999999999999999999999999999887654 4
Q ss_pred cccCCCccCChhhhh---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCC-CCCCHHHHHHHHH
Q 000535 178 SVVGTPYWMAPEVIE---MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP-ESLSPDITDFLRQ 253 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~---g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP-~~ISpELkDLIrk 253 (1437)
+++|||+|||||++. .+.|+-++||||||++..||...+||++..+.+..++.|.+...|.++ ..+|..+.+|+..
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 689999999999984 467999999999999999999999999999999999999999888776 4688999999999
Q ss_pred HhhhcccCCCCHHHHhcCHHHHH
Q 000535 254 CFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLkHPWFQe 276 (1437)
||++-|.+|||.+++|.|+|+..
T Consensus 261 CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHhhCcccCCcHHHHhhcchhcc
Confidence 99999999999999999999863
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=349.40 Aligned_cols=257 Identities=39% Similarity=0.692 Sum_probs=222.0
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|.+.+.||+|+||.||++.+..++..|++|.+..... ...+.+.+|+.+++.++||||+++++++......|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 4789999999999999999999988999999999864432 33466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 999999999998743 58899999999999999999999999999999999999999999999999988765544334
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC--CCCCCCHHHHHHHHHH
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--IPESLSPDITDFLRQC 254 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp--iP~~ISpELkDLIrkC 254 (1437)
....|++.|++||.+....++.++|+|||||++|++++|..||...+....+..+.....+. .+..++..+.++|.+|
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 44578999999999988889999999999999999999999998766544443333222222 2345788999999999
Q ss_pred hhhcccCCCCHHHHhcCHHHHHHH
Q 000535 255 FKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 255 LqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
|..+|++||++.+++.||||+..+
T Consensus 253 l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 253 LEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.93 Aligned_cols=251 Identities=27% Similarity=0.477 Sum_probs=216.2
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
...+.|++.++||+|+||.||+|.+ .+++.||+|.+...... ...+.+|+.++++++||||+++++++. .+..|+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 4567899999999999999999975 46788999998765443 346788999999999999999999874 457899
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
+|||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999999999876666899999999999999999999999999999999999999999999999999987653322
Q ss_pred c-cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 000535 175 N-THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252 (1437)
Q Consensus 175 k-t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIr 252 (1437)
. .....++..|+|||++....++.++||||||+++|+|++ |.+||.+....+....+......+.+..++.++.++|.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMR 237 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1 123345678999999998889999999999999999999 99999877665555555555556777788999999999
Q ss_pred HHhhhcccCCCCHHHHhc
Q 000535 253 QCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLk 270 (1437)
+||..+|++||+++++++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 238 LCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHccCChhhCCCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=381.60 Aligned_cols=259 Identities=28% Similarity=0.490 Sum_probs=239.2
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
-|.+-|.+.+.||+|-|++|-+|++.-+|..||||+|.+..+..-....+.+|+..|+-.+|||||++|+++.....+||
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 35678999999999999999999999999999999999999888888889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEec-cCCcEEEEecccccccccCC
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTT-KEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLd-enG~VKLiDFGLAr~L~esd 173 (1437)
|+|.-++|+|+++|-.+. ..+.|+.+.+|++||+.|+.|+|+..+|||||||+||.+- +-|-|||+|||++..+.+..
T Consensus 95 iLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999998665 3599999999999999999999999999999999997765 56899999999998887654
Q ss_pred cccccccCCCccCChhhhhcCCCCc-cchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 000535 174 VNTHSVVGTPYWMAPEVIEMSGVCA-ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g~~yS~-KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIr 252 (1437)
+..+.||+..|.|||++.+..|+. ++||||||+|||.|+||++||...++.+.+..|+. .....|..+|.+|++||.
T Consensus 174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD-CKYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD-CKYTVPSHVSKECRDLIQ 251 (864)
T ss_pred -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc-ccccCchhhhHHHHHHHH
Confidence 667899999999999999999975 68999999999999999999999998888877764 445788899999999999
Q ss_pred HHhhhcccCCCCHHHHhcCHHHHH
Q 000535 253 QCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.||..||.+|.+.++|..++|+|.
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred HHHhcCchhhccHHHHhccccccC
Confidence 999999999999999999999975
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.05 Aligned_cols=256 Identities=36% Similarity=0.621 Sum_probs=221.0
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.+|...+.||+|++|.||++.+..++..|++|++.... ....+.+.+|+.+++.+.||||+++++++...++.|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 35666789999999999999998899999999886432 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+.+++|.+++.. +++++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++...........
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 9999999999875 4689999999999999999999999999999999999999999999999999876654333334
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCC--CCCCCHHHHHHHHHHh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQCF 255 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppi--P~~ISpELkDLIrkCL 255 (1437)
...|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+......++.....+.. +..++..+.++|.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 46789999999999888899999999999999999999999988766655555444332222 2347899999999999
Q ss_pred hhcccCCCCHHHHhcCHHHHHHH
Q 000535 256 KKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 256 qkDPeKRPSAeELLkHPWFQe~r 278 (1437)
.++|++||++.++++||||++.+
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.50 Aligned_cols=247 Identities=31% Similarity=0.478 Sum_probs=194.4
Q ss_pred EeEecccCcEEEEEEEEcC--CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCeEEEEEee
Q 000535 23 GDEIGKGAYGRVYKGLDLE--NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK--TRSHLHIILEY 98 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrk--TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfe--dd~~LYLVMEY 98 (1437)
+..||+|+||+||+|.+.. ++..||+|.+...... ..+.+|+.++++++||||+++++++. .+..+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 4689999999999998654 5689999998754322 34678999999999999999999885 45788999999
Q ss_pred cCCCCHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEe----ccCCcEEEEeccccc
Q 000535 99 VENGSLANIIKPN-------KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILT----TKEGLVKLADFGVAT 167 (1437)
Q Consensus 99 ceGGSL~DLLKss-------r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILL----denG~VKLiDFGLAr 167 (1437)
+.+ +|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 975 888877522 22358999999999999999999999999999999999999 456789999999998
Q ss_pred ccccCCc---ccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCh---------hHHHHHhhc
Q 000535 168 KLTEADV---NTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPM---------PALFRIVQD 234 (1437)
Q Consensus 168 ~L~esd~---kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~---------eqL~kIiq~ 234 (1437)
.+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..+.++...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 7654321 12345789999999998764 5789999999999999999999999643221 111111100
Q ss_pred CC-------------------------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 235 ER-------------------------------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 235 ~r-------------------------------------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.. .......+..+.+||.+||..||.+|||+.++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 00011235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.23 Aligned_cols=259 Identities=44% Similarity=0.736 Sum_probs=225.6
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
....+.|.+.+.||+|+||.||+|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++++......|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 3466779999999999999999999988899999999876543 4566889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999998653 479999999999999999999999999999999999999999999999999987665433
Q ss_pred cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCC--CCCCHHHHHHH
Q 000535 174 VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP--ESLSPDITDFL 251 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP--~~ISpELkDLI 251 (1437)
.......+++.|++||++.+..++.++|+|||||++|+|++|..||...........+.....+..+ ..++.++.++|
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 2333456889999999998888999999999999999999999999876665555554444433332 34889999999
Q ss_pred HHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 252 RQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.+||+.+|.+||++.+++.||||.+
T Consensus 251 ~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHhccChhhCcCHHHHhhChHhhc
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.91 Aligned_cols=249 Identities=27% Similarity=0.454 Sum_probs=214.9
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
..++|++.+.||+|+||.||+|.+. ++..||+|.+....... +.+.+|+.++++++||||+++++++. ....|++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 4568999999999999999999764 56779999987654432 45789999999999999999999885 4568999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+.+++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999999998665567999999999999999999999999999999999999999999999999999876443211
Q ss_pred -cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 176 -THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 176 -t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
.....++..|+|||.+....++.++||||||+++|+|++ |.+||...+..+....+......+.+..++.++.+|+.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 112345667999999988889999999999999999999 999998877766666666665667788899999999999
Q ss_pred HhhhcccCCCCHHHHh
Q 000535 254 CFKKDARQRPDAKTLL 269 (1437)
Q Consensus 254 CLqkDPeKRPSAeELL 269 (1437)
||.++|++|||+.++.
T Consensus 239 ~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 239 CWKKDPEERPTFEYLQ 254 (260)
T ss_pred HcccCcccCcCHHHHH
Confidence 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.84 Aligned_cols=258 Identities=29% Similarity=0.497 Sum_probs=213.0
Q ss_pred eEeccc--CcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKG--AYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrG--gFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
..||+| +||+||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||++++++|...+..|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 999999999999999999999987666666678899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc------
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN------ 175 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k------ 175 (1437)
++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 99999998665556999999999999999999999999999999999999999999999999866433221111
Q ss_pred -cccccCCCccCChhhhhcC--CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC----------------
Q 000535 176 -THSVVGTPYWMAPEVIEMS--GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER---------------- 236 (1437)
Q Consensus 176 -t~t~~GTp~YmAPEVL~g~--~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r---------------- 236 (1437)
.....++..|+|||++.+. .++.++|||||||++|+|++|.+||........+........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 1112356679999999763 578999999999999999999999977654444333322110
Q ss_pred ------------------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHHHHh
Q 000535 237 ------------------------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRAL 281 (1437)
Q Consensus 237 ------------------------------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~rrsL 281 (1437)
.+.+..+++.+.+||++||..||++|||+.++++||||++.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~ 318 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT 318 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence 111234677899999999999999999999999999998876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.64 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=215.9
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR-----S 90 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd-----~ 90 (1437)
+..+|.+.+.||+|+||+||+|.+..+++.||||.+............+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 56789999999999999999999999999999999876544444556678899999999999999999988643 3
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
..|+||||+. ++|.+++... +++++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 5899999996 6899998744 579999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhh----------------
Q 000535 171 EADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ---------------- 233 (1437)
Q Consensus 171 esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq---------------- 233 (1437)
..........++..|+|||.+.. ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 44323345678999999998865 4688999999999999999999999976543222211110
Q ss_pred -------c----CC---CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 234 -------D----ER---PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 234 -------~----~r---ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
. .. ....+.+++++.++|.+||+.+|++|||+.++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00 01224688999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.68 Aligned_cols=240 Identities=20% Similarity=0.294 Sum_probs=207.3
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH-HHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCeEEEEEee
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE-DLNIIMQEIDLLKNLNHKNIVKYLGSLKT----RSHLHIILEY 98 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee-die~L~REIkILrrLnHPNIVKLigVfed----d~~LYLVMEY 98 (1437)
..||+|+++.||+|.. +|+.||+|++........ ..+.+.+|+.+|++++||||+++++++.+ ..++++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5689999999999987 799999999976543332 24678899999999999999999999876 4578999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSn-GIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|++|+|.+++... +.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+... ..
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PF 178 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cc
Confidence 9999999999754 4689999999999999999999984 9999999999999999999999999999876432 23
Q ss_pred cccCCCccCChhhhhc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhc-CCCCCCCCCCHHHHHHHHHH
Q 000535 178 SVVGTPYWMAPEVIEM--SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-ERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g--~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~-~rppiP~~ISpELkDLIrkC 254 (1437)
...|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+... ...+.+..+++++.+||.+|
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 4578999999999976 67999999999999999999999999877655555544433 34556668999999999999
Q ss_pred hhhcccCCCCHHHHhc
Q 000535 255 FKKDARQRPDAKTLLS 270 (1437)
Q Consensus 255 LqkDPeKRPSAeELLk 270 (1437)
|+.||++|||+.+++.
T Consensus 259 l~~dp~~Rps~~ell~ 274 (283)
T PHA02988 259 TSHDSIKRPNIKEILY 274 (283)
T ss_pred hcCCcccCcCHHHHHH
Confidence 9999999999999985
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.54 Aligned_cols=243 Identities=24% Similarity=0.440 Sum_probs=209.5
Q ss_pred EecccCcEEEEEEEE--cCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 25 EIGKGAYGRVYKGLD--LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 25 vLGrGgFGtVYKArD--rkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
.||+|+||.||+|.+ ..++..||+|++..........+.+..|+.+++.+.||||+++++++. ....++||||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 457899999998766555556677899999999999999999999885 45678999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc---cccc
Q 000535 103 SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN---THSV 179 (1437)
Q Consensus 103 SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k---t~t~ 179 (1437)
+|.+++... +.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++..+...... ....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 999999744 46999999999999999999999999999999999999999999999999999876543211 1123
Q ss_pred cCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhc
Q 000535 180 VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 180 ~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkD 258 (1437)
.+++.|+|||.+....++.++|||||||++|+|++ |.+||......+....+.....++.|..+++++.++|.+||+.|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 34678999999988889999999999999999998 99999877666666666655666788889999999999999999
Q ss_pred ccCCCCHHHHhc
Q 000535 259 ARQRPDAKTLLS 270 (1437)
Q Consensus 259 PeKRPSAeELLk 270 (1437)
|++||++.+|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999853
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.17 Aligned_cols=254 Identities=23% Similarity=0.434 Sum_probs=213.6
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcC-----CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLE-----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrk-----TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~ 90 (1437)
-.++|.+.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35789999999999999999997642 35689999876443 2233445778999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEe
Q 000535 91 HLHIILEYVENGSLANIIKPNK--------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLAD 162 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr--------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiD 162 (1437)
..|+||||+.+|+|.++++... ...++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999999996432 23456778899999999999999999999999999999999999999999
Q ss_pred cccccccccCCccc--ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCC
Q 000535 163 FGVATKLTEADVNT--HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPI 239 (1437)
Q Consensus 163 FGLAr~L~esd~kt--~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppi 239 (1437)
||+++.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |.+||......+....+........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998654432211 12345678999999998889999999999999999998 7899987766665555555656667
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 240 P~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
+..+++.+.+++.+||..+|++||++.++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.24 Aligned_cols=248 Identities=32% Similarity=0.601 Sum_probs=214.8
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCH
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL 104 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL 104 (1437)
||.|+||.||+|++..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999998765432 34566788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--------cc
Q 000535 105 ANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV--------NT 176 (1437)
Q Consensus 105 ~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~--------kt 176 (1437)
.+++... +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 9999754 4799999999999999999999999999999999999999999999999999876543321 22
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCC--CHHHHHHHHHH
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL--SPDITDFLRQC 254 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~I--SpELkDLIrkC 254 (1437)
....++..|++||.+....++.++|+||||+++|+|++|..||......+....+.. .....+..+ +..+.+++.+|
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCcCCCccccCCHHHHHHHHHH
Confidence 345688999999999888899999999999999999999999987766555544443 333444444 99999999999
Q ss_pred hhhcccCCCCH---HHHhcCHHHHH
Q 000535 255 FKKDARQRPDA---KTLLSHPWIQN 276 (1437)
Q Consensus 255 LqkDPeKRPSA---eELLkHPWFQe 276 (1437)
|+.+|.+||++ .++++||||..
T Consensus 238 l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred hcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999 99999999953
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=343.95 Aligned_cols=257 Identities=30% Similarity=0.519 Sum_probs=211.6
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd~~LYLVME 97 (1437)
+|...+.||+|+||.||++.+..++..||+|.+...... .....+.+|+.++.++. ||||+++++++..++..|++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 566778999999999999999999999999998765433 44567889999999996 9999999999999999999999
Q ss_pred ecCCCCHHHHh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 98 YVENGSLANII---KPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 98 YceGGSL~DLL---Kssr~GpLSEs~I~rILrQILsALaYLHSn-GIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
|+.+ ++.++. .....+.+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 9864 555443 323346799999999999999999999985 99999999999999999999999999998765432
Q ss_pred cccccccCCCccCChhhhhcC---CCCccchhhhHHHHHHHHHhCCCCCCCCCC-hhHHHHHhhcCCCCC----CCCCCH
Q 000535 174 VNTHSVVGTPYWMAPEVIEMS---GVCAASDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQDERPPI----PESLSP 245 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g~---~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-~eqL~kIiq~~rppi----P~~ISp 245 (1437)
......|++.|+|||++... .++.++|||||||++|+|++|++||..... ...+.++.....+.+ +..++.
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 163 -AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred -ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 22334689999999999766 688999999999999999999999976542 222333333222222 234789
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
++.+||.+||.++|++||++.++++||||+...
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.94 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=207.1
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS------ 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~------ 90 (1437)
-++|++.+.||+|+||.||+|.+..+++.||||.+............+.+|+.+++++.||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35799999999999999999999999999999998755433333345678999999999999999999886543
Q ss_pred --eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 91 --HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 91 --~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
..|+||||+.+ +|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 46999999965 888888643 34699999999999999999999999999999999999999999999999999986
Q ss_pred cccCCcc----cccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC---CC---
Q 000535 169 LTEADVN----THSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RP--- 237 (1437)
Q Consensus 169 L~esd~k----t~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~---rp--- 237 (1437)
+...... .....++..|+|||++.+. .++.++||||||+++|+|++|.+||...+....+..+.... .+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 6433211 1234678899999988654 47889999999999999999999997765543332221100 00
Q ss_pred ------------CC-------------CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 ------------PI-------------PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 ------------pi-------------P~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.. +...+..+.+||.+||..||.+||++.++++||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00 11235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.93 Aligned_cols=254 Identities=31% Similarity=0.496 Sum_probs=207.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.+|.+.+.||+|+||.||+|.+..++..||+|++...... .....+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 6799999999999999999999999999999998754322 222356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+. ++|.+.+.... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||+++..........
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 996 68877775433 4688999999999999999999999999999999999999999999999999976544332333
Q ss_pred cccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCh-hHHHHHhhcCC-------------------
Q 000535 178 SVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPM-PALFRIVQDER------------------- 236 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~-eqL~kIiq~~r------------------- 236 (1437)
...+++.|+|||++.+. .++.++|||||||++|+|++|.+||...... +.+.++.....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 45679999999998754 5788999999999999999999999765432 22222111000
Q ss_pred --CC--------CC--CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 --PP--------IP--ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 --pp--------iP--~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.. ++ ...++++.+++.+||..||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 00 0125789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=364.36 Aligned_cols=252 Identities=25% Similarity=0.460 Sum_probs=211.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCC-----CeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLEN-----GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkT-----Gk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~ 91 (1437)
++|++.+.||+|+||.||+|++... +..||+|++..... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4699999999999999999986443 35799999975432 34456788999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCC-----------------------------------------------------------
Q 000535 92 LHIILEYVENGSLANIIKPNK----------------------------------------------------------- 112 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr----------------------------------------------------------- 112 (1437)
+|+|||||++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc--cccccC
Q 000535 113 ---------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN--THSVVG 181 (1437)
Q Consensus 113 ---------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k--t~t~~G 181 (1437)
..++++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...... .....+
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 135788999999999999999999999999999999999999999999999999876433211 112335
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC-CCCCCCCCCHHHHHHHHHHhhhcc
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE-RPPIPESLSPDITDFLRQCFKKDA 259 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~-rppiP~~ISpELkDLIrkCLqkDP 259 (1437)
++.|+|||++....++.++|||||||++|+|++ |+.||..........+..... ....+..+++++.++|.+||..||
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 356 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEP 356 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCCh
Confidence 667999999998899999999999999999997 999998766555555554433 445566789999999999999999
Q ss_pred cCCCCHHHHhc
Q 000535 260 RQRPDAKTLLS 270 (1437)
Q Consensus 260 eKRPSAeELLk 270 (1437)
.+||++.++++
T Consensus 357 ~~RPs~~~l~~ 367 (374)
T cd05106 357 TERPTFSQISQ 367 (374)
T ss_pred hhCcCHHHHHH
Confidence 99999999965
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=340.04 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=215.1
Q ss_pred CCceEEEeEecccCcEEEEEEEEcC-----CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLE-----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrk-----TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~ 91 (1437)
.++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4679999999999999999999877 77899999876433 23334567889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC---cEEEEec
Q 000535 92 LHIILEYVENGSLANIIKPNKF-----GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG---LVKLADF 163 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~-----GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG---~VKLiDF 163 (1437)
.|+||||+++++|.+++..... ..+++..+..++.||+.||+|||+++++||||||+||+++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 9999999999999999975432 2589999999999999999999999999999999999998765 6999999
Q ss_pred ccccccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCC
Q 000535 164 GVATKLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIP 240 (1437)
Q Consensus 164 GLAr~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP 240 (1437)
|+++.+...... ......+..|+|||++.+..++.++|||||||++|+|++ |..||...........+........+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP 243 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 999876432211 112233567999999998889999999999999999997 99999876665555555555556677
Q ss_pred CCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 241 ~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
..++.++.+++.+||..+|++||++.++++|
T Consensus 244 ~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 244 KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=389.34 Aligned_cols=260 Identities=40% Similarity=0.777 Sum_probs=228.8
Q ss_pred ccCCceEEEe-----EecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 000535 15 TLDNKYMLGD-----EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR 89 (1437)
Q Consensus 15 tLggRYeIlE-----vLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd 89 (1437)
.+.-.|+.-+ +||+|+||+||-|+|..+....|||.|.... ..+.+-++.||.+-++|+|.|||+++|.+..+
T Consensus 567 ~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen 644 (1226)
T KOG4279|consen 567 KIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSEN 644 (1226)
T ss_pred ceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCC
Confidence 3444555443 7899999999999999999999999987543 35567799999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-CCcEEEEecccc
Q 000535 90 SHLHIILEYVENGSLANIIKPNKFGPF--PESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-EGLVKLADFGVA 166 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKssr~GpL--SEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-nG~VKLiDFGLA 166 (1437)
+++-|.||.++||+|.++++. +.|++ .|..+..|.+||++||.|||++.|||||||-+||||+. .|.+||.|||-+
T Consensus 645 Gf~kIFMEqVPGGSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 645 GFFKIFMEQVPGGSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred CeEEEEeecCCCCcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccc
Confidence 999999999999999999985 56888 89999999999999999999999999999999999975 589999999999
Q ss_pred cccccCCcccccccCCCccCChhhhhcC--CCCccchhhhHHHHHHHHHhCCCCCCCCCChhH-HHHH-hhcCCCCCCCC
Q 000535 167 TKLTEADVNTHSVVGTPYWMAPEVIEMS--GVCAASDIWSVGCTVIELLTCVPPYYELQPMPA-LFRI-VQDERPPIPES 242 (1437)
Q Consensus 167 r~L~esd~kt~t~~GTp~YmAPEVL~g~--~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eq-L~kI-iq~~rppiP~~ 242 (1437)
+.+..-..-+.++-||.-|||||++..+ +|+.++|||||||++.||.||+|||........ .+++ +....|++|..
T Consensus 724 KRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPee 803 (1226)
T KOG4279|consen 724 KRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEE 803 (1226)
T ss_pred hhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHH
Confidence 9887655566788999999999999754 689999999999999999999999987654333 3333 34557889999
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+|.++++||.+|+.+||..||++.++|.+||++..
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999999999999999865
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.22 Aligned_cols=255 Identities=33% Similarity=0.506 Sum_probs=207.0
Q ss_pred ceEEEeEecccCcEEEEEEEEcC--CCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLE--NGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--SHLH 93 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrk--TGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd--~~LY 93 (1437)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ......+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999998864311 22235577899999999999999999999888 8899
Q ss_pred EEEeecCCCCHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc----CCcEEEEecccc
Q 000535 94 IILEYVENGSLANIIKPNK---FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK----EGLVKLADFGVA 166 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr---~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde----nG~VKLiDFGLA 166 (1437)
+||||+++ +|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 7877775322 237899999999999999999999999999999999999999 899999999999
Q ss_pred cccccCCc---ccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChh---------HHHHHhh
Q 000535 167 TKLTEADV---NTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMP---------ALFRIVQ 233 (1437)
Q Consensus 167 r~L~esd~---kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~e---------qL~kIiq 233 (1437)
..+..... .....++++.|+|||++.+. .++.++|||||||++|+|++|.+||....... .+.++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87644321 22345789999999988664 57899999999999999999999997544321 1111100
Q ss_pred -------------------------cCCCCCC-----------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 234 -------------------------DERPPIP-----------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 234 -------------------------~~rppiP-----------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
......+ ...+.++.++|.+||..||++|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0001111 1567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=334.79 Aligned_cols=254 Identities=42% Similarity=0.785 Sum_probs=218.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccc---cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLEN---IAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--SHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~---lSeedie~L~REIkILrrLnHPNIVKLigVfedd--~~L 92 (1437)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999886432 2234566788999999999999999999998763 568
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999998744 46899999999999999999999999999999999999999999999999999875431
Q ss_pred C---cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhc-CCCCCCCCCCHHHH
Q 000535 173 D---VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-ERPPIPESLSPDIT 248 (1437)
Q Consensus 173 d---~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~-~rppiP~~ISpELk 248 (1437)
. .......|+..|+|||++.+..++.++|+|||||++|+|++|.+||..........++... ..+.+|..+++++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence 1 1122456899999999999888999999999999999999999999876665555554433 34557888999999
Q ss_pred HHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 249 DFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 249 DLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
++|.+||. +|.+||++.+++.|||+
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.37 Aligned_cols=258 Identities=27% Similarity=0.476 Sum_probs=219.4
Q ss_pred CCceEEEeEecccCcEEEEEEEEc-----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDr-----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~ 91 (1437)
..+|.+.+.||+|+||.||++.+. .++..||+|.+... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 357999999999999999999853 34567999988643 34456678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEE
Q 000535 92 LHIILEYVENGSLANIIKPNK-----------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKL 160 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr-----------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKL 160 (1437)
+|+||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999997432 235899999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCC
Q 000535 161 ADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERP 237 (1437)
Q Consensus 161 iDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rp 237 (1437)
+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..+...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999986643321 1122345778999999998899999999999999999998 99999887776666666666666
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 238 PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 238 piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
..+..+++++.+|+.+||..+|.+|||+.+++. ++++..
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~~ 280 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNLA 280 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHHH
Confidence 677789999999999999999999999999954 455443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=333.66 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=214.9
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|++.+.||+|+||.||+|.+. +++.||+|.++..... .+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 467999999999999999999864 4678999998765432 355788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 99999999999976555579999999999999999999999999999999999999999999999999998775332111
Q ss_pred -ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 177 -HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 177 -~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
.....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+......+.+..++..+.+++.+|
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 240 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDC 240 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 11223457999999998889999999999999999999 9999987766655555555545566778899999999999
Q ss_pred hhhcccCCCCHHHHhc
Q 000535 255 FKKDARQRPDAKTLLS 270 (1437)
Q Consensus 255 LqkDPeKRPSAeELLk 270 (1437)
|..+|.+||++.+++.
T Consensus 241 l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 241 WKEDPDDRPTFETLQW 256 (261)
T ss_pred hhcCcccCCCHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=336.79 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=213.4
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
..++|.+.+.||+|+||.||+|.+..+ ..||+|++....... +.+.+|+.+++.++||||+++++++. ....|+|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 357899999999999999999987655 469999987644332 45788999999999999999999875 4568999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+.+|+|.+++.......+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||.++.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999999998655557899999999999999999999999999999999999999999999999999876543321
Q ss_pred -cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 176 -THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 176 -t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
.....++..|+|||++....++.++|||||||++|+|++ |.+||......+....+......+.+..++..+.++|.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 123446778999999988889999999999999999999 888998776666555555555556677899999999999
Q ss_pred HhhhcccCCCCHHHHhc
Q 000535 254 CFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLk 270 (1437)
||+++|++||++.++++
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.73 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=216.0
Q ss_pred CceEEEeEecccCcEEEEEEEEcC-----CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLE-----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrk-----TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
.+|++.+.||+|+||.||+|.+.. .+..||+|++.... .....+.+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 358888999999999999998754 35789999987543 334456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcE
Q 000535 93 HIILEYVENGSLANIIKPN--------------KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLV 158 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKss--------------r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~V 158 (1437)
++++||+.+++|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence 9999999999999998522 12458899999999999999999999999999999999999999999
Q ss_pred EEEecccccccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC
Q 000535 159 KLADFGVATKLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE 235 (1437)
Q Consensus 159 KLiDFGLAr~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~ 235 (1437)
||+|||+++........ .....+++.|+|||.+....++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999876433211 123456788999999988889999999999999999998 889998877766666666666
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 236 rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
..+.+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 67778899999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=336.28 Aligned_cols=252 Identities=26% Similarity=0.474 Sum_probs=216.2
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCC---eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENG---DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTG---k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
.++|++.+.||+|+||.||+|.+..++ ..+|+|.++... .......+.+|+.++++++||||+++++++..++..|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 367999999999999999999886544 479999986543 3445667889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+++++|.+++.... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..+....
T Consensus 82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999997543 578999999999999999999999999999999999999999999999999998765432
Q ss_pred ccc---ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHH
Q 000535 174 VNT---HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249 (1437)
Q Consensus 174 ~kt---~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkD 249 (1437)
... ....++..|+|||++.+..++.++|+|||||++|++++ |..||......+....+......+.+..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ 240 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence 111 11223567999999998889999999999999999886 99999887766666666655556667788999999
Q ss_pred HHHHHhhhcccCCCCHHHHhc
Q 000535 250 FLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLk 270 (1437)
++.+||+++|.+||++.++++
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHcccCchhCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=331.56 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=218.8
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
..++|.+.+.||+|+||.||+|.+. ++..||+|.+...... .+.+.+|+.++++++||||+++++++......|+|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 4678999999999999999999864 5678999998765433 35678899999999999999999999998999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999999998765567999999999999999999999999999999999999999999999999999876542211
Q ss_pred -cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 176 -THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 176 -t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
.....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+......+.++......+.+..++.++.+++.+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 112334678999999998889999999999999999998 999998877766677766666667777889999999999
Q ss_pred HhhhcccCCCCHHHHhc
Q 000535 254 CFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLk 270 (1437)
||..+|++||++++++.
T Consensus 240 ~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=362.38 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=212.7
Q ss_pred CCceEEEeEecccCcEEEEEEEE-----cCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLD-----LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArD-----rkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~ 90 (1437)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++.... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34799999999999999999974 34577899999875432 33456788999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCC----------------------------------------------------------
Q 000535 91 HLHIILEYVENGSLANIIKPNK---------------------------------------------------------- 112 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr---------------------------------------------------------- 112 (1437)
..|+|||||++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc--
Q 000535 113 ---------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN-- 175 (1437)
Q Consensus 113 ---------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k-- 175 (1437)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 125788899999999999999999999999999999999999999999999999876443211
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC-CCCCCCCCCHHHHHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE-RPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~-rppiP~~ISpELkDLIrk 253 (1437)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||..........+.+... ....+...+.++.+||.+
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 352 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS 352 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence 112345667999999999999999999999999999998 899998766555555554433 344566678999999999
Q ss_pred HhhhcccCCCCHHHHhcC
Q 000535 254 CFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLkH 271 (1437)
||..||++||++.++++.
T Consensus 353 cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 353 CWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HccCChhHCcCHHHHHHH
Confidence 999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=379.42 Aligned_cols=246 Identities=28% Similarity=0.504 Sum_probs=221.1
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
+.+++.||+|-||+||.|.+ .....||+|.++...+.. +.+.+|+++|++|+|+|||++++++..++.+||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 45677999999999999986 334589999998765544 44679999999999999999999999988999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc-c
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH-S 178 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~-t 178 (1437)
+.|+|.++++...++.+...+...++.||++|++||+++++|||||-..|||++++..+||+|||+|+.+..+.+... +
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999999999986678899999999999999999999999999999999999999999999999999996655443222 2
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqk 257 (1437)
..-...|+|||.+....|+.+|||||||++||||+| |+.||.+....+.+..+..+.+.+.|..||+++.++|..||..
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~ 443 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHE 443 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhC
Confidence 223445999999999999999999999999999998 9999999999999999999999999999999999999999999
Q ss_pred cccCCCCHHHHh
Q 000535 258 DARQRPDAKTLL 269 (1437)
Q Consensus 258 DPeKRPSAeELL 269 (1437)
+|++|||++.+.
T Consensus 444 ~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 444 DPEDRPTFETLR 455 (468)
T ss_pred CcccCCCHHHHH
Confidence 999999999664
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=346.89 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=211.6
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeE----EEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDF----VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~----VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
..+|++.+.||+|+||.||+|.+..++.. ||+|++... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 35799999999999999999998666554 899998643 2334556788999999999999999999998764 57
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
++|+||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 89999999999999998543 46899999999999999999999999999999999999999999999999999876543
Q ss_pred Ccc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHH
Q 000535 173 DVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249 (1437)
Q Consensus 173 d~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkD 249 (1437)
... .....++..|+|||++....++.++|||||||++|+|++ |..||.+....+....+......+.+..++.++.+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 242 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 221 122344678999999999999999999999999999997 99999776544433333344455667788999999
Q ss_pred HHHHHhhhcccCCCCHHHHhcC
Q 000535 250 FLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkH 271 (1437)
++.+||..+|.+||++.+++.+
T Consensus 243 li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 243 IMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=343.55 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=213.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCe--EEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGD--FVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk--~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYL 94 (1437)
++|++.+.||+|+||.||+|.+..++. .+++|.++. .......+.+.+|+.+++++ .||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 579999999999999999999877664 468887763 22334556788999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEE
Q 000535 95 ILEYVENGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKL 160 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr--------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKL 160 (1437)
||||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999999999999996532 135889999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCC
Q 000535 161 ADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPI 239 (1437)
Q Consensus 161 iDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppi 239 (1437)
+|||++....... .......+..|+|||++....++.++|||||||++|+|++ |.+||......+....+......+.
T Consensus 161 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd05089 161 ADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239 (297)
T ss_pred CCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 9999987533211 1111233557999999998889999999999999999997 9999988776666666655555667
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 240 P~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
+..++.++.+||.+||..+|.+||++.++++.
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77899999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.93 Aligned_cols=248 Identities=26% Similarity=0.451 Sum_probs=213.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.+|.+.+.||+|+||.||+|.+. ++..+|+|++....... ..+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 35889999999999999999875 56789999987544332 357789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc-
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT- 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt- 176 (1437)
|+++++|.+++.... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 80 YMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred cCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999997543 478999999999999999999999999999999999999999999999999998764332111
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
....++..|+|||.+....++.++|||||||++|+|++ |.+||......+....+......+.+..++.++.+++.+||
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 238 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW 238 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence 11223457999999998899999999999999999999 89999877666666666555566777789999999999999
Q ss_pred hhcccCCCCHHHHhc
Q 000535 256 KKDARQRPDAKTLLS 270 (1437)
Q Consensus 256 qkDPeKRPSAeELLk 270 (1437)
..+|++||++.++++
T Consensus 239 ~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 239 HEKPEDRPAFKKLLS 253 (256)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.78 Aligned_cols=253 Identities=36% Similarity=0.611 Sum_probs=217.1
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
|.+.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.++++++||||+++++++......|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999889999999998866555455667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccc
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV 179 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~ 179 (1437)
++ +|.+.+.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+.............
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 75 8888887543 579999999999999999999999999999999999999999999999999998876544222335
Q ss_pred cCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC---------------------
Q 000535 180 VGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--------------------- 237 (1437)
Q Consensus 180 ~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--------------------- 237 (1437)
.++..|+|||.+... .++.++|+||||+++|+|++|++||...+..+.+.++......
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 688899999998776 7899999999999999999999999877765554443321100
Q ss_pred --------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 --------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 --------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
...+.++.++.++|.+||.+||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1123468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.57 Aligned_cols=255 Identities=31% Similarity=0.550 Sum_probs=219.6
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccc---cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLEN---IAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~---lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
+|.+.+.||+|+||.||++.+...+..+++|+++... ....+...+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998877777777665432 2333444567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 96 LEYVENGSLANIIKP--NKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 96 MEYceGGSL~DLLKs--sr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
|||+++++|.+++.. .....+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 23457999999999999999999999999999999999999975 579999999998765544
Q ss_pred cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 174 VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..........++.....+..+..++.++.++|.+
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS 239 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHH
Confidence 33445678999999999988889999999999999999999999998766666666666666666777899999999999
Q ss_pred HhhhcccCCCCHHHHhcCHHH
Q 000535 254 CFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLkHPWF 274 (1437)
||..+|++||++.++++||||
T Consensus 240 ~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 240 MLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=333.26 Aligned_cols=247 Identities=32% Similarity=0.553 Sum_probs=208.1
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDL-LKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkI-LrrLnHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||.|+||.||+|.+..+++.||+|++.+.... ......+..|..+ ...++||||+++++++..++.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999999999999998765432 2223334455544 4455899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
++|.++++.. +++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVG 155 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCC
Confidence 9999999754 5799999999999999999999999999999999999999999999999999976543 234568
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC---CCCCCCCCCHHHHHHHHHHhhhc
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~---rppiP~~ISpELkDLIrkCLqkD 258 (1437)
++.|+|||.+.+..++.++||||||+++|+|++|.+||...+.......+.... .......+++++.++|.+||..+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 899999999988888999999999999999999999998766655544443322 12233468999999999999999
Q ss_pred ccCCC---CHHHHhcCHHHHH
Q 000535 259 ARQRP---DAKTLLSHPWIQN 276 (1437)
Q Consensus 259 PeKRP---SAeELLkHPWFQe 276 (1437)
|++|| ++.+++.||||..
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHccCCCcHHHHHcChHhhc
Confidence 99999 5579999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=335.10 Aligned_cols=253 Identities=33% Similarity=0.497 Sum_probs=213.3
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCe-----
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL---NHKNIVKYLGSLKTRSH----- 91 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL---nHPNIVKLigVfedd~~----- 91 (1437)
|++.+.||+|+||.||+|++..+++.||+|.+............+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999988899999999976544333344566788777666 69999999999988776
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e 171 (1437)
+|++|||+.+ +|.+++.......+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999975 899988765445699999999999999999999999999999999999999999999999999987754
Q ss_pred CCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC--------------
Q 000535 172 ADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP-------------- 237 (1437)
Q Consensus 172 sd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp-------------- 237 (1437)
.. ......++..|+|||++.+..++.++|+|||||++|+|++|.+||......+.+.++......
T Consensus 160 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 160 EM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred Cc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 32 223456789999999999888999999999999999999999999887766666555432110
Q ss_pred ------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 ------------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 ------------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
...+.+++.+.++|.+||..||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0012356788999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.44 Aligned_cols=257 Identities=35% Similarity=0.561 Sum_probs=214.2
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--RSHLHII 95 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed--d~~LYLV 95 (1437)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|++++++++||||+++++++.. .+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 479999999999999999999999999999999875433 2445678899999999999999999998854 4578999
Q ss_pred EeecCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 96 LEYVENGSLANIIKP--NKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 96 MEYceGGSL~DLLKs--sr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
|||+++++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999999988753 234568999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----hhHHHHHhhcCCCCCC------CC
Q 000535 174 VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP-----MPALFRIVQDERPPIP------ES 242 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-----~eqL~kIiq~~rppiP------~~ 242 (1437)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||..... .+....+.....+.++ ..
T Consensus 160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 2235678899999999988999999999999999999999999976521 2222222221222211 23
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+++++.++|.+||.++|.+|||+.|++.||||++.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 56789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.94 Aligned_cols=249 Identities=27% Similarity=0.474 Sum_probs=206.0
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH-HHHHHHHHHHHH---hCCCCCcceEEEEEEeCCeEEEEEeecC
Q 000535 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLK---NLNHKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 25 vLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed-ie~L~REIkILr---rLnHPNIVKLigVfedd~~LYLVMEYce 100 (1437)
.||+|+||.||++.+..+++.||+|.+......... .....+|..+++ ...||||+.+++++..++..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998765443222 222334443333 3479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccccc
Q 000535 101 NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180 (1437)
Q Consensus 101 GGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~ 180 (1437)
+++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV 156 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcC
Confidence 99999998744 57999999999999999999999999999999999999999999999999999765433 223457
Q ss_pred CCCccCChhhhh-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--hhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 000535 181 GTPYWMAPEVIE-MSGVCAASDIWSVGCTVIELLTCVPPYYELQP--MPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 181 GTp~YmAPEVL~-g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~--~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqk 257 (1437)
|++.|+|||.+. +..++.++||||+||++|+|++|..||..... ...+.+........++..+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 999999999986 45688999999999999999999999975432 222333333334456778999999999999999
Q ss_pred cccCCC-----CHHHHhcCHHHHHH
Q 000535 258 DARQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 258 DPeKRP-----SAeELLkHPWFQe~ 277 (1437)
||.+|| ++.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCC
Confidence 999999 69999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=334.96 Aligned_cols=249 Identities=26% Similarity=0.434 Sum_probs=214.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.+|.+.+.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.++++++||||+++++++.....+|+|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 46999999999999999999764 3556999998754433 3457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc-c
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN-T 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k-t 176 (1437)
|+.+|+|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.++........ .
T Consensus 80 ~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 80 YMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999999997543 36999999999999999999999999999999999999999999999999999866443211 1
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+........+...+..+.+++.+||
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 238 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW 238 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 12335677999999988889999999999999999998 99999877766666666666666667778999999999999
Q ss_pred hhcccCCCCHHHHhcC
Q 000535 256 KKDARQRPDAKTLLSH 271 (1437)
Q Consensus 256 qkDPeKRPSAeELLkH 271 (1437)
..+|.+||++.+++.+
T Consensus 239 ~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 239 HEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCcccCCCHHHHHHh
Confidence 9999999999999753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=327.61 Aligned_cols=250 Identities=30% Similarity=0.528 Sum_probs=217.2
Q ss_pred eEEEeEecccCcEEEEEEEEcCCC----eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENG----DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTG----k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
+.+.+.||.|+||.||+|.+...+ ..||+|++..... ....+.+..|+.++++++||||+++++++.+.+..|++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 356789999999999999998766 8999999865432 23567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 99999999999997654333999999999999999999999999999999999999999999999999999877654222
Q ss_pred cc-cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 176 TH-SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 176 t~-t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
.. ...+++.|+|||.+....++.++|||||||++|+|++ |.+||...........+........+..++.++.+++.+
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 21 2336789999999988889999999999999999998 889998766666666666666667777899999999999
Q ss_pred HhhhcccCCCCHHHHhc
Q 000535 254 CFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLk 270 (1437)
||..+|++|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 240 CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HCcCChhhCcCHHHHHh
Confidence 99999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=352.77 Aligned_cols=260 Identities=28% Similarity=0.503 Sum_probs=216.6
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCe
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT----RSH 91 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed----d~~ 91 (1437)
++++|.+.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+|++++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 5689999999999999999999999999999999998654444456678889999999999999999998753 457
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e 171 (1437)
+|+||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 899999996 5899998744 5699999999999999999999999999999999999999999999999999977643
Q ss_pred CCcc----cccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhc------------
Q 000535 172 ADVN----THSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD------------ 234 (1437)
Q Consensus 172 sd~k----t~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~------------ 234 (1437)
.... .....|+..|+|||++.. ..++.++|||||||++|+|++|++||...+....+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 3211 124578999999999865 45889999999999999999999999776544333221110
Q ss_pred -------------CCCCC-----CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 235 -------------ERPPI-----PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 235 -------------~rppi-----P~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
..... .+.++.++.++|.+||+.+|++||++.+++.||||.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00111 145789999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=349.38 Aligned_cols=257 Identities=35% Similarity=0.516 Sum_probs=219.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----eEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS-----HLH 93 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~-----~LY 93 (1437)
+|++.+.||.|+||.||+|.+..+++.||+|.+..........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999889999999998765443455677889999999999999999999987765 899
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+. ++|.+++... .++++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999997 4899998754 489999999999999999999999999999999999999999999999999998775543
Q ss_pred ---cccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC------------
Q 000535 174 ---VNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP------------ 237 (1437)
Q Consensus 174 ---~kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp------------ 237 (1437)
.......+++.|+|||++.+. .++.++|+|||||++|+|++|.+||......+.+..+......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 123345689999999999887 7899999999999999999999999877665544443321110
Q ss_pred ------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 238 ------------------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 238 ------------------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
...+.++.++.++|.+||+++|++||++.+++.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 01234688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=369.81 Aligned_cols=260 Identities=32% Similarity=0.531 Sum_probs=222.7
Q ss_pred ccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 000535 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--S 90 (1437)
Q Consensus 13 gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd--~ 90 (1437)
++...-.|.-.+.+|.|+||.||+|....+++.||||..-... ..-.+|+.+|+.+.|||||++.-+|... .
T Consensus 19 ~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 19 GKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred CcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 4445557999999999999999999999999999999875432 2345899999999999999999988542 2
Q ss_pred ---eEEEEEeecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC-CcEEEEecc
Q 000535 91 ---HLHIILEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE-GLVKLADFG 164 (1437)
Q Consensus 91 ---~LYLVMEYceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden-G~VKLiDFG 164 (1437)
+..+||||++. +|.+.++.. ....++.-.++-|++||+.||.|||+.||+||||||+|+|+|.+ |.+||||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 45689999986 999999731 23568999999999999999999999999999999999999976 899999999
Q ss_pred cccccccCCcccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC------
Q 000535 165 VATKLTEADVNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP------ 237 (1437)
Q Consensus 165 LAr~L~esd~kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp------ 237 (1437)
.|+.+..+... .++..|..|+|||.+.+. .|+.+.||||.|||+.||+.|++-|.+.+..+++..|++-...
T Consensus 172 SAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 172 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred cceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998876644 567889999999988764 7999999999999999999999999999998888877652110
Q ss_pred ------------------C----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHHHH
Q 000535 238 ------------------P----IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA 280 (1437)
Q Consensus 238 ------------------p----iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~rrs 280 (1437)
+ +...+++++.+|+.++|.++|.+|.++.+++.||||.+.+..
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1 234578999999999999999999999999999999987643
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=344.75 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=210.6
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeE--EEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDF--VAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~--VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYL 94 (1437)
++|++.+.||+|+||.||+|.+..++.. +++|.+.. .........+.+|+.++.++ +||||+++++++..++.+|+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 4799999999999999999998877765 46666543 22344556788999999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEE
Q 000535 95 ILEYVENGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKL 160 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr--------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKL 160 (1437)
||||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 999999999999996432 236899999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCC
Q 000535 161 ADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPI 239 (1437)
Q Consensus 161 iDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppi 239 (1437)
+|||++....... ......++..|+|||++....++.++|||||||++|+|++ |.+||......+....+........
T Consensus 166 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T cd05088 166 ADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244 (303)
T ss_pred CccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCC
Confidence 9999996432211 1112234667999999988889999999999999999998 9999987665554444433334455
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 240 P~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
+..+++++.+||.+||..+|++||++.+++.+
T Consensus 245 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 245 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=342.46 Aligned_cols=257 Identities=37% Similarity=0.647 Sum_probs=220.5
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
.....+|.+.+.||+|+||.||+|.+..+++.||+|++..... ..+....+.+|+.+++.++||||+++++++.+++..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 4556779999999999999999999998999999999875432 344556788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
|+||||+. |++.+++... .+++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 91 WLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99999997 5887877543 246999999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccCCCccCChhhhh---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCC-CCCCCHHHH
Q 000535 173 DVNTHSVVGTPYWMAPEVIE---MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-PESLSPDIT 248 (1437)
Q Consensus 173 d~kt~t~~GTp~YmAPEVL~---g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppi-P~~ISpELk 248 (1437)
....+++.|+|||++. ...++.++||||||+++|+|++|.+||...+.......+.....+.. +..++.++.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 2456889999999874 45688899999999999999999999987766665555544433333 345788999
Q ss_pred HHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 249 DFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 249 DLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
++|.+||..+|++||++.+++.||||+.
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 9999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=339.50 Aligned_cols=249 Identities=31% Similarity=0.526 Sum_probs=211.2
Q ss_pred EEEeEecccCcEEEEEEEEc----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 21 MLGDEIGKGAYGRVYKGLDL----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 21 eIlEvLGrGgFGtVYKArDr----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.+.+.||.|.||.||+|... ..+..|+||.+.. ....+..+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 57899999999999999987 3568899999954 344556788999999999999999999999999888899999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-- 174 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-- 174 (1437)
|||++|+|.+++.......+++..++.|+.||+.||.|||+++|+|+||++.|||++.++.+||+|||++........
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999977557899999999999999999999999999999999999999999999999999987732211
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
......+...|+|||.+....++.++||||||+++|||++ |..||...+..+...++......+.+..++..+.++|.+
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHH
Confidence 1223456778999999999999999999999999999999 789998887666667776666777788899999999999
Q ss_pred HhhhcccCCCCHHHHhc
Q 000535 254 CFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLk 270 (1437)
||..+|++||++.++++
T Consensus 241 C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HT-SSGGGS--HHHHHH
T ss_pred HcCCChhhCcCHHHHHh
Confidence 99999999999999864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=343.65 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=213.8
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcC-------CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLE-------NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSL 86 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrk-------TGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVf 86 (1437)
...++|.+.+.||+|+||.||+|.+.. +...||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345789999999999999999998643 23579999987543 344556788899999999 799999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEe
Q 000535 87 KTRSHLHIILEYVENGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILT 152 (1437)
Q Consensus 87 edd~~LYLVMEYceGGSL~DLLKssr--------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILL 152 (1437)
...+..|+||||+.+|+|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 99999999999999999999997542 1358899999999999999999999999999999999999
Q ss_pred ccCCcEEEEecccccccccCCccc--ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHH
Q 000535 153 TKEGLVKLADFGVATKLTEADVNT--HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALF 229 (1437)
Q Consensus 153 denG~VKLiDFGLAr~L~esd~kt--~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~ 229 (1437)
+.++.+||+|||+++......... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999998764322111 12234568999999998889999999999999999998 889987655433333
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 230 RIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 230 kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
.+........+..++.++.+||.+||..+|.+||++.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 254 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 444444456777899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.25 Aligned_cols=255 Identities=33% Similarity=0.606 Sum_probs=219.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
..|.....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+.||||+++++++..++..|+|||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 345566789999999999999988999999999865432 234567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+........
T Consensus 99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 9999999998864 4589999999999999999999999999999999999999999999999999976654433344
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--CCCCCCCCHHHHHHHHHHh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER--PPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r--ppiP~~ISpELkDLIrkCL 255 (1437)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+..... ...+..++..+.++|.+||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 56799999999999988899999999999999999999999987666555544432221 1223467899999999999
Q ss_pred hhcccCCCCHHHHhcCHHHHHH
Q 000535 256 KKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 256 qkDPeKRPSAeELLkHPWFQe~ 277 (1437)
..+|.+||++.++++||||.++
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred cCCcccCcCHHHHhhChhhccC
Confidence 9999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=344.43 Aligned_cols=256 Identities=28% Similarity=0.501 Sum_probs=209.0
Q ss_pred EEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecC
Q 000535 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 21 eIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYce 100 (1437)
.+++.+|. ++.||.+++..+++.||+|++..........+.+.+|+.++++++||||+++++++..++..|++||||.
T Consensus 5 ~i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 5 LIGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34444444 4556666666799999999998765666778889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc------
Q 000535 101 NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV------ 174 (1437)
Q Consensus 101 GGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~------ 174 (1437)
+|+|.+++.......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+..+.....
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999999865556799999999999999999999999999999999999999999999999999876543221
Q ss_pred -ccccccCCCccCChhhhhc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC---------------
Q 000535 175 -NTHSVVGTPYWMAPEVIEM--SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER--------------- 236 (1437)
Q Consensus 175 -kt~t~~GTp~YmAPEVL~g--~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r--------------- 236 (1437)
......++..|+|||++.. ..++.++|+||+||++|+|++|..||........+........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 1223457888999999876 3588999999999999999999999987654443332222110
Q ss_pred ------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 237 ------------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 237 ------------------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
......++.++.+||.+||.+||++|||+.++++||||+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 011123356789999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.08 Aligned_cols=246 Identities=27% Similarity=0.482 Sum_probs=214.4
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.+.|++.+.||.|+||.||+|.. .++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+....|+||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 45799999999999999999986 488999999875532 4567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++++|.++++......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 99999999999986655579999999999999999999999999999999999999999999999999998774322
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
....++..|+|||.+....++.++||||||+++|+|++ |..||...........+........+..+++++.++|.+||
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCW 236 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHh
Confidence 12345667999999988889999999999999999997 99999876555444444444455667788999999999999
Q ss_pred hhcccCCCCHHHHhc
Q 000535 256 KKDARQRPDAKTLLS 270 (1437)
Q Consensus 256 qkDPeKRPSAeELLk 270 (1437)
..+|++||++.++++
T Consensus 237 ~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 237 ELDPAKRPTFKQLRE 251 (256)
T ss_pred ccChhhCcCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.65 Aligned_cols=260 Identities=31% Similarity=0.519 Sum_probs=214.9
Q ss_pred ccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 000535 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS-- 90 (1437)
Q Consensus 13 gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~-- 90 (1437)
++...++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 345678899999999999999999999999999999999765443344456778999999999999999999987654
Q ss_pred --------eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEe
Q 000535 91 --------HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLAD 162 (1437)
Q Consensus 91 --------~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiD 162 (1437)
.+|+|+||+++ ++...+... ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 89999999986 777777644 35799999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcc-cccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC---
Q 000535 163 FGVATKLTEADVN-THSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--- 237 (1437)
Q Consensus 163 FGLAr~L~esd~k-t~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp--- 237 (1437)
||++..+...... .....++..|+|||++.. ..++.++|||||||++|+|++|++||......+.+..+......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9999876543321 122356788999998865 35788999999999999999999999876655544333221100
Q ss_pred --------------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 --------------------------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 --------------------------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.....++..+.++|.+||..+|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122468999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=373.02 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=208.4
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
..+..|.+.+.||+|+||.||+|.+..++..||||.... ..+.+|+.+|++++|||||++++++...+..|+
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 346689999999999999999999999999999996331 235689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+. ++|.+++.... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 238 v~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 999995 68998886532 4799999999999999999999999999999999999999999999999999987643221
Q ss_pred --ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-------hhHHHHHhhcCC---CCC---
Q 000535 175 --NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP-------MPALFRIVQDER---PPI--- 239 (1437)
Q Consensus 175 --kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-------~eqL~kIiq~~r---ppi--- 239 (1437)
.....+||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+++.... ..+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 12246799999999999999999999999999999999998766543221 122333322110 000
Q ss_pred -------------------------C---CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 240 -------------------------P---ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 240 -------------------------P---~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+ ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 134568999999999999999999999999999963
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.38 Aligned_cols=249 Identities=26% Similarity=0.452 Sum_probs=212.2
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|.+.+.||+|+||.||+|.+..+ ..+|+|.+...... .+.+.+|+.+++++.|||++++++++. .+..|+||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 47899999999999999999987554 46999987654332 345778999999999999999999885 45689999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc-
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN- 175 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k- 175 (1437)
||+.+++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 9999999999998655556899999999999999999999999999999999999999999999999999876443211
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
.....++..|+|||.+....++.++|||||||++|+|++ |.+||.+....+....+......+.+..++..+.+++.+|
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence 122345678999999988889999999999999999999 9999988766666555555555667778999999999999
Q ss_pred hhhcccCCCCHHHHhc
Q 000535 255 FKKDARQRPDAKTLLS 270 (1437)
Q Consensus 255 LqkDPeKRPSAeELLk 270 (1437)
|.++|++||++.++++
T Consensus 240 l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 240 WKKDPDERPTFEYIQS 255 (260)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.38 Aligned_cols=243 Identities=29% Similarity=0.470 Sum_probs=207.2
Q ss_pred eEecccCcEEEEEEEEcCCC---eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecC
Q 000535 24 DEIGKGAYGRVYKGLDLENG---DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTG---k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYce 100 (1437)
+.||+|+||.||+|.+...+ ..||+|.+...... ...+.+.+|+.+++++.||||+++++++.. ...++||||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 47899999999999876554 78999998765543 455678899999999999999999998764 46899999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc---
Q 000535 101 NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH--- 177 (1437)
Q Consensus 101 GGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~--- 177 (1437)
+|+|.+++... +.+++..+..++.|++.+|+|||..|++||||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 79 LGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999999854 3799999999999999999999999999999999999999999999999999987654332111
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
...++..|+|||.+....++.++|||||||++|+|++ |.+||...+..+....+......+.+..++..+.++|.+||.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1223467999999998889999999999999999998 999998776655555555555567778899999999999999
Q ss_pred hcccCCCCHHHHhc
Q 000535 257 KDARQRPDAKTLLS 270 (1437)
Q Consensus 257 kDPeKRPSAeELLk 270 (1437)
.+|++||++.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.25 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=211.4
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCe----EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGD----FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk----~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
..+|++.+.||+|+||+||+|.+..++. .||+|++.... .......+.+|+.+++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 4579999999999999999999877665 48999886543 34445678899999999999999999999865 457
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
+++|||+++|+|.+++.... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 89999999999999997543 57999999999999999999999999999999999999999999999999999876533
Q ss_pred Ccc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHH
Q 000535 173 DVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249 (1437)
Q Consensus 173 d~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkD 249 (1437)
... .....+++.|+|||.+.+..++.++|||||||++|||++ |.+||...........+......+.+..++.++.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHH
Confidence 211 112334678999999998899999999999999999998 89999765554444444444555667789999999
Q ss_pred HHHHHhhhcccCCCCHHHHhc
Q 000535 250 FLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLk 270 (1437)
++.+||..||++||++.+++.
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.35 Aligned_cols=249 Identities=27% Similarity=0.500 Sum_probs=208.1
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHH-HHHHHH---HHHHHhCCCCCcceEEEEEEeCCeEEEEEeecC
Q 000535 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL-NIIMQE---IDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 25 vLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedi-e~L~RE---IkILrrLnHPNIVKLigVfedd~~LYLVMEYce 100 (1437)
.||+|+||.||+|.+..+++.||+|.+.+........ .....| +..++...||||+++++++.+.+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999999999999999988654332221 122233 334555689999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccccc
Q 000535 101 NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180 (1437)
Q Consensus 101 GGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~ 180 (1437)
||+|.+++... +.+++..+..|+.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+... .....+
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV 156 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcC
Confidence 99999998743 57999999999999999999999999999999999999999999999999999766433 233467
Q ss_pred CCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCC--hhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 000535 181 GTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQP--MPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 181 GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~--~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqk 257 (1437)
|+..|+|||++... .++.++||||+||++|+|++|..||..... .....+........++..++.++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 99999999998754 688999999999999999999999976532 222333344445667778899999999999999
Q ss_pred cccCCC-----CHHHHhcCHHHHHH
Q 000535 258 DARQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 258 DPeKRP-----SAeELLkHPWFQe~ 277 (1437)
+|.+|| ++.++++||||...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=349.56 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=210.2
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR-----S 90 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd-----~ 90 (1437)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.++++++||||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 56899999999999999999999999999999999864322 23445677899999999999999999987543 4
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
..|+|+||+.+ +|.+++.. +++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred eEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 58999999975 88888863 469999999999999999999999999999999999999999999999999998764
Q ss_pred cCCcc---cccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-----------
Q 000535 171 EADVN---THSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE----------- 235 (1437)
Q Consensus 171 esd~k---t~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~----------- 235 (1437)
..... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 33211 123578999999998754 568899999999999999999999997654332222111100
Q ss_pred --------------CCC-----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 236 --------------RPP-----IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 236 --------------rpp-----iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
... ..+.+++++.++|.+||+.+|++||++.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000 113467889999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.43 Aligned_cols=251 Identities=27% Similarity=0.494 Sum_probs=215.7
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCe---EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk---~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
+.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+..|+.+++.+.||||+++++++..+...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 569999999999999999999877664 69999986542 44556789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+++++|.+++... .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 83 ITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999999754 35799999999999999999999999999999999999999999999999999976543221
Q ss_pred cc--ccc---cCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHH
Q 000535 175 NT--HSV---VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDIT 248 (1437)
Q Consensus 175 kt--~t~---~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELk 248 (1437)
.. ... ..+..|+|||.+....++.++|||||||++|+|++ |..||......+....+......+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 241 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALH 241 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHH
Confidence 11 111 12457999999998899999999999999999886 9999988776666666655555666778999999
Q ss_pred HHHHHHhhhcccCCCCHHHHhc
Q 000535 249 DFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 249 DLIrkCLqkDPeKRPSAeELLk 270 (1437)
+++.+||..+|.+||++.+++.
T Consensus 242 ~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 242 QLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=366.09 Aligned_cols=268 Identities=29% Similarity=0.486 Sum_probs=241.5
Q ss_pred CcccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEE
Q 000535 7 TSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85 (1437)
Q Consensus 7 as~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigV 85 (1437)
...-...++-.++|..+++||+|.||.|.+++.+.+++.||+|+++++.. ...++..-..|-++|+..+||.+..+...
T Consensus 157 ~~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 157 EEAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred ccccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence 34445566667889999999999999999999999999999999998754 45667777789999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccc
Q 000535 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGV 165 (1437)
Q Consensus 86 fedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGL 165 (1437)
|+..+++|+||||..||.|+-.+.+ ...|+|..++.|-..|+.||.|||+++||+||||.+|+|++.+|++||+|||+
T Consensus 237 FQt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 237 FQTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred hccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeeccc
Confidence 9999999999999999999988864 35799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCH
Q 000535 166 ATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSP 245 (1437)
Q Consensus 166 Ar~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISp 245 (1437)
|+.-...+....++||||.|+|||++.+..|+.++|+|.+|++||||+||+.||+..+.. .++..+......+|..+++
T Consensus 315 CKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-kLFeLIl~ed~kFPr~ls~ 393 (516)
T KOG0690|consen 315 CKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-KLFELILMEDLKFPRTLSP 393 (516)
T ss_pred chhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-HHHHHHHhhhccCCccCCH
Confidence 987666666778899999999999999999999999999999999999999999987654 4555666666788999999
Q ss_pred HHHHHHHHHhhhcccCCC-----CHHHHhcCHHHHHH
Q 000535 246 DITDFLRQCFKKDARQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRP-----SAeELLkHPWFQe~ 277 (1437)
+++.|+..+|.+||.+|. .+.||.+|+||...
T Consensus 394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 999999999999999996 58999999999643
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=327.99 Aligned_cols=246 Identities=33% Similarity=0.585 Sum_probs=217.7
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCH
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL 104 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe-edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL 104 (1437)
||.|+||.||++.+..+++.|++|++....... .....+..|+.++++++||||+++++.++.+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999998889999999988665432 3566788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCCCc
Q 000535 105 ANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY 184 (1437)
Q Consensus 105 ~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~ 184 (1437)
.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++..
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence 9999754 46999999999999999999999999999999999999999999999999999877554333445678999
Q ss_pred cCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCC
Q 000535 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPD 264 (1437)
Q Consensus 185 YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPS 264 (1437)
|++||.+.+..++.++|+||||+++|+|++|..||...+.......+. ....+++..++..+.++|.+||..||++||+
T Consensus 159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL-KDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999988888999999999999999999999997765544444443 3556778888999999999999999999999
Q ss_pred H---HHHhcCHHH
Q 000535 265 A---KTLLSHPWI 274 (1437)
Q Consensus 265 A---eELLkHPWF 274 (1437)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.72 Aligned_cols=251 Identities=27% Similarity=0.471 Sum_probs=214.7
Q ss_pred CceEEEeEecccCcEEEEEEEEc-----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDr-----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
++|.+.+.||+|+||.||+|.+. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 46999999999999999999854 345678999875432 34446688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcE
Q 000535 93 HIILEYVENGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLV 158 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr--------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~V 158 (1437)
++||||+++++|.+++.... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999996532 2458999999999999999999999999999999999999999999
Q ss_pred EEEecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC
Q 000535 159 KLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE 235 (1437)
Q Consensus 159 KLiDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~ 235 (1437)
+|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+....
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 242 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence 9999999976544321 1223456888999999998999999999999999999998 999998877666665555555
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 236 rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
....+..++..+.+++.+||..+|.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 243 VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 55566778999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=332.61 Aligned_cols=253 Identities=32% Similarity=0.589 Sum_probs=212.9
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEEEEEe
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--SHLHIILE 97 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd--~~LYLVME 97 (1437)
|.+.+.||.|+||.||+|.+..+++.||+|.+............+.+|+.++++++|||++++++++... +..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7889999999999999999999999999999987653344456688999999999999999999999888 89999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-cc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NT 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-kt 176 (1437)
|+++ +|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 9975 8999887543 5799999999999999999999999999999999999999999999999999987755431 12
Q ss_pred ccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC-----------------
Q 000535 177 HSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP----------------- 238 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp----------------- 238 (1437)
....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+....+..+......+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 23467888999998764 457889999999999999999999998766554444333211000
Q ss_pred -------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 239 -------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 239 -------------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
+...+++++.++|.+||..+|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011138899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.84 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=215.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCe---EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk---~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
.++|...+.||+|+||.||+|.+..++. .+++|.+.... .....+.+..|+.++++++||||+++++++...+..|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 4578999999999999999999876554 79999886543 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+++++|.+++... .+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 83 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 83 IITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999754 3579999999999999999999999999999999999999999999999999998764332
Q ss_pred cccc---cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHH
Q 000535 174 VNTH---SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249 (1437)
Q Consensus 174 ~kt~---t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkD 249 (1437)
.... ....++.|+|||++....++.++|||||||++|+|++ |..||......+....+......+.+..++.++.+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 1111 1223457999999998889999999999999999997 99999877766666666555555666778999999
Q ss_pred HHHHHhhhcccCCCCHHHHhc
Q 000535 250 FLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLk 270 (1437)
++.+||..+|++||++.++++
T Consensus 242 li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 242 LMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.63 Aligned_cols=251 Identities=25% Similarity=0.459 Sum_probs=211.5
Q ss_pred ceEEEeEecccCcEEEEEEEEcC-----CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLE-----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrk-----TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.+.||||+++++.+..++..|
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 48899999999999999998753 23678888876543 3345677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceE
Q 000535 94 IILEYVENGSLANIIKPNK----------------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL 151 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr----------------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENIL 151 (1437)
+||||+.+++|.+++.... ..++++..++.++.|++.||.|||++||+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999986421 235889999999999999999999999999999999999
Q ss_pred eccCCcEEEEecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHH
Q 000535 152 TTKEGLVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPAL 228 (1437)
Q Consensus 152 LdenG~VKLiDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL 228 (1437)
++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999986543321 1223345778999999988889999999999999999998 99999876655444
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 229 FRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 229 ~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
..+......+.+..++.++.+++..||+.+|++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 444444455567789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=338.44 Aligned_cols=256 Identities=30% Similarity=0.521 Sum_probs=209.5
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--------
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT-------- 88 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed-------- 88 (1437)
-++|.+.+.||.|+||.||+|.+..+++.||+|.+............+.+|+.++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999987654433333456789999999999999999998744
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 89 d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
...+|+||||+.+ +|...+... ...+++..+..++.|+++||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 3357999999975 777777543 35799999999999999999999999999999999999999999999999999986
Q ss_pred cccCCcc-----------cccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC
Q 000535 169 LTEADVN-----------THSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER 236 (1437)
Q Consensus 169 L~esd~k-----------t~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r 236 (1437)
....... .....|++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 5432211 1234678889999988654 578999999999999999999999987766554444332111
Q ss_pred CC----------------------C-------CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 237 PP----------------------I-------PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 237 pp----------------------i-------P~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.+ . ...+++.+.++|.+||..+|.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 0 02345788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.01 Aligned_cols=244 Identities=25% Similarity=0.476 Sum_probs=209.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSL-KTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVf-edd~~LYLVM 96 (1437)
.+|++.+.||+|+||.||++.. .+..|++|.+... ...+.+.+|+.++++++|+|++++++++ ..+...|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 4799999999999999999976 4888999988643 2345688999999999999999999975 4556799999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
||+++++|.++++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999999987655568999999999999999999999999999999999999999999999999998654322
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
....++..|+|||++....++.++|||||||++|+|++ |.+||...........+........+..+++.+.++|.+||
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 23345678999999998889999999999999999997 99999776554444445445455667789999999999999
Q ss_pred hhcccCCCCHHHHhc
Q 000535 256 KKDARQRPDAKTLLS 270 (1437)
Q Consensus 256 qkDPeKRPSAeELLk 270 (1437)
..+|++|||+.++++
T Consensus 237 ~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 237 HLDAATRPSFLQLRE 251 (256)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.91 Aligned_cols=252 Identities=26% Similarity=0.472 Sum_probs=215.9
Q ss_pred CCceEEEeEecccCcEEEEEEEEc-----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDr-----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~ 91 (1437)
..+|.+.++||+|+||.||+|... .++..+++|.+... .....+.+.+|+.+++.+.||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 457899999999999999999743 35678999987643 34456678999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcE
Q 000535 92 LHIILEYVENGSLANIIKPNKF-------------GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLV 158 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~-------------GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~V 158 (1437)
.|++|||+.+++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 9999999999999999975421 358999999999999999999999999999999999999999999
Q ss_pred EEEecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC
Q 000535 159 KLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE 235 (1437)
Q Consensus 159 KLiDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~ 235 (1437)
||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999976543221 1122345788999999998999999999999999999998 999998877766666666666
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 236 rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
....+..+++.+.++|.+||..||.+||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 66677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=341.21 Aligned_cols=253 Identities=27% Similarity=0.471 Sum_probs=213.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEcC-------CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLE-------NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT 88 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrk-------TGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfed 88 (1437)
.++|.+.+.||+|+||.||+|++.. ....||+|.+.... .......+..|+.+++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4689999999999999999998632 35679999887432 345567788999999999 69999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc
Q 000535 89 RSHLHIILEYVENGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK 154 (1437)
Q Consensus 89 d~~LYLVMEYceGGSL~DLLKssr--------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde 154 (1437)
++.+|+||||+.+|+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 999999999999999999996532 245899999999999999999999999999999999999999
Q ss_pred CCcEEEEecccccccccCCccc--ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHH
Q 000535 155 EGLVKLADFGVATKLTEADVNT--HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRI 231 (1437)
Q Consensus 155 nG~VKLiDFGLAr~L~esd~kt--~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kI 231 (1437)
++.+||+|||+++......... ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 249 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999998765432211 12234567999999998889999999999999999999 89999876655555555
Q ss_pred hhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 232 VQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 232 iq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
........+..++.++.+++.+||..+|++||++.++++
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 250 REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 554455667788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.66 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=211.6
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCC----------------eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcc
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENG----------------DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTG----------------k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIV 80 (1437)
.++|++++.||+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|+.+++++.||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 357999999999999999999876543 568999987543 335567789999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceE
Q 000535 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNK---------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL 151 (1437)
Q Consensus 81 KLigVfedd~~LYLVMEYceGGSL~DLLKssr---------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENIL 151 (1437)
++++++..++..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999997543 126899999999999999999999999999999999999
Q ss_pred eccCCcEEEEecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh--CCCCCCCCCChhH
Q 000535 152 TTKEGLVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT--CVPPYYELQPMPA 227 (1437)
Q Consensus 152 LdenG~VKLiDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT--GkpPF~g~d~~eq 227 (1437)
++.++.++|+|||+++....... ......+++.|+|||++....++.++|||||||++|+|++ +..||......+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 99999999999999986543321 1223456788999999988889999999999999999998 7788877665555
Q ss_pred HHHHhhc-------CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 228 LFRIVQD-------ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 228 L~kIiq~-------~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
+...... ...+.+..++.++.+++.+||..||.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 4444322 112344567899999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=348.07 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=216.9
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS---- 90 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~---- 90 (1437)
.+.++|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3688999999999999999999999999999999998755444444566889999999999999999999987653
Q ss_pred --eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 91 --HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 91 --~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
.+|+||||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 468999999 7799998863 4699999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC-----------
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER----------- 236 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r----------- 236 (1437)
.... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+......++.....
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 168 TDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 6432 234567999999999876 4578899999999999999999999987655444443322110
Q ss_pred -------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 237 -------------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 237 -------------------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
....+.+++.+.++|.+||..||.+|||+.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 012246788999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=346.79 Aligned_cols=261 Identities=30% Similarity=0.487 Sum_probs=215.8
Q ss_pred ccccCCceEE-EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH------------HHHHHHHHHHHHhCCCCCc
Q 000535 13 SKTLDNKYML-GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED------------LNIIMQEIDLLKNLNHKNI 79 (1437)
Q Consensus 13 gktLggRYeI-lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed------------ie~L~REIkILrrLnHPNI 79 (1437)
...+.++|.. .+.||.|+||+||+|.+..+++.||+|++......... ...+.+|+.++++++||||
T Consensus 3 ~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred ccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 3456788875 57799999999999999999999999998755432211 1246789999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEE
Q 000535 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVK 159 (1437)
Q Consensus 80 VKLigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VK 159 (1437)
+++++++..+++.|+||||+. |+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 999999999999999999997 5999998743 5699999999999999999999999999999999999999999999
Q ss_pred EEecccccccccC--------------CcccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 000535 160 LADFGVATKLTEA--------------DVNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQP 224 (1437)
Q Consensus 160 LiDFGLAr~L~es--------------d~kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~ 224 (1437)
|+|||++...... ........+++.|+|||++.+. .++.++|+|||||++|+|++|.+||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999876511 1112234578899999998764 468899999999999999999999988776
Q ss_pred hhHHHHHhhcCCCC---------------------------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 225 MPALFRIVQDERPP---------------------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 225 ~eqL~kIiq~~rpp---------------------------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.+.+..+......+ ....++.++.++|.+||.++|++||++.+++.||||+.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 66555443311000 11345788999999999999999999999999999964
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=333.94 Aligned_cols=253 Identities=35% Similarity=0.589 Sum_probs=215.3
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
|++.+.||+|+||.||+|++..+++.|++|++..........+.+..|+.++++++||||+++++++.+.+.+|+||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999999876534444567788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccc
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV 179 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~ 179 (1437)
. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.............
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 8 59999998643 469999999999999999999999999999999999999999999999999998775543333345
Q ss_pred cCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--------------------C-
Q 000535 180 VGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER--------------------P- 237 (1437)
Q Consensus 180 ~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r--------------------p- 237 (1437)
.++..|+|||.+... .++.++|+|||||++|+|++|.+||......+.+.++..... +
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 568889999998766 788999999999999999999999987665554444332110 0
Q ss_pred -------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 238 -------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 238 -------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
...+.++..+.++|.+||..+|++||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0112357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.54 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=216.6
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEc-------CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDL-------ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGS 85 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDr-------kTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigV 85 (1437)
..-.++|.+.+.||+|+||.||+|++. .++..||+|.+... ........+.+|+.+++.+ +||||++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 345778999999999999999999753 23457999988643 3345567789999999999 89999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceE
Q 000535 86 LKTRSHLHIILEYVENGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL 151 (1437)
Q Consensus 86 fedd~~LYLVMEYceGGSL~DLLKssr--------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENIL 151 (1437)
+......|+||||+.+|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 999999999999999999999997532 235788899999999999999999999999999999999
Q ss_pred eccCCcEEEEecccccccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHH
Q 000535 152 TTKEGLVKLADFGVATKLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPAL 228 (1437)
Q Consensus 152 LdenG~VKLiDFGLAr~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL 228 (1437)
++.++.+||+|||+++.+...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999999876543221 122345678999999988889999999999999999998 88898776655555
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 229 FRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 229 ~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
..+........+..++.++.+||.+||..+|.+||++.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 5554455556677899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.59 Aligned_cols=245 Identities=28% Similarity=0.487 Sum_probs=209.1
Q ss_pred eEecccCcEEEEEEEEcC-CC--eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecC
Q 000535 24 DEIGKGAYGRVYKGLDLE-NG--DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrk-TG--k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYce 100 (1437)
+.||+|+||.||+|.+.. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++++.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998765 33 36999999876554 566788999999999999999999999988 89999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc---ccc
Q 000535 101 NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV---NTH 177 (1437)
Q Consensus 101 GGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~---kt~ 177 (1437)
+++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+..... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 99999999865435799999999999999999999999999999999999999999999999999987754221 111
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhh-cCCCCCCCCCCHHHHHHHHHHh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQ-DERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq-~~rppiP~~ISpELkDLIrkCL 255 (1437)
...++..|+|||++....++.++|||||||++|+|++ |..||......+....+.. ....+.+..++..+.+++.+||
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence 2457788999999998899999999999999999998 9999987666655554442 2333455678899999999999
Q ss_pred hhcccCCCCHHHHhc
Q 000535 256 KKDARQRPDAKTLLS 270 (1437)
Q Consensus 256 qkDPeKRPSAeELLk 270 (1437)
..+|.+||++.++++
T Consensus 239 ~~~p~~Rps~~~~~~ 253 (257)
T cd05040 239 AHNPADRPTFAALRE 253 (257)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.76 Aligned_cols=244 Identities=25% Similarity=0.450 Sum_probs=208.5
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGS 103 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGS 103 (1437)
+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 4689999999999985 468899999886543 33444568899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc-ccccCC
Q 000535 104 LANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT-HSVVGT 182 (1437)
Q Consensus 104 L~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt-~t~~GT 182 (1437)
|.+++.... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++.......... ....++
T Consensus 79 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 79 FLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999987543 468999999999999999999999999999999999999999999999999997654332111 122346
Q ss_pred CccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 183 p~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
..|+|||++....++.++||||||+++|++++ |..||...........+........+..++..+.+++.+||..+|++
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence 67999999988889999999999999999998 99999877666655555555555667789999999999999999999
Q ss_pred CCCHHHHhc
Q 000535 262 RPDAKTLLS 270 (1437)
Q Consensus 262 RPSAeELLk 270 (1437)
||++.++++
T Consensus 238 Rp~~~~l~~ 246 (250)
T cd05085 238 RPKFSELQK 246 (250)
T ss_pred CCCHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.11 Aligned_cols=254 Identities=27% Similarity=0.501 Sum_probs=212.0
Q ss_pred CCceEEEeEecccCcEEEEEEEEc-----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT-R 89 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDr-----kTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfed-d 89 (1437)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++++ .||||+++++++.. +
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 468999999999999999999753 345789999987543 344556788999999999 89999999998764 4
Q ss_pred CeEEEEEeecCCCCHHHHhccCC---------------------------------------------------------
Q 000535 90 SHLHIILEYVENGSLANIIKPNK--------------------------------------------------------- 112 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKssr--------------------------------------------------------- 112 (1437)
..+|++|||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 67899999999999999986432
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--ccccccCCCccCCh
Q 000535 113 --FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV--NTHSVVGTPYWMAP 188 (1437)
Q Consensus 113 --~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~--kt~t~~GTp~YmAP 188 (1437)
..++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+..... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 12689999999999999999999999999999999999999999999999999987643321 12234567789999
Q ss_pred hhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhc-CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHH
Q 000535 189 EVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQD-ERPPIPESLSPDITDFLRQCFKKDARQRPDAK 266 (1437)
Q Consensus 189 EVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~-~rppiP~~ISpELkDLIrkCLqkDPeKRPSAe 266 (1437)
|++.+..++.++|||||||++|+|++ |..||.+....+.+...+.. .....+..+++++.+++.+||+.+|++||++.
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999999999999999998 99999875554444444433 34445667899999999999999999999999
Q ss_pred HHhcC
Q 000535 267 TLLSH 271 (1437)
Q Consensus 267 ELLkH 271 (1437)
+++++
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.73 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=206.5
Q ss_pred cCCceEEEeEe--cccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 000535 16 LDNKYMLGDEI--GKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 16 LggRYeIlEvL--GrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~L 92 (1437)
+.++|.+.+.+ |.|+||.||++.+..++..||+|.+........ |+.+...+ +||||+++++++..++.+
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 34567777776 999999999999999999999999876543321 22222222 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-cEEEEeccccccccc
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKLADFGVATKLTE 171 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-~VKLiDFGLAr~L~e 171 (1437)
|+||||+++++|.+++... +++++..++.++.|+++||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999999999999754 3799999999999999999999999999999999999999998 999999999987643
Q ss_pred CCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChh----HHHHHhhcCCCCCCCCCCHHH
Q 000535 172 ADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMP----ALFRIVQDERPPIPESLSPDI 247 (1437)
Q Consensus 172 sd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~e----qL~kIiq~~rppiP~~ISpEL 247 (1437)
. ....|+..|+|||++....++.++|+||||+++|+|++|..||....... .+.... ....+.++.+++.+
T Consensus 163 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (267)
T PHA03390 163 P----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA 237 (267)
T ss_pred C----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence 2 23568999999999998899999999999999999999999997544322 122222 33345566799999
Q ss_pred HHHHHHHhhhcccCCCC-HHHHhcCHHHH
Q 000535 248 TDFLRQCFKKDARQRPD-AKTLLSHPWIQ 275 (1437)
Q Consensus 248 kDLIrkCLqkDPeKRPS-AeELLkHPWFQ 275 (1437)
.+||.+||+.+|.+||+ ++++++||||.
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999999996 69999999995
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=347.09 Aligned_cols=260 Identities=32% Similarity=0.504 Sum_probs=217.2
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe--CC
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT--RS 90 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfed--d~ 90 (1437)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++++ +||||+++++++.. ..
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 4678899999999999999999999998999999999865444445556778899999999 99999999998864 34
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
.+|+||||+. ++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 7899999997 4999998743 68899999999999999999999999999999999999999999999999998764
Q ss_pred cCCc-----ccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--------
Q 000535 171 EADV-----NTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------- 236 (1437)
Q Consensus 171 esd~-----kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-------- 236 (1437)
.... ....+.|++.|+|||++.. ..++.++|||||||++|+|++|++||..........++.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 4321 2234578999999998754 4578899999999999999999999987665544333322110
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 237 ----------------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 237 ----------------------ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
....+.++.++.++|.+||..+|++|||+.++++|||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 01123478999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.95 Aligned_cols=253 Identities=26% Similarity=0.465 Sum_probs=215.0
Q ss_pred CCceEEEeEecccCcEEEEEEEEc-----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDr-----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~ 91 (1437)
.++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++++.||||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 467999999999999999999874 367899999987543 33445678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceE
Q 000535 92 LHIILEYVENGSLANIIKPNK--------------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL 151 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr--------------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENIL 151 (1437)
.|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 999999999999999996421 124788999999999999999999999999999999999
Q ss_pred eccCCcEEEEecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHH
Q 000535 152 TTKEGLVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPAL 228 (1437)
Q Consensus 152 LdenG~VKLiDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL 228 (1437)
++.++.++|+|||++..+..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+..
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999976543221 1122345677999999998899999999999999999997 88899877766666
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 229 FRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 229 ~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
..+......+.+..++.++.+||.+||..+|++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 243 YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 665555555667788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.59 Aligned_cols=244 Identities=26% Similarity=0.431 Sum_probs=209.0
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGS 103 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGS 103 (1437)
+.||.|+||.||+|.+.. ++.|++|.+...... .....+.+|+.+++++.||||+++++++....+.|+||||+.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 468999999999999877 999999998765433 455678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc--ccccC
Q 000535 104 LANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT--HSVVG 181 (1437)
Q Consensus 104 L~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt--~t~~G 181 (1437)
|.+++... ...+++..+..++.|++.+|.|||+++++||||||+||+++.++.++|+|||++.......... ....+
T Consensus 79 l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 79 LLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999654 3468999999999999999999999999999999999999999999999999998654322111 12234
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhccc
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPe 260 (1437)
+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+......+.+..++.++.+++.+||..+|.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 237 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE 237 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence 567999999988889999999999999999999 8899977665555555544445566778899999999999999999
Q ss_pred CCCCHHHHhc
Q 000535 261 QRPDAKTLLS 270 (1437)
Q Consensus 261 KRPSAeELLk 270 (1437)
+||++.++++
T Consensus 238 ~Rp~~~ell~ 247 (251)
T cd05041 238 NRPSFSEIYN 247 (251)
T ss_pred hCcCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=329.89 Aligned_cols=243 Identities=26% Similarity=0.442 Sum_probs=206.7
Q ss_pred EecccCcEEEEEEEEc--CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 25 EIGKGAYGRVYKGLDL--ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 25 vLGrGgFGtVYKArDr--kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.++++++||||++++++++. ...|+||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999765 446679999986543 34445678899999999999999999998864 5789999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc---ccc
Q 000535 103 SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT---HSV 179 (1437)
Q Consensus 103 SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt---~t~ 179 (1437)
+|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++..+....... ...
T Consensus 80 ~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 80 PLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998743 3579999999999999999999999999999999999999999999999999998654432111 112
Q ss_pred cCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhc
Q 000535 180 VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 180 ~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkD 258 (1437)
.+++.|+|||++....++.++|||||||++|+|++ |..||......+....+........+..+++++.++|.+||..+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 23578999999988889999999999999999996 99999887776666666666667788889999999999999999
Q ss_pred ccCCCCHHHHhc
Q 000535 259 ARQRPDAKTLLS 270 (1437)
Q Consensus 259 PeKRPSAeELLk 270 (1437)
|++||++.++.+
T Consensus 239 ~~~Rp~~~~i~~ 250 (257)
T cd05115 239 WEDRPNFAKVEE 250 (257)
T ss_pred hhhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.90 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=208.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCe----EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGD----FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk----~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
++|++.+.||+|+||+||+|.+..++. .+++|.+... ........+..|+.+++++.||||+++++++. ....+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 478999999999999999999877776 4677776432 22334466778888999999999999999875 45678
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+++||+++|+|.+++.... +.+++..+..|+.||+.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus 85 ~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999997543 579999999999999999999999999999999999999999999999999998764332
Q ss_pred c--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHH
Q 000535 174 V--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 174 ~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDL 250 (1437)
. ......++..|+|||.+....++.++|||||||++|+|++ |..||.+.........+......+.+..++.++.++
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMV 243 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHH
Confidence 1 1223456778999999988889999999999999999998 999998765544333333344555667788999999
Q ss_pred HHHHhhhcccCCCCHHHHhc
Q 000535 251 LRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLk 270 (1437)
+.+||..+|.+||++.++++
T Consensus 244 i~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 244 MVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=326.86 Aligned_cols=251 Identities=25% Similarity=0.471 Sum_probs=214.5
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
...++|++.+.||+|+||.||+|.+ ..+..+++|.+... ....+.+.+|+.++++++|+||+++++++.. ...|+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4568899999999999999999975 45667999987643 2345678889999999999999999999877 78899
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
+|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999999876556789999999999999999999999999999999999999999999999999987643321
Q ss_pred c-cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 000535 175 N-THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252 (1437)
Q Consensus 175 k-t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIr 252 (1437)
. .....++..|+|||++....++.++|+|||||++|++++ |.+||...+.......+......+.+..++.++.+++.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 1 112345677999999988889999999999999999998 99999877666555555555555667788999999999
Q ss_pred HHhhhcccCCCCHHHHhc
Q 000535 253 QCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLk 270 (1437)
+||.++|++||++.++++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=338.50 Aligned_cols=256 Identities=26% Similarity=0.468 Sum_probs=216.7
Q ss_pred cccCCceEEEeEecccCcEEEEEEEE-----cCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLD-----LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLK 87 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArD-----rkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfe 87 (1437)
....++|.+.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 44556899999999999999999975 2356689999887543 234556788999999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 88 TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 88 dd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
..+..|+||||+.+|+|.+++.......+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999999976544558999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC-CCCCCCCC
Q 000535 168 KLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE-RPPIPESL 243 (1437)
Q Consensus 168 ~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~-rppiP~~I 243 (1437)
.+..... ......+++.|+|||.+....++.++||||+||++|+|++ |.+||......+...+..... ....+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 7644321 1122346788999999998889999999999999999998 999998766655555544433 33455678
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 244 SpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
++++.+++.+||.++|++||++.++++
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.23 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=214.2
Q ss_pred CCceEEEeEecccCcEEEEEEEEcC----CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCe
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLE----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT-RSH 91 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrk----TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed-d~~ 91 (1437)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.. .......+.+.+|+.++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 5789999999999999999999865 368899998763 3445667788999999999999999999998765 578
Q ss_pred EEEEEeecCCCCHHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccc
Q 000535 92 LHIILEYVENGSLANIIKPNKF------GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGV 165 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~------GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGL 165 (1437)
.++++||+.+++|.+++..... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 8999999999999999875432 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCC
Q 000535 166 ATKLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPES 242 (1437)
Q Consensus 166 Ar~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ 242 (1437)
++.+...... .....++..|+|||++....++.++|||||||++|++++ |.+||...+..+....+........+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 243 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPIN 243 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCc
Confidence 9876443211 112345678999999998889999999999999999999 9999987665554444444444455667
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 243 LSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
+++++.+++.+||..+|++|||+.++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 244 CPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.35 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=217.6
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe---
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH--- 91 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~--- 91 (1437)
.+.++|.+.+.||+|+||.||+|++..++..||+|++..........+.+.+|+.+++.+.||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 46789999999999999999999999999999999987654445556678889999999999999999998866554
Q ss_pred ---EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 92 ---LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 92 ---LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
.|+|+||+ +++|.+++.. .++++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 5699999874 4699999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC----------
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP---------- 237 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp---------- 237 (1437)
.... .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||........+..+......
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 168 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred cccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 6432 334578899999999865 36788999999999999999999999876665544443322110
Q ss_pred --------------------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 238 --------------------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 238 --------------------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.....+++++.++|.+||..+|++|||+.+++.||||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 011346899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=333.35 Aligned_cols=258 Identities=30% Similarity=0.510 Sum_probs=217.4
Q ss_pred ceEEEeEecccCcEEEEEEEEc---CCCeEEEEEEeeccccC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDL---ENGDFVAIKQVSLENIA--QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDr---kTGk~VAIKVIkke~lS--eedie~L~REIkILrrL-nHPNIVKLigVfedd~~L 92 (1437)
.|++.+.||.|+||.||+|.+. .+|..||+|++...... ....+.+.+|+.+++++ +||||++++++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 47899999998754322 12345678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
|+||||+++++|.+++... .++++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999999754 57999999999999999999999999999999999999999999999999999876443
Q ss_pred Cc-ccccccCCCccCChhhhhcC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCh---hHHHHHhhcCCCCCCCCCCHH
Q 000535 173 DV-NTHSVVGTPYWMAPEVIEMS--GVCAASDIWSVGCTVIELLTCVPPYYELQPM---PALFRIVQDERPPIPESLSPD 246 (1437)
Q Consensus 173 d~-kt~t~~GTp~YmAPEVL~g~--~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~---eqL~kIiq~~rppiP~~ISpE 246 (1437)
.. ......|+..|+|||.+... .++.++||||||+++|+|++|..||...... ..+.+......++++..+++.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHH
Confidence 21 22346789999999998653 4678999999999999999999999643322 223333334456677889999
Q ss_pred HHHHHHHHhhhcccCCC-----CHHHHhcCHHHHHHH
Q 000535 247 ITDFLRQCFKKDARQRP-----DAKTLLSHPWIQNCR 278 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRP-----SAeELLkHPWFQe~r 278 (1437)
+.+++.+||..+|++|| ++.+++.||||+...
T Consensus 239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 99999999999999997 899999999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=323.53 Aligned_cols=248 Identities=27% Similarity=0.488 Sum_probs=212.1
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.+|.+.+.||+|+||.||+|.+. .+..+|+|.+....... +.+.+|++++++++||||+++++++......|+|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 47999999999999999999874 47789999987654433 357789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc-c
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN-T 176 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k-t 176 (1437)
|+.+++|.+++.... +.+++..++.++.|++.+|+|||+.|++||||||+||+++.++.++|+|||++......... .
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 80 FMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999999987543 56899999999999999999999999999999999999999999999999999876443221 1
Q ss_pred ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCL 255 (1437)
....++..|+|||.+.+..++.++||||||+++|+|++ |.+||...........+........+...+.++.+|+.+||
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 238 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW 238 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence 12335678999999988889999999999999999998 99999876655555555444455556678999999999999
Q ss_pred hhcccCCCCHHHHhc
Q 000535 256 KKDARQRPDAKTLLS 270 (1437)
Q Consensus 256 qkDPeKRPSAeELLk 270 (1437)
..+|++||++.++++
T Consensus 239 ~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 239 KERPEDRPSFSLLLH 253 (256)
T ss_pred ccChhhCCCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=331.16 Aligned_cols=250 Identities=30% Similarity=0.519 Sum_probs=204.4
Q ss_pred CCce-EEEeEecccCcEEEEEEE----EcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 000535 17 DNKY-MLGDEIGKGAYGRVYKGL----DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--R 89 (1437)
Q Consensus 17 ggRY-eIlEvLGrGgFGtVYKAr----DrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed--d 89 (1437)
.++| ++.+.||+|+||+||++. ...++..||+|.+.... .......+.+|+.++++++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4566 999999999999998764 34578899999987543 23345667899999999999999999998765 3
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccc
Q 000535 90 SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL 169 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L 169 (1437)
..+|+||||+.+++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 5689999999999999999743 5999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCcc---cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh--------------hHHHH-H
Q 000535 170 TEADVN---THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM--------------PALFR-I 231 (1437)
Q Consensus 170 ~esd~k---t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~--------------eqL~k-I 231 (1437)
...... .....++..|+|||++....++.++|||||||++|+|++|..||...... ..+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 543211 11234567799999998888999999999999999999999998543211 00111 1
Q ss_pred hhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 232 VQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 232 iq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
......+.+..++.++.+++.+||..+|++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 112233456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.75 Aligned_cols=256 Identities=30% Similarity=0.510 Sum_probs=213.0
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR----- 89 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd----- 89 (1437)
.+.++|.+.+.||+|+||.||+|++..+++.||+|++............+.+|+.+++.+.||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 346799999999999999999999999999999999876544334445678999999999999999999998654
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 90 -SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 90 -~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
..+|+||||+.. +|..++. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 356999999964 7777653 3689999999999999999999999999999999999999999999999999986
Q ss_pred cccCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC-----------
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER----------- 236 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r----------- 236 (1437)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 167 ADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 5332 234578899999999876 4688899999999999999999999987665444433322110
Q ss_pred -----------CC--------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 237 -----------PP--------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 237 -----------pp--------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
+. ..+.+++++.+||.+||+.||.+||++.+++.||||+..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 1134678899999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=329.10 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=214.6
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCe----EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGD----FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk----~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
.++|++.+.||+|+||.||+|.+..++. .||+|.+..... ......+.+|+.++++++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 4689999999999999999999876654 589998765432 4455678899999999999999999999987 789
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
++||||+.+|+|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999997543 46999999999999999999999999999999999999999999999999999876543
Q ss_pred Cccc--ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHH
Q 000535 173 DVNT--HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249 (1437)
Q Consensus 173 d~kt--~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkD 249 (1437)
.... ....++..|+|||.+....++.++|+|||||++|++++ |..||......+....+......+.+..++.++.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 2111 11223567999999988889999999999999999998 99999887665555555555556677788999999
Q ss_pred HHHHHhhhcccCCCCHHHHhc
Q 000535 250 FLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLk 270 (1437)
++.+||..+|.+||++.++++
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=327.15 Aligned_cols=252 Identities=28% Similarity=0.489 Sum_probs=214.9
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCC---CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLEN---GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkT---Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
..+|.+.+.||+|+||.||+|.+... ...|++|.+.... .....+.+..|+.+++++.||||+++++++.+ ...|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 45699999999999999999987544 4568999876443 24455678899999999999999999999875 4678
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999997543 368999999999999999999999999999999999999999999999999998765432
Q ss_pred ccc-ccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHH
Q 000535 174 VNT-HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFL 251 (1437)
Q Consensus 174 ~kt-~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLI 251 (1437)
... ....++..|+|||.+....++.++|||||||++|+|++ |..||......+....+......+.+..++.++.++|
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 211 12234567999999988889999999999999999996 9999988777666666666667778889999999999
Q ss_pred HHHhhhcccCCCCHHHHhcC
Q 000535 252 RQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLkH 271 (1437)
.+||..+|++||++.++++.
T Consensus 242 ~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 242 TKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.43 Aligned_cols=245 Identities=27% Similarity=0.450 Sum_probs=204.7
Q ss_pred eEecccCcEEEEEEEEcCCCe--EEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeecC
Q 000535 24 DEIGKGAYGRVYKGLDLENGD--FVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk--~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEYce 100 (1437)
+.||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.++.++ .||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 468999999999999887775 4688877632 2334556788999999999 79999999999999999999999999
Q ss_pred CCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccc
Q 000535 101 NGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA 166 (1437)
Q Consensus 101 GGSL~DLLKssr--------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLA 166 (1437)
+|+|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997532 235889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCH
Q 000535 167 TKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSP 245 (1437)
Q Consensus 167 r~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISp 245 (1437)
....... .......+..|+|||++....++.++|||||||++|+|++ |..||...+..+....+........+..++.
T Consensus 160 ~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05047 160 RGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238 (270)
T ss_pred cccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence 6432211 1112234567999999988889999999999999999997 9999977665555555544445556677899
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
++.+++.+||..+|.+||++.+++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=345.71 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=214.1
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR---- 89 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd---- 89 (1437)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3467899999999999999999999999999999999876544444456788999999999999999999988543
Q ss_pred --CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 90 --SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 90 --~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
...|++++++ +++|.++++. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3578888887 7799998864 359999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC----------
Q 000535 168 KLTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER---------- 236 (1437)
Q Consensus 168 ~L~esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r---------- 236 (1437)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+.....
T Consensus 169 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 169 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6543 2234578999999999866 4688899999999999999999999976655443333221100
Q ss_pred ------------C--------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 237 ------------P--------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 237 ------------p--------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+ ......++++.++|.+||.+||.+||++.+++.||||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0 0112468889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=345.64 Aligned_cols=255 Identities=28% Similarity=0.530 Sum_probs=210.1
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR------ 89 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd------ 89 (1437)
+.++|.+.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 57899999999999999999999999999999999876543 3456688899999999999999999876543
Q ss_pred --------CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-CCcEEE
Q 000535 90 --------SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-EGLVKL 160 (1437)
Q Consensus 90 --------~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-nG~VKL 160 (1437)
...|+||||+. ++|.+++.. +++++..++.++.||+.||.|||++||+||||||+||+++. ++.++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 36899999997 589888863 46999999999999999999999999999999999999985 457999
Q ss_pred EecccccccccCCc---ccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-
Q 000535 161 ADFGVATKLTEADV---NTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE- 235 (1437)
Q Consensus 161 iDFGLAr~L~esd~---kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~- 235 (1437)
+|||+++.+..... ......++..|+|||++.. ..++.++|||||||++|+|++|..||...........+....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999976543211 1122367889999998754 568889999999999999999999998766544443332211
Q ss_pred -----------------------CC-----CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 236 -----------------------RP-----PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 236 -----------------------rp-----piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.. ...+.++.++.+||.+||..||.+||++.+++.||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 012357889999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=397.62 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=233.1
Q ss_pred ccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 000535 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 13 gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~ 91 (1437)
.++=.++|.|+++||+|+||.|..++++.+++.||+|++.+...- ..+-.-|+.|-.+|.--+.+-|+.++..|+++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 344467899999999999999999999999999999999875543 3455678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e 171 (1437)
+|+||||++||+|..++... +++||+.++.|+..|+.||.-||+.|+|||||||+||||+..|++||+|||.|-.+..
T Consensus 150 LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred eEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999999999744 5899999999999999999999999999999999999999999999999999988874
Q ss_pred CC-cccccccCCCccCChhhhhc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CCCCC--CC
Q 000535 172 AD-VNTHSVVGTPYWMAPEVIEM-----SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RPPIP--ES 242 (1437)
Q Consensus 172 sd-~kt~t~~GTp~YmAPEVL~g-----~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rppiP--~~ 242 (1437)
++ ......+|||.|.+||+++. ..|+..+|+|||||++|||+.|..||+...-.+.+-+|+... ...+| ..
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~ 307 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETD 307 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccc
Confidence 43 44556799999999999953 458899999999999999999999999999888888887653 22344 56
Q ss_pred CCHHHHHHHHHHhhhcccCCCC---HHHHhcCHHHHHHH
Q 000535 243 LSPDITDFLRQCFKKDARQRPD---AKTLLSHPWIQNCR 278 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeKRPS---AeELLkHPWFQe~r 278 (1437)
+|+++++||++++. +|+.|.. ++++-.||||.+..
T Consensus 308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 99999999999998 6889988 99999999997653
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=341.73 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=215.3
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCC-------CeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLEN-------GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSL 86 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkT-------Gk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVf 86 (1437)
....+|.+++.||+|+||.||+|++... +..||+|.+... ......+.+.+|+.+++++ +||||+++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3346899999999999999999986432 247899987643 3345567889999999999 799999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEe
Q 000535 87 KTRSHLHIILEYVENGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILT 152 (1437)
Q Consensus 87 edd~~LYLVMEYceGGSL~DLLKssr--------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILL 152 (1437)
...+.+|++|||+.+|+|.+++.... ...++...+..++.|++.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 99999999999999999999997532 2347888899999999999999999999999999999999
Q ss_pred ccCCcEEEEecccccccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHH
Q 000535 153 TKEGLVKLADFGVATKLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALF 229 (1437)
Q Consensus 153 denG~VKLiDFGLAr~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~ 229 (1437)
+.++.+||+|||+++........ .....++..|+|||++....++.++|||||||++|+|++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999876543211 112234567999999999999999999999999999998 889998766555555
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 230 RIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 230 kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
.+......+.+..++.++.++|.+||..+|.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 555555566777889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.27 Aligned_cols=252 Identities=31% Similarity=0.593 Sum_probs=211.8
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEee
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd~~LYLVMEY 98 (1437)
|.+.+.||.|+||+||+|.+..+++.|+||.+....... +.....+|+..++++. ||||+++++++..++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 788999999999999999998899999999987554322 2233457999999998 99999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
+ +|+|.+.+.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~ 157 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTD 157 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCC
Confidence 9 7899999876654578999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred ccCCCccCChhhhh-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC-------------------
Q 000535 179 VVGTPYWMAPEVIE-MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP------------------- 238 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~-g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp------------------- 238 (1437)
..++..|+|||++. ...++.++|+||||+++|+|++|.+||......+...++......+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 56889999999875 4457899999999999999999999998776655554433211100
Q ss_pred ----------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 239 ----------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 239 ----------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.....+..+.++|++||..+|++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 112236889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=324.51 Aligned_cols=243 Identities=26% Similarity=0.495 Sum_probs=208.7
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
++|.+.+.||+|+||.||++. .+++.||+|.+.... ..+.+.+|+.++++++||||+++++++..+ ..|+|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 569999999999999999986 478899999986432 235678899999999999999999998765 4799999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|+.+++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~ 155 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VD 155 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---CC
Confidence 999999999998665567899999999999999999999999999999999999999999999999999764332 12
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
....+..|+|||.+....++.++|+|||||++|+|++ |.+||...........+........+..++.++.+++.+||.
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcC
Confidence 2334677999999988889999999999999999997 999998776655555555454555567789999999999999
Q ss_pred hcccCCCCHHHHhc
Q 000535 257 KDARQRPDAKTLLS 270 (1437)
Q Consensus 257 kDPeKRPSAeELLk 270 (1437)
.+|++||++.+++.
T Consensus 236 ~~p~~Rp~~~~l~~ 249 (254)
T cd05083 236 TEPKKRPSFHKLRE 249 (254)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=323.17 Aligned_cols=246 Identities=26% Similarity=0.452 Sum_probs=203.3
Q ss_pred eEecccCcEEEEEEEEcC---CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCeEEEEEeec
Q 000535 24 DEIGKGAYGRVYKGLDLE---NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK-TRSHLHIILEYV 99 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrk---TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfe-dd~~LYLVMEYc 99 (1437)
+.||+|+||.||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++. .++..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998653 3467999987532 23445677889999999999999999999765 466789999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc----c
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV----N 175 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~----k 175 (1437)
.+|+|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 80 KHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999997543 4577888899999999999999999999999999999999999999999999986543221 1
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
.....++..|+|||.+....++.++|||||||++|+|++ |.+||...+..+....+......+.+..++..+.+++.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 123456778999999988889999999999999999999 5677776665555555555555566677899999999999
Q ss_pred hhhcccCCCCHHHHhcC
Q 000535 255 FKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 255 LqkDPeKRPSAeELLkH 271 (1437)
|..+|++||++.++++.
T Consensus 239 l~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 239 WHPKPEMRPTFSELVSR 255 (262)
T ss_pred cCCChhhCCCHHHHHHH
Confidence 99999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.21 Aligned_cols=253 Identities=34% Similarity=0.600 Sum_probs=215.3
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
|.-...||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++...++.|+||||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33446799999999999999999999999987543 2334566889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccc
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV 179 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~ 179 (1437)
++++|.+++.. +++++..++.++.|++.+|+|||++|++||||+|+||+++.++.++|+|||++..+..........
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 100 EGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 99999998853 358999999999999999999999999999999999999999999999999987765433223346
Q ss_pred cCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC--CCCCCCHHHHHHHHHHhhh
Q 000535 180 VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--IPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 180 ~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp--iP~~ISpELkDLIrkCLqk 257 (1437)
.|++.|+|||.+....++.++|+||+|+++|+|++|.+||...........+....... ....+++.+.+++.+||..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 78999999999988888999999999999999999999998765554433332222222 2345789999999999999
Q ss_pred cccCCCCHHHHhcCHHHHHH
Q 000535 258 DARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 258 DPeKRPSAeELLkHPWFQe~ 277 (1437)
+|.+||++.+++.||||...
T Consensus 257 ~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 257 DPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred CcccCcCHHHHhcChHHhcc
Confidence 99999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.28 Aligned_cols=257 Identities=35% Similarity=0.643 Sum_probs=220.3
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
...+.|...+.||+|+||+||+|.+..++..|++|++..... .......+.+|+.+++.++|||++++++++.+....|
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 345568888999999999999999999999999999876543 2344567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+. |++.+++... ..++++..++.++.|++.+|.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 98 lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 98 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 9999996 5888887643 35799999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccCCCccCChhhhh---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCC-CCCCCHHHHH
Q 000535 174 VNTHSVVGTPYWMAPEVIE---MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-PESLSPDITD 249 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~---g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppi-P~~ISpELkD 249 (1437)
.....|+..|+|||++. ...++.++|||||||++|+|++|.+||...+.......+.....+.. ...++..+.+
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 22457899999999984 45688899999999999999999999988777776666655444333 3457889999
Q ss_pred HHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
|+.+||+++|.+||++.+++.||||+..
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=366.29 Aligned_cols=254 Identities=41% Similarity=0.742 Sum_probs=231.6
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
-|.++++||+|+||.||+|.++.+|..+|||.+..+ .+.+.+.+||.+|+++..|++|++|+.|.....+||||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 478899999999999999999999999999998754 5778899999999999999999999999889999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
|-.|++.++++.+ .++|+|.++..+++..++||+|||...-+|||||..|||++.+|..||+|||.|-++.....+..+
T Consensus 110 CGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 110 CGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred cCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 9999999999865 478999999999999999999999999999999999999999999999999999998876667778
Q ss_pred ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC--CCCCCCHHHHHHHHHHhh
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--IPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp--iP~~ISpELkDLIrkCLq 256 (1437)
+.|||.|||||++..-+|+.++||||||++..||..|++||.+..+...++-+-....+. .|..+|.++.+||++||-
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 999999999999999999999999999999999999999999888776655544444333 345688999999999999
Q ss_pred hcccCCCCHHHHhcCHHHHHH
Q 000535 257 KDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 257 kDPeKRPSAeELLkHPWFQe~ 277 (1437)
++|++|-|+..+++|||+++.
T Consensus 269 K~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 269 KKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred CCHHHHHHHHHHhhhhhhcCC
Confidence 999999999999999999753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=339.57 Aligned_cols=257 Identities=30% Similarity=0.456 Sum_probs=209.9
Q ss_pred ceEEEeEecccCcEEEEEEEEcCC--CeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CCe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLEN--GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT----RSH 91 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkT--Gk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfed----d~~ 91 (1437)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+............+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999887 89999999875443333455678899999999 59999999987533 256
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e 171 (1437)
+|+++||+. ++|.+++... .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 889999986 5899998643 5799999999999999999999999999999999999999999999999999987643
Q ss_pred CCc----ccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-----------
Q 000535 172 ADV----NTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE----------- 235 (1437)
Q Consensus 172 sd~----kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~----------- 235 (1437)
... ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+....
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 221 1234578999999998765 468899999999999999999999997755433332221100
Q ss_pred ----------------C---CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 236 ----------------R---PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 236 ----------------r---ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
. ....+.++..+.+|+.+||+.||.+|||+.+++.|||+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0 012234688999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.69 Aligned_cols=255 Identities=36% Similarity=0.640 Sum_probs=219.8
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
....|...+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.++++++|||++++++++.++...|+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 34558899999999999999999999999999999875433 23445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+.| +|.+++... ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 103 v~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 103 VMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred EEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 9999975 888877643 356999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccCCCccCChhhhh---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCC-CCCCCHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIE---MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-PESLSPDITDF 250 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~---g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppi-P~~ISpELkDL 250 (1437)
....|++.|+|||++. ...++.++|+|||||++|+|++|.+||...........+.....+.. +..+++.+.++
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 2456899999999974 45688899999999999999999999988776666666665544333 34678999999
Q ss_pred HHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 251 LRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
|.+||..+|.+||++.++++|+|+..
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhc
Confidence 99999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=356.01 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=211.9
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCC-----CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLEN-----GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRS 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkT-----Gk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd~ 90 (1437)
.++|.+++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+++. ||||+++++++...+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45788999999999999999987432 4579999986543 3445567899999999996 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCC----------------------------------------------------------
Q 000535 91 HLHIILEYVENGSLANIIKPNK---------------------------------------------------------- 112 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr---------------------------------------------------------- 112 (1437)
.+|+|||||++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999885421
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC
Q 000535 113 ------------------------------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG 156 (1437)
Q Consensus 113 ------------------------------------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG 156 (1437)
...+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 12478888999999999999999999999999999999999999
Q ss_pred cEEEEecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhh
Q 000535 157 LVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQ 233 (1437)
Q Consensus 157 ~VKLiDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq 233 (1437)
.+||+|||+++.+..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||............+.
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~ 354 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence 999999999987643321 1223456788999999998889999999999999999997 9999987654444444333
Q ss_pred -cCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 234 -DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 234 -~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
....+.+..++.++.++|.+||..+|++||++.++.+
T Consensus 355 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3345667789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.91 Aligned_cols=259 Identities=34% Similarity=0.592 Sum_probs=213.2
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLV 95 (1437)
.++|.+.+.||+|+||.||+|.+..+++.||||.+....... ....+.+|+.++..+ .||||+++++++.+....|+|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 467999999999999999999998889999999997654332 334556677766666 599999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
|||+. ++|.+++.... +++++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++..+.....
T Consensus 93 ~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 99985 47888776533 479999999999999999999997 5999999999999999999999999999987654322
Q ss_pred ccccccCCCccCChhhhhcCC----CCccchhhhHHHHHHHHHhCCCCCCCCCC-hhHHHHHhhcCCCCCC--CCCCHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSG----VCAASDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQDERPPIP--ESLSPDI 247 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~----yS~KSDIWSLG~ILYELLTGkpPF~g~d~-~eqL~kIiq~~rppiP--~~ISpEL 247 (1437)
.....+++.|+|||.+.... ++.++||||||+++|+|++|+.||..... .+.+.++.....+..+ ..++.++
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (296)
T cd06618 171 -KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249 (296)
T ss_pred -ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHH
Confidence 22345788999999987553 78899999999999999999999975433 3334444444333333 3478999
Q ss_pred HHHHHHHhhhcccCCCCHHHHhcCHHHHHHHH
Q 000535 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279 (1437)
Q Consensus 248 kDLIrkCLqkDPeKRPSAeELLkHPWFQe~rr 279 (1437)
.+||.+||..||.+||++.+++.||||+..+.
T Consensus 250 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 99999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=368.12 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=202.4
Q ss_pred ccccccCCceEEEeEecccCcEEEEEEEEcCC-CeEEEEEE--------------eec-cccCHHHHHHHHHHHHHHHhC
Q 000535 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLEN-GDFVAIKQ--------------VSL-ENIAQEDLNIIMQEIDLLKNL 74 (1437)
Q Consensus 11 ~~gktLggRYeIlEvLGrGgFGtVYKArDrkT-Gk~VAIKV--------------Ikk-e~lSeedie~L~REIkILrrL 74 (1437)
..+..+.++|++++.||+|+||+||+|..+.. +..++.|. +.+ ..........+.+|+.+|+++
T Consensus 141 ~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 141 KHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred ccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 34456778999999999999999999876432 22222221 111 111223345678999999999
Q ss_pred CCCCcceEEEEEEeCCeEEEEEeecCCCCHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceE
Q 000535 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNK---FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL 151 (1437)
Q Consensus 75 nHPNIVKLigVfedd~~LYLVMEYceGGSL~DLLKssr---~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENIL 151 (1437)
+||||+++++++...+..|+|++++. ++|.+++.... ........++.|+.||+.||.|||++||+||||||+|||
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL 299 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF 299 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 99999999999999999999999995 57877765322 123456778899999999999999999999999999999
Q ss_pred eccCCcEEEEecccccccccCCc-ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCC-C--CChhH
Q 000535 152 TTKEGLVKLADFGVATKLTEADV-NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYE-L--QPMPA 227 (1437)
Q Consensus 152 LdenG~VKLiDFGLAr~L~esd~-kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g-~--d~~eq 227 (1437)
++.++.+||+|||+++.+..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..++.. . .....
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999987754322 23346899999999999999999999999999999999998754432 2 12223
Q ss_pred HHHHhhcCC----------------------C----CC-----CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 228 LFRIVQDER----------------------P----PI-----PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 228 L~kIiq~~r----------------------p----pi-----P~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+.+++.... . .+ ...++.++.++|.+||.+||.+|||+.|+|.||||..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 332222100 0 00 1135677889999999999999999999999999965
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=332.95 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=207.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCC--------------CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLEN--------------GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkT--------------Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLi 83 (1437)
++|++.+.||+|+||.||+|++..+ ...||+|.+... ......+.+.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 5899999999999999999987543 235899998754 3344556788999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEec
Q 000535 84 GSLKTRSHLHIILEYVENGSLANIIKPNK----------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTT 153 (1437)
Q Consensus 84 gVfedd~~LYLVMEYceGGSL~DLLKssr----------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLd 153 (1437)
+++...+..|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999986431 12478899999999999999999999999999999999999
Q ss_pred cCCcEEEEecccccccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh--CCCCCCCCCChhHHH
Q 000535 154 KEGLVKLADFGVATKLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT--CVPPYYELQPMPALF 229 (1437)
Q Consensus 154 enG~VKLiDFGLAr~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT--GkpPF~g~d~~eqL~ 229 (1437)
.++.+||+|||++......... .....++..|+|||++....++.++|||||||++|+|++ +..||......+.+.
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 9999999999999765433211 122345678999999988889999999999999999988 677887765544433
Q ss_pred HHhh-------cCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 230 RIVQ-------DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 230 kIiq-------~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
.+.. ......++.+++.+.+|+.+||..+|++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 244 NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3221 1122345668899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.68 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=207.6
Q ss_pred CCceEEEeEecccCcEEEEEEEEcC----------------CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcc
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLE----------------NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrk----------------TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIV 80 (1437)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4579999999999999999986432 34579999987442 334456788999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHhccCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceE
Q 000535 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKF---------GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL 151 (1437)
Q Consensus 81 KLigVfedd~~LYLVMEYceGGSL~DLLKssr~---------GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENIL 151 (1437)
++++++...+..|+||||+.+++|.+++..... ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999999999999865321 24778899999999999999999999999999999999
Q ss_pred eccCCcEEEEecccccccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh--CCCCCCCCCChhH
Q 000535 152 TTKEGLVKLADFGVATKLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT--CVPPYYELQPMPA 227 (1437)
Q Consensus 152 LdenG~VKLiDFGLAr~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT--GkpPF~g~d~~eq 227 (1437)
++.++.++|+|||+++.+...... .....+++.|++||+.....++.++|||||||++|+|++ |..||......+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 999999999999999876433211 112344678999999888889999999999999999998 7789876655443
Q ss_pred HHHHhh-------cCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 228 LFRIVQ-------DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 228 L~kIiq-------~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
...... ....+.+..+++.+.+|+.+||..||.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 332211 1123445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=326.26 Aligned_cols=246 Identities=29% Similarity=0.463 Sum_probs=207.4
Q ss_pred eEecccCcEEEEEEEEcCCC------eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 24 DEIGKGAYGRVYKGLDLENG------DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTG------k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
+.||+|+||.||+|.+.... ..|++|.+.... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 36899999999999876543 789999886432 23445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-----cEEEEeccccc
Q 000535 98 YVENGSLANIIKPN-----KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-----LVKLADFGVAT 167 (1437)
Q Consensus 98 YceGGSL~DLLKss-----r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-----~VKLiDFGLAr 167 (1437)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999643 223488999999999999999999999999999999999999887 89999999998
Q ss_pred ccccCCcc--cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCC
Q 000535 168 KLTEADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLS 244 (1437)
Q Consensus 168 ~L~esd~k--t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~IS 244 (1437)
.+...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+........+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCP 239 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccch
Confidence 66433211 122345788999999998899999999999999999998 999998766655555555455556677899
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 245 PDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 245 pELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
..+.++|.+||..+|.+||++.++++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.08 Aligned_cols=251 Identities=23% Similarity=0.422 Sum_probs=210.3
Q ss_pred eEEEeEecccCcEEEEEEEEcC---CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLE---NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS------ 90 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrk---TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~------ 90 (1437)
|.+.+.||+|+||.||+|.+.. ++..||||++..........+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998643 5789999999877666667788899999999999999999999886432
Q ss_pred eEEEEEeecCCCCHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccc
Q 000535 91 HLHIILEYVENGSLANIIKPNK----FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA 166 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr----~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLA 166 (1437)
..++++||+.+|+|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3478999999999988874321 125899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCC
Q 000535 167 TKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESL 243 (1437)
Q Consensus 167 r~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~I 243 (1437)
+....... ......+++.|++||.+....++.++|||||||++|+|++ |.+||......+....+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 87643321 1122345678999999998889999999999999999999 89999876655544445555455556678
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 244 SpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
+..+.+++.+||..+|++||++.+++.
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=343.30 Aligned_cols=254 Identities=26% Similarity=0.470 Sum_probs=209.5
Q ss_pred CCceEEEeEecccCcEEEEEEEE-----cCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLD-----LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT-R 89 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArD-----rkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfed-d 89 (1437)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.++.++ +||||+++++++.. +
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35899999999999999999984 3467899999987543 234556788999999999 68999999998755 4
Q ss_pred CeEEEEEeecCCCCHHHHhccCC---------------------------------------------------------
Q 000535 90 SHLHIILEYVENGSLANIIKPNK--------------------------------------------------------- 112 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKssr--------------------------------------------------------- 112 (1437)
..+|+|||||++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 57899999999999999986431
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--ccccccCC
Q 000535 113 --------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV--NTHSVVGT 182 (1437)
Q Consensus 113 --------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~--kt~t~~GT 182 (1437)
...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 12467888899999999999999999999999999999999999999999999987543221 12223456
Q ss_pred CccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHH-hhcCCCCCCCCCCHHHHHHHHHHhhhccc
Q 000535 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRI-VQDERPPIPESLSPDITDFLRQCFKKDAR 260 (1437)
Q Consensus 183 p~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kI-iq~~rppiP~~ISpELkDLIrkCLqkDPe 260 (1437)
+.|+|||++....++.++|||||||++|+|++ |..||............ ......+.+..+++++.+++..||..+|+
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~ 324 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 324 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 78999999988899999999999999999997 99999775544333333 33344556667889999999999999999
Q ss_pred CCCCHHHHhcC
Q 000535 261 QRPDAKTLLSH 271 (1437)
Q Consensus 261 KRPSAeELLkH 271 (1437)
+||++.++++|
T Consensus 325 ~Rps~~eil~~ 335 (343)
T cd05103 325 QRPTFSELVEH 335 (343)
T ss_pred hCcCHHHHHHH
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.79 Aligned_cols=258 Identities=32% Similarity=0.519 Sum_probs=215.9
Q ss_pred ceEEEeEecccCcEEEEEEEEc---CCCeEEEEEEeeccccC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDL---ENGDFVAIKQVSLENIA--QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDr---kTGk~VAIKVIkke~lS--eedie~L~REIkILrrL-nHPNIVKLigVfedd~~L 92 (1437)
+|.+.+.||+|+||.||+|.+. .+++.||+|++++.... ....+.+..|+.++.++ +||||+++++++..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998754322 22345678899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
|+||||+.+|+|.+++... +.+++..+..++.|++.+|.|||+.|++||||||+||+++.++.++|+|||+++.+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999998743 56999999999999999999999999999999999999999999999999999876443
Q ss_pred Cc-ccccccCCCccCChhhhhcCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCh---hHHHHHhhcCCCCCCCCCCHH
Q 000535 173 DV-NTHSVVGTPYWMAPEVIEMSG--VCAASDIWSVGCTVIELLTCVPPYYELQPM---PALFRIVQDERPPIPESLSPD 246 (1437)
Q Consensus 173 d~-kt~t~~GTp~YmAPEVL~g~~--yS~KSDIWSLG~ILYELLTGkpPF~g~d~~---eqL~kIiq~~rppiP~~ISpE 246 (1437)
.. ......|+..|++||.+.+.. ++.++|+||||+++|+|++|..||...... ..+.+.......+.+..++..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHH
Confidence 21 122356899999999987654 788999999999999999999999643322 223333334456677789999
Q ss_pred HHHHHHHHhhhcccCCCC---HHHHhcCHHHHHHH
Q 000535 247 ITDFLRQCFKKDARQRPD---AKTLLSHPWIQNCR 278 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRPS---AeELLkHPWFQe~r 278 (1437)
+.++|.+||+.+|++||| +.++++||||+...
T Consensus 239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 999999999999999998 56789999997643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.19 Aligned_cols=250 Identities=27% Similarity=0.476 Sum_probs=205.9
Q ss_pred eEEEeEecccCcEEEEEEEE----cCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEE
Q 000535 20 YMLGDEIGKGAYGRVYKGLD----LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--SHLH 93 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArD----rkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd--~~LY 93 (1437)
|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++++.||||+++++++... ...|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 68999999999999999974 4578899999986543 344556789999999999999999999998775 6789
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||++|++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+....
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999996542 468999999999999999999999999999999999999999999999999998765432
Q ss_pred c---ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------------ChhHH-HHHhhcC
Q 000535 174 V---NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQ--------------PMPAL-FRIVQDE 235 (1437)
Q Consensus 174 ~---kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d--------------~~eqL-~kIiq~~ 235 (1437)
. ......++..|+|||++.+..++.++|||||||++|+|+++..|+.... ..... ..+....
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence 1 1123557778999999988889999999999999999999876653211 01111 1112233
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 236 rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
..+.+..++..+.+|+.+||+.+|++||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 445567799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.59 Aligned_cols=251 Identities=29% Similarity=0.528 Sum_probs=204.1
Q ss_pred CCceEEEeEecccCcEEEEEEE----EcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGL----DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--RS 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKAr----DrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed--d~ 90 (1437)
..+|++.+.||+|+||.||+|. +..++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3579999999999999999997 3457889999997643 34556778899999999999999999998743 45
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
.+|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 7899999999999999997542 468999999999999999999999999999999999999999999999999998764
Q ss_pred cCCcc---cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---------------hHHHHHh
Q 000535 171 EADVN---THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM---------------PALFRIV 232 (1437)
Q Consensus 171 esd~k---t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~---------------eqL~kIi 232 (1437)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..|+...... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 43211 11123445699999999888999999999999999999987765432210 0111111
Q ss_pred h-cCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 233 Q-DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 233 q-~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
. ....+.+..++.++.+||.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1 2233456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.01 Aligned_cols=245 Identities=27% Similarity=0.460 Sum_probs=198.4
Q ss_pred eEecccCcEEEEEEEEcC--CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLE--NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrk--TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 368999999999996433 45678888775432 344456788899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc--cc
Q 000535 102 GSLANIIKPNKF---GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV--NT 176 (1437)
Q Consensus 102 GSL~DLLKssr~---GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~--kt 176 (1437)
|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 999999975432 3357888899999999999999999999999999999999999999999999976433221 11
Q ss_pred ccccCCCccCChhhhhc-------CCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCC-----CCCCCC
Q 000535 177 HSVVGTPYWMAPEVIEM-------SGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERP-----PIPESL 243 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g-------~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rp-----piP~~I 243 (1437)
....+++.|+|||++.. ..++.++|||||||++|+|++ |.+||......+.+..+...... .++..+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 23346778999999753 346789999999999999999 78898877666655555544332 234568
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 244 SpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
++.+.+++..|+ .||++||++.++++
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 899999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.72 Aligned_cols=253 Identities=23% Similarity=0.444 Sum_probs=211.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcC-----CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLE-----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrk-----TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
.+|++.+.||+|+||.||+|++.. +.+.|++|.+.... .....+.+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 579999999999999999999653 35779999876432 233556788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccc
Q 000535 93 HIILEYVENGSLANIIKPNKF-------GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGV 165 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~-------GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGL 165 (1437)
|+||||+++|+|.+++..... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 999999999999999975542 2699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCc-ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC-CCCCCCC
Q 000535 166 ATKLTEADV-NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE-RPPIPES 242 (1437)
Q Consensus 166 Ar~L~esd~-kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~-rppiP~~ 242 (1437)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........+..+.... ..+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCC
Confidence 875433221 2223456778999999988888999999999999999998 888997765554444433222 2234567
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 243 LSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
++..+.+++.+||..+|++||++.++++.
T Consensus 244 ~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 89999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=371.28 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=210.0
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEE-EEE---e---
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLG-SLK---T--- 88 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLig-Vfe---d--- 88 (1437)
..+++|.+.|.+|||+.||+|++...|+.||+|++... ++...+.+++||.+|+.|. |+|||.|+| ... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34789999999999999999999888899999998765 5778889999999999995 999999999 322 1
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCceEeccCCcEEEEecccc
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG--VIHRDIKGANILTTKEGLVKLADFGVA 166 (1437)
Q Consensus 89 d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnG--IVHRDLKPENILLdenG~VKLiDFGLA 166 (1437)
.-.++|.||||.||.|.+++..+-...|+|.++++|++|+++||.+||... |||||||-|||||+.+|++||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 135789999999999999998665566999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCcccc---------cccCCCccCChhhhh---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhc
Q 000535 167 TKLTEADVNTH---------SVVGTPYWMAPEVIE---MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD 234 (1437)
Q Consensus 167 r~L~esd~kt~---------t~~GTp~YmAPEVL~---g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~ 234 (1437)
+.......... ...-|+.|+|||++. +...++|+|||+|||+||-||....||.+.... .|+..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng 269 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNG 269 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEec
Confidence 76543221111 134699999999884 667899999999999999999999999875433 23333
Q ss_pred CC-CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 235 ER-PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 235 ~r-ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
.+ .|..+.++..+++||+.||+.||++||++.+++.+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 22 22335799999999999999999999999999864
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=370.53 Aligned_cols=259 Identities=26% Similarity=0.442 Sum_probs=233.6
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
.-.+.|.+.+.||+|.|++|.+|++..++..||||+|.+........+.+.+|+++|+.|+|||||+++.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567999999999999999999999999999999999998888877779999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+.+|.+++++... +.+.+..++.++.|++.|++|||+++|||||||++|||++.+.++||+|||++..+... .
T Consensus 133 V~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-L 209 (596)
T ss_pred EEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-c
Confidence 99999999999999855 67889999999999999999999999999999999999999999999999999998754 3
Q ss_pred ccccccCCCccCChhhhhcCCC-CccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~y-S~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrk 253 (1437)
...+.||++.|.|||++.+..| ++.+|+||+|+++|.|++|..||.+.+-.. +..-.......+|-.++-++.++|++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-LRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-ccchheeeeecccceeechhHHHHHH
Confidence 5678999999999999999887 568999999999999999999998755433 33333333445667789999999999
Q ss_pred HhhhcccCCCCHHHHhcCHHHHHH
Q 000535 254 CFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 254 CLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+|.++|.+|++.+++.+|.|....
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred hhccCccccCCHHHhhhhcccchh
Confidence 999999999999999999998654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.26 Aligned_cols=255 Identities=36% Similarity=0.658 Sum_probs=218.8
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
....|...+.||+|+||.||+|++..++..+++|.+..... .......+.+|+.+++.++|||++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 45568888999999999999999999999999999875432 33445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+. |++.+++... ..++++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++......
T Consensus 93 v~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 93 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 999997 5888877543 356899999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCccCChhhhh---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCC-CCCCCHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIE---MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-PESLSPDITDF 250 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~---g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppi-P~~ISpELkDL 250 (1437)
....|++.|+|||.+. ...++.++|||||||++|+|++|..||...+..+....+.....+.. +..++..+.+|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 2456889999999985 34578899999999999999999999987766666665555444333 34688999999
Q ss_pred HHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 251 LRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
|.+||.++|++||++.++++|||+..
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCccccc
Confidence 99999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.80 Aligned_cols=251 Identities=29% Similarity=0.566 Sum_probs=212.9
Q ss_pred ceEEEeEecccCcEEEEEEEEcC-CCeEEEEEEeeccc--------cCHHHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLE-NGDFVAIKQVSLEN--------IAQEDLNIIMQEIDLLKN-LNHKNIVKYLGSLKT 88 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrk-TGk~VAIKVIkke~--------lSeedie~L~REIkILrr-LnHPNIVKLigVfed 88 (1437)
.|.+.+.||+|+||.||+|.+.. .++.+|+|.+.... ........+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999887 68999999886432 223445667789988875 799999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEeccc
Q 000535 89 RSHLHIILEYVENGSLANIIKP--NKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGV 165 (1437)
Q Consensus 89 d~~LYLVMEYceGGSL~DLLKs--sr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGL 165 (1437)
+++.|+||||+++++|.+++.. .....+++..++.++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998853 233579999999999999999999996 6899999999999999999999999999
Q ss_pred ccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCC-CCC
Q 000535 166 ATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE-SLS 244 (1437)
Q Consensus 166 Ar~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~-~IS 244 (1437)
+....... ......|+..|++||++.+..++.++|+||||+++|+|++|.+||...........+......+.+. .++
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 98765543 3345678999999999998889999999999999999999999997766555555554444444443 678
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 245 PDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 245 pELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
+++.++|.+||..||++||++.++..
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 99999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.94 Aligned_cols=236 Identities=24% Similarity=0.432 Sum_probs=195.0
Q ss_pred eEecccCcEEEEEEEEcCCC----------eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 24 DEIGKGAYGRVYKGLDLENG----------DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTG----------k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
+.||+|+||.||+|.+..++ ..+++|.+..... ....+.+|+.+++.++||||+++++++.. ...|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999998776 3577787654331 15678899999999999999999999887 7789
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-------cEEEEecccc
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-------LVKLADFGVA 166 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-------~VKLiDFGLA 166 (1437)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 77 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999997543 2799999999999999999999999999999999999999887 7999999999
Q ss_pred cccccCCcccccccCCCccCChhhhhcC--CCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCC
Q 000535 167 TKLTEADVNTHSVVGTPYWMAPEVIEMS--GVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESL 243 (1437)
Q Consensus 167 r~L~esd~kt~t~~GTp~YmAPEVL~g~--~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~I 243 (1437)
..... .....++..|+|||++... .++.++|||||||++|+|++ |..||......+........ ...+...
T Consensus 156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~ 229 (259)
T cd05037 156 ITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ--HRLPMPD 229 (259)
T ss_pred ccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC--CCCCCCC
Confidence 87654 2234567889999999876 78899999999999999999 57888766543332222222 2223333
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 244 SpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
...+.++|.+||..+|.+||++.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 489999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=365.86 Aligned_cols=254 Identities=29% Similarity=0.506 Sum_probs=226.3
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
.++||.|.||+||-|.++++|+.||||+|.+......+...++.|+.||+++.||.||.+-..|+..+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 3689999999999999999999999999999888777778899999999999999999999999999999999999964
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC---cEEEEecccccccccCCcccccc
Q 000535 103 SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG---LVKLADFGVATKLTEADVNTHSV 179 (1437)
Q Consensus 103 SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG---~VKLiDFGLAr~L~esd~kt~t~ 179 (1437)
++.+.|-....++|+|.....++.||+.||.|||-++|+|.||||+|||+.... ++||||||+|+.+++.. ...+.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrsV 726 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRSV 726 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhhh
Confidence 888888777789999999999999999999999999999999999999997653 79999999999998876 45678
Q ss_pred cCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-hHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhc
Q 000535 180 VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM-PALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258 (1437)
Q Consensus 180 ~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~-eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkD 258 (1437)
+|||.|+|||+++..+|+..-|+||+|+|+|--++|..||....+. +++.+..--..+.-|..+++++.+||+.+|+..
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVk 806 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVK 806 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999654432 222222222334445789999999999999999
Q ss_pred ccCCCCHHHHhcCHHHHHHH
Q 000535 259 ARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 259 PeKRPSAeELLkHPWFQe~r 278 (1437)
..+|.|.+..|.|||+|+..
T Consensus 807 m~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 807 MRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHhcchHhhccchhhhcch
Confidence 99999999999999999764
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.13 Aligned_cols=238 Identities=24% Similarity=0.442 Sum_probs=197.4
Q ss_pred eEecccCcEEEEEEEEcCCCe-------EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 24 DEIGKGAYGRVYKGLDLENGD-------FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk-------~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
+.||+|+||.||+|.+...+. .|++|.+.... ....+.+..|+.+++.+.||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 468999999999998865543 48888765432 334567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCc--------EEEEecccccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGL--------VKLADFGVATK 168 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~--------VKLiDFGLAr~ 168 (1437)
||+.+|+|.++++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++..
T Consensus 79 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 79 EYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred ecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999997543 36899999999999999999999999999999999999987764 69999999876
Q ss_pred cccCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCC-CCCCCCCChhHHHHHhhcCCCCCCCCCCHH
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCV-PPYYELQPMPALFRIVQDERPPIPESLSPD 246 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGk-pPF~g~d~~eqL~kIiq~~rppiP~~ISpE 246 (1437)
.... ....+++.|+|||++.+ ..++.++|||||||++|+|++|. +||.......... .......+|...+.+
T Consensus 158 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 231 (258)
T cd05078 158 VLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ--FYEDRHQLPAPKWTE 231 (258)
T ss_pred cCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH--HHHccccCCCCCcHH
Confidence 5432 23568899999999976 45789999999999999999985 6665544433222 223345566678899
Q ss_pred HHHHHHHHhhhcccCCCCHHHHhc
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
+.++|.+||+.+|++|||+.++++
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.70 Aligned_cols=251 Identities=30% Similarity=0.534 Sum_probs=208.0
Q ss_pred CceEEEeEecccCcEEEEEEEEc----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDL----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--RSH 91 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDr----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed--d~~ 91 (1437)
..|++.+.||+|+||.||+|... .+++.||+|++...... ...+.+.+|+.+++.+.||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46888899999999999999864 34889999998765443 456778999999999999999999999877 568
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e 171 (1437)
.|+||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999997543 3599999999999999999999999999999999999999999999999999988763
Q ss_pred CCcc---cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh--------------hHHHHHhh-
Q 000535 172 ADVN---THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM--------------PALFRIVQ- 233 (1437)
Q Consensus 172 sd~k---t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~--------------eqL~kIiq- 233 (1437)
.... .....++..|++||.+....++.++|||||||++|+|++|..||...... ..+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 3211 11234456799999998888999999999999999999999998653221 11222222
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 234 DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 234 ~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
....+.+..++.++.+++.+||..+|++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2233445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.21 Aligned_cols=245 Identities=23% Similarity=0.411 Sum_probs=197.4
Q ss_pred eEecccCcEEEEEEEEc--CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDL--ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDr--kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.++++++||||+++++++.+...+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 36899999999999754 3567899998875543 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc--c
Q 000535 102 GSLANIIKPNK---FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN--T 176 (1437)
Q Consensus 102 GSL~DLLKssr---~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k--t 176 (1437)
|+|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999996432 235677888899999999999999999999999999999999999999999999765433211 1
Q ss_pred ccccCCCccCChhhhhcC-------CCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCC-----CCCCCCC
Q 000535 177 HSVVGTPYWMAPEVIEMS-------GVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDER-----PPIPESL 243 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL~g~-------~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~r-----ppiP~~I 243 (1437)
....+++.|+|||++... .++.++|||||||++|+|++ |..||......+.......... +.....+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 234678889999998643 35789999999999999996 9999987665554443333222 2222356
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 244 SpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
++.+.+++.+|+ .+|++|||+.+++.
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 889999999999 68999999999963
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=336.32 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=212.9
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCeEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT-RSHLH 93 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed-d~~LY 93 (1437)
.+.++|.+.+.||.|+||.||+|.+..+++.||+|++.+..........+.+|+.++++++||||+++++++.. ....|
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46789999999999999999999999999999999987654444445667899999999999999999999865 56889
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
+||||+ +++|.++++. .++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 999999 5689988863 36899999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhh-------------------
Q 000535 174 VNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ------------------- 233 (1437)
Q Consensus 174 ~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq------------------- 233 (1437)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+..
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 234567899999998765 5689999999999999999999999976543221111100
Q ss_pred ----c--CCCC-----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 234 ----D--ERPP-----IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 234 ----~--~rpp-----iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
. ...+ ..+.+++++.++|.+||+.+|++||++.+++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0 0001 113578899999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=328.48 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=208.5
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCe----EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGD----FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk----~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
.++|++.+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3568999999999999999999877775 57888876433 233344678999999999999999999998654 56
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
++++||+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+...
T Consensus 84 ~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 7999999999999998754 346899999999999999999999999999999999999999999999999999876433
Q ss_pred Cc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHH
Q 000535 173 DV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249 (1437)
Q Consensus 173 d~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkD 249 (1437)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+......+.+..++..+.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 21 1223446778999999998889999999999999999997 89999765443333223333445566778999999
Q ss_pred HHHHHhhhcccCCCCHHHHhcC
Q 000535 250 FLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkH 271 (1437)
++.+||..+|++||++.++++.
T Consensus 243 li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 243 VMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=348.43 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=213.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEc-----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRS 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDr-----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd~ 90 (1437)
.++|.+.+.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.+|.++. ||||+++++++..++
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 356889999999999999999863 356789999997543 2344557889999999997 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCC---------------------------------------------------------
Q 000535 91 HLHIILEYVENGSLANIIKPNKF--------------------------------------------------------- 113 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~--------------------------------------------------------- 113 (1437)
..|+|||||.+|+|.+++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999964321
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc
Q 000535 114 ---------------------------------------GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK 154 (1437)
Q Consensus 114 ---------------------------------------GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde 154 (1437)
..+++..++.|+.||+.||.|||+.+|+||||||+|||++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 23677788999999999999999999999999999999999
Q ss_pred CCcEEEEecccccccccCCc--ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHH
Q 000535 155 EGLVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRI 231 (1437)
Q Consensus 155 nG~VKLiDFGLAr~L~esd~--kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kI 231 (1437)
++.+||+|||+++.+..... ......+++.|+|||.+....++.++|||||||++|+|++ |..||......+...+.
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~ 354 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA 354 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence 99999999999986543221 1223467889999999998889999999999999999998 89999876665555554
Q ss_pred hh-cCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 232 VQ-DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 232 iq-~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
+. ...++.|..++.++.+|+.+||.++|.+||++.+|+..
T Consensus 355 ~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 355 IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 43 33456677899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=375.70 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=209.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999999999999999999754332 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 97 EYVENGSLANIIKPNK---------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 97 EYceGGSL~DLLKssr---------~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
|||+||+|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999999986421 1345667889999999999999999999999999999999999999999999998
Q ss_pred ccccCC------------------cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHH
Q 000535 168 KLTEAD------------------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALF 229 (1437)
Q Consensus 168 ~L~esd------------------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~ 229 (1437)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 762111 01123579999999999999999999999999999999999999997754433332
Q ss_pred HHhhcCCCC--CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 230 RIVQDERPP--IPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 230 kIiq~~rpp--iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
......... ....+++.+.+++.+||.+||++||+..+.+.+
T Consensus 242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 221111111 124688999999999999999999887766543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=347.41 Aligned_cols=259 Identities=26% Similarity=0.509 Sum_probs=222.5
Q ss_pred cCCceEEE-eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 000535 16 LDNKYMLG-DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 16 LggRYeIl-EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LY 93 (1437)
|.+-|++. +.||+|+|+.|-.+.+..+|..||||+|.+.. .....++.+|++++.+. .|+||++++++|+++..+|
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 45556664 57899999999999999999999999998763 45567899999999999 6999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC---cEEEEecccccccc
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG---LVKLADFGVATKLT 170 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG---~VKLiDFGLAr~L~ 170 (1437)
||||-+.||+|...|.++ ..|+|.++.++.++|+.||.|||.+||.||||||+|||....+ -||||||.+...+.
T Consensus 153 LVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 999999999999999865 5699999999999999999999999999999999999997665 58999999987654
Q ss_pred cCC-------cccccccCCCccCChhhhh-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------------
Q 000535 171 EAD-------VNTHSVVGTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTCVPPYYELQP-------------- 224 (1437)
Q Consensus 171 esd-------~kt~t~~GTp~YmAPEVL~-----g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-------------- 224 (1437)
... ....+.+|+..|||||+.. ...|+.+.|.||||+|+|-||+|++||.+.-.
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 322 2234679999999999873 23589999999999999999999999965322
Q ss_pred hhHHHHHhhcCCCCCC----CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 225 MPALFRIVQDERPPIP----ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 225 ~eqL~kIiq~~rppiP----~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
...++..++.....+| ..+|.+.+++|..+|..|+.+|.++..+++|||++.+.
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 3445666666666655 46899999999999999999999999999999998764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.87 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=219.2
Q ss_pred cccccCCceEEE-eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 000535 12 KSKTLDNKYMLG-DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT- 88 (1437)
Q Consensus 12 ~gktLggRYeIl-EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfed- 88 (1437)
....+.++|.+- ++||-|=-|.|..+.++.+++.+|+|++.- ....++|+++--.. .|||||.++++|++
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 344567777775 578999999999999999999999998752 23466888875554 79999999998864
Q ss_pred ---CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC---CcEEEEe
Q 000535 89 ---RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE---GLVKLAD 162 (1437)
Q Consensus 89 ---d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden---G~VKLiD 162 (1437)
...+.+|||.++||+|+..|+.+....|+|+++..|++||..|+.|||+.+|.||||||+|+|...+ -.+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 5778999999999999999998888889999999999999999999999999999999999999754 4799999
Q ss_pred cccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---hHHHHHhhcC----
Q 000535 163 FGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM---PALFRIVQDE---- 235 (1437)
Q Consensus 163 FGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~---eqL~kIiq~~---- 235 (1437)
||+|+.-... ....+.|-||+|.|||++....|+...|+||+|+++|-|+||++||+..... +...+.+...
T Consensus 208 fGFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 208 FGFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 9999876543 3556789999999999999999999999999999999999999999864432 2233333332
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 236 rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
..+-|..+|++.+++|+++|..+|.+|.|+.++++|||+.+.
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 334556789999999999999999999999999999999754
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.01 Aligned_cols=239 Identities=21% Similarity=0.377 Sum_probs=193.3
Q ss_pred eEecccCcEEEEEEEEcC------------CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 000535 24 DEIGKGAYGRVYKGLDLE------------NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrk------------TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~ 91 (1437)
+.||+|+||.||+|.... ....+++|++.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999997532 23358888865432 2344567889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCc-------EEEEecc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGL-------VKLADFG 164 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~-------VKLiDFG 164 (1437)
.++||||+++|+|..++... ..++++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888643 357999999999999999999999999999999999999987663 8999999
Q ss_pred cccccccCCcccccccCCCccCChhhhh-cCCCCccchhhhHHHHHHHHH-hCCCCCCCCCChhHHHHHhhcCCCCCCCC
Q 000535 165 VATKLTEADVNTHSVVGTPYWMAPEVIE-MSGVCAASDIWSVGCTVIELL-TCVPPYYELQPMPALFRIVQDERPPIPES 242 (1437)
Q Consensus 165 LAr~L~esd~kt~t~~GTp~YmAPEVL~-g~~yS~KSDIWSLG~ILYELL-TGkpPF~g~d~~eqL~kIiq~~rppiP~~ 242 (1437)
++...... ....++..|+|||++. ...++.++|||||||++|+|+ .|..||......+. .+.... .......
T Consensus 158 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~-~~~~~~~ 231 (262)
T cd05077 158 IPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEG-QCMLVTP 231 (262)
T ss_pred CCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhc-CccCCCC
Confidence 99765432 2356788999999986 466889999999999999998 58888876443322 222222 2223334
Q ss_pred CCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 243 LSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 243 ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
.+.++.+||.+||..||.+||++.+|+++
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 56889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=362.42 Aligned_cols=148 Identities=31% Similarity=0.572 Sum_probs=136.5
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++....++||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999976543 3344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
||+.|++|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999743 568999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=317.50 Aligned_cols=229 Identities=24% Similarity=0.303 Sum_probs=194.8
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCHHHHh
Q 000535 29 GAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANII 108 (1437)
Q Consensus 29 GgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL~DLL 108 (1437)
|.||.||+|++..+++.||+|.+.... ...+|...+....||||+++++++.+....|+||||++||+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999999999999999987542 1234445556668999999999999999999999999999999998
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCCCccCCh
Q 000535 109 KPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188 (1437)
Q Consensus 109 Kssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAP 188 (1437)
... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++..|+||
T Consensus 77 ~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aP 151 (237)
T cd05576 77 SKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAP 151 (237)
T ss_pred HHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCC
Confidence 754 46999999999999999999999999999999999999999999999999988766442 2234567889999
Q ss_pred hhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCH---
Q 000535 189 EVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDA--- 265 (1437)
Q Consensus 189 EVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSA--- 265 (1437)
|.+....++.++|+||+||++|+|++|..||...... +.......+|..+++.+.++|.+||+.||++||++
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 9998888999999999999999999999887543211 11112234567789999999999999999999985
Q ss_pred --HHHhcCHHH
Q 000535 266 --KTLLSHPWI 274 (1437)
Q Consensus 266 --eELLkHPWF 274 (1437)
.++++||||
T Consensus 227 ~~~~~~~h~~~ 237 (237)
T cd05576 227 GVEDIKSHPFF 237 (237)
T ss_pred chHHHHcCCCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=314.44 Aligned_cols=244 Identities=23% Similarity=0.403 Sum_probs=195.8
Q ss_pred EecccCcEEEEEEEEcCC--CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 25 EIGKGAYGRVYKGLDLEN--GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 25 vLGrGgFGtVYKArDrkT--Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
.||+|+||.||++..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++++.+....|+|||||++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 689999999999975433 3456677665433 2344567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC--ccccc
Q 000535 103 SLANIIKPNK--FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--VNTHS 178 (1437)
Q Consensus 103 SL~DLLKssr--~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd--~kt~t 178 (1437)
+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 9999997542 2457788889999999999999999999999999999999999999999999986532221 11234
Q ss_pred ccCCCccCChhhhhc-------CCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcC-----CCCCCCCCCH
Q 000535 179 VVGTPYWMAPEVIEM-------SGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE-----RPPIPESLSP 245 (1437)
Q Consensus 179 ~~GTp~YmAPEVL~g-------~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~-----rppiP~~ISp 245 (1437)
.+++..|+|||++.. ..++.++|||||||++|+|++ |.+||......+.+..+.... .+.++..+++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 578899999999853 235778999999999999997 577887666655555554433 2334456889
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
.+.+++..|| .+|++||++.++++
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHH
Confidence 9999999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=359.73 Aligned_cols=235 Identities=31% Similarity=0.578 Sum_probs=208.0
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCC
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENG 102 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGG 102 (1437)
++-||.|+.|-||+++- .++.||||+++. .-..+|+-|+.|+||||+.|.++|.....+|||||||..|
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 46689999999999975 689999997641 1235778899999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCC
Q 000535 103 SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT 182 (1437)
Q Consensus 103 SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GT 182 (1437)
-|.++++.. .++.......|..+|+.|+.|||.++|||||||.-||||+.+..|||+|||-++.+... ....+++||
T Consensus 198 qL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGT 274 (904)
T KOG4721|consen 198 QLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGT 274 (904)
T ss_pred cHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhh
Confidence 999999865 57999999999999999999999999999999999999999999999999999887654 355679999
Q ss_pred CccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhh-cCCCCCCCCCCHHHHHHHHHHhhhcccC
Q 000535 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ-DERPPIPESLSPDITDFLRQCFKKDARQ 261 (1437)
Q Consensus 183 p~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq-~~rppiP~~ISpELkDLIrkCLqkDPeK 261 (1437)
..|||||+++..+.+.|+|||||||||||||||..||.+.+....++-+-. ....+.|..|+..++=||++||.-.|..
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999999999999999987665544433321 1234678899999999999999999999
Q ss_pred CCCHHHHhcC
Q 000535 262 RPDAKTLLSH 271 (1437)
Q Consensus 262 RPSAeELLkH 271 (1437)
||++.+|+.|
T Consensus 355 RPSFrqil~H 364 (904)
T KOG4721|consen 355 RPSFRQILLH 364 (904)
T ss_pred CccHHHHHHH
Confidence 9999999988
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=390.60 Aligned_cols=260 Identities=38% Similarity=0.727 Sum_probs=231.5
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
+.+.-+|.-+..||.|.||.||.|.+..+|...|+|.|+.......-...+.+|..++..|+|||+|+++++-.+++..|
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34566899999999999999999999999999999999877766566677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
|.||||+||+|.++++.. +-.+|.....|..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1311 IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999999999743 457788888899999999999999999999999999999999999999999999876542
Q ss_pred c----ccccccCCCccCChhhhhc---CCCCccchhhhHHHHHHHHHhCCCCCCCCC-ChhHHHHHhhcCCCCCCCCCCH
Q 000535 174 V----NTHSVVGTPYWMAPEVIEM---SGVCAASDIWSVGCTVIELLTCVPPYYELQ-PMPALFRIVQDERPPIPESLSP 245 (1437)
Q Consensus 174 ~----kt~t~~GTp~YmAPEVL~g---~~yS~KSDIWSLG~ILYELLTGkpPF~g~d-~~eqL~kIiq~~rppiP~~ISp 245 (1437)
. ....+.||+.|||||++.+ .+...+.||||||||+.||.||+.||...+ .-...+.+..+..|.+|..+|+
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence 1 1235789999999999954 457788999999999999999999997654 4556677778889999999999
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
+-.+||.+||..||.+|.++.+|++|-|-.
T Consensus 1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred hHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 999999999999999999999999986653
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.46 Aligned_cols=238 Identities=24% Similarity=0.412 Sum_probs=193.3
Q ss_pred EecccCcEEEEEEEEcCC------------------------CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcc
Q 000535 25 EIGKGAYGRVYKGLDLEN------------------------GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80 (1437)
Q Consensus 25 vLGrGgFGtVYKArDrkT------------------------Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIV 80 (1437)
.||+|+||.||+|....+ ...|++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 589999999999974321 2458888876432 22345678899999999999999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC----
Q 000535 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG---- 156 (1437)
Q Consensus 81 KLigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG---- 156 (1437)
++++++.++...|+|||||++|+|..++... .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998643 35789999999999999999999999999999999999998654
Q ss_pred ---cEEEEecccccccccCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHH-hCCCCCCCCCChhHHHHH
Q 000535 157 ---LVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELL-TCVPPYYELQPMPALFRI 231 (1437)
Q Consensus 157 ---~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELL-TGkpPF~g~d~~eqL~kI 231 (1437)
.+|++|||++...... ....++..|+|||.+.. ..++.++|||||||++|+|+ +|..||......+.. ..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RF 233 (274)
T ss_pred ccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-HH
Confidence 4899999998654322 22457888999998865 56889999999999999985 699999776544332 22
Q ss_pred hhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 232 VQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 232 iq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
.. .....+...++.+.++|.+||+.+|++||++.+++++
T Consensus 234 ~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YE-KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 2234445567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=319.41 Aligned_cols=254 Identities=21% Similarity=0.277 Sum_probs=195.2
Q ss_pred ccccCCceEEEeEecccCcEEEEEEEEcCC---CeEEEEEEeeccccCH-HHH--------HHHHHHHHHHHhCCCCCcc
Q 000535 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLEN---GDFVAIKQVSLENIAQ-EDL--------NIIMQEIDLLKNLNHKNIV 80 (1437)
Q Consensus 13 gktLggRYeIlEvLGrGgFGtVYKArDrkT---Gk~VAIKVIkke~lSe-edi--------e~L~REIkILrrLnHPNIV 80 (1437)
.....++|++.+.||+|+||.||+|.+..+ +..+++|+........ .+. .....+...+..+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 456678999999999999999999998777 6778888654332111 000 1122333455667899999
Q ss_pred eEEEEEEeCC----eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC
Q 000535 81 KYLGSLKTRS----HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG 156 (1437)
Q Consensus 81 KLigVfedd~----~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG 156 (1437)
++++++.... +.++++|++.. ++.+.+... ..+++..++.|+.|++.||.|||+++|+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 9998765443 45788888754 777777643 3478899999999999999999999999999999999999999
Q ss_pred cEEEEecccccccccCCc-------ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHH
Q 000535 157 LVKLADFGVATKLTEADV-------NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALF 229 (1437)
Q Consensus 157 ~VKLiDFGLAr~L~esd~-------kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~ 229 (1437)
.++|+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643221 1123479999999999999999999999999999999999999998764322211
Q ss_pred H--------HhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 230 R--------IVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 230 k--------Iiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
. .+.... .....+++++.+++..|+..+|++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGK-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhh-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 111111 123467899999999999999999999999864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=355.16 Aligned_cols=257 Identities=28% Similarity=0.496 Sum_probs=208.7
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYL 94 (1437)
=+..|++++.||+||-+.||++.. .+...||+|.+.....+...+.-+..|+..|.+| .|.+||++++|-..++++||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 355799999999999999999975 4456777777776666677788899999999999 59999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||=+ -+|..+|+... ..++.-.++.|..|++.++.++|.+||||-||||.|+|+-. |.+||+|||+|..+..+..
T Consensus 438 vmE~Gd-~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred Eeeccc-ccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 999865 49999998654 33444588899999999999999999999999999999864 7899999999998876643
Q ss_pred --ccccccCCCccCChhhhhcCC-----------CCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC--CCC
Q 000535 175 --NTHSVVGTPYWMAPEVIEMSG-----------VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER--PPI 239 (1437)
Q Consensus 175 --kt~t~~GTp~YmAPEVL~g~~-----------yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r--ppi 239 (1437)
...+.+||+.||+||.+.... .+.++||||||||||+|+.|++||......-.-...+.... .++
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 234679999999999985432 45789999999999999999999965442222122222221 234
Q ss_pred CCCCCH-HHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 240 PESLSP-DITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 240 P~~ISp-ELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
|..-+. ++.++++.||.+||.+||++.++|+|||++-
T Consensus 595 p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 595 PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 433233 3999999999999999999999999999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=361.39 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=236.5
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
-.+.+++..||-||||.|-++........+|+|++++.... ..+.+.+..|-.||..+..|.||++|..|.+++++|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 34567788999999999999987666667999999887654 45667788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
||-|-||.|++.++. .+.|.+..++.|+..+++|++|||++|||+|||||+|++++.+|.+||.|||+|+.+.... +
T Consensus 499 mEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-K 575 (732)
T ss_pred HHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-c
Confidence 999999999999984 4789999999999999999999999999999999999999999999999999999998765 7
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC-CCCCCCCCHHHHHHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-PPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r-ppiP~~ISpELkDLIrkC 254 (1437)
+.++||||.|.|||++.+.+++.++|.||||+++|||++|.|||.+.+++..+..|+++-. ..+|..++....+||+++
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence 8899999999999999999999999999999999999999999999999999888887653 467889999999999999
Q ss_pred hhhcccCCCC-----HHHHhcCHHHHHH
Q 000535 255 FKKDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 255 LqkDPeKRPS-----AeELLkHPWFQe~ 277 (1437)
+..+|.+|.. +.||-+|.||...
T Consensus 656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 656 CRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 9999999985 8999999999754
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=349.32 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=230.1
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH-HHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed-ie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
.+.|..-++||+||||+||-++.+.||+-||+|.+.+..+.... ......|-.||.+.+.+.||.+-..|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 34578889999999999999999999999999998876654432 23456788999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
|..|.||+|.-.|.......|+|..++.|+.+|+.||++||+.+||+|||||+|||+|+.|+|+|+|.|+|..+.....
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~- 342 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP- 342 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc-
Confidence 9999999999999877666899999999999999999999999999999999999999999999999999999887653
Q ss_pred cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---hhHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP---MPALFRIVQDERPPIPESLSPDITDFLR 252 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~---~eqL~kIiq~~rppiP~~ISpELkDLIr 252 (1437)
..+.+||.+|||||+++...|+...|+|||||++|+|+.|+.||..... .+.+.+.+......++..+|+++++|.+
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~ 422 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCE 422 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHH
Confidence 3345999999999999999999999999999999999999999965433 3344555566666788999999999999
Q ss_pred HHhhhcccCCC-----CHHHHhcCHHHHHH
Q 000535 253 QCFKKDARQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 253 kCLqkDPeKRP-----SAeELLkHPWFQe~ 277 (1437)
.+|.+||.+|. .+.++-+||||+..
T Consensus 423 ~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 423 GLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999999997 57799999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=295.03 Aligned_cols=241 Identities=38% Similarity=0.681 Sum_probs=209.5
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCHHHHhc
Q 000535 30 AYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK 109 (1437)
Q Consensus 30 gFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL~DLLK 109 (1437)
+||.||+|.+..++..+++|++........ .+.+.+|+..+++++|+||+++++++......++++||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 689999999988899999999876543322 5788999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccCCCccCChh
Q 000535 110 PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189 (1437)
Q Consensus 110 ssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPE 189 (1437)
... .+++..++.++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|++||
T Consensus 80 ~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE 156 (244)
T smart00220 80 KRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPE 156 (244)
T ss_pred hcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHH
Confidence 543 38999999999999999999999999999999999999999999999999998876543 234567889999999
Q ss_pred hhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCC---CCHHHHHHHHHHhhhcccCCCCHH
Q 000535 190 VIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES---LSPDITDFLRQCFKKDARQRPDAK 266 (1437)
Q Consensus 190 VL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~---ISpELkDLIrkCLqkDPeKRPSAe 266 (1437)
.+....++.++||||||+++|+|++|..||..........+............ ++.++.+++.+||..+|++||++.
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 236 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE 236 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence 99888899999999999999999999999987555555555544443333222 889999999999999999999999
Q ss_pred HHhcCHHH
Q 000535 267 TLLSHPWI 274 (1437)
Q Consensus 267 ELLkHPWF 274 (1437)
++++||||
T Consensus 237 ~~~~~~~~ 244 (244)
T smart00220 237 EALQHPFF 244 (244)
T ss_pred HHhhCCCC
Confidence 99999996
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=363.13 Aligned_cols=251 Identities=25% Similarity=0.503 Sum_probs=223.8
Q ss_pred CCceEEEeEecccCcEEEEEEEEc-----CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDr-----kTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~ 91 (1437)
..+-+..+.||+|+||+||+|+.. .....||||.++... +....+.|+||+++|..|+|||||+|+|+|..++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 345678899999999999999753 334779999987443 34467789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccC--------CC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEE
Q 000535 92 LHIILEYVENGSLANIIKPN--------KF----GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVK 159 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKss--------r~----GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VK 159 (1437)
+|+|+|||..|+|.++|+.. .+ .+|+..+...|+.||+.|++||-++.+|||||-..|+||.++-.||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 99999999999999999643 11 2389999999999999999999999999999999999999999999
Q ss_pred EEecccccccccCCcccc--cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCC
Q 000535 160 LADFGVATKLTEADVNTH--SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDER 236 (1437)
Q Consensus 160 LiDFGLAr~L~esd~kt~--t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~r 236 (1437)
|+|||+++.+...+++.. ...-..+|||||.|....|+.++||||+||+|||+++ |..||++....+.+..+-.+..
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 999999998876654332 1233567999999999999999999999999999998 9999999999999999999888
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHH
Q 000535 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTL 268 (1437)
Q Consensus 237 ppiP~~ISpELkDLIrkCLqkDPeKRPSAeEL 268 (1437)
-+.|..||.++.+||..||..+|.+||++.||
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 89999999999999999999999999999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=363.69 Aligned_cols=252 Identities=26% Similarity=0.482 Sum_probs=224.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCC-C----eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLEN-G----DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkT-G----k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
..-.+.+.||+|.||+||.|.-... + ..||+|.+++. .+..+...|.+|..+|+.++|||||+++|++-+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4568889999999999999986543 3 34899988644 3567778899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccc
Q 000535 93 HIILEYVENGSLANIIKPNK-----FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr-----~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
+|++|||+||+|..+|++.+ ...++......+..||++|+.||+++++|||||-..|+|++....|||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 99999999999999998652 2458899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccccccC--CCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCC
Q 000535 168 KLTEADVNTHSVVG--TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLS 244 (1437)
Q Consensus 168 ~L~esd~kt~t~~G--Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~IS 244 (1437)
.+...+++.....+ ...|||||.+.+..|+.++|||||||++||++| |..||...+..+.+.....+.+.+.|..|+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP 930 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCP 930 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCC
Confidence 76655544333222 356999999999999999999999999999999 999999999999988888888999999999
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 245 PDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 245 pELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
..+.++|.+||+.+|++||++.+|++
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999986
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=356.89 Aligned_cols=254 Identities=32% Similarity=0.603 Sum_probs=219.6
Q ss_pred CCce-EEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--Ce
Q 000535 17 DNKY-MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI--AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--SH 91 (1437)
Q Consensus 17 ggRY-eIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l--Seedie~L~REIkILrrLnHPNIVKLigVfedd--~~ 91 (1437)
.++| +..++||+|+|-+||+|.|..+|..||--.++...+ ..++.+++..|+.+|+.|+|||||++++++.+. ..
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 4555 667799999999999999999999998655544433 345668999999999999999999999999765 45
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCceEeccC-CcEEEEecccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG--VIHRDIKGANILTTKE-GLVKLADFGVATK 168 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnG--IVHRDLKPENILLden-G~VKLiDFGLAr~ 168 (1437)
+.+|+|.+..|+|+.++++. +.++.+.+..|++||++||.|||++. |+|||||.+||||+.+ |.|||+|+|+|..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 89999999999999999855 57899999999999999999999985 9999999999999865 8999999999998
Q ss_pred cccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC--CCCCCCHH
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--IPESLSPD 246 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp--iP~~ISpE 246 (1437)
..... ....+|||.|||||++. ..|+..+||||||.+|.||.|+..||..-....++|+.+..+..| +.+--.++
T Consensus 196 ~r~s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 196 LRKSH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred hhccc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 76543 34589999999999998 789999999999999999999999998877777777766555333 22334789
Q ss_pred HHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+++||.+||.. ...|||+.|+|+||||+.
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 99999999999 999999999999999964
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=353.47 Aligned_cols=251 Identities=30% Similarity=0.485 Sum_probs=214.1
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
+..+...++++||+|.||+||+|++ -..||||++......+++.+.|+.||.++++-+|.||+=+.|++..+.. .|
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred cCHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 3455678899999999999999987 4569999999999999999999999999999999999999999988877 99
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccccc--C
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE--A 172 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~e--s 172 (1437)
|+-+|+|-+|+.+++... .+|.....+.|++||++|+.|||.++|||||||..|||+.+++.|||+|||++..... .
T Consensus 465 iTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999999998654 5799999999999999999999999999999999999999999999999999965322 2
Q ss_pred CcccccccCCCccCChhhhhcC---CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCC----CCCCCCCCH
Q 000535 173 DVNTHSVVGTPYWMAPEVIEMS---GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER----PPIPESLSP 245 (1437)
Q Consensus 173 d~kt~t~~GTp~YmAPEVL~g~---~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~r----ppiP~~ISp 245 (1437)
.......-|...|||||+++.. +|+..+|||||||++|||+||..||........++.+-.+.. ......++.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 2222345678889999999754 688999999999999999999999984444433333333321 123356888
Q ss_pred HHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 246 ELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
++++|+..||.+++++||.+.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999985
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=348.62 Aligned_cols=252 Identities=29% Similarity=0.530 Sum_probs=220.7
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCe---E-EEEEEeec-cccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGD---F-VAIKQVSL-ENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk---~-VAIKVIkk-e~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
++-.+.+.||+|+||+||+|.-...+. . ||+|..+. .....+....+.+|+++|++++|||||+++|+...+..+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344566899999999999998765422 3 89999886 346778889999999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
|+|||+|.||+|.++++..+. .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++.-...
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 999999999999999997643 6999999999999999999999999999999999999999999999999999875422
Q ss_pred CcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHH-hhcCCCCCCCCCCHHHHHH
Q 000535 173 DVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRI-VQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 173 d~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kI-iq~~rppiP~~ISpELkDL 250 (1437)
........-...|+|||.+....|+.++||||+||++||+++ |..||.+....+...++ ..+.+.+.|...+.++..+
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 211111224567999999999999999999999999999999 88999999998888888 4466778888899999999
Q ss_pred HHHHhhhcccCCCCHHHHhc
Q 000535 251 LRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLk 270 (1437)
+.+||..+|++||++.++.+
T Consensus 396 ~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHhccCChhhccCHHHHHH
Confidence 99999999999999999854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=348.20 Aligned_cols=261 Identities=28% Similarity=0.528 Sum_probs=225.9
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-Seedie~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
++=..-|..++.||-|+||+|-+++..++...||+|.+++... ...++..++.|-.||.....+-||+|+..|++++.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 3344558899999999999999999999999999999987653 356677889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc--
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT-- 170 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~-- 170 (1437)
|+||||++||++-.+|-+. +-|+|..++.|+..+..|+++.|..|+|||||||+|||||.+|+|||+|||+|+.+.
T Consensus 705 YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999998744 679999999999999999999999999999999999999999999999999997431
Q ss_pred -------cCC---------------------------------cccccccCCCccCChhhhhcCCCCccchhhhHHHHHH
Q 000535 171 -------EAD---------------------------------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVI 210 (1437)
Q Consensus 171 -------esd---------------------------------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILY 210 (1437)
+.+ ...+..+||+.|+|||++...+|+..+|+||.|+|||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 000 0122468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCChhHHHHHhhcCC---CCCCCCCCHHHHHHHHHHhhhcccCCC---CHHHHhcCHHHHHH
Q 000535 211 ELLTCVPPYYELQPMPALFRIVQDER---PPIPESLSPDITDFLRQCFKKDARQRP---DAKTLLSHPWIQNC 277 (1437)
Q Consensus 211 ELLTGkpPF~g~d~~eqL~kIiq~~r---ppiP~~ISpELkDLIrkCLqkDPeKRP---SAeELLkHPWFQe~ 277 (1437)
||+.|.+||-...+.+.-++++.... .+.-..+|+++.++|.+++. +++.|. .++++-.||||+.+
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 99999999998888877777665432 23446789999999999876 678886 47789999999754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=330.11 Aligned_cols=254 Identities=29% Similarity=0.495 Sum_probs=202.5
Q ss_pred ccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-e
Q 000535 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS-H 91 (1437)
Q Consensus 13 gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~-~ 91 (1437)
-....+.|.-...||+|+||.||+|.- .++..||||.+....... ...+..|+.++.+++|||+|+|+|||.+.+ .
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 334446777788999999999999975 445999999876554332 334999999999999999999999999888 5
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccCCceEeccCCcEEEEecccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG---VIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnG---IVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
.+||+||+++|+|.+++......+++|.....|+.++++||+|||... |+||||||+|||+|++.+.||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 999999999999999998654338999999999999999999999864 99999999999999999999999999966
Q ss_pred cccCCcccccc-cCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--hhHHH----HHhhcC------
Q 000535 169 LTEADVNTHSV-VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP--MPALF----RIVQDE------ 235 (1437)
Q Consensus 169 L~esd~kt~t~-~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~--~eqL~----kIiq~~------ 235 (1437)
.........+. .||.+|++||++.....+.++||||+|++|.|++||+.+.....+ ...+. ..+...
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 54311122222 899999999999999999999999999999999999988764321 11111 111111
Q ss_pred CCCCC-CCCC-----HHHHHHHHHHhhhcccCCCCHHHHh
Q 000535 236 RPPIP-ESLS-----PDITDFLRQCFKKDARQRPDAKTLL 269 (1437)
Q Consensus 236 rppiP-~~IS-----pELkDLIrkCLqkDPeKRPSAeELL 269 (1437)
.+.+. ..++ ..+..+..+|++.+|..||++.+++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 12222 2333 2366788999999999999999974
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=340.35 Aligned_cols=258 Identities=26% Similarity=0.465 Sum_probs=229.0
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYL 94 (1437)
..+|..+.+||+|+||.|.+|..+.+.+.||||++++...- ..+++--+.|-++|... +-|.+++++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 34688999999999999999999999999999999887543 33445556677777776 46789999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||||+.||+|--.|++ .++|.|..+..|+..|+-||-|||++||++||||.+|||++.+|++||+|||+++.-.-.+.
T Consensus 428 VMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 9999999999998874 47899999999999999999999999999999999999999999999999999987666667
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
.+.++||||.|+|||++...+|+..+|+||+|++||||+.|++||.+.+..+... .+......+|+.+|.++.++++..
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~-aI~ehnvsyPKslSkEAv~ickg~ 584 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-AIMEHNVSYPKSLSKEAVAICKGL 584 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHccCcCcccccHHHHHHHHHH
Confidence 7889999999999999999999999999999999999999999999977655544 445556678999999999999999
Q ss_pred hhhcccCCCC-----HHHHhcCHHHHHH
Q 000535 255 FKKDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 255 LqkDPeKRPS-----AeELLkHPWFQe~ 277 (1437)
|.+.|.+|.. -.+|-.||||+..
T Consensus 585 ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 585 LTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred hhcCCccccCCCCccccchhhCcchhhc
Confidence 9999999974 4689999999865
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.39 Aligned_cols=253 Identities=27% Similarity=0.415 Sum_probs=207.0
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----eCCe
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK-----TRSH 91 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfe-----dd~~ 91 (1437)
+.||++.+.||.|||+-||++++..+++.||+|++.... .++.+..++|++..++++|||+++++++.. ....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 568999999999999999999999999999999998765 577888999999999999999999988653 3456
Q ss_pred EEEEEeecCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCceEeccCCcEEEEeccccc
Q 000535 92 LHIILEYVENGSLANIIKPNK--FGPFPESLVAVYIAQVLEGLVYLHEQG--VIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr--~GpLSEs~I~rILrQILsALaYLHSnG--IVHRDLKPENILLdenG~VKLiDFGLAr 167 (1437)
.||+++|...|+|.+.++..+ +..++|.++..|+.+|++||++||+.. ++||||||.|||+...+.++|.|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999997543 346999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCccc---------ccccCCCccCChhhhhcC---CCCccchhhhHHHHHHHHHhCCCCCCCCCC-hhHHHHHhhc
Q 000535 168 KLTEADVNT---------HSVVGTPYWMAPEVIEMS---GVCAASDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQD 234 (1437)
Q Consensus 168 ~L~esd~kt---------~t~~GTp~YmAPEVL~g~---~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-~eqL~kIiq~ 234 (1437)
...-.-... ..-..|..|+|||.+... ..+.++|||||||+||.|+.|..||..... ...+.--+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n 257 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN 257 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence 653211000 012458889999999654 467899999999999999999999953211 0011001111
Q ss_pred CCC--CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 235 ERP--PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 235 ~rp--piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
... |-...+|..+.++|+.||+.||.+||++.+++.+
T Consensus 258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111 2224589999999999999999999999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=351.58 Aligned_cols=257 Identities=37% Similarity=0.686 Sum_probs=231.8
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----eCC
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLK-----TRS 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfe-----dd~ 90 (1437)
.+.|+|.+.||.|.+|.||+++++.+++.+|+|++...... .+.+..|..+++.+ .|||++.++++|. .++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 45699999999999999999999999999999998755433 34566788899888 6999999999885 357
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
.+|||||||.|||..|+++.-.+..+.|..+..|++.++.|+.+||.+.++|||||-.|||++.++.|||+|||.+.++.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 89999999999999999998878899999999999999999999999999999999999999999999999999999988
Q ss_pred cCCcccccccCCCccCChhhhhcC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCC--CCCC
Q 000535 171 EADVNTHSVVGTPYWMAPEVIEMS-----GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESL 243 (1437)
Q Consensus 171 esd~kt~t~~GTp~YmAPEVL~g~-----~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppi--P~~I 243 (1437)
.......+.+|||.|||||++... .|+.++|+||||++..||--|.||+.+..+...++.|....++.+ |...
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kW 254 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKW 254 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhH
Confidence 776677789999999999999643 478899999999999999999999999999988888877665543 5678
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 244 SpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+.++.+||..||.+|.++||+..++|.|||+.+
T Consensus 255 s~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 255 SKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 999999999999999999999999999999963
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=337.79 Aligned_cols=247 Identities=29% Similarity=0.522 Sum_probs=218.8
Q ss_pred EEEeEecccCcEEEEEEEEcCC----CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 21 MLGDEIGKGAYGRVYKGLDLEN----GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 21 eIlEvLGrGgFGtVYKArDrkT----Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.+.+.||.|.||.||+|..... .--||||..+.... ..+.+.|..|.-+|+.++||||++++|+|.+ ...||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 4456789999999999986432 34589998876543 3457889999999999999999999999965 5789999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|.++.|.|+.+++.++ ..|+......|.+||+.||.|||+.++|||||-..|||+.....|||+|||+++.+....++.
T Consensus 470 EL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred ecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999999999998765 569999999999999999999999999999999999999999999999999999988766544
Q ss_pred ccc-cCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 000535 177 HSV-VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 177 ~t~-~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkC 254 (1437)
.+. .-..-|||||.++-..++.++|||.||+++||++. |..||.+....+.+..+.++.+.|.|+.|++.+..|+.+|
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKC 628 (974)
T ss_pred ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHH
Confidence 332 22345999999999999999999999999999986 9999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCHHHHhc
Q 000535 255 FKKDARQRPDAKTLLS 270 (1437)
Q Consensus 255 LqkDPeKRPSAeELLk 270 (1437)
|+++|.+||.+.+|..
T Consensus 629 WayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 629 WAYEPSKRPRFTEIKA 644 (974)
T ss_pred hccCcccCCcHHHHHH
Confidence 9999999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=346.55 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=213.1
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LY 93 (1437)
.+.+.|.+...+|.|+|+.|-.+.+..+++.+++|++.+.. ....+|+.++... +||||+++++++.+..+.|
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 35667999999999999999999999999999999998652 1233566555444 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEe-ccCCcEEEEecccccccccC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILT-TKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILL-denG~VKLiDFGLAr~L~es 172 (1437)
+|||++.|+.+.+.+...+ ....++..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999999999988887543 3337888999999999999999999999999999999 68899999999999987654
Q ss_pred CcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 000535 173 DVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252 (1437)
Q Consensus 173 d~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIr 252 (1437)
..+.|-|..|.|||++...+|+.++||||||++||+||+|+.||........+...+. .+++...+|.++++||.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~--~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ--MPKFSECVSDEAKDLLQ 544 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc--CCccccccCHHHHHHHH
Confidence 3456778999999999999999999999999999999999999987666644444433 33444789999999999
Q ss_pred HHhhhcccCCCCHHHHhcCHHH
Q 000535 253 QCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkHPWF 274 (1437)
.||+.||.+||++.+++.||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=363.13 Aligned_cols=255 Identities=31% Similarity=0.524 Sum_probs=204.0
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE--------
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK-------- 87 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfe-------- 87 (1437)
+..+|+.++.||+||||.||+|+++-+|..||||+|.... +......+.+|+.++.+|+|||||+|+..+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 4556788999999999999999999999999999999876 6677788999999999999999999883210
Q ss_pred ------------------------------------------------e-------------------------------
Q 000535 88 ------------------------------------------------T------------------------------- 88 (1437)
Q Consensus 88 ------------------------------------------------d------------------------------- 88 (1437)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ------------------------C--------CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 000535 89 ------------------------R--------SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136 (1437)
Q Consensus 89 ------------------------d--------~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLH 136 (1437)
+ -.+||=||||+.-.+.+++..+.+.. ....+|++++||+.||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 0 13789999999988888887654322 47789999999999999999
Q ss_pred HCCcccccccCCceEeccCCcEEEEecccccccc------------------cCCcccccccCCCccCChhhhhcCC---
Q 000535 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLT------------------EADVNTHSVVGTPYWMAPEVIEMSG--- 195 (1437)
Q Consensus 137 SnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~------------------esd~kt~t~~GTp~YmAPEVL~g~~--- 195 (1437)
++|||||||||.|||+++++.|||+|||+|+... .+.....+.+||.-|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 0111334578999999999997665
Q ss_pred CCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCC----CHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 196 VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL----SPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 196 yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~I----SpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
|+.|+||||||+||+||+. ||...-+......-+.....|.+..+ -+.-..+|+.||+.||.+||||.|+|++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 9999999999999999984 46443332222222233333333211 2455789999999999999999999999
Q ss_pred HHHH
Q 000535 272 PWIQ 275 (1437)
Q Consensus 272 PWFQ 275 (1437)
.|+.
T Consensus 872 ~llp 875 (1351)
T KOG1035|consen 872 ELLP 875 (1351)
T ss_pred cCCC
Confidence 8886
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.49 Aligned_cols=254 Identities=31% Similarity=0.589 Sum_probs=218.0
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEee
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEY 98 (1437)
.+.++.||.|+.|+||+++.+.+|...|||.+.... ..++.+++...+.++... .+|+||+.+++|..+..+++.||.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 356788999999999999999999999999998665 456677787888876655 599999999999999999999998
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|.- .+..+++. -.++++|..+-.+...+++||.||.. +||+|||+||+|||+++.|++||||||++-++.+.....
T Consensus 173 Ms~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht- 249 (391)
T KOG0983|consen 173 MST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT- 249 (391)
T ss_pred HHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc-
Confidence 842 45555553 34789999999999999999999996 589999999999999999999999999998887665333
Q ss_pred cccCCCccCChhhhhc---CCCCccchhhhHHHHHHHHHhCCCCCCC-CCChhHHHHHhhcCCCCCC--CCCCHHHHHHH
Q 000535 178 SVVGTPYWMAPEVIEM---SGVCAASDIWSVGCTVIELLTCVPPYYE-LQPMPALFRIVQDERPPIP--ESLSPDITDFL 251 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g---~~yS~KSDIWSLG~ILYELLTGkpPF~g-~d~~eqL~kIiq~~rppiP--~~ISpELkDLI 251 (1437)
...|-+.|||||.+.- ..|+.++||||||++++||.||..||.+ ..+.+.+.+++....+.++ ..+|+.+.+|+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFV 329 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHH
Confidence 4578999999999854 3689999999999999999999999986 4567788888886665555 34899999999
Q ss_pred HHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 252 RQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
..||++|+.+||.+.++|+|||+...
T Consensus 330 ~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 330 KDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHhhcCcccCcchHHHhcCcceeec
Confidence 99999999999999999999998643
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.65 Aligned_cols=260 Identities=31% Similarity=0.476 Sum_probs=210.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCC----eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCe
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENG----DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT-RSH 91 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTG----k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed-d~~ 91 (1437)
...|++...||+|+||.||+|...+++ +.||||.++-+.....--....||+.+++.+.||||+.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457999999999999999999766543 379999987653222222456799999999999999999999876 899
Q ss_pred EEEEEeecCCCCHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC----CcEEEEecc
Q 000535 92 LHIILEYVENGSLANIIKPN---KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE----GLVKLADFG 164 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKss---r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden----G~VKLiDFG 164 (1437)
+|+++||.+. +|+++|+-. +...++...+..|+.||+.|+.|||++-|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999986 999999643 23579999999999999999999999999999999999999987 899999999
Q ss_pred cccccccCCc---ccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCC---------ChhHHHHH
Q 000535 165 VATKLTEADV---NTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQ---------PMPALFRI 231 (1437)
Q Consensus 165 LAr~L~esd~---kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d---------~~eqL~kI 231 (1437)
+++.+...-. ....++-|.+|+|||.+.+. .|+.+.|||+.|||+.||++-.|.|.+.. ..+++.+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 9998765432 22346789999999998765 68999999999999999999999886422 23444555
Q ss_pred hhcCCCC----------C--------------------------CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 232 VQDERPP----------I--------------------------PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 232 iq~~rpp----------i--------------------------P~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
..--..| . .+.-++...+|+.+||++||-+|.|++++++|+||+
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 4311100 0 011245688999999999999999999999999997
Q ss_pred HH
Q 000535 276 NC 277 (1437)
Q Consensus 276 e~ 277 (1437)
+.
T Consensus 342 ~d 343 (438)
T KOG0666|consen 342 ED 343 (438)
T ss_pred cC
Confidence 53
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=304.95 Aligned_cols=257 Identities=30% Similarity=0.482 Sum_probs=221.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
.+|.-.++||+|.||+||+|+++.+++.||+|.++.....+.-.....+||.+++.|+|.|||+++++..+++.+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35777899999999999999999999999999999877666556678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
||.. +|..+...- .+.++.+.++.++.|++.||.|+|++++.|||+||+|+||+.+|.+|++|||+++.++-+-.-..
T Consensus 82 ~cdq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HhhH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 9976 888887754 47899999999999999999999999999999999999999999999999999998764421122
Q ss_pred cccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCC------------------
Q 000535 178 SVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERP------------------ 237 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rp------------------ 237 (1437)
.-+-|.+|.+|.++.+. -|+...|+||.|||+.|+.. |.+.|++.+-.+++.+|...-..
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 34569999999998765 48889999999999999986 89999999989998888652111
Q ss_pred -CCC---------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 238 -PIP---------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 238 -piP---------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.+| +.++..-.+++.++|.-+|.+|.+++..++||||..
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 011 223455789999999999999999999999999953
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=321.72 Aligned_cols=260 Identities=27% Similarity=0.466 Sum_probs=237.1
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYL 94 (1437)
.+.|.++.+||+|+|++|..++..++.+.||+|+++++-.. +++++-+..|-.+..+. +||.+|.++.+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46799999999999999999999999999999999987654 46778888899998887 79999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
|.||++||+|--.++++ .+++|+.++.|...|+.||.|||+.||++||||.+|||++..|++||+|+|+++.--.++.
T Consensus 329 vieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 99999999998777654 4799999999999999999999999999999999999999999999999999987655666
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCC-------CCCChhHHHHHhhcCCCCCCCCCCHHH
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY-------ELQPMPALFRIVQDERPPIPESLSPDI 247 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~-------g~d~~eqL~kIiq~~rppiP~~ISpEL 247 (1437)
.+.++||||.|.|||++++..|+..+|+|+||++|+||+.|+.||. ..+..+.+++++......+|..+|-.+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvka 486 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKA 486 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhh
Confidence 7788999999999999999999999999999999999999999994 345567788888888888999999999
Q ss_pred HHHHHHHhhhcccCCC------CHHHHhcCHHHHHHH
Q 000535 248 TDFLRQCFKKDARQRP------DAKTLLSHPWIQNCR 278 (1437)
Q Consensus 248 kDLIrkCLqkDPeKRP------SAeELLkHPWFQe~r 278 (1437)
..+++..|++||.+|. .+.++..|+||+..-
T Consensus 487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 9999999999999996 578999999998653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=327.85 Aligned_cols=261 Identities=30% Similarity=0.474 Sum_probs=218.3
Q ss_pred cccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-C-CC----cce
Q 000535 8 SAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-H-KN----IVK 81 (1437)
Q Consensus 8 s~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-H-PN----IVK 81 (1437)
..|..+..+.++|.+++.+|+|.||.|-++.+..++..||+|+++-- ....+..+-|+.+|.++. + |+ +|.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 45677889999999999999999999999999999999999998632 233344567999999994 2 33 888
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-------
Q 000535 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK------- 154 (1437)
Q Consensus 82 LigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde------- 154 (1437)
+.+||+-.++.+||+|.+ |-|++++++.+...+++-..++.+.+|++++++|||+++++|-||||+|||+..
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 899999999999999998 559999999999999999999999999999999999999999999999999742
Q ss_pred -------------CCcEEEEecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 000535 155 -------------EGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYE 221 (1437)
Q Consensus 155 -------------nG~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g 221 (1437)
+-.|+|+|||.|+...+. ..+.+.|..|+|||++.+.+++.++||||+||||+|+++|...|..
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 225899999999986553 3567899999999999999999999999999999999999999987
Q ss_pred CCChhHH---HHHhhcCCC------------------CCCC----------------------CC---CHHHHHHHHHHh
Q 000535 222 LQPMPAL---FRIVQDERP------------------PIPE----------------------SL---SPDITDFLRQCF 255 (1437)
Q Consensus 222 ~d~~eqL---~kIiq~~rp------------------piP~----------------------~I---SpELkDLIrkCL 255 (1437)
.++.+.+ .++.. ..| .++. .- -.++.+||++||
T Consensus 312 Hen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 312 HENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred CCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 7655532 22221 100 0000 00 135889999999
Q ss_pred hhcccCCCCHHHHhcCHHHHH
Q 000535 256 KKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 256 qkDPeKRPSAeELLkHPWFQe 276 (1437)
..||.+|+|+.|+|.||||..
T Consensus 391 ~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 391 EFDPARRITLREALSHPFFAR 411 (415)
T ss_pred ccCccccccHHHHhcCHHhhc
Confidence 999999999999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=326.89 Aligned_cols=247 Identities=24% Similarity=0.453 Sum_probs=220.7
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
+..+..+||.|.||.||.+.+++..-.||||.++-.. .+++.|.+|+.+|+.++|||+|+|+++|..+..+|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3456779999999999999999999999999987443 5678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t 178 (1437)
|..|+|.+++++-....++.-....++.||..|++||..+++|||||-..|+|+.++..|||+|||+++.+..+.+..+-
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 99999999999877777888888899999999999999999999999999999999999999999999998876554432
Q ss_pred c-cCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 000535 179 V-VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 179 ~-~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLq 256 (1437)
. .-..-|.|||.+....++.++|||+||++|||+.| |-.||.+.+-...+.-..++.+..-|..|++.+..||++||+
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~ 504 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWN 504 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhc
Confidence 1 22445999999999999999999999999999998 888998877655555556677888899999999999999999
Q ss_pred hcccCCCCHHHH
Q 000535 257 KDARQRPDAKTL 268 (1437)
Q Consensus 257 kDPeKRPSAeEL 268 (1437)
++|..||++.|+
T Consensus 505 WsPsDRPsFaei 516 (1157)
T KOG4278|consen 505 WSPSDRPSFAEI 516 (1157)
T ss_pred CCcccCccHHHH
Confidence 999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=331.70 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=179.1
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCC----CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEE------
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLEN----GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS------ 85 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkT----Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigV------ 85 (1437)
-.++|.+.+.||+|+||.||+|.+..+ +..||+|.+...... +....| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 356899999999999999999999888 999999987643211 111111 1222222222222221
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccC
Q 000535 86 LKTRSHLHIILEYVENGSLANIIKPNKFG------------------PFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKG 147 (1437)
Q Consensus 86 fedd~~LYLVMEYceGGSL~DLLKssr~G------------------pLSEs~I~rILrQILsALaYLHSnGIVHRDLKP 147 (1437)
...+..+|+||||+.+++|.+++...... ...+..+..|+.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 24567899999999999999998754211 112345678999999999999999999999999
Q ss_pred CceEecc-CCcEEEEecccccccccCC-cccccccCCCccCChhhhhcC----------------------CCCccchhh
Q 000535 148 ANILTTK-EGLVKLADFGVATKLTEAD-VNTHSVVGTPYWMAPEVIEMS----------------------GVCAASDIW 203 (1437)
Q Consensus 148 ENILLde-nG~VKLiDFGLAr~L~esd-~kt~t~~GTp~YmAPEVL~g~----------------------~yS~KSDIW 203 (1437)
+|||++. ++.+||+|||+++.+.... ......++++.|+|||.+... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 5799999999998654322 223457899999999976432 234567999
Q ss_pred hHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCC-------CCC--------------CCCCHHHHHHHHHHhhhcccCC
Q 000535 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERP-------PIP--------------ESLSPDITDFLRQCFKKDARQR 262 (1437)
Q Consensus 204 SLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rp-------piP--------------~~ISpELkDLIrkCLqkDPeKR 262 (1437)
||||+||||+++..|+. .....+.+++..... ..+ ...+....+||.+||++||++|
T Consensus 364 SlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999999765543 222222222211100 000 1122345689999999999999
Q ss_pred CCHHHHhcCHHHHH
Q 000535 263 PDAKTLLSHPWIQN 276 (1437)
Q Consensus 263 PSAeELLkHPWFQe 276 (1437)
||+.++|+||||+.
T Consensus 442 ~ta~e~L~Hpff~~ 455 (566)
T PLN03225 442 ISAKAALAHPYFDR 455 (566)
T ss_pred CCHHHHhCCcCcCC
Confidence 99999999999965
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=335.59 Aligned_cols=246 Identities=31% Similarity=0.539 Sum_probs=203.5
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS------ 90 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~------ 90 (1437)
.+.|..-+.||+||||.||+++++.+|..||||.++... .....++..+|+++|++|+|||||+++++-+...
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 477999999999999999999999999999999988654 3456778899999999999999999999876543
Q ss_pred eEEEEEeecCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEec--cCC--cEEEEeccc
Q 000535 91 HLHIILEYVENGSLANIIKPNK-FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTT--KEG--LVKLADFGV 165 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr-~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLd--enG--~VKLiDFGL 165 (1437)
...+|||||.||+|+..+++-. ...|+|..++.++.++..||.|||++||+||||||.||++- .+| .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 5679999999999999997421 23599999999999999999999999999999999999974 344 479999999
Q ss_pred ccccccCCcccccccCCCccCChhhhhc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCC----hhHHHHHhhcCC----
Q 000535 166 ATKLTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQP----MPALFRIVQDER---- 236 (1437)
Q Consensus 166 Ar~L~esd~kt~t~~GTp~YmAPEVL~g-~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~----~eqL~kIiq~~r---- 236 (1437)
|+.+.++. ...+.+||+.|.+||++.. ..|+..+|.||+||++|+..||..||..... .+..+.+.....
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 99988765 5667999999999999985 7889999999999999999999999954332 223333332211
Q ss_pred ----------------CCCCCCCCHH----HHHHHHHHhhhcccCCCC
Q 000535 237 ----------------PPIPESLSPD----ITDFLRQCFKKDARQRPD 264 (1437)
Q Consensus 237 ----------------ppiP~~ISpE----LkDLIrkCLqkDPeKRPS 264 (1437)
.|.|..+++. +...+..+|..+|++|..
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 1234444443 567788899999999984
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=323.22 Aligned_cols=270 Identities=27% Similarity=0.485 Sum_probs=225.6
Q ss_pred ccCcccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH-----HHHHHHHHHHHHhCCCCCc
Q 000535 5 TTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-----LNIIMQEIDLLKNLNHKNI 79 (1437)
Q Consensus 5 ttas~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed-----ie~L~REIkILrrLnHPNI 79 (1437)
...++|..-.++.++|.++..||+|||++||+|.|....++||||+-.......++ .+...+|..|-+.|.||.|
T Consensus 450 EdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRI 529 (775)
T KOG1151|consen 450 EDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRI 529 (775)
T ss_pred cchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCccee
Confidence 45788999999999999999999999999999999999999999987655443322 2346789999999999999
Q ss_pred ceEEEEEE-eCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCceEecc--
Q 000535 80 VKYLGSLK-TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG--VIHRDIKGANILTTK-- 154 (1437)
Q Consensus 80 VKLigVfe-dd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnG--IVHRDLKPENILLde-- 154 (1437)
|+++++|. +.+.+|-|+|||+|.+|.-+++.+ +.++|.+++.|+.||+.||.||.+.. |+|.||||.|||+-.
T Consensus 530 VKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 99999995 567899999999999999999865 56999999999999999999999874 999999999999954
Q ss_pred -CCcEEEEecccccccccCCcc-------cccccCCCccCChhhhhcC----CCCccchhhhHHHHHHHHHhCCCCCCCC
Q 000535 155 -EGLVKLADFGVATKLTEADVN-------THSVVGTPYWMAPEVIEMS----GVCAASDIWSVGCTVIELLTCVPPYYEL 222 (1437)
Q Consensus 155 -nG~VKLiDFGLAr~L~esd~k-------t~t~~GTp~YmAPEVL~g~----~yS~KSDIWSLG~ILYELLTGkpPF~g~ 222 (1437)
.|.+||+|||+++.+..+... +....||.+|++||++.-. ..+.++||||+|+|+|.++.|+.||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 478999999999987654322 2246899999999988433 4678999999999999999999999765
Q ss_pred CChhHHHH---HhhcCC--CCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 223 QPMPALFR---IVQDER--PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 223 d~~eqL~k---Iiq~~r--ppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.....+.. |++... .|..+.+++++++||++||++--+.|....++..||||..
T Consensus 688 qsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 688 QSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 44333222 222222 2333578999999999999999999999999999999964
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.87 Aligned_cols=263 Identities=29% Similarity=0.465 Sum_probs=214.5
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--- 88 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfed--- 88 (1437)
+.-...+.|+-...||+|.||+||+|+..++++.||+|++..+.-...--....+|+++|..|+|+|++.++++|..
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 33344778999999999999999999999999999999776543222223456799999999999999999987742
Q ss_pred -----CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEec
Q 000535 89 -----RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADF 163 (1437)
Q Consensus 89 -----d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDF 163 (1437)
...+|+||++|+. +|.-++.. +..+|+...+..++.++..||.|+|++.|+|||+||+|+||+.+|.+||+||
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 3569999999986 89988864 3467999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCc----ccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC--C
Q 000535 164 GVATKLTEADV----NTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE--R 236 (1437)
Q Consensus 164 GLAr~L~esd~----kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~--r 236 (1437)
|+++.+..... .....+-|.+|++||.+.+. .|+.+.|||..||||.+|+++.+-|.+.....++.-|.... .
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99976643321 11234569999999988654 69999999999999999999999998888777766553311 0
Q ss_pred -------------------CCCCC-------------CCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 237 -------------------PPIPE-------------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 237 -------------------ppiP~-------------~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+|++. .-+++..+|+.++|..||.+|+++.++++|.||..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 11211 01357899999999999999999999999999964
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=328.27 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=227.0
Q ss_pred ceEEEeEecccCcEEEEEEEEcCC-C--eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLEN-G--DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkT-G--k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
+.++.+.||+|.||.|++|.+... | -.||||.++...... ....|.+|+.+|.+|+|||+++||++..+ ..+.+|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 467788999999999999998753 4 358999998766554 67889999999999999999999999987 788899
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
||.++.|+|.+.++......|.......|+.||+.|+.||.++++|||||-..|+|+-....|||+|||+.+-+...+..
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999999998877788999999999999999999999999999999999999999999999999999988765422
Q ss_pred c-c--cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHH
Q 000535 176 T-H--SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFL 251 (1437)
Q Consensus 176 t-~--t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLI 251 (1437)
. . ...-...|+|||.++...|+.++|+|++||++|||++ |..||.+......+.++..+.+.+.|+.|+.++.+++
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~im 348 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIM 348 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHH
Confidence 1 1 1122445999999999999999999999999999998 8999999999999999998889999999999999999
Q ss_pred HHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 252 RQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
..||..+|.+||++..|.+.-+.++
T Consensus 349 k~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 349 KNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHhccCCccccccHHHHHHhHHHHh
Confidence 9999999999999999976545543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=298.82 Aligned_cols=254 Identities=27% Similarity=0.498 Sum_probs=213.9
Q ss_pred cCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CeE
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTR--SHL 92 (1437)
Q Consensus 16 LggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd--~~L 92 (1437)
-.++|++...+|+|.|++||.|++..++..++||+++. -..+.+.+|++||..|. ||||++++++..+. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 35689999999999999999999999999999999874 33467899999999995 99999999999774 567
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-cEEEEeccccccccc
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKLADFGVATKLTE 171 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-~VKLiDFGLAr~L~e 171 (1437)
.+|+||+.+.+...+.. .|+...++.+++++++||.|+|++||+|||+||.|++|+... .++|+|||+|.++.+
T Consensus 111 aLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 89999999988777653 688999999999999999999999999999999999999764 799999999999887
Q ss_pred CCcccccccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCC-CCCChhHHHHHhhcC--------------
Q 000535 172 ADVNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYY-ELQPMPALFRIVQDE-------------- 235 (1437)
Q Consensus 172 sd~kt~t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~-g~d~~eqL~kIiq~~-------------- 235 (1437)
.... ...+.+.+|..||.+.+. .|+..-|+|||||++..|+..+.||. +.+..+++.+|.+--
T Consensus 186 ~~eY-nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 186 GKEY-NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred Ccee-eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 6532 335678899999998655 57888999999999999999887774 666777776664310
Q ss_pred --------------CCC--------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHHHH
Q 000535 236 --------------RPP--------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA 280 (1437)
Q Consensus 236 --------------rpp--------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~rrs 280 (1437)
+.+ -..-.++++.+|+.++|.+|-.+|+|+.|++.||||......
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 000 012246999999999999999999999999999999876543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=327.13 Aligned_cols=252 Identities=27% Similarity=0.478 Sum_probs=227.8
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCC---eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENG---DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTG---k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYL 94 (1437)
....|.++||.|-||+||+++-+..| ..||||.++.. ..+.+...|..|+.||-++.||||++|.++....+.+.|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 34589999999999999999877655 56999999754 456677789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
|+|||++|+|..+|+.+. +.|+.-+..-.++.|+.|++||-++|+|||||-..|||++.+-..|++|||+++.+.++..
T Consensus 708 iTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred EhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999999876 6799999999999999999999999999999999999999999999999999998865542
Q ss_pred cccccc---CCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHH
Q 000535 175 NTHSVV---GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 175 kt~t~~---GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDL 250 (1437)
...+.. -..+|.|||.+....++.++||||+|++|||.++ |..||++..+.+.+..+.++.+.|-|.+||..+.+|
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qL 866 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQL 866 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHH
Confidence 222222 2367999999999999999999999999999876 999999999999999999999999999999999999
Q ss_pred HHHHhhhcccCCCCHHHHhcC
Q 000535 251 LRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 251 IrkCLqkDPeKRPSAeELLkH 271 (1437)
+..||++|-.+||.+.+|+..
T Consensus 867 MldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 867 MLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=337.55 Aligned_cols=237 Identities=23% Similarity=0.338 Sum_probs=189.3
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
..|...+.||+|+||.||+|++..++..||+|.+...... ...|++++++++|||||++++++.+.+..|+|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3466778999999999999999899999999988643211 1346889999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH---EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLH---SnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
||++|+|.++++ .+++..+..|+.|++.||+||| +.+|+||||||+||+++.++..++. ||........
T Consensus 764 y~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 764 YIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 999999999996 3889999999999999999999 6699999999999999998887775 6665443221
Q ss_pred ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCCh----hHHHHHhhcC-------CCCCC---
Q 000535 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM----PALFRIVQDE-------RPPIP--- 240 (1437)
Q Consensus 175 kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~----eqL~kIiq~~-------rppiP--- 240 (1437)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....+..... .+.+.
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 2346899999999999999999999999999999999999998542211 1111110000 01111
Q ss_pred ---CCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 241 ---ESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 241 ---~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
.....++.+++.+||+.+|++||++.++++
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 112235778999999999999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=314.58 Aligned_cols=261 Identities=22% Similarity=0.354 Sum_probs=190.6
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEc----------------CCCeEEEEEEeeccccCHH------------HHHHHHH
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDL----------------ENGDFVAIKQVSLENIAQE------------DLNIIMQ 66 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDr----------------kTGk~VAIKVIkke~lSee------------die~L~R 66 (1437)
.-.++|++.++||+|+||+||+|... ..++.||||.+........ ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34678999999999999999999752 2456799999865321100 1122335
Q ss_pred HHHHHHhCCCCCc-----ceEEEEEEe--------CCeEEEEEeecCCCCHHHHhccCC---------------------
Q 000535 67 EIDLLKNLNHKNI-----VKYLGSLKT--------RSHLHIILEYVENGSLANIIKPNK--------------------- 112 (1437)
Q Consensus 67 EIkILrrLnHPNI-----VKLigVfed--------d~~LYLVMEYceGGSL~DLLKssr--------------------- 112 (1437)
|+.++.++.|.++ ++++++|.. .+..|+||||+++++|.++++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777788866554 667777643 357899999999999999986421
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc-ccccccCCCccCChhh
Q 000535 113 -FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NTHSVVGTPYWMAPEV 190 (1437)
Q Consensus 113 -~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~-kt~t~~GTp~YmAPEV 190 (1437)
...+++..++.++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++..+..... ......+|+.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 11245678889999999999999999999999999999999999999999999976543221 1112345899999998
Q ss_pred hhcCC--------------------C--CccchhhhHHHHHHHHHhCCC-CCCCCCChhHH----------HHHhhcCC-
Q 000535 191 IEMSG--------------------V--CAASDIWSVGCTVIELLTCVP-PYYELQPMPAL----------FRIVQDER- 236 (1437)
Q Consensus 191 L~g~~--------------------y--S~KSDIWSLG~ILYELLTGkp-PF~g~d~~eqL----------~kIiq~~r- 236 (1437)
+.... | ..+.||||+||++|+|++|.. ||......... .+......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 75322 1 234799999999999999875 76542221111 11111111
Q ss_pred -CCCCCCCCHHHHHHHHHHhhhcc---cCCCCHHHHhcCHHHH
Q 000535 237 -PPIPESLSPDITDFLRQCFKKDA---RQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 237 -ppiP~~ISpELkDLIrkCLqkDP---eKRPSAeELLkHPWFQ 275 (1437)
......+++..++|+.+||.++| .+|+|+.++|+||||.
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 22345678999999999999876 6899999999999994
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=251.64 Aligned_cols=213 Identities=43% Similarity=0.743 Sum_probs=189.8
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCHH
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLA 105 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL~ 105 (1437)
||.|++|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++|+++++++......+++|||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999998889999999987654322 3567889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-CCcEEEEecccccccccCCcccccccCCCc
Q 000535 106 NIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-EGLVKLADFGVATKLTEADVNTHSVVGTPY 184 (1437)
Q Consensus 106 DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-nG~VKLiDFGLAr~L~esd~kt~t~~GTp~ 184 (1437)
+++.... ..+++..++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+..............+...
T Consensus 80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 80 DLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 9997542 46899999999999999999999999999999999999999 899999999999877554322334567889
Q ss_pred cCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCC
Q 000535 185 WMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRP 263 (1437)
Q Consensus 185 YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRP 263 (1437)
|++||.+... .++.+.|+|++|+++|+| ..+.+++..|+..+|++||
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R~ 206 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKRP 206 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccCc
Confidence 9999999877 788999999999999999 7889999999999999999
Q ss_pred CHHHHhcCH
Q 000535 264 DAKTLLSHP 272 (1437)
Q Consensus 264 SAeELLkHP 272 (1437)
++.++++++
T Consensus 207 ~~~~l~~~~ 215 (215)
T cd00180 207 SAKEILEHL 215 (215)
T ss_pred CHHHHhhCC
Confidence 999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=311.86 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=213.7
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
..-.++++||+|.||+|.+|+- ..+..||+|.++... .....+.|.+||++|.+|+||||++++++|..++.+++|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3568899999999999999974 446999999987543 33445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|++.|+|.+++.++.-....-.....|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+...+++.-
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999999999876433345566778999999999999999999999999999999999999999999997765543221
Q ss_pred --cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHH--hCCCCCCCCCChhHHHHHhhc---C----CCCCCCCCCHH
Q 000535 178 --SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELL--TCVPPYYELQPMPALFRIVQD---E----RPPIPESLSPD 246 (1437)
Q Consensus 178 --t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELL--TGkpPF~g~d~~eqL~kIiq~---~----rppiP~~ISpE 246 (1437)
..+-..+|||||.+....++.++|+|++|+++||++ |...||....+.+...+.-.. . ....|.-|+..
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~ 775 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQG 775 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHH
Confidence 234567899999999999999999999999999976 477899877766555443221 1 23467789999
Q ss_pred HHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 247 LkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+.++|.+||+.|-.+||+++++ |-+|++
T Consensus 776 lyelml~Cw~~es~~RPsFe~l--h~~lq~ 803 (807)
T KOG1094|consen 776 LYELMLRCWRRESEQRPSFEQL--HLFLQE 803 (807)
T ss_pred HHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence 9999999999999999999998 444554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-33 Score=304.23 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=211.7
Q ss_pred EEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL-LKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 21 eIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkI-LrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
+-++.||.|+||+|++..++.+|+..|||.|+.... ..+..++..|.+. ++.-++||||+++|.+..++..||.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 445789999999999999999999999999987765 4455667777765 55568999999999999999999999999
Q ss_pred CCCCHHHHhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 100 ENGSLANIIK---PNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 100 eGGSL~DLLK---ssr~GpLSEs~I~rILrQILsALaYLHSn-GIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
+- ||..+.+ .-....++|..+..|....+.||.||... +|+|||+||+|||++..|.|||||||++-++...- .
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-A 223 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-A 223 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH-H
Confidence 64 6644432 23345799999999999999999999965 89999999999999999999999999998876543 2
Q ss_pred cccccCCCccCChhhhh--cCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-hhHHHHHhhcCCCCCC--C---CCCHHH
Q 000535 176 THSVVGTPYWMAPEVIE--MSGVCAASDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQDERPPIP--E---SLSPDI 247 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~--g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~-~eqL~kIiq~~rppiP--~---~ISpEL 247 (1437)
.....|-..|||||.+. +.+|+.++|+||||++|||+.||..||.+.+. .+++..+..+..+.+. . .++..+
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSM 303 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHH
Confidence 33457888999999985 44699999999999999999999999987554 4555555555544332 2 378999
Q ss_pred HHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 248 kDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
..+|..||.+|-..||.+.+++++||++..
T Consensus 304 ~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 999999999999999999999999999754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=314.22 Aligned_cols=250 Identities=30% Similarity=0.502 Sum_probs=213.9
Q ss_pred eEEEeEecccCcEEEEEEEEc---C----CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCe
Q 000535 20 YMLGDEIGKGAYGRVYKGLDL---E----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDr---k----TGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~ 91 (1437)
..+.+.||.|.||.||+|.-. . ....||||.++..... .+.+.+..|+++|+.+ .||||+.+++++..++.
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 356779999999999999732 1 1467999998766554 7788899999999999 59999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCC------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCc
Q 000535 92 LHIILEYVENGSLANIIKPNK------------F--GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGL 157 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr------------~--GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~ 157 (1437)
+++|+|||..|+|.++++..+ . ..++......+.+||+.|++||++.+++||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998664 0 13889999999999999999999999999999999999999999
Q ss_pred EEEEecccccccccCCccc-ccccC--CCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCC-ChhHHHHHh
Q 000535 158 VKLADFGVATKLTEADVNT-HSVVG--TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQ-PMPALFRIV 232 (1437)
Q Consensus 158 VKLiDFGLAr~L~esd~kt-~t~~G--Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d-~~eqL~kIi 232 (1437)
+||+|||+|+......... ....| ...|||||.+....|+.++||||+|++||||++ |..||.+.. ..+.+..+.
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~ 536 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK 536 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh
Confidence 9999999999766544332 22222 234999999999999999999999999999998 899998866 344444455
Q ss_pred hcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 233 QDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 233 q~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
.+.+...|..|++++.++++.||+.+|++||++.++.+
T Consensus 537 ~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 537 EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 66677899999999999999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=299.44 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=222.5
Q ss_pred ccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC---
Q 000535 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR--- 89 (1437)
Q Consensus 13 gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd--- 89 (1437)
..++..||.-++.+|.|.- .|-.|.|.-.+..||+|++...........+..+|..++..++|+||++++.+|.-.
T Consensus 12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 4567789999999999999 888999999999999999887766667778899999999999999999999999643
Q ss_pred ---CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccc
Q 000535 90 ---SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA 166 (1437)
Q Consensus 90 ---~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLA 166 (1437)
...|+||||+.. +|...+. -.++-..+..|++|++.|++|||+.||+||||||+||++..++.+||.|||++
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence 458999999975 9999887 34788899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC--------
Q 000535 167 TKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP-------- 238 (1437)
Q Consensus 167 r~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp-------- 238 (1437)
+.-... .....++.|..|.|||++.+.+|...+||||+||++.||++|..-|.+.+..++..+++.....+
T Consensus 166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 987655 45567899999999999999899999999999999999999999999988888877765422111
Q ss_pred ----------------------CC-----------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 239 ----------------------IP-----------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 239 ----------------------iP-----------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
+| +.-+.-+.+++.+||..+|++|.+++++|+|||++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 11 01124588999999999999999999999999996
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=320.51 Aligned_cols=256 Identities=44% Similarity=0.739 Sum_probs=231.5
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
.++|+++.++|.|+||.||+|+|+.+++..|+|+++.+.. .++..+..|+-+++..+|||||.|++.+-.+..+|+.|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 5689999999999999999999999999999999987653 45667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt 176 (1437)
|||.||+|.+.-. ..++++|.++....+..+++++|||++|=+|||||-.|||++..|.+|++|||.+..+...-.+.
T Consensus 92 EycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred EecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 9999999999876 56899999999999999999999999999999999999999999999999999999888766677
Q ss_pred ccccCCCccCChhhh---hcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCC----CCCCCCHHHHH
Q 000535 177 HSVVGTPYWMAPEVI---EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP----IPESLSPDITD 249 (1437)
Q Consensus 177 ~t~~GTp~YmAPEVL---~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rpp----iP~~ISpELkD 249 (1437)
.++.|||+|||||+- +..+|+..+|||++|++..|+-.-++|.+...+...++-.-+....+ -+...++.+-+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 789999999999986 45689999999999999999999999998888887777665544322 23567899999
Q ss_pred HHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
|++.+|.++|.+||+++.+|.|||+..
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeecc
Confidence 999999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=308.62 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=221.0
Q ss_pred CcccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC------CCCcc
Q 000535 7 TSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN------HKNIV 80 (1437)
Q Consensus 7 as~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn------HPNIV 80 (1437)
+..+..++.|.++|.+....|+|-||+|..|.+..-|..||||+|.... --.+.-.+|+.||++|+ --|++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 4567789999999999999999999999999999999999999998532 22344568999999995 35799
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-cE
Q 000535 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNK-FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LV 158 (1437)
Q Consensus 81 KLigVfedd~~LYLVMEYceGGSL~DLLKssr-~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-~V 158 (1437)
+|+..|...+++|||+|-+. .+|.++++... .-.|....++.|..|+..||.+|...||+|.||||.|||+++.. .+
T Consensus 498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence 99999999999999999985 59999998542 23488889999999999999999999999999999999999864 69
Q ss_pred EEEecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhh--cCC
Q 000535 159 KLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ--DER 236 (1437)
Q Consensus 159 KLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq--~~r 236 (1437)
||||||.|....+..+. .+.-+..|.|||++.+..|+...|+||+||+||||+||+..|++.+....+.-.+. +..
T Consensus 577 KLCDfGSA~~~~eneit--PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 577 KLCDFGSASFASENEIT--PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eeccCcccccccccccc--HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 99999999998776543 34557789999999999999999999999999999999999998777655543221 000
Q ss_pred CC---------------------------------------CC-----------CCCC-------HHHHHHHHHHhhhcc
Q 000535 237 PP---------------------------------------IP-----------ESLS-------PDITDFLRQCFKKDA 259 (1437)
Q Consensus 237 pp---------------------------------------iP-----------~~IS-------pELkDLIrkCLqkDP 259 (1437)
+. .| +.++ ..+.+|+.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 00 00 0112 358999999999999
Q ss_pred cCCCCHHHHhcCHHHHH
Q 000535 260 RQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 260 eKRPSAeELLkHPWFQe 276 (1437)
++|.|..++|.||||+.
T Consensus 735 ~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 735 EKRITVNQALKHPFITE 751 (752)
T ss_pred hhcCCHHHHhcCCcccC
Confidence 99999999999999963
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=251.13 Aligned_cols=216 Identities=37% Similarity=0.611 Sum_probs=186.5
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
|.+.+.||.|++|.||++.+..+++.+++|.+...... ...+.+.+|+..+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 67889999999999999999888999999998865433 35678889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC-ccccc
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD-VNTHS 178 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd-~kt~t 178 (1437)
.+++|.+++..... .+++..+..++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 80 EGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 99999999986532 28999999999999999999999999999999999999999999999999998876542 12234
Q ss_pred ccCCCccCChhhh-hcCCCCccchhhhHHHHHHHHHhCCCCCCC-CCChhHHHHHhhcCCC
Q 000535 179 VVGTPYWMAPEVI-EMSGVCAASDIWSVGCTVIELLTCVPPYYE-LQPMPALFRIVQDERP 237 (1437)
Q Consensus 179 ~~GTp~YmAPEVL-~g~~yS~KSDIWSLG~ILYELLTGkpPF~g-~d~~eqL~kIiq~~rp 237 (1437)
..++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. ......+.+.+....+
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 5788899999998 666788899999999999999999999977 5556566666555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=317.33 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=201.6
Q ss_pred eEEEeEecccCcEE-EEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEe
Q 000535 20 YMLGDEIGKGAYGR-VYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 20 YeIlEvLGrGgFGt-VYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVME 97 (1437)
|.-.+.+|.|+-|+ ||+|.- .|+.||||.+. .+..+...+||..|+.- .|||||++++.-.++.+.||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 33346778998876 799975 78899999875 34456788999999988 69999999999999999999999
Q ss_pred ecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc---CC--cEEEEecccccccc
Q 000535 98 YVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK---EG--LVKLADFGVATKLT 170 (1437)
Q Consensus 98 YceGGSL~DLLKss--r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde---nG--~VKLiDFGLAr~L~ 170 (1437)
.|.. +|.++++.. .......-..+.++.|+++||++||+.+||||||||+||||+. ++ .++|+|||+++.+.
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9976 999999863 1111122456788999999999999999999999999999986 33 79999999999887
Q ss_pred cCCcc---cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhC-CCCCCCCCChhHHHHHhhcCCCCC--CCCCC
Q 000535 171 EADVN---THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPI--PESLS 244 (1437)
Q Consensus 171 esd~k---t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTG-kpPF~g~d~~eqL~kIiq~~rppi--P~~IS 244 (1437)
.+... ..+..||-+|+|||++....-+.++|||||||++|+.++| ..||..... .-.+|+.+...-. .+.-.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPLPD 740 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccCch
Confidence 65422 3356899999999999988888899999999999999985 899965332 2234444432211 11111
Q ss_pred HHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHHHHhh
Q 000535 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQ 282 (1437)
Q Consensus 245 pELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~rrsLq 282 (1437)
.++.+||.+|+.++|..||++.++|.||+|......+.
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~ 778 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLS 778 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHH
Confidence 28999999999999999999999999999987665554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=292.63 Aligned_cols=261 Identities=30% Similarity=0.482 Sum_probs=204.0
Q ss_pred cccccccC-CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-----C---CCcc
Q 000535 10 FHKSKTLD-NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-----H---KNIV 80 (1437)
Q Consensus 10 F~~gktLg-gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-----H---PNIV 80 (1437)
...+.+|. +||.+.++||.|-|++||+|.|....+.||+|+.+.. +...+....||++|++++ | .+||
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 34577888 9999999999999999999999999999999998743 344466788999999982 3 3699
Q ss_pred eEEEEEEe----CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCceEeccC
Q 000535 81 KYLGSLKT----RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANILTTKE 155 (1437)
Q Consensus 81 KLigVfed----d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSn-GIVHRDLKPENILLden 155 (1437)
+|++.|.. ..+++||+|+. |.+|..+|+...+..++...+.+|++||+.||.|||+. ||+|-||||+|||+..+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 99999975 46899999999 67999999988888899999999999999999999976 99999999999997310
Q ss_pred --------------------------------------------------------------------------------
Q 000535 156 -------------------------------------------------------------------------------- 155 (1437)
Q Consensus 156 -------------------------------------------------------------------------------- 155 (1437)
T Consensus 225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n 304 (590)
T KOG1290|consen 225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN 304 (590)
T ss_pred ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 000535 156 -------------------------------------------------------------------------------- 155 (1437)
Q Consensus 156 -------------------------------------------------------------------------------- 155 (1437)
T Consensus 305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~ 384 (590)
T KOG1290|consen 305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI 384 (590)
T ss_pred cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence
Q ss_pred --C----cEEEEecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCC------
Q 000535 156 --G----LVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQ------ 223 (1437)
Q Consensus 156 --G----~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d------ 223 (1437)
. .|||+|||-|+..... ....+.|..|+|||++.+.+|+..+||||++|++|||.||...|....
T Consensus 385 ~~~~~di~vKIaDlGNACW~~kh---FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r 461 (590)
T KOG1290|consen 385 PLPECDIRVKIADLGNACWVHKH---FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR 461 (590)
T ss_pred CCCccceeEEEeeccchhhhhhh---hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence 0 1344444444433221 112356788999999999999999999999999999999998885311
Q ss_pred ChhHHHHHhh-----------cCC-----------------C-C------------CCCCCCHHHHHHHHHHhhhcccCC
Q 000535 224 PMPALFRIVQ-----------DER-----------------P-P------------IPESLSPDITDFLRQCFKKDARQR 262 (1437)
Q Consensus 224 ~~eqL~kIiq-----------~~r-----------------p-p------------iP~~ISpELkDLIrkCLqkDPeKR 262 (1437)
+.+-+..|+. ... . + ++..-..++.+|+.-||+.+|++|
T Consensus 462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR 541 (590)
T KOG1290|consen 462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR 541 (590)
T ss_pred cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence 1222222221 000 0 0 111113568999999999999999
Q ss_pred CCHHHHhcCHHHHHH
Q 000535 263 PDAKTLLSHPWIQNC 277 (1437)
Q Consensus 263 PSAeELLkHPWFQe~ 277 (1437)
|||.++|+|||+...
T Consensus 542 ~tA~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 542 PTAAQCLKHPWLNPV 556 (590)
T ss_pred ccHHHHhcCccccCC
Confidence 999999999999754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-31 Score=290.06 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=212.3
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CeEEE
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR-----SHLHI 94 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd-----~~LYL 94 (1437)
.+--+.||.|+||.||.+.|..+|+.||+|++..-..+--..+++.+|+++|..++|.|++..++..+-. ..+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 4445789999999999999999999999999875444444567889999999999999999999987644 34788
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCc
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~ 174 (1437)
|+|.+.. +|..+|..- .+++.+.+.-+++||+.||+|||+.+|.||||||.|+|++.|..+||||||+++....++.
T Consensus 135 ~TELmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 9999854 888888743 5799999999999999999999999999999999999999999999999999998766543
Q ss_pred ccc-cccCCCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-----------------
Q 000535 175 NTH-SVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE----------------- 235 (1437)
Q Consensus 175 kt~-t~~GTp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~----------------- 235 (1437)
... .-+-|-+|+|||++.+. .|+.++||||+|||+.|++..+..|....+.+++.-|...-
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 322 23568899999999875 58999999999999999999999998888777766543311
Q ss_pred ----CCCCC------------CCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHHH
Q 000535 236 ----RPPIP------------ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279 (1437)
Q Consensus 236 ----rppiP------------~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~rr 279 (1437)
.++.+ ..-..+...++.++|..||++|.+..+.+.|+|..+.+-
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 01111 122357889999999999999999999999999976543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=294.87 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=214.3
Q ss_pred eEEEeEecccCcEEEEEEEEcCCC----eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENG----DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTG----k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
.+-.++||.|+||+||++.+...| .+||||++.... ..+....+..|+-+|.+|+|||++++++++.... +-||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 445678999999999999987655 468999886543 3344567889999999999999999999997765 8899
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
++|+++|+|.++++.++ +.+-.+....|.+||++||.|||.+++|||||-..|||+.+-..+||.|||+++.+......
T Consensus 776 tq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999999764 67999999999999999999999999999999999999999999999999999988765432
Q ss_pred cc--cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 000535 176 TH--SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252 (1437)
Q Consensus 176 t~--t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIr 252 (1437)
.. ...-.+-|||=|.+....|+.++||||+||++||++| |..|+.+....+.-.-+.++.+.+.|+.++-++..++.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 22 2223455999999999999999999999999999998 99999887766665556667788889999999999999
Q ss_pred HHhhhcccCCCCHHHHhc
Q 000535 253 QCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLk 270 (1437)
+||..|+..||+++++..
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999999865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=294.59 Aligned_cols=199 Identities=33% Similarity=0.493 Sum_probs=177.9
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH------HHHHHHHHHHHHHHhCC---CCCcceEEEEEEeC
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ------EDLNIIMQEIDLLKNLN---HKNIVKYLGSLKTR 89 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe------edie~L~REIkILrrLn---HPNIVKLigVfedd 89 (1437)
.|..+++||.|+||.|++|.++.+...|+||.|.+++.-. .....+-.||.||.+|+ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 4899999999999999999999999999999999876432 23344667999999997 99999999999999
Q ss_pred CeEEEEEeec-CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 90 SHLHIILEYV-ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 90 ~~LYLVMEYc-eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
+++||+||-. +|-+|+++|... ..++|.++..|++|++.|+++||+.||||||||-+||.++.+|.+||+|||.+..
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 9999999964 456899999865 4699999999999999999999999999999999999999999999999999988
Q ss_pred cccCCcccccccCCCccCChhhhhcCCC-CccchhhhHHHHHHHHHhCCCCCCC
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVPPYYE 221 (1437)
Q Consensus 169 L~esd~kt~t~~GTp~YmAPEVL~g~~y-S~KSDIWSLG~ILYELLTGkpPF~g 221 (1437)
..... ...++||..|.|||++.+..| +..-|||+||++||.++....||+.
T Consensus 720 ~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 76553 346899999999999999887 5667999999999999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-27 Score=230.96 Aligned_cols=253 Identities=36% Similarity=0.625 Sum_probs=211.1
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH-HHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCeEEEEEe
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE-DLNIIMQEIDLLKNLNHK-NIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee-die~L~REIkILrrLnHP-NIVKLigVfedd~~LYLVME 97 (1437)
|.+.+.||.|+|+.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 8899999987665543 567789999999999988 79999999988888999999
Q ss_pred ecCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-cEEEEecccccccccCCc-
Q 000535 98 YVENGSLANIIKPNKF-GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKLADFGVATKLTEADV- 174 (1437)
Q Consensus 98 YceGGSL~DLLKssr~-GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-~VKLiDFGLAr~L~esd~- 174 (1437)
|+.++++.+++..... ..+++.....++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977764422 2699999999999999999999999999999999999999998 799999999986654432
Q ss_pred -----ccccccCCCccCChhhhhc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCC---hhHHHHHhhcCCCC-CCCC
Q 000535 175 -----NTHSVVGTPYWMAPEVIEM---SGVCAASDIWSVGCTVIELLTCVPPYYELQP---MPALFRIVQDERPP-IPES 242 (1437)
Q Consensus 175 -----kt~t~~GTp~YmAPEVL~g---~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~---~eqL~kIiq~~rpp-iP~~ 242 (1437)
.....+||..|++||.+.. ..+....|+||+|++++++++|..||..... .......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356789999999999987 5788899999999999999999999877654 34444444333322 2211
Q ss_pred C--------CHHHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 243 L--------SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 243 I--------SpELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
. ...+.+++..++..+|..|.+..+...++|..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 2 15789999999999999999999998886654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=277.19 Aligned_cols=252 Identities=27% Similarity=0.495 Sum_probs=200.5
Q ss_pred cccccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHh--CCCCCcceEEEE
Q 000535 8 SAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKN--LNHKNIVKYLGS 85 (1437)
Q Consensus 8 s~F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrr--LnHPNIVKLigV 85 (1437)
-++=..+++..+..+.+.||+|.||+||+|.+ .|+.||||++.. .+.....+|.+|.+. |+|+||+.+++.
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhc
Confidence 34445678899999999999999999999987 789999999863 233557788888877 499999999986
Q ss_pred EEeC----CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccccCCceEec
Q 000535 86 LKTR----SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ--------GVIHRDIKGANILTT 153 (1437)
Q Consensus 86 fedd----~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSn--------GIVHRDLKPENILLd 153 (1437)
-..+ ..+|||++|.+.|||+|++.+ ..++-.....++..++.||+|||-. .|.|||||..|||+.
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 5332 368999999999999999985 4799999999999999999999943 499999999999999
Q ss_pred cCCcEEEEecccccccccCC----cccccccCCCccCChhhhhcCC----C--CccchhhhHHHHHHHHHhC--------
Q 000535 154 KEGLVKLADFGVATKLTEAD----VNTHSVVGTPYWMAPEVIEMSG----V--CAASDIWSVGCTVIELLTC-------- 215 (1437)
Q Consensus 154 enG~VKLiDFGLAr~L~esd----~kt~t~~GTp~YmAPEVL~g~~----y--S~KSDIWSLG~ILYELLTG-------- 215 (1437)
++|...|+|+|+|....... ......+||.+|||||++...- + -..+||||||.|+||+...
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 99999999999998765542 2344679999999999986441 2 2458999999999999852
Q ss_pred --CCCCCCCCC----hhHHHHHh--hcCCCCCCCCCC-----HHHHHHHHHHhhhcccCCCCHHHHh
Q 000535 216 --VPPYYELQP----MPALFRIV--QDERPPIPESLS-----PDITDFLRQCFKKDARQRPDAKTLL 269 (1437)
Q Consensus 216 --kpPF~g~d~----~eqL~kIi--q~~rppiP~~IS-----pELkDLIrkCLqkDPeKRPSAeELL 269 (1437)
.+||++.-+ .+...+++ +..+|.+|.... ..+..+|+.||..+|.-|.|+--|-
T Consensus 431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 431 EYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred hhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 578875433 33344432 334555554432 3467889999999999999988663
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=301.26 Aligned_cols=203 Identities=19% Similarity=0.215 Sum_probs=152.5
Q ss_pred HhCCC-CCcceEEEEE-------EeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 000535 72 KNLNH-KNIVKYLGSL-------KTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143 (1437)
Q Consensus 72 rrLnH-PNIVKLigVf-------edd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHR 143 (1437)
+.+.| +||++++++| .....++++|||+ +++|.+++... ...+++..++.|++||+.||.|||++||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 35556 5888888887 2335678889987 56999999743 3569999999999999999999999999999
Q ss_pred cccCCceEeccCC-------------------cEEEEecccccccccCC----------------cccccccCCCccCCh
Q 000535 144 DIKGANILTTKEG-------------------LVKLADFGVATKLTEAD----------------VNTHSVVGTPYWMAP 188 (1437)
Q Consensus 144 DLKPENILLdenG-------------------~VKLiDFGLAr~L~esd----------------~kt~t~~GTp~YmAP 188 (1437)
||||+||||+..| .+||+|||+++...... ......+||++||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 45566666665321100 001124689999999
Q ss_pred hhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHH
Q 000535 189 EVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTL 268 (1437)
Q Consensus 189 EVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeEL 268 (1437)
|++.+..|+.++|||||||+||||++|.+||..... ....+.....++......+...+++.+||.++|.+||++.++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 999999999999999999999999999988754321 122222222222212235667899999999999999999999
Q ss_pred hcCHHHHHHH
Q 000535 269 LSHPWIQNCR 278 (1437)
Q Consensus 269 LkHPWFQe~r 278 (1437)
++||||.+..
T Consensus 263 l~h~~~~~~~ 272 (793)
T PLN00181 263 LQSEFINEPR 272 (793)
T ss_pred hhchhhhhhh
Confidence 9999998653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=278.40 Aligned_cols=259 Identities=28% Similarity=0.517 Sum_probs=207.9
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcC---CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLE---NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLK 87 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrk---TGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfe 87 (1437)
....+.+.|.++++||.|.|++||+|.+.. .+..||+|.+... ....++..|+++|..+ .+.||+++.+++.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 355677889999999999999999999887 7899999998754 3345688999999999 6999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-CCcEEEEecccc
Q 000535 88 TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-EGLVKLADFGVA 166 (1437)
Q Consensus 88 dd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-nG~VKLiDFGLA 166 (1437)
.++...+||||++..+..++.. .++...+..|++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 9999999999999989888875 4678899999999999999999999999999999999985 467889999999
Q ss_pred cccccCC----------------------------------cc----------cccccCCCccCChhhhhc-CCCCccch
Q 000535 167 TKLTEAD----------------------------------VN----------THSVVGTPYWMAPEVIEM-SGVCAASD 201 (1437)
Q Consensus 167 r~L~esd----------------------------------~k----------t~t~~GTp~YmAPEVL~g-~~yS~KSD 201 (1437)
....... .. .....||++|.|||++.. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7221000 00 012469999999999854 45788999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCC-ChhHHHHHhh--------------cC------------------------------C
Q 000535 202 IWSVGCTVIELLTCVPPYYELQ-PMPALFRIVQ--------------DE------------------------------R 236 (1437)
Q Consensus 202 IWSLG~ILYELLTGkpPF~g~d-~~eqL~kIiq--------------~~------------------------------r 236 (1437)
|||.|+|+..++++..||.... +.+.+.+++. +. +
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999996422 2222222110 00 0
Q ss_pred C------CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHHH
Q 000535 237 P------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279 (1437)
Q Consensus 237 p------piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~rr 279 (1437)
. .....++..+.+|+.+||+.||.+|.|++|+|+||||....+
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 0 001123557999999999999999999999999999986543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=277.87 Aligned_cols=241 Identities=26% Similarity=0.477 Sum_probs=191.9
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC--CCCCcceEEEEEEeCC----e
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL--NHKNIVKYLGSLKTRS----H 91 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL--nHPNIVKLigVfedd~----~ 91 (1437)
....+.+.||+|.||+||+|.- +++.||||++. ..+.+.+..|-.|.+.. +|+||++++++-+... .
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 3567788999999999999975 66999999976 45667788888887764 8999999999876544 8
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccccCCceEeccCCcEEEEe
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ---------GVIHRDIKGANILTTKEGLVKLAD 162 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSn---------GIVHRDLKPENILLdenG~VKLiD 162 (1437)
++||++|.+.|+|.++++.+ .+++....+++..+++||+|||+. .|+|||||..|||+.+|+...|+|
T Consensus 283 ywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999999865 699999999999999999999963 499999999999999999999999
Q ss_pred cccccccccCC--cccccccCCCccCChhhhhcCC-CC-----ccchhhhHHHHHHHHHhCCC------------CCC--
Q 000535 163 FGVATKLTEAD--VNTHSVVGTPYWMAPEVIEMSG-VC-----AASDIWSVGCTVIELLTCVP------------PYY-- 220 (1437)
Q Consensus 163 FGLAr~L~esd--~kt~t~~GTp~YmAPEVL~g~~-yS-----~KSDIWSLG~ILYELLTGkp------------PF~-- 220 (1437)
||+|..+.+.. ......+||.+|||||++.+.- +. .+.||||+|.+||||++... ||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998876543 2344579999999999996542 22 36799999999999998533 221
Q ss_pred --CCCChhHHHHH--hhcCCCCCCCCC-----CHHHHHHHHHHhhhcccCCCCHHHH
Q 000535 221 --ELQPMPALFRI--VQDERPPIPESL-----SPDITDFLRQCFKKDARQRPDAKTL 268 (1437)
Q Consensus 221 --g~d~~eqL~kI--iq~~rppiP~~I-----SpELkDLIrkCLqkDPeKRPSAeEL 268 (1437)
.....+.+... .+..+|.+|..+ -.-+++.+..||..||+.|.|+.=+
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 01112222222 234455555332 3568999999999999999998855
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=256.56 Aligned_cols=218 Identities=30% Similarity=0.536 Sum_probs=182.6
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEee
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~LYLVMEY 98 (1437)
..-+..||+|+||.|-+.++..+|...|+|.+.....+ .+.+++.+|+.+..+. .+|.+|.+++.+..++.+||.||.
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 44567899999999999999999999999999866544 4556677888876554 799999999999999999999999
Q ss_pred cCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCceEeccCCcEEEEecccccccccCCcc
Q 000535 99 VENGSLANIIKP--NKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 99 ceGGSL~DLLKs--sr~GpLSEs~I~rILrQILsALaYLHSn-GIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~k 175 (1437)
++- ||..+-+. ..++.++|..+-+|+..++.||.|||++ .++|||+||+||||+.+|+||+||||.+-.+.+.-.
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA- 204 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA- 204 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-
Confidence 964 77655432 2457899999999999999999999987 899999999999999999999999999988765432
Q ss_pred cccccCCCccCChhhhh----cCCCCccchhhhHHHHHHHHHhCCCCCCC-CCChhHHHHHhhcCCCCCC
Q 000535 176 THSVVGTPYWMAPEVIE----MSGVCAASDIWSVGCTVIELLTCVPPYYE-LQPMPALFRIVQDERPPIP 240 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~----g~~yS~KSDIWSLG~ILYELLTGkpPF~g-~d~~eqL~kIiq~~rppiP 240 (1437)
..-..|-..|||||.+. ..+|+.++||||||++++||.+++.||.. .++.+++.+++....+.+|
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 22246778899999884 34799999999999999999999999965 4567788888777666665
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=230.01 Aligned_cols=162 Identities=33% Similarity=0.426 Sum_probs=133.2
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccccccC
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG 181 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~G 181 (1437)
|+|.++++.. ..++++..++.|+.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g 66 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRV 66 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCC
Confidence 6899999754 356999999999999999999999998 999999999999999 9999876542 2368
Q ss_pred CCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHh-hcCCCC------CCCCCCH--HHHHHHH
Q 000535 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV-QDERPP------IPESLSP--DITDFLR 252 (1437)
Q Consensus 182 Tp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIi-q~~rpp------iP~~ISp--ELkDLIr 252 (1437)
|+.|||||++.+..++.++|||||||++|+|++|.+||............. ...... .+..++. ++.++|.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999999999999999999999999999999999997655443333222 221111 1223344 6999999
Q ss_pred HHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 253 QCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
+||..+|.+||++.++++|+|+...
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHHH
Confidence 9999999999999999999998643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=246.17 Aligned_cols=250 Identities=26% Similarity=0.292 Sum_probs=203.2
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCC-eEEEEEEeeccccCHHHHHHHHHHHHHHHhCC----CCCcceEEEEE-EeCCeE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENG-DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN----HKNIVKYLGSL-KTRSHL 92 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTG-k~VAIKVIkke~lSeedie~L~REIkILrrLn----HPNIVKLigVf-edd~~L 92 (1437)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|+.++..+. .+++..+++.+ ..+.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999987774 7899998765432221 15778999999986 36899999999 588899
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC-----CcEEEEeccccc
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE-----GLVKLADFGVAT 167 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden-----G~VKLiDFGLAr 167 (1437)
|+||+.+ |.+|.++.+....+.|+...+..++.|++.+|++||+.|++||||||+|+++... ..++|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999998 7799999977766789999999999999999999999999999999999999865 369999999998
Q ss_pred --ccccCC----c---c-cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC--
Q 000535 168 --KLTEAD----V---N-THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-- 235 (1437)
Q Consensus 168 --~L~esd----~---k-t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-- 235 (1437)
.+.... . . .....||..|+++.++.+...+.+.|+||+++++.+|+.|..||..........+.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 321111 0 1 224569999999999999999999999999999999999999997766443333332221
Q ss_pred -CCC-CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 236 -RPP-IPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 236 -rpp-iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
... .....+.++..+...+-..+...+|.+..+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 111 334566788888888888999999999987653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=250.25 Aligned_cols=253 Identities=21% Similarity=0.373 Sum_probs=199.8
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEE-EEEeCCe
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLG-SLKTRSH 91 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLig-Vfedd~~ 91 (1437)
-.+.+.|.|.+.||+|.||.+-+|+|+.+++.+++|.+...... ...+.+|..---.| .|.||+.-++ .|+..+.
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 46788999999999999999999999999999999998866543 34566776654455 5899998877 4788889
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC--CcEEEEeccccccc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE--GLVKLADFGVATKL 169 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden--G~VKLiDFGLAr~L 169 (1437)
++++||||+.|+|.+-+... .+-|.....++.|+++|+.|||++++||||||.+||||-.. ..|||||||+.+..
T Consensus 97 YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999999998754 48899999999999999999999999999999999999543 38999999999875
Q ss_pred ccCCcccccccCCCccCChhhhhcC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCChh----HHHHHhhcCCCCCC
Q 000535 170 TEADVNTHSVVGTPYWMAPEVIEMS-----GVCAASDIWSVGCTVIELLTCVPPYYELQPMP----ALFRIVQDERPPIP 240 (1437)
Q Consensus 170 ~esd~kt~t~~GTp~YmAPEVL~g~-----~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~e----qL~kIiq~~rppiP 240 (1437)
+.. ....--+..|.+||..... ..++.+|+|.||+++|.++||.+||......+ ...+..+...+..|
T Consensus 174 g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 174 GTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred Cce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 432 2222335679999987432 34678899999999999999999996433322 22233333344444
Q ss_pred ---CCCCHHHHHHHHHHhhhcccCC---CCHHHHhcCHHHH
Q 000535 241 ---ESLSPDITDFLRQCFKKDARQR---PDAKTLLSHPWIQ 275 (1437)
Q Consensus 241 ---~~ISpELkDLIrkCLqkDPeKR---PSAeELLkHPWFQ 275 (1437)
..+++.+..+.++-|..+|++| .++.......|..
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 3578999999999999999999 5666665555654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=248.71 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=217.3
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCC-----eEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-E
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENG-----DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSL-K 87 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTG-----k~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVf-e 87 (1437)
..-..|+++...+-+|.||.||.|.++..+ +.|.+|.++ ...++-++..+..|.-.+..+.|||++.+.++. +
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 344567888899999999999999876544 335566654 344566778889999999999999999999987 4
Q ss_pred eCCeEEEEEeecCCCCHHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEE
Q 000535 88 TRSHLHIILEYVENGSLANIIKP------NKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLA 161 (1437)
Q Consensus 88 dd~~LYLVMEYceGGSL~DLLKs------sr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLi 161 (1437)
+....+.++.+..-|+|..++.. .....++-.+......|++.|++|||++||+|.||-..|++|++.-+|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 55678888999988999999872 122347777888899999999999999999999999999999999999999
Q ss_pred ecccccccccCCccccc--ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCC
Q 000535 162 DFGVATKLTEADVNTHS--VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPP 238 (1437)
Q Consensus 162 DFGLAr~L~esd~kt~t--~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rpp 238 (1437)
|=.+++.+-+.++..-+ --....||+||.+....|+.++|+||||++||||+| |+.|+.+.++.+....+..+.+..
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla 518 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA 518 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence 99999988776543321 123556999999999999999999999999999998 999999999998888888888888
Q ss_pred CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 239 iP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
.|-+||.++..++..||+..|++||+++++..
T Consensus 519 QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 519 QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 89999999999999999999999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-26 Score=271.94 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=208.6
Q ss_pred Cce-EEEeEecccCcEEEEEEEEcCCCeEEEEEEeec---cccCHHHH-HHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 000535 18 NKY-MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSL---ENIAQEDL-NIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 18 gRY-eIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkk---e~lSeedi-e~L~REIkILrrLnHPNIVKLigVfedd~~L 92 (1437)
..| .....+|.|++|.|+.+......+.++.|..+. ......+. ..+..|..+-.+|.|||++..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 566789999999999998888777777776552 11222222 2377788888999999998888777766666
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
+-+||||++ +|+.++... +.+....+..++.|++.||+|||+.||.|||+||+|++++.+|.+||+|||.+..+...
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 666999999 999999854 56899999999999999999999999999999999999999999999999999776543
Q ss_pred Cc----ccccccCCCccCChhhhhcCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCChhHHH-HHh-------hcCCCCC
Q 000535 173 DV----NTHSVVGTPYWMAPEVIEMSGVCAA-SDIWSVGCTVIELLTCVPPYYELQPMPALF-RIV-------QDERPPI 239 (1437)
Q Consensus 173 d~----kt~t~~GTp~YmAPEVL~g~~yS~K-SDIWSLG~ILYELLTGkpPF~g~d~~eqL~-kIi-------q~~rppi 239 (1437)
.. ...+.+|+..|+|||++....|+.. .||||.|++++.|.+|+.||......+..+ ... ......+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 32 2346899999999999999999875 799999999999999999997655544432 111 1112234
Q ss_pred CCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 240 P~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
...++.+.+.+|.+||+.+|.+|.|+++|++.+||+...
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 456788999999999999999999999999999998753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=239.99 Aligned_cols=179 Identities=18% Similarity=0.265 Sum_probs=140.5
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcC-CCeEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCcce-EEEEE
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLE-NGDFVAIKQVSLENI---AQEDLNIIMQEIDLLKNLNHKNIVK-YLGSL 86 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrk-TGk~VAIKVIkke~l---Seedie~L~REIkILrrLnHPNIVK-LigVf 86 (1437)
+...+.++|.+.+.||+|+||+||+|++.. ++..||||++..... .......+.+|+++|++++|+|+++ ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 556788999999999999999999998876 678889998753311 2334567899999999999999985 4432
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccc-cCCceEeccCCcEEEEeccc
Q 000535 87 KTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDI-KGANILTTKEGLVKLADFGV 165 (1437)
Q Consensus 87 edd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDL-KPENILLdenG~VKLiDFGL 165 (1437)
+..|+|||||+|++|... . . .. ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-R--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-C--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 467999999999999732 2 1 11 1468899999999999999999999 99999999999999999999
Q ss_pred ccccccCCc--------ccccccCCCccCChhhhhcCC------CCccchhh
Q 000535 166 ATKLTEADV--------NTHSVVGTPYWMAPEVIEMSG------VCAASDIW 203 (1437)
Q Consensus 166 Ar~L~esd~--------kt~t~~GTp~YmAPEVL~g~~------yS~KSDIW 203 (1437)
|+.+..... ...+..+++.|++||.+.... .+...|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 987654321 113467889999999985432 33446666
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=222.56 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=207.1
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~L 92 (1437)
.+++-.|+++++||.|+||+++.+.+.-++.+||||.-.... +.-.+..|....+.| ..++|...+.+.....+-
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 478889999999999999999999999999999999765432 334577888888888 579999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-----cEEEEeccccc
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-----LVKLADFGVAT 167 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG-----~VKLiDFGLAr 167 (1437)
.||||.. |-||.|+..-- ..+|+.+.+..++.|++.-++|+|++.+|+|||||+|+||...+ .|.|+|||+|+
T Consensus 100 iLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 9999998 77888888643 35799999999999999999999999999999999999998654 69999999999
Q ss_pred ccccCCcc-------cccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhh---cCCC
Q 000535 168 KLTEADVN-------THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ---DERP 237 (1437)
Q Consensus 168 ~L~esd~k-------t~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq---~~rp 237 (1437)
.+.....+ ..+..||.+||+-....+...+.+.|+-|||-+++++|-|..||.+......-.+..+ ..+.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 87654422 2356799999999999999999999999999999999999999987654333222222 2211
Q ss_pred -C---CCCCCCHHHHHHHHHHhhhcccCCCCHHHH
Q 000535 238 -P---IPESLSPDITDFLRQCFKKDARQRPDAKTL 268 (1437)
Q Consensus 238 -p---iP~~ISpELkDLIrkCLqkDPeKRPSAeEL 268 (1437)
+ +-..+|.++..-++-.-..+..+-|.++-+
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 1 225688899999999999999999988754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-24 Score=249.37 Aligned_cols=241 Identities=29% Similarity=0.457 Sum_probs=208.9
Q ss_pred EecccCcEEEEEEEE---cCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEeecC
Q 000535 25 EIGKGAYGRVYKGLD---LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 25 vLGrGgFGtVYKArD---rkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd~~LYLVMEYce 100 (1437)
.+|+|+||.|++++. ...+..||+|+.++..........-..|..++...+ ||.+|+++..++.+...|++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 369999999998753 346788999999877655444445556788888886 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCccccccc
Q 000535 101 NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180 (1437)
Q Consensus 101 GGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~ 180 (1437)
||.|...+... ..+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++........ |
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----c 154 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----C 154 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----c
Confidence 99999988754 56889999999999999999999999999999999999999999999999999887654432 9
Q ss_pred CCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhccc
Q 000535 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260 (1437)
Q Consensus 181 GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPe 260 (1437)
||..|||||+++ ++..++|+||+|+++|+|++|..||.. ...+.+.....+.|..++..+.+++..++.++|.
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPE 227 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHH
Confidence 999999999998 788899999999999999999999987 3344455556788899999999999999999999
Q ss_pred CCCC-----HHHHhcCHHHHHHH
Q 000535 261 QRPD-----AKTLLSHPWIQNCR 278 (1437)
Q Consensus 261 KRPS-----AeELLkHPWFQe~r 278 (1437)
.|.. +.++.+|+||+...
T Consensus 228 nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 228 NRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred HHhccCcchhHHHhccchheeee
Confidence 9974 57999999998653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=209.84 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=203.7
Q ss_pred cccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCC
Q 000535 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH-KNIVKYLGSLKTRS 90 (1437)
Q Consensus 12 ~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnH-PNIVKLigVfedd~ 90 (1437)
+...+.+.|+++++||.|+||.+|.|.+..+|..||||+-..... .-.+..|.++.+.|++ ..|..+.-++.+..
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 345678999999999999999999999999999999998653321 1246788999999964 67777777888889
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc---CCcEEEEeccccc
Q 000535 91 HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK---EGLVKLADFGVAT 167 (1437)
Q Consensus 91 ~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde---nG~VKLiDFGLAr 167 (1437)
+-.+|||.. |-+|.+++.-- ...|+-..+.-++-|++.-++|+|.++++||||||+|+|..- ...+.++|||+++
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred cceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 999999998 77999888632 246899999999999999999999999999999999999863 3479999999998
Q ss_pred ccccCCc-------ccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHH---HHhhcCCC
Q 000535 168 KLTEADV-------NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALF---RIVQDERP 237 (1437)
Q Consensus 168 ~L~esd~-------kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~---kIiq~~rp 237 (1437)
.+..... ......||.+|.+-....+...+.+.|+-|+|++|.++.-|..||.+........ +|......
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 7754321 1234679999999999888888999999999999999999999998866544333 23322221
Q ss_pred C----CCCCCCHHHHHHHHHHhhhcccCCCCHHHH
Q 000535 238 P----IPESLSPDITDFLRQCFKKDARQRPDAKTL 268 (1437)
Q Consensus 238 p----iP~~ISpELkDLIrkCLqkDPeKRPSAeEL 268 (1437)
. +-+.+|.++.-.+.-|-..-.++-|....+
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 1 236789999999999999999999987744
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.6e-21 Score=198.39 Aligned_cols=143 Identities=21% Similarity=0.226 Sum_probs=111.9
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH------------------------HHHHHHHHHHHHhCCCCC
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED------------------------LNIIMQEIDLLKNLNHKN 78 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed------------------------ie~L~REIkILrrLnHPN 78 (1437)
.+.||+|+||.||+|.+. +|+.||||+++........ ......|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999999865322111 122345999999998877
Q ss_pred cceEEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccccCCceEeccCCc
Q 000535 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL-HEQGVIHRDIKGANILTTKEGL 157 (1437)
Q Consensus 79 IVKLigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYL-HSnGIVHRDLKPENILLdenG~ 157 (1437)
+.....+... ..+|||||++|+++...+.. .+++++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 6443333222 23899999998877654322 25799999999999999999999 799999999999999998 578
Q ss_pred EEEEeccccccccc
Q 000535 158 VKLADFGVATKLTE 171 (1437)
Q Consensus 158 VKLiDFGLAr~L~e 171 (1437)
++|+|||++.....
T Consensus 156 v~LiDFG~a~~~~~ 169 (190)
T cd05147 156 LYIIDVSQSVEHDH 169 (190)
T ss_pred EEEEEccccccCCC
Confidence 99999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=204.45 Aligned_cols=175 Identities=13% Similarity=0.102 Sum_probs=139.0
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH-HHH------HHHHHHHHHhCCCCCcceEEEEE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNI------IMQEIDLLKNLNHKNIVKYLGSL 86 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed-ie~------L~REIkILrrLnHPNIVKLigVf 86 (1437)
+.+.++|++.+.+|.|+||.||++.+ ++..+|+|++.......+. ... +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 46889999999999999999999755 4778999999765543332 222 57899999999999999999886
Q ss_pred EeC--------CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcE
Q 000535 87 KTR--------SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLV 158 (1437)
Q Consensus 87 edd--------~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~V 158 (1437)
... +..++||||++|.+|.++.. +++ ....+++.+|..+|+.|++|||+||+||+++.+| +
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 543 35899999999999988742 344 2456999999999999999999999999999999 9
Q ss_pred EEEecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHH
Q 000535 159 KLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELL 213 (1437)
Q Consensus 159 KLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELL 213 (1437)
+|+|||......... .. ...+....|+.++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~--a~----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRK--AK----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchh--hH----------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987653321 11 11445556778999999999876654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=208.24 Aligned_cols=235 Identities=20% Similarity=0.290 Sum_probs=155.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCC----------CCCcceEEEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLN----------HKNIVKYLGSLK 87 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLn----------HPNIVKLigVfe 87 (1437)
.+..++.||.|+|+.||.++|..+|+.+|+|+....... ...++.+++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 357788999999999999999999999999998765533 345677777775555532 223333344332
Q ss_pred ---------eC---C-----eEEEEEeecCCCCHHHHhcc---CCCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Q 000535 88 ---------TR---S-----HLHIILEYVENGSLANIIKP---NKFG--PFPESLVAVYIAQVLEGLVYLHEQGVIHRDI 145 (1437)
Q Consensus 88 ---------dd---~-----~LYLVMEYceGGSL~DLLKs---sr~G--pLSEs~I~rILrQILsALaYLHSnGIVHRDL 145 (1437)
.. . ..+++|+-+. ++|.+++.. .... .+.-.....+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 2367888775 588887642 1111 1222223456689999999999999999999
Q ss_pred cCCceEeccCCcEEEEecccccccccCCcccccccCCCccCChhhhhcC--------CCCccchhhhHHHHHHHHHhCCC
Q 000535 146 KGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMS--------GVCAASDIWSVGCTVIELLTCVP 217 (1437)
Q Consensus 146 KPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~--------~yS~KSDIWSLG~ILYELLTGkp 217 (1437)
||+|+|++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|+||..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999998876543221 3345789999987543 46788899999999999999999
Q ss_pred CCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCC
Q 000535 218 PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262 (1437)
Q Consensus 218 PF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKR 262 (1437)
||........... ....+. ++|..++.||..+|+++|++|
T Consensus 249 Pf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9975433211111 122344 789999999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-21 Score=234.27 Aligned_cols=223 Identities=30% Similarity=0.509 Sum_probs=174.0
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LY 93 (1437)
.-....|..++.|..|+||-||.++|+.+.+.+|+| |.+..+ +.|- ++.....|.+|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee-------------
Confidence 345678999999999999999999999999999995 443221 1111 22233444444
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCC
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd 173 (1437)
|+=.++++.. ++++... +.+++|+|+.||+|||+||+|++|+.-|++|++|||+.+......
T Consensus 136 --------gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 --------GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred --------chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4445555533 4555533 789999999999999999999999999999999999986532211
Q ss_pred ---------------cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC--C
Q 000535 174 ---------------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE--R 236 (1437)
Q Consensus 174 ---------------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~--r 236 (1437)
......||||.|.|||++..++|+..+|+|++|+|+|+++-|..||++..+.+.+..++... .
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 12234799999999999999999999999999999999999999999988887776665443 2
Q ss_pred CCCCCCCCHHHHHHHHHHhhhcccCCC---CHHHHhcCHHHHHH
Q 000535 237 PPIPESLSPDITDFLRQCFKKDARQRP---DAKTLLSHPWIQNC 277 (1437)
Q Consensus 237 ppiP~~ISpELkDLIrkCLqkDPeKRP---SAeELLkHPWFQe~ 277 (1437)
+.-...++++++++|.++|+.+|..|. .+-++.+|+||+..
T Consensus 278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 278 PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 223355789999999999999999994 67888999999754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=190.74 Aligned_cols=142 Identities=21% Similarity=0.261 Sum_probs=114.1
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH------------------------HHHHHHHHHHHHHhCCCCC
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE------------------------DLNIIMQEIDLLKNLNHKN 78 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee------------------------die~L~REIkILrrLnHPN 78 (1437)
.+.||+|+||.||+|.+. +|+.||||++........ ....+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 899999999986532100 0223467999999999998
Q ss_pred cceEEEEEEeCCeEEEEEeecCCCCHHHH-hccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCC
Q 000535 79 IVKYLGSLKTRSHLHIILEYVENGSLANI-IKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEG 156 (1437)
Q Consensus 79 IVKLigVfedd~~LYLVMEYceGGSL~DL-LKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG 156 (1437)
|.....+.... .||||||++|+++... +. ..++++..+..++.|++.++.++|+ .||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 75544443332 4899999998855433 33 2468899999999999999999999 9999999999999999 88
Q ss_pred cEEEEeccccccccc
Q 000535 157 LVKLADFGVATKLTE 171 (1437)
Q Consensus 157 ~VKLiDFGLAr~L~e 171 (1437)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-21 Score=234.49 Aligned_cols=243 Identities=21% Similarity=0.315 Sum_probs=186.3
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLEN--IAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~--lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVM 96 (1437)
+|...+.||.+.|=+|.+|++. ...|+||++-+.. ..-....+..+|++ .+.+++||.+++.-+...++..|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7899999999999999999863 3448899987654 23344455556666 66779999999999999999999999
Q ss_pred eecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc--cccCCc
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK--LTEADV 174 (1437)
Q Consensus 97 EYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~--L~esd~ 174 (1437)
+|+.. +|+|.+-.+++ +.+-+.+.|+.|++.||..+|..||+|||||.+||||+..+.+.|+||...+. +.+++.
T Consensus 101 qyvkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99976 99999976653 77778889999999999999999999999999999999999999999988753 333322
Q ss_pred ccc-----cccCCCccCChhhhhcC----------C-CCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCC
Q 000535 175 NTH-----SVVGTPYWMAPEVIEMS----------G-VCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERP 237 (1437)
Q Consensus 175 kt~-----t~~GTp~YmAPEVL~g~----------~-yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rp 237 (1437)
... +...-.+|.|||.+... . .+++.||||+||++.||++ |.|||. ..++..+-.+...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCcc
Confidence 111 22344569999987542 1 4678899999999999998 789884 2222222222100
Q ss_pred C----CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcC
Q 000535 238 P----IPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 238 p----iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkH 271 (1437)
. +..--+..+++||..|++.||.+|.++++.|+.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 001123478999999999999999999999975
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-19 Score=204.07 Aligned_cols=189 Identities=23% Similarity=0.380 Sum_probs=148.0
Q ss_pred CCCCcceEEEEEE---------------------------eCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHH
Q 000535 75 NHKNIVKYLGSLK---------------------------TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127 (1437)
Q Consensus 75 nHPNIVKLigVfe---------------------------dd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQ 127 (1437)
+|||||++...|. ....+|+||..... +|.+++..+ ..+....+-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence 5999999987663 23468999998875 999999754 4778888999999
Q ss_pred HHHHHHHHHHCCcccccccCCceEec--cCC--cEEEEecccccccccCCc------ccccccCCCccCChhhhhcCC--
Q 000535 128 VLEGLVYLHEQGVIHRDIKGANILTT--KEG--LVKLADFGVATKLTEADV------NTHSVVGTPYWMAPEVIEMSG-- 195 (1437)
Q Consensus 128 ILsALaYLHSnGIVHRDLKPENILLd--enG--~VKLiDFGLAr~L~esd~------kt~t~~GTp~YmAPEVL~g~~-- 195 (1437)
+++|+.|||++||.|||+|.+||||. +++ .++|+|||.|---...+. ..-+.-|....||||+....+
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999984 333 689999998854322110 112345788899999986442
Q ss_pred ----CCccchhhhHHHHHHHHHhCCCCCCCCCChhHHH-HHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHH
Q 000535 196 ----VCAASDIWSVGCTVIELLTCVPPYYELQPMPALF-RIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKT 267 (1437)
Q Consensus 196 ----yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~-kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeE 267 (1437)
-..++|.|+.|.+.||++....||+.......-. .+.+...+++|..+++.+.+++..+|+.||.+|++..-
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 1347899999999999999999998744322211 23344567889999999999999999999999998653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=186.97 Aligned_cols=189 Identities=17% Similarity=0.165 Sum_probs=144.0
Q ss_pred EEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH--HHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEe
Q 000535 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE--DLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 21 eIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee--die~L~REIkILrrLn-HPNIVKLigVfedd~~LYLVME 97 (1437)
.+...|++|+||+||.+.. .+..++.+.+........ ....+.+|+++|++|. |++|.+++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4568899999999998864 677887776654432211 1235789999999995 5889999886 34699999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccc-cCCceEeccCCcEEEEecccccccccCCc--
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDI-KGANILTTKEGLVKLADFGVATKLTEADV-- 174 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDL-KPENILLdenG~VKLiDFGLAr~L~esd~-- 174 (1437)
|+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++........
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999998765321 1 1357889999999999999999999 79999999999999999999986544321
Q ss_pred ---c--------cccccCCCccCChhhhhcC-CCC-ccchhhhHHHHHHHHHhCCCCCCCCCC
Q 000535 175 ---N--------THSVVGTPYWMAPEVIEMS-GVC-AASDIWSVGCTVIELLTCVPPYYELQP 224 (1437)
Q Consensus 175 ---k--------t~t~~GTp~YmAPEVL~g~-~yS-~KSDIWSLG~ILYELLTGkpPF~g~d~ 224 (1437)
. .+-...++.|++|+..... ..+ ...++++.|+.+|.++|+..|+.+..+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 0112368889999876543 333 456888999999999999988876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-19 Score=196.44 Aligned_cols=241 Identities=21% Similarity=0.378 Sum_probs=200.2
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeec
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEYc 99 (1437)
..+..+|...--|+.|++++ .|..+++|++.........-..+..|.-.|+-+.||||+.+++.|....++.++..|+
T Consensus 192 lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34556778888899999987 4566777888877666665667888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCceEeccCCcEEE--EecccccccccCCcc
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG--VIHRDIKGANILTTKEGLVKL--ADFGVATKLTEADVN 175 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnG--IVHRDLKPENILLdenG~VKL--iDFGLAr~L~esd~k 175 (1437)
+.|+|+.++.....--.+..++.++..+++.|++|||+.. |.---|....++|+++-..+| +|--++.+.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe------ 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE------ 343 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec------
Confidence 9999999998776666788899999999999999999985 444468889999999876544 343333221
Q ss_pred cccccCCCccCChhhhhcCCCC---ccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHh-hcCCCCCCCCCCHHHHHHH
Q 000535 176 THSVVGTPYWMAPEVIEMSGVC---AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV-QDERPPIPESLSPDITDFL 251 (1437)
Q Consensus 176 t~t~~GTp~YmAPEVL~g~~yS---~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIi-q~~rppiP~~ISpELkDLI 251 (1437)
.+..-.|.||+||.++..+-+ .++|+|||.+++||+.|...||.+..+.+.-.++. .+.+..+|+.++..+..|+
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 123347899999999877543 46799999999999999999999999988887775 4557889999999999999
Q ss_pred HHHhhhcccCCCCHHHHh
Q 000535 252 RQCFKKDARQRPDAKTLL 269 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELL 269 (1437)
+-|+..||.+||.+..++
T Consensus 423 ~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHhcCCCCcCCCcceeh
Confidence 999999999999998774
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=182.67 Aligned_cols=135 Identities=20% Similarity=0.303 Sum_probs=108.7
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---eEE-
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-----NHKNIVKYLGSLKTRS---HLH- 93 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-----nHPNIVKLigVfedd~---~LY- 93 (1437)
.+.||+|+||.||. ++.++.. +||++..... ...+.+.+|+.+++.+ .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 46899999999995 7777666 6998876432 2345689999999999 5799999999998873 544
Q ss_pred EEEee--cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccccccCCceEeccC----CcEEEEecccc
Q 000535 94 IILEY--VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGL-VYLHEQGVIHRDIKGANILTTKE----GLVKLADFGVA 166 (1437)
Q Consensus 94 LVMEY--ceGGSL~DLLKssr~GpLSEs~I~rILrQILsAL-aYLHSnGIVHRDLKPENILLden----G~VKLiDFGLA 166 (1437)
+|||| +.+|+|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+-+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 6689999999753 46666 36688888888 99999999999999999999753 37999994444
Q ss_pred c
Q 000535 167 T 167 (1437)
Q Consensus 167 r 167 (1437)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.8e-18 Score=182.00 Aligned_cols=146 Identities=21% Similarity=0.207 Sum_probs=116.3
Q ss_pred ceEEEeEecccCcEEEEEEE-EcCCCeEEEEEEeeccccCH--------------------H--HHHHHHHHHHHHHhCC
Q 000535 19 KYMLGDEIGKGAYGRVYKGL-DLENGDFVAIKQVSLENIAQ--------------------E--DLNIIMQEIDLLKNLN 75 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKAr-DrkTGk~VAIKVIkke~lSe--------------------e--die~L~REIkILrrLn 75 (1437)
-|.+.+.||+|+||.||+|. +..+|+.||+|++....... . ....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48999999999999999998 67789999999997543210 0 1134578999999997
Q ss_pred CC--CcceEEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccccCCceEe
Q 000535 76 HK--NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG-VIHRDIKGANILT 152 (1437)
Q Consensus 76 HP--NIVKLigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnG-IVHRDLKPENILL 152 (1437)
+. .+.+++++ . ..|+||||+.|++|...... ...+.+..+..++.|++.+|.+||++| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34444443 2 34899999999888765432 235677778899999999999999999 9999999999999
Q ss_pred ccCCcEEEEeccccccccc
Q 000535 153 TKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 153 denG~VKLiDFGLAr~L~e 171 (1437)
+ ++.++|+|||.+.....
T Consensus 183 ~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred E-CCCEEEEEChhhhccCC
Confidence 9 88999999999986544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=168.53 Aligned_cols=136 Identities=21% Similarity=0.259 Sum_probs=115.4
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH------HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE------DLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee------die~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
+.||+|++|.||+|++ .|..+++|+......... ....+.+|+.++..+.|++|.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 778899998664332211 22457789999999999998887777777788899999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
|++|++|.+++.... . ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999986431 2 7889999999999999999999999999999999 78899999999876
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-17 Score=206.83 Aligned_cols=195 Identities=25% Similarity=0.313 Sum_probs=160.2
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCe
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN---HKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn---HPNIVKLigVfedd~~ 91 (1437)
.-+..|.|.+.||+|+||.||+|.+.+ |+.||+|+-+.....+-.+. .+++.+|+ -+.|+.+...+.-.+.
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~-----~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC-----LQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh-----HHHHHhhchhhhcchHHHHHHHccCCc
Confidence 336789999999999999999999877 99999998765543321111 12445554 3556666666666777
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-------CCcEEEEecc
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-------EGLVKLADFG 164 (1437)
Q Consensus 92 LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-------nG~VKLiDFG 164 (1437)
-++|+||.+.|+|.+++. ..+.++|..+..++.|++..|++||..+|||+||||+|+||.. +-.++|+|||
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 899999999999999998 4467999999999999999999999999999999999999963 2259999999
Q ss_pred cccccc--cCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCC
Q 000535 165 VATKLT--EADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVP 217 (1437)
Q Consensus 165 LAr~L~--esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkp 217 (1437)
.+..+. ++.......++|-.+-.+|+..+..|++.+|.|.|..++|.||.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 996543 23334556789999999999999999999999999999999999963
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=166.26 Aligned_cols=133 Identities=22% Similarity=0.276 Sum_probs=108.3
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeeccccCH------HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ------EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 25 vLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe------edie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
.||+|+||.||+|.. ++..+++|......... ....++.+|+.+++.+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999984 67889999865432211 1235678899999999988765555555566678999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEeccccccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL 169 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L 169 (1437)
++|++|.+++.... . .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999876321 1 7899999999999999999999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-18 Score=201.02 Aligned_cols=179 Identities=25% Similarity=0.385 Sum_probs=139.1
Q ss_pred CeEEEEEeecCCCCHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 90 SHLHIILEYVENGSLANIIKPN-KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 90 ~~LYLVMEYceGGSL~DLLKss-r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
.++||.|++|...+|.+||..+ ....-+...+..++.|++.+++| +|.+|||+||.||+...++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 4689999999999999999743 33456778899999999999999 9999999999999999999999999999987
Q ss_pred cccCC------cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhHHHHHhhcCCCCCCC
Q 000535 169 LTEAD------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPE 241 (1437)
Q Consensus 169 L~esd------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT-GkpPF~g~d~~eqL~kIiq~~rppiP~ 241 (1437)
..... .......||..||+||.+.+..|+.++||||||++|||++. -..+|.. ...+..+-.+..++.-.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFL 482 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHh
Confidence 65443 12334689999999999999999999999999999999997 3333322 11122222222222111
Q ss_pred CCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHH
Q 000535 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 242 ~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWF 274 (1437)
.=-+.-..|+..||.+.|.+||++.+.-.|+|.
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 122445689999999999999988877766664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.7e-19 Score=212.84 Aligned_cols=260 Identities=27% Similarity=0.390 Sum_probs=214.3
Q ss_pred CCceEEEeEecccCcEEEEEEEEcC-CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLE-NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrk-TGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd~~LYL 94 (1437)
...|.+.+.||+|+|+.|-.+.+.. ....+|+|.+............+..|..+-+.+. |+|++.+++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 5679999999999999999997744 4566788877665544445566677888888886 9999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccccCCceEeccCC-cEEEEeccccccccc-
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH-EQGVIHRDIKGANILTTKEG-LVKLADFGVATKLTE- 171 (1437)
Q Consensus 95 VMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLH-SnGIVHRDLKPENILLdenG-~VKLiDFGLAr~L~e- 171 (1437)
+++|..|+++++.+........+...+..++.|+..++.|+| ..++.|||+||+|.+++..+ .+++.|||+|..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999999983222225778888999999999999999 99999999999999999999 999999999988766
Q ss_pred CC--cccccccC-CCccCChhhhhcC-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC----CCCCCCCC
Q 000535 172 AD--VNTHSVVG-TPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE----RPPIPESL 243 (1437)
Q Consensus 172 sd--~kt~t~~G-Tp~YmAPEVL~g~-~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~----rppiP~~I 243 (1437)
.+ ......+| ++.|+|||...+. ......|+||+|+++..+++|..||.........+.-.... ....+..+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 32 22335688 9999999999875 45677899999999999999999997655544332222211 23455678
Q ss_pred CHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 244 SpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+....+++.+++..+|..|.+.+++-.+||+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 999999999999999999999999999999965
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-17 Score=167.54 Aligned_cols=140 Identities=24% Similarity=0.326 Sum_probs=111.5
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH--------------------HHHHHHHHHHHHHhCCCCC
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE--------------------DLNIIMQEIDLLKNLNHKN 78 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee--------------------die~L~REIkILrrLnHPN 78 (1437)
.|.+.+.||+|+||.||++.+. +|+.||||++........ ......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999864 799999999775431110 1123567899999998774
Q ss_pred --cceEEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC
Q 000535 79 --IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG 156 (1437)
Q Consensus 79 --IVKLigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG 156 (1437)
+...++ ....++||||++|++|.++... .....++.+++.++.++|+.||+||||||+||+++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444444 2355899999999998776431 34567889999999999999999999999999999999
Q ss_pred cEEEEeccccccccc
Q 000535 157 LVKLADFGVATKLTE 171 (1437)
Q Consensus 157 ~VKLiDFGLAr~L~e 171 (1437)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=187.93 Aligned_cols=147 Identities=20% Similarity=0.277 Sum_probs=117.3
Q ss_pred cccccccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC------HHHHHHHHHHHHHHHhCCCCCcceEE
Q 000535 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA------QEDLNIIMQEIDLLKNLNHKNIVKYL 83 (1437)
Q Consensus 10 F~~gktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS------eedie~L~REIkILrrLnHPNIVKLi 83 (1437)
|.........|...+.||+|+||+||++.+.. ..+++|+....... ....+.+.+|+.+++.++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 44444555566778999999999999998643 33444433222111 11235688999999999999999888
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEec
Q 000535 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADF 163 (1437)
Q Consensus 84 gVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDF 163 (1437)
.++......++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+||
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeC
Confidence 77777778899999999999999875 346789999999999999999999999999999 6788999999
Q ss_pred cccccc
Q 000535 164 GVATKL 169 (1437)
Q Consensus 164 GLAr~L 169 (1437)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-16 Score=183.64 Aligned_cols=198 Identities=25% Similarity=0.472 Sum_probs=157.3
Q ss_pred HHhCCCCCcceEEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-ccccccCCc
Q 000535 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV-IHRDIKGAN 149 (1437)
Q Consensus 71 LrrLnHPNIVKLigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGI-VHRDLKPEN 149 (1437)
|+.+.|.|+.++++.+.+....++|.+||..|+|.|.+... ...++......++++|+.||.|+|...| +|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 46789999999999999999999999999999999999863 3568888899999999999999998866 999999999
Q ss_pred eEeccCCcEEEEecccccccccC--CcccccccCCCccCChhhhhcCC-------CCccchhhhHHHHHHHHHhCCCCCC
Q 000535 150 ILTTKEGLVKLADFGVATKLTEA--DVNTHSVVGTPYWMAPEVIEMSG-------VCAASDIWSVGCTVIELLTCVPPYY 220 (1437)
Q Consensus 150 ILLdenG~VKLiDFGLAr~L~es--d~kt~t~~GTp~YmAPEVL~g~~-------yS~KSDIWSLG~ILYELLTGkpPF~ 220 (1437)
++++....+||+|||+....... ........-...|.|||.+.... .+.+.||||+|+++||+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999999876421 11111223355699999997642 3567899999999999999999997
Q ss_pred CCCC----hhHHHHHhhcCCCCCCC------CCCHHHHHHHHHHhhhcccCCCCHHHHh
Q 000535 221 ELQP----MPALFRIVQDERPPIPE------SLSPDITDFLRQCFKKDARQRPDAKTLL 269 (1437)
Q Consensus 221 g~d~----~eqL~kIiq~~rppiP~------~ISpELkDLIrkCLqkDPeKRPSAeELL 269 (1437)
.... .+.+.++......++.+ .+.+++..++..||..+|..||+++.+-
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 5322 23344433323222221 3456799999999999999999998774
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.8e-16 Score=155.23 Aligned_cols=139 Identities=24% Similarity=0.324 Sum_probs=102.1
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHH----------------------HHHHHHHHHhCCCCC--
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI----------------------IMQEIDLLKNLNHKN-- 78 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~----------------------L~REIkILrrLnHPN-- 78 (1437)
.+.||+|+||.||+|.+. ++..||||++............ ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999876 7999999998764332222111 135666677765443
Q ss_pred cceEEEEEEeCCeEEEEEeecCCCCHHH-HhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccCC
Q 000535 79 IVKYLGSLKTRSHLHIILEYVENGSLAN-IIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEG 156 (1437)
Q Consensus 79 IVKLigVfedd~~LYLVMEYceGGSL~D-LLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLdenG 156 (1437)
+.+++++ ...++||||++++.+.. .+.... . ...+..++.+++.++.++|. .||+||||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4455443 24589999999954321 111110 1 16678999999999999999 9999999999999999 88
Q ss_pred cEEEEeccccccccc
Q 000535 157 LVKLADFGVATKLTE 171 (1437)
Q Consensus 157 ~VKLiDFGLAr~L~e 171 (1437)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.8e-16 Score=143.45 Aligned_cols=133 Identities=20% Similarity=0.173 Sum_probs=112.7
Q ss_pred EEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCeEEEEEeec
Q 000535 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH--KNIVKYLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 22 IlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnH--PNIVKLigVfedd~~LYLVMEYc 99 (1437)
+++.||.|.++.||++.+. +..+++|....... ...+.+|+.+++.+.+ .++.+++.++...+..|++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 4678999999999999873 37899998765432 4567889999999976 58999999988888999999999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccCCceEeccCCcEEEEeccccccc
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ---GVIHRDIKGANILTTKEGLVKLADFGVATKL 169 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSn---GIVHRDLKPENILLdenG~VKLiDFGLAr~L 169 (1437)
.|+++..+ +......++.+++.++.++|.. +++|+|++|.||+++..+.++++|||.++..
T Consensus 76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 98766543 4556677899999999999985 7999999999999999899999999999753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-14 Score=152.33 Aligned_cols=137 Identities=19% Similarity=0.286 Sum_probs=105.4
Q ss_pred eEec-ccCcEEEEEEEEcCCCeEEEEEEeecccc-----------CHHHHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC
Q 000535 24 DEIG-KGAYGRVYKGLDLENGDFVAIKQVSLENI-----------AQEDLNIIMQEIDLLKNLNHKNI--VKYLGSLKTR 89 (1437)
Q Consensus 24 EvLG-rGgFGtVYKArDrkTGk~VAIKVIkke~l-----------Seedie~L~REIkILrrLnHPNI--VKLigVfedd 89 (1437)
..|| .||.|+||.+.. .+..+++|.+..... .......+.+|+.++..|.|++| ++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3466 777788888865 478899998854221 11234567889999999988774 6777764432
Q ss_pred -Ce---EEEEEeecCC-CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecc
Q 000535 90 -SH---LHIILEYVEN-GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFG 164 (1437)
Q Consensus 90 -~~---LYLVMEYceG-GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFG 164 (1437)
.. .++||||++| .+|.+++.. .++++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 22 3599999997 689998864 3466643 5789999999999999999999999999999999999999
Q ss_pred ccccc
Q 000535 165 VATKL 169 (1437)
Q Consensus 165 LAr~L 169 (1437)
.++..
T Consensus 188 ~~~~~ 192 (239)
T PRK01723 188 RGELR 192 (239)
T ss_pred CcccC
Confidence 99763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.4e-14 Score=167.60 Aligned_cols=260 Identities=23% Similarity=0.270 Sum_probs=200.6
Q ss_pred cccCCceEEEeEecc--cCcEEEEEEEE--cCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 000535 14 KTLDNKYMLGDEIGK--GAYGRVYKGLD--LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT 88 (1437)
Q Consensus 14 ktLggRYeIlEvLGr--GgFGtVYKArD--rkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfed 88 (1437)
..+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+........-..-.+|+...+.+ .|+|.++.+..++.
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 345667888899999 99999999998 88999999997433322222223334566666666 48999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCcccccccCCceEeccC-CcEEEEec
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE----GLVYLHEQGVIHRDIKGANILTTKE-GLVKLADF 163 (1437)
Q Consensus 89 d~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILs----ALaYLHSnGIVHRDLKPENILLden-G~VKLiDF 163 (1437)
.+..|+-+|+|. .+|.++... ...-+++..++.++.+... ||.++|+.+++|-|+||.||++..+ ...+++||
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CCcceeeecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 999999999995 688888764 3445899999999999999 9999999999999999999999999 78999999
Q ss_pred ccccccccCCccccc-----ccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcC-CC
Q 000535 164 GVATKLTEADVNTHS-----VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RP 237 (1437)
Q Consensus 164 GLAr~L~esd~kt~t-----~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~-rp 237 (1437)
|+...+......... ..|...|++||..++. ++...|||+||.++.+-.++..++..... ....++-... ..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQGYIPL 345 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCC-CCccccccccCch
Confidence 999998876533322 2678889999998654 78889999999999998887655532210 1111111111 11
Q ss_pred CCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 238 PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 238 piP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
.+-...+.++...+..|+..+|..|+++..+++++++...
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 1223456677779999999999999999999999999743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.5e-12 Score=148.41 Aligned_cols=143 Identities=19% Similarity=0.256 Sum_probs=98.7
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH--HHH------------------------------H------HHH
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ--EDL------------------------------N------IIM 65 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe--edi------------------------------e------~L~ 65 (1437)
+.||.|++|.||+|+. .+|+.||||+.+...... .+. . .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999985 579999999986542110 000 0 133
Q ss_pred HHHHHHHhC----CCCCcceEEEEE-EeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 000535 66 QEIDLLKNL----NHKNIVKYLGSL-KTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE-GLVYLHEQG 139 (1437)
Q Consensus 66 REIkILrrL----nHPNIVKLigVf-edd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILs-ALaYLHSnG 139 (1437)
+|+..+.++ .+.+-+.+-.++ ......++||||++|++|.++......+ .. ...+..+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555555 233323322222 2244579999999999998876532211 22 2345555555 468899999
Q ss_pred cccccccCCceEeccCCcEEEEeccccccccc
Q 000535 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 140 IVHRDLKPENILLdenG~VKLiDFGLAr~L~e 171 (1437)
++|+|+||.||+++.+|.++++|||++..+.+
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999988764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.1e-13 Score=158.38 Aligned_cols=147 Identities=18% Similarity=0.252 Sum_probs=101.0
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC--------------------------------HHHHHHH-
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA--------------------------------QEDLNII- 64 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS--------------------------------eedie~L- 64 (1437)
..|.. +.||.|++|.||+|+...+|+.||||++++.... ++-.+.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 8999999999999998888999999999754210 0111222
Q ss_pred -----HHHHHHHHhC----CCCCcceEEEEEEe-CCeEEEEEeecCCCCHHHHhccCCCC----CCCHHHHHHHHHHHHH
Q 000535 65 -----MQEIDLLKNL----NHKNIVKYLGSLKT-RSHLHIILEYVENGSLANIIKPNKFG----PFPESLVAVYIAQVLE 130 (1437)
Q Consensus 65 -----~REIkILrrL----nHPNIVKLigVfed-d~~LYLVMEYceGGSL~DLLKssr~G----pLSEs~I~rILrQILs 130 (1437)
.+|+..+.++ .+.+.+.+-.++.+ ....+||||||+|+++.++-.-...+ .+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 3344444444 24444444444432 45678999999999998753211112 355555555666654
Q ss_pred HHHHHHHCCcccccccCCceEeccCC----cEEEEecccccccccC
Q 000535 131 GLVYLHEQGVIHRDIKGANILTTKEG----LVKLADFGVATKLTEA 172 (1437)
Q Consensus 131 ALaYLHSnGIVHRDLKPENILLdenG----~VKLiDFGLAr~L~es 172 (1437)
..|++|+|+||.||+++.+| .++++|||++..+.+.
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 59999999999999999988 9999999999887553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.1e-13 Score=168.99 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=200.7
Q ss_pred CCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 17 ggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lS-eedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
.+.+.+.+.+-.|+|+.++.+.-..+|...++|+..+...- ..+.+.+..+-.++-.-.+|-++....-+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45677788999999999999987778877777765543211 11223333333333333456666655555567789999
Q ss_pred EeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC---
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA--- 172 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es--- 172 (1437)
++|..+++|...++.. +..++.-++.++..+.++++|||...+.|||++|.|+++..+|..++.|||........
T Consensus 883 ~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999999999999865 46888889999999999999999999999999999999999999999999854322100
Q ss_pred ------------------C----------cccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 000535 173 ------------------D----------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQP 224 (1437)
Q Consensus 173 ------------------d----------~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~ 224 (1437)
. ...+...||+.|.+||...+......+|+|++|+++++.++|.+||....+
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 112345799999999999999999999999999999999999999998877
Q ss_pred hhHHHHHhhcCC--CCCCCCCCHHHHHHHHHHhhhcccCCCCHH---HHhcCHHHHH
Q 000535 225 MPALFRIVQDER--PPIPESLSPDITDFLRQCFKKDARQRPDAK---TLLSHPWIQN 276 (1437)
Q Consensus 225 ~eqL~kIiq~~r--ppiP~~ISpELkDLIrkCLqkDPeKRPSAe---ELLkHPWFQe 276 (1437)
......+..... +.-+...+++.++++..+|..+|.+|..+. +.-.||||+.
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence 776666554432 223456789999999999999999999887 8888999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-11 Score=147.54 Aligned_cols=185 Identities=23% Similarity=0.348 Sum_probs=144.8
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEee
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVMEY 98 (1437)
.|.+ +..+-++.+..-.|..+.++.+|.|.+++...- +..+.+.+-++.|+.++||||+++++.++.++.+|||+|.
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 4666 555555555333566778899999999876543 4456677888999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH-EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLH-SnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
+. .|..++++ +....+...++||+.||.||| +.+++|++|.-..|+++..|.+||++|.++...........
T Consensus 91 V~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~ 163 (690)
T KOG1243|consen 91 VR--PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK 163 (690)
T ss_pred cc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc
Confidence 94 78888874 447778888999999999998 56899999999999999999999999999866543322122
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhC
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC 215 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTG 215 (1437)
...---.|..|+.+.... ...|.|-|||++++++.|
T Consensus 164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 233334477777665443 456999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1e-11 Score=122.93 Aligned_cols=128 Identities=18% Similarity=0.104 Sum_probs=96.6
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCeEEEEEeecCC
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV-KYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIV-KLigVfedd~~LYLVMEYceG 101 (1437)
.+.|+.|.++.||++.. .+..|++|+...... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 46789999999999986 478899998754321 122356889999988655544 4444432 335799999999
Q ss_pred CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccccccCCceEeccCCcEEEEecccccc
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV-----IHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 102 GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGI-----VHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
.++.+. . . ....++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 76 ~~l~~~-~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE-D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc-c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 877643 0 1 123457899999999999985 9999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.5e-12 Score=150.87 Aligned_cols=252 Identities=23% Similarity=0.205 Sum_probs=192.9
Q ss_pred ccCCceEEEeEecccCcEEEEEEEEc-CCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDL-ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 15 tLggRYeIlEvLGrGgFGtVYKArDr-kTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVfedd~~L 92 (1437)
-...+|..+..||.|.|+.||++... .++..|++|..........+...-..|+.+...+ .|.+++.+...+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 45567899999999999999998644 6789999998776554444444455677777777 599999998888888888
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccC-CcEEEEeccccccccc
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE-GLVKLADFGVATKLTE 171 (1437)
Q Consensus 93 YLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLden-G~VKLiDFGLAr~L~e 171 (1437)
|+=-|||+++++...+... ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||....+.-
T Consensus 342 ~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 8999999999876665322 458889999999999999999999999999999999999987 6889999999975332
Q ss_pred CCcccccccCCCccC--ChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHH
Q 000535 172 ADVNTHSVVGTPYWM--APEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249 (1437)
Q Consensus 172 sd~kt~t~~GTp~Ym--APEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkD 249 (1437)
. .......-+++ +|+......+..+.|++|||..+++..++.+--.. ....+.+..+.. +........+..
T Consensus 420 ~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~-p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 420 S---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDT-PNLPGLKLQLQV 492 (524)
T ss_pred e---cccccccccccccchhhccccccccccccccccccccccccCcccCcc---cccceeeecccc-cCCCchHHhhhh
Confidence 2 11222333444 55566677889999999999999999998753222 222333333333 333444588999
Q ss_pred HHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 250 LIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
+.+.++.+++..||.+.++..|+-|.
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999999999998886554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.5e-11 Score=125.34 Aligned_cols=141 Identities=18% Similarity=0.165 Sum_probs=103.5
Q ss_pred EeEecccCcEEEEEEEEcC------CCeEEEEEEeeccccC--------------------HHHHHHH----HHHHHHHH
Q 000535 23 GDEIGKGAYGRVYKGLDLE------NGDFVAIKQVSLENIA--------------------QEDLNII----MQEIDLLK 72 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrk------TGk~VAIKVIkke~lS--------------------eedie~L----~REIkILr 72 (1437)
...||.|.-+.||.|.... .+..+|||+.+..... ......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998653 3579999988742110 0011222 37999999
Q ss_pred hCCC--CCcceEEEEEEeCCeEEEEEeecCCCCHHH-HhccCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccccCC
Q 000535 73 NLNH--KNIVKYLGSLKTRSHLHIILEYVENGSLAN-IIKPNKFGPFPESLVAVYIAQVLEGLVYL-HEQGVIHRDIKGA 148 (1437)
Q Consensus 73 rLnH--PNIVKLigVfedd~~LYLVMEYceGGSL~D-LLKssr~GpLSEs~I~rILrQILsALaYL-HSnGIVHRDLKPE 148 (1437)
++.. -++.+.+++ ...+|||||+.++.+.. .++. ..+++..+..+..+++.+|..| |+.||+|+||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9843 456666654 45689999997654422 2321 2466677788899999999998 8999999999999
Q ss_pred ceEeccCCcEEEEeccccccccc
Q 000535 149 NILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 149 NILLdenG~VKLiDFGLAr~L~e 171 (1437)
||++. ++.++|+|||.+.....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCCC
Confidence 99997 46799999999977653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.1e-11 Score=135.72 Aligned_cols=200 Identities=23% Similarity=0.355 Sum_probs=145.0
Q ss_pred HHHHhCCCCCcceEEEEEEeC-----CeEEEEEeecCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 000535 69 DLLKNLNHKNIVKYLGSLKTR-----SHLHIILEYVENGSLANIIKPNK--FGPFPESLVAVYIAQVLEGLVYLHEQG-- 139 (1437)
Q Consensus 69 kILrrLnHPNIVKLigVfedd-----~~LYLVMEYceGGSL~DLLKssr--~GpLSEs~I~rILrQILsALaYLHSnG-- 139 (1437)
.-|-++-|.|||+++.|+.+. ....+++||+..|++..++++.+ ...+......+|+.||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 345667899999999988654 45889999999999999997543 245888888999999999999999874
Q ss_pred cccccccCCceEeccCCcEEEEecccccccccC-----CcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHh
Q 000535 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEA-----DVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT 214 (1437)
Q Consensus 140 IVHRDLKPENILLdenG~VKLiDFGLAr~L~es-----d~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLT 214 (1437)
|+|+++...-|++..+|-+|+.- +-....... ........+-++|.+||.=.....+.++|||++|....+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999888752 111111110 001112346788999998776777889999999999999988
Q ss_pred CCCCCC-CCCC---hhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 215 CVPPYY-ELQP---MPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 215 GkpPF~-g~d~---~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
+..--. .... .....+.+.+... .--.+++.+|++.+|..||++.+++-||.+-+
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred heeccCCCcceeehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 764321 1111 1111222211111 11257899999999999999999999997643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=5e-10 Score=114.38 Aligned_cols=140 Identities=16% Similarity=0.212 Sum_probs=108.7
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CeEEEEEee
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH--KNIVKYLGSLKTR---SHLHIILEY 98 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnH--PNIVKLigVfedd---~~LYLVMEY 98 (1437)
+.|+.|.++.||++... +|+.|++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..|+||||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 67899999999999763 3688999987654321 134567899999999965 4467777776654 367899999
Q ss_pred cCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE----------------------------------------- 137 (1437)
Q Consensus 99 ceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHS----------------------------------------- 137 (1437)
++|.++.+.+.. ..+++.....++.+++++|.+||+
T Consensus 82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 999888776531 357777888888888888888884
Q ss_pred ---------------CCcccccccCCceEecc--CCcEEEEecccccc
Q 000535 138 ---------------QGVIHRDIKGANILTTK--EGLVKLADFGVATK 168 (1437)
Q Consensus 138 ---------------nGIVHRDLKPENILLde--nG~VKLiDFGLAr~ 168 (1437)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 66789999999865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.4e-08 Score=120.53 Aligned_cols=215 Identities=18% Similarity=0.240 Sum_probs=161.0
Q ss_pred cEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCeEEEEEeecCC-CCHH
Q 000535 31 YGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK----TRSHLHIILEYVEN-GSLA 105 (1437)
Q Consensus 31 FGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVKLigVfe----dd~~LYLVMEYceG-GSL~ 105 (1437)
-.+.|+|....+|..|++|.+.-... ...+....-+++++++.|+|||++.++|. .+..+++|++|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 35789999999999999999843221 22223445678899999999999999886 35679999999887 5788
Q ss_pred HHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccC
Q 000535 106 NIIKPN-------------KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 106 DLLKss-------------r~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
++.-.. .....+|..+|.|+.|+..||.++|+.|+..+-|.|.+|+++.+-+++|..+|....+.++
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 766322 1224788999999999999999999999999999999999999889999988888776554
Q ss_pred CcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 000535 173 DVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252 (1437)
Q Consensus 173 d~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIr 252 (1437)
... +-|.. .+-|.--||.+++.|.||..--...+...... ...+...++.++.++|.
T Consensus 447 ~~~-----------~le~~------Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~------~~~I~~~yS~D~rn~v~ 503 (655)
T KOG3741|consen 447 PTE-----------PLESQ------QQNDLRDLGLLLLALATGTENSNRTDSTQSSH------LTRITTTYSTDLRNVVE 503 (655)
T ss_pred CCc-----------chhHH------hhhhHHHHHHHHHHHhhcccccccccchHHHH------HHHhhhhhhHHHHHHHH
Confidence 300 01222 34588889999999999964322222211110 11233568999999999
Q ss_pred HHhhhcccCCCCHHHHhcC
Q 000535 253 QCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 253 kCLqkDPeKRPSAeELLkH 271 (1437)
-+...++++ -++.+++.+
T Consensus 504 yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 504 YLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHhcCccc-ccHHHHHHH
Confidence 999999987 788888765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=9.9e-09 Score=110.07 Aligned_cols=133 Identities=19% Similarity=0.220 Sum_probs=101.2
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED------LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed------ie~L~REIkILrrLnHPNIVKLigVfedd~~LYLVME 97 (1437)
..+++|+-+.+|.+.. -|..+++|.=.++...-.+ ..+-.+|+.++.++.--.|...+=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4678999999999954 4445777754443333222 2345679999999865555554555566777889999
Q ss_pred ecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 98 YceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
|++|..|.+.+... ...+++.+-.-+.-||..||+|+||.++||++...+ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888754 145677888888999999999999999999998765 99999999975
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.7e-08 Score=106.96 Aligned_cols=145 Identities=22% Similarity=0.230 Sum_probs=111.5
Q ss_pred EEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH------HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 000535 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE------DLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 22 IlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee------die~L~REIkILrrLnHPNIVKLigVfedd~~LYLV 95 (1437)
.+..|-+|+-+.|+++.. .|+.+.||.-......-. ...+..+|+++|.++.--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 678899999999999975 788888886443332211 235677899999998655655555566666677899
Q ss_pred EeecCC-CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC---cEEEEecccccc
Q 000535 96 LEYVEN-GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG---LVKLADFGVATK 168 (1437)
Q Consensus 96 MEYceG-GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG---~VKLiDFGLAr~ 168 (1437)
|||++| .++.+++...............++++|-..+.-||.++|+|+||..+||++..+| .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4778887655444444444578999999999999999999999999999998776 358999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.7e-08 Score=106.76 Aligned_cols=135 Identities=16% Similarity=0.058 Sum_probs=95.7
Q ss_pred EEEEEEEEcCCCeEEEEEEeeccccCH---------HHHHHHHHHHHHHHhCCCCC--cceEEEEEEe-----CCeEEEE
Q 000535 32 GRVYKGLDLENGDFVAIKQVSLENIAQ---------EDLNIIMQEIDLLKNLNHKN--IVKYLGSLKT-----RSHLHII 95 (1437)
Q Consensus 32 GtVYKArDrkTGk~VAIKVIkke~lSe---------edie~L~REIkILrrLnHPN--IVKLigVfed-----d~~LYLV 95 (1437)
..|+++.. .|+.|.||......... .-...+.+|...+.+|..-+ ..+.+.+++. ....+||
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34666543 67789999764322110 00113668888887773222 3333444432 2357899
Q ss_pred EeecCCC-CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEecc-------CCcEEEEeccccc
Q 000535 96 LEYVENG-SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-------EGLVKLADFGVAT 167 (1437)
Q Consensus 96 MEYceGG-SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLde-------nG~VKLiDFGLAr 167 (1437)
||++++- +|.+++......+.++.....++.+++..+..||..||+|+|+++.|||++. ++.+.|+||+.++
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999885 8999986432345677788899999999999999999999999999999975 3589999999996
Q ss_pred c
Q 000535 168 K 168 (1437)
Q Consensus 168 ~ 168 (1437)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 4
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.1e-07 Score=101.34 Aligned_cols=128 Identities=24% Similarity=0.332 Sum_probs=84.7
Q ss_pred EEEEEEEcCCCeEEEEEEeeccccC----------------------H--HHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 000535 33 RVYKGLDLENGDFVAIKQVSLENIA----------------------Q--EDLNIIMQEIDLLKNLNHK--NIVKYLGSL 86 (1437)
Q Consensus 33 tVYKArDrkTGk~VAIKVIkke~lS----------------------e--edie~L~REIkILrrLnHP--NIVKLigVf 86 (1437)
.||.|.. .+|..+|+|+.+....+ . -......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899976 56789999988743110 0 1123467899999999755 456666543
Q ss_pred EeCCeEEEEEeecC--CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCcccccccCCceEeccCCcEEEEec
Q 000535 87 KTRSHLHIILEYVE--NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY-LHEQGVIHRDIKGANILTTKEGLVKLADF 163 (1437)
Q Consensus 87 edd~~LYLVMEYce--GGSL~DLLKssr~GpLSEs~I~rILrQILsALaY-LHSnGIVHRDLKPENILLdenG~VKLiDF 163 (1437)
..+|||||++ |..+..+... .++......++.+++..+.. +|+.||+|+||.+.||+++.+ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2379999998 6555554432 12244567788888886655 579999999999999999887 8999999
Q ss_pred ccccccc
Q 000535 164 GVATKLT 170 (1437)
Q Consensus 164 GLAr~L~ 170 (1437)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.2e-08 Score=124.06 Aligned_cols=159 Identities=20% Similarity=0.290 Sum_probs=118.8
Q ss_pred HHHHHHHHHHHHC-CcccccccCCceEeccCCcEEEEecccccccccCCccc---cc------ccCCCccCChhhhhcCC
Q 000535 126 AQVLEGLVYLHEQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT---HS------VVGTPYWMAPEVIEMSG 195 (1437)
Q Consensus 126 rQILsALaYLHSn-GIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt---~t------~~GTp~YmAPEVL~g~~ 195 (1437)
.+++.|+.|+|.. ++||+.|.|++|.++.++.|||+.|+++.......... ++ ..-...|.|||++....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3455999999976 89999999999999999999999999987654421111 11 12345699999999988
Q ss_pred CCccchhhhHHHHHHHHH-hCCCCCCCCCChhHHHHHhh----cCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhc
Q 000535 196 VCAASDIWSVGCTVIELL-TCVPPYYELQPMPALFRIVQ----DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 196 yS~KSDIWSLG~ILYELL-TGkpPF~g~d~~eqL~kIiq----~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLk 270 (1437)
.+.++|+||+||++|.+. .|+.-+...... ..+.... .........+++++++-+.+++..++.-||++..++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 899999999999999999 566555443222 2222211 1223345789999999999999999999999999999
Q ss_pred CHHHHHHHHHhhhhc
Q 000535 271 HPWIQNCRRALQSSL 285 (1437)
Q Consensus 271 HPWFQe~rrsLqssL 285 (1437)
.|||+......-..+
T Consensus 265 ~~ff~D~~~~aLrfL 279 (700)
T KOG2137|consen 265 IPFFSDPGLKALRFL 279 (700)
T ss_pred ccccCCchhhhhhhc
Confidence 999987554433333
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.8e-07 Score=94.44 Aligned_cols=126 Identities=16% Similarity=0.117 Sum_probs=91.5
Q ss_pred CCeEEEEEEeeccccCH-----HHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC----CeEEEEEeecCCC-CHHHHhc
Q 000535 42 NGDFVAIKQVSLENIAQ-----EDLNIIMQEIDLLKNLNH--KNIVKYLGSLKTR----SHLHIILEYVENG-SLANIIK 109 (1437)
Q Consensus 42 TGk~VAIKVIkke~lSe-----edie~L~REIkILrrLnH--PNIVKLigVfedd----~~LYLVMEYceGG-SL~DLLK 109 (1437)
.++.|-+|......... -......+|...+..|.. =.+.+.+.+.+.. ...+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 35666666543221111 123456778887777732 2244455555442 3468999999984 7999987
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC---cEEEEeccccccc
Q 000535 110 PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG---LVKLADFGVATKL 169 (1437)
Q Consensus 110 ssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG---~VKLiDFGLAr~L 169 (1437)
... .++......++.+++..+.-||.+||+|+|+++.|||++.++ .+.++||+.++..
T Consensus 111 ~~~--~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWE--QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhc--ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 532 267778889999999999999999999999999999999887 8999999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.4e-07 Score=102.21 Aligned_cols=140 Identities=23% Similarity=0.336 Sum_probs=106.3
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH--------------------HHHHHHHHHHHHHHhCCCC--
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ--------------------EDLNIIMQEIDLLKNLNHK-- 77 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe--------------------edie~L~REIkILrrLnHP-- 77 (1437)
+.++..||-|.-|.||.|.+. .|..+|||.=+....+- -......+|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 578899999999999999864 68999999654321110 1123457899999999654
Q ss_pred CcceEEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCc
Q 000535 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGL 157 (1437)
Q Consensus 78 NIVKLigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~ 157 (1437)
.|.+.+++ +...+||||++|-.|...- ++......++..|+.-+.-+-..||||+|+.+-||+++++|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666654 3568999999997776543 234556667777777777777999999999999999999999
Q ss_pred EEEEeccccccccc
Q 000535 158 VKLADFGVATKLTE 171 (1437)
Q Consensus 158 VKLiDFGLAr~L~e 171 (1437)
++++||--+.....
T Consensus 241 ~~vIDwPQ~v~~~h 254 (304)
T COG0478 241 IVVIDWPQAVPISH 254 (304)
T ss_pred EEEEeCcccccCCC
Confidence 99999988866543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=7.1e-06 Score=96.56 Aligned_cols=241 Identities=18% Similarity=0.220 Sum_probs=158.4
Q ss_pred CceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE------Ee-C
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSL------KT-R 89 (1437)
Q Consensus 18 gRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-nHPNIVKLigVf------ed-d 89 (1437)
.-.-.+..||+|+.+.+|..-. -+. .+.|++......-.. +.+..|..- .||-+-.-+.|- -+ .
T Consensus 11 e~i~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~ 82 (637)
T COG4248 11 EPIPPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRG 82 (637)
T ss_pred cccCCCccccCCccceeeecch--hhc-hhheeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence 3345567899999999998742 223 345777654322111 112233333 566443322222 12 2
Q ss_pred CeEEEEEeecCCCC-HHHHhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecc
Q 000535 90 SHLHIILEYVENGS-LANIIK----PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFG 164 (1437)
Q Consensus 90 ~~LYLVMEYceGGS-L~DLLK----ssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFG 164 (1437)
..+-++|..+.|.. +..+.. ++.+....+....+..+.++.+.+.||..|.+-+|+.++|+|+++++.|.|+|=.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence 23678888887752 333332 2233457788899999999999999999999999999999999999999999855
Q ss_pred cccccccCCcccccccCCCccCChhhhh-----cCCCCccchhhhHHHHHHHHHhC-CCCCCCCCC-----hhHHHHHhh
Q 000535 165 VATKLTEADVNTHSVVGTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTC-VPPYYELQP-----MPALFRIVQ 233 (1437)
Q Consensus 165 LAr~L~esd~kt~t~~GTp~YmAPEVL~-----g~~yS~KSDIWSLG~ILYELLTG-kpPF~g~d~-----~eqL~kIiq 233 (1437)
.-... ..+......+|.+.|.+||.-. +...+...|.|.||+++|+++.| ..||.+... .+.-..|..
T Consensus 163 sfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 44332 3333445678999999999764 33456778999999999999986 899975321 111112211
Q ss_pred c----------CCCCCC-----CCCCHHHHHHHHHHhhhc--ccCCCCHHH
Q 000535 234 D----------ERPPIP-----ESLSPDITDFLRQCFKKD--ARQRPDAKT 267 (1437)
Q Consensus 234 ~----------~rppiP-----~~ISpELkDLIrkCLqkD--PeKRPSAeE 267 (1437)
+ ...+-| .-+++++..|..+|+... +.-|||++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1 111111 246789999999999754 568999984
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1e-05 Score=89.20 Aligned_cols=142 Identities=20% Similarity=0.250 Sum_probs=95.6
Q ss_pred cccCCceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHH-HHHH------HHHHHHHHHhC---CCCCcceEE
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE-DLNI------IMQEIDLLKNL---NHKNIVKYL 83 (1437)
Q Consensus 14 ktLggRYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSee-die~------L~REIkILrrL---nHPNIVKLi 83 (1437)
..+.++|.+.+.+-.....-|.+.. .+|+.+++|..+......+ .... ..+++..+.++ ..-.+..++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 4577899999999998888888775 4789999998765432211 1111 22333333333 333333333
Q ss_pred EEEE-----eCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcE
Q 000535 84 GSLK-----TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLV 158 (1437)
Q Consensus 84 gVfe-----dd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~V 158 (1437)
-+.+ -....+++|||++|..|.+... +++. +...+.+++.-+|+.|++|+|..|.|++++.++ +
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-E
Confidence 3322 2245678999999988876532 3332 345677889999999999999999999998655 9
Q ss_pred EEEecccccc
Q 000535 159 KLADFGVATK 168 (1437)
Q Consensus 159 KLiDFGLAr~ 168 (1437)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-05 Score=88.05 Aligned_cols=141 Identities=14% Similarity=0.150 Sum_probs=104.0
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeecccc-C---HHHHHHHHHHHHHHHhCCC--CCcceEEEEEE---eC--CeEEE
Q 000535 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-A---QEDLNIIMQEIDLLKNLNH--KNIVKYLGSLK---TR--SHLHI 94 (1437)
Q Consensus 26 LGrGgFGtVYKArDrkTGk~VAIKVIkke~l-S---eedie~L~REIkILrrLnH--PNIVKLigVfe---dd--~~LYL 94 (1437)
-|+||-|.|+.... .|+.|-+|.-..... + +.-...+.+|+..|.+|.. -.+.+.+ ++. .. -.-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 46799999999864 344688886541110 0 1234568899999888842 2244444 222 21 24679
Q ss_pred EEeecCC-CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCc--EEEEeccccccc
Q 000535 95 ILEYVEN-GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGL--VKLADFGVATKL 169 (1437)
Q Consensus 95 VMEYceG-GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~--VKLiDFGLAr~L 169 (1437)
|+|-+.| -+|.+++......+.++.....++.+++..+.-||+.|+.|+|+-+.|||++.+|. ++++||.-++..
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 9998865 48999887655566788888899999999999999999999999999999987776 999999888653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.5e-05 Score=81.55 Aligned_cols=140 Identities=20% Similarity=0.292 Sum_probs=83.5
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCC--CcceEEEEE---EeCCeEEEEEe
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK--NIVKYLGSL---KTRSHLHIILE 97 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHP--NIVKLigVf---edd~~LYLVME 97 (1437)
++.|+.|..+.||++.... ..+++|..... .....+.+|+.+++.|... .+.+++.+. ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 4789999999999998644 58999986533 3456677888898888432 345566543 33456899999
Q ss_pred ecCCCCHHH----------------Hhc---cC--CCCCCCHHH---------HHHH------------HHHHHH-HHHH
Q 000535 98 YVENGSLAN----------------IIK---PN--KFGPFPESL---------VAVY------------IAQVLE-GLVY 134 (1437)
Q Consensus 98 YceGGSL~D----------------LLK---ss--r~GpLSEs~---------I~rI------------LrQILs-ALaY 134 (1437)
+++|..+.. .+. .. ...++.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999988777 111 11 111111100 0000 011222 2333
Q ss_pred HHH-------CCcccccccCCceEec-cCCcEEEEecccccc
Q 000535 135 LHE-------QGVIHRDIKGANILTT-KEGLVKLADFGVATK 168 (1437)
Q Consensus 135 LHS-------nGIVHRDLKPENILLd-enG~VKLiDFGLAr~ 168 (1437)
+++ ..++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 3599999999999999 667778999998854
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-07 Score=115.09 Aligned_cols=240 Identities=25% Similarity=0.263 Sum_probs=172.4
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCeEEEEEee
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN-IVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPN-IVKLigVfedd~~LYLVMEY 98 (1437)
|.....+++|+++.+||.+...+...+ .+++... ....-++++|.+++||| .+..++-++.+.+.+++|+|
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 445566799999999999876665555 6665433 33456888999999999 88888888888999999999
Q ss_pred cCCC-CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCcEEEEecccccccccCCcccc
Q 000535 99 VENG-SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 99 ceGG-SL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~ 177 (1437)
|.++ +-...+... .-.+.+-+...+.+.-+++++++|+.-=+||| ||+..+ +..+..||+....+.... ...
T Consensus 316 ~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~ 388 (829)
T KOG0576|consen 316 CSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPR 388 (829)
T ss_pred hcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccc
Confidence 9887 332222111 11244445556677778899999988778998 777665 678999999998887654 566
Q ss_pred cccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCC-----CCHHHH-HHH
Q 000535 178 SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES-----LSPDIT-DFL 251 (1437)
Q Consensus 178 t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~-----ISpELk-DLI 251 (1437)
+..+++.++|||+.....+....|.|++|.--.+|--|.+|-.... .....+ +..+..+.- .++... ++.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~--g~~p~s~~L~~~~aw~~~~~~~~~ 464 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMI--GNGPNSPMLTDKSAWSPVFHRDFP 464 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCC--CCCCCccccchhhhcCcccccCCc
Confidence 7889999999999999999999999999987777777877754311 111100 000001110 111122 477
Q ss_pred HHHhhhcccCCCCHHHHhcCHHHHHHH
Q 000535 252 RQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 252 rkCLqkDPeKRPSAeELLkHPWFQe~r 278 (1437)
..|+...|..|+....++-|.+|..|.
T Consensus 465 ~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 465 APCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred ccccCCCCCCCcchhhHHHHHHhccCc
Confidence 889999999999999999999997764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.8e-06 Score=101.56 Aligned_cols=145 Identities=17% Similarity=0.228 Sum_probs=93.2
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeecccc---------------------------CH-HHH----HH------HH
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI---------------------------AQ-EDL----NI------IM 65 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l---------------------------Se-edi----e~------L~ 65 (1437)
+.|+.++-|.||+|+- .+|+.||||+.+..-. .. +.+ +. +.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6889999999999985 4599999998864210 00 001 11 23
Q ss_pred HHHHHHHhC-----CCCCcceEEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 000535 66 QEIDLLKNL-----NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140 (1437)
Q Consensus 66 REIkILrrL-----nHPNIVKLigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGI 140 (1437)
+|..-+.++ +.|+|.--.=+++-.+.-.|+|||++|-.+.+...-.. ..++.+.+.....++ -+..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 455555544 23333222222233456689999999988888742111 224433333322221 1233445899
Q ss_pred ccccccCCceEeccCCcEEEEecccccccccC
Q 000535 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 141 VHRDLKPENILLdenG~VKLiDFGLAr~L~es 172 (1437)
+|.|.+|.||+++.+|.+.+.|||+...+.+.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999999887654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.8e-05 Score=85.95 Aligned_cols=136 Identities=18% Similarity=0.201 Sum_probs=85.0
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN--IVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPN--IVKLigVfedd~~LYLVMEYceG 101 (1437)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+.+.+..+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 67899999999984 25567889875422 2234688999999986433 56777887778888999999999
Q ss_pred CC-HHHHh---------------------ccCCCCCCCHHH-HHHHHHH----------HHHH-HHHHHH----CCcccc
Q 000535 102 GS-LANII---------------------KPNKFGPFPESL-VAVYIAQ----------VLEG-LVYLHE----QGVIHR 143 (1437)
Q Consensus 102 GS-L~DLL---------------------Kssr~GpLSEs~-I~rILrQ----------ILsA-LaYLHS----nGIVHR 143 (1437)
.+ +...+ ..-+....+... ...+..+ +... ..+|.. ..++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 63 21111 110000111111 0111101 1111 122221 247899
Q ss_pred cccCCceEeccCCcEEEEecccccc
Q 000535 144 DIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 144 DLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
|+.|.||+++.++ +.|+||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PLN03200 cellulose synthase-interactive protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=0.00022 Score=96.58 Aligned_cols=245 Identities=17% Similarity=0.201 Sum_probs=172.3
Q ss_pred HHHhHhhhcchhhHHHhhhhhhHHHHHHHHhhhcCchH-H---HHHhhhcCCChhHHHhhhcccchhhhccccccCCCCc
Q 000535 1123 ADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPI-L---LKCVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHL 1198 (1437)
Q Consensus 1123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---lk~~~~~s~~~~~l~~~~~~~ai~~l~~~l~~~~~~~ 1198 (1437)
+-++-.|...+...+ .+.++.+..+|-++|.--.|+. . ..++-.|-.||..-..|+.+|||++|+..|...+
T Consensus 342 ayll~l~d~~~~~~~-~i~~~~v~~~LV~Llr~k~p~~vqe~V~eALasl~gN~~l~~~L~~~daik~LV~LL~~~~--- 417 (2102)
T PLN03200 342 AYALMVFDSSAESTR-AFDPTVIEQILVKLLKPRDTKLVQERIIEALASLYGNAYLSRKLNHAEAKKVLVGLITMAT--- 417 (2102)
T ss_pred HHHHHhcCCchhhhh-hccccccHHHHHHHhCCCCCchhHHHHHHHHHHhcCChHHHHHHHhccchhhhhhhhccCC---
Confidence 334344444444444 4555566666667776555554 2 5566667788887788888999999999998874
Q ss_pred hHHHHHHHHHHHHhhhhcchhhHHHHHhcCCchhhhhhhccCCc-ccccchhhhhhhcccchhhHHHHHHcCCceeeecc
Q 000535 1199 VSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNL 1277 (1437)
Q Consensus 1199 ~~~~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~~p-~~~~~lp~l~~~a~~~~~~~~~~~~~~~~~~~~~~ 1277 (1437)
.++..+..-++.+||.-+..+.+.-+..|.||.|.+++.+.++ .+.+|+=.|.-++-.....|..+..+||+...++|
T Consensus 418 -~evQ~~Av~aL~~L~~~~~e~~~aIi~~ggIp~LV~LL~s~s~~iQ~~A~~~L~nLa~~ndenr~aIieaGaIP~LV~L 496 (2102)
T PLN03200 418 -ADVQEELIRALSSLCCGKGGLWEALGGREGVQLLISLLGLSSEQQQEYAVALLAILTDEVDESKWAITAAGGIPPLVQL 496 (2102)
T ss_pred -HHHHHHHHHHHHHHhCCCHHHHHHHHHcCcHHHHHHHHcCCCHHHHHHHHHHHHHHHcCCHHHHHHHHHCCCHHHHHHH
Confidence 4677788889999999999999999999999999999998776 56677777888877777788999999999999999
Q ss_pred cccccceee--ehhhhhhhhhccCchhHHHHHhhhHHHHHHHHHhhccCCCchhhhhhHHHHHHhhccccccccccccCc
Q 000535 1278 LENEVWSVT--ALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGL 1355 (1437)
Q Consensus 1278 ~~~~~~~~~--a~~~~~~~l~~~~~~~kve~~l~~~~~~~~~v~~~~~~~~~~f~~~l~~~~k~~~~s~~~~~~~a~~~~ 1355 (1437)
|..+...+- |.-+|.-.-+|+++.++ .+.+-.+|..||++++......-.+.+..+-.++... .++.
T Consensus 497 L~s~~~~iqeeAawAL~NLa~~~~qir~---iV~~aGAIppLV~LL~sgd~~~q~~Aa~AL~nLi~~~--------d~~~ 565 (2102)
T PLN03200 497 LETGSQKAKEDSATVLWNLCCHSEDIRA---CVESAGAVPALLWLLKNGGPKGQEIAAKTLTKLVRTA--------DAAT 565 (2102)
T ss_pred HcCCCHHHHHHHHHHHHHHhCCcHHHHH---HHHHCCCHHHHHHHHhCCCHHHHHHHHHHHHHHHhcc--------chhH
Confidence 987643221 11111111123222222 2224468889999998765544466666666665432 2334
Q ss_pred hHHHHhhcccchhHHHHHHHHHHHHHHh
Q 000535 1356 TPLLIARLDHQDAIARLNLLKLIKAVYE 1383 (1437)
Q Consensus 1356 ~~~~~~~l~h~~~~~r~~ll~~~~~~~~ 1383 (1437)
.+.+..-|.|.++-.....|+.+.+|..
T Consensus 566 I~~Lv~LLlsdd~~~~~~aL~vLgnIls 593 (2102)
T PLN03200 566 ISQLTALLLGDLPESKVHVLDVLGHVLS 593 (2102)
T ss_pred HHHHHHHhcCCChhHHHHHHHHHHHHHh
Confidence 4556677999999999999998888864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.8e-05 Score=86.16 Aligned_cols=142 Identities=20% Similarity=0.234 Sum_probs=99.7
Q ss_pred EEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH----------------------HHHHHHHHHHHHhCC--CC
Q 000535 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED----------------------LNIIMQEIDLLKNLN--HK 77 (1437)
Q Consensus 22 IlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed----------------------ie~L~REIkILrrLn--HP 77 (1437)
+...|..|.-+.||+|.. .++..+|+|+++........ ..-..+|+.-|+++. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 344777899999999974 56899999998754322111 112356788888873 44
Q ss_pred CcceEEEEEEeCCeEEEEEeecCCCC-HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEeccC
Q 000535 78 NIVKYLGSLKTRSHLHIILEYVENGS-LANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKE 155 (1437)
Q Consensus 78 NIVKLigVfedd~~LYLVMEYceGGS-L~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLden 155 (1437)
.+.+-+.+. ...|||||+.... -.=.|+ .-++.+..+..+..++++.+.-|-. .++||+||..-|||+. +
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C
Confidence 455555555 3479999995431 011111 1123444688888999999988887 8999999999999999 8
Q ss_pred CcEEEEecccccccccC
Q 000535 156 GLVKLADFGVATKLTEA 172 (1437)
Q Consensus 156 G~VKLiDFGLAr~L~es 172 (1437)
+.+.|+|||-+....++
T Consensus 203 ~~p~iID~~QaV~~~hp 219 (268)
T COG1718 203 GEPYIIDVSQAVTIDHP 219 (268)
T ss_pred CeEEEEECccccccCCC
Confidence 88999999999876543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.2e-07 Score=116.32 Aligned_cols=221 Identities=16% Similarity=0.044 Sum_probs=160.8
Q ss_pred cccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCeEEEEEeecCCCCHHHHhccC--CCCCCCHHHHHHHHHHHH
Q 000535 54 ENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK--TRSHLHIILEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVL 129 (1437)
Q Consensus 54 e~lSeedie~L~REIkILrrLnHPNIVKLigVfe--dd~~LYLVMEYceGGSL~DLLKss--r~GpLSEs~I~rILrQIL 129 (1437)
+.+.+...+.+..|..-++.+.|+++.....-.. .....|.+++||.+|.+++.|-+. +..++.+.-+.....+.+
T Consensus 1266 e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsv 1345 (2724)
T KOG1826|consen 1266 ENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSV 1345 (2724)
T ss_pred HHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHH
Confidence 3344455555666777777889999888776553 345678999999999999998643 223455555555555657
Q ss_pred HHHHHHHHCC-----cccccccCCceEeccCCcEEEEecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhh
Q 000535 130 EGLVYLHEQG-----VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204 (1437)
Q Consensus 130 sALaYLHSnG-----IVHRDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWS 204 (1437)
.+..-+|+.. .+|+++|+-|.+|..+.++|+.++|+.+...+.........+++.|+.|++.+.-.++.++|+|.
T Consensus 1346 l~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1346 LNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILR 1425 (2724)
T ss_pred hccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHH
Confidence 7777777542 78999999999999999999999999995444444455678899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCChhHHHHHhhc-CCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHH
Q 000535 205 VGCTVIELLTCVPPYYELQPMPALFRIVQD-ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 205 LG~ILYELLTGkpPF~g~d~~eqL~kIiq~-~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQ 275 (1437)
.|+-+|....|..+|.... .+.+..++.. ....++...|.+.-.....+|-+....||.-...+..+.+-
T Consensus 1426 ~s~~ly~rs~~n~~fi~fl-q~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYFIFFL-QPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHHhcccHHHHHHH-HHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999999999887774311 1122222222 22334445566666777777778889999998888776653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.1e-05 Score=97.52 Aligned_cols=205 Identities=20% Similarity=0.349 Sum_probs=149.1
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe----EEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 000535 59 EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH----LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134 (1437)
Q Consensus 59 edie~L~REIkILrrLnHPNIVKLigVfedd~~----LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaY 134 (1437)
.++.....|...+..+.|+|++.++.|...+.. ..+..+||.+.++...+..- +..+....+.+..++++|+.|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHH
Confidence 344555667788888999999999988754432 34557899999999998754 678999999999999999999
Q ss_pred HHHCCcccccccCC---ceEeccCCcEEEE--ecccccccccCCcccccccCCCccCChhhhhcCCCCcc--chhhhHHH
Q 000535 135 LHEQGVIHRDIKGA---NILTTKEGLVKLA--DFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA--SDIWSVGC 207 (1437)
Q Consensus 135 LHSnGIVHRDLKPE---NILLdenG~VKLi--DFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~K--SDIWSLG~ 207 (1437)
+|+....|.-+..+ +--.+..+.+.+. ||+......... ......-+..|.+||......+..+ .|+|++|.
T Consensus 302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred HHHhccceeEEecccccccccCccceeecchhhhcccccCCCcc-cchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 99997666665555 3334455666666 888888776544 2233445667888888776665544 69999999
Q ss_pred HHHHHHhCCCCCCCCCChhHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHH
Q 000535 208 TVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 208 ILYELLTGkpPF~g~d~~eqL~kIiq~~rppiP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe 276 (1437)
.+..+..|..+-....... . ..+........+++.+|+..++++|+++.+++.|+|...
T Consensus 381 l~~~~~~~~~i~~~~~~~~---~-------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVPV---S-------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred HHhhhhhcCcccccccchh---h-------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 9999998765432111110 0 111122227889999999999999999999999999854
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.94 E-value=7.4e-05 Score=79.98 Aligned_cols=138 Identities=16% Similarity=0.096 Sum_probs=85.5
Q ss_pred eEecccCc-EEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEeecCC
Q 000535 24 DEIGKGAY-GRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EvLGrGgF-GtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNIVKLigVfedd~~LYLVMEYceG 101 (1437)
+.|-.|.. +.||++.. .+..+.+|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 44555665 78999964 34678888865432 234678999988883 44466778877777778999999999
Q ss_pred CCHHHHh-------------------ccCC--CCCCCHH---HHHHHHH-------------------HHHHHHHHHH--
Q 000535 102 GSLANII-------------------KPNK--FGPFPES---LVAVYIA-------------------QVLEGLVYLH-- 136 (1437)
Q Consensus 102 GSL~DLL-------------------Kssr--~GpLSEs---~I~rILr-------------------QILsALaYLH-- 136 (1437)
.++.+.. ...+ ..++... ....... .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8776432 1110 0011110 0000000 0111122221
Q ss_pred -----HCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 137 -----EQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 137 -----SnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12489999999999999988888999998854
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00018 Score=91.30 Aligned_cols=147 Identities=17% Similarity=0.303 Sum_probs=92.5
Q ss_pred EEeEecccCcEEEEEEEEcCCC--eEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CeEE
Q 000535 22 LGDEIGKGAYGRVYKGLDLENG--DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNI--VKYLGSLKTR---SHLH 93 (1437)
Q Consensus 22 IlEvLGrGgFGtVYKArDrkTG--k~VAIKVIkke~lSeedie~L~REIkILrrLn-HPNI--VKLigVfedd---~~LY 93 (1437)
-++.++.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.+. |+++ .+++.++.+. +..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3678899999999998764432 46788876543221 12345789999999995 6664 7777777654 5689
Q ss_pred EEEeecCCCCHHH--------------------Hh---ccCCC--------CC---CCHHHHHHHHHH------------
Q 000535 94 IILEYVENGSLAN--------------------II---KPNKF--------GP---FPESLVAVYIAQ------------ 127 (1437)
Q Consensus 94 LVMEYceGGSL~D--------------------LL---Kssr~--------Gp---LSEs~I~rILrQ------------ 127 (1437)
+||||++|..+.+ .+ +.-.. +. +.+..+..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999999864321 11 11000 00 112233332222
Q ss_pred ---HHHHHHHHHH-----------CCcccccccCCceEeccC-C-cEEEEeccccccc
Q 000535 128 ---VLEGLVYLHE-----------QGVIHRDIKGANILTTKE-G-LVKLADFGVATKL 169 (1437)
Q Consensus 128 ---ILsALaYLHS-----------nGIVHRDLKPENILLden-G-~VKLiDFGLAr~L 169 (1437)
+...+.+|.. ..+||+|+++.||+++.+ + .+-|.||.++..-
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2223456632 249999999999999853 3 4679999998653
|
|
| >PF05804 KAP: Kinesin-associated protein (KAP) | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00071 Score=84.97 Aligned_cols=226 Identities=23% Similarity=0.341 Sum_probs=165.8
Q ss_pred HhHhhhcchhhHHHhhhhhhHHHHHHHHhhhcCchHH---HHHhhhcCCChhHHHhhhcccchhhhccccccCCCCchHH
Q 000535 1125 LLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPIL---LKCVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSL 1201 (1437)
Q Consensus 1125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---lk~~~~~s~~~~~l~~~~~~~ai~~l~~~l~~~~~~~~~~ 1201 (1437)
+|+.+|- |+.|+.-|-.+.++.-|..++++=-++.+ +.|+++||....+=+.+-..++|..|+.+|.-++ ..
T Consensus 272 lLlNLAe-d~~ve~kM~~~~iV~~Lv~~Ldr~n~ellil~v~fLkkLSi~~ENK~~m~~~giV~kL~kLl~s~~----~~ 346 (708)
T PF05804_consen 272 LLLNLAE-DPRVELKMVNKGIVSLLVKCLDRENEELLILAVTFLKKLSIFKENKDEMAESGIVEKLLKLLPSEN----ED 346 (708)
T ss_pred HHHHHhc-ChHHHHHHHhcCCHHHHHHHHcCCCHHHHHHHHHHHHHHcCCHHHHHHHHHcCCHHHHHHHhcCCC----HH
Confidence 4566664 66777777889999999999888777765 4899999999999999999999999999986542 35
Q ss_pred HHHHHHHHHHhhhhcchhhHHHHHhcCCchhhhhhhccCCcccccchhhhhhhcccchhhHHHHHHcCCceeeecccccc
Q 000535 1202 IHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENE 1281 (1437)
Q Consensus 1202 ~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~~p~~~~~lp~l~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 1281 (1437)
..+..+..+|||+--..-|. +-.+.|+||.|..++. +...+++++=+|+.+...-+ +|
T Consensus 347 l~~~aLrlL~NLSfd~~~R~-~mV~~GlIPkLv~LL~-d~~~~~val~iLy~LS~dd~-~r------------------- 404 (708)
T PF05804_consen 347 LVNVALRLLFNLSFDPELRS-QMVSLGLIPKLVELLK-DPNFREVALKILYNLSMDDE-AR------------------- 404 (708)
T ss_pred HHHHHHHHHHHhCcCHHHHH-HHHHCCCcHHHHHHhC-CCchHHHHHHHHHHhccCHh-hH-------------------
Confidence 67789999999998887765 7889999999998886 45677778777776654321 12
Q ss_pred cceeeehhhhhhhhhccCchhHHHHHhhhHHHHHHHHHhhccCCCchhhhhhHHHHHHhhccccccccccc-cCchHHHH
Q 000535 1282 VWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAV-NGLTPLLI 1360 (1437)
Q Consensus 1282 ~~~~~a~~~~~~~l~~~~~~~kve~~l~~~~~~~~~v~~~~~~~~~~f~~~l~~~~k~~~~s~~~~~~~a~-~~~~~~~~ 1360 (1437)
..+-..+.|+.|++++..++++.=..-|=.++--+...++-+..+.. +|+..++.
T Consensus 405 ------------------------~~f~~TdcIp~L~~~Ll~~~~~~v~~eliaL~iNLa~~~rnaqlm~~g~gL~~L~~ 460 (708)
T PF05804_consen 405 ------------------------SMFAYTDCIPQLMQMLLENSEEEVQLELIALLINLALNKRNAQLMCEGNGLQSLMK 460 (708)
T ss_pred ------------------------HHHhhcchHHHHHHHHHhCCCccccHHHHHHHHHHhcCHHHHHHHHhcCcHHHHHH
Confidence 23333456777888888888877766566777777888888877766 66666665
Q ss_pred hhcccchhHHHHHHHHHHHHHHhcCCCCcccccccChhHHHHHHHHHHhc
Q 000535 1361 ARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRD 1410 (1437)
Q Consensus 1361 ~~l~h~~~~~r~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1410 (1437)
.-+..+++. |+|+||+|-.|.+.-+. .+..-+-++++.+..
T Consensus 461 ra~~~~D~l----LlKlIRNiS~h~~~~k~-----~f~~~i~~L~~~v~~ 501 (708)
T PF05804_consen 461 RALKTRDPL----LLKLIRNISQHDGPLKE-----LFVDFIGDLAKIVSS 501 (708)
T ss_pred HHHhcccHH----HHHHHHHHHhcCchHHH-----HHHHHHHHHHHHhhc
Confidence 556666654 88999999987643333 334445566655543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00047 Score=74.10 Aligned_cols=74 Identities=14% Similarity=0.184 Sum_probs=46.9
Q ss_pred EeEecccCcEE-EEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CeEEEE
Q 000535 23 GDEIGKGAYGR-VYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK---NIVKYLGSLKTR---SHLHII 95 (1437)
Q Consensus 23 lEvLGrGgFGt-VYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHP---NIVKLigVfedd---~~LYLV 95 (1437)
++.|+.|+... ||+. +..+++|+.... .....+.+|.++++.|... -+.++++..... ...|++
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 35788777775 9986 235777865431 1234688899999887531 244444443332 245889
Q ss_pred EeecCCCCHH
Q 000535 96 LEYVENGSLA 105 (1437)
Q Consensus 96 MEYceGGSL~ 105 (1437)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0014 Score=72.01 Aligned_cols=128 Identities=26% Similarity=0.337 Sum_probs=92.1
Q ss_pred CCceEEEeEecccCc-EEEEEEEEcCCCeEEEEEEeeccc----------cCH---------HHHHHHHHHHHHHHhC--
Q 000535 17 DNKYMLGDEIGKGAY-GRVYKGLDLENGDFVAIKQVSLEN----------IAQ---------EDLNIIMQEIDLLKNL-- 74 (1437)
Q Consensus 17 ggRYeIlEvLGrGgF-GtVYKArDrkTGk~VAIKVIkke~----------lSe---------edie~L~REIkILrrL-- 74 (1437)
...++.++.||.|.. |.||+++- .|+.||+|+.+.-. ... ....-+..|.+...+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 99999975 78899999933210 110 1123466777777666
Q ss_pred -CCCCc--ceEEEEEEeC------------------CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHH
Q 000535 75 -NHKNI--VKYLGSLKTR------------------SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133 (1437)
Q Consensus 75 -nHPNI--VKLigVfedd------------------~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALa 133 (1437)
.+.++ |++++|..-. ....||.||++... .+. ..-+.+|++-+.
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHH
Confidence 45566 9999988321 12468888886533 122 233567888899
Q ss_pred HHHHCCcccccccCCceEeccCCcEEEEecccc
Q 000535 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVA 166 (1437)
Q Consensus 134 YLHSnGIVHRDLKPENILLdenG~VKLiDFGLA 166 (1437)
.+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999999987 2479999975
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0016 Score=69.29 Aligned_cols=75 Identities=17% Similarity=0.193 Sum_probs=48.1
Q ss_pred EeEecccCcEEEEEEEEcC-CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCeEEEEEeecC
Q 000535 23 GDEIGKGAYGRVYKGLDLE-NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN-IVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrk-TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPN-IVKLigVfedd~~LYLVMEYce 100 (1437)
.+.|..|-...+|++.... .++.|++|+...... . .-...+|+.+++.+...+ ..+++..+. . .+||||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--L-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--c-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 4678888889999996533 357888997653221 1 112347888888885433 344444332 2 37999999
Q ss_pred CCCH
Q 000535 101 NGSL 104 (1437)
Q Consensus 101 GGSL 104 (1437)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00073 Score=73.24 Aligned_cols=130 Identities=22% Similarity=0.224 Sum_probs=94.3
Q ss_pred EEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcce-EEEEEEeCCeEEEEEeec
Q 000535 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK-YLGSLKTRSHLHIILEYV 99 (1437)
Q Consensus 21 eIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIVK-LigVfedd~~LYLVMEYc 99 (1437)
++.+.|++|.+|.||++.+ .|..+|+|+-+.. .....+..|+++|..+.--++-+ ++.|.++ ++.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 4567899999999999986 5668999985533 34467889999999998777654 4444333 3459999
Q ss_pred CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccccc-CCceEeccCCcEEEEeccccccc
Q 000535 100 ENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIK-GANILTTKEGLVKLADFGVATKL 169 (1437)
Q Consensus 100 eGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLK-PENILLdenG~VKLiDFGLAr~L 169 (1437)
.|-+|.++-... + .+-+..+++.-.-|-..||-|+.|. |...+|..++.+.|+||..|+..
T Consensus 95 ~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 998887765411 1 2334456666566778899999985 66666666668999999999853
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0026 Score=68.10 Aligned_cols=101 Identities=30% Similarity=0.277 Sum_probs=79.4
Q ss_pred HHHHHHHhCCC-CCcceEEEEEEeCCeEEEEEeecCCCCHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCc
Q 000535 66 QEIDLLKNLNH-KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKP-NKFGPFPESLVAVYIAQVLEGLVYLHE---QGV 140 (1437)
Q Consensus 66 REIkILrrLnH-PNIVKLigVfedd~~LYLVMEYceGGSL~DLLKs-sr~GpLSEs~I~rILrQILsALaYLHS---nGI 140 (1437)
.|.-+|+.+.+ +++.+++|+|-. ++|+||...+++...... .....-++.....|+.++++.+++++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47778888865 699999999832 678999987766532100 011236889999999999999999997 357
Q ss_pred ccccccCCceEeccCCcEEEEecccccccc
Q 000535 141 IHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 141 VHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
.-.|++|+|+-++++|.+|++|...+....
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 788999999999999999999999886543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0024 Score=71.32 Aligned_cols=139 Identities=16% Similarity=0.137 Sum_probs=75.6
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-----CCCcceEE---EEEEeCCeEEE
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-----HKNIVKYL---GSLKTRSHLHI 94 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn-----HPNIVKLi---gVfedd~~LYL 94 (1437)
.+.|+.|....+|.... ++..+++|++. .... +.+..|+.+++.|. .|.++.-. .+....+..++
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 45667788889999864 23468899875 2222 23334555555552 33333211 12234567899
Q ss_pred EEeecCCCCHH-----------HHhc---c--CCCC-----CCC--H-HH-HH-----------HHHHHHH-HHHHHHH-
Q 000535 95 ILEYVENGSLA-----------NIIK---P--NKFG-----PFP--E-SL-VA-----------VYIAQVL-EGLVYLH- 136 (1437)
Q Consensus 95 VMEYceGGSL~-----------DLLK---s--sr~G-----pLS--E-s~-I~-----------rILrQIL-sALaYLH- 136 (1437)
+++|++|..+. +.+- . .... ... . .. .. ..+.+.+ ..+..+-
T Consensus 100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 99999987431 1110 0 0000 000 0 00 00 0111111 1122222
Q ss_pred ------HCCcccccccCCceEeccCCcEEEEecccccc
Q 000535 137 ------EQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 137 ------SnGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
..+++|+|++|.||+++.+...-|+||+.+..
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 23799999999999998666668999999854
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0034 Score=68.21 Aligned_cols=133 Identities=20% Similarity=0.323 Sum_probs=94.8
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccc--------------cCHHHHHHHHHHHHHHHhCC------CCCcceEE
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLEN--------------IAQEDLNIIMQEIDLLKNLN------HKNIVKYL 83 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~--------------lSeedie~L~REIkILrrLn------HPNIVKLi 83 (1437)
..||+|+.=.||.-- .+...+||++.... ..........+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 578999999999853 45667789987665 11112345566776666665 78899999
Q ss_pred EEEEeCCeEEEEEeecCC------CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCC-
Q 000535 84 GSLKTRSHLHIILEYVEN------GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG- 156 (1437)
Q Consensus 84 gVfedd~~LYLVMEYceG------GSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG- 156 (1437)
|+.+++.-.-+|+|.+.. -+|.++++.. .+++ ... ..+-.-..||-+++|+.+|++|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999999999997643 2688888533 4655 333 3344555788999999999999999997543
Q ss_pred ---cEEEEe-cccc
Q 000535 157 ---LVKLAD-FGVA 166 (1437)
Q Consensus 157 ---~VKLiD-FGLA 166 (1437)
.++|+| ||-.
T Consensus 157 ~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 157 GEFRLVLIDGLGEK 170 (199)
T ss_pred CceEEEEEeCCCCc
Confidence 577777 3443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF05804 KAP: Kinesin-associated protein (KAP) | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0046 Score=77.96 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=181.2
Q ss_pred HHhhhhhhHHHHHHHHhhhcCchHH---HHHhhhcCCChhHHHhhhcccchhhhccccccCCCCchHHHHHHHHHHHHhh
Q 000535 1137 KSYMCSQSLLSRLFQMFNRIEPPIL---LKCVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNL 1213 (1437)
Q Consensus 1137 ~~~~~~~~~~~~~~~~~~~~~~~~~---lk~~~~~s~~~~~l~~~~~~~ai~~l~~~l~~~~~~~~~~~~~~~~~~~~n~ 1213 (1437)
|+-|....++.+|.+++..=.+..+ |+.+-|||-|+++-..+.++..|..|++.|. +.+ ++.+ ++..+|||
T Consensus 324 K~~m~~~giV~kL~kLl~s~~~~l~~~aLrlL~NLSfd~~~R~~mV~~GlIPkLv~LL~--d~~-~~~v---al~iLy~L 397 (708)
T PF05804_consen 324 KDEMAESGIVEKLLKLLPSENEDLVNVALRLLFNLSFDPELRSQMVSLGLIPKLVELLK--DPN-FREV---ALKILYNL 397 (708)
T ss_pred HHHHHHcCCHHHHHHHhcCCCHHHHHHHHHHHHHhCcCHHHHHHHHHCCCcHHHHHHhC--CCc-hHHH---HHHHHHHh
Confidence 8888899999999999976555544 7899999999999999999999999999996 232 3332 78899999
Q ss_pred hhcchhhHHHHHhcCCchhhhhhhccCCccc--ccchhhhhhhcccchhhHHHHHHcCCceeeecccccccceeeehhhh
Q 000535 1214 CKINKRRQEQAAENGIIPHLMHFIMSDSPLK--QYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSI 1291 (1437)
Q Consensus 1214 c~~~k~rqe~aa~~giip~~~~~~~~~~p~~--~~~lp~l~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~ 1291 (1437)
|.-.+.|- .-+..+.||.+++.+.+.+.-. .-++.+++.+|+.-||..... .-+||..-+...-. |+ |+.
T Consensus 398 S~dd~~r~-~f~~TdcIp~L~~~Ll~~~~~~v~~eliaL~iNLa~~~rnaqlm~-~g~gL~~L~~ra~~--~~----D~l 469 (708)
T PF05804_consen 398 SMDDEARS-MFAYTDCIPQLMQMLLENSEEEVQLELIALLINLALNKRNAQLMC-EGNGLQSLMKRALK--TR----DPL 469 (708)
T ss_pred ccCHhhHH-HHhhcchHHHHHHHHHhCCCccccHHHHHHHHHHhcCHHHHHHHH-hcCcHHHHHHHHHh--cc----cHH
Confidence 99877664 5566688999999988754332 235689999999999995554 45888877766432 22 333
Q ss_pred h-hh----hhccCchhHHHHHhhhHHHHHHHHHhhccCCCchh-hhhhHHHHHHhhccccccccccccCchHHHHhhccc
Q 000535 1292 A-VC----LAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHF-VHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDH 1365 (1437)
Q Consensus 1292 ~-~~----l~~~~~~~kve~~l~~~~~~~~~v~~~~~~~~~~f-~~~l~~~~k~~~~s~~~~~~~a~~~~~~~~~~~l~h 1365 (1437)
. .+ =.|+. ..+ .+. .+||..|+++.+.|....| .+.|--+-.+-..+-..+..+-..++.|.|...|.-
T Consensus 470 LlKlIRNiS~h~~---~~k-~~f-~~~i~~L~~~v~~~~~ee~~vE~LGiLaNL~~~~ld~~~ll~~~~llp~L~~~L~~ 544 (708)
T PF05804_consen 470 LLKLIRNISQHDG---PLK-ELF-VDFIGDLAKIVSSGDSEEFVVECLGILANLTIPDLDWAQLLQEYNLLPWLKDLLKP 544 (708)
T ss_pred HHHHHHHHHhcCc---hHH-HHH-HHHHHHHHHHhhcCCcHHHHHHHHHHHHhcccCCcCHHHHHHhCCHHHHHHHHhCC
Confidence 2 11 13432 233 344 3599999999999987776 343332222111222444455566888888888842
Q ss_pred c--hhHHHHHHHHHHHHHHhcCCCCcccccccChhHHHHHHHHHHh
Q 000535 1366 Q--DAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERR 1409 (1437)
Q Consensus 1366 ~--~~~~r~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1409 (1437)
. +.=+-|....++.+++ .-+....+++++++...|-+|+...|
T Consensus 545 g~~~dDl~LE~Vi~~gtla-~d~~~A~lL~~sgli~~Li~LL~~kq 589 (708)
T PF05804_consen 545 GASEDDLLLEVVILLGTLA-SDPECAPLLAKSGLIPTLIELLNAKQ 589 (708)
T ss_pred CCCChHHHHHHHHHHHHHH-CCHHHHHHHHhCChHHHHHHHHHhhC
Confidence 2 2246778888888877 56788889999999999999988877
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.004 Score=70.43 Aligned_cols=80 Identities=15% Similarity=0.067 Sum_probs=57.2
Q ss_pred ceEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCeE
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH---KNIVKYLGSLKT---RSHL 92 (1437)
Q Consensus 19 RYeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnH---PNIVKLigVfed---d~~L 92 (1437)
.-.-.+.||.|..+.||.... .+..+.+|..+. . .....+..|...|+.|.- -.+.++++++.. .+..
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 445567899999999999864 223567777432 1 122467889999988842 467788877754 4678
Q ss_pred EEEEeecCCCCH
Q 000535 93 HIILEYVENGSL 104 (1437)
Q Consensus 93 YLVMEYceGGSL 104 (1437)
+||||+++|+++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0074 Score=66.54 Aligned_cols=140 Identities=16% Similarity=0.177 Sum_probs=83.9
Q ss_pred EEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCC--CcceEEE------EEEeCCeEE
Q 000535 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK--NIVKYLG------SLKTRSHLH 93 (1437)
Q Consensus 22 IlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHP--NIVKLig------Vfedd~~LY 93 (1437)
-.+.|..|....+|+... .+..+++|+... .....+..|+.++..|.+- .+.+++. +...++..+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 356788888889999864 345788898753 1224466788887777322 2444443 223456778
Q ss_pred EEEeecCCCCHHH-----------Hh---cc--CCCC-C------CC--HHHHH--------HHHHHHHHHHHHHHH---
Q 000535 94 IILEYVENGSLAN-----------II---KP--NKFG-P------FP--ESLVA--------VYIAQVLEGLVYLHE--- 137 (1437)
Q Consensus 94 LVMEYceGGSL~D-----------LL---Ks--sr~G-p------LS--Es~I~--------rILrQILsALaYLHS--- 137 (1437)
+|++|++|..+.. .+ .. .... . .. ..... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876421 00 00 0000 0 00 00000 011112233444443
Q ss_pred ----CCcccccccCCceEeccCCcEEEEecccccc
Q 000535 138 ----QGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 138 ----nGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987788999999854
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0025 Score=69.31 Aligned_cols=135 Identities=19% Similarity=0.225 Sum_probs=77.5
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCeEEEEEeecCCCC
Q 000535 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI-VKYLGSLKTRSHLHIILEYVENGS 103 (1437)
Q Consensus 25 vLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNI-VKLigVfedd~~LYLVMEYceGGS 103 (1437)
.+..|-...+|+.. .++..|++|........ -.. ...+|..+++.+....+ .+++... . -++||||++|..
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~-~~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA-LGV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc-ccC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence 35667778899886 45778888875432111 001 24678888888854333 3333333 2 268999999866
Q ss_pred HHH--------------Hh---ccCC--CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCccccccc
Q 000535 104 LAN--------------II---KPNK--FGPFPE-SLVAVYIAQV---------LEGLVYLHE--------QGVIHRDIK 146 (1437)
Q Consensus 104 L~D--------------LL---Kssr--~GpLSE-s~I~rILrQI---------LsALaYLHS--------nGIVHRDLK 146 (1437)
+.. .+ ...+ ..+++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 532 11 1111 111221 1222222222 111222222 248999999
Q ss_pred CCceEeccCCcEEEEecccccc
Q 000535 147 GANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 147 PENILLdenG~VKLiDFGLAr~ 168 (1437)
|.||+++.++ ++|+||..+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999877 78999999865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0098 Score=66.66 Aligned_cols=141 Identities=16% Similarity=0.148 Sum_probs=81.2
Q ss_pred EEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCC--CcceEEE------EEEeCCeEE
Q 000535 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK--NIVKYLG------SLKTRSHLH 93 (1437)
Q Consensus 22 IlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnHP--NIVKLig------Vfedd~~LY 93 (1437)
....++.|-...+|++.. ++..+++|+..... . .+.+..|+.++..|... .+.+++. +....+..+
T Consensus 26 ~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred eccccCCccccceEEEEe--CCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 356677787789999864 34467789765421 1 22345667777766321 2334333 122356789
Q ss_pred EEEeecCCCCHH-----------HHh---cc--CCCC-C----CCHHH-----HH----------HHHHHHHHHHHHHHH
Q 000535 94 IILEYVENGSLA-----------NII---KP--NKFG-P----FPESL-----VA----------VYIAQVLEGLVYLHE 137 (1437)
Q Consensus 94 LVMEYceGGSL~-----------DLL---Ks--sr~G-p----LSEs~-----I~----------rILrQILsALaYLHS 137 (1437)
++++|++|..+. ..+ .. .... + ..... .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999985431 111 10 0000 0 00000 00 001123334555542
Q ss_pred -------CCcccccccCCceEeccCCcEEEEecccccc
Q 000535 138 -------QGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 138 -------nGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
.+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5799999999999999988778999999854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0026 Score=78.00 Aligned_cols=143 Identities=15% Similarity=0.195 Sum_probs=88.1
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCH--HH---------------------------HHHH------HHHH
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ--ED---------------------------LNII------MQEI 68 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSe--ed---------------------------ie~L------~REI 68 (1437)
+.||.-+.|.||+|+-+. |+.||||+-+..-... .+ .+.+ .+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 588999999999998655 9999999865421100 01 1112 2233
Q ss_pred HHHHh----CCCCCcce---EEEEEEe-CCeEEEEEeecCCCCHHHH--hccCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 000535 69 DLLKN----LNHKNIVK---YLGSLKT-RSHLHIILEYVENGSLANI--IKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138 (1437)
Q Consensus 69 kILrr----LnHPNIVK---LigVfed-d~~LYLVMEYceGGSL~DL--LKssr~GpLSEs~I~rILrQILsALaYLHSn 138 (1437)
+-..+ +.|-+... +=.++.+ .....|+||||+|..+.|+ |++. .++...+...+.+.. ++.|-..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH--HHHHHhc
Confidence 32222 23444111 2222222 3456899999999866544 3333 355554443333222 2334467
Q ss_pred CcccccccCCceEecc----CCcEEEEecccccccccC
Q 000535 139 GVIHRDIKGANILTTK----EGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 139 GIVHRDLKPENILLde----nG~VKLiDFGLAr~L~es 172 (1437)
|++|.|=+|.||++.. ++.+.+.|||+...+.+.
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8999999999999994 568999999999887654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0069 Score=67.24 Aligned_cols=76 Identities=21% Similarity=0.206 Sum_probs=48.1
Q ss_pred EeEecccCcEEEEEEEEcC------CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCeEEEE
Q 000535 23 GDEIGKGAYGRVYKGLDLE------NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI-VKYLGSLKTRSHLHII 95 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrk------TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNI-VKLigVfedd~~LYLV 95 (1437)
++.|..|--..||++.... .++.|++|+..... .......+|..+++.+....+ .+++.++. + .+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 3566777777899987533 25789999865432 122345678888888743333 34555543 2 358
Q ss_pred EeecCCCCHH
Q 000535 96 LEYVENGSLA 105 (1437)
Q Consensus 96 MEYceGGSL~ 105 (1437)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999987664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.011 Score=70.52 Aligned_cols=79 Identities=22% Similarity=0.160 Sum_probs=54.8
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeecccc-----CHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCeEEE
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-----AQEDLNIIMQEIDLLKNLN---HKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l-----Seedie~L~REIkILrrLn---HPNIVKLigVfedd~~LYL 94 (1437)
.+.||.|.+..||++.+...++.|+||.-..... .....++...|.+.|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 3789999999999998854446899997532111 0124566777888888873 2456666666 4456789
Q ss_pred EEeecCCCC
Q 000535 95 ILEYVENGS 103 (1437)
Q Consensus 95 VMEYceGGS 103 (1437)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0013 Score=76.70 Aligned_cols=138 Identities=20% Similarity=0.303 Sum_probs=99.5
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH---------------H-----HHHHHHHHHHHhCC-CC-
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED---------------L-----NIIMQEIDLLKNLN-HK- 77 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed---------------i-----e~L~REIkILrrLn-HP- 77 (1437)
|.++..||-|.-+.||.+-+ ..|.++++|.-+....+-.. + -...+|+..|+.|. |-
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67889999999999999976 55888999864433221111 1 12356888888884 32
Q ss_pred CcceEEEEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCceEeccCCc
Q 000535 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGL 157 (1437)
Q Consensus 78 NIVKLigVfedd~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVHRDLKPENILLdenG~ 157 (1437)
-+.+.+++ ...++|||++.|..|....+-. .+..+...+..-+--|..+|+||+|..--||++++++.
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 24455544 3568999999998887765321 23345555666677888999999999999999999999
Q ss_pred EEEEecccccccc
Q 000535 158 VKLADFGVATKLT 170 (1437)
Q Consensus 158 VKLiDFGLAr~L~ 170 (1437)
++++||--+....
T Consensus 241 i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 241 IVVIDFPQMVSTS 253 (465)
T ss_pred EEEeechHhhccC
Confidence 9999998765543
|
|
| >PLN03200 cellulose synthase-interactive protein; Provisional | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.022 Score=78.34 Aligned_cols=279 Identities=17% Similarity=0.177 Sum_probs=161.7
Q ss_pred HHhHhhhcchhhHHHhhhhhhHHHHHHHHhhhcCchHHHHHh----hhcCCChhHHHhhhcccchhhhccccccCCCCch
Q 000535 1124 DLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPILLKCV----NHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLV 1199 (1437)
Q Consensus 1124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lk~~----~~~s~~~~~l~~~~~~~ai~~l~~~l~~~~~~~~ 1199 (1437)
-.|...+..+......+.....+..+.++++.-.|....++. +.++.+++.-+.+-.+.||..|+.+|+. |+..
T Consensus 169 ~AL~nLs~~~en~~~~IIeaGaVp~LV~LLsS~d~~lQ~eAa~aLa~Lass~ee~~~aVIeaGaVP~LV~LL~s--g~~~ 246 (2102)
T PLN03200 169 GALRNLCGSTDGFWSATLEAGGVDILVKLLSSGNSDAQANAASLLARLMMAFESSISKVLDAGAVKQLLKLLGQ--GNEV 246 (2102)
T ss_pred HHHHHHhcCccchHHHHHHcCCHHHHHHHHcCCCHHHHHHHHHHHHHHHcCChHHHHHHHHCCCHHHHHHHHcc--CCCh
Confidence 344555666666666666667888888888876666554432 3345667677777789999999999964 2221
Q ss_pred HHHHHHHHHHHHhhhhcchhhHHHHHhcCCchhhhhhhccCC----------cccccch--------------hhhhhhc
Q 000535 1200 SLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDS----------PLKQYAL--------------PLLCDMA 1255 (1437)
Q Consensus 1200 ~~~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~~----------p~~~~~l--------------p~l~~~a 1255 (1437)
.+..+-..++.|||.-+..=.....+.|.||.|.+.+.+.+ .|+++|. |.|++.-
T Consensus 247 -~VRE~AA~AL~nLAs~s~e~r~~Iv~aGgIp~LI~lL~sp~~e~~~~~~~~~Lqe~AvwALsNIcgg~~~ll~~L~~ll 325 (2102)
T PLN03200 247 -SVRAEAAGALEALSSQSKEAKQAIADAGGIPALINATVAPSKEFMQGEFAQALQENAMGALANICGGMSALILYLGELS 325 (2102)
T ss_pred -HHHHHHHHHHHHHhcCCHHHHHHHHHCCCHHHHHHHHhCcchhhhccccchHHHHHHHHHHHHHhCCchhhHHHHHHhh
Confidence 44556777899999987666667788999999999986422 2344444 3444333
Q ss_pred ccchhhHHHHHHcCCceeeecccccccceeeehhh------hhhhhhccCchh---HHHHH-------------hhhHHH
Q 000535 1256 HASRNSREQLRAHGGLDVYLNLLENEVWSVTALDS------IAVCLAHDNDNR---KVEQA-------------LLKKDA 1313 (1437)
Q Consensus 1256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~------~~~~l~~~~~~~---kve~~-------------l~~~~~ 1313 (1437)
|+.|..--.--.+|+++--+.+++++.=.+.++|+ +...+.|.+... .|=++ |.+.++
T Consensus 326 ~s~rd~~~~ada~gALayll~l~d~~~~~~~~i~~~~v~~~LV~Llr~k~p~~vqe~V~eALasl~gN~~l~~~L~~~da 405 (2102)
T PLN03200 326 ESPRSPAPIADTLGALAYALMVFDSSAESTRAFDPTVIEQILVKLLKPRDTKLVQERIIEALASLYGNAYLSRKLNHAEA 405 (2102)
T ss_pred cccchHHHHHHHHhhHHHHHHhcCCchhhhhhccccccHHHHHHHhCCCCCchhHHHHHHHHHHhcCChHHHHHHHhccc
Confidence 33333222222333333333333332211222221 222222322211 01111 111122
Q ss_pred HHHHHHhhccCCCchhhhhhHHHHHHhhccccccccccccCchHHHHhhcccchhHHHHHHHHHHHHHHhcCCCCccccc
Q 000535 1314 VQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIV 1393 (1437)
Q Consensus 1314 ~~~~v~~~~~~~~~~f~~~l~~~~k~~~~s~~~~~~~a~~~~~~~~~~~l~h~~~~~r~~ll~~~~~~~~~~~~~~~~~~ 1393 (1437)
+.-||+.++.--...=.+...-+.-+..........+...|..+.|+..|.|.+..++-.-++.++++....++..+.+.
T Consensus 406 ik~LV~LL~~~~~evQ~~Av~aL~~L~~~~~e~~~aIi~~ggIp~LV~LL~s~s~~iQ~~A~~~L~nLa~~ndenr~aIi 485 (2102)
T PLN03200 406 KKVLVGLITMATADVQEELIRALSSLCCGKGGLWEALGGREGVQLLISLLGLSSEQQQEYAVALLAILTDEVDESKWAIT 485 (2102)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHhCCCHHHHHHHHHcCcHHHHHHHHcCCCHHHHHHHHHHHHHHHcCCHHHHHHHH
Confidence 22233333222211112222222222223344445666778899999999999999999999999999887777888888
Q ss_pred ccChhHHHHHHH
Q 000535 1394 ENDLPQKLQNLI 1405 (1437)
Q Consensus 1394 ~~~~~~~~~~~~ 1405 (1437)
+.|....|-+++
T Consensus 486 eaGaIP~LV~LL 497 (2102)
T PLN03200 486 AAGGIPPLVQLL 497 (2102)
T ss_pred HCCCHHHHHHHH
Confidence 888777777776
|
|
| >PF10508 Proteasom_PSMB: Proteasome non-ATPase 26S subunit; InterPro: IPR019538 The 26S proteasome is an enzymatic complex that degrades ubiquitinated proteins in eukaryotic cells | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0056 Score=74.24 Aligned_cols=190 Identities=21% Similarity=0.320 Sum_probs=149.5
Q ss_pred hhhHHHHHhcCCchhhhhhhccCCc-ccccchhhhhhhcccchhhHHHHHHcCCceeeeccccccccee--eehhhhhhh
Q 000535 1218 KRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSV--TALDSIAVC 1294 (1437)
Q Consensus 1218 k~rqe~aa~~giip~~~~~~~~~~p-~~~~~lp~l~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~a~~~~~~~ 1294 (1437)
+...=.....+++|.|+..+..++| .|+.++=.|+.+++.+...-+.+-.++=+..-+.+|.|+-=+| .|..++...
T Consensus 67 ~~~~~~~l~~~~~~~L~~gL~h~~~~Vr~l~l~~l~~~~~~~~~~~~~~~~~~l~~~i~~~L~~~d~~Va~~A~~~L~~l 146 (503)
T PF10508_consen 67 SALSPDSLLPQYQPFLQRGLTHPSPKVRRLALKQLGRIARHSEGAAQLLVDNELLPLIIQCLRDPDLSVAKAAIKALKKL 146 (503)
T ss_pred hccCHHHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHhcCCHHHHHHhcCccHHHHHHHHHcCCcHHHHHHHHHHHHHH
Confidence 3333334467888999998888776 6888888899998877665555655665555566776665444 345555544
Q ss_pred hhccCchhHHHHHhhhHHHHHHHHHhhccCCCchhhhhhHHHHHHhhccccccccccccCchHHHHhhcccchhHHHHHH
Q 000535 1295 LAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNL 1374 (1437)
Q Consensus 1295 l~~~~~~~kve~~l~~~~~~~~~v~~~~~~~~~~f~~~l~~~~k~~~~s~~~~~~~a~~~~~~~~~~~l~h~~~~~r~~l 1374 (1437)
..+. ... +.|++...+..|.+.+..|.+...-.++|-+.+|-..|+.........|+.+.+..-|+-.|-.+++|.
T Consensus 147 ~~~~---~~~-~~l~~~~~~~~L~~l~~~~~~~vR~Rv~el~v~i~~~S~~~~~~~~~sgll~~ll~eL~~dDiLvqlna 222 (503)
T PF10508_consen 147 ASHP---EGL-EQLFDSNLLSKLKSLMSQSSDIVRCRVYELLVEIASHSPEAAEAVVNSGLLDLLLKELDSDDILVQLNA 222 (503)
T ss_pred hCCc---hhH-HHHhCcchHHHHHHHHhccCHHHHHHHHHHHHHHHhcCHHHHHHHHhccHHHHHHHHhcCccHHHHHHH
Confidence 4332 222 347788889999999999888788899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCcccccccChhHHHHHHHHHHhccc
Q 000535 1375 LKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQ 1412 (1437)
Q Consensus 1375 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1412 (1437)
+.++..+.+ ++..-+.+++.++.++|-+++.+-....
T Consensus 223 lell~~La~-~~~g~~yL~~~gi~~~L~~~l~~~~~dp 259 (503)
T PF10508_consen 223 LELLSELAE-TPHGLQYLEQQGIFDKLSNLLQDSEEDP 259 (503)
T ss_pred HHHHHHHHc-ChhHHHHHHhCCHHHHHHHHHhccccCC
Confidence 999999999 7777888999999999999988776433
|
26S proteasome non-ATPase regulatory subunit 5 is one of a number of chaperones that are involved in the assembly of the proteasome. The chaperones dissociate before 26S proteasome formation is complete [].; GO: 0044183 protein binding involved in protein folding |
| >cd00020 ARM Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.012 Score=55.10 Aligned_cols=107 Identities=18% Similarity=0.220 Sum_probs=79.8
Q ss_pred hhHHHHHHHHhhhcCchHH---HHHhhhcCCC-hhHHHhhhcccchhhhccccccCCCCchHHHHHHHHHHHHhhhhcch
Q 000535 1143 QSLLSRLFQMFNRIEPPIL---LKCVNHLSTD-PNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINK 1218 (1437)
Q Consensus 1143 ~~~~~~~~~~~~~~~~~~~---lk~~~~~s~~-~~~l~~~~~~~ai~~l~~~l~~~~~~~~~~~~~~~~~~~~n~c~~~k 1218 (1437)
..++..+.+++..-.|... +.++.+++.+ +.+.+.+-+.++|+.|++.|.-+ -..+....+.++.|||.-.+
T Consensus 6 ~~~i~~l~~~l~~~~~~~~~~a~~~l~~l~~~~~~~~~~~~~~~~i~~l~~~l~~~----~~~v~~~a~~~L~~l~~~~~ 81 (120)
T cd00020 6 AGGLPALVSLLSSSDENVQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQLLKSE----DEEVVKAALWALRNLAAGPE 81 (120)
T ss_pred cCChHHHHHHHHcCCHHHHHHHHHHHHHHhcCCHHHHHHHHHCCChHHHHHHHhCC----CHHHHHHHHHHHHHHccCcH
Confidence 3355555665555555543 5578888665 78888888889999999998753 35677789999999999999
Q ss_pred hhHHHHHhcCCchhhhhhhccC-Ccccccchhhhhh
Q 000535 1219 RRQEQAAENGIIPHLMHFIMSD-SPLKQYALPLLCD 1253 (1437)
Q Consensus 1219 ~rqe~aa~~giip~~~~~~~~~-~p~~~~~lp~l~~ 1253 (1437)
...+.+..+|+||.|.+.+.++ ...++.++=+|+.
T Consensus 82 ~~~~~~~~~g~l~~l~~~l~~~~~~~~~~a~~~l~~ 117 (120)
T cd00020 82 DNKLIVLEAGGVPKLVNLLDSSNEDIQKNATGALSN 117 (120)
T ss_pred HHHHHHHHCCChHHHHHHHhcCCHHHHHHHHHHHHH
Confidence 9999999999999999999875 3444555444443
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.013 Score=71.80 Aligned_cols=160 Identities=23% Similarity=0.324 Sum_probs=104.6
Q ss_pred HHHHHHHHHhCCCCCcceEEEEEEeC-CeEEEEEeecCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 000535 64 IMQEIDLLKNLNHKNIVKYLGSLKTR-SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142 (1437)
Q Consensus 64 L~REIkILrrLnHPNIVKLigVfedd-~~LYLVMEYceGGSL~DLLKssr~GpLSEs~I~rILrQILsALaYLHSnGIVH 142 (1437)
+.....+++.+.|+|...++++.+.. ....+|||++. .||.++++.+... +..+. +|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~------~~s~~---------------~~ 86 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLK------DESLL---------------AH 86 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccc------hhhhc---------------cc
Confidence 33456789999999999999988653 45889999994 6999998754311 01111 22
Q ss_pred ccccCCceEeccCCcEEEEecccccccccCCcccccccCCCccCChhhhhcCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 000535 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYEL 222 (1437)
Q Consensus 143 RDLKPENILLdenG~VKLiDFGLAr~L~esd~kt~t~~GTp~YmAPEVL~g~~yS~KSDIWSLG~ILYELLTGkpPF~g~ 222 (1437)
|=+ +-| .++++| -++.. . ....| +++||||+|.++.++.-|..-|...
T Consensus 87 ~~~-~~~-------~~~~td-~~~t~---~----~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 87 GVL-HLN-------IIYITD-HFLTK---Y----PSPIG----------------PKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred ccc-eeh-------hhhccc-ccccc---C----CCCCC----------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence 211 111 233344 11100 0 01111 3999999999999999998777665
Q ss_pred CChhHHHHHhhcCCCC-----------CCCCCCHHHHHHHHHHhhhcccCCCCHHHHhcCHHHHHH
Q 000535 223 QPMPALFRIVQDERPP-----------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 223 d~~eqL~kIiq~~rpp-----------iP~~ISpELkDLIrkCLqkDPeKRPSAeELLkHPWFQe~ 277 (1437)
...+.+..+.+-...+ +...++..+.++..+|+-..|..||...++.+++-|.+.
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 5555444443322211 123467778999999999999999999999999988765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.047 Score=63.63 Aligned_cols=148 Identities=14% Similarity=0.186 Sum_probs=84.7
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--eEEEE
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH--KNIVKYLGSLKTRS--HLHII 95 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLnH--PNIVKLigVfedd~--~LYLV 95 (1437)
..+++.+-.|--..+|...+ +++.+++. ...............+|..+|+.+.- .-+...+++|.++. ..|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34455554444444566554 37888888 33222223455667788888888843 23344455555443 78999
Q ss_pred EeecCCCCHHHHhccCCC------------------------------CCCCHHHHHHHHHHH--------------HHH
Q 000535 96 LEYVENGSLANIIKPNKF------------------------------GPFPESLVAVYIAQV--------------LEG 131 (1437)
Q Consensus 96 MEYceGGSL~DLLKssr~------------------------------GpLSEs~I~rILrQI--------------LsA 131 (1437)
|+|++|..+.+....... +.+....+..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999998433221110000 001111111121111 122
Q ss_pred HHHHHHC--------CcccccccCCceEeccCCcEEEEecccccccc
Q 000535 132 LVYLHEQ--------GVIHRDIKGANILTTKEGLVKLADFGVATKLT 170 (1437)
Q Consensus 132 LaYLHSn--------GIVHRDLKPENILLdenG~VKLiDFGLAr~L~ 170 (1437)
..+++.+ .++|+|+++.||+|+..+-+-|.||+++..-.
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 3444432 38999999999999999889999999997643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.16 Score=56.40 Aligned_cols=30 Identities=33% Similarity=0.401 Sum_probs=26.2
Q ss_pred CCcccccccCCceEeccCCcEEEEecccccc
Q 000535 138 QGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 138 nGIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
.+++|+|+++.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999998754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.046 Score=65.17 Aligned_cols=143 Identities=20% Similarity=0.248 Sum_probs=95.4
Q ss_pred EEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHH-----------------------H-HHHHHHHHHHHhCCC
Q 000535 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-----------------------L-NIIMQEIDLLKNLNH 76 (1437)
Q Consensus 21 eIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeed-----------------------i-e~L~REIkILrrLnH 76 (1437)
.|-..|..|.-+.||.|.. .+|..+|||+++...+.-.+ + --..+|+.-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4556788999999999974 67888999998743221111 1 123467888888854
Q ss_pred CCcceEEEEEEeCCeEEEEEeecCCCC-HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCceEecc
Q 000535 77 KNIVKYLGSLKTRSHLHIILEYVENGS-LANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTK 154 (1437)
Q Consensus 77 PNIVKLigVfedd~~LYLVMEYceGGS-L~DLLKssr~GpLSEs~I~rILrQILsALaYLHS-nGIVHRDLKPENILLde 154 (1437)
-.|.- =..+.- ....|||+|+.+.. -.-.|+ .-.++...+..+-.|++.-+.-|.+ .++||.||.--|+|+.
T Consensus 226 aGIP~-PePIlL-k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 226 AGIPC-PEPILL-KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH- 299 (520)
T ss_pred cCCCC-CCceee-ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence 33221 111111 13468999995311 111222 2357888888888899988888765 4899999999999985
Q ss_pred CCcEEEEecccccccc
Q 000535 155 EGLVKLADFGVATKLT 170 (1437)
Q Consensus 155 nG~VKLiDFGLAr~L~ 170 (1437)
+|.++|+|-+-+....
T Consensus 300 dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHD 315 (520)
T ss_pred CCEEEEEEccccccCC
Confidence 5789999988776543
|
|
| >cd00020 ARM Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.0083 Score=56.12 Aligned_cols=98 Identities=23% Similarity=0.324 Sum_probs=82.0
Q ss_pred cccchhhhccccccCCCCchHHHHHHHHHHHHhhhhcchhhHHHHHhcCCchhhhhhhccC-Ccccccchhhhhhhcccc
Q 000535 1180 RADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSD-SPLKQYALPLLCDMAHAS 1258 (1437)
Q Consensus 1180 ~~~ai~~l~~~l~~~~~~~~~~~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~-~p~~~~~lp~l~~~a~~~ 1258 (1437)
..+.|+.|++.|.-. + ..+....+.++.|+|.-+..-.++..+.|+||.+.+++.++ ..++..++-.|+-+++..
T Consensus 5 ~~~~i~~l~~~l~~~--~--~~~~~~a~~~l~~l~~~~~~~~~~~~~~~~i~~l~~~l~~~~~~v~~~a~~~L~~l~~~~ 80 (120)
T cd00020 5 QAGGLPALVSLLSSS--D--ENVQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQLLKSEDEEVVKAALWALRNLAAGP 80 (120)
T ss_pred HcCChHHHHHHHHcC--C--HHHHHHHHHHHHHHhcCCHHHHHHHHHCCChHHHHHHHhCCCHHHHHHHHHHHHHHccCc
Confidence 356778888877543 3 56777899999999999877777888889999999998874 678899999999999999
Q ss_pred hhhHHHHHHcCCceeeecccccc
Q 000535 1259 RNSREQLRAHGGLDVYLNLLENE 1281 (1437)
Q Consensus 1259 ~~~~~~~~~~~~~~~~~~~~~~~ 1281 (1437)
...++.++.+|.+..-+.+|+++
T Consensus 81 ~~~~~~~~~~g~l~~l~~~l~~~ 103 (120)
T cd00020 81 EDNKLIVLEAGGVPKLVNLLDSS 103 (120)
T ss_pred HHHHHHHHHCCChHHHHHHHhcC
Confidence 88999999999888888887776
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.13 Score=59.80 Aligned_cols=142 Identities=13% Similarity=0.139 Sum_probs=82.0
Q ss_pred eEEEeEecccCcEEEEEEEEcC----CCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCeEEE
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLE----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV-KYLGSLKTRSHLHI 94 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrk----TGk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNIV-KLigVfedd~~LYL 94 (1437)
..-.+.|-.|-...+|++.... .++.|++|+..... ...+++ ..|..+++.+..-++- ++++.+.. + .
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~ 110 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---R 110 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeech-HHHHHHHHHHHHcCCCCceEEEECC-c---e
Confidence 3445677678888999986432 34789999876432 222232 5788888888543333 44555532 2 5
Q ss_pred EEeecCCCCHHHH--------------h---ccCC--CC--CCCHHHHHHHHHHHH-----------------HHHHHH-
Q 000535 95 ILEYVENGSLANI--------------I---KPNK--FG--PFPESLVAVYIAQVL-----------------EGLVYL- 135 (1437)
Q Consensus 95 VMEYceGGSL~DL--------------L---Kssr--~G--pLSEs~I~rILrQIL-----------------sALaYL- 135 (1437)
|++|+++.++... + +... .. ......+..++.++. ..+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 8999987665311 0 1110 00 111223333332221 111112
Q ss_pred ---H----HCCcccccccCCceEecc-CCcEEEEecccccc
Q 000535 136 ---H----EQGVIHRDIKGANILTTK-EGLVKLADFGVATK 168 (1437)
Q Consensus 136 ---H----SnGIVHRDLKPENILLde-nG~VKLiDFGLAr~ 168 (1437)
. ...++|+|+++.|||+++ ++.++++||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 125899999999999986 46899999988854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.077 Score=59.87 Aligned_cols=31 Identities=23% Similarity=0.305 Sum_probs=26.0
Q ss_pred CcccccccCCceEeccCCc-EEEEeccccccc
Q 000535 139 GVIHRDIKGANILTTKEGL-VKLADFGVATKL 169 (1437)
Q Consensus 139 GIVHRDLKPENILLdenG~-VKLiDFGLAr~L 169 (1437)
.++|+|++|.|||++.++. .-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 3899999999999997554 569999998653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.21 Score=56.51 Aligned_cols=30 Identities=13% Similarity=0.111 Sum_probs=27.9
Q ss_pred CcccccccCCceEeccCCcEEEEecccccc
Q 000535 139 GVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 139 GIVHRDLKPENILLdenG~VKLiDFGLAr~ 168 (1437)
+++|+|+.+.||+++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999999865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.11 Score=61.64 Aligned_cols=77 Identities=17% Similarity=0.115 Sum_probs=50.1
Q ss_pred EecccCcEEEEEEEEcCCCeEEEEEEeeccc-----cCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCeEEEEEe
Q 000535 25 EIGKGAYGRVYKGLDLENGDFVAIKQVSLEN-----IAQEDLNIIMQEIDLLKNLN--HKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 25 vLGrGgFGtVYKArDrkTGk~VAIKVIkke~-----lSeedie~L~REIkILrrLn--HPNIVKLigVfedd~~LYLVME 97 (1437)
.||.|--.-||++.+...++.++||.-.... ...-..++...|...|+... .|..++-+.++ ++....+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence 5799999999999975444689998643211 11234556677888887773 46544433333 4556679999
Q ss_pred ecCCC
Q 000535 98 YVENG 102 (1437)
Q Consensus 98 YceGG 102 (1437)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 99653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.21 Score=57.56 Aligned_cols=141 Identities=16% Similarity=0.209 Sum_probs=79.3
Q ss_pred EEEeEecccCcEEEEEEEEcCC---CeEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCeEEEEE
Q 000535 21 MLGDEIGKGAYGRVYKGLDLEN---GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI-VKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 21 eIlEvLGrGgFGtVYKArDrkT---Gk~VAIKVIkke~lSeedie~L~REIkILrrLnHPNI-VKLigVfedd~~LYLVM 96 (1437)
.-.+.|..|=...+|++..... +..|++|+..... ..-+ .-.+|..+++.+..-++ .++++++. .+ +|.
T Consensus 17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~ 89 (330)
T PLN02421 17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--DYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ 89 (330)
T ss_pred eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc--CeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence 3446666688888999864332 3478899875432 1111 23568888888854444 34555552 32 489
Q ss_pred eecCCCCHHH--------------Hhc---cCC--CC--CCCHHHHHHHHHHH----------------------HHHHH
Q 000535 97 EYVENGSLAN--------------IIK---PNK--FG--PFPESLVAVYIAQV----------------------LEGLV 133 (1437)
Q Consensus 97 EYceGGSL~D--------------LLK---ssr--~G--pLSEs~I~rILrQI----------------------LsALa 133 (1437)
+|++|..|.. .++ ..+ .. +-....+..++.++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9998765421 111 111 00 11122233333222 11122
Q ss_pred HHH----HCC----cccccccCCceEecc-CCcEEEEecccccc
Q 000535 134 YLH----EQG----VIHRDIKGANILTTK-EGLVKLADFGVATK 168 (1437)
Q Consensus 134 YLH----SnG----IVHRDLKPENILLde-nG~VKLiDFGLAr~ 168 (1437)
.+. ..+ ++|.|+.+.|||+++ ++.++++||..|..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 221 112 799999999999975 46899999999854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.48 Score=54.45 Aligned_cols=76 Identities=18% Similarity=0.200 Sum_probs=48.4
Q ss_pred eEEEeEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCeEEEEE
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN---HKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 20 YeIlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn---HPNIVKLigVfedd~~LYLVM 96 (1437)
-.-.+.++.|....+|+.. .+++.|.+|+-.. .....+..|..-|+.|. .-.+.+.+.+....+..||||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 3455788999999999986 6788899998652 22345677888888873 445778888888777779999
Q ss_pred eecCCC
Q 000535 97 EYVENG 102 (1437)
Q Consensus 97 EYceGG 102 (1437)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.44 Score=57.66 Aligned_cols=76 Identities=17% Similarity=0.104 Sum_probs=52.6
Q ss_pred EEeEecccCcEEEEEEEEcCCCeEEEEEEeecccc--C---HHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCeEE
Q 000535 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI--A---QEDLNIIMQEIDLLKNLN---HKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 22 IlEvLGrGgFGtVYKArDrkTGk~VAIKVIkke~l--S---eedie~L~REIkILrrLn---HPNIVKLigVfedd~~LY 93 (1437)
..+.||.|.-..||+..+ .+..|+||.-..... . .....+...|...|+.+. ..++.+++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999986 345688997552211 1 124555666777777764 246777887776 4467
Q ss_pred EEEeecCC
Q 000535 94 IILEYVEN 101 (1437)
Q Consensus 94 LVMEYceG 101 (1437)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.81 E-value=0.22 Score=59.95 Aligned_cols=78 Identities=21% Similarity=0.176 Sum_probs=52.5
Q ss_pred EeEecccCcEEEEEEEEcCCCeEEEEEEeec----cccCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCeEEEEE
Q 000535 23 GDEIGKGAYGRVYKGLDLENGDFVAIKQVSL----ENIAQEDLNIIMQEIDLLKNLN--HKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 23 lEvLGrGgFGtVYKArDrkTGk~VAIKVIkk----e~lSeedie~L~REIkILrrLn--HPNIVKLigVfedd~~LYLVM 96 (1437)
.+.||.|--.-||++.+...++.|+||.-.. .....-..++..-|..+|+.+. .|..|+=+.++ ++....+||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~~vM 112 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNCCVM 112 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhhHHH
Confidence 5789999999999998744456788885432 1111234567778888888873 46555433333 455667899
Q ss_pred eecCC
Q 000535 97 EYVEN 101 (1437)
Q Consensus 97 EYceG 101 (1437)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 99854
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.01 E-value=1.9 Score=49.81 Aligned_cols=70 Identities=21% Similarity=0.159 Sum_probs=43.1
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhCC---CCCcceEE---E--EEEeCCeEEEEEeecC
Q 000535 29 GAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN---HKNIVKYL---G--SLKTRSHLHIILEYVE 100 (1437)
Q Consensus 29 GgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrLn---HPNIVKLi---g--Vfedd~~LYLVMEYce 100 (1437)
+.-..||+... .++..|++|+...... ....+..|+..+..|. -| ++... + +...++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~---~~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW---SDAQILEEHAFALELAEAEIP-VVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC---CHHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 44567999863 4567899998764432 2344666777776662 22 22211 1 2334567889999998
Q ss_pred CCC
Q 000535 101 NGS 103 (1437)
Q Consensus 101 GGS 103 (1437)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.97 Score=59.88 Aligned_cols=139 Identities=19% Similarity=0.203 Sum_probs=77.0
Q ss_pred eEecccCcEEEEEEEEcCCCeEEEEEEeeccccCHHHHHHHHHHHHHHHhC-------CCCCcceEE-----EEEEe-CC
Q 000535 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-------NHKNIVKYL-----GSLKT-RS 90 (1437)
Q Consensus 24 EvLGrGgFGtVYKArDrkTGk~VAIKVIkke~lSeedie~L~REIkILrrL-------nHPNIVKLi-----gVfed-d~ 90 (1437)
+.|+ |.+-.+|+... .++..|++|+..... . ...+..|..+|.-| ..|.+++-. ..... ++
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G 104 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-P---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDG 104 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-c---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCC
Confidence 5564 45688899863 567789999987542 1 12233444455433 344444422 11121 22
Q ss_pred --eEEEEEeecCCCCHHHHhc---------------------cCCC----C--CCCH---------------HHHHHHHH
Q 000535 91 --HLHIILEYVENGSLANIIK---------------------PNKF----G--PFPE---------------SLVAVYIA 126 (1437)
Q Consensus 91 --~LYLVMEYceGGSL~DLLK---------------------ssr~----G--pLSE---------------s~I~rILr 126 (1437)
+.+-+++|++|..+.+... .... . .+.. ...+.++.
T Consensus 105 ~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~ 184 (1013)
T PRK06148 105 EPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVE 184 (1013)
T ss_pred ceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHH
Confidence 5677899999977755110 0000 0 0111 11112222
Q ss_pred HHHHHHH-----HHH--HCCcccccccCCceEeccCC--cEE-EEecccccc
Q 000535 127 QVLEGLV-----YLH--EQGVIHRDIKGANILTTKEG--LVK-LADFGVATK 168 (1437)
Q Consensus 127 QILsALa-----YLH--SnGIVHRDLKPENILLdenG--~VK-LiDFGLAr~ 168 (1437)
+++.... .+. ..++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 185 ~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 185 RFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3333222 121 24799999999999999875 454 999999864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1437 | ||||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-53 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-52 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-51 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-50 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-50 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-50 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-50 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-47 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-47 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-45 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-45 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-44 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-44 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-44 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-44 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-44 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-44 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-43 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-42 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-42 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-42 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-40 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-40 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-40 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-39 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-39 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-39 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-39 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-39 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-39 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-39 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-39 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-39 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-38 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-36 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-31 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-31 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-31 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-31 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-31 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-31 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-31 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-31 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-31 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-31 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-31 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-31 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-31 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-31 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-31 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-31 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-31 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-31 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-31 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-31 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-31 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-31 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-31 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-31 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-31 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-31 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-31 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-31 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-31 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-31 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-31 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-31 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-31 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-31 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-30 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-30 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-30 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-30 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-29 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-29 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-29 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-29 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-29 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-29 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-29 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-29 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-29 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-29 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-28 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-28 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-28 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-28 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-28 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-28 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-28 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-28 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-28 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-28 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-28 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-28 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-28 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-28 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-27 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-27 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-27 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-27 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-27 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-27 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-27 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-27 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-27 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-27 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-27 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-27 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-27 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-27 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-27 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-27 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-27 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-27 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-27 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-27 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-27 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-27 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-27 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-27 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-27 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-27 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-27 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-27 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-27 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-27 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-27 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-27 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-27 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-27 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-27 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-27 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-27 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-27 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-27 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-26 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-26 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-26 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-26 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-26 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-26 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-26 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-26 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-26 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-26 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-26 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-26 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-26 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-26 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-26 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-26 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-26 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-26 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-26 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-26 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-26 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-26 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-26 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-26 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-26 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-26 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-26 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-26 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-26 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-26 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-26 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-26 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-26 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-26 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-26 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-26 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-26 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-26 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-26 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-26 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-26 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-25 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-25 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-25 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-25 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-25 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-25 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-25 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-25 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-25 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-25 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-25 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-25 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-25 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-25 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-25 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-25 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-25 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-25 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-25 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-25 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-25 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-25 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-25 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-25 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-25 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-25 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-25 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-25 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-25 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-25 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-25 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-25 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-25 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-25 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-25 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-25 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-25 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-25 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-25 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-25 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-25 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-25 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-24 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-24 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-24 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-24 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-24 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-24 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-24 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-24 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-24 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-24 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-24 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-24 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-24 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-24 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-24 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-24 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-24 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-24 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-24 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-24 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-24 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-24 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-24 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-23 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-23 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-23 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-23 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-23 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-23 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-23 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-23 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-23 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-23 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-23 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-23 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-23 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-23 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-23 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-23 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-23 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-23 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-23 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-23 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-23 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-23 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-23 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-23 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-23 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-23 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-23 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-23 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-23 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-23 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-23 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-23 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-23 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-23 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-23 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-23 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-23 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-23 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-23 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-23 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-23 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-23 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-23 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-23 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-23 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-22 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-22 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-22 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-22 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-22 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-22 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-22 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-22 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-22 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-22 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-22 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-22 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-22 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-22 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-22 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-22 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-22 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-22 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-22 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-22 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-22 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-22 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-22 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-22 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-22 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-22 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-22 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-22 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-22 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-22 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-22 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-22 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-22 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-22 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-21 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-21 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-21 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-21 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-21 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-21 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-21 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-21 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-21 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-21 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-21 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-21 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-21 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-21 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-21 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-21 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-21 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-21 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-21 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-21 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-21 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-21 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-21 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-21 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-21 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-21 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-21 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-21 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-21 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-21 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-21 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-21 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-21 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-21 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-20 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-20 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-20 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-20 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-20 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-20 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-20 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-20 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-20 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-20 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-20 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-20 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-20 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-20 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-20 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-20 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-20 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-20 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-20 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-20 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-20 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-20 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-20 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-20 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-20 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-20 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-20 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-20 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-20 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-20 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-19 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-19 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-19 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-19 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-19 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-19 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-19 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-19 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-19 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-19 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-19 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-19 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-19 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-19 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-19 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-19 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-19 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-19 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-19 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-19 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-19 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-19 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-19 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-19 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-19 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-19 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-19 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-19 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-19 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-19 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-19 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-19 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-19 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-19 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-19 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-19 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-19 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-19 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-19 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-19 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-19 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-19 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-19 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-19 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-19 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-19 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-19 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-19 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-19 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-19 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-19 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-19 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-19 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-19 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-19 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-19 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-19 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-19 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-19 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-19 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-19 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-19 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-18 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-18 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-18 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-18 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-18 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-18 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-18 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-18 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-18 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-18 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-18 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-18 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-18 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-17 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-17 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-17 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-17 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-17 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-17 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-17 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-17 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-17 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-17 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-17 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-17 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-17 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-16 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-16 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-16 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-16 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-16 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-16 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-16 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-15 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-15 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-15 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-15 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-15 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-15 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-15 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-15 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-15 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-15 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-15 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-15 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-15 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-15 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-15 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-15 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-15 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-15 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-15 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-15 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-15 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-15 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-15 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-15 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-15 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-15 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-15 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-15 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-15 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-15 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-15 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-15 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-15 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-14 |
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1437 | |||
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-138 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-128 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-119 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-114 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-110 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-104 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-104 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-103 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-103 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-103 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-102 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-101 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-100 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-99 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-99 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-95 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-95 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-88 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 9e-85 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-83 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-82 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-80 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-80 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-80 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 7e-80 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-79 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-73 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-72 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-65 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-65 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-64 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-64 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-64 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-63 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-63 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 8e-63 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-62 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-62 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-61 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-61 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 5e-61 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-61 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-60 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-60 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-60 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-60 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-59 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-59 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-59 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-59 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-59 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-59 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-59 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 7e-59 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-59 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 8e-59 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 9e-59 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-58 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-58 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-58 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-58 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-58 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-58 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-58 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-57 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-57 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-57 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 7e-57 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-57 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-56 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-56 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-55 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-55 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-55 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 7e-55 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 8e-55 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-55 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-54 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-53 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-53 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-53 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 8e-53 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-52 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-52 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-52 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-51 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-51 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-50 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-50 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 4e-50 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 9e-50 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-49 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-49 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-49 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-49 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-49 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-48 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-48 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-48 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-48 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-48 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 6e-48 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-48 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-48 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-47 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-47 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-47 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-47 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-47 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-47 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-47 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-47 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-46 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-46 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-46 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-46 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-46 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-46 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 7e-46 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-45 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-45 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-45 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-45 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-45 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-45 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-45 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-45 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-45 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-44 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-44 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-44 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-44 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-44 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-44 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-44 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-44 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-44 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 5e-44 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-44 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 8e-44 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-44 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 9e-44 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-43 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-43 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-43 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-43 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-43 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-43 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-43 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-43 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-43 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-43 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-43 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-43 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-43 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-43 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-43 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-42 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-42 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-42 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-42 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-42 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-42 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-42 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-42 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-42 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 6e-42 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-42 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-42 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-42 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-41 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-41 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-41 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-41 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-41 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-41 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-41 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 7e-41 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 8e-41 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-40 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-40 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-40 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-39 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-39 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-39 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-39 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-38 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-38 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 8e-38 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-37 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-37 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-37 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-37 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-37 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-37 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-37 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 9e-37 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-36 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-36 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-36 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-36 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-36 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-36 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-36 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 9e-36 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-35 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-35 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-35 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-35 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-35 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-35 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-34 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-34 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-34 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-34 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-33 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-33 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-33 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-33 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 7e-33 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-32 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 9e-32 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-31 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-31 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-28 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-20 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-19 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-18 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-18 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 6e-17 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 8e-17 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-16 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-14 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 5e-14 | |
| 1wa5_B | 530 | Importin alpha subunit; nuclear transport/complex, | 3e-13 | |
| 1wa5_B | 530 | Importin alpha subunit; nuclear transport/complex, | 1e-11 | |
| 1wa5_B | 530 | Importin alpha subunit; nuclear transport/complex, | 5e-11 | |
| 1wa5_B | 530 | Importin alpha subunit; nuclear transport/complex, | 1e-07 | |
| 1wa5_B | 530 | Importin alpha subunit; nuclear transport/complex, | 4e-05 | |
| 2jdq_A | 450 | Importin alpha-1 subunit; transport, PB2 subunit, | 6e-13 | |
| 2jdq_A | 450 | Importin alpha-1 subunit; transport, PB2 subunit, | 9e-12 | |
| 2jdq_A | 450 | Importin alpha-1 subunit; transport, PB2 subunit, | 1e-07 | |
| 2jdq_A | 450 | Importin alpha-1 subunit; transport, PB2 subunit, | 2e-07 | |
| 2jdq_A | 450 | Importin alpha-1 subunit; transport, PB2 subunit, | 2e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 | |
| 2z6g_A | 780 | B-catenin; FULL-length, beta-catenin, cell adhesio | 1e-11 | |
| 2z6g_A | 780 | B-catenin; FULL-length, beta-catenin, cell adhesio | 3e-06 | |
| 2z6g_A | 780 | B-catenin; FULL-length, beta-catenin, cell adhesio | 4e-05 | |
| 2z6g_A | 780 | B-catenin; FULL-length, beta-catenin, cell adhesio | 8e-05 | |
| 2z6g_A | 780 | B-catenin; FULL-length, beta-catenin, cell adhesio | 1e-04 | |
| 2z6g_A | 780 | B-catenin; FULL-length, beta-catenin, cell adhesio | 5e-04 | |
| 4db8_A | 252 | Armadillo-repeat protein; solenoid repeat, de novo | 1e-10 | |
| 4db8_A | 252 | Armadillo-repeat protein; solenoid repeat, de novo | 4e-06 | |
| 3oqs_A | 510 | Importin subunit alpha-2; importin alpha, karyophe | 2e-10 | |
| 3oqs_A | 510 | Importin subunit alpha-2; importin alpha, karyophe | 8e-08 | |
| 3oqs_A | 510 | Importin subunit alpha-2; importin alpha, karyophe | 1e-07 | |
| 3oqs_A | 510 | Importin subunit alpha-2; importin alpha, karyophe | 1e-06 | |
| 3oqs_A | 510 | Importin subunit alpha-2; importin alpha, karyophe | 2e-05 | |
| 1jdh_A | 529 | Beta-catenin; beta-catenin, protein-protein comple | 1e-09 | |
| 1jdh_A | 529 | Beta-catenin; beta-catenin, protein-protein comple | 5e-08 | |
| 1jdh_A | 529 | Beta-catenin; beta-catenin, protein-protein comple | 5e-08 | |
| 1jdh_A | 529 | Beta-catenin; beta-catenin, protein-protein comple | 6e-06 | |
| 1jdh_A | 529 | Beta-catenin; beta-catenin, protein-protein comple | 7e-06 | |
| 3nmz_A | 458 | APC variant protein; protein-protein complex, arma | 4e-09 | |
| 3nmw_A | 354 | APC variant protein; ARMADIILO repeats domain, cel | 2e-08 | |
| 3nmw_A | 354 | APC variant protein; ARMADIILO repeats domain, cel | 4e-04 | |
| 1xqr_A | 296 | HSPBP1 protein; armadillo repeat, superhelical twi | 5e-08 | |
| 1xqr_A | 296 | HSPBP1 protein; armadillo repeat, superhelical twi | 6e-06 | |
| 2z6h_A | 644 | Catenin beta-1, beta-catenin; C-terminal domain, a | 2e-07 | |
| 2z6h_A | 644 | Catenin beta-1, beta-catenin; C-terminal domain, a | 1e-06 | |
| 2z6h_A | 644 | Catenin beta-1, beta-catenin; C-terminal domain, a | 4e-06 | |
| 2z6h_A | 644 | Catenin beta-1, beta-catenin; C-terminal domain, a | 5e-06 | |
| 2z6h_A | 644 | Catenin beta-1, beta-catenin; C-terminal domain, a | 1e-05 | |
| 4db6_A | 210 | Armadillo repeat protein; solenoid repeat, armadil | 2e-07 | |
| 4db6_A | 210 | Armadillo repeat protein; solenoid repeat, armadil | 7e-06 | |
| 4db6_A | 210 | Armadillo repeat protein; solenoid repeat, armadil | 4e-05 | |
| 4db6_A | 210 | Armadillo repeat protein; solenoid repeat, armadil | 5e-04 | |
| 3now_A | 810 | UNC-45 protein, SD10334P; armadillo repeat, HSP90, | 2e-06 | |
| 3now_A | 810 | UNC-45 protein, SD10334P; armadillo repeat, HSP90, | 2e-05 | |
| 3now_A | 810 | UNC-45 protein, SD10334P; armadillo repeat, HSP90, | 7e-05 | |
| 1xm9_A | 457 | Plakophilin 1; armadillo repeat, cell adhesion; 2. | 1e-04 | |
| 3l6x_A | 584 | Catenin delta-1; catenin, armadillo, ARM, JMD, CE | 3e-04 | |
| 1b3u_A | 588 | Protein (protein phosphatase PP2A); scaffold prote | 4e-04 |
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-138
Identities = 109/297 (36%), Positives = 170/297 (57%), Gaps = 15/297 (5%)
Query: 2 SRQTTTSAFHKSKTLDNKYML-----GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI 56
S ++T +S L+ Y +GKG YG VY G DL N +AIK++ +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD- 59
Query: 57 AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPF 116
+ +EI L K+L HKNIV+YLGS + I +E V GSL+ +++ +K+GP
Sbjct: 60 -SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR-SKWGPL 117
Query: 117 P--ESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL-TTKEGLVKLADFGVATKLTEAD 173
E + Y Q+LEGL YLH+ ++HRDIKG N+L T G++K++DFG + +L +
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177
Query: 174 VNTHSVVGTPYWMAPEVIEMS--GVCAASDIWSVGCTVIELLTCVPPYYEL-QPMPALFR 230
T + GT +MAPE+I+ G A+DIWS+GCT+IE+ T PP+YEL +P A+F+
Sbjct: 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK 237
Query: 231 I-VQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLR 286
+ + P IPES+S + F+ +CF+ D +R A LL +++ + ++ +
Sbjct: 238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-128
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 17/269 (6%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ +G+G++G V++ D + G A+K+V LE +E+ L+
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSP 110
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
IV G+++ ++I +E +E GSL +IK + G PE Y+ Q LEGL YLH
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 138 QGVIHRDIKGANILTTKEG-LVKLADFGVATKLTE-----ADVNTHSVVGTPYWMAPEVI 191
+ ++H D+K N+L + +G L DFG A L + + + GT MAPEV+
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE--RPPIPESLSPDITD 249
A DIWS C ++ +L P+ + P +I + IP S +P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288
Query: 250 FLRQCFKKDARQRPDAKTLLSHPWIQNCR 278
+++ +K+ R A L
Sbjct: 289 AIQEGLRKEPVHRASAMELRRKVGKALQE 317
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-119
Identities = 77/264 (29%), Positives = 136/264 (51%), Gaps = 14/264 (5%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
EIG+G++ VYKGLD E VA ++ + + + +E ++LK L H NIV+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 82 YLGS----LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
+ S +K + + ++ E + +G+L +K +F ++ + Q+L+GL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 138 QG--VIHRDIKGANIL-TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMS 194
+ +IHRD+K NI T G VK+ D G+AT + +V+GTP +MAPE+ E
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYE-E 204
Query: 195 GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--IPESLSPDITDFLR 252
+ D+++ G ++E+ T PY E Q ++R V P + P++ + +
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 253 QCFKKDARQRPDAKTLLSHPWIQN 276
C +++ +R K LL+H + Q
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-114
Identities = 87/330 (26%), Positives = 157/330 (47%), Gaps = 1/330 (0%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
++++ KY+ +IG+G++G+ E+G IK++++ ++ ++ +E+ +L
Sbjct: 19 YFQSME-KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
N+ H NIV+Y S + L+I+++Y E G L I K F E + + Q+
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI 191
L ++H++ ++HRDIK NI TK+G V+L DFG+A L + +GTPY+++PE+
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFL 251
E SDIW++GC + EL T + + +I+ PP+ S D+ +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257
Query: 252 RQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSEDNQS 311
Q FK++ R RP ++L +I S + + IP++ S
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPAS 317
Query: 312 AGESLSAPKAEAFETGSRKELLSPAATHLS 341
S+S A+ + K + A
Sbjct: 318 GQNSISVMPAQKITKPAAKYGIPLAYKKYG 347
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-110
Identities = 93/277 (33%), Positives = 146/277 (52%), Gaps = 8/277 (2%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNH 76
+ + +IG+G + VY+ L +G VA+K+V + ++ + ++EIDLLK LNH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNK--FGPFPESLVAVYIAQVLEGLVY 134
N++KY S + L+I+LE + G L+ +IK K PE V Y Q+ L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMS 194
+H + V+HRDIK AN+ T G+VKL D G+ + HS+VGTPY+M+PE I +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 195 GVCAASDIWSVGCTVIELLTCVPPYY-ELQPMPALF-RIVQDERPPIP-ESLSPDITDFL 251
G SDIWS+GC + E+ P+Y + + +L +I Q + PP+P + S ++ +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271
Query: 252 RQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHS 288
C D +RPD + + SSL H
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRMH--ACTASSLEHH 306
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-104
Identities = 79/361 (21%), Positives = 139/361 (38%), Gaps = 58/361 (16%)
Query: 18 NKYMLGDEIGKGA--YGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
Y L IGKG V G++V +++++LE + E + + E+ + K N
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
H NIV Y + + L ++ ++ GS ++I + E +A + VL+ L Y+
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV-------VGTPYWMAP 188
H G +HR +K ++IL + +G V L+ + V V W++P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 189 EVIE--MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--------- 237
EV++ + G A SDI+SVG T EL P+ ++ L + P
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 238 ------------------------------------PIPESLSPDITDFLRQCFKKDARQ 261
P + SP F+ QC +++
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324
Query: 262 RPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSEDNQSAGESLSAPKA 321
RP A TLL+H + + +R +L +R V + + + + G + +
Sbjct: 325 RPSASTLLNHSFFKQIKRRASEALPE--LLRPVTPITNFEGSQSQDHSGIFGLVTNLEEL 382
Query: 322 E 322
E
Sbjct: 383 E 383
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-104
Identities = 84/341 (24%), Positives = 148/341 (43%), Gaps = 31/341 (9%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
Y + +IG G +V++ L+ E AIK V+LE + L+ EI L L
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 77 KN--IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
+ I++ T ++++++E N L + +K K Y +LE +
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHT 123
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH--SVVGTPYWMAPEVIE 192
+H+ G++H D+K AN L G++KL DFG+A ++ + S VGT +M PE I+
Sbjct: 124 IHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 193 -----------MSGVCAASDIWSVGCTVIELLTCVPPYYELQ-PMPALFRIVQ-DERPPI 239
S + SD+WS+GC + + P+ ++ + L I+ +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNV----- 294
P+ D+ D L+ C K+D +QR LL+HP++Q + + +
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQL 302
Query: 295 ----EENGSADAEIPSEDNQSAGESLSAPKAEAFETGSRKE 331
N A ++ S GES ++ ++ FE K+
Sbjct: 303 VGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 343
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-103
Identities = 85/356 (23%), Positives = 152/356 (42%), Gaps = 31/356 (8%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL 61
+ ++SA Y + +IG G +V++ L+ E AIK V+LE + L
Sbjct: 40 DDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL 98
Query: 62 NIIMQEIDLLKNLNHKN--IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPES 119
+ EI L L + I++ T ++++++E N L + +K K
Sbjct: 99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK--KKKSIDPW 155
Query: 120 LVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH-- 177
Y +LE + +H+ G++H D+K AN L G++KL DFG+A ++ +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKD 214
Query: 178 SVVGTPYWMAPEVIE-----------MSGVCAASDIWSVGCTVIELLTCVPPYYELQ-PM 225
S VG +M PE I+ S + SD+WS+GC + + P+ ++ +
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 226 PALFRIVQ-DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSS 284
L I+ + P+ D+ D L+ C K+D +QR LL+HP++Q +
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334
Query: 285 LRHSGTMRNV---------EENGSADAEIPSEDNQSAGESLSAPKAEAFETGSRKE 331
+ + N A ++ S GES ++ ++ FE K+
Sbjct: 335 AKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 390
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 328 bits (844), Expect = e-103
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 30/285 (10%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NH 76
++ ++IG G +G V+K + +G AIK+ D ++E+ L H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNK--FGPFPESLVAVYIAQVLEGLVY 134
++V+Y + H+ I EY GSLA+ I N F E+ + + QV GL Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 135 LHEQGVIHRDIKGANILTTKEG-------------------LVKLADFGVATKLTEADVN 175
+H ++H DIK +NI ++ + K+ D G T+++ +
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS----S 186
Query: 176 THSVVGTPYWMAPEVI-EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD 234
G ++A EV+ E +DI+++ TV+ P I Q
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQG 243
Query: 235 ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279
P IP+ LS + T+ L+ D +RP A L+ H + + R
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-103
Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 22/293 (7%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
+ T F Y + +IG G +V++ L+ E AIK V+LE +
Sbjct: 11 VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT 69
Query: 61 LNIIMQEIDLLKNLNHKN--IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPE 118
L+ EI L L + I++ T ++++++E N L + +K K
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK--KKKSIDP 126
Query: 119 SLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH- 177
Y +LE + +H+ G++H D+K AN L G++KL DFG+A ++ +
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 185
Query: 178 -SVVGTPYWMAPEVIE-----------MSGVCAASDIWSVGCTVIELLTCVPPYYELQ-P 224
S VGT +M PE I+ S + SD+WS+GC + + P+ ++
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 225 MPALFRIVQ-DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
+ L I+ + P+ D+ D L+ C K+D +QR LL+HP++Q
Sbjct: 246 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-102
Identities = 110/287 (38%), Positives = 165/287 (57%), Gaps = 8/287 (2%)
Query: 1 MSRQTTTSAFHKSKTLD----NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI 56
M+ S + L + ++IGKG++G V+KG+D VAIK + LE
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE- 59
Query: 57 AQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPF 116
A++++ I QEI +L + + KY GS + L II+EY+ GS ++++P GP
Sbjct: 60 AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPL 116
Query: 117 PESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176
E+ +A + ++L+GL YLH + IHRDIK AN+L ++ G VKLADFGVA +LT+ +
Sbjct: 117 DETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176
Query: 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER 236
++ VGTP+WMAPEVI+ S + +DIWS+G T IEL PP+ EL PM LF I ++
Sbjct: 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP 236
Query: 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQS 283
P + + S + +F+ C K+ RP AK LL H +I +
Sbjct: 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-101
Identities = 94/267 (35%), Positives = 145/267 (54%), Gaps = 10/267 (3%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ + E+G GA+G+VYK + E G A K + + ++E+L + EI++L +H
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPY 77
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IVK LG+ L I++E+ G++ I+ E + V Q+LE L +LH +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
+IHRD+K N+L T EG ++LADFGV+ K + S +GTPYWMAPEV+ +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 199 AS-----DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFL 251
DIWS+G T+IE+ PP++EL PM L +I + + P + P S + DFL
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256
Query: 252 RQCFKKDARQRPDAKTLLSHPWIQNCR 278
+ K+ RP A LL HP++ +
Sbjct: 257 KIALDKNPETRPSAAQLLEHPFVSSIT 283
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-100
Identities = 97/262 (37%), Positives = 143/262 (54%), Gaps = 7/262 (2%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
KY ++IG+GA G VY +D+ G VAI+Q++L+ Q +I+ EI +++ + N
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPN 78
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV YL S L +++EY+ GSL +++ E +A + L+ L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
VIHRDIK NIL +G VKL DFG ++T ++VGTPYWMAPEV+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQCFK 256
DIWS+G IE++ PPY P+ AL+ I + P + PE LS DFL +C +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255
Query: 257 KDARQRPDAKTLLSHPWIQNCR 278
D +R AK LL H +++ +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAK 277
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = 4e-99
Identities = 108/262 (41%), Positives = 157/262 (59%), Gaps = 7/262 (2%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ + +++G+G+YG VYK + E G VAIKQV +E DL I++EI +++ + +
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPH 85
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+VKY GS + L I++EY GS+++II+ E +A + L+GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM 144
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
IHRDIK NIL EG KLADFGVA +LT+ ++V+GTP+WMAPEVI+ G
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQCFK 256
+DIWS+G T IE+ PPY ++ PM A+F I + P PE S + TDF++QC
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLV 264
Query: 257 KDARQRPDAKTLLSHPWIQNCR 278
K QR A LL HP++++ +
Sbjct: 265 KSPEQRATATQLLQHPFVRSAK 286
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = 7e-99
Identities = 89/262 (33%), Positives = 142/262 (54%), Gaps = 7/262 (2%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+IG+G+ G V + +G VA+K + L Q+ ++ E+ ++++ H N
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFN 103
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+V+ S L +++E+++ G+L +I+ E +A VL+ L YLH Q
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
GVIHRDIK +IL T +G VKL+DFG ++++ S+VGTPYWMAPEVI S
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQCFK 256
DIWS+G VIE++ PPY+ P+ A+ R+ P + +SP + DFL +
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280
Query: 257 KDARQRPDAKTLLSHPWIQNCR 278
+D ++R A+ LL HP++
Sbjct: 281 RDPQERATAQELLDHPFLLQTG 302
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = 4e-98
Identities = 100/299 (33%), Positives = 152/299 (50%), Gaps = 25/299 (8%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MS ++ + ++ + Y L + IG GA V + VAIK+++LE Q
Sbjct: 1 MSEDSSALPWSINR---DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTS 56
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK------PNKFG 114
++ +++EI + +H NIV Y S + L ++++ + GS+ +IIK +K G
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 115 PFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174
ES +A + +VLEGL YLH+ G IHRD+K NIL ++G V++ADFGV+ L
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176
Query: 175 NT-----HSVVGTPYWMAPEVIE-MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPAL 228
T + VGTP WMAPEV+E + G +DIWS G T IEL T PY++ PM L
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236
Query: 229 FRIVQDERPPIPES---------LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278
+Q++ P + + C +KD +RP A LL H + Q +
Sbjct: 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = 2e-97
Identities = 96/275 (34%), Positives = 147/275 (53%), Gaps = 16/275 (5%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NH 76
+ L + +G G YG+VYKG ++ G AIK + + ++ I QEI++LK +H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHH 80
Query: 77 KNIVKYLGS------LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
+NI Y G+ L +++E+ GS+ ++IK K E +A ++L
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV 190
GL +LH+ VIHRDIKG N+L T+ VKL DFGV+ +L ++ +GTPYWMAPEV
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 191 IEMSGVCAAS-----DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-PESLS 244
I A+ D+WS+G T IE+ PP ++ PM ALF I ++ P + + S
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260
Query: 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279
F+ C K+ QRP + L+ HP+I++
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = 1e-95
Identities = 66/266 (24%), Positives = 116/266 (43%), Gaps = 9/266 (3%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
+ +G G+YG V+K E+G A+K+ +D + E+
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110
Query: 72 KNL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFG-PFPESLVAVYIAQVL 129
+ + H V+ + + L++ E SL + +G PE+ V Y+ L
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--AWGASLPEAQVWGYLRDTL 167
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
L +LH QG++H D+K ANI G KL DFG+ +L A G P +MAPE
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEVQEGDPRYMAPE 226
Query: 190 VIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249
+++ A+D++S+G T++E+ + + + L + P LS ++
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG--YLPPEFTAGLSSELRS 283
Query: 250 FLRQCFKKDARQRPDAKTLLSHPWIQ 275
L + D + R A+ LL+ P ++
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVLR 309
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = 2e-95
Identities = 95/265 (35%), Positives = 143/265 (53%), Gaps = 11/265 (4%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHK 77
+ EIG G++G VY D+ N + VAIK++S + E I++E+ L+ L H
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
N ++Y G +++EY GS +++++ +K P E +A L+GL YLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS 172
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI---EMS 194
+IHRD+K NIL ++ GLVKL DFG A+ + A+ S VGTPYWMAPEVI +
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----SFVGTPYWMAPEVILAMDEG 228
Query: 195 GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-PESLSPDITDFLRQ 253
D+WS+G T IEL PP + + M AL+ I Q+E P + S +F+
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288
Query: 254 CFKKDARQRPDAKTLLSHPWIQNCR 278
C +K + RP ++ LL H ++ R
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVLRER 313
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 5e-88
Identities = 66/294 (22%), Positives = 119/294 (40%), Gaps = 31/294 (10%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
+ + + + IG G +G+V+K +G IK+V N +E+ L
Sbjct: 6 DKRFGMD-FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKAL 58
Query: 72 KNLNHKNIVKYLGS----------------LKTRSHLHIILEYVENGSLANIIKPNKFGP 115
L+H NIV Y G L I +E+ + G+L I+ +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 116 FPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175
+ L Q+ +G+ Y+H + +I+RD+K +NI VK+ DFG+ T L + D
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGK 177
Query: 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE 235
GT +M+PE I D++++G + ELL +E F ++
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLR-- 232
Query: 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSG 289
I + L++ K RP+ +L + +++ + + RH+
Sbjct: 233 DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW--KKSPEKNERHTA 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 9e-85
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 11/269 (4%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
Y + IG G+YGR K +G + K++ ++ + + +++ E++LL+ L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 78 NIVKYLGS--LKTRSHLHIILEYVENGSLANIIKPNKF--GPFPESLVAVYIAQVLEGLV 133
NIV+Y +T + L+I++EY E G LA++I E V + Q+ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 134 YLHEQG-----VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
H + V+HRD+K AN+ + VKL DFG+A L + VGTPY+M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 189 EVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALF-RIVQDERPPIPESLSPDI 247
E + SDIWS+GC + EL +PP+ L +I + + IP S ++
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
+ + + RP + +L +P I
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 3e-83
Identities = 77/266 (28%), Positives = 132/266 (49%), Gaps = 13/266 (4%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID-LLKNLNHKNIVKY 82
E+G+GAYG V K + +G +A+K++ + ++ ++ ++D ++ ++ V +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIK--PNKFGPFPESLVAVYIAQVLEGLVYLHEQG- 139
G+L + I +E + + SL K +K PE ++ +++ L +LH +
Sbjct: 72 YGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA 199
VIHRD+K +N+L G VK+ DFG++ L + V G +MAPE I
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKG 189
Query: 200 ----SDIWSVGCTVIELLTCVPPYYELQ-PMPALFRIVQDERPPIPESL-SPDITDFLRQ 253
SDIWS+G T+IEL PY P L ++V++ P +P S + DF Q
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ 249
Query: 254 CFKKDARQRPDAKTLLSHPWIQNCRR 279
C KK++++RP L+ HP+
Sbjct: 250 CLKKNSKERPTYPELMQHPFFTLHES 275
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 1e-82
Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 17/270 (6%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID-LLKNLNHKNIVKY 82
EIG+GAYG V K + +G +A+K++ + +++ ++ ++D ++++ + IV++
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIK---PNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
G+L I +E + + S K PE ++ ++ L +L E
Sbjct: 87 YGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 140 -VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
+IHRDIK +NIL + G +KL DFG++ +L ++ T G +MAPE I+ S
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSASRQ 204
Query: 199 A----SDIWSVGCTVIELLTCVPPYYELQPMP-ALFRIVQDERPPIPESL----SPDITD 249
SD+WS+G T+ EL T PY + + L ++V+ + P + S SP +
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFIN 264
Query: 250 FLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279
F+ C KD +RP K LL HP+I
Sbjct: 265 FVNLCLTKDESKRPKYKELLKHPFILMYEE 294
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 1e-80
Identities = 64/294 (21%), Positives = 129/294 (43%), Gaps = 28/294 (9%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ +G+G +G V++ + + AIK++ L N + +M+E+ L L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 63
Query: 78 NIVKYLGS------------LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI 125
IV+Y + + +L+I ++ +L + + E V ++I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 126 -AQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH------- 177
Q+ E + +LH +G++HRD+K +NI T + +VK+ DFG+ T + + +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 178 -----SVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV 232
VGT +M+PE I + DI+S+G + EL P +++ + L +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVRTLTDVR 241
Query: 233 QDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLR 286
+ PP+ P ++ +RP+A ++ + ++ ++ LR
Sbjct: 242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLR 295
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 1e-80
Identities = 81/266 (30%), Positives = 137/266 (51%), Gaps = 14/266 (5%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID-LLKNLNHKNIVKY 82
E+G G G+V+K + G +A+KQ+ +E+ I+ ++D +LK+ + IV+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVI 141
G+ T + + I +E + + +K GP PE ++ +++ L YL E+ GVI
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAA-- 199
HRD+K +NIL + G +KL DFG++ +L D G +MAPE I+
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 200 ---SDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQDERPPIPESL--SPDITDFLRQ 253
+D+WS+G +++EL T PY + L +++Q+E P +P + S D F++
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD 266
Query: 254 CFKKDARQRPDAKTLLSHPWIQNCRR 279
C KD R+RP LL H +I+
Sbjct: 267 CLTKDHRKRPKYNKLLEHSFIKRYET 292
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 7e-80
Identities = 84/300 (28%), Positives = 142/300 (47%), Gaps = 49/300 (16%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYL 83
E+G G G V+K +G +A K + LE I N I++E+ +L N IV +
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG-VIH 142
G+ + + I +E+++ GSL ++K K G PE ++ V++GL YL E+ ++H
Sbjct: 98 GAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 155
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RD+K +NIL G +KL DFGV+ +L ++ N+ VGT +M+PE ++ + SDI
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQGTHYSVQSDI 213
Query: 203 WSVGCTVIELLTCVPPY--------------------------------------YELQP 224
WS+G +++E+ P + +P
Sbjct: 214 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273
Query: 225 MPALF----RIVQDERPPIPESL-SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279
A+F IV + P +P + S + DF+ +C K+ +R D K L+ H +I+
Sbjct: 274 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 2e-79
Identities = 76/290 (26%), Positives = 133/290 (45%), Gaps = 37/290 (12%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ + +G+GA+G+V K + + + AIK++ +E L+ I+ E+ LL +LNH+
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQ 62
Query: 78 NIVKYLGS-------------LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVY 124
+V+Y + +K +S L I +EY ENG+L ++I
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-NQQRDEYWRL 121
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA------------ 172
Q+LE L Y+H QG+IHRD+K NI + VK+ DFG+A + +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 173 --DVNTHSVVGTPYWMAPEVIEMSGVC-AASDIWSVGCTVIELLTCVPPYY---ELQPMP 226
N S +GT ++A EV++ +G D++S+G E++ P + +
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILK 239
Query: 227 ALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
L + + P ++ +R D +RP A+TLL+ W+
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 250 bits (639), Expect = 4e-73
Identities = 63/279 (22%), Positives = 115/279 (41%), Gaps = 23/279 (8%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HK 77
+ D +G GA G + + + VA+K+ I E + +E+ LL+ + H
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKR-----ILPECFSFADREVQLLRESDEHP 78
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
N+++Y + K R +I +E +L ++ K + Q GL +LH
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 138 QGVIHRDIKGANILTTKEGL-----VKLADFGVATKLTE---ADVNTHSVVGTPYWMAPE 189
++HRD+K NIL + ++DFG+ KL + V GT W+APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 190 VIEMS---GVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRI--VQDERPPIPESL 243
++ DI+S GC +++ P+ + A + + +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQ 282
+ + + D ++RP AK +L HP+ + + LQ
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQ 295
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 4e-72
Identities = 66/283 (23%), Positives = 114/283 (40%), Gaps = 23/283 (8%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
+ Y+ ++G+G + V L +G F A+K++ Q+D +E D+ + NH
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNH 85
Query: 77 KNIVKYLGSLKTRS----HLHIILEYVENGSLANIIK--PNKFGPFPESLVAVYIAQVLE 130
NI++ + ++L + + G+L N I+ +K E + + +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH---------SVVG 181
GL +H +G HRD+K NIL EG L D G + + +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 182 TPYWMAPEVIEMSGVCA---ASDIWSVGCTVIELLTCVPPY-YELQPMPALFRIVQDE-R 236
T + APE+ + C +D+WS+GC + ++ PY Q ++ VQ++
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW-IQNCR 278
P S + L D QRP LLS +Q
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-65
Identities = 73/249 (29%), Positives = 134/249 (53%), Gaps = 10/249 (4%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+ ++IG G++G V++ +G VA+K + ++ E +N ++E+ ++K L H NIV
Sbjct: 41 IKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQG- 139
++G++ +L I+ EY+ GSL ++ + + + +A V +G+ YLH +
Sbjct: 99 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 140 -VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
++HR++K N+L K+ VK+ DFG++ +++ S GTP WMAPEV+
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 199 ASDIWSVGCTVI--ELLTCVPPYYELQPMPALFRIV-QDERPPIPESLSPDITDFLRQCF 255
SD++S G VI EL T P+ L P + + + +R IP +L+P + + C+
Sbjct: 219 KSDVYSFG--VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 256 KKDARQRPD 264
+ +RP
Sbjct: 277 TNEPWKRPS 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 4e-65
Identities = 74/309 (23%), Positives = 128/309 (41%), Gaps = 45/309 (14%)
Query: 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKN 73
T ++ ++L D +G+GA V++G + GD AIK + + +++ M+E ++LK
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKK 63
Query: 74 LNHKNIVKYLGSL--KTRSHLHIILEYVENGSLAN-IIKPNKFGPFPESLVAVYIAQVLE 130
LNHKNIVK T H +I+E+ GSL + +P+ PES + + V+
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 131 GLVYLHEQGVIHRDIKGANIL----TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWM 186
G+ +L E G++HR+IK NI+ + + KL DFG A +L + D S+ GT ++
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYL 182
Query: 187 APEVIEMSGVC--------AASDIWSVGCTVIELLTCVPPYY------------------ 220
P++ E + + A D+WS+G T T P+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 221 ----------ELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
+ + P + + L +T L + D + +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 271 HPWIQNCRR 279
R
Sbjct: 303 ETSDILHRG 311
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-64
Identities = 76/281 (27%), Positives = 123/281 (43%), Gaps = 23/281 (8%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
G+ +GKG +G+ K E G+ + +K L +E ++E+ +++ L H N++K
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMK--ELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQGV 140
++G L L+ I EY++ G+L IIK + +P S V A + G+ YLH +
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQR-VSFAKDIASGMAYLHSMNI 129
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH--------------SVVGTPYWM 186
IHRD+ N L + V +ADFG+A + + +VVG PYWM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE--RPPIPESLS 244
APE+I D++S G + E++ V + P F + P +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP 249
Query: 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSL 285
P +C D +RP L W++ R L L
Sbjct: 250 PSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMHLAGHL 288
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 3e-64
Identities = 68/259 (26%), Positives = 125/259 (48%), Gaps = 4/259 (1%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNHK 77
+Y+ G +GKG + + ++ D + + A K V + + + EI + ++L H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
++V + G + + ++LE SL + K + E Y+ Q++ G YLH
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC 197
VIHRD+K N+ ++ VK+ DFG+ATK+ + GTP ++APEV+ G
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 198 AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257
D+WS+GC + LL PP +E + + ++ IP+ ++P +++ +
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 252
Query: 258 DARQRPDAKTLLSHPWIQN 276
D RP LL+ + +
Sbjct: 253 DPTARPTINELLNDEFFTS 271
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-64
Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 6/266 (2%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDL 70
K + + +G +GKG +G VY + ++ +A+K + + + + + +E+++
Sbjct: 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
+L H NI++ G + +++ILEY G++ ++ K F E A YI ++
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELAN 120
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV 190
L Y H + VIHRDIK N+L G +K+ADFG + + GT ++ PE+
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLDYLPPEM 178
Query: 191 IEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250
IE D+WS+G E L PP+ RI + E P+ ++ D
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDL 237
Query: 251 LRQCFKKDARQRPDAKTLLSHPWIQN 276
+ + K + QRP + +L HPWI
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITA 263
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-63
Identities = 70/260 (26%), Positives = 137/260 (52%), Gaps = 3/260 (1%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNH 76
+ +G+ +GKG++ VY+ + G VAIK + + + + + + E+ + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
+I++ + ++++++LE NG + +K N+ PF E+ ++ Q++ G++YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQIITGMLYLH 129
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
G++HRD+ +N+L T+ +K+ADFG+AT+L +++ GTP +++PE+ S
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
SD+WS+GC LL PP+ + V +P LS + D + Q +
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLR 248
Query: 257 KDARQRPDAKTLLSHPWIQN 276
++ R ++L HP++
Sbjct: 249 RNPADRLSLSSVLDHPFMSR 268
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 7e-63
Identities = 68/258 (26%), Positives = 124/258 (48%), Gaps = 4/258 (1%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNHK 77
+Y+ G +GKG + + ++ D + + A K V + + + EI + ++L H+
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
++V + G + + ++LE SL + K + E Y+ Q++ G YLH
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC 197
VIHRD+K N+ ++ VK+ DFG+ATK+ + GTP ++APEV+ G
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 198 AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257
D+WS+GC + LL PP +E + + ++ IP+ ++P +++ +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPP-FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 278
Query: 258 DARQRPDAKTLLSHPWIQ 275
D RP LL+ +
Sbjct: 279 DPTARPTINELLNDEFFT 296
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 8e-63
Identities = 79/277 (28%), Positives = 132/277 (47%), Gaps = 16/277 (5%)
Query: 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID 69
+ T+D+ ++ ++G GA+G V+ + +G IK ++ + Q + I EI+
Sbjct: 14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIE 72
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANII--KPNKFGPFPESLVAVYIAQ 127
+LK+L+H NI+K + +++I++E E G L I + E VA + Q
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 128 VLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPY 184
++ L Y H Q V+H+D+K NIL T+ +K+ DFG+A + + + GT
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAAGTAL 191
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQDER---PPI 239
+MAPEV + V DIWS G V+ LLT P+ + + + +
Sbjct: 192 YMAPEVFK-RDVTFKCDIWSAG--VVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVE 247
Query: 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
L+P D L+Q KD +RP A +L H W +
Sbjct: 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-62
Identities = 82/275 (29%), Positives = 135/275 (49%), Gaps = 14/275 (5%)
Query: 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID 69
+ T +Y + +GKG++G V K D A+K ++ + +D + I++E++
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
LLK L+H NI+K L+ S +I+ E G L + I K F E A I QV
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII--KRKRFSEHDAARIIKQVF 131
Query: 130 EGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWM 186
G+ Y+H+ ++HRD+K NIL K+ +K+ DFG++T + + +GT Y++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRIGTAYYI 190
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-----ERPPIPE 241
APEV+ + D+WS G + LL+ PP+Y + + + V+ + P
Sbjct: 191 APEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWR- 247
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
++S D D +R+ R A L HPWIQ
Sbjct: 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-62
Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 18/292 (6%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS---LENIAQEDLNIIMQE 67
++ Y L + IGKG + V + ++ E G A+K V + + +E
Sbjct: 17 DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 68 IDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANII--KPNKFGPFPESLVAVYI 125
+ L H +IV+ L + + L+++ E+++ L I + + + E++ + Y+
Sbjct: 77 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 126 AQVLEGLVYLHEQGVIHRDIKGANIL-TTKEG--LVKLADFGVATKLTEADVNTHSVVGT 182
Q+LE L Y H+ +IHRD+K +L +KE VKL FGVA +L E+ + VGT
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196
Query: 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQDERPPIP 240
P++MAPEV++ D+W G VI LL+ P+Y + LF + + +
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCG--VILFILLSGCLPFYGTKER--LFEGIIKGKYKMN 252
Query: 241 ESLSPDIT----DFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHS 288
I+ D +R+ D +R L+HPW++ R
Sbjct: 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE 304
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-61
Identities = 80/283 (28%), Positives = 137/283 (48%), Gaps = 14/283 (4%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL 70
K L Y ++G GAYG V D AIK + +++ + +++E+ +
Sbjct: 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAV 89
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
LK L+H NI+K + + + ++++E + G L + I F E AV I QVL
Sbjct: 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII--HRMKFNEVDAAVIIKQVLS 147
Query: 131 GLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
G+ YLH+ ++HRD+K N+L K+ L+K+ DFG++ +GT Y++A
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIA 206
Query: 188 PEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-----ERPPIPES 242
PEV+ D+WS+G + LL PP+ Q + R V+ + P +
Sbjct: 207 PEVLRKK-YDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWK-N 263
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSL 285
+S D ++Q + D+++R A+ L HPWI+ +S +
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGI 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 5e-61
Identities = 73/305 (23%), Positives = 128/305 (41%), Gaps = 42/305 (13%)
Query: 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL- 71
++L N + +G G+ G V G VA+K+ + + +I + EI LL
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR-----MLIDFCDIALMEIKLLT 63
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKF-----GPFPESLVAVYIA 126
++ +H N+++Y S T L+I LE +L ++++ E +
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 127 QVLEGLVYLHEQGVIHRDIKGANIL-------------TTKEGLVKLADFGVATKLTEAD 173
Q+ G+ +LH +IHRD+K NIL + + ++DFG+ KL
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 174 ----VNTHSVVGTPYWMAPEVIEMSGVCA-------ASDIWSVGCTVIELLTC-VPPYY- 220
N ++ GT W APE++E S + DI+S+GC +L+ P+
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 221 ELQPMPALFRIV---QDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277
+ + R + + + SL + TD + Q D +RP A +L HP
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302
Query: 278 RRALQ 282
+ L+
Sbjct: 303 SKKLE 307
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-61
Identities = 84/278 (30%), Positives = 135/278 (48%), Gaps = 20/278 (7%)
Query: 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID 69
+ T +Y + +GKG++G V K D A+K ++ + +D + I++E++
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
LLK L+H NI+K L+ S +I+ E G L + I K F E A I QV
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII--KRKRFSEHDAARIIKQVF 131
Query: 130 EGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWM 186
G+ Y+H+ ++HRD+K NIL K+ +K+ DFG++T + +GT Y++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYI 190
Query: 187 APEVIEMS-GVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQD-----ERPP 238
APEV+ + D+WS G VI LL+ PP+Y + + + V+ + P
Sbjct: 191 APEVLRGTYD--EKCDVWSAG--VILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQ 245
Query: 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
++S D D +R+ R A L HPWIQ
Sbjct: 246 WR-TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 7e-61
Identities = 73/272 (26%), Positives = 130/272 (47%), Gaps = 6/272 (2%)
Query: 5 TTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI- 63
T + K K + + +G +GKG +G VY + +N +A+K + + +E +
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 64 IMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAV 123
+ +EI++ +L H NI++ R ++++LE+ G L ++ K G F E A
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSAT 118
Query: 124 YIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTP 183
++ ++ + L Y HE+ VIHRDIK N+L +G +K+ADFG + + ++ GT
Sbjct: 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAP-SLRRRTMCGTL 176
Query: 184 YWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL 243
++ PE+IE D+W G E L +PP+ R + + P L
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-ETHRRIVNVDLKFPPFL 235
Query: 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
S D + + + QR K ++ HPW++
Sbjct: 236 SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-60
Identities = 76/275 (27%), Positives = 129/275 (46%), Gaps = 15/275 (5%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEID 69
H + ++Y +GKG++G V D G A+K +S + Q D +++E+
Sbjct: 19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
LLK L+H NI+K + + + +++ E G L + I F E A I QVL
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII--SRKRFSEVDAARIIRQVL 136
Query: 130 EGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWM 186
G+ Y+H+ ++HRD+K N+L +K+ +++ DFG++T + +GT Y++
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYI 195
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-----ERPPIPE 241
APEV+ + D+WS G + LL+ PP+ + + V+ E P
Sbjct: 196 APEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWK- 252
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
+S D +R+ R A+ L H WIQ
Sbjct: 253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-60
Identities = 79/328 (24%), Positives = 127/328 (38%), Gaps = 54/328 (16%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS---LENIAQ 58
R+ L KY L IG+G+YG V ++ + AIK ++ + I
Sbjct: 10 GRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69
Query: 59 EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSL-------------- 104
+D+ I E+ L+K L+H NI + + ++ +++E G L
Sbjct: 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129
Query: 105 ------------------------ANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+ + + E L++ + Q+ L YLH QG+
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189
Query: 141 IHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNT----HSVVGTPYWMAPEVIEMS 194
HRDIK N L T K +KL DFG++ + + + + GTPY++APEV+ +
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 195 GVC--AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE----SLSPDIT 248
D WS G + LL P+ V +++ LSP
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPG-VNDADTISQVLNKKLCFENPNYNVLSPLAR 308
Query: 249 DFLRQCFKKDARQRPDAKTLLSHPWIQN 276
D L ++ +R DA L HPWI
Sbjct: 309 DLLSNLLNRNVDERFDAMRALQHPWISQ 336
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-60
Identities = 74/278 (26%), Positives = 134/278 (48%), Gaps = 17/278 (6%)
Query: 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLK 72
S + Y + +E+GKGA+ V + + G A K ++ + ++ D + +E + +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 73 NLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGL 132
L H NIV+ S++ S +++ + V G L I + E+ + I Q+LE +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESI 118
Query: 133 VYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
Y H G++HR++K N+L K VKLADFG+A ++ +++ H GTP +++PE
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLSPE 177
Query: 190 VIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQD-----ERPPIPES 242
V++ DIW+ G VI LL PP+++ + L+ ++ P +
Sbjct: 178 VLKKDPYSKPVDIWACG--VILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWD-T 233
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA 280
++P+ + + ++R A L PWI N R
Sbjct: 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 7e-60
Identities = 74/312 (23%), Positives = 129/312 (41%), Gaps = 45/312 (14%)
Query: 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKN 73
T ++ ++L D +G+GA V++G + GD AIK + + +++ M+E ++LK
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKK 63
Query: 74 LNHKNIVKYLGSL--KTRSHLHIILEYVENGSLAN-IIKPNKFGPFPESLVAVYIAQVLE 130
LNHKNIVK T H +I+E+ GSL + +P+ PES + + V+
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 131 GLVYLHEQGVIHRDIKGANIL----TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWM 186
G+ +L E G++HR+IK NI+ + + KL DFG A +L + D S+ GT ++
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYL 182
Query: 187 APEVIEMSGVC--------AASDIWSVGCTVIELLTCVPPYY------------------ 220
P++ E + + A D+WS+G T T P+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 221 ----------ELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
+ + P + + L +T L + D + +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 271 HPWIQNCRRALQ 282
R +
Sbjct: 303 ETSDILHRMVIH 314
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-59
Identities = 73/267 (27%), Positives = 118/267 (44%), Gaps = 27/267 (10%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQV--SLENIAQEDLNIIMQEIDLLKNLNHKNI 79
L + IG G +G+VY+ GD VA+K + + + + QE L L H NI
Sbjct: 11 LEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQ 138
+ G +L +++E+ G L ++ + P + V A Q+ G+ YLH++
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP----DILVNWAVQIARGMNYLHDE 124
Query: 139 G---VIHRDIKGANILTTKEG--------LVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
+IHRD+K +NIL ++ ++K+ DFG+A + + G WMA
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA--AGAYAWMA 182
Query: 188 PEVIEMSGVCAASDIWSVGCTVI--ELLTCVPPYYELQPMPALFRIV-QDERPPIPESLS 244
PEVI S SD+WS G V+ ELLT P+ + + + + PIP +
Sbjct: 183 PEVIRASMFSKGSDVWSYG--VLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240
Query: 245 PDITDFLRQCFKKDARQRPDAKTLLSH 271
+ C+ D RP +L
Sbjct: 241 EPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-59
Identities = 68/284 (23%), Positives = 128/284 (45%), Gaps = 22/284 (7%)
Query: 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKN 73
K L KYM+ +++G+G +G V++ ++ + K V ++ Q + +EI +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNI 57
Query: 74 LNHKNIVKYLGSLKTRSHLHIILEYVENGSLAN-IIKPNKFGPFPESLVAVYIAQVLEGL 132
H+NI+ S ++ L +I E++ + I E + Y+ QV E L
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEAL 115
Query: 133 VYLHEQGVIHRDIKGANIL-TTKEG-LVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV 190
+LH + H DI+ NI+ T+ +K+ +FG A +L D + P + APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPEV 174
Query: 191 IEMSGVCAASDIWSVGCTVIE--LLTCVPPYY-ELQPMPALFRIVQD-----ERPPIPES 242
+ V A+D+WS+G + LL+ + P+ E + + + +
Sbjct: 175 HQHDVVSTATDMWSLG--TLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFK-E 229
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLR 286
+S + DF+ + K+ + R A L HPW++ + + +
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-59
Identities = 77/298 (25%), Positives = 133/298 (44%), Gaps = 19/298 (6%)
Query: 4 QTTTSAFHKSKTLDNKYML-GDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLN 62
T F + +N Y+L E+G+G + V + + G A K + Q+
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA 73
Query: 63 IIMQEIDLLKNLNH-KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLV 121
I+ EI +L+ ++ + S + +ILEY G + ++ P E+ V
Sbjct: 74 EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV 133
Query: 122 AVYIAQVLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHS 178
I Q+LEG+ YLH+ ++H D+K NIL G +K+ DFG++ K+ A
Sbjct: 134 IRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LRE 192
Query: 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYY-ELQPMPALFRIVQD- 234
++GTP ++APE++ + A+D+W++G +I LLT P+ E + +
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIG--IIAYMLLTHTSPFVGEDN--QETYLNISQV 248
Query: 235 ----ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHS 288
S+S TDF++ K+ +RP A+ LSH W+Q +
Sbjct: 249 NVDYSEETFS-SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEET 305
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-59
Identities = 74/294 (25%), Positives = 128/294 (43%), Gaps = 23/294 (7%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-----------QE 59
K + Y ++G GAYG V + AIK + ++
Sbjct: 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 60 DLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPES 119
I EI LLK+L+H NI+K + + + +++ E+ E G L I F E
Sbjct: 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII--NRHKFDEC 146
Query: 120 LVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNT 176
A + Q+L G+ YLH+ ++HRDIK NIL +K+ DFG+++ ++ D
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKL 205
Query: 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER 236
+GT Y++APEV++ D+WS G + LL PP+ Q + + V+ +
Sbjct: 206 RDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGK 263
Query: 237 PPIPE----SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLR 286
++S + + ++ D +R A+ L+ WI+ + S +
Sbjct: 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQ 317
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-59
Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 17/261 (6%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+G IG G++G VYKG +GD VA+K +++ + L E+ +L+ H NI+
Sbjct: 28 VGQRIGSGSFGTVYKGK--WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQGV 140
++G T L I+ ++ E SL + + F + + IA Q G+ YLH + +
Sbjct: 85 FMGYS-TAPQLAIVTQWCEGSSLYHHLH-ASETKFEMKKL-IDIARQTARGMDYLHAKSI 141
Query: 141 IHRDIKGANILTTKEGLVKLADFGVAT--KLTEADVNTHSVVGTPYWMAPEVIEMSGVCA 198
IHRD+K NI ++ VK+ DFG+AT + G+ WMAPEVI M
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 199 ---ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-----ERPPIPESLSPDITDF 250
SD+++ G + EL+T PY + + +V + + + +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 251 LRQCFKKDARQRPDAKTLLSH 271
+ +C KK +RP +L+
Sbjct: 262 MAECLKKKRDERPSFPRILAE 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-59
Identities = 75/288 (26%), Positives = 137/288 (47%), Gaps = 17/288 (5%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL 70
+ S + Y + +E+GKGA+ V + + G A K ++ + ++ D + +E +
Sbjct: 22 NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI 81
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
+ L H NIV+ S++ S +++ + V G L I + E+ + I Q+LE
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILE 139
Query: 131 GLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
+ Y H G++HR++K N+L K VKLADFG+A ++ +++ H GTP +++
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLS 198
Query: 188 PEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQD-----ERPPIP 240
PEV++ DIW+ G VI LL PP+++ + L+ ++ P
Sbjct: 199 PEVLKKDPYSKPVDIWACG--VILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWD 255
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHS 288
+++P+ + + ++R A L PWI N R + R
Sbjct: 256 -TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 302
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-59
Identities = 71/286 (24%), Positives = 130/286 (45%), Gaps = 22/286 (7%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL 70
++ Y L + IG+G++G V + A K++ + ED++ QEI++
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEI 59
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
+K+L+H NI++ + + + +++++E G L + F ES A + VL
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV--HKRVFRESDAARIMKDVLS 117
Query: 131 GLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
+ Y H+ V HRD+K N L + + +KL DFG+A + + + VGTPY+++
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKVGTPYYVS 176
Query: 188 PEVIEMS-GVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQD-----ERPPI 239
P+V+E G D WS G V+ LL PP+ + +++
Sbjct: 177 PQVLEGLYG--PECDEWSAG--VMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDW 231
Query: 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSL 285
++SP +R+ K +QR + L H W + + +L
Sbjct: 232 L-NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 7e-59
Identities = 68/267 (25%), Positives = 117/267 (43%), Gaps = 23/267 (8%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQV-----SLENIAQEDLNIIMQEIDLLKNLNH 76
+IGKG +G V+KG +++ VAIK + E E +E+ ++ NLNH
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
NIVK G + +++E+V G L + + +K P S+ + + G+ Y+
Sbjct: 83 PNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 137 EQG--VIHRDIKGANILTTKEG-----LVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
Q ++HRD++ NI K+ADFG++ + + ++G WMAPE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPE 196
Query: 190 VIEMSGVCA--ASDIWSVGCTVIELLTCVPPYYELQPMPALFR---IVQDERPPIPESLS 244
I +D +S + +LT P+ E F + RP IPE
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 245 PDITDFLRQCFKKDARQRPDAKTLLSH 271
P + + + C+ D ++RP ++
Sbjct: 257 PRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 7e-59
Identities = 77/250 (30%), Positives = 125/250 (50%), Gaps = 18/250 (7%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+ + +G+GA+G V K VAIKQ+ E+ + + E+ L +NH NIVK
Sbjct: 12 VEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKA----FIVELRQLSRVNHPNIVK 65
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHE--- 137
G+ + + +++EY E GSL N++ + P+ + A+ Q +G+ YLH
Sbjct: 66 LYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 138 QGVIHRDIKGANILTTKEGLV-KLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
+ +IHRD+K N+L G V K+ DFG A + N G+ WMAPEV E S
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN---KGSAAWMAPEVFEGSNY 180
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQ--PMPALFRIVQDERPPIPESLSPDITDFLRQC 254
D++S G + E++T P+ E+ ++ + RPP+ ++L I + +C
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRC 240
Query: 255 FKKDARQRPD 264
+ KD QRP
Sbjct: 241 WSKDPSQRPS 250
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 8e-59
Identities = 50/254 (19%), Positives = 110/254 (43%), Gaps = 21/254 (8%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
++ + G ++KG G+ + +K + + + + +E L+ +H N++
Sbjct: 14 FLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 82 YLGSLKT--RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQ 138
LG+ ++ H +I ++ GSL N++ +S AV A + G+ +LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQ-AVKFALDMARGMAFLHTL 130
Query: 139 G--VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
+ + +++ ++ +++ V + P W+APE ++
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQKKPE 185
Query: 197 CA---ASDIWSVGCTVI--ELLTCVPPYYELQPMPALFRIV-QDERPPIPESLSPDITDF 250
++D+WS V+ EL+T P+ +L M ++ + RP IP +SP ++
Sbjct: 186 DTNRRSADMWSFA--VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKL 243
Query: 251 LRQCFKKDARQRPD 264
++ C +D +RP
Sbjct: 244 MKICMNEDPAKRPK 257
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 9e-59
Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 20/281 (7%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS------LENIAQEDLNIIM 65
K L ++Y++ +G GA G V + + VAI+ +S + +
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188
Query: 66 QEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI 125
EI++LK LNH I+K + +I+LE +E G L + + N E+ +Y
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN--KRLKEATCKLYF 245
Query: 126 AQVLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGT 182
Q+L + YLHE G+IHRD+K N+L ++ L+K+ DFG + L E + ++ GT
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGT 304
Query: 183 PYWMAPEVIEMSGVCA---ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ----DE 235
P ++APEV+ G A D WS+G + L+ PP+ E + +L + +
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364
Query: 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
P + +S D +++ D + R + L HPW+Q+
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-58
Identities = 71/296 (23%), Positives = 130/296 (43%), Gaps = 24/296 (8%)
Query: 9 AFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS----LENIAQEDLNII 64
K + +++ Y +G+E+G G + V K + G A K + + I
Sbjct: 3 EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 65 MQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVY 124
+E+ +L+ + H N++ + R+ + +ILE V G L + + + E +
Sbjct: 63 EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANIL----TTKEGLVKLADFGVATKLTEADVNTHSVV 180
I Q+L+G+ YLH + + H D+K NI+ +KL DFG+A ++ + ++
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYY-ELQPMPALFRIVQD--- 234
GTP ++APE++ + +D+WS+G VI LL+ P+ + + +
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANITSVSY 235
Query: 235 --ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHS 288
+ S DF+R+ K+ R+R + L HPWI R S
Sbjct: 236 DFDEEFFS-HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRES 290
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-58
Identities = 70/282 (24%), Positives = 129/282 (45%), Gaps = 24/282 (8%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE----DLNIIMQEIDL 70
+++ Y +G+E+G G + V K G A K + ++ I +E+++
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
L+ + H NI+ + ++ + +ILE V G L + + + E ++ Q+L+
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILD 119
Query: 131 GLVYLHEQGVIHRDIKGANIL----TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWM 186
G+ YLH + + H D+K NI+ +KL DFG+A K+ + ++ GTP ++
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFV 178
Query: 187 APEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYY-ELQPMPALFRIVQD-----ERPP 238
APE++ + +D+WS+G VI LL+ P+ E + + +
Sbjct: 179 APEIVNYEPLGLEADMWSIG--VITYILLSGASPFLGETK--QETLTNISAVNYDFDEEY 234
Query: 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA 280
+ S DF+R+ KD ++R L H WI+ RR
Sbjct: 235 FS-NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-58
Identities = 73/287 (25%), Positives = 132/287 (45%), Gaps = 16/287 (5%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
+Y L +E+GKGA+ V + + + G A ++ + ++ D + +E +
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
+ L H NIV+ S+ H ++I + V G L I + E+ + I Q+LE
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADASHCIQQILEA 122
Query: 132 LVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
+++ H+ GV+HR++K N+L K VKLADFG+A ++ GTP +++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 189 EVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQD-----ERPPIPE 241
EV+ D+W+ G VI LL PP+++ + L++ ++ P
Sbjct: 183 EVLRKDPYGKPVDLWACG--VILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWD- 238
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHS 288
+++P+ D + + + +R A L HPWI + R
Sbjct: 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-58
Identities = 60/266 (22%), Positives = 124/266 (46%), Gaps = 22/266 (8%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+G+ IGKG +G+VY G +G+ VAI+ + +E ++ L +E+ + H+N+V
Sbjct: 37 IGELIGKGRFGQVYHGR--WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQGV 140
++G+ + HL II + +L ++++ + + IA ++++G+ YLH +G+
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKT-RQIAQEIVKGMGYLHAKGI 151
Query: 141 IHRDIKGANILTTKEGLVKLADFGVA-----TKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
+H+D+K N+ G V + DFG+ + + G +APE+I
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 196 VCA---------ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE-SLSP 245
SD++++G EL P+ ++++ +P + + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 246 DITDFLRQCFKKDARQRPDAKTLLSH 271
+I+D L C+ + +RP L+
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDM 296
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 6e-58
Identities = 75/284 (26%), Positives = 139/284 (48%), Gaps = 19/284 (6%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
K ++ + Y + +E+G GA+G V++ ++ G K ++ D + EI ++
Sbjct: 45 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIM 102
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
L+H ++ + + + + +ILE++ G L + I + E+ V Y+ Q EG
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEG 161
Query: 132 LVYLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
L ++HE ++H DIK NI+ T K VK+ DFG+ATKL ++ T + APE
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK-VTTATAEFAAPE 220
Query: 190 VIEMSGVCAASDIWSVGCTVIE--LLTCVPPYY-ELQPMPALFRIVQD-----ERPPIPE 241
+++ V +D+W++G V+ LL+ + P+ E + V+ +
Sbjct: 221 IVDREPVGFYTDMWAIG--VLGYVLLSGLSPFAGEDD--LETLQNVKRCDWEFDEDAFS- 275
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSL 285
S+SP+ DF++ +K+ R+R L HPW++ L S +
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 7e-58
Identities = 63/282 (22%), Positives = 116/282 (41%), Gaps = 33/282 (11%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHK 77
+ + + +G + VY+ D+ +G A+K++ +E I+QE+ +K L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHP 86
Query: 78 NIVKYLGS-------LKTRSHLHIILEYVENGSLANIIKPNKF-GPFPESLVAVYIAQVL 129
NIV++ + T ++L + G L +K + GP V Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 130 EGLVYLHEQG--VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV-------- 179
+ ++H Q +IHRD+K N+L + +G +KL DFG AT ++ + S
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 180 ----VGTPYWMAPEVIEMSGVCAA---SDIWSVGCTVIELLTCVPPYYELQPMPALFRIV 232
TP + PE+I++ DIW++GC + L P+ + A RIV
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIV 262
Query: 233 QDE-RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
+ P ++ +R + + +R ++
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-57
Identities = 72/298 (24%), Positives = 130/298 (43%), Gaps = 23/298 (7%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS----LENIAQEDLNIIMQE 67
+ + +D+ Y G+E+G G + V K + G A K + + I +E
Sbjct: 5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 68 IDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
+ +LK + H N++ + ++ + +ILE V G L + + + E ++ Q
Sbjct: 65 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQ 122
Query: 128 VLEGLVYLHEQGVIHRDIKGANIL----TTKEGLVKLADFGVATKLTEADVNTHSVVGTP 183
+L G+ YLH + H D+K NI+ + +K+ DFG+A K+ + ++ GTP
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTP 181
Query: 184 YWMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQD-----ER 236
++APE++ + +D+WS+G VI LL+ P+ V E
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIG--VITYILLSGASPFLG-DTKQETLANVSAVNYEFED 238
Query: 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN-CRRALQSSLRHSGTMRN 293
+ S DF+R+ KD ++R + L HPWI+ + S + M
Sbjct: 239 EYFS-NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-57
Identities = 85/303 (28%), Positives = 140/303 (46%), Gaps = 26/303 (8%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS------LENIAQEDLNIIM 65
K L ++Y++ +G GA G V + + VAIK +S + +
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 66 QEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI 125
EI++LK LNH I+K + +I+LE +E G L + + N E+ +Y
Sbjct: 64 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN--KRLKEATCKLYF 120
Query: 126 AQVLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGT 182
Q+L + YLHE G+IHRD+K N+L ++ L+K+ DFG + L E + ++ GT
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGT 179
Query: 183 PYWMAPEVIEMSGVCA---ASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQ---- 233
P ++APEV+ G A D WS+G VI L+ PP+ E + +L +
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLG--VILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 234 DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN--CRRALQSSLRHSGTM 291
+ P + +S D +++ D + R + L HPW+Q+ +R Q L
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENES 297
Query: 292 RNV 294
+
Sbjct: 298 TAL 300
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-57
Identities = 60/328 (18%), Positives = 120/328 (36%), Gaps = 71/328 (21%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAI-------KQVSLENIAQE--------DLN 62
+ +G+G +G V++ + + AI ++++ E + +E
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 63 II-----------------------------------------MQEIDLLKNLNHKNIVK 81
I+ +I + + KN V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI-AQVLEGLVYLHEQGV 140
L + +L+I ++ +L + + E V ++I Q+ E + +LH +G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLT------------EADVNTHSVVGTPYWMAP 188
+HRD+K +NI T + +VK+ DFG+ T + A VGT +M+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 189 EVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDIT 248
E I + DI+S+G + ELL E + + + + P + P
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI--ITDVRNLKFPLLFTQKYPQEH 303
Query: 249 DFLRQCFKKDARQRPDAKTLLSHPWIQN 276
++ +RP+A ++ + +N
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 7e-57
Identities = 74/295 (25%), Positives = 128/295 (43%), Gaps = 17/295 (5%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
K + + Y + +E+G GA+G V++ + G+ A K V + + D + +EI +
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTM 208
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
L H +V + + + + +I E++ G L + ++ E Y+ QV +G
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKG 267
Query: 132 LVYLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
L ++HE +H D+K NI+ T + +KL DFG+ L GT + APE
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTTGTAEFAAPE 326
Query: 190 VIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQD-----ERPPIPES 242
V E V +D+WSVG V+ LL+ + P+ + R V+ +
Sbjct: 327 VAEGKPVGYYTDMWSVG--VLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSG- 382
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEEN 297
+S D DF+R+ D R L HPW+ + S S + ++
Sbjct: 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 437
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 8e-57
Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 24/296 (8%)
Query: 9 AFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS----LENIAQEDLNII 64
K + +++ Y +G+E+G G + V K + G A K + + I
Sbjct: 3 ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 65 MQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVY 124
+E+ +L+ + H NI+ + R+ + +ILE V G L + + + E +
Sbjct: 63 EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANIL----TTKEGLVKLADFGVATKLTEADVNTHSVV 180
I Q+L+G+ YLH + + H D+K NI+ +KL DFG+A ++ + ++
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYY-ELQPMPALFRIVQD--- 234
GTP ++APE++ + +D+WS+G VI LL+ P+ + + +
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANITAVSY 235
Query: 235 --ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHS 288
+ S DF+R+ K+ R+R + L HPWI R S
Sbjct: 236 DFDEEFFS-QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRES 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-56
Identities = 75/273 (27%), Positives = 131/273 (47%), Gaps = 16/273 (5%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
++ + ++ + +G GA+ V+ G A+K + ++ + EI +L
Sbjct: 3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVL 60
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
K + H+NIV ++ +H +++++ V G L + I + G + E ++ I QVL
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDASLVIQQVLSA 118
Query: 132 LVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
+ YLHE G++HRD+K N+L + + + DFG++ ++T GTP ++AP
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST--ACGTPGYVAP 176
Query: 189 EVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-----ERPPIPESL 243
EV+ A D WS+G LL PP+YE + LF +++ E P +
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWD-DI 234
Query: 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
S DF+ +KD +R + LSHPWI
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-56
Identities = 70/308 (22%), Positives = 130/308 (42%), Gaps = 33/308 (10%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS-------LE 54
+R H + Y + +G+G V + + A+K +
Sbjct: 1 TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60
Query: 55 NIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKF 113
QE ++E+D+L+ ++ H NI++ + +T + ++ + ++ G L + +
Sbjct: 61 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120
Query: 114 GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173
E + +LE + LH+ ++HRD+K NIL + +KL DFG + +L +
Sbjct: 121 --LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 174 VNTHSVVGTPYWMAPEVIEMSGVCA------ASDIWSVGCTVIE--LLTCVPPYY-ELQP 224
V GTP ++APE+IE S D+WS G VI LL PP++ Q
Sbjct: 179 K-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG--VIMYTLLAGSPPFWHRKQM 235
Query: 225 MPALFRIVQD-----ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279
+ + R++ P S + D + + ++R A+ L+HP+ Q
Sbjct: 236 L--MLRMIMSGNYQFGSPEWD-DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ--- 289
Query: 280 ALQSSLRH 287
+ +RH
Sbjct: 290 YVVEEVRH 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-55
Identities = 74/271 (27%), Positives = 134/271 (49%), Gaps = 13/271 (4%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDL 70
+ K ++ + G +G+G++ V +L AIK + +I +E+ + + +E D+
Sbjct: 25 RKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
+ L+H VK + + L+ L Y +NG L I+ K G F E+ Y A+++
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVS 141
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN--THSVVGTPYWMAP 188
L YLH +G+IHRD+K NIL ++ +++ DFG A L+ +S VGT +++P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 189 EVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDIT 248
E++ C +SD+W++GC + +L+ +PP+ +F+ + PE P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQKIIKLEYDFPEKFFPKAR 260
Query: 249 DFLRQCFKKDARQRP------DAKTLLSHPW 273
D + + DA +R L +HP+
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-55
Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 20/276 (7%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL 70
L + + + E+G+GA VY+ A+K + D I+ EI +
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGV 101
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
L L+H NI+K +T + + ++LE V G L + I + G + E A + Q+LE
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV--EKGYYSERDAADAVKQILE 159
Query: 131 GLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
+ YLHE G++HRD+K N+L + +K+ADFG++ + + +V GTP + A
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCA 218
Query: 188 PEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQD-----ERPPIP 240
PE++ D+WSVG +I LL P+Y+ + +FR + + P
Sbjct: 219 PEILRGCAYGPEVDMWSVG--IITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWD 276
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
+S + D +R+ D ++R L HPW+
Sbjct: 277 -EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 6e-55
Identities = 65/296 (21%), Positives = 125/296 (42%), Gaps = 29/296 (9%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSL------E 54
M + + +K KY D IG+G V + + G A+K + +
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP 136
Query: 55 NIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKF 113
+E +E +L+ + H +I+ + S ++ S + ++ + + G L + + +
Sbjct: 137 EQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT--EK 194
Query: 114 GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173
E + +LE + +LH ++HRD+K NIL ++L+DFG + L +
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 174 VNTHSVVGTPYWMAPEVIEMSGVCA------ASDIWSVGCTVIE--LLTCVPPYY-ELQP 224
+ GTP ++APE+++ S D+W+ G VI LL PP++ Q
Sbjct: 255 K-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG--VILFTLLAGSPPFWHRRQ- 310
Query: 225 MPALFRIVQD-----ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
+ R++ + P S + D + + + D R A+ L HP+ +
Sbjct: 311 -ILMLRMIMEGQYQFSSPEWD-DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 7e-55
Identities = 63/304 (20%), Positives = 127/304 (41%), Gaps = 30/304 (9%)
Query: 7 TSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQ 66
S F++ L + +G+G++ K + ++ A+K I++ +
Sbjct: 3 DSPFYQHYDL---DLKDKPLGEGSFSICRKCVHKKSNQAFAVKI-----ISKRMEANTQK 54
Query: 67 EIDLLKNL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI 125
EI LK H NIVK + H +++E + G L IK K F E+ + +
Sbjct: 55 EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK--KKKHFSETEASYIM 112
Query: 126 AQVLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGT 182
+++ + ++H+ GV+HRD+K N+L +K+ DFG A + + T
Sbjct: 113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
Query: 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYY------ELQPMPALFRIVQD 234
++ APE++ +G + D+WS+G VI +L+ P+ + + ++
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLG--VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230
Query: 235 -----ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSG 289
E ++S + D ++ D +R L + W+Q+ + + L
Sbjct: 231 GDFSFEGEAWK-NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPD 289
Query: 290 TMRN 293
+ +
Sbjct: 290 ILGS 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-55
Identities = 80/303 (26%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS------------------ 52
N+Y L DEIGKG+YG V + + + A+K +S
Sbjct: 6 SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRG 65
Query: 53 ------LENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK------TRSHLHIILEYVE 100
+ + + QEI +LK L+H N+VK L HL+++ E V
Sbjct: 66 TRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVK----LVEVLDDPNEDHLYMVFELVN 121
Query: 101 NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKL 160
G + + P E Y +++G+ YLH Q +IHRDIK +N+L ++G +K+
Sbjct: 122 QGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKI 178
Query: 161 ADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM-----SGVCAASDIWSVGCTVIELLT- 214
ADFGV+ + +D + VGTP +MAPE + SG A D+W++G T+ +
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSG--KALDVWAMGVTLYCFVFG 236
Query: 215 CVPPYYELQPMPALFRIVQDERPPIPE--SLSPDITDFLRQCFKKDARQRPDAKTLLSHP 272
P + + + L ++ + P+ ++ D+ D + + K+ R + HP
Sbjct: 237 QCP--FMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294
Query: 273 WIQ 275
W+
Sbjct: 295 WVT 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 8e-55
Identities = 65/302 (21%), Positives = 119/302 (39%), Gaps = 47/302 (15%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-------------- 63
N Y + + +G + ++ L ++ F A+K+ + ++
Sbjct: 31 NDYRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 64 -IMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANII------KPNKFGPF 116
E+ ++ ++ ++ + G + ++II EY+EN S+ N
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 117 PESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175
P ++ I VL Y+H + + HRD+K +NIL K G VKL+DFG + + D
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKK 206
Query: 176 THSVVGTPYWMAPEVIEMSGVC--AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ 233
GT +M PE A DIWS+G + + V P+ + LF ++
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 234 DERPPIPES-------------------LSPDITDFLRQCFKKDARQRPDAKTLLSHPWI 274
+ P LS + DFL+ +K+ +R ++ L H W+
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326
Query: 275 QN 276
+
Sbjct: 327 AD 328
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-54
Identities = 68/274 (24%), Positives = 134/274 (48%), Gaps = 15/274 (5%)
Query: 12 KSKTLDNKYMLG--DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID 69
K +++ Y + + +G G +G+V+K + G +A K + +D + EI
Sbjct: 81 KQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEIS 138
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
++ L+H N+++ + ++++ + +++EYV+ G L + I + E +++ Q+
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQIC 197
Query: 130 EGLVYLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
EG+ ++H+ ++H D+K NIL +K+ DFG+A + + GTP ++A
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK-VNFGTPEFLA 256
Query: 188 PEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPMPALFRIVQ---DERPPIPES 242
PEV+ V +D+WSVG VI LL+ + P+ L I+ D +
Sbjct: 257 PEVVNYDFVSFPTDMWSVG--VIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD 314
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
+S + +F+ + K+ R A L HPW+ +
Sbjct: 315 ISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-53
Identities = 74/299 (24%), Positives = 130/299 (43%), Gaps = 27/299 (9%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID- 69
S + Y + ++IG G+Y + + A+K + + ++ D +EI+
Sbjct: 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRD---PTEEIEI 68
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLAN-IIKPNKFGPFPESLVAVYIAQV 128
LL+ H NI+ +++++ E ++ G L + I++ F E + + +
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTI 125
Query: 129 LEGLVYLHEQGVIHRDIKGANIL-TTKEG---LVKLADFGVATKLTEADVNTHSVVGTPY 184
+ + YLH QGV+HRD+K +NIL + G +++ DFG A +L + + T
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPM--PALFRIVQD-----E 235
++APEV+E G AA DIWS+G V+ +LT P+ + +
Sbjct: 186 FVAPEVLERQGYDAACDIWSLG--VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243
Query: 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNV 294
S+S D + + D QR A +L HPWI + + Q L V
Sbjct: 244 GGYWN-SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLV 301
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-53
Identities = 83/303 (27%), Positives = 132/303 (43%), Gaps = 35/303 (11%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
KY +IG+G+YG V+K + + G VAIK+ I ++EI +LK L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
N+V L + + LH++ EY ++ ++ + + PE LV Q L+ + + H+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLT-EADVNTHSVVGTPYWMAPEVIEMSGV 196
IHRD+K NIL TK ++KL DFG A LT +D V T ++ +PE++
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQ 179
Query: 197 CAAS-DIWSVGCTVIELLTCVP--------------------PYYELQPMPALFRIVQDE 235
D+W++GC ELL+ VP Q + + +
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 236 RPPIPES----------LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSL 285
+ P PE +S L+ C D +R + LL HP+ +N R +
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAK 299
Query: 286 RHS 288
H
Sbjct: 300 EHD 302
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-53
Identities = 78/302 (25%), Positives = 125/302 (41%), Gaps = 31/302 (10%)
Query: 11 HKSKTLDNKYMLGDE-IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID 69
K + + Y L + +G G G+V + G A+K + D QE+D
Sbjct: 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVD 73
Query: 70 LLKNL-NHKNIVK----YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVY 124
+IV Y + L II+E +E G L + I+ F E A
Sbjct: 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI 133
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVG 181
+ + + +LH + HRD+K N+L K+ ++KL DFG A + T+ + T
Sbjct: 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT--PCY 191
Query: 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYY---ELQPMPALFRIVQD-- 234
TPY++APEV+ + D+WS+G VI LL PP+Y P + R ++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLG--VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249
Query: 235 ---ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTM 291
P +S D +R K D +R ++HPWI Q+ L + +
Sbjct: 250 YGFPNPEWS-EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVL 308
Query: 292 RN 293
+
Sbjct: 309 QE 310
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 8e-53
Identities = 62/276 (22%), Positives = 104/276 (37%), Gaps = 13/276 (4%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL 70
++T + + + +G G +G V + + + G+ VAIKQ E ++ EI +
Sbjct: 8 LPTQTCGP-WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-KNRERWCLEIQI 65
Query: 71 LKNLNHKNIVK------YLGSLKTRSHLHIILEYVENGSLAN-IIKPNKFGPFPESLVAV 123
+K LNH N+V L L + +EY E G L + + E +
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 124 YIAQVLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVV 180
++ + L YLHE +IHRD+K NI+ + + K+ D G A +L + V
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFV 184
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIP 240
GT ++APE++E D WS G E +T P+ V+++
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
W+Q
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC 280
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-52
Identities = 81/298 (27%), Positives = 132/298 (44%), Gaps = 49/298 (16%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII-MQEIDLLKNLNH 76
KY +G+G+YG V K + + G VAIK+ + + + I M+EI LLK L H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRH 83
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
+N+V L K + +++ E+V++ ++ + ++ +V Y+ Q++ G+ + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLT-EADVNTHSVVGTPYWMAPEVIEMSG 195
+IHRDIK NIL ++ G+VKL DFG A L +V V T ++ APE++
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDV 200
Query: 196 VCAAS-DIWSVGCTVIELLTCVPPYYELQPMPA------LFRIVQDERPPIPES------ 242
+ D+W++GC V E+ P L P L+ I+ IP
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEP----L--FPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 243 ------------------------LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
LS + D ++C D +RP LL H + Q
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-52
Identities = 75/300 (25%), Positives = 133/300 (44%), Gaps = 27/300 (9%)
Query: 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID 69
K+ +D+ + +G G G+V + + + A+K + +D +E++
Sbjct: 54 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVE 106
Query: 70 LLKNL-NHKNIVK----YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVY 124
L +IV+ Y R L I++E ++ G L + I+ F E +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVG 181
+ + E + YLH + HRD+K N+L ++KL DFG A K T + + +
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-KETTSHNSLTTPCY 225
Query: 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYYELQPM---PALFRIVQDER 236
TPY++APEV+ + D+WS+G VI LL PP+Y + P + ++ +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
Query: 237 P--PIPE--SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMR 292
P PE +S ++ +R K + QR ++HPWI + Q+ L S ++
Sbjct: 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 343
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 4e-52
Identities = 40/310 (12%), Positives = 90/310 (29%), Gaps = 46/310 (14%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE-DLNIIMQEIDLLKNLNHK 77
K L + + G V+ D+E + A+K ++ +L + + L +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 78 NIVKYLGSLK--------------------------TRSHLHIILEYVENGSLANIIK-- 109
+ + + ++ +++ L +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181
Query: 110 ---PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA 166
G + + AQ++ L +G++H N+ +G + L D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 167 TKLTEADVNTHSVVGTPYWMAPEVIEMSGVC--AASDIWSVGCTVIELLTCVPPYYELQP 224
K+ + + E + S A + W +G ++ + P+ + P
Sbjct: 242 WKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 225 MPALFRIVQDERPPIPESL--------SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
R P +SL + + + D R+R + P
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
Query: 277 CRRALQSSLR 286
+ + SSL
Sbjct: 359 LQNEISSSLS 368
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-51
Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 6/272 (2%)
Query: 5 TTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII 64
+ S + + N Y L IGKG + +V + G VAIK + + L +
Sbjct: 3 SIASCADEQPHIGN-YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL 61
Query: 65 MQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVY 124
+E+ ++K LNH NIVK ++T L++I+EY G + + + G E
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV--AHGRMKEKEARSK 119
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY 184
Q++ + Y H++ ++HRD+K N+L + +K+ADFG + + T + G P
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFCGAPP 178
Query: 185 WMAPEVIEMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL 243
+ APE+ + D+WS+G + L++ P+ Q + L V + IP +
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFYM 237
Query: 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
S D + L++ + +R + ++ WI
Sbjct: 238 STDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-51
Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 53/288 (18%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L + +GKG YG V++G G+ VA+K S + E+ L H+NI+
Sbjct: 12 LLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSW---FRETELYNTVMLRHENILG 66
Query: 82 YLGSLKTRSHLH----IILEYVENGSLANIIKPNKFGPFPESL-VAVYIAQVLEGLVYLH 136
++ S T H +I Y E GSL + ++ L + + IA GL +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL-DTVSCLRIVLSIAS---GLAHLH 122
Query: 137 EQ--------GVIHRDIKGANILTTKEGLVKLADFGVATKL----TEADVNTHSVVGTPY 184
+ + HRD+K NIL K G +AD G+A + DV + VGT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 185 WMAPEVIE--MSGVCAAS----DIWSVGCTVIELLTCV----------PPYYELQPMPAL 228
+MAPEV++ + C S DIW+ G + E+ + PP+Y++ P
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 229 FRIVQD------ERPPIPESLSPD-----ITDFLRQCFKKDARQRPDA 265
F ++ +RP IP D + +++C+ ++ R A
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-50
Identities = 37/311 (11%), Positives = 83/311 (26%), Gaps = 52/311 (16%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL----------------- 61
+ G +G+ + D E G+ + +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 62 ---------NIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI-ILEYVENGSLANII--- 108
+ DL+K+ K +++ + L L +L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 109 --KPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA 166
+ QV+ L LH G++H ++ +I+ + G V L F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 167 TKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA-----------ASDIWSVGCTVIELLTC 215
+ + + PE+ + + D W++G + +
Sbjct: 254 VRDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 216 VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
P + + I + +++ + L + R + P +
Sbjct: 310 DLPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364
Query: 276 NCRRALQSSLR 286
R L ++L
Sbjct: 365 QLRTELSAALP 375
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-50
Identities = 73/304 (24%), Positives = 132/304 (43%), Gaps = 45/304 (14%)
Query: 12 KSKTLDNKYMLGDE-IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL 70
S ++ Y L ++ +G+GA+ RV ++L A+K + + + + +E+++
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEM 63
Query: 71 LKNL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
L H+N+++ + + +++ E + GS+ + I K F E +V + V
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASVVVQDVA 121
Query: 130 EGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNT-------HSV 179
L +LH +G+ HRD+K NIL + VK+ DF + + + + +
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 180 VGTPYWMAPEVIEMSGVCA-----ASDIWSVGCTVIE--LLTCVPPYY------------ 220
G+ +MAPEV+E A D+WS+G VI LL+ PP+
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG--VILYILLSGYPPFVGRCGSDCGWDRG 239
Query: 221 --ELQPMPALFRIVQD-----ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
LF +Q+ +S D + + +DA+QR A +L HPW
Sbjct: 240 EACPACQNMLFESIQEGKYEFPDKDWA-HISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298
Query: 274 IQNC 277
+Q C
Sbjct: 299 VQGC 302
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-50
Identities = 60/255 (23%), Positives = 116/255 (45%), Gaps = 10/255 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLG 84
IGKG++G+V + A+K ++ + + ++ + +E+ +++ L H +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S + + ++++ + G L ++ + F E V ++I +++ L YL Q +IHRD
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCA---ASD 201
+K NIL + G V + DF +A L ++ GT +MAPE+ A D
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199
Query: 202 IWSVGCTVIELLTCVPPYYEL--QPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
WS+G T ELL PY+ + + P + S ++ L++ + +
Sbjct: 200 WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNP 259
Query: 260 RQR-PDAKTLLSHPW 273
QR + + P+
Sbjct: 260 DQRFSQLSDVQNFPY 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-49
Identities = 66/262 (25%), Positives = 119/262 (45%), Gaps = 8/262 (3%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ L +G+GAYG V ++ + VA+K V ++ + I +EI + K LNH+N
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHEN 66
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+VK+ G + + ++ LEY G L + I+P+ PE + Q++ G+VYLH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT--HSVVGTPYWMAPEVIEMSG- 195
G+ HRDIK N+L + +K++DFG+AT + + + GT ++APE+++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 196 VCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIP-ESLSPDITDFLRQ 253
D+WS G + +L +P + + P + + L +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 254 CFKKDARQRPDAKTLLSHPWIQ 275
++ R + W
Sbjct: 245 ILVENPSARITIPDIKKDRWYN 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-49
Identities = 73/288 (25%), Positives = 120/288 (41%), Gaps = 53/288 (18%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+ +IGKG YG V+ G G+ VA+K A EI + H+NI+
Sbjct: 41 MVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASW---FRETEIYQTVLMRHENILG 95
Query: 82 YLGS----LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL-VAVYIAQVLEGLVYLH 136
++ + + + L++I +Y ENGSL + +K L +A GL +LH
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL-DAKSMLKLAYSSVS---GLCHLH 151
Query: 137 EQ--------GVIHRDIKGANILTTKEGLVKLADFGVATKLT----EADVNTHSVVGTPY 184
+ + HRD+K NIL K G +AD G+A K E D+ ++ VGT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 185 WMAPEVIEMSGVCA------ASDIWSVGCTVIELLTCV----------PPYYELQPMPAL 228
+M PEV++ S +D++S G + E+ PY++L P
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 229 FRIVQD------ERPPIPESLSPD-----ITDFLRQCFKKDARQRPDA 265
+ +++ RP P S D + + +C+ + R A
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-49
Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNH 76
KY ++IG+G YG V+K + E + VA+K+V L++ E + ++EI LLK L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKH 60
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
KNIV+ L + L ++ E+ + L + G +V ++ Q+L+GL + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
+ V+HRD+K N+L + G +KLA+FG+A + VV T ++ P+V+ +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 177
Query: 196 V-CAASDIWSVGCTVIELLTCVPPYY----ELQPMPALFRIVQ-----DER--------- 236
+ + D+WS GC EL P + L RI + E
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 237 -----PPIPE---------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
P P L+ D L+ K + QR A+ L HP+ +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-49
Identities = 74/305 (24%), Positives = 132/305 (43%), Gaps = 11/305 (3%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ L +G+GAYG V ++ + VA+K V ++ + I +EI + K LNH+N
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHEN 66
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+VK+ G + + ++ LEY G L + I+P+ PE + Q++ G+VYLH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT--HSVVGTPYWMAPEVIEMSG- 195
G+ HRDIK N+L + +K++DFG+AT + + + GT ++APE+++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 196 VCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIP-ESLSPDITDFLRQ 253
D+WS G + +L +P + + P + + L +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 254 CFKKDARQRPDAKTLLSHPWIQ-NCRRALQSSLRHSGTMRNVEENGSADAEIPSEDNQSA 312
++ R + W ++ + SG + E I S + S
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVS--ESPSGFSKHIQSNLDFSP 302
Query: 313 GESLS 317
S S
Sbjct: 303 VNSAS 307
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-48
Identities = 72/288 (25%), Positives = 118/288 (40%), Gaps = 53/288 (18%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L + IGKG +G V++G G+ VA+K S EI L H+NI+
Sbjct: 46 LQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILG 100
Query: 82 YLGSLK----TRSHLHIILEYVENGSLANIIKPNKFGPFPESL-VAVYIAQVLEGLVYLH 136
++ + T + L ++ +Y E+GSL + + + +A+ A GL +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-TVEGMIKLALSTAS---GLAHLH 156
Query: 137 EQ--------GVIHRDIKGANILTTKEGLVKLADFGVATKL----TEADVNTHSVVGTPY 184
+ + HRD+K NIL K G +AD G+A + D+ + VGT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 185 WMAPEVIEMSGVCA------ASDIWSVGCTVIELLTCV----------PPYYELQPMPAL 228
+MAPEV++ S +DI+++G E+ PYY+L P
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 229 FRIVQD------ERPPIPESLS-----PDITDFLRQCFKKDARQRPDA 265
++ RP IP + +R+C+ + R A
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 6/267 (2%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEID 69
H + Y+LGD +G G +G+V G G VA+K ++ + I D+ I +EI
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
LK H +I+K + T + +++EYV G L + I K G E Q+L
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC--KHGRVEEMEARRLFQQIL 121
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
+ Y H V+HRD+K N+L K+ADFG++ +++ + G+P + APE
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSCGSPNYAAPE 180
Query: 190 VIEMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDIT 248
VI DIWS G + LL P+ + + +P LF+ ++ IPE L+ +
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 249 DFLRQCFKKDARQRPDAKTLLSHPWIQ 275
L + D +R K + H W +
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 73/256 (28%), Positives = 127/256 (49%), Gaps = 11/256 (4%)
Query: 26 IGKGAYGRVY---KGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82
+G+G++G+V+ K + A+K + + D E D+L +NH IVK
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
+ +T L++IL+++ G L + K F E V Y+A++ L +LH G+I+
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLGIIY 149
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RD+K NIL +EG +KL DFG++ + + + +S GT +MAPEV+ G ++D
Sbjct: 150 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 209
Query: 203 WSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR 262
WS G + E+LT P+ + ++ + +P+ LSP+ LR FK++ R
Sbjct: 210 WSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANR 268
Query: 263 -----PDAKTLLSHPW 273
+ + H +
Sbjct: 269 LGAGPDGVEEIKRHSF 284
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-48
Identities = 83/301 (27%), Positives = 139/301 (46%), Gaps = 54/301 (17%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNH 76
+++ +++G G Y VYKGL+ G +VA+K+V L++ +E ++EI L+K L H
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKH 62
Query: 77 KNIVKYLGSLKTRSHLHIILEYVEN---GSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
+NIV+ + T + L ++ E+++N + + N +LV + Q+L+GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPYWMAPEVI- 191
+ HE ++HRD+K N+L K G +KL DFG+A + + VV T ++ AP+V+
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLM 181
Query: 192 ---EMSGVCAASDIWSVGCTVIELLTCVP------------------------------- 217
S + DIWS GC + E++T P
Sbjct: 182 GSRTYS---TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 218 -PYYEL----QPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHP 272
P Y +P L +++Q L ++ DFL + + R AK L HP
Sbjct: 239 LPKYNPNIQQRPPRDLRQVLQPHTKE---PLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 273 W 273
W
Sbjct: 296 W 296
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-48
Identities = 73/270 (27%), Positives = 134/270 (49%), Gaps = 20/270 (7%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI--IMQEIDLLKNLNH 76
KY++GD +G+G+YG+V + LD E A+K + + + + + +EI LL+ L H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 77 KNIVKYLG--SLKTRSHLHIILEYVENGS---LANIIKPNKFGPFPESLVAVYIAQVLEG 131
KN+++ + + + +++++EY G L ++ + FP Y Q+++G
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE----KRFPVCQAHGYFCQLIDG 121
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT--HSVVGTPYWMAPE 189
L YLH QG++H+DIK N+L T G +K++ GVA L + + G+P + PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 190 VIEMSGVC----AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSP 245
+ +G+ DIWS G T+ + T + P+ + LF + IP P
Sbjct: 182 IA--NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYAIPGDCGP 238
Query: 246 DITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
++D L+ + + +R + + H W +
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-48
Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 51/296 (17%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI---IMQEIDLLKNL 74
+Y D +G+G + VYK D VAIK++ L + ++ I ++EI LL+ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
+H NI+ L + +S++ ++ +++E L IIK + S + Y+ L+GL Y
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD-VNTHSVVGTPYWMAPEVI-- 191
LH+ ++HRD+K N+L + G++KLADFG+A + TH VV T ++ APE++
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFG 186
Query: 192 -EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPA------LFRIVQ-----DER--- 236
M GV D+W+VGC + ELL VP +P L RI + E
Sbjct: 187 ARMYGV--GVDMWAVGCILAELLLRVP----F--LPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 237 --------------PPIP-----ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
P IP + D+ D ++ F + R A L +
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-48
Identities = 78/303 (25%), Positives = 119/303 (39%), Gaps = 53/303 (17%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII----MQEIDLLKN 73
++Y EIG GAYG VYK D +G FVA+K V + N + ++E+ LL+
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN-GGGGGGGLPISTVREVALLRR 67
Query: 74 LN---HKNIVKYL-----GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYI 125
L H N+V+ + + ++ E+V+ L + P + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 126 AQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYW 185
Q L GL +LH ++HRD+K NIL T G VKLADFG+A + T VV T ++
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-TLWY 185
Query: 186 MAPEVIEMSGVCAASDIWSVGCTVIELLTCVP---------------------------- 217
APEV+ S D+WSVGC E+ P
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245
Query: 218 ----PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
P P + + +P + L + + +R A L H +
Sbjct: 246 DVSLPRGAFPPRGP-----RPVQSVVP-EMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 274 IQN 276
+
Sbjct: 300 LHK 302
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-48
Identities = 77/291 (26%), Positives = 125/291 (42%), Gaps = 43/291 (14%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNH 76
Y+ D++G+G Y VYKG + VA+K++ LE+ +E ++E+ LLK+L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKH 59
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
NIV + T L ++ EY++ L + + V +++ Q+L GL Y H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD-DCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
Q V+HRD+K N+L + G +KLADFG+A K + VV T ++ P+++ S
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST 176
Query: 196 V-CAASDIWSVGCTVIELLTCVP--------------------------------PYYEL 222
D+W VGC E+ T P ++
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 223 QPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
P + P L D D L + + + R R A+ + HP+
Sbjct: 237 YNYPKYRA--EALLSHAP-RLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-47
Identities = 70/254 (27%), Positives = 129/254 (50%), Gaps = 12/254 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
+G G++GRV E+G+ A+K + + + + + + E +L+ +N +VK
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
S K S+L++++EYV G + + ++ + G F E Y AQ++ YLH +I+RD
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K N+L ++G +++ DFG A ++ T ++ GTP +APE+I G A D W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWA 223
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR-- 262
+G + E+ PP++ QP+ ++ + + P S D+ D LR + D +R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFG 282
Query: 263 ---PDAKTLLSHPW 273
+ +H W
Sbjct: 283 NLKNGVNDIKNHKW 296
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-47
Identities = 56/294 (19%), Positives = 98/294 (33%), Gaps = 37/294 (12%)
Query: 17 DNKYMLGDEIGKGAYGRVYKG-----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
+ +G+GA+ +VY+ D +N +K N + I Q ++ L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--WEFYIGTQLMERL 121
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANII---KPNKFGPFPESLVAVYIAQV 128
K +K+ + ++ ++ E G+L N I K P+ LV + ++
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 129 LEGLVYLHEQGVIHRDIKGANIL-----------TTKEGLVKLADFGVA--TKLTEADVN 175
L + +H+ +IH DIK N + + L D G + KL
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE 235
+ T + E++ D + V TV +L + + +
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 236 RPP-------------IPESLSPDITDFLRQCFKKDARQRPDAK-TLLSHPWIQ 275
P IP+ D LRQ KK +Q K L + I
Sbjct: 302 LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 2e-47
Identities = 72/254 (28%), Positives = 126/254 (49%), Gaps = 12/254 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
+G G++GRV+ NG + A+K + E + + + E +L + H I++ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ + + +I++Y+E G L ++++ K FP + Y A+V L YLH + +I+RD
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 131
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K NIL K G +K+ DFG A K T+++ GTP ++APEV+ + D WS
Sbjct: 132 LKPENILLDKNGHIKITDFGFA-K--YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWS 188
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR-- 262
G + E+L P+Y+ M + + + P + D+ D L + +D QR
Sbjct: 189 FGILIYEMLAGYTPFYDSNTM-KTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLG 247
Query: 263 ---PDAKTLLSHPW 273
+ + +HPW
Sbjct: 248 NLQNGTEDVKNHPW 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-47
Identities = 74/265 (27%), Positives = 126/265 (47%), Gaps = 19/265 (7%)
Query: 26 IGKGAYGRVY---KGLDLENGDFVAIKQVSLENIAQ--EDLNIIMQEIDLLKNLNHKN-I 79
+G GAYG+V+ K + G A+K + I Q + E +L+++ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
V + +T + LH+IL+Y+ G L + + F E V +Y+ +++ L +LH+ G
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPYWMAPEVIEMS--GV 196
+I+RDIK NIL G V L DFG++ + + + GT +MAP+++ G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239
Query: 197 CAASDIWSVGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
A D WS+G + ELLT P+ E + R + PP P+ +S D +++
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 299
Query: 254 CFKKDARQR-----PDAKTLLSHPW 273
KD ++R DA + H +
Sbjct: 300 LLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-47
Identities = 68/266 (25%), Positives = 125/266 (46%), Gaps = 13/266 (4%)
Query: 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIM---QEIDL 70
K ++ +Y + D++G G VY D VAIK + + +E + +E+
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP--PREKEETLKRFEREVHN 64
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
L+H+NIV + + ++++EY+E +L+ I+ + GP + Q+L+
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILD 122
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NTHSVVGTPYWMAPE 189
G+ + H+ ++HRDIK NIL +K+ DFG+A L+E + T+ V+GT + +PE
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 190 VIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249
+ +DI+S+G + E+L PP+ + + +QD P + + DI
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242
Query: 250 FLRQ----CFKKDARQRP-DAKTLLS 270
L +KD R + +
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEMKD 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-47
Identities = 51/338 (15%), Positives = 98/338 (28%), Gaps = 44/338 (13%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL------------------ 61
+ G +G+ + D E G+ + +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 62 --------NIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY-VENGSLANIIK--- 109
+ DL+K+ K +++ + L Y +L +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 110 --PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167
+ QV+ L LH G++H ++ +I+ + G V L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 168 KL-TEADVNTHSVVGTPYWMAPEVIEMSG-----VCAASDIWSVGCTVIELLTCVPPYYE 221
+ A P A ++ + A D W++G + + P +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 222 LQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRAL 281
+ I + IP+ + + FLR R + P + R L
Sbjct: 320 DAALGGSEWIFRSC-KNIPQPVRALLEGFLR----YPKEDRLLPLQAMETPEYEQLRTEL 374
Query: 282 QSSLRHSGTMRNVEENGSADAEIPSE-DNQSAGESLSA 318
++L T G A S+ D A E+++A
Sbjct: 375 SAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAVTA 412
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-47
Identities = 77/258 (29%), Positives = 132/258 (51%), Gaps = 13/258 (5%)
Query: 26 IGKGAYGRVY---KGLDLENGDFVAIKQVSLENIAQ--EDLNIIMQEIDLLKNLNHKNIV 80
+GKG YG+V+ K G A+K + I + +D E ++L+ + H IV
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
+ + +T L++ILEY+ G L ++ + G F E Y+A++ L +LH++G+
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELFMQLE--REGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS 200
I+RD+K NI+ +G VKL DFG+ + TH+ GT +MAPE++ SG A
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAV 202
Query: 201 DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDAR 260
D WS+G + ++LT PP+ + + + +P L+ + D L++ K++A
Sbjct: 203 DWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAA 261
Query: 261 QR-----PDAKTLLSHPW 273
R DA + +HP+
Sbjct: 262 SRLGAGPGDAGEVQAHPF 279
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-47
Identities = 76/311 (24%), Positives = 141/311 (45%), Gaps = 43/311 (13%)
Query: 3 RQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLN 62
+ SA + ++D Y ++G+G YG VYK +D + VAIK++ LE+ +E +
Sbjct: 20 GSMSVSAAPSATSIDR-YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVP 77
Query: 63 I-IMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLV 121
++E+ LLK L H+NI++ + LH+I EY EN L + +K ++
Sbjct: 78 GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVI 134
Query: 122 AVYIAQVLEGLVYLHEQGVIHRDIKGANIL-----TTKEGLVKLADFGVA-TKLTEADVN 175
++ Q++ G+ + H + +HRD+K N+L ++ ++K+ DFG+A
Sbjct: 135 KSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 176 THSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVPPY---YELQPMPALFRI 231
TH ++ T ++ PE++ S + DIWS+ C E+L P + E+ + +F +
Sbjct: 195 THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253
Query: 232 V--------------------------QDERPPIPESLSPDITDFLRQCFKKDARQRPDA 265
+ + + + L + D L + D +R A
Sbjct: 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313
Query: 266 KTLLSHPWIQN 276
K L HP+ +
Sbjct: 314 KNALEHPYFSH 324
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-46
Identities = 71/292 (24%), Positives = 125/292 (42%), Gaps = 53/292 (18%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
L + +G +G V+K ++VA+K +++ Q N E+ L + H+
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQD-KQSWQNE--YEVYSLPGMKHE 78
Query: 78 NIVKYLGSLKTRSHLH----IILEYVENGSLANIIKPNKFGPFPESL-VAVYIAQVLEGL 132
NI++++G+ K + + +I + E GSL++ +K N + E +A +A+ GL
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV-SWNELCHIAETMAR---GL 134
Query: 133 VYLHEQ----------GVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--VNTHSVV 180
YLHE + HRDIK N+L +ADFG+A K +TH V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 181 GTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTC-----------VPPYYELQP 224
GT +MAPEV+E D++++G + EL + + P+ E
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 225 MPALFRIVQD------ERPPIPESLSPD-----ITDFLRQCFKKDARQRPDA 265
+Q+ +RP + + + + + +C+ DA R A
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-46
Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 43/295 (14%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNH 76
KY +++G+G YG VYK D G VA+K++ L+ E + ++EI LLK L+H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHH 78
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
NIV + + + L ++ E++E L ++ +S + +Y+ Q+L G+ + H
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD-ENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
+ ++HRD+K N+L +G +KLADFG+A TH VV T ++ AP+V+ S
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSK 195
Query: 196 V-CAASDIWSVGCTVIELLTCVP--------------------------------PYYEL 222
+ DIWS+GC E++T P P ++
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 223 QPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277
+ + + IP + D L D +R A+ ++HP+ ++
Sbjct: 256 RTFQVFEK--KPWSSIIP-GFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-46
Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 5/252 (1%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
LG++IG+G +G V+ G + VA+K E + + +QE +LK +H NIV+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
+G + ++I++E V+ G ++ ++L+ + G+ YL + I
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ-MVGDAAAGMEYLESKCCI 235
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-PY-WMAPEVIEMSGVCAA 199
HRD+ N L T++ ++K++DFG++ + + + P W APE + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 200 SDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G + E + PY L + + R P PE + + QC+ +
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYE 355
Query: 259 ARQRPDAKTLLS 270
QRP T+
Sbjct: 356 PGQRPSFSTIYQ 367
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 86/294 (29%), Positives = 135/294 (45%), Gaps = 44/294 (14%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNH 76
KY ++IG+G YG VYK + G+ A+K++ LE E + ++EI +LK L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKH 59
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
NIVK + T+ L ++ E+++ L ++ G ++ Q+L G+ Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVA-TKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
++ V+HRD+K N+L +EG +K+ADFG+A TH +V T ++ AP+V+ S
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSK 176
Query: 196 V-CAASDIWSVGCTVIELLTCVPPYYELQP----MPALFRIVQ-----DER--------- 236
DIWSVGC E++ P L P L RI + + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTP----LFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 237 ---------PPIP-----ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
P+P + L D L + K D QR AK L H + +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 5e-46
Identities = 82/323 (25%), Positives = 143/323 (44%), Gaps = 59/323 (18%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
M++Q + + Y +IG+G +G V+K + G VA+K+V +EN +E
Sbjct: 1 MAKQYDSVECPFCDEVSK-YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEG 58
Query: 61 LNI-IMQEIDLLKNLNHKNIV--------KYLGSLKTRSHLHIILEYVENGSLANIIKPN 111
I ++EI +L+ L H+N+V K + + ++++ ++ E+ LA ++ N
Sbjct: 59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS-N 116
Query: 112 KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171
F S + + +L GL Y+H ++HRD+K AN+L T++G++KLADFG+A +
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 172 ADVN-----THSVVGTPYWMAPEVI---EMSGVCAASDIWSVGCTVIELLTCVP------ 217
A + T+ VV T ++ PE++ G D+W GC + E+ T P
Sbjct: 177 AKNSQPNRYTNRVV-TLWYRPPELLLGERDYGP--PIDLWGAGCIMAEMWTRSPIMQGNT 233
Query: 218 --------------------------PYYE-LQPMPALFRIVQDERPPIPESLSPDITDF 250
YE L+ + R V+D P D
Sbjct: 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV--RDPYALDL 291
Query: 251 LRQCFKKDARQRPDAKTLLSHPW 273
+ + D QR D+ L+H +
Sbjct: 292 IDKLLVLDPAQRIDSDDALNHDF 314
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 7e-46
Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 7/259 (2%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLNHK 77
Y++ + +G+G++G+V + VA+K +S + + + D+++ + +EI LK L H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
+I+K + T + + +++EY G L + I E + Q++ + Y H
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHR 126
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSG-V 196
++HRD+K N+L VK+ADFG++ +T+ + + G+P + APEVI
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPEVINGKLYA 185
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
D+WS G + +L P+ + + +P LF+ V +P+ LSP +R+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIV 244
Query: 257 KDARQRPDAKTLLSHPWIQ 275
D QR + + PW
Sbjct: 245 ADPMQRITIQEIRRDPWFN 263
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 74/254 (29%), Positives = 124/254 (48%), Gaps = 9/254 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G+V + G + A+K + E I +D + + E +L+N H +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ +T L ++EY G L + + F E Y A+++ L YLH + V++RD
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
IK N++ K+G +K+ DFG+ + + GTP ++APEV+E + A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 190
Query: 205 VGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR-- 262
+G + E++ P+Y Q LF ++ E P +LSP+ L KKD +QR
Sbjct: 191 LGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249
Query: 263 ---PDAKTLLSHPW 273
DAK ++ H +
Sbjct: 250 GGPSDAKEVMEHRF 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-45
Identities = 86/365 (23%), Positives = 150/365 (41%), Gaps = 20/365 (5%)
Query: 1 MSRQTTTSAFHKSKTLDN--KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ 58
M R T+ + + +Y +IG G +G D + VA+K +
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID 60
Query: 59 EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPE 118
E+ + +EI ++L H NIV++ + T +HL II+EY G L I G F E
Sbjct: 61 EN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSE 115
Query: 119 SLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNT 176
+ Q+L G+ Y H + HRD+K N L + +K+ DFG + K +
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQP 174
Query: 177 HSVVGTPYWMAPEVIEMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFR----I 231
S VGTP ++APEV+ +D+WS G T+ +L P+ + P +R
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQR 233
Query: 232 VQDERPPIPES--LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ-NCRRALQSSLRHS 288
+ + IP+ +SP+ + + F D R + +H W N L +
Sbjct: 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTG 293
Query: 289 GTMRNVEENGSADAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAATHLSKSDKEHS 348
+ E+ + I +++ ++ + F +L S+S+ +
Sbjct: 294 SQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDF-MTDNLDLDDDMDDFDSESEIDID 352
Query: 349 SNGNL 353
S+G +
Sbjct: 353 SSGEI 357
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-45
Identities = 70/301 (23%), Positives = 116/301 (38%), Gaps = 68/301 (22%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA---QEDLNIIMQEIDLLKNLNHKN 78
L + IG+G YG VYKG + VA+K S N E + I + + H N
Sbjct: 17 LLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINE------KNIYRVPLMEHDN 68
Query: 79 IVKYLG-----SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
I +++ + R +++EY NGSL + + +A + + GL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTR---GLA 125
Query: 134 YLHEQ---------GVIHRDIKGANILTTKEGLVKLADFGVATKLT--------EADVNT 176
YLH + + HRD+ N+L +G ++DFG++ +LT E D
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 177 HSVVGTPYWMAPEVIE-------MSGVCAASDIWSVGCTVIELLTCV------------- 216
S VGT +MAPEV+E D++++G E+
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 217 PPYYELQPMPALFRIVQD------ERPPIPESLSPD------ITDFLRQCFKKDARQRPD 264
+ F +Q +RP PE+ + + + + C+ +DA R
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305
Query: 265 A 265
A
Sbjct: 306 A 306
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-45
Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 26/287 (9%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ--- 58
T + + +Y LG +GKG +G V+ G L + VAIK + +
Sbjct: 15 GTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP 74
Query: 59 -EDLNIIMQEIDLLKNLN----HKNIVKYLGSLKTRSHLHIILEYVENGS-LANIIKPNK 112
D E+ LL + H +++ L +T+ ++LE L + I
Sbjct: 75 LSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK- 133
Query: 113 FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL-TTKEGLVKLADFGVATKLTE 171
GP E + QV+ + + H +GV+HRDIK NIL + G KL DFG L +
Sbjct: 134 -GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192
Query: 172 ADVNTHSVVGTPYWMAPEVIEMSGVCAAS-DIWSVGCTVI--ELLTCVPPYYELQPMPAL 228
GT + PE I A +WS+G ++ +++ P+ Q
Sbjct: 193 EPYTDF--DGTRVYSPPEWISRHQYHALPATVWSLG--ILLYDMVCGDIPFERDQ----- 243
Query: 229 FRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
I+ + P +SPD +R+C RP + +L PW+Q
Sbjct: 244 -EIL-EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-45
Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 10/257 (3%)
Query: 22 LGDEIGKGAYGRVYKG-LDLENGDF---VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+G GA+G VYKG E VAIK++ E + + I+ E ++ ++++
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNP 77
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
++ + LG + S + +I + + G L + ++ +K + L+ + Q+ +G+ YL +
Sbjct: 78 HVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGMNYLED 135
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG-TPY-WMAPEVIEMSG 195
+ ++HRD+ N+L VK+ DFG+A L + H+ G P WMA E I
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 196 VCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
SD+WS G TV EL+T PY + + + ER P P + D+ +R+C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKC 255
Query: 255 FKKDARQRPDAKTLLSH 271
+ DA RP + L+
Sbjct: 256 WMIDADSRPKFRELIIE 272
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-45
Identities = 64/259 (24%), Positives = 120/259 (46%), Gaps = 11/259 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
+G+G +G V+ G A K+++ + + + M E +L ++ + IV
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 85 SLKTRSHLHIILEYVENGSLANIIK--PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIH 142
+ +T++ L +++ + G + I F E Y AQ++ GL +LH++ +I+
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 143 RDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
RD+K N+L +G V+++D G+A +L T GTP +MAPE++ + D
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDY 372
Query: 203 WSVGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
+++G T+ E++ P+ E L + V ++ P+ SP DF +KD
Sbjct: 373 FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDP 432
Query: 260 RQR-----PDAKTLLSHPW 273
+R L +HP
Sbjct: 433 EKRLGFRDGSCDGLRTHPL 451
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-45
Identities = 71/286 (24%), Positives = 126/286 (44%), Gaps = 24/286 (8%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ--- 58
T + + + L+++Y +G +G G +G VY G+ + + VAIK V + I+
Sbjct: 27 LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 86
Query: 59 -EDLNIIMQEIDLLKNLNHK--NIVKYLGSLKTRSHLHIILEYVEN-GSLANIIKPNKFG 114
+ + E+ LLK ++ +++ L + +ILE E L + I G
Sbjct: 87 LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--G 144
Query: 115 PFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL-TTKEGLVKLADFGVATKLTEAD 173
E L + QVLE + + H GV+HRDIK NIL G +KL DFG L +
Sbjct: 145 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 204
Query: 174 VNTHSVVGTPYWMAPEVIEMSG-VCAASDIWSVGCTVI--ELLTCVPPYYELQPMPALFR 230
GT + PE I ++ +WS+G ++ +++ P+ +
Sbjct: 205 YTDF--DGTRVYSPPEWIRYHRYHGRSAAVWSLG--ILLYDMVCGDIPFEHDE------E 254
Query: 231 IVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
I++ + + +S + +R C RP + + +HPW+Q+
Sbjct: 255 IIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-45
Identities = 65/257 (25%), Positives = 116/257 (45%), Gaps = 10/257 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G V G A K++ + I + + + E +L+ +N + +V
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ +T+ L ++L + G L I FPE+ Y A++ GL LH + +++RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWS 204
+K NIL G ++++D G+A + E VGT +MAPEV++ + D W+
Sbjct: 312 LKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 205 VGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQ 261
+GC + E++ P+ + + R+V++ E SP Q KD +
Sbjct: 371 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAE 430
Query: 262 R-----PDAKTLLSHPW 273
R A+ + HP
Sbjct: 431 RLGCRGGSAREVKEHPL 447
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-45
Identities = 68/245 (27%), Positives = 117/245 (47%), Gaps = 9/245 (3%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L ++G+G +G V+ G VAIK + ++ E +QE ++K L H+ +V+
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQ 243
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQGV 140
+ + ++I+ EY+ GSL + +K G + V +A Q+ G+ Y+
Sbjct: 244 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAA 199
+HRD++ ANIL + + K+ADFG+A + + + P W APE
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 200 SDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G + EL T PY + L ++ + R P P + D + QC++K+
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 421
Query: 259 ARQRP 263
+RP
Sbjct: 422 PEERP 426
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-44
Identities = 78/309 (25%), Positives = 134/309 (43%), Gaps = 19/309 (6%)
Query: 21 MLGDEIGKGAYGRVYKGLDLENGD----FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
+G G +G V+KG+ + G+ V IK + + ++ + + + +L+H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHMLAIGSLDH 74
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
+IV+ LG L S L ++ +Y+ GSL + ++ ++ P+ L+ + Q+ +G+ YL
Sbjct: 75 AHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN-WGVQIAKGMYYLE 132
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG-TPY-WMAPEVIEMS 194
E G++HR++ N+L V++ADFGVA L D TP WMA E I
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 195 GVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
SD+WS G TV EL+T PY L+ + + ER P+ + D+ + +
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVK 252
Query: 254 CFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSEDNQSAG 313
C+ D RP K L + R ++ E +
Sbjct: 253 CWMIDENIRPTFKELANE---------FTRMARDPPRYLVIKRESGPGIAPGPEPHGLTN 303
Query: 314 ESLSAPKAE 322
+ L + E
Sbjct: 304 KKLEEVELE 312
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 2e-44
Identities = 80/267 (29%), Positives = 128/267 (47%), Gaps = 6/267 (2%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEID 69
H + Y+LGD +G G +G+V G G VA+K ++ + I D+ I +EI
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
LK H +I+K + T S + +++EYV G L + I N G E Q+L
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQIL 126
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
G+ Y H V+HRD+K N+L K+ADFG++ +++ + + G+P + APE
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAPE 185
Query: 190 VIEMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDIT 248
VI DIWS G + LL P+ + +P LF+ + D P+ L+P +
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 249 DFLRQCFKKDARQRPDAKTLLSHPWIQ 275
L+ + D +R K + H W +
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 66/251 (26%), Positives = 119/251 (47%), Gaps = 7/251 (2%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
EIG G +G V+ G N D VAIK + +++ED ++E +++ L+H +V+
Sbjct: 12 FVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDF---IEEAEVMMKLSHPKLVQ 67
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
G ++ + ++ E++E+G L++ ++ + E+L+ V EG+ YL E VI
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG-MCLDVCEGMAYLEEACVI 126
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAAS 200
HRD+ N L + ++K++DFG+ + + + + P W +PEV S + S
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 201 DIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
D+WS G + E+ + PY + I R P S + + C+++
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERP 246
Query: 260 RQRPDAKTLLS 270
RP LL
Sbjct: 247 EDRPAFSRLLR 257
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 83/301 (27%), Positives = 131/301 (43%), Gaps = 51/301 (16%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDL-ENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLKNLN 75
+Y EIG+GAYG+V+K DL G FVA+K+V ++ +E + + ++E+ +L++L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLE 69
Query: 76 ---HKNIVK-----YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
H N+V+ + + L ++ E+V+ L + P + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
+L GL +LH V+HRD+K NIL T G +KLADFG+A + T VV T ++ A
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRA 187
Query: 188 PEVIEMSGVCAASDIWSVGCTVIELLTCVP------------------------------ 217
PEV+ S D+WSVGC E+ P
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 218 --PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
P A Q + + D L +C + +R A + LSHP+ Q
Sbjct: 248 ALPRQAFHSKSA-----QPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 276 N 276
+
Sbjct: 302 D 302
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-44
Identities = 74/334 (22%), Positives = 122/334 (36%), Gaps = 38/334 (11%)
Query: 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLE-NGDFVAIKQVSLENIAQEDLNIIMQEIDLLK 72
+ +Y + I G G +Y LD NG V +K + + E + M E L
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAMAERQFLA 134
Query: 73 NLNHKNIVKYL-----GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
+ H +IV+ +I++EYV SL P + Y+ +
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLE 190
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
+L L YLH G+++ D+K NI+ T+E +KL D G +++ + GTP + A
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINS----FGYLYGTPGFQA 245
Query: 188 PEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY--ELQPMPALFRIVQDERPPIPESLSP 245
PE++ +G A+DI++VG T+ L +P + +P E P+
Sbjct: 246 PEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------EDDPVL-KTYD 295
Query: 246 DITDFLRQCFKKDARQRP-DAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEI 304
LR+ D RQR A+ + L LR
Sbjct: 296 SYGRLLRRAIDPDPRQRFTTAEEM---------SAQLTGVLREVVAQDTGVPRPGLSTIF 346
Query: 305 PSEDNQSAGESLSAPKAEAFETGSRKELLSPAAT 338
+ + L A + E L+
Sbjct: 347 SPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEI 380
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-44
Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 18/267 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEID-LLKNLNHKNIVKYL 83
IG+G+Y +V + A+K V E + ED++ + E + NH +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+T S L ++EYV G L ++ + PE Y A++ L YLHE+G+I+R
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N+L EG +KL D+G+ + T + GTP ++APE++ + D W
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 194
Query: 204 SVGCTVIELLTCVPPYYELQPMPA--------LFRIVQDERPPIPESLSPDITDFLRQCF 255
++G + E++ P+ + LF+++ +++ IP SLS L+
Sbjct: 195 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 254
Query: 256 KKDARQR------PDAKTLLSHPWIQN 276
KD ++R + HP+ +N
Sbjct: 255 NKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-44
Identities = 74/255 (29%), Positives = 125/255 (49%), Gaps = 10/255 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKNIVKYLG 84
+GKG +G+V + G + A+K + E I +D + + E +L+N H +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH-EQGVIHR 143
S +T L ++EY G L + + F E Y A+++ L YLH E+ V++R
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N++ K+G +K+ DFG+ + + + GTP ++APEV+E + A D W
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 333
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR- 262
+G + E++ P+Y Q LF ++ E P +L P+ L KKD +QR
Sbjct: 334 GLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 392
Query: 263 ----PDAKTLLSHPW 273
DAK ++ H +
Sbjct: 393 GGGSEDAKEIMQHRF 407
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 66/251 (26%), Positives = 114/251 (45%), Gaps = 7/251 (2%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L E+G G +G V G + VA+K + ++++++ QE + L+H +VK
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEF---FQEAQTMMKLSHPKLVK 67
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
+ G ++I+ EY+ NG L N ++ + G P L+ V EG+ +L I
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE-MCYDVCEGMAFLESHQFI 126
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAAS 200
HRD+ N L ++ VK++DFG+ + + + P W APEV + S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 201 DIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
D+W+ G + E+ + PY + ++ Q R P S I + C+ +
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELP 246
Query: 260 RQRPDAKTLLS 270
+RP + LLS
Sbjct: 247 EKRPTFQQLLS 257
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-44
Identities = 73/311 (23%), Positives = 130/311 (41%), Gaps = 21/311 (6%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE------DLNIIMQEIDLLK 72
KY +G GA+G V+ +D E V +K + E + ++ L + EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 73 NLNHKNIVKYLGSLKTRSHLHIILE-YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
+ H NI+K L + + +++E + L I + E L + Q++
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSA 142
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI 191
+ YL + +IHRDIK NI+ ++ +KL DFG A L ++ GT + APEV+
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFCGTIEYCAPEVL 201
Query: 192 EMSG-VCAASDIWSVGCTVIELLTCVPPYYELQP-MPALFRIVQDERPPIPESLSPDITD 249
+ ++WS+G T+ L+ P+ EL+ + A P +S ++
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH--------PPYLVSKELMS 253
Query: 250 FLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSEDN 309
+ + +R + L++ PW+ L N E+G A N
Sbjct: 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVN-LADYTWEEVFRVNKPESGVLSAASLEMGN 312
Query: 310 QSAGESLSAPK 320
+S + A +
Sbjct: 313 RSLSDVAQAQE 323
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-44
Identities = 69/254 (27%), Positives = 123/254 (48%), Gaps = 9/254 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEID-LLKNLNHKNIVKYL 83
IGKG++G+V F A+K + + I + ++ IM E + LLKN+ H +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
S +T L+ +L+Y+ G L ++ + F E Y A++ L YLH +++R
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K NIL +G + L DFG+ + E + T + GTP ++APEV+ D W
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 223
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR- 262
+G + E+L +PP+Y + ++ + ++ + +++ L +KD +R
Sbjct: 224 CLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 282
Query: 263 ---PDAKTLLSHPW 273
D + SH +
Sbjct: 283 GAKDDFMEIKSHVF 296
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-44
Identities = 63/253 (24%), Positives = 117/253 (46%), Gaps = 7/253 (2%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+ ++G G YG VY+G+ + VA+K + + + E+ ++E ++K + H N+V+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQ 73
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
LG +II E++ G+L + ++ ++ Q+ + YL ++ I
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-PY-WMAPEVIEMSGVCAA 199
HRD+ N L + LVK+ADFG++ +L D T P W APE + +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 200 SDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+W+ G + E+ T + PY + + +D R PE + + +R C++ +
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 252
Query: 259 ARQRPDAKTLLSH 271
RP +
Sbjct: 253 PSDRPSFAEIHQA 265
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-44
Identities = 62/245 (25%), Positives = 116/245 (47%), Gaps = 7/245 (2%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
+ ++G G YG VY+G+ + VA+K + + + E+ ++E ++K + H N+V+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQ 280
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
LG +II E++ G+L + ++ ++ Q+ + YL ++ I
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 340
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-PY-WMAPEVIEMSGVCAA 199
HR++ N L + LVK+ADFG++ +L D T P W APE + +
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 200 SDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+W+ G + E+ T + PY + + +D R PE + + +R C++ +
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 459
Query: 259 ARQRP 263
RP
Sbjct: 460 PSDRP 464
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-44
Identities = 68/306 (22%), Positives = 119/306 (38%), Gaps = 50/306 (16%)
Query: 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID 69
K+ +D+ + +G G G+V + + + A+K + +D +E++
Sbjct: 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVE 62
Query: 70 LLKNL-NHKNIVK----YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVY 124
L +IV+ Y R L I++E ++ G L + I+ F E +
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVG 181
+ + E + YLH + HRD+K N+L ++KL DFG A + G
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE----------TTG 172
Query: 182 TPYWMAPEVIEMSGVCAASDIWSVGCTVIE--LLTCVPPYY---ELQPMPALFRIVQD-- 234
Y D+WS+G VI LL PP+Y L P + ++
Sbjct: 173 EKY--DKSC----------DMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
Query: 235 ---ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTM 291
P +S ++ +R K + QR ++HPWI + Q+ L S +
Sbjct: 219 YEFPNPEWS-EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVL 277
Query: 292 RNVEEN 297
+ +E
Sbjct: 278 KEDKER 283
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-44
Identities = 71/254 (27%), Positives = 125/254 (49%), Gaps = 12/254 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEID-LLKNLNHKNIVKYL 83
+GKG++G+V+ + F AIK + + + +D+ M E L H +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ +T+ +L ++EY+ G L I+ F S Y A+++ GL +LH +G+++R
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K NIL K+G +K+ADFG+ + D T++ GTP ++APE++ + D W
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWW 202
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR- 262
S G + E+L P++ Q LF ++ + P P L + D L + F ++ +R
Sbjct: 203 SFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 261
Query: 263 ---PDAKTLLSHPW 273
D + HP
Sbjct: 262 GVRGDIR---QHPL 272
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-43
Identities = 68/245 (27%), Positives = 117/245 (47%), Gaps = 9/245 (3%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L ++G+G +G V+ G VAIK + ++ E +QE ++K L H+ +V+
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQ 326
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA-QVLEGLVYLHEQGV 140
+ + ++I+ EY+ GSL + +K G + V +A Q+ G+ Y+
Sbjct: 327 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAA 199
+HRD++ ANIL + + K+ADFG+A + + + P W APE
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 200 SDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G + EL T PY + L ++ + R P P + D + QC++K+
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 504
Query: 259 ARQRP 263
+RP
Sbjct: 505 PEERP 509
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-43
Identities = 76/320 (23%), Positives = 124/320 (38%), Gaps = 67/320 (20%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL 61
+ S + + Y IG G++G V++ +E+ + VAIK+V + +
Sbjct: 24 VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD---KRFK 79
Query: 62 NIIMQEIDLLKNLNHKNIVKYL------GSLKTRSHLHIILEYVENGSLANIIK--PNKF 113
N +E+ +++ + H N+V G K L+++LEYV ++ +
Sbjct: 80 N---RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLK 135
Query: 114 GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE-GLVKLADFGVATKLTEA 172
P L+ +Y+ Q+L L Y+H G+ HRDIK N+L G++KL DFG A L
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195
Query: 173 DVNTHSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVP-------------- 217
+ N + + Y+ APE+I + DIWS GC + EL+ P
Sbjct: 196 EPNVSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254
Query: 218 ------------------------PYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
P P +FR PD D + +
Sbjct: 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFR----------PRTPPDAIDLISR 304
Query: 254 CFKKDARQRPDAKTLLSHPW 273
+ R A L HP+
Sbjct: 305 LLEYTPSARLTAIEALCHPF 324
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 72/275 (26%), Positives = 129/275 (46%), Gaps = 28/275 (10%)
Query: 22 LGDEIGKGAYGRVYKG----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
++G+G +G+V G+ VA+K + + + +EI++L+NL H+
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHE 83
Query: 78 NIVKYLG--SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
NIVKY G + + + +I+E++ +GSL + NK + + Y Q+ +G+ YL
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICKGMDYL 142
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT---P-YWMAPEVI 191
+ +HRD+ N+L E VK+ DFG+ K E D ++V P +W APE +
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLT-KAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 192 EMSGVCAASDIWSVGCTVIELLT---------------CVPPYYELQPMPALFRIVQDER 236
S ASD+WS G T+ ELLT P + ++ + + + +R
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261
Query: 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
P P + ++ +R+C++ R + L+
Sbjct: 262 LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-43
Identities = 61/261 (23%), Positives = 118/261 (45%), Gaps = 14/261 (5%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V A+K ++ + + + +E D+L N + K I
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ + ++L+++++Y G L ++ PE + Y+A+++ + +H+ +HRD
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 145 IKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVIEMSGVCA----- 198
IK NIL G ++LADFG KL + V + VGTP +++PE+++
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260
Query: 199 ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE----RPPIPESLSPDITDFLRQC 254
D WS+G + E+L P+Y + +I+ + P +S + D +R+
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRL 320
Query: 255 FKKDARQ--RPDAKTLLSHPW 273
+ + + HP+
Sbjct: 321 ICSREHRLGQNGIEDFKKHPF 341
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 69/259 (26%), Positives = 127/259 (49%), Gaps = 11/259 (4%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ IG+G +G VY G L+N A+K ++ +++ + E ++K+ +H N
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 79 IVKYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
++ LG L++ ++L Y+++G L N I+ P + L+ + QV +G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKYLAS 146
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPY-WMAPEVIEM 193
+ +HRD+ N + ++ VK+ADFG+A + + + V+ + P WMA E ++
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 194 SGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252
SD+WS G + EL+T PPY ++ ++Q R PE + + +
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 266
Query: 253 QCFKKDARQRPDAKTLLSH 271
+C+ A RP L+S
Sbjct: 267 KCWHPKAEMRPSFSELVSR 285
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-43
Identities = 73/311 (23%), Positives = 131/311 (42%), Gaps = 46/311 (14%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
++ T + + Y IG G++G VY+ ++G+ VAIK+V + +
Sbjct: 37 VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRF 93
Query: 61 LNIIMQEIDLLKNLNHKNIVKYL------GSLKTRSHLHIILEYVENGSLANIIK--PNK 112
N +E+ +++ L+H NIV+ G K +L+++L+YV ++ + +
Sbjct: 94 KN---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA 149
Query: 113 FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE-GLVKLADFGVATKLTE 171
P V +Y+ Q+ L Y+H G+ HRDIK N+L + ++KL DFG A +L
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 172 ADVNTHSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVP------------- 217
+ N + + Y+ APE+I + ++ D+WS GC + ELL P
Sbjct: 210 GEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268
Query: 218 -------P----YYELQPMPALFRIVQDERPPIPESL----SPDITDFLRQCFKKDARQR 262
P E+ P F+ Q + P + P+ + + R
Sbjct: 269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328
Query: 263 PDAKTLLSHPW 273
+H +
Sbjct: 329 LTPLEACAHSF 339
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 72/253 (28%), Positives = 124/253 (49%), Gaps = 9/253 (3%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L + +G G +G V+ G VA+K + +++ + + E +L+K L H+ +V+
Sbjct: 17 LVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAF---LAEANLMKQLQHQRLVR 72
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
+ T+ ++II EY+ENGSL + +K + + AQ+ EG+ ++ E+ I
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-PY-WMAPEVIEMSGVCAA 199
HRD++ ANIL + K+ADFG+A +L E + T P W APE I
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 200 SDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G + E++T PY + + + + R P++ ++ +R C+K+
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 250
Query: 259 ARQRPDAKTLLSH 271
RP L S
Sbjct: 251 PEDRPTFDYLRSV 263
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 73/293 (24%), Positives = 131/293 (44%), Gaps = 19/293 (6%)
Query: 22 LGDEIGKGAYGRVYKG-LDLENGDF---VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+G GA+G VYKG E VAIK++ E + + I+ E ++ ++++
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNP 77
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
++ + LG + S + +I + + G L + ++ +K + L+ + Q+ +G+ YL +
Sbjct: 78 HVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGMNYLED 135
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG-TPY-WMAPEVIEMSG 195
+ ++HRD+ N+L VK+ DFG+A L + H+ G P WMA E I
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 196 VCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
SD+WS G TV EL+T PY + + + ER P P + D+ + +C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255
Query: 255 FKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSE 307
+ DA RP + L+ R ++ + P++
Sbjct: 256 WMIDADSRPKFRELIIE---------FSKMARDPQRYLVIQGDERMHLPSPTD 299
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-43
Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 16/260 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+G V A+K +S + + D +E D++ N +V+
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRD 144
+ + +L++++EY+ G L N++ PE Y A+V+ L +H G IHRD
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193
Query: 145 IKGANILTTKEGLVKLADFGVATKLTEAD-VNTHSVVGTPYWMAPEVIEMSGVCA----A 199
+K N+L K G +KLADFG K+ + V + VGTP +++PEV++ G
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP---PIPESLSPDITDFLRQCFK 256
D WSVG + E+L P+Y + +I+ + P +S + + + F
Sbjct: 254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FL 312
Query: 257 KDARQR---PDAKTLLSHPW 273
D R + + H +
Sbjct: 313 TDREVRLGRNGVEEIKRHLF 332
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-43
Identities = 66/264 (25%), Positives = 128/264 (48%), Gaps = 18/264 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKNLNHKNIVKYLG 84
IG+GA+ V + G A+K ++ ++ + +++ +E D+L N + + I +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 85 SLKTRSHLHIILEYVENGSLANIIKPNKFGP-FPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+ + ++L++++EY G L ++ KFG P + Y+A+++ + +H G +HR
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLS--KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 144 DIKGANILTTKEGLVKLADFGVATKL-TEADVNTHSVVGTPYWMAPEVIEMSGVCAAS-- 200
DIK NIL + G ++LADFG KL + V + VGTP +++PE+++ G +
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 201 -----DIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER----PPIPESLSPDITDFL 251
D W++G E+ P+Y +IV + P + E + + DF+
Sbjct: 247 YGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFI 306
Query: 252 RQCFKKDARQ--RPDAKTLLSHPW 273
++ + R A +HP+
Sbjct: 307 QRLLCPPETRLGRGGAGDFRTHPF 330
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 7/252 (2%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
E+G G +G V G VAIK + ++++++ ++E ++ NL+H+ +V+
Sbjct: 28 FLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQ 83
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
G + + II EY+ NG L N ++ + + L+ V E + YL + +
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQFL 142
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAAS 200
HRD+ N L +G+VK++DFG++ + + + + P W PEV+ S + S
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 201 DIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
DIW+ G + E+ + PY I Q R P S + + C+ + A
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 262
Query: 260 RQRPDAKTLLSH 271
+RP K LLS+
Sbjct: 263 DERPTFKILLSN 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 77/272 (28%), Positives = 132/272 (48%), Gaps = 20/272 (7%)
Query: 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIM---QEIDL 70
L ++Y LG+ +G G V+ DL + VA+K V ++A D + + +E
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLA-RDPSFYLRFRREAQN 65
Query: 71 LKNLNHKNIVK-Y-LGSLKTRSHLH--IILEYVENGSLANIIKPNKFGPFPESLVAVYIA 126
LNH IV Y G +T + I++EYV+ +L +I+ GP IA
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIA 123
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV---NTHSVVGTP 183
+ L + H+ G+IHRD+K ANI+ + VK+ DFG+A + ++ T +V+GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 184 YWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESL 243
+++PE V A SD++S+GC + E+LT PP+ P+ ++ V+++ P P +
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED-PIPPSAR 242
Query: 244 SPDITDFLRQ----CFKKDARQRP-DAKTLLS 270
++ L K+ R A + +
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 72/259 (27%), Positives = 126/259 (48%), Gaps = 11/259 (4%)
Query: 21 MLGDEIGKGAYGRVYKG-LDLENGDF--VAIKQVSLENIAQEDLNI-IMQEIDLLKNLNH 76
L +++G G++G V +G D +G VA+K + + ++Q + ++E++ + +L+H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
+N+++ G + + ++ E GSL + ++ ++ +L Y QV EG+ YL
Sbjct: 81 RNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR-YAVQVAEGMGYLE 138
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--PY-WMAPEVIEM 193
+ IHRD+ N+L LVK+ DFG+ L + D + P+ W APE ++
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 194 SGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQD-ERPPIPESLSPDITDFL 251
ASD W G T+ E+ T P+ L L +I ++ ER P PE DI + +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 258
Query: 252 RQCFKKDARQRPDAKTLLS 270
QC+ RP L
Sbjct: 259 VQCWAHKPEDRPTFVALRD 277
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-43
Identities = 66/251 (26%), Positives = 128/251 (50%), Gaps = 7/251 (2%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L ++G G +G V+ ++ VA+K + +++ E + E +++K L H +VK
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAF---LAEANVMKTLQHDKLVK 247
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
+ T+ ++II E++ GSL + +K ++ P + + AQ+ EG+ ++ ++ I
Sbjct: 248 LHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAAS 200
HRD++ ANIL + + K+ADFG+A + + + P W APE I S
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 201 DIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDA 259
D+WS G ++E++T PY + + + + R P PE+ ++ + + +C+K
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 426
Query: 260 RQRPDAKTLLS 270
+RP + + S
Sbjct: 427 EERPTFEYIQS 437
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-43
Identities = 70/267 (26%), Positives = 124/267 (46%), Gaps = 18/267 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEID-LLKNLNHKNIVKYL 83
IG+G+Y +V + A++ V E + ED++ + E + NH +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+T S L ++EYV G L ++ + PE Y A++ L YLHE+G+I+R
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N+L EG +KL D+G+ + T + GTP ++APE++ + D W
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 237
Query: 204 SVGCTVIELLTCVPPYYELQPMPA--------LFRIVQDERPPIPESLSPDITDFLRQCF 255
++G + E++ P+ + LF+++ +++ IP SLS L+
Sbjct: 238 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 297
Query: 256 KKDARQR------PDAKTLLSHPWIQN 276
KD ++R + HP+ +N
Sbjct: 298 NKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-42
Identities = 75/256 (29%), Positives = 124/256 (48%), Gaps = 11/256 (4%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEID-LLKNLNHKNIVKYL 83
+GKG++G+V E GD A+K + + I Q +D+ M E L NH + +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+T L ++E+V G L I+ K F E+ Y A+++ L++LH++G+I+R
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQ--KSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N+L EG KLADFG+ + V T + GTP ++APE+++ A D W
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWW 208
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR- 262
++G + E+L P+ + LF + ++ P L D T L+ K+ R
Sbjct: 209 AMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRL 267
Query: 263 -----PDAKTLLSHPW 273
+L HP+
Sbjct: 268 GSLTQGGEHAILRHPF 283
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 9/256 (3%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ IG G G V G G VAIK + + + E ++ +H N
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPN 111
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
I++ G + I+ EY+ENGSL ++ + LV + V G+ YL +
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG-MLRGVGAGMRYLSDL 170
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--PY-WMAPEVIEMSG 195
G +HRD+ N+L + K++DFG++ L + ++ G P W APE I
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 196 VCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
+ASD+WS G + E+L PY+ + + + + R P P + + C
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDC 290
Query: 255 FKKDARQRPDAKTLLS 270
+ KD QRP ++S
Sbjct: 291 WHKDRAQRPRFSQIVS 306
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-42
Identities = 78/317 (24%), Positives = 129/317 (40%), Gaps = 49/317 (15%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
MS +A +S+ +++ + G+G +G V G + G VAIK+V +
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRF 62
Query: 61 LNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH-------LHIILEYVENGSLANIIK--PN 111
N +Q + L L+H NIV+ T L++++EYV + +L +
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYR 121
Query: 112 KFGPFPESLVAVYIAQVLEGLVYLHEQ--GVIHRDIKGANILTTKE-GLVKLADFGVATK 168
+ P L+ V++ Q++ + LH V HRDIK N+L + G +KL DFG A K
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 169 LTEADVNTHSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVP---------- 217
L+ ++ N + + Y+ APE+I + A DIWSVGC E++ P
Sbjct: 182 LSPSEPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240
Query: 218 ----------P----YYELQPMPALFRIVQDERPPIPESL-------SPDITDFLRQCFK 256
P +L P + + P + + D L +
Sbjct: 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 257 KDARQRPDAKTLLSHPW 273
+R L HP+
Sbjct: 301 YLPEERMKPYEALCHPY 317
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 77/259 (29%), Positives = 121/259 (46%), Gaps = 11/259 (4%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
IGKG +G VY G D AIK +S + + ++E L++ LNH N
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREGLLMRGLNHPN 83
Query: 79 IVKYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
++ +G L H++L Y+ +G L I+ + P + L++ + QV G+ YL E
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS-FGLQVARGMEYLAE 142
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPY-WMAPEVIEM 193
Q +HRD+ N + + VK+ADFG+A + + + V H P W A E ++
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 194 SGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252
SD+WS G + ELLT PPY + P + Q R P PE + ++
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQ 262
Query: 253 QCFKKDARQRPDAKTLLSH 271
QC++ D RP + L+
Sbjct: 263 QCWEADPAVRPTFRVLVGE 281
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 68/285 (23%), Positives = 125/285 (43%), Gaps = 17/285 (5%)
Query: 6 TTSAFHKSKTLDNKYMLGDE-------IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ 58
TT+ K N+ + +GKG++G+V + A+K + + + Q
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 59 -EDLNIIMQEID-LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPF 116
+D+ M E L + + +T L+ ++EYV G L I+ + G F
Sbjct: 61 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRF 118
Query: 117 PESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176
E Y A++ GL +L +G+I+RD+K N++ EG +K+ADFG+ + V T
Sbjct: 119 KEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178
Query: 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER 236
+ GTP ++APE+I + D W+ G + E+L P+ + LF+ + +
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN 237
Query: 237 PPIPESLSPDITDFLRQCFKKDARQR-----PDAKTLLSHPWIQN 276
P+S+S + + K +R + + H + +
Sbjct: 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 59/256 (23%), Positives = 111/256 (43%), Gaps = 9/256 (3%)
Query: 21 MLGDEIGKGAYGRVYKG-LDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ E+G G +G V KG ++ VA+K + E + ++ E ++++ L++
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV+ +G + +++E E G L ++ N+ + + + QV G+ YL E
Sbjct: 80 IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES 136
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--PY-WMAPEVIEMSG 195
+HRD+ N+L + K++DFG++ L + + P W APE I
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 196 VCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
+ SD+WS G + E + PY ++ + + ER P ++ D + C
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 256
Query: 255 FKKDARQRPDAKTLLS 270
+ D RP +
Sbjct: 257 WTYDVENRPGFAAVEL 272
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 66/280 (23%), Positives = 111/280 (39%), Gaps = 20/280 (7%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIM---QEIDLLKNLNH 76
Y L +G+G G VY+ D VA+K +S D +E L
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQE 93
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
++V + L++ + + LA +++ + GP + Q+ L H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NTHSVVGTPYWMAPEVIEMSG 195
G HRD+K NIL + + L DFG+A+ T+ + + VGT Y+MAPE S
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 196 VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDIT----DFL 251
+DI+++ C + E LT PP Y+ + + + P P ++ P I +
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP-YQGDQLSVMGAHINQA-IPRPSTVRPGIPVAFDAVI 269
Query: 252 RQCFKKDARQR-PDAKTLLSHPWIQNCRRALQSSLRHSGT 290
+ K+ R L AL ++ + T
Sbjct: 270 ARGMAKNPEDRYVTCGDLS-----AAAHAALATADQDRAT 304
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 61/253 (24%), Positives = 112/253 (44%), Gaps = 13/253 (5%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVK 81
L IGKG +G V G G+ VA+K + + + + E ++ L H N+V+
Sbjct: 25 LLQTIGKGEFGDVMLGD--YRGNKVAVKCIK-NDATAQAF---LAEASVMTQLRHSNLVQ 78
Query: 82 YLGS-LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
LG ++ + L+I+ EY+ GSL + ++ + + V E + YL
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCAA 199
+HRD+ N+L +++ + K++DFG+ + + P W APE +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFSTK 194
Query: 200 SDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
SD+WS G + E+ + PY + + R+ + + P+ P + + ++ C+ D
Sbjct: 195 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLD 254
Query: 259 ARQRPDAKTLLSH 271
A RP L
Sbjct: 255 AAMRPSFLQLREQ 267
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-42
Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 13/246 (5%)
Query: 21 MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIV 80
L IGKG +G V G G+ VA+K + + + + E ++ L H N+V
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK-NDATAQAF---LAEASVMTQLRHSNLV 249
Query: 81 KYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG 139
+ LG ++ + L+I+ EY+ GSL + ++ + + V E + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 140 VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVCA 198
+HRD+ N+L +++ + K++DFG+ + + P W APE +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFST 365
Query: 199 ASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257
SD+WS G + E+ + PY + + R+ + + P+ P + D ++ C+
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHL 425
Query: 258 DARQRP 263
DA RP
Sbjct: 426 DAATRP 431
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-42
Identities = 69/268 (25%), Positives = 123/268 (45%), Gaps = 20/268 (7%)
Query: 22 LGDEIGKGAYGRVYKG-LDLENGDF--VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
LG +GKG +G V + L E+G F VA+K + + IA D+ ++E +K +H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 79 IVKYLG------SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVA---VYIA-QV 128
+ K +G + +IL ++++G L + ++ G P +L V +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPY- 184
G+ YL + IHRD+ N + ++ V +ADFG++ K+ D S + P
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--PVK 204
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESL 243
W+A E + + SD+W+ G T+ E++T PY ++ ++ R P
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPEC 264
Query: 244 SPDITDFLRQCFKKDARQRPDAKTLLSH 271
++ D + QC+ D +QRP L
Sbjct: 265 MEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-42
Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 22 LGDEIGKGAYGRVYKG----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
++GKG +G V L G VA+KQ L++ + +EI +LK L+
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSD 84
Query: 78 NIVKYLG--SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
IVKY G R L +++EY+ +G L + ++ ++ L+ Y +Q+ +G+ YL
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL-YSSQICKGMEYL 143
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG---TPY-WMAPEVI 191
+ +HRD+ NIL E VK+ADFG+A KL D + + V +P W APE +
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 192 EMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPA-------------LFRIVQD-ER 236
+ SD+WS G + EL T C L ++++ +R
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262
Query: 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
P P + ++ + ++ C+ + RP L
Sbjct: 263 LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 76/254 (29%), Positives = 123/254 (48%), Gaps = 8/254 (3%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
LG IG+G +G V++G+ EN VAIK + +QE ++ +H +
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPH 77
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IVK +G + T + + II+E G L + ++ K+ SL+ Y Q+ L YL +
Sbjct: 78 IVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESK 135
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVC 197
+HRDI N+L + VKL DFG++ + ++ S P WMAPE I
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 198 AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
+ASD+W G + E+L V P+ ++ + RI ER P+P + P + + +C+
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 255
Query: 257 KDARQRPDAKTLLS 270
D +RP L +
Sbjct: 256 YDPSRRPRFTELKA 269
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 28/275 (10%)
Query: 22 LGDEIGKGAYGRVYKG----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
++GKG +G V L G+ VA+K+ L++ +E L +EI++LK+L H
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHD 71
Query: 78 NIVKYLG--SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
NIVKY G R +L +I+EY+ GSL + ++ +K L+ Y +Q+ +G+ YL
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGMEYL 130
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--P-YWMAPEVIE 192
+ IHRD+ NIL E VK+ DFG+ L + P +W APE +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 193 MSGVCAASDIWSVGCTVIELLT----------------CVPPYYELQPMPALFRIVQDER 236
S ASD+WS G + EL T ++ + + + R
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
P P+ +I + +C+ + QRP + L
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-41
Identities = 67/260 (25%), Positives = 129/260 (49%), Gaps = 16/260 (6%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLKNLNHKN---IVK 81
IG+G +G VY + G A+K + + I + + + E +L ++ + IV
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 82 YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVI 141
+ T L IL+ + G L + + G F E+ + Y A+++ GL ++H + V+
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 142 HRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM-SGVCAAS 200
+RD+K ANIL + G V+++D G+A ++ H+ VGT +MAPEV++ +++
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 201 DIWSVGCTVIELLTCVPPYYELQPM--PALFRIVQDERPPIPESLSPDITDFLRQCFKKD 258
D +S+GC + +LL P+ + + + R+ +P+S SP++ L ++D
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 432
Query: 259 ARQR-----PDAKTLLSHPW 273
+R A+ + P+
Sbjct: 433 VNRRLGCLGRGAQEVKESPF 452
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 62/278 (22%), Positives = 124/278 (44%), Gaps = 21/278 (7%)
Query: 22 LGDEIGKGAYGRVYKGL---DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
LG +G+G +G V +G + VA+K + L+N +Q ++ + E +K+ +H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 79 IVKYLG-----SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVA---VYIA-QVL 129
+++ LG S + +IL +++ G L + ++ P+ + + +
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPY-W 185
G+ YL + +HRD+ N + + V +ADFG++ K+ D + + P W
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 215
Query: 186 MAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLS 244
+A E + + SD+W+ G T+ E+ T + PY +Q ++ R PE
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCL 275
Query: 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQ 282
++ + + C++ D RP L ++ +L
Sbjct: 276 DELYEIMYSCWRTDPLDRPTFSVLRLQ--LEKLLESLP 311
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 69/275 (25%), Positives = 119/275 (43%), Gaps = 11/275 (4%)
Query: 21 MLGDEIGKGAYGRVYKG-LDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ E+G G +G V +G + VAIK + + + D +M+E ++ L++
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPY 71
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IV+ +G + L +++E G L + + P S VA + QV G+ YL E+
Sbjct: 72 IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--PY-WMAPEVIEMSG 195
+HRD+ N+L K++DFG++ L D + P W APE I
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 196 VCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
+ SD+WS G T+ E L+ PY +++ + I Q +R P P++ + C
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 249
Query: 255 FKKDARQRPDAKTLLSH--PWIQNCRRALQSSLRH 287
+ RPD T+ + ++ H
Sbjct: 250 WIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 284
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-41
Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 11/259 (4%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ IG+G +G VY G L+N A+K ++ +++ + E ++K+ +H N
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 79 IVKYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
++ LG L++ ++L Y+++G L N I+ P + L+ + QV +G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLAS 210
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPY-WMAPEVIEM 193
+ +HRD+ N + ++ VK+ADFG+A + + + V+ + P WMA E ++
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 194 SGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252
SD+WS G + EL+T PPY ++ ++Q R PE + + +
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 330
Query: 253 QCFKKDARQRPDAKTLLSH 271
+C+ A RP L+S
Sbjct: 331 KCWHPKAEMRPSFSELVSR 349
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-41
Identities = 71/257 (27%), Positives = 117/257 (45%), Gaps = 10/257 (3%)
Query: 22 LGDEIGKGAYGRVYKGL----DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
IG G +G VYKG+ + VAIK + ++ + E ++ +H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NI++ G + + II EY+ENG+L ++ LV + + G+ YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG-MLRGIAAGMKYLAN 165
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--PY-WMAPEVIEMS 194
+HRD+ NIL + K++DFG++ L + T++ G P W APE I
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 195 GVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
+ASD+WS G + E++T PY+EL + I R P P I + Q
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ 285
Query: 254 CFKKDARQRPDAKTLLS 270
C++++ +RP ++S
Sbjct: 286 CWQQERARRPKFADIVS 302
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 80/275 (29%), Positives = 128/275 (46%), Gaps = 30/275 (10%)
Query: 22 LGDEIGKGAYGRVYKG----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
++GKG +G V L G+ VA+K+ L++ +E L +EI++LK+L H
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHD 102
Query: 78 NIVKYLG--SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
NIVKY G R +L +I+EY+ GSL + ++ +K L+ Y +Q+ +G+ YL
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGMEYL 161
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT---P-YWMAPEVI 191
+ IHRD+ NIL E VK+ DFG+ K+ D + V P +W APE +
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLT-KVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 192 EMSGVCAASDIWSVGCTVIELLTC----------------VPPYYELQPMPALFRIVQDE 235
S ASD+WS G + EL T ++ + + +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280
Query: 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
R P P+ +I + +C+ + QRP + L
Sbjct: 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 73/254 (28%), Positives = 120/254 (47%), Gaps = 8/254 (3%)
Query: 22 LGDEIGKGAYGRVYKG-LDLENGDF--VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
L +G+G +G VY+G G+ VA+K ++ ++ M E ++KNL+H +
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IVK +G + II+E G L + ++ NK +LV Y Q+ + + YL
Sbjct: 75 IVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-YSLQICKAMAYLESI 132
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVC 197
+HRDI NIL VKL DFG++ + + D SV P WM+PE I
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 198 AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
ASD+W + E+L+ P++ L+ + + + +R P P+ P + + +C+
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 252
Query: 257 KDARQRPDAKTLLS 270
D RP L+
Sbjct: 253 YDPSDRPRFTELVC 266
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-41
Identities = 75/254 (29%), Positives = 123/254 (48%), Gaps = 8/254 (3%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDF---VAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
LG IG+G +G V++G+ + + VAIK + +QE ++ +H +
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPH 452
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
IVK +G + T + + II+E G L + ++ KF SL+ Y Q+ L YL +
Sbjct: 453 IVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALAYLESK 510
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY-WMAPEVIEMSGVC 197
+HRDI N+L + VKL DFG++ + ++ S P WMAPE I
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 198 AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
+ASD+W G + E+L V P+ ++ + RI ER P+P + P + + +C+
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 630
Query: 257 KDARQRPDAKTLLS 270
D +RP L +
Sbjct: 631 YDPSRRPRFTELKA 644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-41
Identities = 75/274 (27%), Positives = 129/274 (47%), Gaps = 30/274 (10%)
Query: 22 LGDEIGKGAYGRVYKG----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
++G+G +G+V + G+ VA+K + + + + QEID+L+ L H+
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYHE 93
Query: 78 NIVKYLG--SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
+I+KY G + L +++EYV GSL + + + G L+ + Q+ EG+ YL
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLL-FAQQICEGMAYL 150
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT---P-YWMAPEVI 191
H Q IHRD+ N+L + LVK+ DFG+A K + V P +W APE +
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 192 EMSGVCAASDIWSVGCTVIELLT---------------CVPPYYELQPMPALFRIVQDER 236
+ ASD+WS G T+ ELLT ++ + + + ER
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
P P+ ++ ++ C++ +A RP + L+
Sbjct: 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-40
Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 9/256 (3%)
Query: 22 LGDEIGKGAYGRVYKG---LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ +G G +G V G L + VAIK + ++ + E ++ +H N
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
I++ G + + I+ EY+ENGSL + ++ + LV + + G+ YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG-MLRGIASGMKYLSDM 166
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--PY-WMAPEVIEMSG 195
G +HRD+ NIL + K++DFG+ L + ++ G P W +PE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 196 VCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254
+ASD+WS G + E+++ PY+E+ + + + R P P + + C
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDC 286
Query: 255 FKKDARQRPDAKTLLS 270
++KD RP + ++S
Sbjct: 287 WQKDRNNRPKFEQIVS 302
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 3e-40
Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 11/274 (4%)
Query: 17 DNKYMLGDEIGKGAYGRVYKG-LDLENGDF-VAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
DN + E+G G +G V +G + VAIK + + + D +M+E ++ L
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQL 393
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
++ IV+ +G + L +++E G L + + P S VA + QV G+ Y
Sbjct: 394 DNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKY 451
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT--PY-WMAPEVI 191
L E+ +HR++ N+L K++DFG++ L D + P W APE I
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 192 EMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250
+ SD+WS G T+ E L+ PY +++ + I Q +R P P++
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 571
Query: 251 LRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSS 284
+ C+ RPD T+ ++ C +L S
Sbjct: 572 MSDCWIYKWEDRPDFLTVEQR--MRACYYSLASK 603
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 159 bits (402), Expect = 3e-40
Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 10/258 (3%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEID-LLKNLNHKNIVKYL 83
+GKG++G+V + A+K + + + Q +D+ M E L + +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHR 143
+T L+ ++EYV G L I+ + G F E Y A++ GL +L +G+I+R
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 144 DIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIW 203
D+K N++ EG +K+ADFG+ + V T + GTP ++APE+I + D W
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 526
Query: 204 SVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQR- 262
+ G + E+L P+ + LF+ + + P+S+S + + K +R
Sbjct: 527 AFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 585
Query: 263 ----PDAKTLLSHPWIQN 276
+ + H + +
Sbjct: 586 GCGPEGERDIKEHAFFRY 603
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-39
Identities = 78/336 (23%), Positives = 123/336 (36%), Gaps = 82/336 (24%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKG--LDLENGDFVAIKQVSLENIAQEDLNIIMQEID 69
+ + D G ++G+G YG VYK D ++ A+KQ+ I+ +EI
Sbjct: 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIA 70
Query: 70 LLKNLNHKNIVKYLG--SLKTRSHLHIILEYVENGSLANIIK-------PNKFGPFPESL 120
LL+ L H N++ + ++ +Y E+ L +IIK K P +
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE----GLVKLADFGVA-------TKL 169
V + Q+L+G+ YLH V+HRD+K ANIL E G VK+AD G A L
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 170 TEADVNTHSVVGTPYWMAPEVIEMSGV---CAASDIWSVGCTVIELLTCVP--------- 217
+ D VV T ++ APE+ + G A DIW++GC ELLT P
Sbjct: 190 ADLD----PVVVTFWYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 218 --------------------------------PYYE-----LQPMPALFRIVQDERPPIP 240
P + + +
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
L++ D +R ++ + P+
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 31/278 (11%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNL-N 75
G +G GA+G+V + L D VA+K + + + +M E+ +L L N
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGN 85
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSL------------ANIIKPNKFGPFPESLVA- 122
H NIV LG+ +I EY G L + P +L
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 123 --VYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV---NT 176
+ + QV +G+ +L + IHRD+ NIL T + K+ DFG+A +
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 177 HSVVGTPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQD 234
++ + P WMAPE I SD+WS G + EL + PY + ++++++
Sbjct: 206 NARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263
Query: 235 -ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
R PE ++ D ++ C+ D +RP K ++
Sbjct: 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-39
Identities = 77/330 (23%), Positives = 130/330 (39%), Gaps = 76/330 (23%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
D +Y+L ++G G + V+ D+ N VA+K V + EI LL+ +N
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RG-DKVYTEAAEDEIKLLQRVN 73
Query: 76 -----------HKNIVKYLGSLKTR----SHLHIILEYVENGSLANIIKPNKFGPFPESL 120
+I+K L + H+ ++ E V +L +IK + P
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIY 132
Query: 121 VAVYIAQVLEGLVYLH-EQGVIHRDIKGANIL------TTKEGLVKLADFGVATKLTEAD 173
V Q+L GL Y+H G+IH DIK N+L +K+AD G A E
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-- 190
Query: 174 VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVP---------PYYELQ- 223
+ + + T + +PEV+ + +DIWS C + EL+T +
Sbjct: 191 -HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 224 ---------PMPALF------------------RIVQDERPPIPESLS----------PD 246
+P+ I + + P+ + L+ +
Sbjct: 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309
Query: 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
I+DFL + D R+R DA L++HPW+++
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-39
Identities = 68/300 (22%), Positives = 134/300 (44%), Gaps = 27/300 (9%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
+ E+G+G++G VY+G+ + + VAIK V+ E + + + E ++K N
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNC 87
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLAN-------IIKPNKFGPFPESLVAVYIA-QV 128
++V+ LG + +I+E + G L + + N P + +A ++
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPY- 184
+G+ YL+ +HRD+ N + ++ VK+ DFG+ + E D ++ P
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL--PVR 205
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESL 243
WM+PE ++ SD+WS G + E+ T PY L L +++ P++
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC 265
Query: 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAE 303
+ + +R C++ + + RP ++S I+ ++ R + EEN + E
Sbjct: 266 PDMLFELMRMCWQYNPKMRPSFLEIISS--IKEE---MEPGFREV-SFYYSEENKLPEPE 319
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 71/270 (26%), Positives = 122/270 (45%), Gaps = 25/270 (9%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
L +G GA+G VY+G + N VA+K + E +++D + E ++ NH
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNH 92
Query: 77 KNIVKYLG-SLKTRSHLHIILEYVENGSLAN---IIKPNKFGPFPESLVA-VYIA-QVLE 130
+NIV+ +G SL++ I++E + G L + +P P +++ +++A +
Sbjct: 93 QNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEG---LVKLADFGVATKLTEAD---VNTHSVVGTPY 184
G YL E IHRDI N L T G + K+ DFG+A + A +++ P
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML--PV 209
Query: 185 -WMAPEVIEMSGVC-AASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPE 241
WM PE M G+ + +D WS G + E+ + PY L + R P+
Sbjct: 210 KWMPPEAF-MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 268
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
+ + + QC++ RP+ +L
Sbjct: 269 NCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-38
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 27/278 (9%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
L +G GA+G VY+G + N VA+K + E +++D + E ++ NH
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNH 133
Query: 77 KNIVKYLG-SLKTRSHLHIILEYVENGSLAN---IIKPNKFGPFPESLVA-VYIA-QVLE 130
+NIV+ +G SL++ I+LE + G L + +P P +++ +++A +
Sbjct: 134 QNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEG---LVKLADFGVATKLTEAD---VNTHSVVGTPY 184
G YL E IHRDI N L T G + K+ DFG+A + A +++ P
Sbjct: 193 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML--PV 250
Query: 185 -WMAPEVIEMSGVC-AASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPE 241
WM PE M G+ + +D WS G + E+ + PY L + R P+
Sbjct: 251 KWMPPEAF-MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 309
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279
+ + + QC++ RP+ +L I+ C +
Sbjct: 310 NCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYCTQ 345
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-38
Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 29/287 (10%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
L E+G+GA+G+V+ +L VA+K +L+ ++ +E +LL L H
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQREAELLTMLQH 102
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSL---------ANIIKPNKFGPFPESLVA---VY 124
++IV++ G L ++ EY+ +G L + P L +
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 125 IA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVV 180
+A QV G+VYL +HRD+ N L + +VK+ DFG++ + D V +++
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 181 GTPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPP 238
P WM PE I SD+WS G + E+ T P+Y+L A+ I Q
Sbjct: 223 --PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE 280
Query: 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSL 285
P + P++ +R C++++ +QR K + + +Q +A L
Sbjct: 281 RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQALAQAPPVYL 325
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 75/284 (26%), Positives = 130/284 (45%), Gaps = 32/284 (11%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
L E+G+GA+G+V+ +L VA+K +L++ +E +LL NL H
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREAELLTNLQH 76
Query: 77 KNIVKYLG-SLKTRSHLHIILEYVENGSL----------ANIIKPNKFGPFPESLVA--- 122
++IVK+ G + ++ EY+++G L A I+ + L
Sbjct: 77 EHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 123 VYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHS 178
++IA Q+ G+VYL Q +HRD+ N L LVK+ DFG++ + D V H+
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 179 VVGTPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDER 236
++ P WM PE I SD+WS G + E+ T P+++L + I Q
Sbjct: 196 ML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 253
Query: 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRA 280
P ++ D + C++++ +QR + K + + +A
Sbjct: 254 LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKI--LHALGKA 295
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-37
Identities = 78/334 (23%), Positives = 136/334 (40%), Gaps = 88/334 (26%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
T KY LG +G G++G V + D+E+G A+K+V +D +E+D++K L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVL 57
Query: 75 NHKNIVKYLGSLKTRSH--------------------------------------LHIIL 96
+H NI+K + T L++I+
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 97 EYVENGSLANIIK--PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILT-T 153
EYV + +L ++K P +L+++YI Q+ + ++H G+ HRDIK N+L +
Sbjct: 118 EYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 154 KEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAAS------DIWSVGC 207
K+ +KL DFG A KL ++ + + + ++ APE++ A+ D+WS+GC
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELM-----LGATEYTPSIDLWSIGC 230
Query: 208 TVIELLTCVP--------------------P----YYELQPMPALFRIVQDERPP----I 239
EL+ P P + P R + +
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290
Query: 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
PE D L Q + + R + ++HP+
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 62/303 (20%), Positives = 120/303 (39%), Gaps = 61/303 (20%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-N 75
+ Y L ++G+G Y V++ +++ N + V +K + ++ I +EI +L+NL
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-KKK----IKREIKILENLRG 89
Query: 76 HKNIVKYLGSLKTRSHLHIIL--EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
NI+ +K L E+V N + + + + Y+ ++L+ L
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALD 144
Query: 134 YLHEQGVIHRDIKGANILTTKE-GLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI- 191
Y H G++HRD+K N++ E ++L D+G+A V + Y+ PE++
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-SRYFKGPELLV 203
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPY-----YELQPMPALFRIVQ------------- 233
+ + D+WS+GC + ++ P+ Q L RI +
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ----LVRIAKVLGTEDLYDYIDK 259
Query: 234 -------------DERPPIP----------ESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
+SP+ DFL + + D + R A+ +
Sbjct: 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319
Query: 271 HPW 273
HP+
Sbjct: 320 HPY 322
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 69/278 (24%), Positives = 128/278 (46%), Gaps = 32/278 (11%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNL-N 75
LG +G+GA+G+V + ++ VA+K + E + +M E+ +L ++ +
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 89
Query: 76 HKNIVKYLG-SLKTRSHLHIILEYVENGSL-------------ANIIKPNKFGPFPESLV 121
H N+V LG K L +I+E+ + G+L + + + F
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 122 AVYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV---NTH 177
+ + QV +G+ +L + IHRD+ NIL +++ +VK+ DFG+A + +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 178 SVVGTPY-WMAPEVIEMSGVC-AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQD 234
+ + P WMAPE I V SD+WS G + E+ + PY ++ R +++
Sbjct: 210 ARL--PLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 235 -ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
R P+ +P++ + C+ + QRP L+ H
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 27/274 (9%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
+E+G+ +G+VYKG G+ VAIK + + E L L H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQH 71
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSL----------ANIIKPNKFGPFPESLVA---V 123
N+V LG + L +I Y +G L +++ + +L V
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 124 YIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSV 179
++ Q+ G+ YL V+H+D+ N+L + VK++D G+ ++ AD + +S+
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 180 VGTPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERP 237
+ P WMAPE I SDIWS G + E+ + + PY + I +
Sbjct: 192 L--PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL 249
Query: 238 PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
P P+ + + +C+ + +RP K + S
Sbjct: 250 PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-37
Identities = 84/329 (25%), Positives = 134/329 (40%), Gaps = 63/329 (19%)
Query: 2 SRQTTTSAFHKSK------TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS--L 53
SR + F+ + T+ +Y IG GA G V D VAIK++S
Sbjct: 3 SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF 62
Query: 54 ENIAQEDLNIIMQEIDLLKNLNHKNIVKYL------GSLKTRSHLHIILEYVENGSLANI 107
+N Q +E+ L+K +NHKNI+ L SL+ ++I++E ++ +L +
Sbjct: 63 QN--QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQV 119
Query: 108 IKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167
I+ ++ + Q+L G+ +LH G+IHRD+K +NI+ + +K+ DFG+A
Sbjct: 120 IQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 168 KLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVP---------- 217
+ + T VV T Y+ APEVI G DIWSVGC + E++
Sbjct: 176 TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 234
Query: 218 ------------------------------PYYELQPMPALFR-IVQDERPPIPESLSPD 246
P Y LF ++ + +
Sbjct: 235 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 294
Query: 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
D L + DA +R L HP+I
Sbjct: 295 ARDLLSKMLVIDASKRISVDEALQHPYIN 323
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-37
Identities = 81/328 (24%), Positives = 132/328 (40%), Gaps = 59/328 (17%)
Query: 1 MSRQTTTSAFHKSK------TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLE 54
MS+ + F+ + T+ +Y IG GA G V D VAIK++S
Sbjct: 39 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98
Query: 55 NIAQEDLNIIMQEIDLLKNLNHKNIVKYL------GSLKTRSHLHIILEYVENGSLANII 108
Q +E+ L+K +NHKNI+ L +L+ +++++E ++ +L +I
Sbjct: 99 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI 157
Query: 109 KPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168
+ ++ + Q+L G+ +LH G+IHRD+K +NI+ + +K+ DFG+A
Sbjct: 158 Q----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVP----------- 217
+ + T VV T Y+ APEVI G DIWSVGC + E++
Sbjct: 214 AGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 272
Query: 218 -----------------------------PYYELQPMPALF-RIVQDERPPIPESLSPDI 247
P Y P LF + + +
Sbjct: 273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 332
Query: 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
D L + D +R L HP+I
Sbjct: 333 RDLLSKMLVIDPAKRISVDDALQHPYIN 360
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-37
Identities = 77/326 (23%), Positives = 130/326 (39%), Gaps = 73/326 (22%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
+ +Y + IGKG++G+V K D + VA+K V N + +EI +L++L
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV--RNE-KRFHRQAAEEIRILEHLR 151
Query: 76 HK------NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
+ N++ L + R+H+ + E + +L +IK NKF F LV + +L
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEG--LVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
+ L LH+ +IH D+K NIL ++G +K+ DFG + + ++ + + ++ A
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYRA 267
Query: 188 PEVIEMSGVCAASDIWSVGCTVI---------------ELLTC------VPPYYELQ--- 223
PEVI + D+WS+GC + + L C +P L
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 224 -----------PMPALFRIVQDERPPIPESLS-----------------------PDITD 249
P + D + S P D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 250 FLRQCFKKDARQRPDAKTLLSHPWIQ 275
FL+QC + D R L HPW++
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 57/273 (20%), Positives = 110/273 (40%), Gaps = 38/273 (13%)
Query: 21 MLGDEIGKGAYGRVYKGLDLENGDF-------VAIKQVSLENIAQEDLNIIMQEIDLLKN 73
+ + +G+G + +++KG+ E GD+ V +K L+ + + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV--LDKAHRNYSESFFEAASMMSK 68
Query: 74 LNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
L+HK++V G ++ E+V+ GSL +K NK + Q+ +
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE-VAKQLAAAMH 127
Query: 134 YLHEQGVIHRDIKGANILTTKEG--------LVKLADFGVATKLTEADVNTHSVVGTPY- 184
+L E +IH ++ NIL +E +KL+D G++ + D
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------IL 177
Query: 185 -----WMAPEVIEMSGV-CAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERP 237
W+ PE IE A+D WS G T+ E+ + P L L +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237
Query: 238 PIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
P P+ + ++ + + C + RP + ++
Sbjct: 238 PAPK--AAELANLINNCMDYEPDHRPSFRAIIR 268
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-36
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 37/296 (12%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
+IG+GA+GRV++ L + VA+K + E + + +E L+ ++
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDN 109
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSL------------------ANIIKPNKFGPFPE 118
NIVK LG + ++ EY+ G L + P P
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 119 SLVA---VYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD- 173
L + IA QV G+ YL E+ +HRD+ N L + +VK+ADFG++ + AD
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 174 --VNTHSVVGTPY-WMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALF 229
+ + + P WM PE I + SD+W+ G + E+ + + PYY + ++
Sbjct: 230 YKADGNDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 287
Query: 230 RIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSL 285
+ PE+ ++ + +R C+ K RP ++ +Q + ++
Sbjct: 288 YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI--LQRMCERAEGTV 341
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 71/283 (25%), Positives = 129/283 (45%), Gaps = 37/283 (13%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
LG +G+G +G+V K L+ VA+K + EN + +L ++ E ++LK +NH
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQVNH 85
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSL------------------ANIIKPNKFGPFPE 118
+++K G+ L +I+EY + GSL + + P
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 119 SLVA---VYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174
+L + A Q+ +G+ YL E ++HRD+ NIL + +K++DFG++ + E D
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 175 ---NTHSVVGTPY-WMAPEVIEMSGVC-AASDIWSVGCTVIELLTC-VPPYYELQPMPAL 228
+ + P WMA E + + SD+WS G + E++T PY + P
Sbjct: 206 YVKRSQGRI--PVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 229 FRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
+ R P++ S ++ + QC+K++ +RP +
Sbjct: 263 NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-36
Identities = 70/284 (24%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNL-N 75
G +G GA+G+V + VA+K + E + +M E+ ++ L +
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGS 107
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSL-------------ANIIKPNKFGPFPESLVA 122
H+NIV LG+ +++I EY G L I N+ E +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 123 -------VYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174
+ A QV +G+ +L + +HRD+ N+L T +VK+ DFG+A +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 175 ---NTHSVVGTPY-WMAPEVIEMSGVC-AASDIWSVGCTVIELLTC-VPPYYELQPMPAL 228
++ + P WMAPE + G+ SD+WS G + E+ + V PY +
Sbjct: 228 YVVRGNARL--PVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284
Query: 229 FRIVQD-ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
++++Q+ + P + +I ++ C+ D+R+RP L S
Sbjct: 285 YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 32/278 (11%)
Query: 22 LGDEIGKGAYGRVYKGL-------DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
LG +G+GA+G+V + VA+K + ++ ++DL+ ++ E++++K +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMI 97
Query: 75 -NHKNIVKYLGSLKTRSHLHIILEYVENGSL-------------ANIIKPNKFGPFPESL 120
HKNI+ LG+ L++I+EY G+L +
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 121 VAVYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNT 176
V Q+ G+ YL Q IHRD+ N+L T+ ++K+ADFG+A + D T
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 177 HSVVGTPY-WMAPEVIEMSGVC-AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQ 233
+ + P WMAPE + V SD+WS G + E+ T PY + + +
Sbjct: 218 NGRL--PVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 234 DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
R P + + ++ +R C+ QRP K L+
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 79/310 (25%), Positives = 138/310 (44%), Gaps = 56/310 (18%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
L ++YM +G G G V+ +D + VAIK++ L + + + ++EI +++ L
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRL 65
Query: 75 NHKNIVK--------------YLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
+H NIVK +GSL + ++I+ EY+E LAN+++ P E
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG---PLLEEH 121
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKLADFGVA----TKLTEADVN 175
+++ Q+L GL Y+H V+HRD+K AN+ E ++K+ DFG+A +
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 176 THSVVGTPYWMAPEVI-EMSGVCAASDIWSVGCTVIELLTC------------------- 215
+ +V T ++ +P ++ + A D+W+ GC E+LT
Sbjct: 182 SEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
Query: 216 --VPPYYELQPMPALFRIVQDERPPIP----ESLSPDIT----DFLRQCFKKDARQRPDA 265
V + Q + ++ + P L P I+ DFL Q R A
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 266 KTLLSHPWIQ 275
+ LSHP++
Sbjct: 301 EEALSHPYMS 310
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-36
Identities = 69/307 (22%), Positives = 124/307 (40%), Gaps = 50/307 (16%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI---------IM 65
+ + Y + I G+YG V G+D E G VAIK+V +NI ++
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 66 QEIDLLKNLNHKNIVKYL-----GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
+EI LL + +H NI+ L+++ E + LA +I +
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR-IVISPQH 135
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
+ ++ +L GL LHE GV+HRD+ NIL + + DF +A + T TH V
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 181 GTPYWMAPEVI-EMSGVCAASDIWSVGCTVIELLTC---------------------VPP 218
++ APE++ + G D+WS GC + E+ P
Sbjct: 196 -HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 219 YYELQPM--PALFRIVQDERPPIP----ESLSPDIT----DFLRQCFKKDARQRPDAKTL 268
++ P+ +++ +P ++ P D + + + + ++R +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 269 LSHPWIQ 275
L HP+ +
Sbjct: 315 LRHPYFE 321
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-36
Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 32/278 (11%)
Query: 22 LGDEIGKGAYGRVYKGL-------DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
LG +G+G +G+V + VA+K + ++ ++DL+ ++ E++++K +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMI 143
Query: 75 -NHKNIVKYLGSLKTRSHLHIILEYVENGSL----------ANIIKPNKFGPFPESLVA- 122
HKNI+ LG+ L++I+EY G+L + E +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 123 --VYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNT 176
V Q+ G+ YL Q IHRD+ N+L T+ ++K+ADFG+A + D T
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 177 HSVVGTPY-WMAPEVIEMSGVC-AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQ 233
+ + P WMAPE + V SD+WS G + E+ T PY + + +
Sbjct: 264 NGRL--PVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320
Query: 234 DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
R P + + ++ +R C+ QRP K L+
Sbjct: 321 GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 77/323 (23%), Positives = 128/323 (39%), Gaps = 61/323 (18%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS-LENIAQE 59
M ++ ++ + + + L +G+GAYG V G+ VAIK++ +
Sbjct: 1 MPKRIV---YN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PL 51
Query: 60 DLNIIMQEIDLLKNLNHKNIVKYL-----GSLKTRSHLHIILEYVENGSLANIIKPNKFG 114
++EI +LK+ H+NI+ S + + ++II E ++ L +I
Sbjct: 52 FALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ--- 107
Query: 115 PFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174
+ + +I Q L + LH VIHRD+K +N+L +K+ DFG+A + E+
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 175 NTHSVVGTPYWM----------APEVI-EMSGVCAASDIWSVGCTVIELLTCVPPYYELQ 223
+ G M APEV+ + A D+WS GC + EL P +
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
Query: 224 PMPALFRIVQ-------DE-------------------RPPIP-ESLSPDIT----DFLR 252
L I D P P E + P + D L+
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 253 QCFKKDARQRPDAKTLLSHPWIQ 275
+ D +R AK L HP++Q
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQ 310
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 22 LGDEIGKGAYGRVYKGL--DLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNL-N 75
G +G GA+G+V + L D VA+K + ++ +M E+ ++ +L
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMSHLGQ 108
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVA-----------VY 124
H+NIV LG+ + +I EY G L N ++ + A ++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 125 IA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVV 180
+ QV +G+ +L + IHRD+ N+L T + K+ DFG+A + V ++ +
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 181 GTPY-WMAPEVIEMSGVC-AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQD-ER 236
P WMAPE I V SD+WS G + E+ + + PY + +++V+D +
Sbjct: 229 --PVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ 285
Query: 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
P +I ++ C+ + RP + + S
Sbjct: 286 MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-35
Identities = 75/276 (27%), Positives = 126/276 (45%), Gaps = 28/276 (10%)
Query: 22 LGDEIGKGAYGRVYKGL-------DLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
LG +G+GA+G+V VA+K + + ++DL+ ++ E++++K +
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMI 131
Query: 75 -NHKNIVKYLGSLKTRSHLHIILEYVENGSL----------ANIIKPNKFGPFPESLVA- 122
HKNI+ LG+ L++I+EY G+L N E L +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 123 --VYIA-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV 179
V A QV G+ YL + IHRD+ N+L T++ ++K+ADFG+A + D +
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 180 VGT-PY-WMAPEVIEMSGVC-AASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDE 235
G P WMAPE + + SD+WS G + E+ T PY + + +
Sbjct: 252 NGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310
Query: 236 RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
R P + + ++ +R C+ QRP K L+
Sbjct: 311 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-35
Identities = 63/247 (25%), Positives = 106/247 (42%), Gaps = 38/247 (15%)
Query: 6 TTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIM 65
+ H + ++Y + IG G+YG V + D VAIK++ D I+
Sbjct: 41 SMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL 100
Query: 66 QEIDLLKNLNHKNIVKYL-----GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
+EI +L LNH ++VK L ++ L+++LE ++ + + E
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPV--YLTELH 157
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN----- 175
+ + +L G+ Y+H G++HRD+K AN L ++ VK+ DFG+A + +
Sbjct: 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 176 -----------------------THSVVGTPYWMAPEVI-EMSGVCAASDIWSVGCTVIE 211
T VV T ++ APE+I A D+WS+GC E
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVV-TRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 212 LLTCVPP 218
LL +
Sbjct: 277 LLNMIKE 283
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-35
Identities = 82/345 (23%), Positives = 130/345 (37%), Gaps = 102/345 (29%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNII----------M 65
L+N +++ ++G G +GRV ++N + A+K ++
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-------------VVRNIKKYTRSAK 79
Query: 66 QEIDLLKNLNH-----KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL 120
E D+LK + + NIVKY G H+ +I E + SL II N + F
Sbjct: 80 IEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIED 138
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANIL-------------------------TTKE 155
+ +Y ++L+ L YL + + H D+K NIL TK
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 156 GLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC 215
+KL DFG AT ++ S++ T + APEVI G +SD+WS GC + EL T
Sbjct: 199 TGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 216 VPPY-----YE--------LQPMPA------------LFRIVQDERPPIPESLS------ 244
+ E +QP+P + + + PE+ S
Sbjct: 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315
Query: 245 --------------PDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
DFL + D RP LL H +++
Sbjct: 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 77/345 (22%), Positives = 130/345 (37%), Gaps = 96/345 (27%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLE-NGDFVAIKQVSLENIAQEDLNII---------- 64
L +Y + D +G+GA+G+V + +D + G VA+K I+
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVK-------------IVKNVDRYCEAA 58
Query: 65 MQEIDLLKNLNHK------NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPE 118
EI +L++LN V+ L + H+ I+ E + S + IK N F PF
Sbjct: 59 RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRL 117
Query: 119 SLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL-------------------TTKEGLVK 159
+ Q+ + + +LH + H D+K NIL T +K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 160 LADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPY 219
+ DFG AT E + ++V T ++ APEVI G D+WS+GC +IE +
Sbjct: 178 VVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 220 -----YE--------LQPMPALF------------------------RIVQDERPPIPES 242
E L P+P R V P+ E
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294
Query: 243 LSPD------ITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRAL 281
+ + D +++ + D +R + L HP+ ++++
Sbjct: 295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-34
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
++Y + IGKG++G+V K D ++VAIK + +N + LN E+ LL+ +N
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNK-KAFLNQAQIEVRLLELMN 108
Query: 76 H------KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
IV R+HL ++ E + +L ++++ F +L + Q+
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 130 EGLVYLH--EQGVIHRDIKGANILTTKEG--LVKLADFGVATKLTEADVNTHSVVGTPYW 185
L++L E +IH D+K NIL +K+ DFG + +L + + + + ++
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFY 224
Query: 186 MAPEVIEMSGVCAASDIWSVGCTVIELLTCVP 217
+PEV+ A D+WS+GC ++E+ T P
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 42/260 (16%), Positives = 80/260 (30%), Gaps = 40/260 (15%)
Query: 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDLLK 72
+ + +Y L G + ++ LD VA+ V + + +D L + L
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 73 NLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGL 132
++ + + L + TR+ ++ E++ GSL + P P + +
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVG-AIRAMQSLAAAA 142
Query: 133 VYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIE 192
H GV + + + +G V LA
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--------------------------- 175
Query: 193 MSGVCAASDIWSVGCTVIELLTCVPPYYE---LQPMPALFRIVQDERPPIPESLSPDI-- 247
M DI +G ++ LL P E + R +P P + DI
Sbjct: 176 MPDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPF 234
Query: 248 --TDFLRQCFKKDARQRPDA 265
+ + + D R +
Sbjct: 235 QISAVAARSVQGDGGIRSAS 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 69/269 (25%), Positives = 128/269 (47%), Gaps = 22/269 (8%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDF--VAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKN 78
D IG+G +G+V K ++G AIK++ E +++D E+++L L +H N
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVA-------------VYI 125
I+ LG+ + R +L++ +EY +G+L + ++ ++ + ++
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 126 A-QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY 184
A V G+ YL ++ IHRD+ NIL + + K+ADFG++ T + P
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--PV 205
Query: 185 -WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPES 242
WMA E + S SD+WS G + E+++ PY + ++ Q R P +
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLSH 271
++ D +RQC+++ +RP +L
Sbjct: 266 CDDEVYDLMRQCWREKPYERPSFAQILVS 294
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-34
Identities = 78/304 (25%), Positives = 134/304 (44%), Gaps = 57/304 (18%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS--LENIAQEDLNIIMQEIDLLK 72
L Y+ +G GAYG V +D +G+ VAIK++S ++ + +E+ LLK
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLK 78
Query: 73 NLNHKNIVKYL------GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA 126
++ H+N++ L SL+ ++++ +++ L I+ F E + +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG----LKFSEEKIQYLVY 133
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA----TKLTEADVNTHSVVGT 182
Q+L+GL Y+H GV+HRD+K N+ ++ +K+ DFG+A ++T V T
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-------YVVT 186
Query: 183 PYWMAPEVI-EMSGVCAASDIWSVGCTVIELLTCVP------PYYELQ--------PMPA 227
++ APEVI DIWSVGC + E+LT +L P
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 228 LFRIVQDE-----------RPPIP-ESLSPDIT----DFLRQCFKKDARQRPDAKTLLSH 271
+ + D+ P L P + D L + + D +R A L+H
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 272 PWIQ 275
P+ +
Sbjct: 307 PFFE 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 75/323 (23%), Positives = 137/323 (42%), Gaps = 62/323 (19%)
Query: 2 SRQTTTSAFHKSK------TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS--L 53
S S F++ + + Y +G GAYG V +D G VAIK++
Sbjct: 3 SPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF 62
Query: 54 ENIAQEDLNIIMQEIDLLKNLNHKNIVKYL------GSLKTRSHLHIILEYVENGSLANI 107
++ + +E+ LLK++ H+N++ L +L + ++++ ++ L +
Sbjct: 63 QS--ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKL 119
Query: 108 IKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA- 166
+K E + + Q+L+GL Y+H G+IHRD+K N+ ++ +K+ DFG+A
Sbjct: 120 MKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176
Query: 167 ---TKLTEADVNTHSVVGTPYWMAPEVI-EMSGVCAASDIWSVGCTVIELLTCVPPY--- 219
+++T V T ++ APEVI DIWSVGC + E++T +
Sbjct: 177 QADSEMTGY-------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 220 -YELQ----------PMPALFRIVQDE-----------RPPIP-ESLSPDIT----DFLR 252
+ Q P + +Q + S+ + + + L
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289
Query: 253 QCFKKDARQRPDAKTLLSHPWIQ 275
+ DA QR A L+HP+ +
Sbjct: 290 KMLVLDAEQRVTAGEALAHPYFE 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 44/298 (14%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
+ +Y +G GAYG V D + G VA+K++S + +E+ LLK++
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 75 NHKNIVKYL------GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQV 128
H+N++ L SL+ + ++++ + L NI+K + V I Q+
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ---KLTDDHVQFLIYQI 141
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
L GL Y+H +IHRD+K +N+ ++ +K+ DFG+A AD T V T ++ AP
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVA-TRWYRAP 198
Query: 189 EVI-EMSGVCAASDIWSVGCTVIELLTCVPPY----YELQ----------PMPALFRIVQ 233
E++ DIWSVGC + ELLT + + Q P L + +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 234 DE-----------RPPIP-ESLSPDIT----DFLRQCFKKDARQRPDAKTLLSHPWIQ 275
E P + ++ D L + D+ +R A L+H +
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 76/340 (22%), Positives = 120/340 (35%), Gaps = 96/340 (28%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLE-NGDFVAIKQVSLENIAQEDLNII---------- 64
L +Y + +G+G +G+V + LD VA+K II
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALK-------------IIRNVGKYREAA 63
Query: 65 MQEIDLLKNLNHK------NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPE 118
EI++LK + K V H+ I E + + +K N F P+P
Sbjct: 64 RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPL 122
Query: 119 SLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL-------------------TTKEGLVK 159
V Q+ L +LHE + H D+K NIL + K ++
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 160 LADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPY 219
+ADFG AT E + ++V T ++ PEVI G D+WS+GC + E +
Sbjct: 183 VADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239
Query: 220 -----YE--------LQPMPALF------------------------RIVQDERPPIPES 242
E L P+P+ R V++ P+
Sbjct: 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299
Query: 243 LSPD------ITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
+ D + D +R+ + D QR L HP+
Sbjct: 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-33
Identities = 74/302 (24%), Positives = 130/302 (43%), Gaps = 48/302 (15%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS-LENIAQEDLNIIMQEIDLLKN 73
+ +Y IG+GAYG V D N VAIK++S E+ Q ++EI +L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 81
Query: 74 LNHKNIVKYL-----GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQV 128
H+NI+ +++ ++I+ + +E L ++K + ++ Q+
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQI 137
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVA----TKLTEADVNTHSVVGTPY 184
L GL Y+H V+HRD+K +N+L +K+ DFG+A T V T +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRW 196
Query: 185 WMAPEVI-EMSGVCAASDIWSVGCTVIELLTCVPPY----YELQ----------PMPALF 229
+ APE++ G + DIWSVGC + E+L+ P + Y Q P
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 230 RIVQDE-----------RPPIP-ESLSPDIT----DFLRQCFKKDARQRPDAKTLLSHPW 273
+ + + +P L P+ D L + + +R + + L+HP+
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 274 IQ 275
++
Sbjct: 317 LE 318
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-33
Identities = 74/337 (21%), Positives = 133/337 (39%), Gaps = 79/337 (23%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVS--LENIAQEDLNIIMQEIDLLK 72
+ KY L ++GKGAYG V+K +D G+ VA+K++ +N D +EI +L
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILT 63
Query: 73 NLN-HKNIVKYLGSLKTRS--HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
L+ H+NIV L L+ + ++++ +Y+E L +I+ N + Q++
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN---ILEPVHKQYVVYQLI 119
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV---------- 179
+ + YLH G++HRD+K +NIL E VK+ADFG++ T+++
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 180 -----------VGTPYWMAPEVI-EMSGVCAASDIWSVGCTVIELLTCVP---------- 217
V T ++ APE++ + D+WS+GC + E+L P
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 218 -------------------------------PYYELQPMPALFRIVQDERPPIPESL--- 243
I + + +
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 244 --SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278
+ + D L + + + +R A L HP++
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 28/205 (13%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85
+G+G +G+VYKG L +G VA+K++ E +L E++++ H+N+++ G
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHRNLLRLRGF 95
Query: 86 LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESL---------VAVYIAQVLEGLVYLH 136
T + ++ Y+ NGS+A+ + +A+ A GL YLH
Sbjct: 96 CMTPTERLLVYPYMANGSVASCL----RERPESQPPLDWPKRQRIALGSA---RGLAYLH 148
Query: 137 EQG---VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH---SVVGTPYWMAPEV 190
+ +IHRD+K ANIL +E + DFG+A KL + +TH +V GT +APE
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYK-DTHVTTAVRGTIGHIAPEY 206
Query: 191 IEMSGVCAA-SDIWSVGCTVIELLT 214
+ +G + +D++ G ++EL+T
Sbjct: 207 L-STGKSSEKTDVFGYGVMLLELIT 230
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-32
Identities = 67/259 (25%), Positives = 108/259 (41%), Gaps = 36/259 (13%)
Query: 2 SRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE-- 59
R+ K+ + + Y++ IG+G+YG VY D VAIK+V+ + ++
Sbjct: 10 GRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN--RMFEDLI 67
Query: 60 DLNIIMQEIDLLKNLNHKNIVKYL-----GSLKTRSHLHIILEYVENGSLANIIKPNKFG 114
D I++EI +L L I++ L L+I+LE ++ L + K
Sbjct: 68 DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI-- 124
Query: 115 PFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV 174
E + + +L G ++HE G+IHRD+K AN L ++ VK+ DFG+A +
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 175 NTHSV----------------------VGTPYWMAPEVI-EMSGVCAASDIWSVGCTVIE 211
V T ++ APE+I + DIWS GC E
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244
Query: 212 LLTCVPPYYELQPMP-ALF 229
LL + + LF
Sbjct: 245 LLNMLQSHINDPTNRFPLF 263
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 76/267 (28%), Positives = 125/267 (46%), Gaps = 42/267 (15%)
Query: 26 IGKGAYGRVYKG-LDLENGDFVAIKQVSLENIAQEDLNII------MQEIDLLKNLNHKN 78
+G+G +G VYKG ++ VA+K+++ A D+ QEI ++ H+N
Sbjct: 39 MGEGGFGVVYKGYVN---NTTVAVKKLA----AMVDITTEELKQQFDQEIKVMAKCQHEN 91
Query: 79 IVKYLGSLKTRSHLHIILEYVENGSLANII-KPNKFGPFPESL---VAVYIAQVLEGLVY 134
+V+ LG L ++ Y+ NGSL + + + P + +A A G+ +
Sbjct: 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN---GINF 148
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH---SVVGTPYWMAPEVI 191
LHE IHRDIK ANIL + K++DFG+A + +E T +VGT +MAPE
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFGLA-RASEKFAQTVMTSRIVGTTAYMAPEA- 206
Query: 192 EMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALF---RIVQDERPPIPESLSPDI 247
+ G + SDI+S G ++E++T +P E + L ++DE I + + +
Sbjct: 207 -LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265
Query: 248 TDFLR-----------QCFKKDARQRP 263
D QC + +RP
Sbjct: 266 NDADSTSVEAMYSVASQCLHEKKNKRP 292
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 26 IGKGAYGRVYKGLDLENGDFVAIKQVSLENI--AQEDLNIIMQEIDLLKNLNHKNIVKYL 83
IG G +G+VYKG+ L +G VA+K+ + E+ +E EI+ L H ++V +
Sbjct: 47 IGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFET----EIETLSFCRHPHLVSLI 101
Query: 84 GSLKTRSHLHIILEYVENGSLAN----IIKPNKFGPFPESL-VAVYIAQVLEGLVYLHEQ 138
G R+ + +I +Y+ENG+L P + + L + + A+ GL YLH +
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR---GLHYLHTR 158
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH---SVVGTPYWMAPEVIEMSG 195
+IHRD+K NIL + + K+ DFG++ K TH V GT ++ PE + G
Sbjct: 159 AIIHRDVKSINILLDENFVPKITDFGIS-KKGTELDQTHLSTVVKGTLGYIDPEYF-IKG 216
Query: 196 -VCAASDIWSVGCTVIELLTCVPP 218
+ SD++S G + E+L
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 80/372 (21%), Positives = 125/372 (33%), Gaps = 118/372 (31%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIK-QVSLENIAQEDLNIIMQEIDLLKN 73
+ +Y + ++G G + V+ D++ FVA+K S E+ + L+ EI LLK+
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLKS 89
Query: 74 L--------NHKNIVKYLGSLKTRS----HLHIILEYVENGSLANIIKPNKFGPFPESLV 121
+ N + +V+ L K H+ ++ E V L I + + P V
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCV 148
Query: 122 AVYIAQVLEGLVYLHEQ-GVIHRDIKGANIL----------------------------- 151
I QVL+GL YLH + +IH DIK NIL
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 152 --------------------TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI 191
++ VK+AD G A + + T + + EV+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYRSLEVL 265
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYE-------------------LQPMPA----- 227
SG +DIWS C EL T + L +P
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325
Query: 228 -------------LFRIVQDERPPIPESL----------SPDITDFLRQCFKKDARQRPD 264
L I + + + E L + TDFL + +R
Sbjct: 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385
Query: 265 AKTLLSHPWIQN 276
A L HPW+ +
Sbjct: 386 AAECLRHPWLNS 397
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 8e-20
Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 4/149 (2%)
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGT-PY- 184
QV +G+ +L + IHRD+ NIL +++ +VK+ DFG+A + + P
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 185 WMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQD-ERPPIPES 242
WMAPE I SD+WS G + E+ + PY ++ R +++ R P+
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 320
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLSH 271
+P++ + C+ + QRP L+ H
Sbjct: 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 27/124 (21%), Positives = 54/124 (43%), Gaps = 8/124 (6%)
Query: 22 LGDEIGKGAYGRVYKG-----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-N 75
LG +G+GA+G+V + VA+K + E + +M E+ +L ++ +
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 84
Query: 76 HKNIVKYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
H N+V LG K L +I+E+ + G+L+ ++ + P Q + +
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 135 LHEQ 138
+
Sbjct: 145 IPVD 148
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 38/226 (16%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
N+++LG +IG G +G +Y + A V +E L E+ + + K
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL---FSELKFYQRVAKK 93
Query: 78 NIVKYLGSLKTRSHLHI-------ILEYVENG-----------SLANIIKPNKFGPFPES 119
+ +K K +L I + E+ L I N G F +S
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN--GTFKKS 151
Query: 120 LVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNTH 177
V ++L+ L Y+HE +H DIK AN+L V LAD+G++ + +
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 178 -------SVVGTPYWM---APEVIEMSGVCAASDIWSVGCTVIELL 213
GT + A + + +S SD+ +G ++ L
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALS---RRSDVEILGYCMLRWL 254
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH- 76
N+Y LG +IG G++G +Y G D+ G+ VAIK E + + + + E + K +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHI-ESKIYKMMQGG 64
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENG-SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
I + +++E + G SL ++ F V + Q++ + Y+
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYI 121
Query: 136 HEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTH-------SVVGTPYW 185
H + IHRD+K N L K LV + DFG+A K +A + H ++ GT +
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 186 M---APEVIEMSGVCAASDIWSVGCTVIELL 213
IE S D+ S+G ++
Sbjct: 182 ASINTHLGIEQS---RRDDLESLGYVLMYFN 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NH 76
Y +G IG+G++G +++G +L N VAIK + A + E K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGC 65
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENG-SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
I + H ++++ + G SL +++ F VA+ Q+L + +
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 122
Query: 136 HEQGVIHRDIKGANIL-----TTKEGLVKLADFGVATKLTEADVNTH-------SVVGTP 183
HE+ +++RDIK N L + ++ + DFG+ + H ++ GT
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 184 YWM---APEVIEMSGVCAASDIWSVGCTVIELLT 214
+M E S D+ ++G + L
Sbjct: 183 RYMSINTHLGREQS---RRDDLEALGHVFMYFLR 213
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 6e-17
Identities = 78/488 (15%), Positives = 163/488 (33%), Gaps = 56/488 (11%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-H 76
NK+ LG +IG G++G +Y G +++ + VAIK +++ ++ E + + L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGG 62
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENG-SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
I + ++++ + G SL ++ V + Q++ + ++
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFV 119
Query: 136 HEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTH-------SVVGTPYW 185
H + +HRDIK N L + V + DFG+A K + + H ++ GT +
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 186 M---APEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQ--PMPALFRIVQDERPPIP 240
IE S D+ S+G ++ L P+ L+ + + +++
Sbjct: 180 ASVNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236
Query: 241 -----ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVE 295
+ + C +PD L + L R +
Sbjct: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYL----------KRL---FRDLFIREGFQ 283
Query: 296 ENGSADAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAATHLSKSDKEHSSNGNLAE 355
+ D I Q + + + P+A G E ++G +
Sbjct: 284 FDYVFDWTILK--YQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSM 341
Query: 356 ERVENPEDEPLSDQVPTLAIHEMSLVQTGSGR-LPSNKITATNDQSQLQEITNTSDKDEM 414
+R P + + + ++ + S + ++S
Sbjct: 342 DRRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSS---RD 398
Query: 415 LINGETQSPESRRKNLDSKHGGKGTSISVDNKSFGFSPRTDNNSLQKAVKTS----ATVG 470
++ +T P SR + D+ G + S S ++S + + +
Sbjct: 399 VMPIDTSEP-SRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALK 457
Query: 471 GNELSRFS 478
G E F
Sbjct: 458 GIEGLNFD 465
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 46/214 (21%), Positives = 88/214 (41%), Gaps = 27/214 (12%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NH 76
+ +G +IG G +G + G +L ++VAIK LE + + E K L +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEP-MKSRAPQLHLEYRFYKQLGSG 64
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENG-SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
I + + ++LE + G SL ++ F V + Q++ + Y+
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYV 121
Query: 136 HEQGVIHRDIKGANIL-----TTKEGLVKLADFGVATKLTEADVNTH-------SVVGTP 183
H + +I+RD+K N L + ++ + DF +A + + + H S+ GT
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 184 YWMAPEV---IEMSGVCAASDIWSVGCTVIELLT 214
+M+ E S D+ ++G + L
Sbjct: 182 RYMSINTHLGKEQS---RRDDLEALGHMFMYFLR 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 8e-16
Identities = 36/231 (15%), Positives = 75/231 (32%), Gaps = 45/231 (19%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDF--------VAIK-----------QVSLENIAQ 58
++ L + G +Y+ ++K Q + A+
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 59 EDLNIIMQEIDLLKNLNHKNIVKYLGS-LKTRSHLHIILEYVENG-SLANIIKPNKFGPF 116
+ + L + I +G + + ++L + G SL + + +
Sbjct: 102 PLQ---VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVL 156
Query: 117 PESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADV 174
E V ++L+ L +LHE +H ++ NI + V LA +G A +
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC--PS 214
Query: 175 NTH---------SVVGTPYWM---APEVIEMSGVCAASDIWSVGCTVIELL 213
H G ++ + S SD+ S+G +++ L
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS---RRSDLQSLGYCMLKWL 262
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 35/196 (17%), Positives = 68/196 (34%), Gaps = 29/196 (14%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ +G IG+G +G +Y D+ + + V + + D + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP 93
Query: 78 NIVKYLGSLKTRSHLHI-------ILEYVENG-----------SLANIIKPNKFGPFPES 119
++ + +L + + + L I + N F
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRK 152
Query: 120 LVAVYIAQVLEGLVYLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNTH 177
V ++L+ L Y+HE +H DIK +N+L V L D+G+A + V+
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 178 -------SVVGTPYWM 186
GT +
Sbjct: 213 YAADPKRCHDGTIEFT 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 5e-14
Identities = 37/231 (16%), Positives = 69/231 (29%), Gaps = 54/231 (23%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI------AQEDLNIIMQEIDLL 71
K ++IG+G +G V++ + + VAIK +++E Q+ I+ EI +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 72 KNL---------NHKNIVKYLG------------------------------SLKTRSHL 92
K L + + L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ-GVIHRDIKGANIL 151
I+LE+ G ++ + + Q+ L HRD+ N+L
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 152 TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDI 202
K L KL T + + + + +E G+ D+
Sbjct: 195 LKKTSLKKLHYTLNGKSST---IPSCGLQVSIIDYTLSRLERDGIVVFCDV 242
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 3e-13
Identities = 34/257 (13%), Positives = 89/257 (34%), Gaps = 10/257 (3%)
Query: 1161 LLKCVNHLSTDPN-CLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKR 1219
+K LS + ++ + +A + L+ + ++ E AL N+
Sbjct: 108 TVKFRQILSREHRPPIDVVIQAGVVPRLVEFMRENQ---PEMLQLEAAWALTNIASGTSA 164
Query: 1220 RQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLL 1278
+ + + +P + + + S +K+ A+ L ++A S + R+ + ++ L L
Sbjct: 165 QTKVVVDADAVPLFIQLLYTGSVEVKEQAIWALGNVAGDSTDYRDYVLQCNAMEPILGLF 224
Query: 1279 ENEVWSV--TALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPF 1336
+ S+ TA +++ A+ L K S V
Sbjct: 225 NSNKPSLIRTATWTLSNLCRGKKPQPDWSVV---SQALPTLAKLIYSMDTETLVDACWAI 281
Query: 1337 LKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVEND 1396
+ + + L+ L H+ + + L+ + + + Q+++
Sbjct: 282 SYLSDGPQEAIQAVIDVRIPKRLVELLSHESTLVQTPALRAVGNIVTGNDLQTQVVINAG 341
Query: 1397 LPQKLQNLIEERRDGQR 1413
+ L+ L+ ++ +
Sbjct: 342 VLPALRLLLSSPKENIK 358
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 1e-11
Identities = 49/332 (14%), Positives = 105/332 (31%), Gaps = 21/332 (6%)
Query: 1087 SGVLNARPGSATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLL 1146
S V + + L M LN+D +E L ++ + ++
Sbjct: 73 SSVSADQQFYSQLQQELPQMTQQLNSDDMQEQLSATVKFRQILSREHRPPIDVVIQAGVV 132
Query: 1147 SRLFQMFNRIEPPILLKCV-----NHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSL 1201
RL + +P +L N S + + ADA+ I L +
Sbjct: 133 PRLVEFMRENQPEMLQLEAAWALTNIASGTSAQTKVVVDADAVPLFIQLLYTGSVEVKE- 191
Query: 1202 IHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRN 1260
+ + AL N+ + ++ + + ++ S+ P L + A L ++ +
Sbjct: 192 ---QAIWALGNVAGDSTDYRDYVLQCNAMEPILGLFNSNKPSLIRTATWTLSNLCRGKKP 248
Query: 1261 SREQLRAHGGLDVYLNLLENE-----VWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQ 1315
+ L L+ + V + A+ ++ + QA++ +
Sbjct: 249 QPDWSVVSQALPTLAKLIYSMDTETLVDACWAISYLS---DGPQEAI---QAVIDVRIPK 302
Query: 1316 KLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLL 1375
+LV+ L I+T + + G+ P L L +
Sbjct: 303 RLVELLSHESTLVQTPALRAVGNIVTGNDLQTQVVINAGVLPALRLLLSSPKENIKKEAC 362
Query: 1376 KLIKAVYEHHPRPKQLIVENDLPQKLQNLIEE 1407
I + + Q +++ +L L L+E
Sbjct: 363 WTISNITAGNTEQIQAVIDANLIPPLVKLLEV 394
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 5e-11
Identities = 34/293 (11%), Positives = 94/293 (32%), Gaps = 20/293 (6%)
Query: 1099 SSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEP 1158
+ ++ N++ + L + + L L ++ ++
Sbjct: 213 QCNAMEPILGLFNSN-KPSLIRTATWTLSNLCRGKKPQPDWSVVSQALPTLAKLIYSMDT 271
Query: 1159 PILLKCVNHLS----TDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLC 1214
L+ +S ++ + K L+ L H +L+ + L A+ N+
Sbjct: 272 ETLVDACWAISYLSDGPQEAIQAVIDVRIPKRLVELL----SHESTLVQTPALRAVGNIV 327
Query: 1215 KINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDV 1273
N + + G++P L + S +K+ A + ++ + + + +
Sbjct: 328 TGNDLQTQVVINAGVLPALRLLLSSPKENIKKEACWTISNITAGNTEQIQAVIDANLIPP 387
Query: 1274 YLNLLENEVWSV--TALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVH 1331
+ LLE + A +I+ + + + L+ + ++ L + +
Sbjct: 388 LVKLLEVAEYKTKKEACWAISNASSGGLQRPDIIRYLVSQGCIKPLCDLL-EIADNRIIE 446
Query: 1332 ILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEH 1384
+ L+ I K + + + D I + ++ I ++
Sbjct: 447 VTLDALENILKMGEADKEARGLNINE-------NADFIEKAGGMEKIFNCQQN 492
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 35/181 (19%), Positives = 61/181 (33%), Gaps = 6/181 (3%)
Query: 604 DESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSILQLINQIV 663
+ +V AC + + Q + L+ELL T V L+ + IV
Sbjct: 268 SMDTETLVDACWAISYLSDGPQEAIQAVIDVRIPKRLVELLSHESTLVQTPALRAVGNIV 327
Query: 664 KDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFIACRGIP 723
N + G++P + + ++ EA + + + ++ +Q I IP
Sbjct: 328 TGNDLQTQVVINAGVLPALRLLLSSPKE-NIKKEACWTISNITAGNTEQIQAVIDANLIP 386
Query: 724 VLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLINTLYSLN 783
LV LE K ++ AI R D R G + L + L +
Sbjct: 387 PLVKLLEVAEYKTKKEACWAISNA-----SSGGLQRPDIIRYLVSQGCIKPLCDLLEIAD 441
Query: 784 E 784
Sbjct: 442 N 442
|
| >1wa5_B Importin alpha subunit; nuclear transport/complex, nuclear transport, exportin, RAN GTPase, protein transport; HET: GTP; 2.0A {Saccharomyces cerevisiae} SCOP: a.118.1.1 PDB: 1un0_A 2c1t_A 1bk5_A 1ee5_A 1bk6_A 1ee4_A Length = 530 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 24/183 (13%), Positives = 60/183 (32%), Gaps = 9/183 (4%)
Query: 605 ESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSILQLINQIVK 664
S + A L + + + + + + P++ L + +I + ++ + +
Sbjct: 185 GSVEVKEQAIWALGNVAGDSTDYRDYVLQCNAMEPILGLFNSNKPSLIRTATWTLSNLCR 244
Query: 665 DNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFIACRGIPV 724
+ + + +P + + E ++A + + L +Q I R
Sbjct: 245 GKKPQPDWSVVSQALPTLAKL-IYSMDTETLVDACWAISYLSDGPQEAIQAVIDVRIPKR 303
Query: 725 LVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLINTLYSLNE 784
LV L + + A+ + T + ++ G+L L L S E
Sbjct: 304 LVELLSHESTLVQTPALRAVGNI--------VTGNDLQTQVVINAGVLPALRLLLSSPKE 355
Query: 785 ATR 787
+
Sbjct: 356 NIK 358
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 6e-13
Identities = 46/325 (14%), Positives = 107/325 (32%), Gaps = 28/325 (8%)
Query: 1100 SGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPP 1159
+G + + L+++ + E+ L A T + Y+ ++L L Q+F++
Sbjct: 106 AGAVPIFIELLSSEFE-DVQEQAVWALGNIAGDSTMCRDYVLDCNILPPLLQLFSKQNRL 164
Query: 1160 ILLK----CVNHLSTDPNCLENLQR-ADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLC 1214
+ + +++L + + + + L L + D + + ++ AL L
Sbjct: 165 TMTRNAVWALSNLCRGKSPPPEFAKVSPCLNVLSWLLFVSD----TDVLADACWALSYLS 220
Query: 1215 KINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDV 1273
+ + + G+ L+ +M + + AL + ++ + + L
Sbjct: 221 DGPNDKIQAVIDAGVCRRLVELLMHNDYKVVSPALRAVGNIVTGDDIQTQVILNCSALQS 280
Query: 1274 YLNLLENEVWSV--TALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVH 1331
L+LL + S+ A +I+ A + Q ++ + L+ Q+
Sbjct: 281 LLHLLSSPKESIKKEACWTISNITAGNRAQI---QTVIDANIFPALISILQTAEFRTRKE 337
Query: 1332 ILEPFLKIITKSSRINT-TLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPK- 1389
+ S L G L L D+ L ++ + +
Sbjct: 338 AAWAITNATSGGSAEQIKYLVELGCIKPLCDLLTVMDSKIVQVALNGLENILRLGEQEAK 397
Query: 1390 ----------QLIVENDLPQKLQNL 1404
LI E K++ L
Sbjct: 398 RNGTGINPYCALIEEAYGLDKIEFL 422
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 9e-12
Identities = 32/247 (12%), Positives = 78/247 (31%), Gaps = 10/247 (4%)
Query: 1171 DPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGII 1230
+P E + + + L K+ + E L N+ N + + G +
Sbjct: 53 NPPIDEVISTPGVVARFVEFLKRKE---NCTLQFESAWVLTNIASGNSLQTRIVIQAGAV 109
Query: 1231 PHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENE---VWSVT 1286
P + + S+ +++ A+ L ++A S R+ + L L L + +
Sbjct: 110 PIFIELLSSEFEDVQEQAVWALGNIAGDSTMCRDYVLDCNILPPLLQLFSKQNRLTMTRN 169
Query: 1287 ALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRI 1346
A+ +++ + + + + L + +
Sbjct: 170 AVWALSNLCRGKSPPPEFAKV---SPCLNVLSWLLFVSDTDVLADACWALSYLSDGPNDK 226
Query: 1347 NTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIE 1406
+ G+ L+ L H D L+ + + Q+I+ Q L +L+
Sbjct: 227 IQAVIDAGVCRRLVELLMHNDYKVVSPALRAVGNIVTGDDIQTQVILNCSALQSLLHLLS 286
Query: 1407 ERRDGQR 1413
++ +
Sbjct: 287 SPKESIK 293
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 1e-07
Identities = 32/199 (16%), Positives = 63/199 (31%), Gaps = 8/199 (4%)
Query: 595 SRLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICS 654
+R V L+ E+ + L I Q + + + +ELL V
Sbjct: 67 ARFVEFLKRKENCTLQFESAWVLTNIASGNSLQTRIVIQAGAVPIFIELLSSEFEDVQEQ 126
Query: 655 ILQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQ 714
+ + I D++ ++ ++P ++ + A + L LC+ S +
Sbjct: 127 AVWALGNIAGDSTMCRDYVLDCNILPPLLQLFSKQNRLTMTRNAVWALSNLCRGKSPPPE 186
Query: 715 MFIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLR 774
+ VL L + D W + L S ND + G+ R
Sbjct: 187 FAKVSPCLNVLSWLLFVSDTD------VLADACWALSYL--SDGPNDKIQAVIDAGVCRR 238
Query: 775 LINTLYSLNEATRLASISV 793
L+ L + ++
Sbjct: 239 LVELLMHNDYKVVSPALRA 257
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 27/187 (14%), Positives = 62/187 (33%), Gaps = 8/187 (4%)
Query: 605 ESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSILQLINQIVK 664
D + AC L + + Q + L+ELL +V+ L+ + IV
Sbjct: 204 SDTDVLADACWALSYLSDGPNDKIQAVIDAGVCRRLVELLMHNDYKVVSPALRAVGNIVT 263
Query: 665 DNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFIACRGIPV 724
+ + + ++ + ++ EA + + + + +Q I P
Sbjct: 264 GDDIQTQVILNCSALQSLLHL-LSSPKESIKKEACWTISNITAGNRAQIQTVIDANIFPA 322
Query: 725 LVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLINTLYSLNE 784
L+ L+ + R+ AI S + + + G + L + L ++
Sbjct: 323 LISILQTAEFRTRKEAAWAI---TNAT----SGGSAEQIKYLVELGCIKPLCDLLTVMDS 375
Query: 785 ATRLASI 791
++
Sbjct: 376 KIVQVAL 382
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 35/198 (17%), Positives = 68/198 (34%), Gaps = 12/198 (6%)
Query: 594 FSRLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVIC 653
RLV L + A + + I Q Q + L L+ LL P+ +
Sbjct: 236 CRRLVELLM-HNDYKVVSPALRAVGNIVTGDDIQTQVILNCSALQSLLHLLSSPKESIKK 294
Query: 654 SILQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSL-T 712
I+ I N + + P ++ + R EAA+ + S
Sbjct: 295 EACWTISNITAGNRAQIQTVIDANIFPALI-SILQTAEFRTRKEAAWAITNATSGGSAEQ 353
Query: 713 LQMFIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKL------QRSTPRNDFCRIA 766
++ + I L L +K +V +A++G+ + +L + T N +C +
Sbjct: 354 IKYLVELGCIKPLCDLLTVMDSK---IVQVALNGLENILRLGEQEAKRNGTGINPYCALI 410
Query: 767 AKNGILLRLINTLYSLNE 784
+ L ++ N+
Sbjct: 411 EEAYGLDKIEFLQSHENQ 428
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 1e-11
Identities = 72/515 (13%), Positives = 156/515 (30%), Gaps = 156/515 (30%)
Query: 971 SDQVRPLLSLLEKEPPSRHFSGQLDYVRHVPGMERHESILPLLHASNDKKTNG------- 1023
D + +LS ++D++ + L L K+
Sbjct: 39 QDMPKSILS-----------KEEIDHIIMSK--DAVSGTLRLFWTLLSKQEEMVQKFVEE 85
Query: 1024 ----ELDFLMAEFAE------------VSGRGRENGNLDSTPKLSHKTATKKMGTLSSNE 1067
FLM+ + R R + K + + + L
Sbjct: 86 VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY-NVSRLQPYLKL---- 140
Query: 1068 GAASMSGIVSQTASGVLSGSGVLNARPGSATSSGLLSH-MV----STLNADVAREYLEKV 1122
+ A +L RP +L ++ + + DV Y KV
Sbjct: 141 ----------RQA--------LLELRPAK----NVLIDGVLGSGKTWVALDVCLSY--KV 176
Query: 1123 ADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPILLKCVNHLSTDPNCLENLQRAD 1182
++F +K+ +++L L ++ +I+P + +H S + ++Q
Sbjct: 177 -QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS-DHSSNIKLRIHSIQ--A 232
Query: 1183 AIKYLIPNLDLKDGHLVSLI------HSEVLHALFNL-CKI--------------NKRRQ 1221
++ L+ + ++ L+ +++ +A FNL CKI
Sbjct: 233 ELRRLLKSKPYEN----CLLVLLNVQNAKAWNA-FNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 1222 EQAAEN---GIIPH-----LMHFI-MSDSPLKQYAL---PLLCDMAHASRNSREQLRAHG 1269
+ ++ + P L+ ++ L + L P + S
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES----------- 336
Query: 1270 GLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQAL--LKKDAVQKLVKFFQSC--- 1324
+ L +N W D + +E +L L+ +K+ F
Sbjct: 337 -IRDGLATWDN--WKHVNCDKL---------TTIIESSLNVLEPAEYRKM---FDRLSVF 381
Query: 1325 PEPHFVHILEPFLKII-TKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKL-----I 1378
P HI L +I + + + VN L + +++ + + L +
Sbjct: 382 PPS--AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL 439
Query: 1379 KAVYEHHPRPKQLIVENDLPQKLQN--LIEERRDG 1411
+ Y H + ++ ++P+ + LI D
Sbjct: 440 ENEYALH---RSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 1e-10
Identities = 104/750 (13%), Positives = 203/750 (27%), Gaps = 214/750 (28%)
Query: 220 YELQPMPALFR-IVQDERPPIPESLS-PDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277
+E ++ I+ ++ D+ D + K+ + ++
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKE-----EIDHIIMSK----- 58
Query: 278 RRALQSSLRHSGTMRNVEENGSADAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAA 337
A+ +LR T+ + +E Q E + + + + E P+
Sbjct: 59 -DAVSGTLRLFWTLLSKQEEMV----------QKFVEEVLRINYKFLMSPIKTEQRQPSM 107
Query: 338 ---THLSKSDKEHSSNGNLAEERVENPED-----EPLSDQVPT--LAIHEMSLVQTGSGR 387
++ + D+ ++ N A+ V + + L + P + I + GSG
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV----LGSG- 162
Query: 388 LPSNKITATNDQSQLQEITNTSDKDEML-IN-GETQSPES---RRKNLDSKHGGKGTSIS 442
K D ++ D ++ +N SPE+ + L + TS S
Sbjct: 163 ----KTWVALDVCLSYKVQCKMD-FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 443 VDNKSFGFSPRTDNNSLQKAVKTSATVGGNELSR-FSDTPGDASL---DDLFHPLEKSLE 498
+ + +S+Q EL R P + L ++ +
Sbjct: 218 ----DHSSNIKLRIHSIQ-----------AELRRLLKSKPYENCLLVLLNVQNA------ 256
Query: 499 DRAAEA--------STSASASSSHVNQSHAAVADTGKNDLATKLRATIAQKQMENEMGQT 550
+A A T+ V D T + + M T
Sbjct: 257 -KAWNAFNLSCKILLTTRFKQ----------VTDFLSAATTTHIS------LDHHSMTLT 299
Query: 551 NGSGGDLFRLMIGVLKDDVIDIDGLVFDEKLPAE--NLFPLQAVEFSRLV--GSLRPDES 606
L + D LP E P + + + G D
Sbjct: 300 PDEVKSLLLKYLDCRPQD------------LPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 607 EDAIVSACQKLIAIF--HQRPG-QKQFFVTQHGLLPLMELLELPQTRVICSILQLINQIV 663
+ +I P ++ F S+
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDR-------------------LSV-------- 380
Query: 664 KDNSDFQENACLVGLIPV-VMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFIACRGI 722
F +A IP ++ D + M + +L + S + Q + I
Sbjct: 381 -----FPPSA----HIPTILLSLIWFDVIKSDVMV---VVNKLHKYSLVEKQPKESTISI 428
Query: 723 P----VLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLINT 778
P L LE +YA +R +V + + ++ +D +
Sbjct: 429 PSIYLELKVKLENEYALHRSIV--------DHYNIPKTFDSDDLIPPYLDQYFYSHIG-- 478
Query: 779 LYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPLTLTDQADGVKVRH 838
+ L R LDF F + K+RH
Sbjct: 479 -HHLKNIEH------------PERMTLFRMVFLDFR---FLEQ-------------KIRH 509
Query: 839 GMIDHPLSTGTQEPSRASTSHSQRSDVNQSEPRFLATDNDRSQSPNGVLD--ATVASKL- 895
T + S ++ + +P D + N +LD + L
Sbjct: 510 --------DSTAWNASGSILNTL-QQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLI 560
Query: 896 -SDSTLLEKNANLATKEPSVAMSKERDLDR 924
S T L + A L ++ ++ + + R
Sbjct: 561 CSKYTDLLRIA-LMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 4e-10
Identities = 99/719 (13%), Positives = 201/719 (27%), Gaps = 225/719 (31%)
Query: 38 LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS-LKTRSHLHII- 95
+D E G + + +D+ + ++ + N + K++ S L HII
Sbjct: 7 MDFETG------EHQYQY---KDILSVFED-AFVDNFDCKDVQDMPKSILSKEEIDHIIM 56
Query: 96 ---------------LEYVENGS---LANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
L E + +++ N + + + +Y+ +
Sbjct: 57 SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 138 QGVIHRDI---------KGANILTTKEGLVKLADFGVATKLTEADVNTHSVVG---TPYW 185
+ ++ D + L ++ L++L +V V+G T W
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP--------AKNVLIDGVLGSGKT--W 165
Query: 186 MAPEVIEMSGV-CAASD--IW-SVG-CTVIELLTCVPPYYELQPMPALFRIV-------Q 233
+A +V V C W ++ C E + L+ + L +
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV--------LEMLQKLLYQIDPNWTSRS 217
Query: 234 DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLL-----SHPWIQN-----CRRALQS 283
D I + I LR+ K +P LL + N C+ L
Sbjct: 218 DHSSNIKLRIH-SIQAELRRLLK----SKPYENCLLVLLNVQNAKAWNAFNLSCKILL-- 270
Query: 284 SLRHSGTMRNVE----ENGSADAEIPSEDNQSAGESLSAPKAEAFETGSRKELLSPAATH 339
T R + + + I + + K LL
Sbjct: 271 ------TTRFKQVTDFLSAATTTHISLDHHS-----------MTLTPDEVKSLLL-KYLD 312
Query: 340 LSKSDKEHSSNGNLAEERVE-NPEDEPLSDQVPTLAIHEMSLVQTGSGRLPSNKITATND 398
D L E + NP + S++ + + AT D
Sbjct: 313 CRPQD--------LPREVLTTNP-----------RRL---SII----AESIRDGL-ATWD 345
Query: 399 QSQLQEITNTSDKDEMLINGETQSPESRRKNLDSKHGGKGTSISVDNKSFGFSPRTDNNS 458
+ + E +N P RK D +SV
Sbjct: 346 NWKHVNCDKLTTIIESSLN--VLEPAEYRKMFD--------RLSV--------------- 380
Query: 459 LQKAVKTSATVGGNELSRF---SDTPGDASLDDLFHPLEKSLEDRAAEASTSASASSSHV 515
+ + LS + + H + SL ++ + ST S
Sbjct: 381 FPPSAHIPTIL----LSLIWFDVIKSDVMVVVNKLH--KYSLVEKQPKEST----ISIP- 429
Query: 516 NQSHAAVADTGKNDLATKLRATIAQK-QMENEMGQTNGSGGDLFRLMIGVLKDDVID--I 572
+ +L+ + + + + D + + DD+I +
Sbjct: 430 -------------SIYLELKVKLENEYALHRSI-------VDHYNIPKTFDSDDLIPPYL 469
Query: 573 DGLVF-------DEKLPAE--NLFPLQAVEFSRLVGSLRPDESEDAIVSACQKLIAIFHQ 623
D + E LF + ++F L +R D + +A ++ Q
Sbjct: 470 DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTA---WNASGSILNTLQQ 526
Query: 624 RPGQKQFFVTQHG-----LLPLMELLELPQTRVICS----ILQLINQIVKDNSDFQENA 673
K + + +++ L + +ICS +L++ ++ ++ E A
Sbjct: 527 LKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIA--LMAEDEAIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 4e-09
Identities = 98/618 (15%), Positives = 172/618 (27%), Gaps = 200/618 (32%)
Query: 542 QMENEMGQTNGSGGDLFRLMIGVLKDDVI-DID-GLVFDEKLPAENLFPLQAVEFSRLVG 599
M+ E G+ D+ + V +D + + D V D L E ++
Sbjct: 6 HMDFETGEHQYQYKDI----LSVFEDAFVDNFDCKDVQDMPKSI-----LSKEEIDHIIM 56
Query: 600 SLRPDESEDAIVSACQKLIAIFHQRPGQ--KQFFVTQHGLLP----LMELL--ELPQTRV 651
S D VS +L + + ++F L LM + E Q +
Sbjct: 57 S--KDA-----VSGTLRLFWTLLSKQEEMVQKFVEE--VLRINYKFLMSPIKTEQRQPSM 107
Query: 652 ICSI-LQLINQIVKDNSDFQE------------NACLVGLIP---VV---M-GF------ 685
+ + ++ +++ DN F + L+ L P V+ + G
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 686 --AVPDRPREVRMEAAYF----------------LQQLCQ--SSSLTLQMFIACRGIPVL 725
+ +M+ F LQ+L + T + + I +
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN-IKLR 226
Query: 726 VGFLEA---DYAKYREMVH--LAIDGMW-----QVFKLQRSTPRNDFCRIAAKNGILLRL 775
+ ++A K + + L + + F L C+I L
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS--------CKI---------L 269
Query: 776 INTLYSLNEATRLASISVGGGFPGDGL-AERPRSGQLDFSHPIFTQSET----------- 823
+ T TR ++ D L A LD T E
Sbjct: 270 L-T-------TRFKQVT-------DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 824 PLTLTDQADGVKVRH-GMI-----DHP-LSTGTQEPSRASTSHSQRSDVNQSEP-----R 871
P L + R +I D + + + S +N EP
Sbjct: 315 PQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
Query: 872 F--LATDNDRSQSPNGVL-----------DATVASKLSDSTLLEKNANLATKE-PSVAMS 917
F L+ + P +L V +KL +L+EK +T PS+ +
Sbjct: 375 FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE 434
Query: 918 KERDLDRWKFDPSRTEIDLRQQRIASAVNRTSIDKPPKSPEGASN------GFPTTTTQS 971
+ L+ E L + + + D P G +
Sbjct: 435 LKVKLEN--------EYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH 486
Query: 972 DQVRPLLSLLEKEPPSRHFSGQLDY------VRHV-PGMERHESILPLL----------- 1013
+ L ++ F LD+ +RH SIL L
Sbjct: 487 PERMTLFRMV--------F---LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC 535
Query: 1014 --HASNDKKTNGELDFLM 1029
++ N LDFL
Sbjct: 536 DNDPKYERLVNAILDFLP 553
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 2e-04
Identities = 59/390 (15%), Positives = 111/390 (28%), Gaps = 149/390 (38%)
Query: 21 MLGDEIGKGAY-GRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNI 79
+LG GK V ++ I ++L+N + + M + LL ++
Sbjct: 158 VLG--SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ-KLLYQIDPNWT 214
Query: 80 VKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVA---VYIAQVLEGLVYLH 136
+ S + +H I L ++K P+ L+ V A+
Sbjct: 215 SRSDHSSNIKLRIHSIQAE-----LRRLLKSK---PYENCLLVLLNVQNAKAWNAF---- 262
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPY--------WM-- 186
++ +LTT+ V DF A T ++ HS+ TP ++
Sbjct: 263 -------NLSCKILLTTRFKQV--TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 187 -----APEVIEMS----GVCAAS-----DIWS----VGC----TVIEL-LTCVPP----- 218
EV+ + + A S W V C T+IE L + P
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 219 -YYELQPMPALFRIVQDERPPIPESL---------SPDITDFLRQCFKK----------- 257
+ L ++F IP L D+ + + K
Sbjct: 374 MFDRL----SVFP----PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425
Query: 258 --------DARQRPDA-----KTLLSH--------------PWI------------QNCR 278
+ + + + ++++ H P++ +N
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE 485
Query: 279 RA---------------LQSSLRHSGTMRN 293
L+ +RH T N
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWN 515
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 3e-04
Identities = 43/357 (12%), Positives = 91/357 (25%), Gaps = 121/357 (33%)
Query: 9 AF-HKSKTL----DNKYMLGDEIGKGAYGRVY-----KGLDLENGD--FVAIKQVSLENI 56
AF K L + + D + + L + + +++
Sbjct: 261 AFNLSCKILLTTRFKQ--VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318
Query: 57 AQEDLNIIMQEIDLLKNL--NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPN--- 111
+E L + + ++ + + II SL N+++P
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII-----ESSL-NVLEPAEYR 372
Query: 112 ----KFGPFPESLVAVYI-AQVLEGL-------------VYLHEQGVIHRDIKGANILTT 153
+ FP S +I +L + LH+ ++ +
Sbjct: 373 KMFDRLSVFPPS---AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ--------P 421
Query: 154 KEGLVKLADFGVATKLT-EADVNTHSVV---------------GTP----YW-------- 185
KE + + + K+ E + H + P Y+
Sbjct: 422 KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHL 481
Query: 186 ----MAPEVIEMSG-----------VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFR 230
+ + S W+ +++ L + Y
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP--------Y 533
Query: 231 IVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRH 287
I ++ P E L I DFL + + L+ L+ +L
Sbjct: 534 ICDND--PKYERLVNAILDFLPKI----------EENLICSK----YTDLLRIALMA 574
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 1e-11
Identities = 47/304 (15%), Positives = 93/304 (30%), Gaps = 17/304 (5%)
Query: 1100 SGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPP 1159
+G L MV+ LN ++L D L A + K + + L +
Sbjct: 275 AGGLQKMVALLNKTNV-KFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYE 333
Query: 1160 ILLK----CVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCK 1215
LL + LS + + A ++ L +L LV L L NL
Sbjct: 334 KLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQ----NCLWTLRNLSD 389
Query: 1216 INKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVY 1274
+++ G++ L+ + SD + A +L ++ + ++ + GG++
Sbjct: 390 AATKQEGME---GLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEAL 446
Query: 1275 LNLLENEVWSVTALDSIAVCLAH----DNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFV 1330
+ + + L H D + A+ + +VK +
Sbjct: 447 VRTVLRAGDREDITEPAICALRHLTSRHQDAEMAQNAVRLHYGLPVVVKLLHPPSHWPLI 506
Query: 1331 HILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQ 1390
++ + + L G P L+ L + +
Sbjct: 507 KATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRME 566
Query: 1391 LIVE 1394
IVE
Sbjct: 567 EIVE 570
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 3e-06
Identities = 35/225 (15%), Positives = 74/225 (32%), Gaps = 23/225 (10%)
Query: 1197 HLVSLIHSE-------VLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQ--YA 1247
L L++ E + L K R ++ ++ + + + ++
Sbjct: 154 ELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCT 213
Query: 1248 LPLLCDMAHASRNSREQLRAHGGLDVYLNLLENE-----VWSVTALDSIAVCLAHDNDNR 1302
L +++H R + GG+ +N+L + ++T L + L +
Sbjct: 214 SGTLHNLSH-HREGLLAIFKSGGIPALVNMLGSPVDSVLFHAITTLHN----LLLHQEGA 268
Query: 1303 KVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVN-GLTPLLIA 1361
K A+ +QK+V F+ I L+I+ ++ + + + G L+
Sbjct: 269 K--MAVRLAGGLQKMVALLNK-TNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVN 325
Query: 1362 RLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIE 1406
+ L + V K IVE Q L +
Sbjct: 326 IMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLT 370
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 4e-05
Identities = 39/307 (12%), Positives = 99/307 (32%), Gaps = 53/307 (17%)
Query: 1099 SSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEP 1158
++ + + LN + + + K A ++ + ++ + + + M S ++S + +
Sbjct: 148 ATRAIPELTKLLNDED-QVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTND 206
Query: 1159 PILLKCV----NHLSTDPNCLENLQRADAIKYLI-----PNLDLKD-------------- 1195
+C ++LS L + ++ I L+ P +
Sbjct: 207 VETARCTSGTLHNLSHHREGLLAIFKSGGIPALVNMLGSPVDSVLFHAITTLHNLLLHQE 266
Query: 1196 ------------GHLVSLIHSE-------VLHALFNLCKINKRRQEQAAENGIIPHLMHF 1236
+V+L++ L L N+ + +G L++
Sbjct: 267 GAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNI 326
Query: 1237 IMSDSP--LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVC 1294
+ + + L +L ++ S N + + GG+ L + S + +
Sbjct: 327 MRTYTYEKLLWTTSRVLKVLSVCSSN-KPAIVEAGGMQALGLHLTDP--SQRLVQNCLWT 383
Query: 1295 LAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAV-- 1352
L + +D + + + LV+ S L +T ++ N +
Sbjct: 384 LRNLSDAA--TKQEGMEGLLGTLVQLLGSDDINVVTCAAG-ILSNLTCNNYKNKMMVCQV 440
Query: 1353 NGLTPLL 1359
G+ L+
Sbjct: 441 GGIEALV 447
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 8e-05
Identities = 24/137 (17%), Positives = 42/137 (30%), Gaps = 21/137 (15%)
Query: 1164 CVNHLSTDPNCLENLQRADAIKYLI------------------PNLDLKDGHLVSLIHSE 1205
+ +L+ P L+ AI L+ +G + I
Sbjct: 512 LIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEA 571
Query: 1206 VLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQ 1264
AL L + R IP + + S +++ A +LC++A E
Sbjct: 572 CTGALHILARDIHNRI-VIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEA-AEA 629
Query: 1265 LRAHGGLDVYLNLLENE 1281
+ A G LL +
Sbjct: 630 IEAEGATAPLTELLHSR 646
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 24/137 (17%), Positives = 46/137 (33%), Gaps = 5/137 (3%)
Query: 596 RLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSI 655
LV +R E + + +++ + K V G+ L L P R++ +
Sbjct: 322 ALVNIMRTYTYEKLLWTTS-RVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNC 380
Query: 656 LQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQM 715
L + + + + GL+ ++ + V AA L L ++ M
Sbjct: 381 LWTLRNLSDAATKQEGME---GLLGTLVQL-LGSDDINVVTCAAGILSNLTCNNYKNKMM 436
Query: 716 FIACRGIPVLVGFLEAD 732
GI LV +
Sbjct: 437 VCQVGGIEALVRTVLRA 453
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 20/136 (14%), Positives = 45/136 (33%), Gaps = 2/136 (1%)
Query: 595 SRLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICS 654
S +V +++ + L + H R G G+ L+ +L P V+
Sbjct: 195 SAIVRTMQNTNDVETARCTSGTLHNLSHHREG-LLAIFKSGGIPALVNMLGSPVDSVLFH 253
Query: 655 ILQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQ 714
+ ++ ++ + L G + ++ + LQ L + +
Sbjct: 254 AITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNV-KFLAITTDCLQILAYGNQESKL 312
Query: 715 MFIACRGIPVLVGFLE 730
+ +A G LV +
Sbjct: 313 IILASGGPQALVNIMR 328
|
| >4db8_A Armadillo-repeat protein; solenoid repeat, de novo protein; 2.50A {Synthetic construct} Length = 252 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 40/246 (16%), Positives = 81/246 (32%), Gaps = 23/246 (9%)
Query: 1197 HLVSLIHSEVLH-------ALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYAL 1248
+ ++S+ + + + + + G +P L+ + S + + Q AL
Sbjct: 16 QMTQQLNSDDMQEQLSATRKFSQILSDGNEQIQAVIDAGALPALVQLLSSPNEQILQEAL 75
Query: 1249 PLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCL---AHDNDNRKVE 1305
L ++A + + G L + LL + + L L A + +
Sbjct: 76 WALSNIASGGNEQIQAVIDAGALPALVQLLSSP--NEQILQEALWALSNIASGGNEQI-- 131
Query: 1306 QALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDH 1365
QA++ A+ LV+ S E L I + + + G P L+ L
Sbjct: 132 QAVIDAGALPALVQLLSSPNEQILQEALWALSNIASGGNEQIQAVIDAGALPALVQLLSS 191
Query: 1366 QDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMAT 1425
+ L + + KQ + E +KL+ L +++ A
Sbjct: 192 PNEQILQEALWALSNIASGGNEQKQAVKEAGALEKLEQLQSH--------ENEKIQKEAQ 243
Query: 1426 SLLKAL 1431
L+ L
Sbjct: 244 EALEKL 249
|
| >4db8_A Armadillo-repeat protein; solenoid repeat, de novo protein; 2.50A {Synthetic construct} Length = 252 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 24/112 (21%), Positives = 47/112 (41%), Gaps = 5/112 (4%)
Query: 1171 DPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGII 1230
++ + A A+ L+ L L + L E L AL N+ + + + G +
Sbjct: 127 GNEQIQAVIDAGALPALV-QL-LSSPNEQIL--QEALWALSNIASGGNEQIQAVIDAGAL 182
Query: 1231 PHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENE 1281
P L+ + S + + Q AL L ++A ++ ++ G L+ L +E
Sbjct: 183 PALVQLLSSPNEQILQEALWALSNIASGGNEQKQAVKEAGALEKLEQLQSHE 234
|
| >3oqs_A Importin subunit alpha-2; importin alpha, karyopherin alpha, nuclear localisation SIGN recognition, chloride intracellular channel 4, CLIC4 NLS; 2.00A {Mus musculus} PDB: 3rz9_A 3rzx_A 1q1s_C 1q1t_C 3tpo_A 3knd_A 1ejy_I 1iq1_C 1ejl_I 1pjn_B 1pjm_B 3q5u_A 3fey_C 3fex_C 1ial_A 1y2a_C 3btr_C 3l3q_A* 3ve6_A 2c1m_A ... Length = 510 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 2e-10
Identities = 44/252 (17%), Positives = 82/252 (32%), Gaps = 9/252 (3%)
Query: 1168 LSTDPN-CLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAE 1226
LS + ++N+ RA I + L D S I E AL N+ + + +
Sbjct: 85 LSREKQPPIDNIIRAGLIPKFVSFLGKTD---CSPIQFESAWALTNIASGTSEQTKAVVD 141
Query: 1227 NGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSV 1285
G IP + + S + + A+ L ++A R+ + HG +D L LL S
Sbjct: 142 GGAIPAFISLLASPHAHISEQAVWALGNIAGDGSAFRDLVIKHGAIDPLLALLAVPDLST 201
Query: 1286 TALDSIAVCLAH-DNDNR-KVEQALLK--KDAVQKLVKFFQSCPEPHFVHILEPFLKIIT 1341
A + N R K L + + LV+ +
Sbjct: 202 LACGYLRNLTWTLSNLCRNKNPAPPLDAVEQILPTLVRLLHHNDPEVLADSCWAISYLTD 261
Query: 1342 KSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKL 1401
+ + G+ P L+ L + L+ I + Q +++
Sbjct: 262 GPNERIEMVVKKGVVPQLVKLLGATELPIVTPALRAIGNIVTGTDEQTQKVIDAGALAVF 321
Query: 1402 QNLIEERRDGQR 1413
+L+ + +
Sbjct: 322 PSLLTNPKTNIQ 333
|
| >3oqs_A Importin subunit alpha-2; importin alpha, karyopherin alpha, nuclear localisation SIGN recognition, chloride intracellular channel 4, CLIC4 NLS; 2.00A {Mus musculus} PDB: 3rz9_A 3rzx_A 1q1s_C 1q1t_C 3tpo_A 3knd_A 1ejy_I 1iq1_C 1ejl_I 1pjn_B 1pjm_B 3q5u_A 3fey_C 3fex_C 1ial_A 1y2a_C 3btr_C 3l3q_A* 3ve6_A 2c1m_A ... Length = 510 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 8e-08
Identities = 32/193 (16%), Positives = 66/193 (34%), Gaps = 7/193 (3%)
Query: 594 FSRLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVIC 653
+LV L + A + + I Q Q + L LL P+T +
Sbjct: 276 VPQLV-KLLGATELPIVTPALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLTNPKTNIQK 334
Query: 654 SILQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSL-T 712
++ I D + GL+P ++ + + + EAA+ + ++
Sbjct: 335 EATWTMSNITAGRQDQIQQVVNHGLVPFLV-GVLSKADFKTQKEAAWAITNYTSGGTVEQ 393
Query: 713 LQMFIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPR-NDFCRIAAKNGI 771
+ + C I L+ L A K ++ + +D + +F+ + + G
Sbjct: 394 IVYLVHCGIIEPLMNLLSAKDTK---IIQVILDAISNIFQAAEKLGETEKLSIMIEECGG 450
Query: 772 LLRLINTLYSLNE 784
L ++ NE
Sbjct: 451 LDKIEALQRHENE 463
|
| >3oqs_A Importin subunit alpha-2; importin alpha, karyopherin alpha, nuclear localisation SIGN recognition, chloride intracellular channel 4, CLIC4 NLS; 2.00A {Mus musculus} PDB: 3rz9_A 3rzx_A 1q1s_C 1q1t_C 3tpo_A 3knd_A 1ejy_I 1iq1_C 1ejl_I 1pjn_B 1pjm_B 3q5u_A 3fey_C 3fex_C 1ial_A 1y2a_C 3btr_C 3l3q_A* 3ve6_A 2c1m_A ... Length = 510 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 42/325 (12%), Positives = 94/325 (28%), Gaps = 26/325 (8%)
Query: 1096 SATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNR 1155
T + + +V +N++ L+ ++ + L+ + +
Sbjct: 52 QGTVNWSVEDIVKGINSNNLESQLQATQAARKLLSREKQPPIDNIIRAGLIPKFVSFLGK 111
Query: 1156 IEPPILLKCV-----NHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHAL 1210
+ + N S + + AI I L H I + + AL
Sbjct: 112 TDCSPIQFESAWALTNIASGTSEQTKAVVDGGAIPAFISLLASPHAH----ISEQAVWAL 167
Query: 1211 FNLCKINKRRQEQAAENGIIPHLMHFIMSDSP------LKQYALPLLCDMAHASRNSREQ 1264
N+ ++ ++G I L+ + + L ++ +
Sbjct: 168 GNIAGDGSAFRDLVIKHGAIDPLLALLAVPDLSTLACGYLRNLTWTLSNLCRNKNPAPPL 227
Query: 1265 LRAHGGLDVYLNLLENE-----VWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVK 1319
L + LL + S A+ + N+ + ++KK V +LVK
Sbjct: 228 DAVEQILPTLVRLLHHNDPEVLADSCWAISYLT---DGPNERI---EMVVKKGVVPQLVK 281
Query: 1320 FFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIK 1379
+ P L I+T + + G + + L + + +
Sbjct: 282 LLGATELPIVTPALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLTNPKTNIQKEATWTMS 341
Query: 1380 AVYEHHPRPKQLIVENDLPQKLQNL 1404
+ Q +V + L L +
Sbjct: 342 NITAGRQDQIQQVVNHGLVPFLVGV 366
|
| >3oqs_A Importin subunit alpha-2; importin alpha, karyopherin alpha, nuclear localisation SIGN recognition, chloride intracellular channel 4, CLIC4 NLS; 2.00A {Mus musculus} PDB: 3rz9_A 3rzx_A 1q1s_C 1q1t_C 3tpo_A 3knd_A 1ejy_I 1iq1_C 1ejl_I 1pjn_B 1pjm_B 3q5u_A 3fey_C 3fex_C 1ial_A 1y2a_C 3btr_C 3l3q_A* 3ve6_A 2c1m_A ... Length = 510 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 27/229 (11%), Positives = 76/229 (33%), Gaps = 19/229 (8%)
Query: 1102 LLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPIL 1161
L ++ + +V + + + + ++ +L ++ E PI+
Sbjct: 236 TLVRLLHHNDPEVLAD----SCWAISYLTDGPNERIEMVVKKGVVPQLVKLLGATELPIV 291
Query: 1162 LKCV----NHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKIN 1217
+ N ++ + + A A+ L + I E + N+
Sbjct: 292 TPALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLTNPKTN----IQKEATWTMSNITAGR 347
Query: 1218 KRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMA-HASRNSREQLRAHGGLDVYL 1275
+ + +Q +G++P L+ + ++ A + + + L G ++ +
Sbjct: 348 QDQIQQVVNHGLVPFLVGVLSKADFKTQKEAAWAITNYTSGGTVEQIVYLVHCGIIEPLM 407
Query: 1276 NLLENEVWSV-----TALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVK 1319
NLL + + A+ +I + K+ + + + K+
Sbjct: 408 NLLSAKDTKIIQVILDAISNIFQAAEKLGETEKLSIMIEECGGLDKIEA 456
|
| >3oqs_A Importin subunit alpha-2; importin alpha, karyopherin alpha, nuclear localisation SIGN recognition, chloride intracellular channel 4, CLIC4 NLS; 2.00A {Mus musculus} PDB: 3rz9_A 3rzx_A 1q1s_C 1q1t_C 3tpo_A 3knd_A 1ejy_I 1iq1_C 1ejl_I 1pjn_B 1pjm_B 3q5u_A 3fey_C 3fex_C 1ial_A 1y2a_C 3btr_C 3l3q_A* 3ve6_A 2c1m_A ... Length = 510 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 28/178 (15%), Positives = 62/178 (34%), Gaps = 8/178 (4%)
Query: 604 DESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSILQLINQIV 663
+ + +C + + + + V + + L++LL + ++ L+ I IV
Sbjct: 243 HNDPEVLADSCWAISYLTDGPNERIEMVVKKGVVPQLVKLLGATELPIVTPALRAIGNIV 302
Query: 664 KDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFIACRGIP 723
+ + G + V + + ++ EA + + + +Q + +P
Sbjct: 303 TGTDEQTQKVIDAGALAVFPSL-LTNPKTNIQKEATWTMSNITAGRQDQIQQVVNHGLVP 361
Query: 724 VLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGILLRLINTLYS 781
LVG L K ++ AI S + GI+ L+N L +
Sbjct: 362 FLVGVLSKADFKTQKEAAWAITNYT-------SGGTVEQIVYLVHCGIIEPLMNLLSA 412
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-09
Identities = 57/374 (15%), Positives = 102/374 (27%), Gaps = 71/374 (18%)
Query: 1100 SGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPP 1159
+G L MV+ LN ++L D L A + K + + L +
Sbjct: 142 AGGLQKMVALLNKTNV-KFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYE 200
Query: 1160 ILLK----CVNHLSTDPNCLENLQRADAIKYLIPNLDLKDG------------------- 1196
LL + LS + + A ++ L +L
Sbjct: 201 KLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATK 260
Query: 1197 ---------HLVSLIHS-------EVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSD 1240
LV L+ S L NL N + + + G I L+ ++
Sbjct: 261 QEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRA 320
Query: 1241 SPLKQ------YALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVC 1294
+ AL L + ++ +R H GL V + LL ++ +
Sbjct: 321 GDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLI 380
Query: 1295 --LAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAV 1352
LA N L ++ A+ +LV+ + + +
Sbjct: 381 RNLALCPANH---APLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVE 437
Query: 1353 NGLTPL--LIARLDHQDAIARLNLLKLI----------------KAVYE--HHPRPKQLI 1392
L L + ++ I LN + L + E + I
Sbjct: 438 GCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAI 497
Query: 1393 VENDLPQKLQNLIE 1406
L L+
Sbjct: 498 EAEGATAPLTELLH 511
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-08
Identities = 35/225 (15%), Positives = 73/225 (32%), Gaps = 23/225 (10%)
Query: 1197 HLVSLIHSE-------VLHALFNLCKINKRRQEQAAENGIIPHLMHFIMS--DSPLKQYA 1247
L L++ E + L K R ++ ++ + + D +
Sbjct: 21 ELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCT 80
Query: 1248 LPLLCDMAHASRNSREQLRAHGGLDVYLNLLENE-----VWSVTALDSIAVCLAHDNDNR 1302
L +++H R + GG+ + +L + +++T L + L +
Sbjct: 81 AGTLHNLSH-HREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHN----LLLHQEGA 135
Query: 1303 KVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVN-GLTPLLIA 1361
K A+ +QK+V F+ I L+I+ ++ + + + G L+
Sbjct: 136 K--MAVRLAGGLQKMVALLNK-TNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVN 192
Query: 1362 RLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIE 1406
+ L + V K IVE Q L +
Sbjct: 193 IMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLT 237
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-08
Identities = 32/230 (13%), Positives = 77/230 (33%), Gaps = 18/230 (7%)
Query: 1209 ALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRA 1267
A+ NL + IP L + + + A ++ ++ + +R+
Sbjct: 1 AVVNLINYQD---DAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRS 57
Query: 1268 HGGLDVYLNLLENEVWSVTALDSIAVCL---AHDNDNRKVEQALLKKDAVQKLVKFFQSC 1324
+ + ++N V A L +H + A+ K + LVK S
Sbjct: 58 PQMVSAIVRTMQNTN-DVETARCTAGTLHNLSHHREGL---LAIFKSGGIPALVKMLGSP 113
Query: 1325 PEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEH 1384
+ + + ++ + + G ++A L+ + ++ +
Sbjct: 114 VDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYG 173
Query: 1385 HPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHIN 1434
+ K +I+ + PQ L N++ R+ + + +LK L +
Sbjct: 174 NQESKLIILASGGPQALVNIM-------RTYTYEKLLWTTSRVLKVLSVC 216
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 6e-06
Identities = 39/353 (11%), Positives = 107/353 (30%), Gaps = 36/353 (10%)
Query: 1097 ATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRI 1156
S ++S +V T+ E A L + + + L +M
Sbjct: 55 MRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSH-HREGLLAIFKSGGIPALVKMLGSP 113
Query: 1157 EPPILLKCV----NHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFN 1212
+L + N L ++ A ++ ++ L+ + + L
Sbjct: 114 VDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTN----VKFLAITTDCLQI 169
Query: 1213 LCKINKRRQEQAAENGIIPHLMHFIMSDSP--LKQYALPLLCDMAHASRNSREQLRAHGG 1270
L N+ + +G L++ + + + L +L ++ +++ + GG
Sbjct: 170 LAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSV-CSSNKPAIVEAGG 228
Query: 1271 LDVYLNLLENEVWSVTALDSIAVCL---AHDNDNRKVEQALLKKDAVQKLVKFFQSCPEP 1327
+ L + S + + L + ++ + + LV+ S
Sbjct: 229 MQALGLHLTDP--SQRLVQNCLWTLRNLSDAATKQEGMEG-----LLGTLVQLLGSDDIN 281
Query: 1328 HFVHILEPFLKIITKSSRINTTL-----AVNGLTPLLIARLDHQDAIAR-LNLLKLIKAV 1381
L +T ++ N + + L ++ D +D + L+ + +
Sbjct: 282 VVTCAAG-ILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSR 340
Query: 1382 YEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHIN 1434
++ + + + + L+ + + L++ L +
Sbjct: 341 HQEAEMAQNAVRLHYGLPVVVKLL-------HPPSHWPLIKATVGLIRNLALC 386
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 7e-06
Identities = 24/136 (17%), Positives = 46/136 (33%), Gaps = 5/136 (3%)
Query: 597 LVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSIL 656
LV +R E + + +++ + K V G+ L L P R++ + L
Sbjct: 190 LVNIMRTYTYEKLLWTTS-RVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCL 248
Query: 657 QLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMF 716
+ + + + GL+ ++ + V AA L L ++ M
Sbjct: 249 WTLRNLSDAATKQEGME---GLLGTLVQL-LGSDDINVVTCAAGILSNLTCNNYKNKMMV 304
Query: 717 IACRGIPVLVGFLEAD 732
GI LV +
Sbjct: 305 CQVGGIEALVRTVLRA 320
|
| >3nmz_A APC variant protein; protein-protein complex, armadillo repeats, cell adhesion-CE complex; 3.01A {Homo sapiens} Length = 458 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 4e-09
Identities = 49/288 (17%), Positives = 99/288 (34%), Gaps = 30/288 (10%)
Query: 1167 HLSTDPNCLENLQRADAIKYLI-------PNLDLKDGHLVSLIHSEVLHALFNLCKINKR 1219
LS D + ++ + L + H + AL NL +
Sbjct: 174 KLSFDEEHRHAMNELGGLQAIAELLQVDCEMYGLTNDHYSITLRRYAGMALTNLTFGDVA 233
Query: 1220 RQEQ-AAENGIIPHLMHFIMSDSP-LKQYALPLLCDMA-HASRNSREQLRAHGGLDVYLN 1276
+ + G + L+ + S+S L+Q +L +++ A NS++ LR G + +
Sbjct: 234 NKATLCSMKGCMRALVAQLKSESEDLQQVIASVLRNLSWRADVNSKKTLREVGSVKALME 293
Query: 1277 LL-ENEVWSV--TALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHIL 1333
E + S + L ++ AH +N+ A+ LV + + + I+
Sbjct: 294 CALEVKKESTLKSVLSALWNLSAHCTENKA--DICAVDGALAFLVGTLTYRSQTNTLAII 351
Query: 1334 EPFLKIITKSSRINTT-------LAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHP 1386
E I+ S + T L N L+ L N + + +P
Sbjct: 352 ESGGGILRNVSSLIATNEDHRQILRENNCLQTLLQHLKSHSLTIVSNACGTLWNLSARNP 411
Query: 1387 RPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHIN 1434
+ ++ + + L+NLI + + + + L+ L N
Sbjct: 412 KDQEALWDMGAVSMLKNLIHSKHKM--------IAMGSAAALRNLMAN 451
|
| >3nmw_A APC variant protein; ARMADIILO repeats domain, cell adhesion-cell cycle complex; 1.60A {Homo sapiens} PDB: 3nmx_A 3t7u_A 3au3_A 3qhe_A Length = 354 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 47/303 (15%), Positives = 100/303 (33%), Gaps = 56/303 (18%)
Query: 1162 LKCVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLH-------ALFNLC 1214
+ + LS D + ++ + L + + AL NL
Sbjct: 53 VCVLMKLSFDEEHRHAMNELGGLQAIAELLQVDCEMYGLTNDHYSITLRRYAGMALTNLT 112
Query: 1215 KINKR-RQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMA-HASRNSREQLRAHGGL 1271
+ + + G + L+ + S+S L+Q +L +++ A NS++ LR G +
Sbjct: 113 FGDVANKATLCSMKGCMRALVAQLKSESEDLQQVIASVLRNLSWRADVNSKKTLREVGSV 172
Query: 1272 DVYLNLLENEVWSVTALDSIAVCL----AHDNDNRKVEQALLKKDAVQKLVKFFQSCPEP 1327
+ EV + L S+ L AH +N+ A+ LV +
Sbjct: 173 KALMECA-LEVKKESTLKSVLSALWNLSAHCTENKA--DICAVDGALAFLVGTLTYRSQT 229
Query: 1328 HFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLK-LIKAVYEHHP 1386
+ + I+E + + ++ L+ DH+ + N L+ L++ + H
Sbjct: 230 NTLAIIE------------SGGGILRNVSSLIATNEDHRQILRENNCLQTLLQHLKSHSL 277
Query: 1387 RPK------------------QLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLL 1428
+ + + L+NLI + + + + L
Sbjct: 278 TIVSNACGTLWNLSARNPKDQEALWDMGAVSMLKNLIHSKHKM--------IAMGSAAAL 329
Query: 1429 KAL 1431
+ L
Sbjct: 330 RNL 332
|
| >3nmw_A APC variant protein; ARMADIILO repeats domain, cell adhesion-cell cycle complex; 1.60A {Homo sapiens} PDB: 3nmx_A 3t7u_A 3au3_A 3qhe_A Length = 354 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 22/144 (15%), Positives = 52/144 (36%), Gaps = 6/144 (4%)
Query: 1171 DPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNL---CKINKRRQEQAAEN 1227
N + A+ +L+ L + I L N+ N+ ++ EN
Sbjct: 203 TENKADICAVDGALAFLVGTLTYRSQTNTLAIIESGGGILRNVSSLIATNEDHRQILREN 262
Query: 1228 GIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSV- 1285
+ L+ + S S + A L +++ + +E L G + + NL+ ++ +
Sbjct: 263 NCLQTLLQHLKSHSLTIVSNACGTLWNLSARNPKDQEALWDMGAVSMLKNLIHSKHKMIA 322
Query: 1286 -TALDSIAVCLAHDNDNRKVEQAL 1308
+ ++ +A+ K +
Sbjct: 323 MGSAAALRNLMANRPAKYKDANIM 346
|
| >1xqr_A HSPBP1 protein; armadillo repeat, superhelical twist, chaperone; 2.10A {Homo sapiens} SCOP: a.118.1.21 PDB: 1xqs_A* Length = 296 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 27/202 (13%), Positives = 61/202 (30%), Gaps = 10/202 (4%)
Query: 593 EFSRLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLM-ELLELPQTRV 651
G + A + L + F G+ L+ LE +
Sbjct: 40 PMPPTAGEAEQAADQQEREGALELLADLCENMDNAADF-CQLSGMHLLVGRYLEAGAAGL 98
Query: 652 ICSILQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSL 711
QLI ++ + QE +G + ++ D VR++A + + L +
Sbjct: 99 RWRAAQLIGTCSQNVAAIQEQVLGLGALRKLLRLLDRDACDTVRVKALFAISCLVREQEA 158
Query: 712 TLQMFIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQRSTPRNDFCRIAAKNGI 771
L F+ G VL+ ++ K + + + + G+
Sbjct: 159 GLLQFLRLDGFSVLMRAMQQQVQKLKVKSAFLLQNLLVG--------HPEHKGTLCSMGM 210
Query: 772 LLRLINTLYSLNEATRLASISV 793
+ +L+ + + + +
Sbjct: 211 VQQLVALVRTEHSPFHEHVLGA 232
|
| >1xqr_A HSPBP1 protein; armadillo repeat, superhelical twist, chaperone; 2.10A {Homo sapiens} SCOP: a.118.1.21 PDB: 1xqs_A* Length = 296 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 27/188 (14%), Positives = 60/188 (31%), Gaps = 12/188 (6%)
Query: 1101 GLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPP- 1159
+ +V A + A L+ +Q ++ + L +L ++ +R
Sbjct: 81 SGMHLLVGRYLEAGAAGLRWRAAQLIGTCSQNVAAIQEQVLGLGALRKLLRLLDRDACDT 140
Query: 1160 ILLKCVNHLST----DPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCK 1215
+ +K + +S L R D L+ + + + + L NL
Sbjct: 141 VRVKALFAISCLVREQEAGLLQFLRLDGFSVLMRAMQQQV----QKLKVKSAFLLQNLLV 196
Query: 1216 INKRRQEQAAENGIIPHLMHFIMS-DSPLKQYALPLLCDMAHASRNSREQLRAHGGLDVY 1274
+ + G++ L+ + + SP ++ L LC + + R
Sbjct: 197 GHPEHKGTLCSMGMVQQLVALVRTEHSPFHEHVLGALCSLVTDFPQGVRECREPELG--L 254
Query: 1275 LNLLENEV 1282
LL +
Sbjct: 255 EELLRHRC 262
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 2e-07
Identities = 31/218 (14%), Positives = 76/218 (34%), Gaps = 14/218 (6%)
Query: 1221 QEQA-AENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLL 1278
Q+ A IP L + + + A ++ ++ + +R+ + + +
Sbjct: 6 QDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTM 65
Query: 1279 ENEVWSVTALDSIAVC--LAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPF 1336
+N TA + L+H + A+ K + LVK S + + +
Sbjct: 66 QNTNDVETARCTAGTLHNLSHHREGL---LAIFKSGGIPALVKMLGSPVDSVLFYAITTL 122
Query: 1337 LKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVEND 1396
++ + + G ++A L+ + ++ + + K +I+ +
Sbjct: 123 HNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASG 182
Query: 1397 LPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALHIN 1434
PQ L N++ R+ + + +LK L +
Sbjct: 183 GPQALVNIM-------RTYTYEKLLWTTSRVLKVLSVC 213
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 35/232 (15%), Positives = 74/232 (31%), Gaps = 23/232 (9%)
Query: 1197 HLVSLIHSE-------VLHALFNLCKINKRRQEQAAENGIIPHLMHFIMS--DSPLKQYA 1247
L L++ E + L K R ++ ++ + + D +
Sbjct: 18 ELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCT 77
Query: 1248 LPLLCDMAHASRNSREQLRAHGGLDVYLNLLENE-----VWSVTALDSIAVCLAHDNDNR 1302
L +++H R + GG+ + +L + +++T L + L +
Sbjct: 78 AGTLHNLSH-HREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHN----LLLHQEGA 132
Query: 1303 KVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVN-GLTPLLIA 1361
K A+ +QK+V F+ I L+I+ ++ + + + G L+
Sbjct: 133 K--MAVRLAGGLQKMVALLNK-TNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVN 189
Query: 1362 RLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEERRDGQR 1413
+ L + V K IVE Q L + +
Sbjct: 190 IMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLV 241
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 4e-06
Identities = 44/256 (17%), Positives = 82/256 (32%), Gaps = 40/256 (15%)
Query: 1100 SGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPP 1159
GLL +V L +D + A +L + K +C + L + R
Sbjct: 262 EGLLGTLVQLLGSDDINV-VTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDR 320
Query: 1160 ILLKC-----VNHLSTDPNCLENLQRADAIKYLIPNLD--LKDGHLVSLIHSEVLHALFN 1212
+ + HL++ E Q A + Y +P + L LI + V L
Sbjct: 321 EDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATV--GLIR 378
Query: 1213 LCKINKRRQEQAAENGIIPHLMHFIMSDSP-----------------------LKQYALP 1249
+ E G IP L+ ++ + +
Sbjct: 379 NLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTG 438
Query: 1250 LLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSV--TALDSIAVCLAHDNDNRKVEQA 1307
L +A N R +R + +++ LL + + ++ A + LA D + +A
Sbjct: 439 ALHILARDVHN-RIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLC-ELAQDKEAA---EA 493
Query: 1308 LLKKDAVQKLVKFFQS 1323
+ + A L + S
Sbjct: 494 IEAEGATAPLTELLHS 509
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 5e-06
Identities = 41/339 (12%), Positives = 98/339 (28%), Gaps = 60/339 (17%)
Query: 1097 ATSSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRI 1156
S ++S +V T+ E A L + + + L +M
Sbjct: 52 MRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSH-HREGLLAIFKSGGIPALVKMLGSP 110
Query: 1157 EPPILLKCV----NHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFN 1212
+L + N L ++ A ++ ++ L+ + + L
Sbjct: 111 VDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTN----VKFLAITTDCLQI 166
Query: 1213 LCKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPLLCDMAHASRNSREQLRAHGGLD 1272
L N+ + +G L++ + + + K LL + +
Sbjct: 167 LAYGNQESKLIILASGGPQALVNIMRTYTYEK-----LLWTTSRVLKV------------ 209
Query: 1273 VYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHI 1332
L+ + N+ A+++ +Q L + +
Sbjct: 210 ----------------------LSVCSSNK---PAIVEAGGMQALGLHLTDPSQRLVQNC 244
Query: 1333 LEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLI 1392
L + S + GL L+ L D ++ + ++ + K ++
Sbjct: 245 LWTLRNL---SDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMV 301
Query: 1393 VENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKAL 1431
+ + L + R+G + + + A L+ L
Sbjct: 302 CQVGGIEALVRTV------LRAGDREDITEPAICALRHL 334
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 1e-05
Identities = 25/133 (18%), Positives = 46/133 (34%), Gaps = 5/133 (3%)
Query: 597 LVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSIL 656
LV +R E + + +++ + K V G+ L L P R++ + L
Sbjct: 187 LVNIMRTYTYEKLLWTTS-RVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCL 245
Query: 657 QLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMF 716
+ + + + GL+ ++ D V AA L L ++ M
Sbjct: 246 WTLRNLSDAATKQEGME---GLLGTLVQLLGSDDIN-VVTCAAGILSNLTCNNYKNKMMV 301
Query: 717 IACRGIPVLVGFL 729
GI LV +
Sbjct: 302 CQVGGIEALVRTV 314
|
| >4db6_A Armadillo repeat protein; solenoid repeat, armadillo repeat motif, de novo protein; 1.80A {Synthetic construct} PDB: 4db9_A 4dba_A Length = 210 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 28/140 (20%), Positives = 55/140 (39%), Gaps = 19/140 (13%)
Query: 1197 HLVSLIHSE-------VLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYAL 1248
+V ++S L L + + + + G +P L+ + S + + Q AL
Sbjct: 16 QMVQQLNSPDQQELQSALRKLSQIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEAL 75
Query: 1249 PLLCDMAHASRNSREQLRAHGGLDVYLNLLENE-----VWSVTALDSIAVCLAHDNDNRK 1303
L ++A + + G L + LL + ++ AL +IA + N+
Sbjct: 76 WALSNIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEALWALSNIA---SGGNEQI- 131
Query: 1304 VEQALLKKDAVQKLVKFFQS 1323
QA++ A+ LV+ S
Sbjct: 132 --QAVIDAGALPALVQLLSS 149
|
| >4db6_A Armadillo repeat protein; solenoid repeat, armadillo repeat motif, de novo protein; 1.80A {Synthetic construct} PDB: 4db9_A 4dba_A Length = 210 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 26/118 (22%), Positives = 49/118 (41%), Gaps = 10/118 (8%)
Query: 1181 ADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSD 1240
A A+ L+ L L + I E L AL N+ + + + G +P L+ + S
Sbjct: 95 AGALPALV-QL-LSSPNEQ--ILQEALWALSNIASGGNEQIQAVIDAGALPALVQLLSSP 150
Query: 1241 SP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENE-----VWSVTALDSIA 1292
+ + Q AL L ++A ++ ++ G L+ L +E + AL+ +
Sbjct: 151 NEQILQEALWALSNIASGGNEQKQAVKEAGALEKLEQLQSHENEKIQKEAQEALEKLQ 208
|
| >4db6_A Armadillo repeat protein; solenoid repeat, armadillo repeat motif, de novo protein; 1.80A {Synthetic construct} PDB: 4db9_A 4dba_A Length = 210 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 39/218 (17%), Positives = 71/218 (32%), Gaps = 22/218 (10%)
Query: 1221 QEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLE 1279
+P ++ + S Q AL L +A + + G L + LL
Sbjct: 5 HHHHHHGSELPQMVQQLNSPDQQELQSALRKLSQIASGGNEQIQAVIDAGALPALVQLLS 64
Query: 1280 NEVWSV-----TALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILE 1334
+ + AL +IA + N+ QA++ A+ LV+ S P +
Sbjct: 65 SPNEQILQEALWALSNIA---SGGNEQI---QAVIDAGALPALVQLLSS-PNEQILQEAL 117
Query: 1335 PFLKIITKSSRINTTLAVN-GLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIV 1393
L I ++ G P L+ L + L + + KQ +
Sbjct: 118 WALSNIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEALWALSNIASGGNEQKQAVK 177
Query: 1394 ENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKAL 1431
E +KL+ L + +++ A L+ L
Sbjct: 178 EAGALEKLEQLQSHENEK--------IQKEAQEALEKL 207
|
| >4db6_A Armadillo repeat protein; solenoid repeat, armadillo repeat motif, de novo protein; 1.80A {Synthetic construct} PDB: 4db9_A 4dba_A Length = 210 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 28/149 (18%), Positives = 58/149 (38%), Gaps = 2/149 (1%)
Query: 596 RLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGLLPLMELLELPQTRVICSI 655
++V L + + SA +KL I Q Q + L L++LL P +++
Sbjct: 16 QMVQQLN-SPDQQELQSALRKLSQIASGGNEQIQAVIDAGALPALVQLLSSPNEQILQEA 74
Query: 656 LQLINQIVKDNSDFQENACLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQM 715
L ++ I ++ + G +P ++ ++ EA + L + + +Q
Sbjct: 75 LWALSNIASGGNEQIQAVIDAGALPALVQLLSSPNE-QILQEALWALSNIASGGNEQIQA 133
Query: 716 FIACRGIPVLVGFLEADYAKYREMVHLAI 744
I +P LV L + + + A+
Sbjct: 134 VIDAGALPALVQLLSSPNEQILQEALWAL 162
|
| >3now_A UNC-45 protein, SD10334P; armadillo repeat, HSP90, myosin, tetra-tricopeptide repeat, binding protein required for myosin function; 2.99A {Drosophila melanogaster} Length = 810 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 2e-06
Identities = 38/278 (13%), Positives = 90/278 (32%), Gaps = 23/278 (8%)
Query: 1163 KCVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLC--KINKRR 1220
+ +N + + + +K L+ +G H+ AL + +
Sbjct: 517 RVLNAVCGLKELRGKVVQEGGVKALLRM--ALEGTEKGKRHA--TQALARIGITINPEVS 572
Query: 1221 QEQAAENGIIPHLMHFIMSDSPLKQ--YALPLLCDMAHASRNSREQLRAHGGLDVYLNLL 1278
+I L++ + D + +L L ++A + + R+++ G+ L
Sbjct: 573 FSGQRSLDVIRPLLNLLQQDCTALENFESLMALTNLASMNESVRQRIIKEQGVSKIEYYL 632
Query: 1279 ENEVWSVT--ALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEP---HFVHIL 1333
+ +T A + + ++ + E D V+ L + E L
Sbjct: 633 MEDHLYLTRAAAQCLCNLVMSEDVIKMFEGN---NDRVKFLALLCEDEDEETATACAGAL 689
Query: 1334 EPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIV 1393
+ K LA+ +L + + + + +I + + +
Sbjct: 690 AIITSVSVKCCEK--ILAIASWLDILHTLIANPSPAVQHRGIVIILNMINAGEEIAKKLF 747
Query: 1394 ENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKAL 1431
E D+ + L L + D + +++AT L A
Sbjct: 748 ETDIMELLSGLGQLPDDTRAK-----AREVATQCLAAA 780
|
| >3now_A UNC-45 protein, SD10334P; armadillo repeat, HSP90, myosin, tetra-tricopeptide repeat, binding protein required for myosin function; 2.99A {Drosophila melanogaster} Length = 810 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 2e-05
Identities = 35/258 (13%), Positives = 83/258 (32%), Gaps = 20/258 (7%)
Query: 1164 CVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQ 1223
+ + N + ++ + P L+L +L + E L AL NL +N+ +++
Sbjct: 559 ALARIGITINPEVSFSGQRSLDVIRPLLNLLQQDCTALENFESLMALTNLASMNESVRQR 618
Query: 1224 AAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEV 1282
+ + + +++M D L + A LC++ + + + + L E+E
Sbjct: 619 IIKEQGVSKIEYYLMEDHLYLTRAAAQCLCNLVMSEDVIKMFEGNNDRVKFLALLCEDED 678
Query: 1283 WSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITK 1342
+ A+ + + E+ L + L + P P H + +
Sbjct: 679 EETATACAGALAIITSVSVKCCEKILAIASWLDILHTLIAN-PSPAVQHRGIVIILNMIN 737
Query: 1343 SSRINTTLAVN-GLTPLLIARLDHQD------------AIARLNLLKLIKAVYEHHPRPK 1389
+ + LL D +A ++I+
Sbjct: 738 AGEEIAKKLFETDIMELLSGLGQLPDDTRAKAREVATQCLAAAERYRIIERSDNA---EI 794
Query: 1390 QLIVENDLPQKLQNLIEE 1407
+ K+ +I++
Sbjct: 795 PDVFAE--NSKISEIIDD 810
|
| >3now_A UNC-45 protein, SD10334P; armadillo repeat, HSP90, myosin, tetra-tricopeptide repeat, binding protein required for myosin function; 2.99A {Drosophila melanogaster} Length = 810 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 7e-05
Identities = 37/294 (12%), Positives = 78/294 (26%), Gaps = 14/294 (4%)
Query: 1117 EYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPILLKCVNHLSTDPNCLE 1176
+ AD L + + ++ + L + L V N
Sbjct: 394 DIRRWAADGLAYLTLDAECKEKLIEDKASIHALMDLARGGNQSCLYGVVTTFV---NLCN 450
Query: 1177 NLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHF 1236
++ + + +I H+ H L ++ INKR A GI L
Sbjct: 451 AYEKQEMLPEMIELAKFAKQHI------PEEHELDDVDFINKRIT-VLANEGITTALCAL 503
Query: 1237 IMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVC- 1294
++S ++ +L + R ++ GG+ L + + A+
Sbjct: 504 AKTESHNSQELIARVLNAVCGLKEL-RGKVVQEGGVKALLRMALEGTEKGKRHATQALAR 562
Query: 1295 LAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVN- 1353
+ + D ++ L+ Q L + + +
Sbjct: 563 IGITINPEVSFSGQRSLDVIRPLLNLLQQDCTALENFESLMALTNLASMNESVRQRIIKE 622
Query: 1354 GLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLIEE 1407
+ L + + + K ND + L L E+
Sbjct: 623 QGVSKIEYYLMEDHLYLTRAAAQCLCNLVMSEDVIKMFEGNNDRVKFLALLCED 676
|
| >1xm9_A Plakophilin 1; armadillo repeat, cell adhesion; 2.80A {Homo sapiens} SCOP: a.118.1.24 Length = 457 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 22/114 (19%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 1209 ALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRA 1267
+ + C ++ ++Q + G I L+ + S + ++Q A L ++ S ++ + R
Sbjct: 25 YIQHTCFQDESAKQQVYQLGGICKLVDLLRSPNQNVQQAAAGALRNLVFRSTTNKLETRR 84
Query: 1268 HGGLDVYLNLLENEVWSVTALDSIAVCLAH--DNDNRKVEQALLKKDAVQKLVK 1319
G+ ++LL + + L + D K E L DA+ L
Sbjct: 85 QNGIREAVSLLRRT-GNAEIQKQLTGLLWNLSSTDELKEE---LIADALPVLAD 134
|
| >3l6x_A Catenin delta-1; catenin, armadillo, ARM, JMD, CE adhesion, complex, cell-CELL adhesion, ARVCF, delta-catenin DP120, JAC-1, cell membrane, membrane; 2.40A {Homo sapiens} PDB: 3l6y_A Length = 584 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 3e-04
Identities = 30/276 (10%), Positives = 89/276 (32%), Gaps = 17/276 (6%)
Query: 597 LVGSLRPDESEDAIVSAC---QKLIAIFHQRPGQKQFFVTQHGLLP-LMELLELPQTRVI 652
+ L+ ++ + ++ Q L A + + Q L + +LL RV+
Sbjct: 313 YISLLKESKTPAILEASAGAIQNLCAGRWTYGRYIRSALRQEKALSAIADLLTNEHERVV 372
Query: 653 CSILQLINQIVKDNSDFQENAC-----LVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQ 707
+ + + D + + LV +P + + + + + ++
Sbjct: 373 KAASGALRNLAVDARNKELIGKHAIPNLVKNLPGGQQNSSWNFSEDTVISILNTINEVIA 432
Query: 708 SSSLTLQMFIACRGIPVLVGFLEADYAKYREMVH--LAIDGMWQVFKLQRSTPRNDFCRI 765
+ + +GI LV ++ +E+ L + +W +L++ + + +
Sbjct: 433 ENLEAAKKLRETQGIEKLVLINKSGNRSEKEVRAAALVLQTIWGYKELRKPLEKEGWKKS 492
Query: 766 AAKNGILLRLINTLYSLNEATRLASISVGGGFPGDGLAERPRSGQLDFSHPIFTQSETPL 825
+ + + + + L I +++ + + + +++
Sbjct: 493 DFQVNLNNASRSQSSHSYDDSTLPLIDRNQK------SDKKPDREEIQMSNMGSNTKSLD 546
Query: 826 TLTDQADGVKVRHGMIDHPLSTGTQEPSRASTSHSQ 861
+ + +D G EP + +T Q
Sbjct: 547 NNYSTPNERGDHNRTLDRSGDLGDMEPLKGTTPLMQ 582
|
| >1b3u_A Protein (protein phosphatase PP2A); scaffold protein, phosphorylation, heat repeat; 2.30A {Homo sapiens} SCOP: a.118.1.2 PDB: 2ie4_A* 2ie3_A* 2npp_A* 3k7v_A* 3k7w_A* 3fga_A* 2pf4_A 2iae_A 2nym_A* 2nyl_A* 3dw8_A* 2pkg_A 3c5w_A Length = 588 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 47/356 (13%), Positives = 113/356 (31%), Gaps = 63/356 (17%)
Query: 1103 LSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNR-IEPPIL 1161
+ + + ++ + L L++ +A+ + + L + +
Sbjct: 266 FTELQKAVGPEITKTDLVPAFQNLMKDCEAEVRAAASHKVKEFCENLSADCRENVIMSQI 325
Query: 1162 LKCVNHLSTDPN-------------CLENLQRADAIKYLIPNLD--LKDGHLVSLIHSEV 1206
L C+ L +D N L + + I++L+P LKD EV
Sbjct: 326 LPCIKELVSDANQHVKSALASVIMGLSPILGKDNTIEHLLPLFLAQLKDEC------PEV 379
Query: 1207 -LHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAH--ASRNSR 1262
L+ + NL +N+ + ++P ++ ++ + + +A
Sbjct: 380 RLNIISNLDCVNEVIGIRQLSQSLLPAIVELAEDAKWRVRLAIIEYMPLLAGQLGVEFFD 439
Query: 1263 EQLRAHGGLDVYLNLLENEVWSV--TALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKF 1320
E+L + + L + V+++ A ++ L ++ K V
Sbjct: 440 EKL-----NSLCMAWLVDHVYAIREAATSNL-KKLVEKFGKEWAHATIIPK------VLA 487
Query: 1321 FQSCPEPH----FVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLK 1376
P + + ++ + L P ++ A R N+ K
Sbjct: 488 MSGDPNYLHRMTTLFCINVLSEVCGQDITTKHML------PTVLRMAGDPVANVRFNVAK 541
Query: 1377 LIKAVYEHHPRPKQLIVENDLPQKLQNLIEER-RDGQRSGGQVLVKQMATSLLKAL 1431
++ + +++++ L+ L +++ D VK A L L
Sbjct: 542 SLQKIGPILDNS---TLQSEVKPILEKLTQDQDVD---------VKYFAQEALTVL 585
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1437 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-83 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-82 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-81 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-80 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-78 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-78 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-77 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-76 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-76 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-75 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-74 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-73 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-73 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-72 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-72 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-70 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-68 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-68 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-68 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-67 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-67 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-67 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-66 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-66 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-64 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-63 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-62 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-61 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-61 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-61 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-60 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-59 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-58 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-57 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-56 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-55 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-55 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-54 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-50 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-25 | |
| d1q1sc_ | 434 | a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus | 5e-06 | |
| d1q1sc_ | 434 | a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus | 1e-04 | |
| d1q1sc_ | 434 | a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus | 5e-04 | |
| d1jdha_ | 529 | a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) | 1e-05 | |
| d1jdha_ | 529 | a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) | 4e-05 | |
| d1jdha_ | 529 | a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) | 2e-04 | |
| d1xm9a1 | 457 | a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo | 4e-05 | |
| d1xm9a1 | 457 | a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo | 0.002 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (697), Expect = 2e-83
Identities = 99/275 (36%), Positives = 154/275 (56%), Gaps = 12/275 (4%)
Query: 11 HKSKTLD--NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEI 68
H ++ L+ + + + E+G GA+G+VYK + E A K + ++ +E+L M EI
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEI 60
Query: 69 DLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQV 128
D+L + +H NIVK L + ++L I++E+ G++ ++ P ES + V Q
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLTESQIQVVCKQT 119
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
L+ L YLH+ +IHRD+K NIL T +G +KLADFGV+ K T S +GTPYWMAP
Sbjct: 120 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179
Query: 189 EVI-----EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPE 241
EV+ + +D+WS+G T+IE+ PP++EL PM L +I + E P P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 239
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
S + DFL++C +K+ R LL HP++
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (684), Expect = 7e-82
Identities = 73/262 (27%), Positives = 130/262 (49%), Gaps = 7/262 (2%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL-NIIMQEIDLLKN 73
L++ + +G +GKG +G VY + ++ +A+K + + + + + + +E+++ +
Sbjct: 4 ALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 74 LNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
L H NI++ G + +++ILEY G++ ++ K F E A YI ++ L
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALS 120
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
Y H + VIHRDIK N+L G +K+ADFG + + ++ GT ++ PE+IE
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEG 178
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
D+WS+G E L PP+ RI + E P+ ++ D + +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISR 237
Query: 254 CFKKDARQRPDAKTLLSHPWIQ 275
K + QRP + +L HPWI
Sbjct: 238 LLKHNPSQRPMLREVLEHPWIT 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (682), Expect = 3e-81
Identities = 97/263 (36%), Positives = 142/263 (53%), Gaps = 7/263 (2%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
KY ++IG+GA G VY +D+ G VAI+Q++L+ Q +I+ EI +++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNP 77
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NIV YL S L +++EY+ GSL +++ E +A + L+ L +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS 134
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC 197
VIHRDIK NIL +G VKL DFG ++T ++VGTPYWMAPEV+
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 198 AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI--PESLSPDITDFLRQCF 255
DIWS+G IE++ PPY P+ AL+ I + P + PE LS DFL +C
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 256 KKDARQRPDAKTLLSHPWIQNCR 278
D +R AK LL H +++ +
Sbjct: 255 DMDVEKRGSAKELLQHQFLKIAK 277
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (674), Expect = 2e-80
Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 9/265 (3%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
Y + IG G+YGR K +G + K++ ++ + + +++ E++LL+ L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 79 IVKYLGSL--KTRSHLHIILEYVENGSLANIIK--PNKFGPFPESLVAVYIAQVLEGLVY 134
IV+Y + +T + L+I++EY E G LA++I + E V + Q+ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 135 LHEQG-----VIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
H + V+HRD+K AN+ + VKL DFG+A L + VGTPY+M+PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 190 VIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249
+ SDIWS+GC + EL +PP+ +I + + IP S ++ +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNE 244
Query: 250 FLRQCFKKDARQRPDAKTLLSHPWI 274
+ + RP + +L +P I
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (661), Expect = 1e-78
Identities = 79/271 (29%), Positives = 141/271 (52%), Gaps = 15/271 (5%)
Query: 15 TLDNKYM-LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKN 73
+ D +++ EIG+G++ VYKGLD E VA ++ + + + +E ++LK
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 64
Query: 74 LNHKNIVKYLGS----LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
L H NIV++ S +K + + ++ E + +G+L +K +F ++ + Q+L
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQIL 122
Query: 130 EGLVYLHEQG--VIHRDIKGANIL-TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWM 186
+GL +LH + +IHRD+K NI T G VK+ D G+A L A +V+GTP +M
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASF-AKAVIGTPEFM 180
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--IPESLS 244
APE+ E + D+++ G ++E+ T PY E Q ++R V P +
Sbjct: 181 APEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 245 PDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
P++ + + C +++ +R K LL+H + Q
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 259 bits (664), Expect = 1e-78
Identities = 92/267 (34%), Positives = 135/267 (50%), Gaps = 11/267 (4%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLN 75
+ + EIG G++G VY D+ N + VAIK++S E I++E+ L+ L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
H N ++Y G +++EY + + K P E +A L+GL YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
H +IHRD+K NIL ++ GLVKL DFG A+ + +S VGTPYWMAPEVI
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMD 187
Query: 196 ---VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPES-LSPDITDFL 251
D+WS+G T IEL PP + + M AL+ I Q+E P + S +F+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 252 RQCFKKDARQRPDAKTLLSHPWIQNCR 278
C +K + RP ++ LL H ++ R
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 256 bits (655), Expect = 9e-77
Identities = 76/301 (25%), Positives = 144/301 (47%), Gaps = 9/301 (2%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
K ++ + Y + +E+G GA+G V++ ++ G K ++ D + EI ++
Sbjct: 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIM 80
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
L+H ++ + + + + +ILE++ G L + I E+ V Y+ Q EG
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEG 139
Query: 132 LVYLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
L ++HE ++H DIK NI+ T K VK+ DFG+ATKL ++ T + APE
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTTATAEFAAPE 198
Query: 190 VIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RPPIPESLSPD 246
+++ V +D+W++G LL+ + P+ + L + + + S+SP+
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIPS 306
DF++ +K+ R+R L HPW++ L S + S + ++ A+ P+
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPA 318
Query: 307 E 307
Sbjct: 319 P 319
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (645), Expect = 2e-76
Identities = 75/274 (27%), Positives = 137/274 (50%), Gaps = 13/274 (4%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED-LNIIMQEIDL 70
+ K ++ + G +G+G++ V +L AIK + +I +E+ + + +E D+
Sbjct: 3 RKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
+ L+H VK + + L+ L Y +NG L I K G F E+ Y A+++
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVS 119
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN--THSVVGTPYWMAP 188
L YLH +G+IHRD+K NIL ++ +++ DFG A L+ +S VGT +++P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 189 EVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDIT 248
E++ C +SD+W++GC + +L+ +PP+ +I++ E PE P
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKAR 238
Query: 249 DFLRQCFKKDARQRPDAK------TLLSHPWIQN 276
D + + DA +R + L +HP+ ++
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 6e-76
Identities = 65/263 (24%), Positives = 121/263 (46%), Gaps = 8/263 (3%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ L +G+GAYG V ++ + VA+K V ++ + I +EI + K LNH+
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHE 63
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
N+VK+ G + + ++ LEY G L + I+P+ PE + Q++ G+VYLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKL--TEADVNTHSVVGTPYWMAPEVIEMSG 195
G+ HRDIK N+L + +K++DFG+AT + + + GT ++APE+++
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 196 V-CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE--RPPIPESLSPDITDFLR 252
D+WS G + +L P+ + + +++ + + L
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 253 QCFKKDARQRPDAKTLLSHPWIQ 275
+ ++ R + W
Sbjct: 242 KILVENPSARITIPDIKKDRWYN 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 253 bits (647), Expect = 1e-75
Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 9/269 (3%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
K + + Y + +E+G GA+G V++ + G+ A K V + + D + +EI +
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTM 77
Query: 72 KNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
L H +V + + + + +I E++ G L + ++ E Y+ QV +G
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKG 136
Query: 132 LVYLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
L ++HE +H D+K NI+ T + +KL DFG+ L + GT + APE
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPE 195
Query: 190 VIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RPPIPESLSPD 246
V E V +D+WSVG LL+ + P+ L + + +S D
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
DF+R+ D R L HPW+
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLT 284
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 248 bits (634), Expect = 1e-74
Identities = 77/273 (28%), Positives = 135/273 (49%), Gaps = 10/273 (3%)
Query: 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEID 69
+ +++ + + Y D +G GA+ V D VAIK ++ + + + + EI
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIA 59
Query: 70 LLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
+L + H NIV ++ HL++I++ V G L + I + G + E + I QVL
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVL 117
Query: 130 EGLVYLHEQGVIHRDIKGANIL---TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWM 186
+ + YLH+ G++HRD+K N+L ++ + ++DFG++ K+ + + GTP ++
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACGTPGYV 176
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RPPIPESL 243
APEV+ A D WS+G LL PP+Y+ +I++ E P + +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
S DF+R +KD +R + L HPWI
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 2e-74
Identities = 83/306 (27%), Positives = 140/306 (45%), Gaps = 49/306 (16%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
D+ + E+G G G V+K +G +A K + LE I N I++E+ +L N
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 63
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
IV + G+ + + I +E+++ GSL ++K K G PE ++ V++GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 137 EQ-GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
E+ ++HRD+K +NIL G +KL DFGV+ +L ++ +S VGT +M+PE ++ +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 179
Query: 196 VCAASDIWSVGCTVIELLTCVPPYY----------------------------------- 220
SDIWS+G +++E+ P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 221 -------ELQPMPALFRIVQDERPPIPES-LSPDITDFLRQCFKKDARQRPDAKTLLSHP 272
+ L IV + P +P S + DF+ +C K+ +R D K L+ H
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 273 WIQNCR 278
+I+
Sbjct: 300 FIKRSD 305
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 2e-73
Identities = 78/319 (24%), Positives = 145/319 (45%), Gaps = 16/319 (5%)
Query: 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKN 73
K L KYM+ +++G+G +G V++ ++ + K V ++ Q ++ +EI +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 74 LNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
H+NI+ S ++ L +I E++ + I + F E + Y+ QV E L
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQ 116
Query: 134 YLHEQGVIHRDIKGANIL--TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI 191
+LH + H DI+ NI+ T + +K+ +FG A +L D N + P + APEV
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVH 175
Query: 192 EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RPPIPESLSPDIT 248
+ V A+D+WS+G V LL+ + P+ + I+ E + +S +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 249 DFLRQCFKKDARQRPDAKTLLSHPWIQ----NCRRALQSSLRHSGTMRNVEENGSADAEI 304
DF+ + K+ + R A L HPW++ + +L+H + + +
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDL--NMV 293
Query: 305 PSEDNQSAGESLSAPKAEA 323
S S G ++ + K +
Sbjct: 294 VSAARISCGGAIRSQKGVS 312
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 3e-73
Identities = 68/264 (25%), Positives = 132/264 (50%), Gaps = 7/264 (2%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDL--NIIMQEIDLLKN 73
+++ ++L +GKG++G+V+ + F AIK + + + +D ++++ L
Sbjct: 1 IED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 59
Query: 74 LNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
H + + +T+ +L ++EY+ G L I+ F S Y A+++ GL
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQ 117
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
+LH +G+++RD+K NIL K+G +K+ADFG+ + D T++ GTP ++APE++
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
+ D WS G + E+L P++ LF ++ + P P L + D L +
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIRMDNPFYPRWLEKEAKDLLVK 236
Query: 254 CFKKDARQRPDAKT-LLSHPWIQN 276
F ++ +R + + HP +
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 1e-72
Identities = 72/274 (26%), Positives = 128/274 (46%), Gaps = 17/274 (6%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ +G IG G++G VYKG + VA+K +++ + L E+ +L+ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NI+ ++G T L I+ ++ E SL + + + F + Q +G+ YLH
Sbjct: 65 NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA 122
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN--THSVVGTPYWMAPEVIEM-- 193
+ +IHRD+K NI ++ VK+ DFG+AT + + + G+ WMAPEVI M
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 194 -SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQD-----ERPPIPESLSPDI 247
+ SD+++ G + EL+T PY + + +V + + + +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRAL 281
+ +C KK +RP +L+ I+ R+L
Sbjct: 243 KRLMAECLKKKRDERPLFPQILAS--IELLARSL 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 239 bits (612), Expect = 4e-72
Identities = 66/274 (24%), Positives = 124/274 (45%), Gaps = 20/274 (7%)
Query: 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-------QEDLNIIMQEIDLL 71
Y + +G+G V + + A+K + + QE ++E+D+L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 72 KNLN-HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
+ ++ H NI++ + +T + ++ + ++ G L + + + E + +LE
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLE 121
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV 190
+ LH+ ++HRD+K NIL + +KL DFG + +L + V GTP ++APE+
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSYLAPEI 180
Query: 191 IEMS------GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RPPIPE 241
IE S G D+WS G + LL PP++ + M L I+ P +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
S + D + + ++R A+ L+HP+ Q
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 1e-70
Identities = 62/256 (24%), Positives = 114/256 (44%), Gaps = 11/256 (4%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ L IGKG +G V G G+ VA+K + + AQ + E ++ L H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQA----FLAEASVMTQLRHS 60
Query: 78 NIVKYLGS-LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
N+V+ LG ++ + L+I+ EY+ GSL + ++ + + V E + YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
+HRD+ N+L +++ + K++DFG+ + + + W APE +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALREKKF 177
Query: 197 CAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255
SD+WS G + E+ + PY + + R+ + + P+ P + + ++ C+
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 256 KKDARQRPDAKTLLSH 271
DA RP L
Sbjct: 238 HLDAAMRPSFLQLREQ 253
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 8e-69
Identities = 71/289 (24%), Positives = 131/289 (45%), Gaps = 16/289 (5%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI----IMQE 67
+ + +D+ Y G+E+G G + V K + G A K + + I +E
Sbjct: 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 68 IDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
+ +LK + H N++ + ++ + +ILE V G L + + E ++ Q
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQ 121
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGL----VKLADFGVATKLTEADVNTHSVVGTP 183
+L G+ YLH + H D+K NI+ + +K+ DFG+A K+ + + + GTP
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-IFGTP 180
Query: 184 YWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---RPPIP 240
++APE++ + +D+WS+G LL+ P+ L +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ--NCRRALQSSLRH 287
+ S DF+R+ KD ++R + L HPWI+ + ++AL S+ H
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 230 bits (588), Expect = 3e-68
Identities = 73/268 (27%), Positives = 135/268 (50%), Gaps = 13/268 (4%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKN 73
+L + + + +G G++GRV+ NG + A+K + E + + + E +L
Sbjct: 2 SLQD-FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 74 LNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
+ H I++ G+ + + +I++Y+E G L ++++ ++ FP + Y A+V L
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALE 118
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
YLH + +I+RD+K NIL K G +K+ DFG A + + T+++ GTP ++APEV+
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST 175
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
+ D WS G + E+L P+Y+ M +I+ E P + D+ D L +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSR 234
Query: 254 CFKKDARQR-----PDAKTLLSHPWIQN 276
+D QR + + +HPW +
Sbjct: 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 3e-68
Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 13/280 (4%)
Query: 18 NKYMLGD-EIGKGAYGRVYKGLDLENGD--FVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
+ ++ D E+G G +G V +G+ VAIK + + + D +M+E ++ L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQL 66
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
++ IV+ +G + L +++E G L + K P S VA + QV G+ Y
Sbjct: 67 DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKY 124
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPYWMAPEVI 191
L E+ +HRD+ N+L K++DFG++ L D + W APE I
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 192 EMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250
+ SD+WS G T+ E L+ PY +++ + I Q +R P P++
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244
Query: 251 LRQCFKKDARQRPDAKTL---LSHPWIQNCRRALQSSLRH 287
+ C+ RPD T+ + + + H
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 284
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 5e-68
Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 7/256 (2%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
E+G G +G V G VAIK + ++++++ ++E ++ NL+H+
Sbjct: 4 KDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMNLSHE 59
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
+V+ G + + II EY+ NG L N ++ + F + V E + YL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES 118
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH-SVVGTPYWMAPEVIEMSGV 196
+ +HRD+ N L +G+VK++DFG++ + + + + W PEV+ S
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 197 CAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255
+ SDIW+ G + E+ + PY I Q R P S + + C+
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 256 KKDARQRPDAKTLLSH 271
+ A +RP K LLS+
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 7e-68
Identities = 74/268 (27%), Positives = 131/268 (48%), Gaps = 10/268 (3%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-AQEDLNIIMQEIDLLKN 73
T+++ + +GKG +G+V + G + A+K + E I A++++ + E +L+N
Sbjct: 3 TMND-FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 74 LNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
H + + +T L ++EY G L + + F E Y A+++ L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALE 119
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM 193
YLH + V++RDIK N++ K+G +K+ DFG+ + + GTP ++APEV+E
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQ 253
+ A D W +G + E++ P+Y LF ++ E P +LSP+ L
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEIRFPRTLSPEAKSLLAG 238
Query: 254 CFKKDARQRP-----DAKTLLSHPWIQN 276
KKD +QR DAK ++ H + +
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 227 bits (579), Expect = 1e-67
Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 13/273 (4%)
Query: 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI-IMQEIDLLK 72
L ++Y LG+ +G G V+ DL VA+K + + + +E
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 73 NLNHKNIVKYLGSLKTRSH----LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQV 128
LNH IV + + + +I++EYV+ +L +I+ GP IA
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADA 120
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPYW 185
+ L + H+ G+IHRD+K ANI+ + VK+ DFG+A + ++ T +V+GT +
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 186 MAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---IPES 242
++PE V A SD++S+GC + E+LT PP+ P+ ++ V+++ P E
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
LS D+ + + K+ R + ++
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 2e-67
Identities = 62/274 (22%), Positives = 112/274 (40%), Gaps = 17/274 (6%)
Query: 11 HKSKTLDNKYMLGDEIGKGAYGRVYKGL--DLENGDFVAIKQVSLENIAQEDLNIIMQEI 68
K TL++K E+G G +G V KG + VA+K + E + ++ E
Sbjct: 5 RKLLTLEDK-----ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 59
Query: 69 DLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQV 128
++++ L++ IV+ +G +++E E G L + + + + + QV
Sbjct: 60 NVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQV 116
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE---ADVNTHSVVGTPYW 185
G+ YL E +HRD+ N+L + K++DFG++ L W
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 186 MAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLS 244
APE I + SD+WS G + E + PY ++ + + ER P
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 236
Query: 245 PDITDFLRQCFKKDARQRPDAKTL---LSHPWIQ 275
++ D + C+ D RP + L + +
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 4e-67
Identities = 68/255 (26%), Positives = 121/255 (47%), Gaps = 7/255 (2%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
L + +G G +G V+ G VA+K + +++ + + E +L+K L H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQ 68
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
+V+ + T+ ++II EY+ENGSL + +K + + AQ+ EG+ ++ E
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN-THSVVGTPYWMAPEVIEMSGV 196
+ IHRD++ ANIL + K+ADFG+A + + + W APE I
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFR-IVQDERPPIPESLSPDITDFLRQCF 255
SD+WS G + E++T Y P + + + + R P++ ++ +R C+
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 256 KKDARQRPDAKTLLS 270
K+ RP L S
Sbjct: 248 KERPEDRPTFDYLRS 262
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 6e-67
Identities = 78/337 (23%), Positives = 143/337 (42%), Gaps = 23/337 (6%)
Query: 12 KSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLL 71
K+ +D+ + +G G G+V + + + A+K + +D +E++L
Sbjct: 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELH 58
Query: 72 KNL-NHKNIVKYLGSLKT----RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIA 126
+IV+ + + R L I++E ++ G L + I+ F E + +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 127 QVLEGLVYLHEQGVIHRDIKGANILTTK---EGLVKLADFGVATKLTEADVNTHSVVGTP 183
+ E + YLH + HRD+K N+L T ++KL DFG A + T + + + TP
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTP 177
Query: 184 YWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYY---ELQPMPALFRIVQDERPPIP 240
Y++APEV+ + D+WS+G + LL PP+Y L P + ++ + P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 241 E----SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEE 296
+S ++ +R K + QR ++HPWI + Q+ L S ++ +E
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 297 NGSADAEIPSEDNQSAGESLSAPKAEAFETGSRKELL 333
E + + K + E S LL
Sbjct: 298 RWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLL 334
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-66
Identities = 68/269 (25%), Positives = 117/269 (43%), Gaps = 18/269 (6%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ----EDLNIIMQEIDLL 71
L+++Y +G +G G +G VY G+ + + VAIK V + I+ + + E+ LL
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 72 KNLN--HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
K ++ +++ L + +ILE E + G E L + QVL
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVL 120
Query: 130 EGLVYLHEQGVIHRDIKGANIL-TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
E + + H GV+HRDIK NIL G +KL DFG L D GT + P
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPP 178
Query: 189 EVIEMSGVCA-ASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDI 247
E I ++ +WS+G + +++ P+ + + + + +S +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQVFFRQRVSSEC 231
Query: 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
+R C RP + + +HPW+Q+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 7e-66
Identities = 67/256 (26%), Positives = 120/256 (46%), Gaps = 7/256 (2%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
++ EIG G +G V+ G L N D VAIK + +++ED ++E +++ L+H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDF---IEEAEVMMKLSHP 60
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
+V+ G ++ + ++ E++E+G L++ ++ + G F + V EG+ YL E
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NTHSVVGTPYWMAPEVIEMSGV 196
VIHRD+ N L + ++K++DFG+ + + ++ W +PEV S
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 197 CAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255
+ SD+WS G + E+ + PY + I R P S + + C+
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 256 KKDARQRPDAKTLLSH 271
K+ RP LL
Sbjct: 240 KERPEDRPAFSRLLRQ 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 225 bits (575), Expect = 7e-66
Identities = 67/274 (24%), Positives = 134/274 (48%), Gaps = 17/274 (6%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQ----EIDL 70
T+++ + + IG+G +G VY + G A+K + + I + + + L
Sbjct: 2 TMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 71 LKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
+ + IV + T L IL+ + G L + + G F E+ + Y A+++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIIL 118
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV 190
GL ++H + V++RD+K ANIL + G V+++D G+A ++ H+ VGT +MAPEV
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEV 176
Query: 191 IEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQP--MPALFRIVQDERPPIPESLSPDI 247
++ +++D +S+GC + +LL P+ + + + R+ +P+S SP++
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 248 TDFLRQCFKKDARQRP-----DAKTLLSHPWIQN 276
L ++D +R A+ + P+ ++
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 7e-66
Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 9/263 (3%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
L ++G+G +G V+ G VAIK + ++ E +QE ++K L H+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHE 72
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
+V+ + + ++I+ EY+ GSL + +K + AQ+ G+ Y+
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN-THSVVGTPYWMAPEVIEMSGV 196
+HRD++ ANIL + + K+ADFG+A + + + W APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 197 CAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255
SD+WS G + EL T PY + L ++ + R P P + D + QC+
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 251
Query: 256 KKDARQRPDAKTLLS--HPWIQN 276
+K+ +RP + L + + +
Sbjct: 252 RKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 2e-65
Identities = 69/259 (26%), Positives = 120/259 (46%), Gaps = 8/259 (3%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDF---VAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
+ LG IG+G +G V++G+ + + VAIK + +QE ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 65
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
+H +IVK +G + T + + II+E G L + + + + + +Y Q+ L Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAY 123
Query: 135 LHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD-VNTHSVVGTPYWMAPEVIEM 193
L + +HRDI N+L + VKL DFG++ + ++ WMAPE I
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 194 SGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252
+ASD+W G + E+L V P+ ++ + RI ER P+P + P + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243
Query: 253 QCFKKDARQRPDAKTLLSH 271
+C+ D +RP L +
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 217 bits (554), Expect = 4e-64
Identities = 64/282 (22%), Positives = 126/282 (44%), Gaps = 14/282 (4%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+ ++G G YG VY+G+ + VA+K + + + E+ ++E ++K + H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHP 73
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
N+V+ LG +II E++ G+L + ++ ++ Q+ + YL +
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS-VVGTPYWMAPEVIEMSGV 196
+ IHRD+ N L + LVK+ADFG++ +T H+ W APE + +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV-QDERPPIPESLSPDITDFLRQCF 255
SD+W+ G + E+ T Y + ++ ++ +D R PE + + +R C+
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253
Query: 256 KKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEEN 297
+ + RP + +A ++ + S VE+
Sbjct: 254 QWNPSDRPSFAEIH---------QAFETMFQESSISDEVEKE 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 5e-64
Identities = 65/285 (22%), Positives = 117/285 (41%), Gaps = 32/285 (11%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDF-----VAIKQVSLENIAQEDLNIIMQEIDLLK 72
G +G GA+G+V VA+K + E + +M E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMT 95
Query: 73 NL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNK------------------- 112
L +H+NIV LG+ +++I EY G L N ++ +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 113 --FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170
+ + QV +G+ +L + +HRD+ N+L T +VK+ DFG+A +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 171 EADVNT--HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPA 227
+ WMAPE + SD+WS G + E+ + V PY +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 228 LFRIVQDE-RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
++++Q+ + P + +I ++ C+ D+R+RP L S
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 217 bits (553), Expect = 7e-64
Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 21/295 (7%)
Query: 7 TSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQEDLNI 63
F K + + IG G +G V G G FVAIK + ++ +
Sbjct: 16 VREFAKEIDISC-VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF 74
Query: 64 IMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAV 123
+ E ++ +H N++ G + + + II E++ENGSL + ++ G F +
Sbjct: 75 -LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVG 132
Query: 124 YIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSV---- 179
+ + G+ YL + +HRD+ NIL + K++DFG++ L + +
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 180 -VGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERP 237
W APE I+ +ASD+WS G + E+++ PY+++ + I QD R
Sbjct: 193 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 252
Query: 238 PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMR 292
P P + + C++KD RP ++ L +R+ +++
Sbjct: 253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV---------NTLDKMIRNPNSLK 298
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-63
Identities = 85/295 (28%), Positives = 137/295 (46%), Gaps = 31/295 (10%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
++N + ++IG+G YG VYK + G+ VA+K++ L+ + + ++EI LLK LN
Sbjct: 1 MEN-FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
H NIVK L + T + L+++ E++ + + P L+ Y+ Q+L+GL +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSG 195
H V+HRD+K N+L EG +KLADFG+A V T ++ APE++
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 196 VC-AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---------------- 238
A DIWS+GC E++T + + LFRI + P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 239 ------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRAL 281
+ L D L Q D +R AK L+HP+ Q+ + +
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 2e-63
Identities = 74/264 (28%), Positives = 127/264 (48%), Gaps = 11/264 (4%)
Query: 17 DNKYMLGDEIGKGAYGRVYKG-LDLENGD--FVAIKQVSLENIAQED-LNIIMQEIDLLK 72
+ L +++G G++G V +G D +G VA+K + + ++Q + ++ ++E++ +
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 73 NLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGL 132
+L+H+N+++ G + T + ++ E GSL + + G F ++ Y QV EG+
Sbjct: 67 SLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGM 124
Query: 133 VYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD---VNTHSVVGTPYWMAPE 189
YL + IHRD+ N+L LVK+ DFG+ L + D V W APE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 190 VIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQD-ERPPIPESLSPDI 247
++ ASD W G T+ E+ T P+ L L +I ++ ER P PE DI
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 248 TDFLRQCFKKDARQRPDAKTLLSH 271
+ + QC+ RP L
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 4e-63
Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 33/292 (11%)
Query: 24 DEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNI---IMQEIDLLKNLNHKNIV 80
D +G+G + VYK D VAIK++ L + ++ I ++EI LL+ L+H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 81 KYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGV 140
L + +S++ ++ +++E I + S + Y+ L+GL YLH+ +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 141 IHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVI-EMSGVCAA 199
+HRD+K N+L + G++KLADFG+A + V T ++ APE++
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 200 SDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE------------------ 241
D+W+VGC + ELL VP + L RI + P E
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 242 ---------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSS 284
+ D+ D ++ F + R A L + N
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-62
Identities = 72/301 (23%), Positives = 139/301 (46%), Gaps = 22/301 (7%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDF--VAIKQVSLENIAQEDLNIIMQEIDLLKNL- 74
N D IG+G +G+V K ++G AIK++ E +++D E+++L L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 68
Query: 75 NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKF--------------GPFPESL 120
+H NI+ LG+ + R +L++ +EY +G+L + ++ ++
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 121 VAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVV 180
+ + A V G+ YL ++ IHRD+ NIL + + K+ADFG++ + E V
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKTMGR 187
Query: 181 GTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCV-PPYYELQPMPALFRIVQDERPPI 239
WMA E + S SD+WS G + E+++ PY + ++ Q R
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSH--PWIQNCRRALQSSLRHSGTMRNVEEN 297
P + ++ D +RQC+++ +RP +L ++ + + ++L T ++ +
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS 307
Query: 298 G 298
Sbjct: 308 A 308
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 213 bits (543), Expect = 1e-62
Identities = 78/287 (27%), Positives = 126/287 (43%), Gaps = 32/287 (11%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
KY ++IG+G YG VYK + G+ A+K++ LE + + ++EI +LK L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NIVK + T+ L ++ E+++ + G ++ Q+L G+ Y H+
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD 118
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC 197
+ V+HRD+K N+L +EG +K+ADFG+A + T ++ AP+V+ S
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 198 -AASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP------------------ 238
DIWSVGC E++ P + + L RI + P
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 239 ----------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
+ L D L + K D QR AK L H + +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (539), Expect = 6e-62
Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 31/283 (10%)
Query: 18 NKYMLGDEIGKGAYGRVYKG-----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLK 72
N +IG+GA+GRV++ L E VA+K + E + + +E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMA 71
Query: 73 NLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIK----------------------P 110
++ NIVK LG + ++ EY+ G L ++
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 111 NKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLT 170
P + QV G+ YL E+ +HRD+ N L + +VK+ADFG++ +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 171 EADVN--THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPA 227
AD + WM PE I + SD+W+ G + E+ + + PYY +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 228 LFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270
++ + PE+ ++ + +R C+ K RP ++
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-61
Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 37/298 (12%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGD-FVAIKQVSLENIAQEDLNIIMQEIDLLKNL- 74
D +Y EIG+GAYG+V+K DL+NG FVA+K+V ++ + ++E+ +L++L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 75 --NHKNIVKYLG-----SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQ 127
H N+V+ + L ++ E+V+ + K P + + Q
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 124
Query: 128 VLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMA 187
+L GL +LH V+HRD+K NIL T G +KLADFG+A ++ + SVV T ++ A
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQMALTSVVVTLWYRA 183
Query: 188 PEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--------- 238
PEV+ S D+WSVGC E+ P + + L +I+ P
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 239 -----------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCRR 279
+ D L +C + +R A + LSHP+ Q+ R
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (537), Expect = 4e-61
Identities = 70/265 (26%), Positives = 132/265 (49%), Gaps = 12/265 (4%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNH 76
+++ +G G++GRV E+G+ A+K + + + + + + + E +L+ +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 KNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
+VK S K S+L++++EYV G + + + + G F E Y AQ++ YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 EQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGV 196
+I+RD+K N+L ++G +++ DFG A ++ T ++ GTP +APE+I G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGY 215
Query: 197 CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256
A D W++G + E+ PP++ QP+ ++ + + P S D+ D LR +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
Query: 257 KDARQR-----PDAKTLLSHPWIQN 276
D +R + +H W
Sbjct: 275 VDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 4e-61
Identities = 73/303 (24%), Positives = 130/303 (42%), Gaps = 46/303 (15%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+KY +IG+G +G V+K + G VA+K+V +EN + ++EI +L+ L H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 78 NIVKYLGSLKTRS--------HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
N+V + +T++ ++++ ++ E+ + N F S + + +L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLL 127
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH----SVVGTPYW 185
GL Y+H ++HRD+K AN+L T++G++KLADFG+A + A + + V T ++
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 186 MAPEVI-EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE--- 241
PE++ D+W GC + E+ T P L I Q PE
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 242 ----------------------------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPW 273
P D + + D QR D+ L+H +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 274 IQN 276
+
Sbjct: 308 FWS 310
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (531), Expect = 6e-61
Identities = 52/280 (18%), Positives = 104/280 (37%), Gaps = 27/280 (9%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
N+Y LG +IG G++G +Y G D+ G+ VAIK ++ + + E + K +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGG 62
Query: 78 NIVKYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH 136
+ + + +++E + + F V + Q++ + Y+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH 120
Query: 137 EQGVIHRDIKGANILTTKEG---LVKLADFGVATKLTEADVNTH-------SVVGTPYWM 186
+ IHRD+K N L LV + DFG+A K +A + H ++ GT +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 187 APEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------PPI 239
+ D+ S+G ++ P+ L+ + + +
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 PESLSPDITDFLRQCFKKDARQRPDAKTL---LSHPWIQN 276
+ + +L C +PD L + + +
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 9e-60
Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 42/299 (14%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
+ +Y IG+GAYG V D N VAIK++S Q ++EI +L
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFR 64
Query: 76 HKNIVKYLGSLKTRSHLH----IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEG 131
H+NI+ ++ + ++ ++ L ++K + ++ Q+L G
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRG 121
Query: 132 LVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH---SVVGTPYWMAP 188
L Y+H V+HRD+K +N+L +K+ DFG+A +T V T ++ AP
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 189 EVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE------ 241
E++ S G + DIWSVGC + E+L+ P + + L I+ P E
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 242 ------------------------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
+ D L + + +R + + L+HP+++
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 1e-59
Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 32/289 (11%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
KY ++IG+G YG V+K + E + VA+K+V L++ + + ++EI LLK L HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 78 NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
NIV+ L + L ++ E+ + N G +V ++ Q+L+GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC 197
+ V+HRD+K N+L + G +KLA+FG+A + V T ++ P+V+ + +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 198 -AASDIWSVGCTVIELLTCVPPYYELQPMPALF-RIVQDERPP----------------- 238
+ D+WS GC EL P + + RI + P
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 239 -----------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276
+ L+ D L+ K + QR A+ L HP+ +
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-59
Identities = 62/270 (22%), Positives = 121/270 (44%), Gaps = 17/270 (6%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLD-----LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLK 72
K + E+G+G++G VY+G+ E VAIK V+ E + + + E ++K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMK 78
Query: 73 NLNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNK--------FGPFPESLVAVY 124
N ++V+ LG + +I+E + G L + ++ + P S +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 125 IAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--VNTHSVVGT 182
++ +G+ YL+ +HRD+ N + ++ VK+ DFG+ + E D +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 183 PYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCV-PPYYELQPMPALFRIVQDERPPIPE 241
WM+PE ++ SD+WS G + E+ T PY L L +++ P+
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258
Query: 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
+ + + +R C++ + + RP ++S
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-59
Identities = 66/259 (25%), Positives = 125/259 (48%), Gaps = 11/259 (4%)
Query: 22 LGDEIGKGAYGRVYKGLDLEN---GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN 78
+ IG+G +G VY G L+N A+K ++ +++ + E ++K+ +H N
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPN 89
Query: 79 IVKYLG-SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE 137
++ LG L++ ++L Y+++G L N I+ P + L+ + QV +G+ +L
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLAS 148
Query: 138 QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH----SVVGTPYWMAPEVIEM 193
+ +HRD+ N + ++ VK+ADFG+A + + + ++ WMA E ++
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 194 SGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLR 252
SD+WS G + EL+T PPY ++ ++Q R PE + + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268
Query: 253 QCFKKDARQRPDAKTLLSH 271
+C+ A RP L+S
Sbjct: 269 KCWHPKAEMRPSFSELVSR 287
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-59
Identities = 71/297 (23%), Positives = 129/297 (43%), Gaps = 19/297 (6%)
Query: 20 YMLGDEIGKGAYGRVYKGLDLENGDF----VAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
+ +G GA+G VYKGL + G+ VAIK++ + + I + E ++ +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI-LDEAYVMASVD 69
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
+ ++ + LG T S + +I + + G L + + + + Q+ +G+ YL
Sbjct: 70 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--VNTHSVVGTPYWMAPEVIEM 193
++ ++HRD+ N+L VK+ DFG+A L + + WMA E I
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 194 SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV-QDERPPIPESLSPDITDFLR 252
SD+WS G TV EL+T Y+ P + I+ + ER P P + D+ +
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 247
Query: 253 QCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEENGSADAEIPSEDN 309
+C+ DA RP + L+ R ++ + P++ N
Sbjct: 248 KCWMIDADSRPKFRELIIE---------FSKMARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-59
Identities = 71/278 (25%), Positives = 115/278 (41%), Gaps = 27/278 (9%)
Query: 18 NKYMLGDEIGKGAYGRVYKG-----LDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLK 72
N+ G +G GA+G+V + + + VA+K + + +M E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLS 81
Query: 73 NL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKF----------------GP 115
L NH NIV LG+ +I EY G L N ++ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 116 FPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD-- 173
+ + QV +G+ +L + IHRD+ NIL T + K+ DFG+A +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 174 VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFR--I 231
V + WMAPE I SD+WS G + EL + Y P+ + F I
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 232 VQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLL 269
+ R PE ++ D ++ C+ D +RP K ++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 6e-59
Identities = 67/314 (21%), Positives = 117/314 (37%), Gaps = 42/314 (13%)
Query: 1 MSRQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQED 60
++ T + + Y IG G++G VY+ ++G+ VAIK+V +
Sbjct: 3 VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---- 58
Query: 61 LNIIMQEIDLLKNLNHKNIVKYL------GSLKTRSHLHIILEYVENGSLANIIK-PNKF 113
+E+ +++ L+H NIV+ G K +L+++L+YV
Sbjct: 59 --FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 114 GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANI-LTTKEGLVKLADFGVATKLTEA 172
P V +Y+ Q+ L Y+H G+ HRDIK N+ L ++KL DFG A +L
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 173 DVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV 232
+ N + Y + + ++ D+WS GC + ELL P + + L I+
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 233 QDERPPIPE----------------------------SLSPDITDFLRQCFKKDARQRPD 264
+ P E P+ + + R
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 265 AKTLLSHPWIQNCR 278
+H + R
Sbjct: 297 PLEACAHSFFDELR 310
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-58
Identities = 72/279 (25%), Positives = 130/279 (46%), Gaps = 26/279 (9%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDL-------ENGDFVAIKQVSLENIAQEDLNIIMQEIDL 70
++ +LG +G+GA+G+V + VA+K + + ++DL+ ++ E+++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEM 71
Query: 71 LKNL-NHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKP--------------NKFGP 115
+K + HKNI+ LG+ L++I+EY G+L ++ N
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 116 FPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD-- 173
+ QV G+ YL + IHRD+ N+L T++ ++K+ADFG+A + D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 174 VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV- 232
T + WMAPE + SD+WS G + E+ T Y P+ LF+++
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 233 QDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
+ R P + + ++ +R C+ QRP K L+
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-58
Identities = 79/290 (27%), Positives = 134/290 (46%), Gaps = 19/290 (6%)
Query: 4 QTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDL---ENGDFVAIKQVSLENIAQ-- 58
+T H K + L +G GAYG+V+ + + G A+K + I Q
Sbjct: 10 RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69
Query: 59 EDLNIIMQEIDLLKNLNHK-NIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFP 117
+ E +L+++ +V + +T + LH+IL+Y+ G L + + F
Sbjct: 70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFT 127
Query: 118 ESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN-T 176
E V +Y+ +++ L +LH+ G+I+RDIK NIL G V L DFG++ + +
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187
Query: 177 HSVVGTPYWMAPEVIEM--SGVCAASDIWSVGCTVIELLTCVPPYY---ELQPMPALFRI 231
+ GT +MAP+++ SG A D WS+G + ELLT P+ E + R
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247
Query: 232 VQDERPPIPESLSPDITDFLRQCFKKDARQRP-----DAKTLLSHPWIQN 276
+ PP P+ +S D +++ KD ++R DA + H + Q
Sbjct: 248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-57
Identities = 71/287 (24%), Positives = 127/287 (44%), Gaps = 19/287 (6%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGD----FVAIKQVSLENIAQEDLNIIMQEIDLLKN 73
+ IG G +G VYKG+ + VAIK + ++ ++ + E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF-LGEAGIMGQ 65
Query: 74 LNHKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
+H NI++ G + + II EY+ENG+L ++ K G F + + + G+
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMK 124
Query: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS---VVGTPYWMAPEV 190
YL +HRD+ NIL + K++DFG++ L + T++ W APE
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 191 IEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249
I +ASD+WS G + E++T PY+EL + I R P P I
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244
Query: 250 FLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGTMRNVEE 296
+ QC++++ +RP ++ L +R +++ + +
Sbjct: 245 LMMQCWQQERARRPKFADIV---------SILDKLIRAPDSLKTLAD 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-56
Identities = 74/300 (24%), Positives = 127/300 (42%), Gaps = 44/300 (14%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
+ Y +G GAYG V +D G VAIK++ ++ +E+ LLK++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 76 HKNIVKYLG------SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVL 129
H+N++ L +L + ++++ ++ + K E + + Q+L
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM----KHEKLGEDRIQFLVYQML 131
Query: 130 EGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPE 189
+GL Y+H G+IHRD+K N+ ++ +K+ DFG+A +AD V T ++ APE
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYRAPE 188
Query: 190 VI-EMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---------- 238
VI DIWSVGC + E++T + + L I++ P
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 239 --------------------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278
I + SP + L + DA QR A L+HP+ ++
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 194 bits (494), Expect = 5e-56
Identities = 49/274 (17%), Positives = 97/274 (35%), Gaps = 24/274 (8%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
+ Y +G IG+G++G +++G +L N VAIK + A + + + LL
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY-RTYKLLAGCT 61
Query: 76 HKNIVKYLGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
V Y G H ++++ + + + F VA+ Q+L + +
Sbjct: 62 GIPNVYYFGQ--EGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSI 117
Query: 136 HEQGVIHRDIKGANILTTK-----EGLVKLADFGVATKLTEADVNTH-------SVVGTP 183
HE+ +++RDIK N L + ++ + DFG+ + H ++ GT
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 184 YWMAPEVIEMSGVCAASDIWSVGCTVIELLT---CVPPYYELQPMPALFRIVQDERPPIP 240
+M+ D+ ++G + L RI + ++
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 241 ESL----SPDITDFLRQCFKKDARQRPDAKTLLS 270
L + ++ PD L
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-55
Identities = 66/278 (23%), Positives = 122/278 (43%), Gaps = 24/278 (8%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLD-----LENGDFVAIKQVSLENIAQEDLNIIMQEIDLLK 72
++ LG +G+GA+G+V + VA+K + E ++ + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 73 NLNHKNIVKYLGS-LKTRSHLHIILEYVENGSLANIIKPNKF--------------GPFP 117
+H N+V LG+ K L +I+E+ + G+L+ ++ +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 118 ESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--VN 175
+ Y QV +G+ +L + IHRD+ NIL +++ +VK+ DFG+A + + V
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQD 234
WMAPE I SD+WS G + E+ + PY ++ R +++
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252
Query: 235 -ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271
R P+ +P++ + C+ + QRP L+ H
Sbjct: 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 2e-55
Identities = 74/311 (23%), Positives = 122/311 (39%), Gaps = 53/311 (17%)
Query: 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL 74
T+ +Y IG GA G V D VAIK++S Q +E+ L+K +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 75 NHKNIVKYLG------SLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQV 128
NHKNI+ L +L+ +++++E ++ I ++ + Q+
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQM 128
Query: 129 LEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAP 188
L G+ +LH G+IHRD+K +NI+ + +K+ DFG+A + + T V T Y+ AP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAP 187
Query: 189 EVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE------- 241
EVI G DIWSVGC + E++ + + ++++ P PE
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 242 ----------------------------------SLSPDITDFLRQCFKKDARQRPDAKT 267
+ D L + D +R
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 268 LLSHPWIQNCR 278
L HP+I
Sbjct: 308 ALQHPYINVWY 318
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 189 bits (480), Expect = 9e-54
Identities = 57/303 (18%), Positives = 121/303 (39%), Gaps = 53/303 (17%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-H 76
+ Y L ++G+G Y V++ +++ N + V +K + + I +EI +L+NL
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGG 89
Query: 77 KNIVKYLGSLKTRSH--LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVY 134
NI+ +K ++ E+V N + + + + Y+ ++L+ L Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 135 LHEQGVIHRDIKGANIL-TTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV-IE 192
H G++HRD+K N++ + ++L D+G+A V + Y+ PE+ ++
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-RVASRYFKGPELLVD 203
Query: 193 MSGVCAASDIWSVGCTVIELLTCVPPYY-------------------------------- 220
+ D+WS+GC + ++ P++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 221 -----ELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275
++ + R + +SP+ DFL + + D + R A+ + HP+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
Query: 276 NCR 278
Sbjct: 324 TVV 326
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-53
Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 42/299 (14%)
Query: 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN 75
+ +Y +G GAYG V D + G VA+K++S + +E+ LLK++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 76 HKNIVKYLGSLKTRSHLH-----IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLE 130
H+N++ L L ++ ++ L NI K + V I Q+L
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILR 132
Query: 131 GLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEV 190
GL Y+H +IHRD+K +N+ ++ +K+ DFG+A D V T ++ APE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEI 189
Query: 191 IEMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPE-------- 241
+ DIWSVGC + ELLT + + L I++ P E
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 242 ----------------------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278
+P D L + D+ +R A L+H +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-50
Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 51/295 (17%)
Query: 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHK 77
+L + IGKG +G V++G G+ VA+K S EI L H+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHE 57
Query: 78 NIVKYLGSL----KTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLV 133
NI+ ++ + T + L ++ +Y E+GSL + + + GL
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLA 114
Query: 134 YLHEQ--------GVIHRDIKGANILTTKEGLVKLADFGVATKLTEA----DVNTHSVVG 181
+LH + + HRD+K NIL K G +AD G+A + A D+ + VG
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 182 TPYWMAPEVIEMS------GVCAASDIWSVGCTVIELLTCVP----------PYYELQP- 224
T +MAPEV++ S +DI+++G E+ PYY+L P
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 225 ---MPALFRIVQDE--RPPIPESLSP-----DITDFLRQCFKKDARQRPDAKTLL 269
+ + ++V ++ RP IP + +R+C+ + R A +
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 1e-43
Identities = 72/338 (21%), Positives = 123/338 (36%), Gaps = 76/338 (22%)
Query: 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH 76
D +Y+L ++G G + V+ D+ N VA+K V + + E EI LL+ +N
Sbjct: 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVND 68
Query: 77 KNIVKYLGS---------------LKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLV 121
+ K H+ ++ E + LA +IK + P V
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA-LIKKYEHRGIPLIYV 127
Query: 122 AVYIAQVLEGLVYL-HEQGVIHRDIKGANILTTKEG------LVKLADFGVATKLTEADV 174
Q+L GL Y+ G+IH DIK N+L +K+AD G A E
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--- 184
Query: 175 NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ- 233
+ + + T + +PEV+ + +DIWS C + EL+T + +
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244
Query: 234 ----------------------------------------------DERPPIPESLSPDI 247
E+ + + +I
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304
Query: 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSL 285
+DFL + D R+R DA L++HPW+++ + +
Sbjct: 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (253), Expect = 5e-25
Identities = 31/203 (15%), Positives = 68/203 (33%), Gaps = 28/203 (13%)
Query: 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDL-LKNLNHKNIV 80
+G +G+G V+ E +K + + + + + DL L ++
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 81 KYLGSLKTRSHLHII--LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQ 138
+L+ L + + N L +I + + +LE + + +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 139 GVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVC- 197
G++H D+ N+L ++EG + + DF + V E++E
Sbjct: 123 GIVHGDLSQYNVLVSEEG-IWIIDFPQS-------------VEVGEEGWREILERDVRNI 168
Query: 198 ---------AASDIWSVGCTVIE 211
DI S +++
Sbjct: 169 ITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} Length = 434 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Score = 48.3 bits (113), Expect = 5e-06
Identities = 35/189 (18%), Positives = 67/189 (35%), Gaps = 9/189 (4%)
Query: 1149 LFQMFNRIEPPILLKCV----NHLSTDPN-CLENLQRADAIKYLIPNLDLKDGHLVSLIH 1203
+ + N L+ LS + ++N+ RA I + L D S I
Sbjct: 18 IVKGINSNNLESQLQATQAARKLLSREKQPPIDNIIRAGLIPKFVSFLGKTD---CSPIQ 74
Query: 1204 SEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSR 1262
E AL N+ + + + G IP + + S + + A+ L ++A R
Sbjct: 75 FESAWALTNIASGTSEQTKAVVDGGAIPAFISLLASPHAHISEQAVWALGNIAGDGSAFR 134
Query: 1263 EQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQ 1322
+ + HG +D L LL S A + ++ + + DAV++++
Sbjct: 135 DLVIKHGAIDPLLALLAVPDLSTLACGYLRNLTWTLSNLCRNKNPAPPLDAVEQILPTLV 194
Query: 1323 SCPEPHFVH 1331
+
Sbjct: 195 RLLHHNDPE 203
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} Length = 434 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Score = 43.6 bits (101), Expect = 1e-04
Identities = 41/315 (13%), Positives = 96/315 (30%), Gaps = 12/315 (3%)
Query: 1102 LLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQM-FNRIEPPI 1160
++++ +A ++ + + + ++ + + V + LL+ L + +
Sbjct: 103 AFISLLASPHAHISEQAVWALGNIAGDGSAFRDLVIKHGAIDPLLALLAVPDLSTLACGY 162
Query: 1161 LLKCVNHLSTDPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRR 1220
L LS DA++ ++P L H + ++ A+ L R
Sbjct: 163 LRNLTWTLSNLCRNKNPAPPLDAVEQILPTLVRLLHHNDPEVLADSCWAISYLTDGPNER 222
Query: 1221 QEQAAENGIIPHLMHFIMSDSPLKQYALPLLCDMAHASRNSREQ-LRAHGGLDVYLNLLE 1279
E + G++P L+ + + + + Q + G L V+ +LL
Sbjct: 223 IEMVVKKGVVPQLVKLLGATELPIVTPALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLT 282
Query: 1280 NEVWSVT-ALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLK 1338
N ++ + ++ + V LV
Sbjct: 283 NPKTNIQKEATWTMSNITAGRQDQIQQVV--NHGLVPFLVGVLSKADFKTQKEAAWAITN 340
Query: 1339 IITKSSRINTTLAVN-GLTPLLIARLDHQDAIARLNLLKLIKAV------YEHHPRPKQL 1391
+ + V+ G+ L+ L +D +L I + + +
Sbjct: 341 YTSGGTVEQIVYLVHCGIIEPLMNLLSAKDTKIIQVILDAISNIFQAAEKLGETEKLSIM 400
Query: 1392 IVENDLPQKLQNLIE 1406
I E K++ L
Sbjct: 401 IEECGGLDKIEALQR 415
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} Length = 434 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.1 bits (97), Expect = 5e-04
Identities = 44/315 (13%), Positives = 79/315 (25%), Gaps = 6/315 (1%)
Query: 1099 SSGLLSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEP 1158
+GL+ VS L + A L A + + + +
Sbjct: 54 RAGLIPKFVSFLGKTDCSPIQFESAWALTNIASGTSEQTKAVVDGGAIPAFISLLASPHA 113
Query: 1159 PILLKCVNHLSTDPNCLENLQRADAIKYLI-PNLDLKDGHLVSLIHSEVLHAL----FNL 1213
I + V L + I P L L +S + L L NL
Sbjct: 114 HISEQAVWALGNIAGDGSAFRDLVIKHGAIDPLLALLAVPDLSTLACGYLRNLTWTLSNL 173
Query: 1214 CKINKRRQEQAAENGIIPHLMHFIMSDSPLKQYALPLLCDMAHASRNSREQLRAHGGLDV 1273
C+ A I+P L+ + + P N R ++ G+
Sbjct: 174 CRNKNPAPPLDAVEQILPTLVRLLHHNDPEVLADSCWAISYLTDGPNERIEMVVKKGVVP 233
Query: 1274 YLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHIL 1333
L L ++ + Q ++ A+ +
Sbjct: 234 QLVKLLGATELPIVTPALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLTNPKTNIQKEAT 293
Query: 1334 EPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLK-LIKAVYEHHPRPKQLI 1392
I + +GL P L+ L D + + +
Sbjct: 294 WTMSNITAGRQDQIQQVVNHGLVPFLVGVLSKADFKTQKEAAWAITNYTSGGTVEQIVYL 353
Query: 1393 VENDLPQKLQNLIEE 1407
V + + L NL+
Sbjct: 354 VHCGIIEPLMNLLSA 368
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} Length = 529 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (109), Expect = 1e-05
Identities = 26/168 (15%), Positives = 54/168 (32%), Gaps = 7/168 (4%)
Query: 1126 LLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPILLKCVNHLSTDPNCLENLQRADAIK 1185
LL +K+ + L+ + + + L + ++ QR ++
Sbjct: 363 LLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAH--QDTQRRTSMG 420
Query: 1186 YLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LK 1244
+G + I AL L + R IP + + S ++
Sbjct: 421 --GTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIV-IRGLNTIPLFVQLLYSPIENIQ 477
Query: 1245 QYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIA 1292
+ A +LC++A + + E + A G LL + V +
Sbjct: 478 RVAAGVLCELAQ-DKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAV 524
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} Length = 529 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 4e-05
Identities = 28/217 (12%), Positives = 59/217 (27%), Gaps = 11/217 (5%)
Query: 1198 LVSLIHSE-------VLHALFNLCKINKRRQEQAAENGIIPHLMHFIMS--DSPLKQYAL 1248
L L++ E + L K R ++ ++ + + D +
Sbjct: 22 LTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTA 81
Query: 1249 PLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQAL 1308
L +++H + GG+ + +L + V SV + +
Sbjct: 82 GTLHNLSHHREG-LLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAV- 139
Query: 1309 LKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDA 1368
+QK+V + + + + +G L+ +
Sbjct: 140 RLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTY 199
Query: 1369 IARLNLLKLIKAVYEHHPRPKQLIVENDLPQKLQNLI 1405
L + V K IVE Q L +
Sbjct: 200 EKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHL 236
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} Length = 529 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (100), Expect = 2e-04
Identities = 17/125 (13%), Positives = 37/125 (29%), Gaps = 4/125 (3%)
Query: 1162 LKCVNHLST-DPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRR 1220
V+ LS + + ++ + ++ + + L NL +
Sbjct: 38 AVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTN---DVETARCTAGTLHNLSHHREGL 94
Query: 1221 QEQAAENGIIPHLMHFIMSDSPLKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLEN 1280
GI + + YA+ L ++ ++ +R GGL + LL
Sbjct: 95 LAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNK 154
Query: 1281 EVWSV 1285
Sbjct: 155 TNVKF 159
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 457 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (105), Expect = 4e-05
Identities = 20/148 (13%), Positives = 54/148 (36%), Gaps = 10/148 (6%)
Query: 1198 LVSLIHS-------EVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALP 1249
V + S + + + C ++ ++Q + G I L+ + S + ++Q A
Sbjct: 7 AVQYLSSQDEKYQAIGAYYIQHTCFQDESAKQQVYQLGGICKLVDLLRSPNQNVQQAAAG 66
Query: 1250 LLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVC--LAHDNDNRKVEQA 1307
L ++ S ++ + R G+ ++LL + + L+ ++ ++ A
Sbjct: 67 ALRNLVFRSTTNKLETRRQNGIREAVSLLRRTGNAEIQKQLTGLLWNLSSTDELKEELIA 126
Query: 1308 LLKKDAVQKLVKFFQSCPEPHFVHILEP 1335
+++ F + + E
Sbjct: 127 DALPVLADRVIIPFSGWCDGNSNMSREV 154
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 457 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 0.002
Identities = 11/52 (21%), Positives = 19/52 (36%)
Query: 693 EVRMEAAYFLQQLCQSSSLTLQMFIACRGIPVLVGFLEADYAKYREMVHLAI 744
+ + AY++Q C Q GI LV L + ++ A+
Sbjct: 17 KYQAIGAYYIQHTCFQDESAKQQVYQLGGICKLVDLLRSPNQNVQQAAAGAL 68
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1437 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1wa5b_ | 503 | Karyopherin alpha {Baker's yeast (Saccharomyces ce | 98.58 | |
| d1jdha_ | 529 | beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | 98.56 | |
| d1wa5b_ | 503 | Karyopherin alpha {Baker's yeast (Saccharomyces ce | 98.44 | |
| d1q1sc_ | 434 | Importin alpha {Mouse (Mus musculus) [TaxId: 10090 | 98.39 | |
| d1q1sc_ | 434 | Importin alpha {Mouse (Mus musculus) [TaxId: 10090 | 98.38 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.86 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d1jdha_ | 529 | beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | 97.6 | |
| d1xqra1 | 264 | Hsp70-binding protein 1 (HspBP1) {Human (Homo sapi | 97.45 | |
| d1xqra1 | 264 | Hsp70-binding protein 1 (HspBP1) {Human (Homo sapi | 96.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d1b3ua_ | 588 | Constant regulatory domain of protein phosphatase | 96.46 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.43 | |
| d1xm9a1 | 457 | Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | 95.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.96 | |
| d1xm9a1 | 457 | Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | 91.13 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=423.41 Aligned_cols=255 Identities=38% Similarity=0.676 Sum_probs=232.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 98567984842259579999999679909999993056348888999999999998179998214889998189699999
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVM 96 (1437)
..+|++.+.||+|+||.||+|++..++..||+|++...... ..+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 10538878981285829999999899989999998430172--7999999999998679998805857798899989999
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 61489998898611999999999999999999999999998893211125883686459919997206631245577665
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k~ 176 (1437)
|||+||+|.+++.. +++++..++.|+.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 97 Ey~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp ECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EECCCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCC
T ss_conf 70379808988641---599999999999999999999998797226776888688789968642515641321366644
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCHHHHHHHHHH
Q ss_conf 4444897667714331079896641355999999998199999999983589997624899--99999998999999998
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPESLSPDITDFLRQC 254 (1437)
Q Consensus 177 ~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp--pLPk~ISeELkDLIkkL 254 (1437)
...+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+....+..+.....+ ..+..+|+++++||.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 44444777368266447998801203137299999804889989979999999998579998888553799999999998
Q ss_pred HHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 2310069999999950988999
Q 000535 255 FKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 255 LskDPekRPSAeEILkHPWLQe 276 (1437)
|.+||.+|||+.|+++||||+.
T Consensus 254 L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp TCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCCHHHCCCHHHHHCCHHHCC
T ss_conf 6699668909999964996577
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=419.09 Aligned_cols=254 Identities=27% Similarity=0.498 Sum_probs=229.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCH-HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 85679848422595799999996799099999930563488-88999999999998179998214889998189699999
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSe-EeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVM 96 (1437)
++|++.+.||+|+||.||+|+++.++..||+|++.+..... ...+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 61489998898611999999999999999999999999998893211125883686459919997206631245577665
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k~ 176 (1437)
|||++|+|.+++... +++++..++.|+.|++.||+|||++||+||||||+|||++.++.+||+|||+|...... ..
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~ 161 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RR 161 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CC
T ss_pred EECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCC--CC
T ss_conf 504798589887504--89999999999999999999999889465220234414668998711555633544888--52
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 44448976677143310798966413559999999981999999999835899976248999999999899999999823
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkLLs 256 (1437)
...+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+.+.+ +......+|..+|+++.+||.+||.
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-i~~~~~~~p~~~s~~~~~li~~~L~ 240 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-ISRVEFTFPDFVTEGARDLISRLLK 240 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHTTCCCCCTTSCHHHHHHHHHHTC
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHCCCCCCCCCCCHHHHHHHHHHCC
T ss_conf 355788763499997589989314404675999998329999888999999999-9718999986689999999999764
Q ss_pred HCCCCCCCHHHHHCCHHHHH
Q ss_conf 10069999999950988999
Q 000535 257 KDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 257 kDPekRPSAeEILkHPWLQe 276 (1437)
+||.+|||+.|+++||||+.
T Consensus 241 ~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 241 HNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp SSGGGSCCHHHHHTCHHHHH
T ss_pred CCHHHCCCHHHHHCCCCCCC
T ss_conf 79768909999971907078
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=419.86 Aligned_cols=258 Identities=27% Similarity=0.467 Sum_probs=234.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 98567984842259579999999679909999993056348-88899999999999817999821488999818969999
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lS-eEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLV 95 (1437)
-++|++++.||+|+||.||+|+++.++..||+|++.+.... ......+.+|+.+|++++||||++++++++++..+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96148999889861199999999999999999999999999889321112588368645991999720663124557766
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k 175 (1437)
||||+||+|.+++... +.++|..++.|+.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus 84 ~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCCCC
T ss_conf 0035798605555325--67759999999999965211343159622464777847658998888205652003567862
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 54444897667714331079896641355999999998199999999983589997624899999999989999999982
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 176 ~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkLL 255 (1437)
....+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+...... .+......+|..+|+++++||.+||
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~i~~~~~~~p~~~s~~~~dli~~~L 240 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-LILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred CCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCHHHHHHHHHHC
T ss_conf 055100889966665048988833310223067889987899999969999999-9852899898668999999998666
Q ss_pred HHCCCCCCC-----HHHHHCCHHHHHH
Q ss_conf 310069999-----9999509889999
Q 000535 256 KKDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 256 skDPekRPS-----AeEILkHPWLQel 277 (1437)
.+||.+|++ +.++++||||++.
T Consensus 241 ~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 241 KKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCCHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf 389344225652349999729150369
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=422.85 Aligned_cols=262 Identities=29% Similarity=0.518 Sum_probs=234.4
Q ss_pred CCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 65564239856798484225957999999967990999999305634888899999999999817999821488999818
Q 000535 10 FHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR 89 (1437)
Q Consensus 10 Fe~setLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfedd 89 (1437)
|+..+.+.++|++.+.||+|+||.||+|+++.++..||+|++.+..... ....+.+|+.+|++++||||+++++++.++
T Consensus 1 ~~~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESG 79 (307)
T ss_dssp CEECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEEC
T ss_conf 9987877666699889940658399999999999899999981577312-899999999999867998999198999989
Q ss_pred CEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC---CCCCEEEEECCCC
Q ss_conf 9699999614899988986119999999999999999999999999988932111258836864---5991999720663
Q 000535 90 SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTT---KEGLVKLADFGVA 166 (1437)
Q Consensus 90 d~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIs---sDG~VKLiDFGLA 166 (1437)
+.+|+|||||+||+|.+++... +++++..++.|+.|++.||.|||++||+||||||+|||+. .++.+||+|||++
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred CEEEEEEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEE
T ss_conf 9888988526898488865303--67887899999999999987524130556870463001104688824998315435
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC---CCCCCCC
Q ss_conf 1245577665444489766771433107989664135599999999819999999998358999762489---9999999
Q 000535 167 TKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER---PPIPESL 243 (1437)
Q Consensus 167 r~L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~r---ppLPk~I 243 (1437)
+...... ...+.+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.........+..... .+.+..+
T Consensus 158 ~~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 158 KMEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred EECCCCC-EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 8725897-044003284225918873799980787345159999998597999998999999998616877787666678
Q ss_pred CHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHH
Q ss_conf 98999999998231006999999995098899
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 244 SeELkDLIkkLLskDPekRPSAeEILkHPWLQ 275 (1437)
|+++.+||.+||.+||.+|||+.|+++||||+
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 99999999997608975791899986298447
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=423.26 Aligned_cols=257 Identities=30% Similarity=0.534 Sum_probs=236.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEEE
Q ss_conf 85679848422595799999996799099999930563488889999999999981799982148899981--8969999
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--RSHLHII 95 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfed--dd~LYLV 95 (1437)
++|++.+.||+|+||.||+|+++.++..||+|++......+...+.+.+|+.++++++||||+++++++.+ +..+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 9614899988986119--9999999999999999999999999889-----32111258836864599199972066312
Q 000535 96 LEYVENGSLANIIKPN--KFGPFPESLVAVYIAQVLEGLVYLHEQG-----VIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 96 MEYieGGSLsDLLKss--k~GpLSEkeIlqILrQILsALeYLHSkG-----IVHRDIKPENILIssDG~VKLiDFGLAr~ 168 (1437)
||||+||+|.+++... ..+.+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 45577665444489766771433107989664135599999999819999999998358999762489999999998999
Q 000535 169 LTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDIT 248 (1437)
Q Consensus 169 L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELk 248 (1437)
+..........+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+...++.......++..+|+++.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 243 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
T ss_conf 24577755667788232799998399999389887527899998018899899899999999971899889743599999
Q ss_pred HHHHHHHHHCCCCCCCHHHHHCCHHH
Q ss_conf 99999823100699999999509889
Q 000535 249 DFLRQCFKKDARQRPDAKTLLSHPWI 274 (1437)
Q Consensus 249 DLIkkLLskDPekRPSAeEILkHPWL 274 (1437)
+||.+||..||.+|||+.|+++|||+
T Consensus 244 ~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 244 EIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 99999767995579189999729819
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=417.92 Aligned_cols=260 Identities=31% Similarity=0.531 Sum_probs=225.3
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 42398567984842259579999999679909999993056348888999999999998179998214889998189699
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 14 etLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LY 93 (1437)
+...++|++.+.||+|+||.||+|++..++..||+|+++... .......+.+|+.+|++++|||||++++++.++..+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 787568889789712778099999998999699999987540-9789999999999998679999994999999899999
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99961489998898611999999999999999999999999998-89321112588368645991999720663124557
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 94 LVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHS-kGIVHRDIKPENILIssDG~VKLiDFGLAr~L~es 172 (1437)
+|||||+||+|.+++.+. +.+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 81 iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 999767998689987424--999999999999999999999998599971445779946878998999548776256788
Q ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----------------------
Q ss_conf 766544448976677143310798966413559999999981999999999835899-----------------------
Q 000535 173 DVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALF----------------------- 229 (1437)
Q Consensus 173 d~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~----------------------- 229 (1437)
...+.+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+......
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf --621113771411946875899894888998999999999888998998878999999887517754577421233322
Q ss_pred -------------------HHHHCCCCCCC-CCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHHH
Q ss_conf -------------------97624899999-99998999999998231006999999995098899999
Q 000535 230 -------------------RIVQDERPPIP-ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 230 -------------------KIIk~~rppLP-k~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQelr 278 (1437)
.+.....+.++ ..+|+++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf 111122235413477887665026876676444899999999998689946790899996098647698
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=415.15 Aligned_cols=263 Identities=26% Similarity=0.429 Sum_probs=232.1
Q ss_pred CCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 56556423985679848422595799999996799099999930563488889999999999981799982148899981
Q 000535 9 AFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT 88 (1437)
Q Consensus 9 qFe~setLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfed 88 (1437)
+.... .+-++|++.+.||+|+||.||+|++..+|..||+|++.... ....+.+.+|+.+|++++|||||++++++.+
T Consensus 18 ~l~~~-~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 94 (350)
T d1koaa2 18 EIKHD-HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED 94 (350)
T ss_dssp CCBCS-CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CCCCC-CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
T ss_conf 68988-78657589889840768199999988999899999984524--3169999999999986799799929999998
Q ss_pred CCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC--CCCEEEEECCCC
Q ss_conf 896999996148999889861199999999999999999999999999889321112588368645--991999720663
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK--EGLVKLADFGVA 166 (1437)
Q Consensus 89 dd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIss--DG~VKLiDFGLA 166 (1437)
++.+|+|||||+||+|.+++... .+++++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 95 ~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 95 DNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp TTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred CCEEEEEEECCCCCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHH
T ss_conf 99999999857998899999762-37899999999999999999999756976000154673641688986999545210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC---CCCCCC
Q ss_conf 12455776654444897667714331079896641355999999998199999999983589997624899---999999
Q 000535 167 TKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP---PIPESL 243 (1437)
Q Consensus 167 r~L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp---pLPk~I 243 (1437)
+.+.... .....+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+.+.++...... ..+..+
T Consensus 174 ~~~~~~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 252 (350)
T d1koaa2 174 AHLDPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252 (350)
T ss_dssp EECCTTS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGC
T ss_pred EECCCCC-CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 4425654-320006862421889975899872676554659999998598998997999999999847889894223589
Q ss_pred CHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 989999999982310069999999950988999
Q 000535 244 SPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 244 SeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
|+++.+||.+||.+||.+|||+.|+++||||+.
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 999999999975689667908999862913288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=415.19 Aligned_cols=258 Identities=27% Similarity=0.485 Sum_probs=231.7
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 23985679848422595799999996799099999930563488889999999999981799982148899981896999
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 15 tLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYL 94 (1437)
.+.++|++.+.||+|+||.||+|++..++..||+|++.... ..+...+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 85403599899931778299999998999799999988726--4679999999999986799798919999998999999
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 99614899988986119999999999999999999999999988932111258836864--5991999720663124557
Q 000535 95 ILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTT--KEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 95 VMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIs--sDG~VKLiDFGLAr~L~es 172 (1437)
|||||+||+|.+++... ..++++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|..+...
T Consensus 104 vmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEECCCCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 99828998088889863-89989999999999999999999977926513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCHHHHH
Q ss_conf 76654444897667714331079896641355999999998199999999983589997624899---999999989999
Q 000535 173 DVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP---PIPESLSPDITD 249 (1437)
Q Consensus 173 d~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp---pLPk~ISeELkD 249 (1437)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+....+.++...... ..+..+|+++.+
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred C-CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
T ss_conf 7-201004764534899974799897633389899999999688998997999999999847889893002479999999
Q ss_pred HHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 999982310069999999950988999
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 250 LIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
||.+||.+||.+|||+.|+|+||||+.
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 999975699668918999960973488
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=411.73 Aligned_cols=258 Identities=29% Similarity=0.521 Sum_probs=228.2
Q ss_pred CCCCCCCE-EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE---
Q ss_conf 64239856-79848422595799999996799099999930563488889999999999981799982148899981---
Q 000535 13 SKTLDNKY-MLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT--- 88 (1437)
Q Consensus 13 setLgnRY-kIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfed--- 88 (1437)
+...+++| ++.++||+|+||+||+|++..++..||+|++..........+.+.+|+++|++++|||||++++++++
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred CCCCCCCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
T ss_conf 84778877885169700828499999999999599999985122798999999999999985799985069999840334
Q ss_pred -CCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEC-CCCCEEEEECC
Q ss_conf -896999996148999889861199999999999999999999999999889--32111258836864-59919997206
Q 000535 89 -RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQG--VIHRDIKGANILTT-KEGLVKLADFG 164 (1437)
Q Consensus 89 -dd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkG--IVHRDIKPENILIs-sDG~VKLiDFG 164 (1437)
+..+|+|||||++|+|.+++... +.+++..++.|+.|++.||+|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CCCEEEEEEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECC
T ss_conf 588899999578989489997513--554699999999999999999997899799687674351166799988980057
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCC
Q ss_conf 6312455776654444897667714331079896641355999999998199999999983589997624899--99999
Q 000535 165 VATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPES 242 (1437)
Q Consensus 165 LAr~L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp--pLPk~ 242 (1437)
+++..... ...+.+||+.|+|||++.. .|+.++||||+||++|+|++|++||.+......+.+.+..... .++..
T Consensus 161 la~~~~~~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (270)
T d1t4ha_ 161 LATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237 (270)
T ss_dssp GGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred CCEECCCC--CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
T ss_conf 65423687--6677553813008988478-99986711007999999987889998765599999999738998656755
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHH
Q ss_conf 998999999998231006999999995098899
Q 000535 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 243 ISeELkDLIkkLLskDPekRPSAeEILkHPWLQ 275 (1437)
+++++.+||.+||.+||++|||+.|+++||||+
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 789999999997637975892999996775409
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=419.04 Aligned_cols=256 Identities=38% Similarity=0.662 Sum_probs=230.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 98567984842259579999999679909999993056348888999999999998179998214889998189699999
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVM 96 (1437)
.+.|++.+.||+|+||.||+|++..++..||+|++.... ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 037598479930778199999999999399999987289--999999999999998679999884988980099589999
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 61489998898611999999999999999999999999998893211125883686459919997206631245577665
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k~ 176 (1437)
|||+||+|.+++... .+++++..++.|+.|++.||.|||++||+||||||+|||++.++.+||+|||+|..........
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred ECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCCCC
T ss_conf 627998188999862-8999999999999999999999998898871407003148789998997161230357786410
Q ss_pred CCCCCCCCCCCHHHHH-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCHHHHH
Q ss_conf 4444897667714331-----0798966413559999999981999999999835899976248999--99999989999
Q 000535 177 HSVVGTPYWMAPEVIE-----MSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP--IPESLSPDITD 249 (1437)
Q Consensus 177 ~t~vGTp~YmAPEVLk-----g~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rpp--LPk~ISeELkD 249 (1437)
.+.+||+.|+|||++. ...|+.++||||+||++|+|++|++||.+.+..+.+.++.....+. .+..+|+++.+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred CCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
T ss_conf 01025626479999832025788888066578789999998208899999899999999970799877765669999999
Q ss_pred HHHHHHHHCCCCCCCHHHHHCCHHHH
Q ss_conf 99998231006999999995098899
Q 000535 250 FLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 250 LIkkLLskDPekRPSAeEILkHPWLQ 275 (1437)
||.+||++||.+|||+.|+++||||+
T Consensus 248 li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred HHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 99997669966891999996292318
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=417.23 Aligned_cols=257 Identities=25% Similarity=0.427 Sum_probs=225.7
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 39856798484225957999999967990999999305634888899999999999817999821488999818969999
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 16 LgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLV 95 (1437)
+-++|++.+.||+|+||.||+|+++.++..||+|++.+.... +..+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 874608998972174809999999999979999998456641-2799999999999857998884696540467436798
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC--
Q ss_conf 961489998898611999999999999999999999999998893211125883686459919997206631245577--
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD-- 173 (1437)
Q Consensus 96 MEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd-- 173 (1437)
||||+||+|.+++... +.+++..++.|+.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf 8645898089997537--99999999999999999999999759835754689978878998798323142240468865
Q ss_pred CCCCCCCCCCCCCCHHHHHCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCHHHHHH
Q ss_conf 66544448976677143310798-96641355999999998199999999983589997624899--9999999899999
Q 000535 174 VNTHSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP--PIPESLSPDITDF 250 (1437)
Q Consensus 174 ~k~~t~vGTp~YmAPEVLkg~~y-S~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp--pLPk~ISeELkDL 250 (1437)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|++||.................. ..+..+|+++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
T ss_conf 31113255747428728618999997101617379999998299788889859999999863888788644699999999
Q ss_pred HHHHHHHCCCCCCCHHHHHCCHHHH
Q ss_conf 9998231006999999995098899
Q 000535 251 LRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 251 IkkLLskDPekRPSAeEILkHPWLQ 275 (1437)
|.+||..||++|||+.|+++||||+
T Consensus 240 i~~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred HHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 9997679966890999996198458
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=410.17 Aligned_cols=254 Identities=35% Similarity=0.638 Sum_probs=228.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 98567984842259579999999679909999993056348-88899999999999817999821488999818969999
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lS-eEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLV 95 (1437)
...|.+.+.||+|+||.||+|++..++..||+|++...... ....+.+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 78567627970188809999999899939999998444435889999999999999977899982389999989988999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96148999889861199999999999999999999999999889321112588368645991999720663124557766
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k 175 (1437)
||||.+|+|..++... +++++..++.|+.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp EECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC----
T ss_conf 9806999457899737--9999999999999999999999868976667884217987999789844365334677----
Q ss_pred CCCCCCCCCCCCHHHHHC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC-CCCCCHHHHHHH
Q ss_conf 544448976677143310---7989664135599999999819999999998358999762489999-999998999999
Q 000535 176 THSVVGTPYWMAPEVIEM---SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPI-PESLSPDITDFL 251 (1437)
Q Consensus 176 ~~t~vGTp~YmAPEVLkg---~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rppL-Pk~ISeELkDLI 251 (1437)
....+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||.+......+.++.....+.. +..+|+++.+||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHH
T ss_conf 87313476636889983467888672145455899999998788999997999999999828999888788899999999
Q ss_pred HHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 9982310069999999950988999
Q 000535 252 RQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 252 kkLLskDPekRPSAeEILkHPWLQe 276 (1437)
.+||..||.+|||+.++++||||+.
T Consensus 248 ~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 9977379657918999971997537
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=409.47 Aligned_cols=262 Identities=26% Similarity=0.455 Sum_probs=233.9
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCH----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 6423985679848422595799999996799099999930563488----889999999999981799982148899981
Q 000535 13 SKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ----EDLNIIMQEIDLLKNLNHKNIVKYLGSLKT 88 (1437)
Q Consensus 13 setLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSe----EeieeLlREIkILKrLkHPNIVKLlGVfed 88 (1437)
.+.+.++|++++.||+|+||.||+|+++.+|..||+|++.+..... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
T ss_conf 78855677982798117895999999999998999999875663213406899999999999986799899938899997
Q ss_pred CCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC----CEEEEECC
Q ss_conf 89699999614899988986119999999999999999999999999988932111258836864599----19997206
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG----LVKLADFG 164 (1437)
Q Consensus 89 dd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG----~VKLiDFG 164 (1437)
+..+|+|||||+||+|.+++... +++++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCCHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 99899999867786431001035--6421557899999999998766625422113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC---CCC
Q ss_conf 63124557766544448976677143310798966413559999999981999999999835899976248999---999
Q 000535 165 VATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---IPE 241 (1437)
Q Consensus 165 LAr~L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rpp---LPk 241 (1437)
++....... ...+..||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+.+..+....... .+.
T Consensus 163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred HHHHCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHHCC
T ss_conf 421057776-3122477774309999818999976652214099999970889988999999999998168888701047
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf 999899999999823100699999999509889999
Q 000535 242 SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 242 ~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
.+|+++.+||.+||..||.+|||+.++++||||+..
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 889999999999863896689199999619041888
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=415.56 Aligned_cols=260 Identities=27% Similarity=0.539 Sum_probs=229.3
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 42398567984842259579999999679909999993056348-88899999999999817999821488999818969
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 14 etLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lS-eEeieeLlREIkILKrLkHPNIVKLlGVfeddd~L 92 (1437)
+.-.++|++++.||+|+||.||+|+++.++..||+|++.+.... ....+.+.+|+.++++++||||+++++++.+++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
T ss_conf 98998778988985087909999999899979999998657755777899999999999876888861799999989988
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99996148999889861199999999999999999999999999889321112588368645991999720663124557
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~es 172 (1437)
|+|||||+||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 9999704898777765315--99999999999999999997621650884767741236688853886032102422567
Q ss_pred C--CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 7--66544448976677143310798966413559999999981999999999835899976248999999999899999
Q 000535 173 D--VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 173 d--~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDL 250 (1437)
. ....+.+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+......++... ...+|..+++++.+|
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEKFFPKARDL 240 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CCCCCTTCCHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHH
T ss_conf 7643335556775525844002689896662304569999980388998995999999999718-999985479999999
Q ss_pred HHHHHHHCCCCCCCHHHH------HCCHHHHH
Q ss_conf 999823100699999999------50988999
Q 000535 251 LRQCFKKDARQRPDAKTL------LSHPWIQN 276 (1437)
Q Consensus 251 IkkLLskDPekRPSAeEI------LkHPWLQe 276 (1437)
|.+||.+||.+|||+.|+ ++||||+.
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCC
T ss_conf 99985579768919789737789876976478
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=405.07 Aligned_cols=254 Identities=28% Similarity=0.526 Sum_probs=229.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 8567984842259579999999679909999993056348-888999999999998179998214889998189699999
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lS-eEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVM 96 (1437)
++|++++.||+|+||.||+|+++.++..||+|++.+.... ....+.+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 61489998898611999999999999999999999999998893211125883686459919997206631245577665
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k~ 176 (1437)
||+.||+|.+++... +.+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+... .
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T 195 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred CCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC---C
T ss_conf 233466226667515--89899999999999999899998599861767999936077897886101033322566---6
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 44448976677143310798966413559999999981999999999835899976248999999999899999999823
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkLLs 256 (1437)
...+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+....+.++.. ....++..+++++.+||.+||.
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~li~~~L~ 274 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-GKVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCTTCCHHHHHHHHHHSC
T ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHH
T ss_conf 433676356788997179988533114500789999758899899599999999861-7988976689999999999834
Q ss_pred HCCCCCC-----CHHHHHCCHHHHHH
Q ss_conf 1006999-----99999509889999
Q 000535 257 KDARQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 257 kDPekRP-----SAeEILkHPWLQel 277 (1437)
+||.+|+ ++.++++||||+..
T Consensus 275 ~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 275 VDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HCHHHCCCCCCCCHHHHHCCCCCCCC
T ss_conf 09986065534549999719051589
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=405.91 Aligned_cols=258 Identities=27% Similarity=0.473 Sum_probs=230.5
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 42398567984842259579999999679909999993056348888999999999998179998214889998189699
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 14 etLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LY 93 (1437)
+.|.++|.+++.||+|+||.||+|+++.++..||+|+++... .+...+.+|+.+|++++||||+++++++++++.+|
T Consensus 1 ~~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf 987010588789831778399999998999699999975786---65999999999998579979890989998899889
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC--CCEEEEECCCCCCCCC
Q ss_conf 99961489998898611999999999999999999999999998893211125883686459--9199972066312455
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE--GLVKLADFGVATKLTE 171 (1437)
Q Consensus 94 LVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssD--G~VKLiDFGLAr~L~e 171 (1437)
+|||||+||+|.+++.... .++++..++.|+.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf 9995389980889987538-999999999999999999999987699751355444344378851899764411100346
Q ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCHHHH
Q ss_conf 7766544448976677143310798966413559999999981999999999835899976248999---9999998999
Q 000535 172 ADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---IPESLSPDIT 248 (1437)
Q Consensus 172 sd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rpp---LPk~ISeELk 248 (1437)
.. .....+|++.|+|||++.+..|+.++||||+||++|+|++|.+||.+.+....+.++....... .+..+|+++.
T Consensus 157 ~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CC-CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCCCCCHHHH
T ss_conf 77-53212233222340210487778401130279999999828999999899999999983899988022367899999
Q ss_pred HHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 9999982310069999999950988999
Q 000535 249 DFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 249 DLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
+||.+||.+||.+|||+.|+++||||++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 9999986699668909999963996566
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=406.69 Aligned_cols=254 Identities=28% Similarity=0.550 Sum_probs=230.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 8567984842259579999999679909999993056348-888999999999998179998214889998189699999
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lS-eEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVM 96 (1437)
++|++.+.||+|+||.||+|+++.++..||+|++.+.... ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 61489998898611999999999999999999999999998893211125883686459919997206631245577665
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNT 176 (1437)
Q Consensus 97 EYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k~ 176 (1437)
|||+||+|..++... ..+++..++.|+.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T 158 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---B
T ss_pred EECCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC---C
T ss_conf 503786322343222--21110079999999987655412476770556810503868998898317521671245---6
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 44448976677143310798966413559999999981999999999835899976248999999999899999999823
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFK 256 (1437)
Q Consensus 177 ~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkLLs 256 (1437)
.+.+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+......++... ...+|..+++++.++|.+||.
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPFFNEDVKDLLSRLIT 237 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTC
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHHHHHH
T ss_conf 4345763435999983899980430465333689997598999996999999999708-988997789999999999954
Q ss_pred HCCCCCC-----CHHHHHCCHHHHHH
Q ss_conf 1006999-----99999509889999
Q 000535 257 KDARQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 257 kDPekRP-----SAeEILkHPWLQel 277 (1437)
+||.+|+ +++++++||||++.
T Consensus 238 ~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 238 RDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HCHHHCCCCCHHHHHHHHCCCCCCCC
T ss_conf 49976664310219999819351467
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=405.88 Aligned_cols=256 Identities=26% Similarity=0.470 Sum_probs=222.6
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHH-HHHHH---HHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 856798484225957999999967990999999305634888-89999---99999998179998214889998189699
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE-DLNII---MQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeE-eieeL---lREIkILKrLkHPNIVKLlGVfeddd~LY 93 (1437)
++|++.+.||+|+||.||+|++..++..||+|++.+...... ....+ ..|+.+++.++||||+++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99961489998898611999999999999999999999999998893211125883686459919997206631245577
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd 173 (1437)
+|||||+||+|.+++... +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCCC-
T ss_conf 999914898389998732--55327899999999999999999779622044422167858896798220102333788-
Q ss_pred CCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 66544448976677143310-7989664135599999999819999999998358--99976248999999999899999
Q 000535 174 VNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPA--LFRIVQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 174 ~k~~t~vGTp~YmAPEVLkg-~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eq--L~KIIk~~rppLPk~ISeELkDL 250 (1437)
.....+||+.|+|||++.. ..|+.++||||+||++|+|++|++||.+...... +.+........++..+|+++.+|
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred -CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
T ss_conf -6433113455421687603899984410467789999998599988889989999999860468887887789999999
Q ss_pred HHHHHHHCCCCCCC-----HHHHHCCHHHHHH
Q ss_conf 99982310069999-----9999509889999
Q 000535 251 LRQCFKKDARQRPD-----AKTLLSHPWIQNC 277 (1437)
Q Consensus 251 IkkLLskDPekRPS-----AeEILkHPWLQel 277 (1437)
|.+||.+||.+||+ +.++++||||++.
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf 99985669888088743579999749102378
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=405.53 Aligned_cols=257 Identities=27% Similarity=0.506 Sum_probs=229.5
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 8567984842259579999999679909999993056348-888999999999998-17999821488999818969999
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLK-NLNHKNIVKYLGSLKTRSHLHII 95 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lS-eEeieeLlREIkILK-rLkHPNIVKLlGVfeddd~LYLV 95 (1437)
++|.+++.||+|+||+||+|.++.+++.||+|++.+.... ....+.+..|+.++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96148999889861199999999999999999999999999889321112588368645991999720663124557766
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k 175 (1437)
||||+||+|.+++... +++++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEECCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCCCC
T ss_conf 7503798089986404--78999999999999999999998689340347654044448996301555302323566533
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 54444897667714331079896641355999999998199999999983589997624899999999989999999982
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 176 ~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkLL 255 (1437)
....+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+......++ ....+.+|..+|+++.+||.+||
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-~~~~~~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMDNPFYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCCCCTTSCHHHHHHHHHHS
T ss_pred CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCHHHHHHHHHHC
T ss_conf 45457877768999982799883232011227898987388999998999999999-71899897567999999999965
Q ss_pred HHCCCCCCCHH-HHHCCHHHHHH
Q ss_conf 31006999999-99509889999
Q 000535 256 KKDARQRPDAK-TLLSHPWIQNC 277 (1437)
Q Consensus 256 skDPekRPSAe-EILkHPWLQel 277 (1437)
.+||.+||++. ++++||||++.
T Consensus 239 ~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp CSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CCCCCCCCCHHHHHHHCCHHCCC
T ss_conf 44898783889999809013158
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=396.00 Aligned_cols=258 Identities=25% Similarity=0.460 Sum_probs=228.8
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCH-------HHHHHHHHHHHHHHHCC-CCCCCEEEEEEE
Q ss_conf 3985679848422595799999996799099999930563488-------88999999999998179-998214889998
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQ-------EDLNIIMQEIDLLKNLN-HKNIVKYLGSLK 87 (1437)
Q Consensus 16 LgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSe-------EeieeLlREIkILKrLk-HPNIVKLlGVfe 87 (1437)
+.++|++.+.||+|+||.||+|++..+++.||+|++.+..... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CCCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECC
T ss_conf 96638885288417684999999999998999999962446411478889999999999999998507997479976214
Q ss_pred ECCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 18969999961489998898611999999999999999999999999998893211125883686459919997206631
Q 000535 88 TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 88 ddd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr 167 (1437)
+++.+|||||||+||+|.++++.+ +++++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCEEEEEECCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEE
T ss_conf 676059999768986689999865--999999999999999999999987599432346254898689983871240316
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHC------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC---C
Q ss_conf 24557766544448976677143310------79896641355999999998199999999983589997624899---9
Q 000535 168 KLTEADVNTHSVVGTPYWMAPEVIEM------SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP---P 238 (1437)
Q Consensus 168 ~L~esd~k~~t~vGTp~YmAPEVLkg------~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp---p 238 (1437)
.+.... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...... +
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred ECCCCC-CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 726887-2134524678889888605344567889923318565602310322888988999999999998189888985
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 99999989999999982310069999999950988999
Q 000535 239 IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 239 LPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
....+|+++.+||.+||.++|.+|||+.|+++||||++
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf 43468999999999976589668919999973978797
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.10 Aligned_cols=254 Identities=25% Similarity=0.446 Sum_probs=217.2
Q ss_pred CCCCCEEEEE-EECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE----
Q ss_conf 2398567984-84225957999999967990999999305634888899999999999817-99982148899981----
Q 000535 15 TLDNKYMLGD-EIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT---- 88 (1437)
Q Consensus 15 tLgnRYkIlE-kLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrL-kHPNIVKLlGVfed---- 88 (1437)
.+-++|.+.+ .||+|+||.||+|++..++..||+|++... ..+.+|+.++.++ +||||+++++++++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred CCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
T ss_conf 70148798107965454869999998899989999998974-------77999999999866999978298999503468
Q ss_pred CCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEEECCC
Q ss_conf 896999996148999889861199999999999999999999999999889321112588368645---99199972066
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK---EGLVKLADFGV 165 (1437)
Q Consensus 89 dd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIss---DG~VKLiDFGL 165 (1437)
+.++|+|||||+||+|.+++......++++..++.|+.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 97899999778998499999862787757999999999999999999976986444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHCCCCCCC--
Q ss_conf 312455776654444897667714331079896641355999999998199999999983589997---624899999--
Q 000535 166 ATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRI---VQDERPPIP-- 240 (1437)
Q Consensus 166 Ar~L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KI---Ik~~rppLP-- 240 (1437)
++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.........+ +......++
T Consensus 161 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 161 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred EEECCCCC-CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 23336888-64322677563792777489888888887645167788658899889887788999999985388888985
Q ss_pred --CCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf --999989999999982310069999999950988999
Q 000535 241 --ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 241 --k~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
..+|+++.+||.+||.+||++|||+.++++||||++
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHC
T ss_conf 43469999999999975699657909999970987617
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=393.36 Aligned_cols=259 Identities=32% Similarity=0.551 Sum_probs=226.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 85679848422595799999996799099999930563488889999999999981799982148899981896999996
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVME 97 (1437)
++|++.+.||+|+||.||+|++..++..||+|+++.....+...+.+.+|+.++++++||||+++++++.++..+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 14899988986119999999999999999999999999988932111258836864599199972066312455776654
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k~~ 177 (1437)
|+.+ ++.+++.....+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred ECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCCCCE
T ss_conf 2377-445554420256888899999999999999986528899213571140113467621035786134368864100
Q ss_pred CCCCCCCCCCHHHHHCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-----------------C-
Q ss_conf 444897667714331079-896641355999999998199999999983589997624899-----------------9-
Q 000535 178 SVVGTPYWMAPEVIEMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP-----------------P- 238 (1437)
Q Consensus 178 t~vGTp~YmAPEVLkg~~-yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp-----------------p- 238 (1437)
..+||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+..+.+.++...... .
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred EECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 10365215411221366577742210333313427966879989889999999999832898333144422242124345
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf ----------999999899999999823100699999999509889999
Q 000535 239 ----------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 239 ----------LPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
....+++++.+||.+||..||.+|||+.|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 4322220444166789999999999763995579189999678701469
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=393.87 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=219.9
Q ss_pred EEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHH---HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
Q ss_conf 98484225957999999967990999999305634888---899999999999817999821488999818969999961
Q 000535 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE---DLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEY 98 (1437)
Q Consensus 22 IlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeE---eieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVMEY 98 (1437)
.++.||+|+||+||+|++..++..||+|+++....... ....+.+|+.++++++|||||++++++.+++++|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 48999889861199999999999999999999999999889321112588368645991999720663124557766544
Q 000535 99 VENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHS 178 (1437)
Q Consensus 99 ieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k~~t 178 (1437)
+.++++..++. ..+.+++..++.|++|++.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred HCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 34507765541--2667789999999999999998863163550357762588537784114657610005787554330
Q ss_pred CCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------------------
Q ss_conf 448976677143310-79896641355999999998199999999983589997624899--------------------
Q 000535 179 VVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP-------------------- 237 (1437)
Q Consensus 179 ~vGTp~YmAPEVLkg-~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp-------------------- 237 (1437)
.+||+.|+|||++.. ..|+.++||||+||++|+|++|.+||.+....+.+.++......
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred EECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHHCC
T ss_conf 20473336399972677888056436304289999859699999999999999998518997254521000213443034
Q ss_pred --C-----CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf --9-----99999989999999982310069999999950988999
Q 000535 238 --P-----IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 238 --p-----LPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
. +...+++++.+||.+||..||++|||+.|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 7898867856568999999999976389456908999967996578
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=386.52 Aligned_cols=266 Identities=22% Similarity=0.415 Sum_probs=228.8
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEE
Q ss_conf 87667656556423985679848422595799999996799099999930563488889999999999981799982148
Q 000535 3 RQTTTSAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKY 82 (1437)
Q Consensus 3 rq~sasqFe~setLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKL 82 (1437)
+++....|+ .-.++|++.+.||+|+||.||+|++..++..||+|+++.... ..+.+.+|+.+|++++|||||++
T Consensus 5 ~~p~~~~we---i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~ 78 (287)
T d1opja_ 5 SSPNYDKWE---MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQL 78 (287)
T ss_dssp TSTTCCTTB---CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCCCCCE---ECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC---HHHHHHHHHHHHHHCCCCCEECC
T ss_conf 989976517---457993986598208880899999999996999999777610---39999999999986799988267
Q ss_pred EEEEEECCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEE
Q ss_conf 89998189699999614899988986119999999999999999999999999988932111258836864599199972
Q 000535 83 LGSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLAD 162 (1437)
Q Consensus 83 lGVfeddd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiD 162 (1437)
++++.+.+.+|+|||||++|+|.+++.......+++..++.|+.|++.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred CCCEEECCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECC
T ss_conf 75274578547876314676067775303554157999999999999978889878930576045768998999289832
Q ss_pred CCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HCCCCCCC
Q ss_conf 0663124557766-544448976677143310798966413559999999981999999999835899976-24899999
Q 000535 163 FGVATKLTEADVN-THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIV-QDERPPIP 240 (1437)
Q Consensus 163 FGLAr~L~esd~k-~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KII-k~~rppLP 240 (1437)
||+++........ .....|++.|+|||++.+..|+.++||||+||++|+|++|..||........+.+.+ ....++++
T Consensus 159 FG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~ 238 (287)
T d1opja_ 159 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238 (287)
T ss_dssp CCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 44546537887221035566546669278727999810430217899999986799887742599999998558888887
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 999989999999982310069999999950988999
Q 000535 241 ESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 241 k~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
..+++++.+||.+||..||.+|||+.++++ ||+.
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~ 272 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFET 272 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred CCCHHHHHHHHHHHCCCCHHHCCCHHHHHH--HHHH
T ss_conf 433099999999975779768939999999--9999
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.77 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=223.5
Q ss_pred CCCEEEEEE-ECCCCCEEEEEEEECC--CCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 985679848-4225957999999967--9909999993056348888999999999998179998214889998189699
Q 000535 17 DNKYMLGDE-IGKGAYGRVYKGLDLE--NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 17 gnRYkIlEk-LGkGSFGtVYKArDkk--TGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LY 93 (1437)
.++|.+.+. ||+|+||.||+|.++. ++..||||+++.. ......+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEE
T ss_conf 44718878487306080999999960897689999998820-397899999999999986799888068656036-8079
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99961489998898611999999999999999999999999998893211125883686459919997206631245577
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd 173 (1437)
+|||||++|+|.+++... .+.+++..+..|+.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 85 lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCC
T ss_conf 999807899689975212-5699999999999999998789986881057676466045468854203313421155434
Q ss_pred C---CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 6---6544448976677143310798966413559999999981-99999999983589997624899999999989999
Q 000535 174 V---NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITD 249 (1437)
Q Consensus 174 ~---k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkD 249 (1437)
. .....+||+.|+|||++....++.++||||+||++|||++ |.+||.+....+....+..+.++++|+.+|+++.+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
T ss_conf 32113562113743358688727999954123220178999993899999997999999999818999999767899999
Q ss_pred HHHHHHHHCCCCCCCHHHHH---CCHHHH
Q ss_conf 99998231006999999995---098899
Q 000535 250 FLRQCFKKDARQRPDAKTLL---SHPWIQ 275 (1437)
Q Consensus 250 LIkkLLskDPekRPSAeEIL---kHPWLQ 275 (1437)
||.+||..+|++||++.+++ +|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 99997577976890999999999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.09 Aligned_cols=259 Identities=32% Similarity=0.502 Sum_probs=219.1
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCC-CEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEEE----
Q ss_conf 98567984842259579999999679-90999999305634888899999999999817---99982148899981----
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLEN-GDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL---NHKNIVKYLGSLKT---- 88 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkT-Gk~VAIKVIkke~lSeEeieeLlREIkILKrL---kHPNIVKLlGVfed---- 88 (1437)
.++|++.+.||+|+||.||+|++..+ +..||+|+++...........+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf -8969999961489998898611999999999999999999999999998893211125883686459919997206631
Q 000535 89 -RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 89 -dd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr 167 (1437)
...+|++|||+.++.+..... .....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCEEEEEEEECCCCCHHHHHH-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHHHH
T ss_conf 6746999997405871444443-037899989999999999999999975889835798627898589975421000101
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-----------
Q ss_conf 245577665444489766771433107989664135599999999819999999998358999762489-----------
Q 000535 168 KLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER----------- 236 (1437)
Q Consensus 168 ~L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~r----------- 236 (1437)
...... .....+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+.+.++.....
T Consensus 165 ~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred HHCCCC-CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCCCCCC
T ss_conf 100234-5777654851148310017988811100032899999987879989989899999999840799611053211
Q ss_pred ---------------CCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf ---------------99999999899999999823100699999999509889999
Q 000535 237 ---------------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 237 ---------------ppLPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
..++..+++.+.+||.+||.+||++|||+.|+|+||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 11033302234564544044589999999999874896679189999669634075
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.52 Aligned_cols=253 Identities=25% Similarity=0.447 Sum_probs=221.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCC-----EEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCE
Q ss_conf 85679848422595799999996799-----0999999305634888899999999999817-99982148899981896
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENG-----DFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTG-----k~VAIKVIkke~lSeEeieeLlREIkILKrL-kHPNIVKLlGVfeddd~ 91 (1437)
++|++++.||+|+||.||+|++...+ ..||+|.+.... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 9939701983078819999998578855420499999966335-878999999999999971589968687788862995
Q ss_pred EEEEEEECCCCCHHHHHCCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 9999961489998898611999---------------------9999999999999999999999988932111258836
Q 000535 92 LHIILEYVENGSLANIIKPNKF---------------------GPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANI 150 (1437)
Q Consensus 92 LYLVMEYieGGSLsDLLKssk~---------------------GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENI 150 (1437)
+|+|||||++|+|.++++..+. ..+++..++.|+.|++.||.|||+++|+||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHCC
T ss_conf 89999727999599999862577751022100001222001257789999999999999999999739905052703214
Q ss_pred EECCCCCEEEEECCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHH
Q ss_conf 864599199972066312455776--6544448976677143310798966413559999999981-9999999998358
Q 000535 151 LTTKEGLVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPA 227 (1437)
Q Consensus 151 LIssDG~VKLiDFGLAr~L~esd~--k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eq 227 (1437)
|++.++.+||+|||+|+....... ...+.+||+.|+|||++....|+.++||||+||++|+|++ |.+||.+......
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred CCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 43459828985142222045778615623435787657838872799996330300039999998389999999898999
Q ss_pred HHHHHHCC-CCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCC
Q ss_conf 99976248-999999999899999999823100699999999509
Q 000535 228 LFRIVQDE-RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 228 L~KIIk~~-rppLPk~ISeELkDLIkkLLskDPekRPSAeEILkH 271 (1437)
+.+++... +++.|..+|+++.+||.+||..||++|||+.|+++|
T Consensus 276 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 999985699899887678999999999758896689399999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=381.10 Aligned_cols=255 Identities=26% Similarity=0.466 Sum_probs=225.6
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCE---EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 239856798484225957999999967990---99999930563488889999999999981799982148899981896
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGD---FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 15 tLgnRYkIlEkLGkGSFGtVYKArDkkTGk---~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~ 91 (1437)
.-.++|++.+.||+|+||.||+|.++.++. .||+|.+.... .....+.+.+|+.+|++++|||||++++++..++.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 08004278569802788299999995799788999999978445-98999999999999985799888618999962887
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99999614899988986119999999999999999999999999988932111258836864599199972066312455
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 92 LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~e 171 (1437)
+|+|||||++|+|.+++... .+.+++..+..|+.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEECCCCCCEEEECCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 79999722798530021045-67999999999999999988988527983576150448988999199888443157567
Q ss_pred CCCC-----CCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCH
Q ss_conf 7766-----544448976677143310798966413559999999981-9999999998358999762489999999998
Q 000535 172 ADVN-----THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSP 245 (1437)
Q Consensus 172 sd~k-----~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KIIk~~rppLPk~ISe 245 (1437)
.... .....||+.|+|||++....|+.++||||+||++|||++ |.+||.+....+....+....+.+.+..+++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHH
T ss_conf 77765365025666883003878883699786121445357899998679999999999999999973788999742269
Q ss_pred HHHHHHHHHHHHCCCCCCCHHHHHCC
Q ss_conf 99999999823100699999999509
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 246 ELkDLIkkLLskDPekRPSAeEILkH 271 (1437)
++.+||.+||..||.+|||+.++++.
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999999758797689299999999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.59 Aligned_cols=251 Identities=28% Similarity=0.489 Sum_probs=217.7
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHH----HHHHHHHHHHHHHHCC--CCCCCEEEEEEEEC
Q ss_conf 39856798484225957999999967990999999305634888----8999999999998179--99821488999818
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQE----DLNIIMQEIDLLKNLN--HKNIVKYLGSLKTR 89 (1437)
Q Consensus 16 LgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeE----eieeLlREIkILKrLk--HPNIVKLlGVfedd 89 (1437)
+.++|++++.||+|+||.||+|++..++..||+|++.+...... ....+.+|+.++++++ ||||+++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
T ss_conf 78837996798408783999999999997999999856884433455679999999999997435898812799998309
Q ss_pred CEEEEEEEECCC-CCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC-CCEEEEECCCCC
Q ss_conf 969999961489-998898611999999999999999999999999998893211125883686459-919997206631
Q 000535 90 SHLHIILEYVEN-GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE-GLVKLADFGVAT 167 (1437)
Q Consensus 90 d~LYLVMEYieG-GSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssD-G~VKLiDFGLAr 167 (1437)
+.+|+||||+.+ +++.+++... +.+++..++.|+.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CEEEEEEEECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCE
T ss_conf 96899998336862289998615--8999999999999999999999877975566761114774478848977546535
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 24557766544448976677143310798-96641355999999998199999999983589997624899999999989
Q 000535 168 KLTEADVNTHSVVGTPYWMAPEVIEMSGV-CAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPPIPESLSPD 246 (1437)
Q Consensus 168 ~L~esd~k~~t~vGTp~YmAPEVLkg~~y-S~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rppLPk~ISeE 246 (1437)
..... ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.... .+ ......++..+|++
T Consensus 160 ~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i-~~~~~~~~~~~s~~ 230 (273)
T d1xwsa_ 160 LLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI-IRGQVFFRQRVSSE 230 (273)
T ss_dssp ECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH-HHCCCCCSSCCCHH
T ss_pred ECCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HH-HHCCCCCCCCCCHH
T ss_conf 32444--55665658774799998489978865332554034536756889988736------77-61544778779999
Q ss_pred HHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf 9999999823100699999999509889999
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 247 LkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
+.+||.+||..||.+|||+.|+++||||++.
T Consensus 231 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9999999760897589399998539866788
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.80 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=223.2
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----
Q ss_conf 398567984842259579999999679909999993056348888999999999998179998214889998189-----
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS----- 90 (1437)
Q Consensus 16 LgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd----- 90 (1437)
+.++|++.+.||+|+||.||+|.+..++..||+|++++........+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -EEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf -6999996148999889861199999999999999999999999999889321112588368645991999720663124
Q 000535 91 -HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL 169 (1437)
Q Consensus 91 -~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L 169 (1437)
.+|+||||| +.+|..+++. +++++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEECC-CCCHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECC
T ss_conf 1599998405-5218999874---02269999999999999999987378764566851111210012211343102206
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-------------
Q ss_conf 5577665444489766771433107-98966413559999999981999999999835899976248-------------
Q 000535 170 TEADVNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE------------- 235 (1437)
Q Consensus 170 ~esd~k~~t~vGTp~YmAPEVLkg~-~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~------------- 235 (1437)
... ....+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+....+..+....
T Consensus 172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred CCC---CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCC
T ss_conf 876---31024553335889981787899650103003899999978699888976899999985037884888865300
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf -----------------999999999899999999823100699999999509889999
Q 000535 236 -----------------RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 236 -----------------rppLPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
...+...+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 03443311578666556677556899999999999772995579299999639623758
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=379.40 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=227.1
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC--
Q ss_conf 42398567984842259579999999679909999993056348-888999999999998179998214889998189--
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA-QEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS-- 90 (1437)
Q Consensus 14 etLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lS-eEeieeLlREIkILKrLkHPNIVKLlGVfeddd-- 90 (1437)
..|.++|++.+.||+|+||.||+|++..+++.||+|++++.... ......+.+|+.++++++||||+++++++..+.
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred CCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC
T ss_conf 57062069868996089929999999999989999998556646989999999999999856999887311435432688
Q ss_pred --EEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf --699999614899988986119999999999999999999999999988932111258836864599199972066312
Q 000535 91 --HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 91 --~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~ 168 (1437)
.+|+|||||+|++|.+++... +++++..++.|+.|++.||+|||++||+||||||+|||++.++..+++|||.+..
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred CCEEEEEEECCCCCEEHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHH
T ss_conf 76699999778898710112035--8999999999999999999999857952763467556657543201003444322
Q ss_pred CCCCC---CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC---CCCC
Q ss_conf 45577---66544448976677143310798966413559999999981999999999835899976248999---9999
Q 000535 169 LTEAD---VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP---IPES 242 (1437)
Q Consensus 169 L~esd---~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rpp---LPk~ 242 (1437)
..... ......+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+...+++.....+ .+..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCC
T ss_conf 12354433334642576243699998399999663202652899999769799899699999999984699997100347
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHH
Q ss_conf 998999999998231006999999995098899
Q 000535 243 LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQ 275 (1437)
Q Consensus 243 ISeELkDLIkkLLskDPekRPSAeEILkHPWLQ 275 (1437)
+|+++.+||.+||.+||.+||+..+.+.|+|++
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 899999999998667976777399999999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.08 Aligned_cols=250 Identities=23% Similarity=0.402 Sum_probs=219.3
Q ss_pred EEECCCCCEEEEEEEECC--CCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEECCC
Q ss_conf 484225957999999967--990999999305634888899999999999817999821488999818969999961489
Q 000535 24 DEIGKGAYGRVYKGLDLE--NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 24 EkLGkGSFGtVYKArDkk--TGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVMEYieG 101 (1437)
++||+|+||.||+|.+.. +++.||+|+++.........+.+.+|+.+|++++|||||++++++..+ .+|+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059-77999974788
Q ss_pred CCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC---CCCC
Q ss_conf 9988986119999999999999999999999999988932111258836864599199972066312455776---6544
Q 000535 102 GSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV---NTHS 178 (1437)
Q Consensus 102 GSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~---k~~t 178 (1437)
|+|.++++.. .++++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCCCC
T ss_conf 9689997522--57899999999999999976687479556777611310235675123413453313432344322445
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 448976677143310798966413559999999981-9999999998358999762489999999998999999998231
Q 000535 179 VVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCFKK 257 (1437)
Q Consensus 179 ~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkLLsk 257 (1437)
..||+.|+|||++....++.++||||+|+++|||++ |++||.+....+....+..+.++++|..+|+++.+||.+||..
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 67784203916653799984344303403132896589999999899999999982899999865679999999997588
Q ss_pred CCCCCCCHHHHH---CCHHHHH
Q ss_conf 006999999995---0988999
Q 000535 258 DARQRPDAKTLL---SHPWIQN 276 (1437)
Q Consensus 258 DPekRPSAeEIL---kHPWLQe 276 (1437)
||.+|||+.+++ +|+|+.-
T Consensus 250 dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHCCCHHHHHHHHHCHHHHC
T ss_conf 9768909899999852887504
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=382.26 Aligned_cols=256 Identities=30% Similarity=0.482 Sum_probs=223.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 85679848422595799999996799099999930563488889999999999981799982148899981896999996
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVME 97 (1437)
++|++.++||+|+||.||+|++. ++..||+|++......+...+.+.+|+.+|++++||||+++++++.+++..|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf 99634318722778189999968-99999999981232685899999999999986799868766012046773158997
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 14899988986119999999999999999999999999988932111258836864599199972066312455776654
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k~~ 177 (1437)
|+.++.+..+... .+.+++..++.|+.|++.||+|||+++|+||||||+|||++.++.+||+|||.+...........
T Consensus 81 ~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEHHHHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCCCCC
T ss_conf 4004567899860--47751445689999999999986057488267877505686899787323664301146765410
Q ss_pred CCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--------------------
Q ss_conf 44489766771433107-989664135599999999819999999998358999762489--------------------
Q 000535 178 SVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDER-------------------- 236 (1437)
Q Consensus 178 t~vGTp~YmAPEVLkg~-~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~r-------------------- 236 (1437)
...|++.|+|||++... .++.++||||+||++|+|++|++||.+.+..+.+.++.....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred EECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCCCCC
T ss_conf 10243110137887178888841002111758999977979989889899999999863899711042123332214333
Q ss_pred --------CCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf --------9999999989999999982310069999999950988999
Q 000535 237 --------PPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 237 --------ppLPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
......+++.+.+||.+||.+||++|||+.|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 335676466651258999999999986689668909999856922074
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.62 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=219.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 98567984842259579999999679909999993056348888999999999998179998214889998189699999
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVM 96 (1437)
.++|.+.+.||+|+||.||+|+. +..||+|+++.........+.+.+|+.+|++++|||||++++++. ++.+|+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEE---CCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEEE
T ss_conf 45189988983078858999999---998999999734699899999999999998479987864567971-55899999
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC--C
Q ss_conf 61489998898611999999999999999999999999998893211125883686459919997206631245577--6
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD--V 174 (1437)
Q Consensus 97 EYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd--~ 174 (1437)
|||++|+|.+++...+ +++++..+..|+.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 83 Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp ECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred ECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCCC
T ss_conf 6589988899985235-789999999999999999888750999516147899798189978875002213335567763
Q ss_pred CCCCCCCCCCCCCHHHHHCC---CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-CC----CCCCCCCHH
Q ss_conf 65444489766771433107---98966413559999999981999999999835899976248-99----999999989
Q 000535 175 NTHSVVGTPYWMAPEVIEMS---GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE-RP----PIPESLSPD 246 (1437)
Q Consensus 175 k~~t~vGTp~YmAPEVLkg~---~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~-rp----pLPk~ISeE 246 (1437)
......||+.|+|||++... .|+.++||||+||++|||++|+.||.+......+...+... .. .++..++++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHHCCCCCHHH
T ss_conf 12566557431799999505689999531516359999999978899899896999999996588898600036555499
Q ss_pred HHHHHHHHHHHCCCCCCCHHHHHCCHHHHHHH
Q ss_conf 99999998231006999999995098899999
Q 000535 247 ITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 247 LkDLIkkLLskDPekRPSAeEILkHPWLQelr 278 (1437)
+.+||.+||..||.+|||+.+++++ ++.++
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~--Le~l~ 271 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS--IELLA 271 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHHH--HHHHH
T ss_conf 9999999758897689299999999--99999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.41 Aligned_cols=255 Identities=26% Similarity=0.461 Sum_probs=221.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 98567984842259579999999679909999993056348888999999999998179998214889998189699999
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIIL 96 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVM 96 (1437)
.++|++.+.||+|+||.||+|++. ++..||||++...... .+.+.+|+.++++++|||||++++++. ++.+|+||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEEC-CCCEEEEE
T ss_conf 899388679810798289999999-9999999998647688---899999999998679998857873104-59769999
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC-C
Q ss_conf 614899988986119999999999999999999999999988932111258836864599199972066312455776-6
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-N 175 (1437)
Q Consensus 97 EYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~-k 175 (1437)
|||++|+|.+++......++++..+..|+.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCCC
T ss_conf 95789828888751478988788999999999999999974895467564225156202440423410147735886442
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 5444489766771433107989664135599999999819-999999998358999762489999999998999999998
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 176 ~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTG-kpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkL 254 (1437)
.....|++.|+|||++....|+.++||||+||++|+|+|| .+||...........+....+++.|..+++++.+||.+|
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 246 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
T ss_conf 03567744445828983799982456452579999999689888888899999999970688889655719999999997
Q ss_pred HHHCCCCCCCHHHHHC--CHHHHH
Q ss_conf 2310069999999950--988999
Q 000535 255 FKKDARQRPDAKTLLS--HPWIQN 276 (1437)
Q Consensus 255 LskDPekRPSAeEILk--HPWLQe 276 (1437)
|..||++|||+.++++ ++||..
T Consensus 247 l~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 247 WKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 588976893999999986113213
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.79 Aligned_cols=253 Identities=26% Similarity=0.459 Sum_probs=222.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 85679848422595799999996799099999930563488889999999999981799982148899981896999996
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVME 97 (1437)
++|.+.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCH---HHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEE
T ss_conf 99588889820888299999988-99999999987886768---999999999996689975653524315993379998
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC-CC
Q ss_conf 14899988986119999999999999999999999999988932111258836864599199972066312455776-65
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NT 176 (1437)
Q Consensus 98 YieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~-k~ 176 (1437)
||++|+|.+++... ...+++..++.|+.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp CCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred ECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEEE
T ss_conf 36999189975201-34788999999999999987765316431044315326666887768655321002368873350
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 44448976677143310798966413559999999981-99999999983589997624899999999989999999982
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 177 ~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkLL 255 (1437)
....||+.|+|||++....|+.++||||+|+++|||++ |.+||......+.+..+....+...|..+++++.+||.+||
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 239 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred CCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
T ss_conf 43001766678578607999840332105999999987898887789999999999806888995436799999999976
Q ss_pred HHCCCCCCCHHHHHCCHHHHHH
Q ss_conf 3100699999999509889999
Q 000535 256 KKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 256 skDPekRPSAeEILkHPWLQel 277 (1437)
..||++|||+.+++++ ++++
T Consensus 240 ~~~p~~Rps~~~il~~--L~~i 259 (263)
T d1sm2a_ 240 KERPEDRPAFSRLLRQ--LAEI 259 (263)
T ss_dssp CSSGGGSCCHHHHHHH--HHHH
T ss_pred CCCHHHCCCHHHHHHH--HHHH
T ss_conf 5797689199999999--9999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.22 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=217.0
Q ss_pred CCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 56556423985679848422595799999996799099999930563488889999999999981799982148899981
Q 000535 9 AFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT 88 (1437)
Q Consensus 9 qFe~setLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfed 88 (1437)
...+.+...-+|...+.||+|+||+||+|++..+++.||+|++...... ..+|+.+|++++||||+++++++..
T Consensus 11 ~~~p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~ 84 (350)
T d1q5ka_ 11 GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYS 84 (350)
T ss_dssp SSSSCCCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CCCCCCCCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH------HHHHHHHHHHCCCCCCCCEEEEEEE
T ss_conf 9999985667767516982176839999999999979999998816068------9999999986689898738789974
Q ss_pred ------CCEEEEEEEECCCCCHHHHHC-CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC-CEEE
Q ss_conf ------896999996148999889861-19999999999999999999999999988932111258836864599-1999
Q 000535 89 ------RSHLHIILEYVENGSLANIIK-PNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKL 160 (1437)
Q Consensus 89 ------dd~LYLVMEYieGGSLsDLLK-ssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG-~VKL 160 (1437)
..++|+|||||+++.+..+.. .....++++..++.|++|++.||+|||++||+||||||+|||++.++ .+||
T Consensus 85 ~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp C--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEE
T ss_pred CCCCCCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEE
T ss_conf 47657731899998416886078888631036899999999999999999999986687645788603787358971167
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC----
Q ss_conf 720663124557766544448976677143310-798966413559999999981999999999835899976248----
Q 000535 161 ADFGVATKLTEADVNTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDE---- 235 (1437)
Q Consensus 161 iDFGLAr~L~esd~k~~t~vGTp~YmAPEVLkg-~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~---- 235 (1437)
+|||++..+.... ...+.+|++.|+|||++.+ ..|+.++||||+||++|+|++|++||......+.+.++....
T Consensus 165 ~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 165 CDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243 (350)
T ss_dssp CCCTTCEECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ECCCCHHHCCCCC-CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCH
T ss_conf 3366054404776-532002555556827764046888210002465277855028799898799999999999748981
Q ss_pred ---------------CC---------CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf ---------------99---------9999999899999999823100699999999509889999
Q 000535 236 ---------------RP---------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 236 ---------------rp---------pLPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
.+ .....+++++.+||.+||.+||.+|||+.|+|+||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 776543062101103554456744443156899999999999765895579299999669845246
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.10 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=216.5
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----
Q ss_conf 2398567984842259579999999679909999993056348888999999999998179998214889998189----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS---- 90 (1437)
Q Consensus 15 tLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd---- 90 (1437)
.++.+|++++.||+|+||.||+|.+..++..||||++.+.. .....+.+.+|+.+|++++||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCC
T ss_conf 73898599789940648099999999999499999980310-95899999999999997689898858889950564554
Q ss_pred -EEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf -6999996148999889861199999999999999999999999999889321112588368645991999720663124
Q 000535 91 -HLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL 169 (1437)
Q Consensus 91 -~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L 169 (1437)
++|++ +|+.+|+|.++++.. ++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 84 KDVYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp CCEEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEE-EEECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 149999-962598656644058---9999999999999999999999789867778764378879997787545705650
Q ss_pred CCCCC---CCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------
Q ss_conf 55776---6544448976677143310-79896641355999999998199999999983589997624899--------
Q 000535 170 TEADV---NTHSVVGTPYWMAPEVIEM-SGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP-------- 237 (1437)
Q Consensus 170 ~esd~---k~~t~vGTp~YmAPEVLkg-~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp-------- 237 (1437)
..... .....+|++.|+|||++.. ..++.++||||+||++|+|++|++||.+....+...........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 47776410101102652000387860478887410100467013377669799788888999998765206997566423
Q ss_pred ----------------------CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf ----------------------9999999899999999823100699999999509889999
Q 000535 238 ----------------------PIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 238 ----------------------pLPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
.....+++++.+||.+||.+||.+|||+.++|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 43322220244677557787778378999999999999764895679089998619865558
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.11 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=224.6
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 85679848422595799999996799099999930563488889999999999981799982148899981896999996
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVME 97 (1437)
++|++.+.||+|+||+||+|++..++..||+|+++...........+.+|+.+++.++||||+++++++.+...+++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 14899988986119999999999999999999999999988932111258836864599199972066312455776654
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTH 177 (1437)
Q Consensus 98 YieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k~~ 177 (1437)
++.++++..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+...........
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred ECCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCCCCE
T ss_conf 02332221121235--6540367899999999998774339986001467612113378266520460110468875100
Q ss_pred CCCCCCCCCCHHHHHCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHC---------------------
Q ss_conf 444897667714331079-89664135599999999819999999998358999-7624---------------------
Q 000535 178 SVVGTPYWMAPEVIEMSG-VCAASDIWSVGCTVIELLTCVPPYYELQPMPALFR-IVQD--------------------- 234 (1437)
Q Consensus 178 t~vGTp~YmAPEVLkg~~-yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~K-IIk~--------------------- 234 (1437)
...+++.|+|||++.... ++.++||||+||++|+|++|+.||........... +...
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred EECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCCCC
T ss_conf 10344310146675069888804440265418899851899998899999999999861189973551344322211334
Q ss_pred -------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf -------899999999989999999982310069999999950988999
Q 000535 235 -------ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 235 -------~rppLPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
........+++.+.+||.+||++||.+|||+.|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred CCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 4454431043306568999999999986499668909999964953407
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.82 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=216.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--------
Q ss_conf 985679848422595799999996799099999930563488889999999999981799982148899981--------
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT-------- 88 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfed-------- 88 (1437)
-++|++.+.||+|+||+||+|++..++..||||++......+.....+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 89699999614899988986119999999999999999999999999988932111258836864599199972066312
Q 000535 89 RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 89 dd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~ 168 (1437)
+..+|+||||+.++.+..... ....+++..++.+++|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEECCCCCCCCHHHH--CCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEEE
T ss_conf 763899985357874101222--034433089999999999999885229988567672220366899687631350022
Q ss_pred CCCCC----CCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC---CCC
Q ss_conf 45577----665444489766771433107-9896641355999999998199999999983589997624899---999
Q 000535 169 LTEAD----VNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP---PIP 240 (1437)
Q Consensus 169 L~esd----~k~~t~vGTp~YmAPEVLkg~-~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp---pLP 240 (1437)
+.... ....+.+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.........+...... ...
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHC
T ss_conf 35544432113566024978742899707999891787006786466174487998998999999999984189982553
Q ss_pred C----------------------------CCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 9----------------------------99989999999982310069999999950988999
Q 000535 241 E----------------------------SLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 241 k----------------------------~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
. ..++++.+||.+||.+||++|||+.|+|+||||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 4432034443320133445550334044459989999999987389658909999974950156
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.04 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=223.8
Q ss_pred CCCCCCC---CCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 5655642---3985679848422595799999996799099999930563488889999999999981799982148899
Q 000535 9 AFHKSKT---LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGS 85 (1437)
Q Consensus 9 qFe~set---LgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGV 85 (1437)
.++.++. +-++|++.+.||+|+||+||+|++..++..||||++............+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~ 84 (355)
T d2b1pa1 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84 (355)
T ss_dssp EEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred EEEECCCCEEECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 99958940453377599889621758599999999999899999988233697999999999999986489876489989
Q ss_pred EEE------CCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEE
Q ss_conf 981------89699999614899988986119999999999999999999999999988932111258836864599199
Q 000535 86 LKT------RSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVK 159 (1437)
Q Consensus 86 fed------dd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VK 159 (1437)
+.. ..++|+|||||.+ ++.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++
T Consensus 85 f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 85 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp ECSCCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred EECCCCCCCCCEEEEEEECCCH-HHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 7025643457626999841446-7787650----3899999999999999999886522112456776321136544313
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-
Q ss_conf 9720663124557766544448976677143310798966413559999999981999999999835899976248999-
Q 000535 160 LADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERPP- 238 (1437)
Q Consensus 160 LiDFGLAr~L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rpp- 238 (1437)
++|||+++...... .....+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+......++......+
T Consensus 160 l~df~~~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 160 ILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp ECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EECHHHHHCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 20102321146665-53322146555581331477778774333566257898659899888977889999997205898
Q ss_pred --------------------C--------------------CCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf --------------------9--------------------9999989999999982310069999999950988999
Q 000535 239 --------------------I--------------------PESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 239 --------------------L--------------------Pk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
. +...++++.+||++||..||++||||+|+|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 799987656677776417543566642126433354321013337999999999987699457908999966942087
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.74 Aligned_cols=252 Identities=26% Similarity=0.430 Sum_probs=220.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCE----EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 856798484225957999999967990----9999993056348888999999999998179998214889998189699
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGD----FVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk----~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LY 93 (1437)
.+|++.+.||+|+||.||+|.+..++. .||+|.+.... .....+.+.+|+.++++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEE
T ss_conf 999783198208992999999958998898999999965134-979999999999999867998881589999619-836
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99961489998898611999999999999999999999999998893211125883686459919997206631245577
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd 173 (1437)
+++||+.+|+|.+.+... ...+++..++.|+.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEEEECCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCCC
T ss_conf 999842687401011133-4579999999999999999999987695047621203116799875860255222335444
Q ss_pred C--CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 6--6544448976677143310798966413559999999981-999999999835899976248999999999899999
Q 000535 174 V--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDF 250 (1437)
Q Consensus 174 ~--k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDL 250 (1437)
. ......||+.|+|||++.+..|+.++||||+||++|||+| |.+||.+....+....+..+.+++.|..+++++.+|
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~l 245 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf 53223651058644670887469998356544079999999977999999999899999997599899985568999999
Q ss_pred HHHHHHHCCCCCCCHHHHHCCH
Q ss_conf 9998231006999999995098
Q 000535 251 LRQCFKKDARQRPDAKTLLSHP 272 (1437)
Q Consensus 251 IkkLLskDPekRPSAeEILkHP 272 (1437)
|.+||..+|.+|||+.+++.|.
T Consensus 246 i~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHCCCCHHHCCCHHHHHHHH
T ss_conf 9984789934691999999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.48 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=226.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCC---EEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 985679848422595799999996799---09999993056348888999999999998179998214889998189699
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENG---DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTG---k~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LY 93 (1437)
.++|++++.||+|+||.||+|++..++ ..||+|.+... ......+.+.+|+.++++++||||+++++++. ++.+|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEE
T ss_conf 89969877993078829999999369964499999993656-68799999999999998689999856988995-37479
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99961489998898611999999999999999999999999998893211125883686459919997206631245577
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEAD 173 (1437)
Q Consensus 94 LVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd 173 (1437)
+||||+++|+|.+++.... +++++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+....
T Consensus 84 iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCCC
T ss_conf 9998406980776542247-899999999999999877523022674414102655320678967876503421336776
Q ss_pred C-CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6-6544448976677143310798966413559999999981-9999999998358999762489999999998999999
Q 000535 174 V-NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFL 251 (1437)
Q Consensus 174 ~-k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLI 251 (1437)
. ......||+.|+|||++....|+.++||||+||++|+|++ |.+||.+....+...++....+.++++.+|+++.+||
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 242 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred CEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
T ss_conf 23305400583103266751699887452444247899998269999888999999999981899989877799999999
Q ss_pred HHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf 99823100699999999509889999
Q 000535 252 RQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 252 kkLLskDPekRPSAeEILkHPWLQel 277 (1437)
.+||..||.+|||+.+++++ ++.+
T Consensus 243 ~~cl~~dp~~Rps~~ei~~~--L~~i 266 (273)
T d1mp8a_ 243 TKCWAYDPSRRPRFTELKAQ--LSTI 266 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HHHCCCCHHHCCCHHHHHHH--HHHH
T ss_conf 99768797689299999999--9999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.83 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=221.3
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-----
Q ss_conf 239856798484225957999999967990999999305634888899999999999817999821488999818-----
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR----- 89 (1437)
Q Consensus 15 tLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfedd----- 89 (1437)
.+.++|++.+.||+|+||+||+|++..++..||||++.+........+.+.+|+.+|++++||||+++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf 58987188889831788399999999999799999988200286899999999999986689874259999963464566
Q ss_pred CEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 96999996148999889861199999999999999999999999999889321112588368645991999720663124
Q 000535 90 SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL 169 (1437)
Q Consensus 90 d~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L 169 (1437)
...+++++|+.||+|.+++.. +++++..++.++.|++.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred CCEEEEEEEECCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC
T ss_conf 864999996258862320022---45309999999999999999997388765166776334554322001321000125
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-----------
Q ss_conf 5577665444489766771433107-9896641355999999998199999999983589997624899-----------
Q 000535 170 TEADVNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQDERP----------- 237 (1437)
Q Consensus 170 ~esd~k~~t~vGTp~YmAPEVLkg~-~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk~~rp----------- 237 (1437)
.. ...+..|++.|+|||++.+. .++.++||||+||++|+|++|++||.+.+.......+......
T Consensus 172 ~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 172 DD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp TG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred CC---CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCC
T ss_conf 75---444434543555835533775678551243205899999768899788988999999997307997577320010
Q ss_pred -----------C--------CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf -----------9--------999999899999999823100699999999509889999
Q 000535 238 -----------P--------IPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 238 -----------p--------LPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
. ....+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 24454443035578755566267899999999999775883459389998559954879
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.43 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=224.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 85679848422595799999996799099999930563488889999999999981799982148899981896999996
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHLHIILE 97 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~LYLVME 97 (1437)
++|++.+.||+|+||+||+|++ .++..||+|++++..... +.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCH---HHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
T ss_conf 9979968982078839999998-899899999987475778---999999999996689860158899850781699997
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC-CC
Q ss_conf 14899988986119999999999999999999999999988932111258836864599199972066312455776-65
Q 000535 98 YVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-NT 176 (1437)
Q Consensus 98 YieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~-k~ 176 (1437)
|+++|+|.+++.... ..+++..+++|+.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 80 y~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 80 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEEE
T ss_conf 048993888641024-6776899999999999999987546843466541358876998479886144202357872252
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 44448976677143310798966413559999999981-99999999983589997624899999999989999999982
Q 000535 177 HSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQCF 255 (1437)
Q Consensus 177 ~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkLL 255 (1437)
....||+.|+|||++....|+.++||||+|+++|||+| |+.||.+....+...++....+.+.|..+++++.+||.+||
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 238 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred CCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
T ss_conf 46578877578078637998852103364324673975599998899999999999807978996546599999999976
Q ss_pred HHCCCCCCCHHHHHCC
Q ss_conf 3100699999999509
Q 000535 256 KKDARQRPDAKTLLSH 271 (1437)
Q Consensus 256 skDPekRPSAeEILkH 271 (1437)
+.||++|||+.++++|
T Consensus 239 ~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 239 HEKADERPTFKILLSN 254 (258)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCCHHHCCCHHHHHHH
T ss_conf 6897689399999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.74 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=221.3
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCC----EEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 423985679848422595799999996799----0999999305634888899999999999817999821488999818
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENG----DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTR 89 (1437)
Q Consensus 14 etLgnRYkIlEkLGkGSFGtVYKArDkkTG----k~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfedd 89 (1437)
+.-.+.|.+.+.||+|+||.||+|....++ ..||+|.+.... .......+.+|+.++++++|||||++++++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 5788996861598117790999999968998787999999988445-968999999999999856898783236778338
Q ss_pred CEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 96999996148999889861199999999999999999999999999889321112588368645991999720663124
Q 000535 90 SHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKL 169 (1437)
Q Consensus 90 d~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L 169 (1437)
..+++|||||.++++.+++.... +.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCEEEEEEECCCCCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 80389997213574022210234-54208999999999998541212123425765644278889984998455103003
Q ss_pred CCCCC---CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCH
Q ss_conf 55776---654444897667714331079896641355999999998199-99999998358999762489999999998
Q 000535 170 TEADV---NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCV-PPYYELQPMPALFRIVQDERPPIPESLSP 245 (1437)
Q Consensus 170 ~esd~---k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGk-pPF~g~s~~eqL~KIIk~~rppLPk~ISe 245 (1437)
..... ......||+.|+|||++.+..++.++||||+|+++|||+++. +||......+....+..+.+++.+..+++
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCHHHHH
T ss_conf 57876526742677773434888870499997355634489899999679886556899999999863578998504579
Q ss_pred HHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf 99999999823100699999999509889999
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 246 ELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
++.+||.+||..+|++||++.++++ .+..+
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~--~L~~l 270 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS--ILDKL 270 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH--HHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHH--HHHHH
T ss_conf 9999999977679768939999999--99998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=365.52 Aligned_cols=251 Identities=24% Similarity=0.463 Sum_probs=210.9
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE--CCEE
Q ss_conf 398567984842259579999999679909999993056348888999999999998179-9982148899981--8969
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKT--RSHL 92 (1437)
Q Consensus 16 LgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLk-HPNIVKLlGVfed--dd~L 92 (1437)
..++|++++.||+|+||+||+|++..++..||+|+++... .+.+.+|+.+|+.+. ||||+++++++.. ...+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCE
T ss_conf 9867189789831748199999988999799999988899-----99999999999851579987679999981687712
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC-CEEEEECCCCCCCCC
Q ss_conf 9999614899988986119999999999999999999999999988932111258836864599-199972066312455
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEG-LVKLADFGVATKLTE 171 (1437)
Q Consensus 93 YLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG-~VKLiDFGLAr~L~e 171 (1437)
|+|||||.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEEEECCCCCHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 6888631798589974-----68999999999999999998876433443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHH------------C---
Q ss_conf 77665444489766771433107-989664135599999999819999999998358-999762------------4---
Q 000535 172 ADVNTHSVVGTPYWMAPEVIEMS-GVCAASDIWSVGCTVIELLTCVPPYYELQPMPA-LFRIVQ------------D--- 234 (1437)
Q Consensus 172 sd~k~~t~vGTp~YmAPEVLkg~-~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eq-L~KIIk------------~--- 234 (1437)
.. .....++|+.|+|||++.+. .++.++||||+||++|+|++|..||........ ...+.. .
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf 87-44432248642476102688888845232335455587604889998876018999999998788415555542254
Q ss_pred ---------------------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf ---------------------8999999999899999999823100699999999509889999
Q 000535 235 ---------------------ERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 235 ---------------------~rppLPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
........+++++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred CCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 4474300000333433112115521124489999999999866995689089999649355887
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.91 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=222.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEE--EEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCEEEE
Q ss_conf 8567984842259579999999679909--99999305634888899999999999817-99982148899981896999
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDLENGDF--VAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRSHLHI 94 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDkkTGk~--VAIKVIkke~lSeEeieeLlREIkILKrL-kHPNIVKLlGVfeddd~LYL 94 (1437)
++|++.+.||+|+||.||+|++..++.. ||+|.+.... ..+..+.+.+|+.+|+++ +||||+++++++.+.+.+|+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
T ss_conf 9968877982078828999999899969999999978233-857999999999999862289988367888841873699
Q ss_pred EEEECCCCCHHHHHCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEE
Q ss_conf 99614899988986119--------------9999999999999999999999999889321112588368645991999
Q 000535 95 ILEYVENGSLANIIKPN--------------KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKL 160 (1437)
Q Consensus 95 VMEYieGGSLsDLLKss--------------k~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKL 160 (1437)
||||+++|+|.++++.. ....+++..+..++.|++.||.|+|+++|+||||||+|||++.++.+||
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCEEE
T ss_conf 99802898699998640355555123101234578999999999999999987663089545550520489868876387
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 72066312455776654444897667714331079896641355999999998199-99999998358999762489999
Q 000535 161 ADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCV-PPYYELQPMPALFRIVQDERPPI 239 (1437)
Q Consensus 161 iDFGLAr~L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGk-pPF~g~s~~eqL~KIIk~~rppL 239 (1437)
+|||+++...... ......||..|+|||.+....|+.++||||||+++|+|++|. +||.+.+..+....+..+.+++.
T Consensus 169 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~ 247 (309)
T d1fvra_ 169 ADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247 (309)
T ss_dssp CCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCC
T ss_pred CCCCCCCCCCCCC-CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 4344322444223-455301377555538752699996221531388999998368999999999999999982688888
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCC
Q ss_conf 99999899999999823100699999999509
Q 000535 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 240 Pk~ISeELkDLIkkLLskDPekRPSAeEILkH 271 (1437)
+..+++++.+||.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 76678999999999767896689499999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.76 Aligned_cols=258 Identities=28% Similarity=0.491 Sum_probs=223.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC---CCCEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCE
Q ss_conf 85679848422595799999996---79909999993056348--8889999999999981799-982148899981896
Q 000535 18 NKYMLGDEIGKGAYGRVYKGLDL---ENGDFVAIKQVSLENIA--QEDLNIIMQEIDLLKNLNH-KNIVKYLGSLKTRSH 91 (1437)
Q Consensus 18 nRYkIlEkLGkGSFGtVYKArDk---kTGk~VAIKVIkke~lS--eEeieeLlREIkILKrLkH-PNIVKLlGVfeddd~ 91 (1437)
++|++.+.||+|+||.||+|++. .++..||+|++.+.... ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99999614899988986119999999999999999999999999988932111258836864599199972066312455
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTE 171 (1437)
Q Consensus 92 LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~e 171 (1437)
+|++|||+.+|+|.+++... +.+++..++.++.|++.||+|+|+++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EEEEEECCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHHCC
T ss_conf 00123123411799998730--4543788888899999999885149989654773201246999888741320222034
Q ss_pred CC-CCCCCCCCCCCCCCHHHHHCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHCCCCCCCCCCCH
Q ss_conf 77-665444489766771433107--98966413559999999981999999999835899---9762489999999998
Q 000535 172 AD-VNTHSVVGTPYWMAPEVIEMS--GVCAASDIWSVGCTVIELLTCVPPYYELQPMPALF---RIVQDERPPIPESLSP 245 (1437)
Q Consensus 172 sd-~k~~t~vGTp~YmAPEVLkg~--~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~---KIIk~~rppLPk~ISe 245 (1437)
.. ....+..|++.|++||.+... .++.++||||+||+||+|++|..||.+........ +......++++..+|+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 261 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCH
T ss_conf 44432212223333310687605776887132517777999999768999888877779999998335689988654799
Q ss_pred HHHHHHHHHHHHCCCCCC-----CHHHHHCCHHHHHH
Q ss_conf 999999998231006999-----99999509889999
Q 000535 246 DITDFLRQCFKKDARQRP-----DAKTLLSHPWIQNC 277 (1437)
Q Consensus 246 ELkDLIkkLLskDPekRP-----SAeEILkHPWLQel 277 (1437)
++.+||.+||.+||.+|| ++.|+++||||+..
T Consensus 262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCC
T ss_conf 9999999974458988199974509999749723489
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.13 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=219.1
Q ss_pred CCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 65655642398567984842259579999999679909999993056348888999999999998179998214889998
Q 000535 8 SAFHKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLK 87 (1437)
Q Consensus 8 sqFe~setLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfe 87 (1437)
..|+.. .++|++.+.||+|+||.||+|++..+ ..||+|++...... .+.+.+|+.++++++|||||++++++.
T Consensus 10 ~~~~i~---~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 10 DAWEIP---RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp TCSBCC---GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCEECC---HHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 560747---79979846993079809999999999-99999998804488---899999999998666678868999982
Q ss_pred ECCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 18969999961489998898611999999999999999999999999998893211125883686459919997206631
Q 000535 88 TRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVAT 167 (1437)
Q Consensus 88 ddd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr 167 (1437)
++.+|+|||||++|+|..++.......+++..++.|+.|++.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 83 -~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 83 -EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp -SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred -CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHH
T ss_conf -3975999994479943542000035530599999999999999998754114335312307999899929984425554
Q ss_pred CCCCCCC-CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCH
Q ss_conf 2455776-65444489766771433107989664135599999999819-999999998358999762489999999998
Q 000535 168 KLTEADV-NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPIPESLSP 245 (1437)
Q Consensus 168 ~L~esd~-k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTG-kpPF~g~s~~eqL~KIIk~~rppLPk~ISe 245 (1437)
.+..... ......|++.|+|||++....++.++||||+|+++|+|++| .+||......+.+..+....+.+.+..+++
T Consensus 162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (285)
T d1fmka3 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred HCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCH
T ss_conf 25688733524545566545808983799891774132358999998689999988889999999982689999832379
Q ss_pred HHHHHHHHHHHHCCCCCCCHHHHHC
Q ss_conf 9999999982310069999999950
Q 000535 246 DITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 246 ELkDLIkkLLskDPekRPSAeEILk 270 (1437)
++.+||.+||+.||++||++.++++
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999999975669758919999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=359.83 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=225.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 985679848422595799999996-----799099999930563488889999999999981799982148899981896
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSH 91 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDk-----kTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd~ 91 (1437)
.++|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.++++++||||+++++++.....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-CHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf 88938867982078839999998887657788299999988210-85799999999999996689976552466605980
Q ss_pred EEEEEEECCCCCHHHHHCCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 999996148999889861199----------------------9999999999999999999999998893211125883
Q 000535 92 LHIILEYVENGSLANIIKPNK----------------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGAN 149 (1437)
Q Consensus 92 LYLVMEYieGGSLsDLLKssk----------------------~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPEN 149 (1437)
.++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+++|+||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCC
T ss_conf 38999815899299999852755421000011100121034678898999999999999998554135786854884011
Q ss_pred EEECCCCCEEEEECCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCHH
Q ss_conf 6864599199972066312455776--65444489766771433107989664135599999999819-99999999835
Q 000535 150 ILTTKEGLVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMP 226 (1437)
Q Consensus 150 ILIssDG~VKLiDFGLAr~L~esd~--k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTG-kpPF~g~s~~e 226 (1437)
||++.++.+||+|||+++.+..... ...+.+|++.|+|||++....|+.++||||+||++|||++| .+||.+....+
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCHHH
T ss_conf 68989992898331442113677641115777767676798997268898056302523629999806899999989999
Q ss_pred HHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 89997624899999999989999999982310069999999950988999
Q 000535 227 ALFRIVQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 227 qL~KIIk~~rppLPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
....+.....+++|..+++++.+||.+||..+|.+|||+.++++ ++++
T Consensus 251 ~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~ 298 (301)
T d1lufa_ 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR 298 (301)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred HHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH--HHHH
T ss_conf 99999739978887325299999999974889657939999999--9998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.34 Aligned_cols=253 Identities=27% Similarity=0.483 Sum_probs=223.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCC-------EEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE
Q ss_conf 985679848422595799999996799-------0999999305634888899999999999817-99982148899981
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENG-------DFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT 88 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTG-------k~VAIKVIkke~lSeEeieeLlREIkILKrL-kHPNIVKLlGVfed 88 (1437)
.++|.+++.||+|+||.||+|++..++ ..||+|++.... .......+.+|+..+.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 8996970098516782899999857875556675499999988112-868899999999999981399969734652201
Q ss_pred CCEEEEEEEECCCCCHHHHHCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
Q ss_conf 896999996148999889861199--------------999999999999999999999999889321112588368645
Q 000535 89 RSHLHIILEYVENGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK 154 (1437)
Q Consensus 89 dd~LYLVMEYieGGSLsDLLKssk--------------~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIss 154 (1437)
++.+|+|||||++|+|.+++.... ...+++..++.++.|++.||+|||+++|+||||||+|||++.
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCEEECC
T ss_conf 88689999736999099999860677643222334574346799999999999999998766379786302210224547
Q ss_pred CCCEEEEECCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHH
Q ss_conf 99199972066312455776--6544448976677143310798966413559999999981-99999999983589997
Q 000535 155 EGLVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRI 231 (1437)
Q Consensus 155 DG~VKLiDFGLAr~L~esd~--k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KI 231 (1437)
++.+||+|||+++....... .....+|++.|+|||++....|+.++||||||+++|+|++ |.+||.+.........+
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i 250 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
T ss_conf 89767622111011355555431466788846632667517988825554775888887401798989999999999999
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHC
Q ss_conf 624899999999989999999982310069999999950
Q 000535 232 VQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 232 Ik~~rppLPk~ISeELkDLIkkLLskDPekRPSAeEILk 270 (1437)
..+..++.|..+++++.+||.+||++||.+|||+.|+++
T Consensus 251 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 728888987435299999999976679767939999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.07 Aligned_cols=254 Identities=26% Similarity=0.472 Sum_probs=216.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE-C
Q ss_conf 9856798484225957999999967-----990999999305634888899999999999817-99982148899981-8
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLE-----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKT-R 89 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkk-----TGk~VAIKVIkke~lSeEeieeLlREIkILKrL-kHPNIVKLlGVfed-d 89 (1437)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... .......+.+|+.++.++ +|+||+.+++++.. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC
T ss_conf 79979844984167839999998677755578399999986001-71789999999999886149984997411540479
Q ss_pred CEEEEEEEECCCCCHHHHHCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC
Q ss_conf 96999996148999889861199--------------9999999999999999999999998893211125883686459
Q 000535 90 SHLHIILEYVENGSLANIIKPNK--------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKE 155 (1437)
Q Consensus 90 d~LYLVMEYieGGSLsDLLKssk--------------~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssD 155 (1437)
..+++|||||++|+|.++++... ...+++..+..|+.|++.||.|||+++|+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC
T ss_conf 75799998458992999998536666653222023321468999999999999999998873797178677310657799
Q ss_pred CCEEEEECCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHH-
Q ss_conf 9199972066312455776--65444489766771433107989664135599999999819-9999999983589997-
Q 000535 156 GLVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRI- 231 (1437)
Q Consensus 156 G~VKLiDFGLAr~L~esd~--k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTG-kpPF~g~s~~eqL~KI- 231 (1437)
+.+||+|||+|+....... .....+||+.|+|||++.+..++.++||||+||++|+|++| .+||.+......+...
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~ 250 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 82898457520011356652224751667210203686468899663221367899999868899998999899999999
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCC
Q ss_conf 6248999999999899999999823100699999999509
Q 000535 232 VQDERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSH 271 (1437)
Q Consensus 232 Ik~~rppLPk~ISeELkDLIkkLLskDPekRPSAeEILkH 271 (1437)
..+.+++.+..+++++.+||.+||..||.+|||+.++++|
T Consensus 251 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 6389888886578999999999767796679199999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.77 Aligned_cols=251 Identities=24% Similarity=0.460 Sum_probs=223.1
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEE
Q ss_conf 985679848422595799999996799099999930563488889999999999981799982148899981-8969999
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT-RSHLHII 95 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfed-dd~LYLV 95 (1437)
.++|++.+.||+|+||.||+|++ .+..||+|+++... ..+.+.+|+.++++++||||+++++++.+ ++.+|+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHEEEEEEEECCCCEEEEEEEE--CCEEEEEEEECCHH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 89948857982079808999999--99099999988577----7999999999998678989854987887238928999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96148999889861199999999999999999999999999889321112588368645991999720663124557766
Q 000535 96 LEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVN 175 (1437)
Q Consensus 96 MEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~k 175 (1437)
|||+++|+|.+++.......+++..++.|+.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCC---
T ss_conf 96369998999987457888899999999999985232113376553666567601468997763245600344787---
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 544448976677143310798966413559999999981-9999999998358999762489999999998999999998
Q 000535 176 THSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDERPPIPESLSPDITDFLRQC 254 (1437)
Q Consensus 176 ~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KIIk~~rppLPk~ISeELkDLIkkL 254 (1437)
.....+++.|+|||++.+..++.++||||||+++|||++ |++||......+....+....+++++..+++++.+||.+|
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 236 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 236 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 76556664677817872798885887775799999999789999999999999999980899999765799999999997
Q ss_pred HHHCCCCCCCHHHHHCCHHHHHHH
Q ss_conf 231006999999995098899999
Q 000535 255 FKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 255 LskDPekRPSAeEILkHPWLQelr 278 (1437)
|..||.+|||+.+++++ +++++
T Consensus 237 l~~dP~~Rps~~~l~~~--L~~i~ 258 (262)
T d1byga_ 237 WHLDAAMRPSFLQLREQ--LEHIK 258 (262)
T ss_dssp TCSSGGGSCCHHHHHHH--HHHHH
T ss_pred CCCCHHHCCCHHHHHHH--HHHHH
T ss_conf 56697689399999999--99998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.04 Aligned_cols=254 Identities=24% Similarity=0.440 Sum_probs=224.0
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 39856798484225957999999967-----9909999993056348888999999999998179998214889998189
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLE-----NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 16 LgnRYkIlEkLGkGSFGtVYKArDkk-----TGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd 90 (1437)
-.++|.+.+.||+|+||.||+|.+.. ++..||||++... ........+.+|+.++++++||||+++++++..+.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 68991883598207881899999878644778968999998701-28689999999999999769998841254784288
Q ss_pred EEEEEEEECCCCCHHHHHCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEE
Q ss_conf 699999614899988986119--------999999999999999999999999988932111258836864599199972
Q 000535 91 HLHIILEYVENGSLANIIKPN--------KFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLAD 162 (1437)
Q Consensus 91 ~LYLVMEYieGGSLsDLLKss--------k~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiD 162 (1437)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCCEEEEEE
T ss_conf 10677760489988999875033211344468879999999999999999987647965432867754035996499942
Q ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 066312455776--65444489766771433107989664135599999999819-999999998358999762489999
Q 000535 163 FGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTC-VPPYYELQPMPALFRIVQDERPPI 239 (1437)
Q Consensus 163 FGLAr~L~esd~--k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTG-kpPF~g~s~~eqL~KIIk~~rppL 239 (1437)
||+++.+..... ......|++.|+|||.+.+..++.++||||+|+++|+|++| .+||.+.+..+.+..+....+++.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~ 256 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred CCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 45420235776303134023163237888873699883334443789999999689999999899999999980888888
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCHHHHHC
Q ss_conf 9999989999999982310069999999950
Q 000535 240 PESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 240 Pk~ISeELkDLIkkLLskDPekRPSAeEILk 270 (1437)
+..+++.+.++|.+||+.+|++|||+.++++
T Consensus 257 p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 6335399999999975779658939999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.31 Aligned_cols=253 Identities=27% Similarity=0.460 Sum_probs=221.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECC
Q ss_conf 985679848422595799999996-----7990999999305634888899999999999817-9998214889998189
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDL-----ENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNL-NHKNIVKYLGSLKTRS 90 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDk-----kTGk~VAIKVIkke~lSeEeieeLlREIkILKrL-kHPNIVKLlGVfeddd 90 (1437)
.++|++++.||+|+||.||+|... .+++.||+|+++... .......+.+|+.+++.+ +|||||++++++.+..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 89969854982068829999998066447788699999987424-87799999999999876269998878998983199
Q ss_pred EEEEEEEECCCCCHHHHHCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
Q ss_conf 6999996148999889861199----------------999999999999999999999999889321112588368645
Q 000535 91 HLHIILEYVENGSLANIIKPNK----------------FGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK 154 (1437)
Q Consensus 91 ~LYLVMEYieGGSLsDLLKssk----------------~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIss 154 (1437)
.+|+|||||++|+|.++++... ...+++..+..|+.||+.||.|||+++++||||||+||+++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCC
T ss_conf 78999973799879999985356654444453322233458899999999999999999887579266624102100002
Q ss_pred CCCEEEEECCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHH
Q ss_conf 99199972066312455776--6544448976677143310798966413559999999981-99999999983589997
Q 000535 155 EGLVKLADFGVATKLTEADV--NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRI 231 (1437)
Q Consensus 155 DG~VKLiDFGLAr~L~esd~--k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KI 231 (1437)
++.+|++|||+++....... .....+||+.|+|||++....++.++||||||+++|+|++ |.+||......+.+.++
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 57521023401023367886158620135968767788617999974001025899999985899887789989999999
Q ss_pred HH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHC
Q ss_conf 62-4899999999989999999982310069999999950
Q 000535 232 VQ-DERPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLS 270 (1437)
Q Consensus 232 Ik-~~rppLPk~ISeELkDLIkkLLskDPekRPSAeEILk 270 (1437)
+. ..++..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 261 i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 8668988985436599999999975779657929999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.24 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=215.6
Q ss_pred EEEEEECCCCCEEEEEEEECCCC---EEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEEE
Q ss_conf 79848422595799999996799---099999930563488889999999999981799982148899981-89699999
Q 000535 21 MLGDEIGKGAYGRVYKGLDLENG---DFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKT-RSHLHIIL 96 (1437)
Q Consensus 21 kIlEkLGkGSFGtVYKArDkkTG---k~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfed-dd~LYLVM 96 (1437)
.+.+.||+|+||+||+|++..++ ..||+|.+... ......+.+.+|+.+|++++||||+++++++.. ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 2666981368809999999779987999999998843-697899999999999986789998678678980699438999
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC--
Q ss_conf 614899988986119999999999999999999999999988932111258836864599199972066312455776--
Q 000535 97 EYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADV-- 174 (1437)
Q Consensus 97 EYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~esd~-- 174 (1437)
|||++|+|.+++... ...+++..+..++.|++.||.|+|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEECCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCC
T ss_conf 874067414421013-4540489999999998876520033676257766875767799988991065232255665553
Q ss_pred --CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --65444489766771433107989664135599999999819999999-998358999762489999999998999999
Q 000535 175 --NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYE-LQPMPALFRIVQDERPPIPESLSPDITDFL 251 (1437)
Q Consensus 175 --k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g-~s~~eqL~KIIk~~rppLPk~ISeELkDLI 251 (1437)
......||+.|+|||++....++.++||||||+++|||++|..||.. ....+....+..+.++..|..+++++.+||
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
T ss_conf 10025655564556768874379997457466199999999789999888999999999980898899644759999999
Q ss_pred HHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf 99823100699999999509889999
Q 000535 252 RQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 252 kkLLskDPekRPSAeEILkHPWLQel 277 (1437)
.+||..||++||++.|++++ ++..
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~--L~~i 291 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSR--ISAI 291 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HHHCCCCHHHCCCHHHHHHH--HHHH
T ss_conf 99768897689399999999--9999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.87 Aligned_cols=256 Identities=28% Similarity=0.494 Sum_probs=220.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECC-CC--EEEEEEEEECCCCCH-HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 9856798484225957999999967-99--099999930563488-8899999999999817999821488999818969
Q 000535 17 DNKYMLGDEIGKGAYGRVYKGLDLE-NG--DFVAIKQVSLENIAQ-EDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 17 gnRYkIlEkLGkGSFGtVYKArDkk-TG--k~VAIKVIkke~lSe-EeieeLlREIkILKrLkHPNIVKLlGVfeddd~L 92 (1437)
..+|++.+.||+|+||.||+|+... ++ ..||+|++.+..... ...+.+.+|+.+|++++||||+++++++.+ +.+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 4891997898038883999999988999079999999983555798999999999999986899998789877740-100
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99996148999889861199999999999999999999999999889321112588368645991999720663124557
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEA 172 (1437)
Q Consensus 93 YLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDFGLAr~L~es 172 (1437)
++|||||++|++.+.+... .+++++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred HEEEEEECCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCCC
T ss_conf 1146542386125444212-689999999999999999998752178752056688815655654332561155530358
Q ss_pred CC---CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHH
Q ss_conf 76---6544448976677143310798966413559999999981-999999999835899976248-999999999899
Q 000535 173 DV---NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLT-CVPPYYELQPMPALFRIVQDE-RPPIPESLSPDI 247 (1437)
Q Consensus 173 d~---k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLT-GkpPF~g~s~~eqL~KIIk~~-rppLPk~ISeEL 247 (1437)
.. ......|+..|+|||++.+..++.++||||+|+++|||++ |.+||.+.+..+....+.... +++.+..+|+++
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHH
T ss_conf 87526547632573107999983799994215661489999999689999999699999999984799999854453999
Q ss_pred HHHHHHHHHHCCCCCCCHHHHHCCHHHHH
Q ss_conf 99999982310069999999950988999
Q 000535 248 TDFLRQCFKKDARQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 248 kDLIkkLLskDPekRPSAeEILkHPWLQe 276 (1437)
.+||.+||..||.+|||+.+++ .++.+
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~--~~L~~ 271 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALR--DFLLE 271 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred HHHHHHHCCCCHHHCCCHHHHH--HHHHH
T ss_conf 9999997688966792999999--99996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-45 Score=339.99 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=207.3
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCC-CCEEEEEEEECCEEE
Q ss_conf 2398567984842259579999999679909999993056348888999999999998179998-214889998189699
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN-IVKYLGSLKTRSHLH 93 (1437)
Q Consensus 15 tLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPN-IVKLlGVfeddd~LY 93 (1437)
-++++|++.+.||+|+||.||+|++..++..||+|++...... ..+..|+++++.+.|++ |+.+.+++.+....+
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred EECCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEE
T ss_conf 1888899968985078809999999889989999997210058----889999999997038996017999995198778
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEEECCCCCCCC
Q ss_conf 9996148999889861199999999999999999999999999889321112588368645---9919997206631245
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK---EGLVKLADFGVATKLT 170 (1437)
Q Consensus 94 LVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIss---DG~VKLiDFGLAr~L~ 170 (1437)
+||||+. +++.+.+... .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+|+.+.
T Consensus 80 ivme~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEECCC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEECC-CCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf 9998738-7133324430-6887689999999999999999997994426678766064335777615650467513425
Q ss_pred CCCC-------CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------CCC
Q ss_conf 5776-------65444489766771433107989664135599999999819999999998358999762-------489
Q 000535 171 EADV-------NTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPALFRIVQ-------DER 236 (1437)
Q Consensus 171 esd~-------k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL~KIIk-------~~r 236 (1437)
.... .....+||+.|+|||++.+..++.++||||+||++|+|++|..||...........+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCH
T ss_conf 54455410001357767873532999991899898321886177899998498766553057799999985235678983
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHH---HCCHHH
Q ss_conf 99999999899999999823100699999999---509889
Q 000535 237 PPIPESLSPDITDFLRQCFKKDARQRPDAKTL---LSHPWI 274 (1437)
Q Consensus 237 ppLPk~ISeELkDLIkkLLskDPekRPSAeEI---LkHPWL 274 (1437)
+.....+|+++.+||.+||..+|++||++.++ |+|+|.
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 57534788999999999843995579199999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-44 Score=333.16 Aligned_cols=256 Identities=20% Similarity=0.276 Sum_probs=212.6
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCEE
Q ss_conf 423985679848422595799999996799099999930563488889999999999981799-9821488999818969
Q 000535 14 KTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNH-KNIVKYLGSLKTRSHL 92 (1437)
Q Consensus 14 etLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkH-PNIVKLlGVfeddd~L 92 (1437)
.+++++|++++.||+|+||.||+|++..+++.||+|++...... ..+.+|+++++.+.| +|++.+++++......
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
T ss_conf 97898069979984178829999999889979999997502582----99999999999964899987799996018811
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC-----CCCEEEEECCCCC
Q ss_conf 99996148999889861199999999999999999999999999889321112588368645-----9919997206631
Q 000535 93 HIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTK-----EGLVKLADFGVAT 167 (1437)
Q Consensus 93 YLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIss-----DG~VKLiDFGLAr 167 (1437)
|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 77 ~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEEC-CCCHHHHHHHHC-CCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 7999964-888799997520-31106899999999999999999779662667713152347543447956872366057
Q ss_pred CCCCCC-------CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHCC--
Q ss_conf 245577-------6654444897667714331079896641355999999998199999999983589---9976248--
Q 000535 168 KLTEAD-------VNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPMPAL---FRIVQDE-- 235 (1437)
Q Consensus 168 ~L~esd-------~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~eqL---~KIIk~~-- 235 (1437)
.+.... ......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+....... .++....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf 71467665411102467627751026798964888886999898319999998698767885302199999999705679
Q ss_pred --CCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHH
Q ss_conf --999999999899999999823100699999999509889999
Q 000535 236 --RPPIPESLSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNC 277 (1437)
Q Consensus 236 --rppLPk~ISeELkDLIkkLLskDPekRPSAeEILkHPWLQel 277 (1437)
...+...+|+++.+++..|+..+|++||++..+.+ +|++.
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~--~l~~~ 276 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKV 276 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH--HHHHH
T ss_pred CCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHH
T ss_conf 9958965799899999999984399300859999999--99999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-44 Score=328.61 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=198.4
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----E
Q ss_conf 398567984842259579999999679909999993056348888999999999998179998214889998189----6
Q 000535 16 LDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTRS----H 91 (1437)
Q Consensus 16 LgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPNIVKLlGVfeddd----~ 91 (1437)
|...|.+.+.||+|+||.||+|+. +|..||+|++.... ........|+..+..++||||+++++++.++. .
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEE
T ss_conf 986899988982078819999999--99899999987200---4679999999999627998683268899837986048
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEECCCCCEEEEEC
Q ss_conf 9999961489998898611999999999999999999999999998--------89321112588368645991999720
Q 000535 92 LHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE--------QGVIHRDIKGANILTTKEGLVKLADF 163 (1437)
Q Consensus 92 LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHS--------kGIVHRDIKPENILIssDG~VKLiDF 163 (1437)
+|+|||||++|+|.+++++. ++++..++.++.|++.||.|+|+ ++|+||||||+|||++.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEEC
T ss_conf 99999646698989998658---999899999999999999998876652046898661531731357868877688763
Q ss_pred CCCCCCCCCCC----CCCCCCCCCCCCCHHHHHCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCC----------
Q ss_conf 66312455776----654444897667714331079------8966413559999999981999999999----------
Q 000535 164 GVATKLTEADV----NTHSVVGTPYWMAPEVIEMSG------VCAASDIWSVGCTVIELLTCVPPYYELQ---------- 223 (1437)
Q Consensus 164 GLAr~L~esd~----k~~t~vGTp~YmAPEVLkg~~------yS~KSDIWSLGVILYELLTGkpPF~g~s---------- 223 (1437)
|++..+..... .....+||+.|+|||++.... ++.++|||||||++|+|++|.+||....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCC
T ss_conf 86623467776200135525035476782210565454677767501220159999999628998876631124101225
Q ss_pred ----CHHHHHHHHHC--CCCCCCCC-----CCHHHHHHHHHHHHHCCCCCCCHHHHHCCHHHHHHH
Q ss_conf ----83589997624--89999999-----998999999998231006999999995098899999
Q 000535 224 ----PMPALFRIVQD--ERPPIPES-----LSPDITDFLRQCFKKDARQRPDAKTLLSHPWIQNCR 278 (1437)
Q Consensus 224 ----~~eqL~KIIk~--~rppLPk~-----ISeELkDLIkkLLskDPekRPSAeEILkHPWLQelr 278 (1437)
......+.... .++.++.. ....+.+|+.+||..||.+|||+.|++++ +.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~--L~~i~ 296 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLS 296 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHH
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH--HHHHH
T ss_conf 56430999999875024688877655776899999999999760698589599999999--99888
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-43 Score=325.53 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=207.7
Q ss_pred CCCCCCCCC-CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----------C
Q ss_conf 565564239-8567984842259579999999679909999993056348888999999999998179-----------9
Q 000535 9 AFHKSKTLD-NKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-----------H 76 (1437)
Q Consensus 9 qFe~setLg-nRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLk-----------H 76 (1437)
+...++.+. +||++++.||+|+||.||+|++..++..||||++++.. ...+.+.+|+.+++.+. |
T Consensus 3 p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~ 79 (362)
T d1q8ya_ 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGA 79 (362)
T ss_dssp CCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CCCCCCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHCCHHHHHHHHCCC
T ss_conf 888888844785799899750778189999999999799999983431---33689999999999840145555542276
Q ss_pred CCCCEEEEEEEE--CCEEEEEEEECCCC-CHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEE
Q ss_conf 982148899981--89699999614899-98898611999999999999999999999999998-893211125883686
Q 000535 77 KNIVKYLGSLKT--RSHLHIILEYVENG-SLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE-QGVIHRDIKGANILT 152 (1437)
Q Consensus 77 PNIVKLlGVfed--dd~LYLVMEYieGG-SLsDLLKssk~GpLSEkeIlqILrQILsALeYLHS-kGIVHRDIKPENILI 152 (1437)
+||+++++++.. ....+++++++..+ .............+++..++.++.|++.||.|||+ .||+||||||+|||+
T Consensus 80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 159 (362)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred CCEEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEE
T ss_conf 76478998763125652023432000354200000122346786899999999999998887640586465677057056
Q ss_pred CCCC------CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCH-
Q ss_conf 4599------199972066312455776654444897667714331079896641355999999998199999999983-
Q 000535 153 TKEG------LVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYELQPM- 225 (1437)
Q Consensus 153 ssDG------~VKLiDFGLAr~L~esd~k~~t~vGTp~YmAPEVLkg~~yS~KSDIWSLGVILYELLTGkpPF~g~s~~- 225 (1437)
+.++ .++++|||.+..... .....+||+.|+|||++....|+.++||||+||++++|++|+.||......
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ECCCCCCCCCEEEEEECCCCCCCCC---CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 3057656443056753144212344---5422366521057132146677764320123789999987889989875543
Q ss_pred -----HHHHHHHH--C------------------------C---------------CCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf -----58999762--4------------------------8---------------999999999899999999823100
Q 000535 226 -----PALFRIVQ--D------------------------E---------------RPPIPESLSPDITDFLRQCFKKDA 259 (1437)
Q Consensus 226 -----eqL~KIIk--~------------------------~---------------rppLPk~ISeELkDLIkkLLskDP 259 (1437)
..+..... + . ....+...++++.+||.+||.+||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred CCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCH
T ss_conf 21026899999998379987886245322000132012202432357764442100015674358999999999877994
Q ss_pred CCCCCHHHHHCCHHHHH
Q ss_conf 69999999950988999
Q 000535 260 RQRPDAKTLLSHPWIQN 276 (1437)
Q Consensus 260 ekRPSAeEILkHPWLQe 276 (1437)
.+|||+.|+|+||||++
T Consensus 317 ~~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKD 333 (362)
T ss_dssp TTCBCHHHHHTCGGGTT
T ss_pred HHCCCHHHHHCCCCCCC
T ss_conf 57908999966934078
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.8e-22 Score=170.63 Aligned_cols=167 Identities=16% Similarity=0.169 Sum_probs=124.0
Q ss_pred EEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC----------------HHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 67984842259579999999679909999993056348----------------88899999999999817999821488
Q 000535 20 YMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIA----------------QEDLNIIMQEIDLLKNLNHKNIVKYL 83 (1437)
Q Consensus 20 YkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lS----------------eEeieeLlREIkILKrLkHPNIVKLl 83 (1437)
|.++++||+|+||.||+|++. +++.||+|+++..... ........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 022778024856599999979-9999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCEEEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEC
Q ss_conf 99981896999996148999889861199999999999999999999999999889321112588368645991999720
Q 000535 84 GSLKTRSHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADF 163 (1437)
Q Consensus 84 GVfeddd~LYLVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHSkGIVHRDIKPENILIssDG~VKLiDF 163 (1437)
++.. .+++|||+++..+.+ +++..+..++.|++.++.|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EECC----CEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEEC
T ss_conf 8628----889999504565420---------0157899999999999999826888983689036114289-8999877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHH-----HHCCCCCCCCHHHHHHHHH
Q ss_conf 663124557766544448976677143-----3107989664135599999
Q 000535 164 GVATKLTEADVNTHSVVGTPYWMAPEV-----IEMSGVCAASDIWSVGCTV 209 (1437)
Q Consensus 164 GLAr~L~esd~k~~t~vGTp~YmAPEV-----Lkg~~yS~KSDIWSLGVIL 209 (1437)
|.|......... .|....+ +-...|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCCCCCCCCCH--------HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 884308998709--------9998779999999757899844689999987
|
| >d1wa5b_ a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin alpha species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.58 E-value=2.7e-07 Score=66.65 Aligned_cols=94 Identities=15% Similarity=0.369 Sum_probs=53.0
Q ss_pred ECCCCEEECCCCCCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHEEECCCCEEEEECC
Q ss_conf 04601000347889850223119999999831053134466642793043532365587445343201233321677335
Q 000535 676 VGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQR 755 (1437)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (1437)
-|+||..+.+...+.+.+++.+|+..+..+|..+.-....++..+++|+++.+|.....+.++.+-.++. .+-.
T Consensus 118 ~g~i~~Lv~~l~~~~~~~iq~~a~~~L~ni~~~~~~~~~~~~~~g~i~~l~~lL~s~~~~i~~~a~~~L~------nia~ 191 (503)
T d1wa5b_ 118 AGVVPRLVEFMRENQPEMLQLEAAWALTNIASGTSAQTKVVVDADAVPLFIQLLYTGSVEVKEQAIWALG------NVAG 191 (503)
T ss_dssp TTCHHHHHHTTSTTSCHHHHHHHHHHHHHHTTSCHHHHHHHHHTTCHHHHHHHHHHCCHHHHHHHHHHHH------HHHT
T ss_pred CCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHH------HHHH
T ss_conf 7984999998717999999999999999997498887799996787478999855997158999999999------9854
Q ss_pred CCCCCHHHHHHHHCCHHHHHHH
Q ss_conf 7885015588772052688887
Q 000535 756 STPRNDFCRIAAKNGILLRLIN 777 (1437)
Q Consensus 756 ~~~~~~~~~~~~~~~~~~~~~~ 777 (1437)
-..+++.+....|++..|+.
T Consensus 192 --~~~~~r~~l~~~~~~~~L~~ 211 (503)
T d1wa5b_ 192 --DSTDYRDYVLQCNAMEPILG 211 (503)
T ss_dssp --TCHHHHHHHHHTTCHHHHHH
T ss_pred --HHHHHHHHHHHHCCCCCCHH
T ss_conf --11899998874135563012
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=4.3e-06 Score=57.95 Aligned_cols=124 Identities=21% Similarity=0.256 Sum_probs=92.3
Q ss_pred HHHHHHCCCCHHHHHHHHCCCCHHHHCCCCCC------------------CCCCCHHHHHHHHHHHHHHHHHCCHHHHHH
Q ss_conf 99843117991588742103502331122345------------------788734889999999998653036045899
Q 000535 1162 LKCVNHLSTDPNCLENLQRADAIKYLIPNLDL------------------KDGHLVSLIHSEVLHALFNLCKINKRRQEQ 1223 (1437)
Q Consensus 1162 lk~~~~~s~~~~~l~~~~~~~ai~~l~~~l~~------------------~~~~~~~~~~~~~~~~~~n~c~~~k~rqe~ 1223 (1437)
+.++.|++.++.....+..+.+|+.|+..|.. .++....++......+++++++....|+.-
T Consensus 377 ~~~l~~l~~~~~~~~~l~~~g~i~~L~~lL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~al~~la~~~~~r~~~ 456 (529)
T d1jdha_ 377 VGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVI 456 (529)
T ss_dssp HHHHHHHTTSGGGHHHHHHTTHHHHHHHHHHHHHHHHC-----------CBTTBCHHHHHHHHHHHHHHHTTSHHHHHHH
T ss_pred HHHHHHCCHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 99875000035666666532657999999866788999999860346776412131999999999999984498889999
Q ss_pred HHHCCCCHHHHHHHCCCCC-CCCCCHHHHHHHCCCCHHHHHHHHHCCCCEEEECCCCCCCCEEEE
Q ss_conf 9962970121221014896-532202356210013512499998708900000102455302430
Q 000535 1224 AAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTA 1287 (1437)
Q Consensus 1224 aa~~giip~~~~~~~~~~p-~~~~~lp~l~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a 1287 (1437)
.+.|.||.|.....++.| .+..|+-.||.+++. ..+++.+...||+...++|+.+.-..|-.
T Consensus 457 -~~~~~i~~Lv~lL~~~~~~v~~~a~~aL~~L~~~-~~~~~~i~~~g~~~~L~~Ll~s~n~~v~~ 519 (529)
T d1jdha_ 457 -RGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQD-KEAAEAIEAEGATAPLTELLHSRNEGVAT 519 (529)
T ss_dssp -HHTTCHHHHHHGGGCSCHHHHHHHHHHHHHHTTS-HHHHHHHHHTTCHHHHHHGGGCSSHHHHH
T ss_pred -HHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCC-HHHHHHHHHCCCHHHHHHHHCCCCHHHHH
T ss_conf -9788899999986799989999999999998659-46699999888899999985799999999
|
| >d1wa5b_ a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin alpha species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.44 E-value=1.2e-05 Score=54.83 Aligned_cols=314 Identities=13% Similarity=0.102 Sum_probs=182.2
Q ss_pred HHHHHHCCCHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHHHHCCCHHH---HHHHHHCCCCH-HHHHHH
Q ss_conf 12343101279999999998888675302213588765336699999998420492378---99843117991-588742
Q 000535 1103 LSHMVSTLNADVAREYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRIEPPIL---LKCVNHLSTDP-NCLENL 1178 (1437)
Q Consensus 1103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---lk~~~~~s~~~-~~l~~~ 1178 (1437)
+.++..+-+.++......-+.+| +..+...+.++.....+..+.++++--.+... ..++.|++... ...+..
T Consensus 167 l~~lL~s~~~~i~~~a~~~L~ni----a~~~~~~r~~l~~~~~~~~L~~ll~~~~~~~~~~~~~~l~nl~~~~~~~~~~~ 242 (503)
T d1wa5b_ 167 FIQLLYTGSVEVKEQAIWALGNV----AGDSTDYRDYVLQCNAMEPILGLFNSNKPSLIRTATWTLSNLCRGKKPQPDWS 242 (503)
T ss_dssp HHHHHHHCCHHHHHHHHHHHHHH----HTTCHHHHHHHHHTTCHHHHHHGGGSCCHHHHHHHHHHHHHHHCCSSSCCCHH
T ss_pred HHHHHCCCCHHHHHHHHHHHHHH----HHHHHHHHHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHHHHHHCCCCCCHHHH
T ss_conf 99985599715899999999998----54118999988741355630120456888999999999999846874204799
Q ss_pred HCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCCHHHHHHHCCCCC-CCCCCHHHHHHHCCC
Q ss_conf 1035023311223457887348899999999986530360458999962970121221014896-532202356210013
Q 000535 1179 QRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHA 1257 (1437)
Q Consensus 1179 ~~~~ai~~l~~~l~~~~~~~~~~~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~~p-~~~~~lp~l~~~a~~ 1257 (1437)
.-..++.+|...+.-.| .++....+.++.++|.-+....+...+.|++|.+...+.++++ .+..|+-++..++..
T Consensus 243 ~~~~~l~~l~~~l~~~d----~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~l~~ll~~~~~~v~~~al~~l~nl~~~ 318 (503)
T d1wa5b_ 243 VVSQALPTLAKLIYSMD----TETLVDACWAISYLSDGPQEAIQAVIDVRIPKRLVELLSHESTLVQTPALRAVGNIVTG 318 (503)
T ss_dssp HHGGGHHHHHHHTTCCC----HHHHHHHHHHHHHHHSSCHHHHHHHHHTTCHHHHHHGGGCSCHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHHHHCCCC----HHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 99999999998723563----89999999998753227711110011223311101102578636445677777778778
Q ss_pred CHHHHHHHHHCCCCEEEECCCCCCCCEE--EEHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCHHHHHHHH
Q ss_conf 5124999987089000001024553024--30013566661357316999986327999999874025898412343699
Q 000535 1258 SRNSREQLRAHGGLDVYLNLLENEVWSV--TALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEP 1335 (1437)
Q Consensus 1258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1335 (1437)
...-...+..+|.++....+++++-+.+ .++-.+.-..++ +...-+.+++..+++.++..+......--......
T Consensus 319 ~~~~~~~~~~~~~l~~l~~ll~~~~~~i~~~~~~~l~nl~~~---~~~~~~~i~~~~~l~~li~~l~~~~~~v~~~a~~~ 395 (503)
T d1wa5b_ 319 NDLQTQVVINAGVLPALRLLLSSPKENIKKEACWTISNITAG---NTEQIQAVIDANLIPPLVKLLEVAEYKTKKEACWA 395 (503)
T ss_dssp CHHHHHHHHHTTHHHHHHHHTTCSCHHHHHHHHHHHHHHTTS---CHHHHHHHHHTTCHHHHHHHHHHSCHHHHHHHHHH
T ss_pred HHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHC---CHHHHHHHHHCCCCCHHHHHCCCCCHHHHHHHHHH
T ss_conf 888787631234099999996399788899998778888614---69888999971465236776026873689999999
Q ss_pred HHHHHHCC---CCCCCCCCCCCCHHHHHHHCCCCHHHHHHHHHHHHHHHHHC-------CCCC----CCCCCCCCHHHHH
Q ss_conf 99985015---42100000259417999630530147898799999999840-------9998----6520026815999
Q 000535 1336 FLKIITKS---SRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEH-------HPRP----KQLIVENDLPQKL 1401 (1437)
Q Consensus 1336 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~ll~~~~~~~~~-------~~~~----~~~~~~~~~~~~~ 1401 (1437)
+..++... +.+-..|...|....++.-|+..+.-+....|..+.++... .... ...+-+++..
T Consensus 396 l~nl~~~~~~~~~~~~~l~~~~~l~~l~~~L~~~d~~~~~~~L~~l~~ll~~~~~~~~~~~~~~~~~~~~iee~g~~--- 472 (503)
T d1wa5b_ 396 ISNASSGGLQRPDIIRYLVSQGCIKPLCDLLEIADNRIIEVTLDALENILKMGEADKEARGLNINENADFIEKAGGM--- 472 (503)
T ss_dssp HHHHHHHTTTCTHHHHHHHHTTCHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHHHHHHTCSSCHHHHHHHHTTHH---
T ss_pred HHHHHHCCCCCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHCCCH---
T ss_conf 99997365354899999998976999999865998899999999999999988877565302301899999988779---
Q ss_pred HHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 9999997303567852358899999999831035
Q 000535 1402 QNLIEERRDGQRSGGQVLVKQMATSLLKALHINT 1435 (1437)
Q Consensus 1402 ~~~~~~~~~~~~~~~~vlv~~~a~~l~~~~~~~~ 1435 (1437)
+.|+++| ..+---|+++|..++.-.|..+
T Consensus 473 -~~i~~Lq----~~~~~~i~~~A~~il~~~f~~~ 501 (503)
T d1wa5b_ 473 -EKIFNCQ----QNENDKIYEKAYKIIETYFGEE 501 (503)
T ss_dssp -HHHHGGG----GCSCHHHHHHHHHHHHHHSSSC
T ss_pred -HHHHHHH----CCCCHHHHHHHHHHHHHHCCCC
T ss_conf -9999987----6998999999999999875876
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.39 E-value=7.3e-06 Score=56.34 Aligned_cols=174 Identities=12% Similarity=0.185 Sum_probs=116.4
Q ss_pred HHHHCCCC-HHHHHHHHCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCCHHHHHHHCCCCC
Q ss_conf 84311799-15887421035023311223457887348899999999986530360458999962970121221014896
Q 000535 1164 CVNHLSTD-PNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP 1242 (1437)
Q Consensus 1164 ~~~~~s~~-~~~l~~~~~~~ai~~l~~~l~~~~~~~~~~~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~~p 1242 (1437)
|+.+++.. ......+...++++.|+..+.-. -..+....+.++.|+|.-+.....+..+.|+++.+.+...+..+
T Consensus 211 ~l~~l~~~~~~~~~~~~~~~~~~~Lv~ll~~~----~~~~~~~al~~l~~l~~~~~~~~~~~~~~~~~~~l~~ll~~~~~ 286 (434)
T d1q1sc_ 211 AISYLTDGPNERIEMVVKKGVVPQLVKLLGAT----ELPIVTPALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLTNPKT 286 (434)
T ss_dssp HHHHHTSSCHHHHHHHHTTTCHHHHHHHHTCS----CHHHHHHHHHHHHHHTTSCHHHHHHHHHTTGGGGHHHHTTCSSH
T ss_pred HHCCCCHHHHHHHHHHHHCCCCHHCCCCCCCC----HHHHHHCHHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHCCCCH
T ss_conf 64022012345677776315420100002343----06554021221356776666778999852564057776136414
Q ss_pred -CCCCCHHHHHHHCCCCHHHHHHHHHCCCCEEEECCCCCCCCEEE--EHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf -53220235621001351249999870890000010245530243--001356666135731699998632799999987
Q 000535 1243 -LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVT--ALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVK 1319 (1437)
Q Consensus 1243 -~~~~~lp~l~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1319 (1437)
.+..|+-+|+.++......+..+..+|++...+.++.++-+.+. |.-++.....+ .+...+ ..+.+..+++.|+.
T Consensus 287 ~v~~~a~~~L~~l~~~~~~~~~~i~~~~~i~~li~~l~~~~~~v~~~a~~~l~nl~~~-~~~~~~-~~l~~~~~i~~L~~ 364 (434)
T d1q1sc_ 287 NIQKEATWTMSNITAGRQDQIQQVVNHGLVPFLVGVLSKADFKTQKEAAWAITNYTSG-GTVEQI-VYLVHCGIIEPLMN 364 (434)
T ss_dssp HHHHHHHHHHHHHTTSCHHHHHHHHHTTCHHHHHHHHHSSCHHHHHHHHHHHHHHHHH-SCHHHH-HHHHHTTCHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHC-CCHHHH-HHHHHCCCHHHHHH
T ss_conf 6668888788652004504577776654689999877515868899999999999834-999999-99998976999999
Q ss_pred HHCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 402589841234369999985015
Q 000535 1320 FFQSCPEPHFVHILEPFLKIITKS 1343 (1437)
Q Consensus 1320 ~~~~~~~~~~~~~~~~~~~~~~~~ 1343 (1437)
+++..-..-...+|+.+.+++...
T Consensus 365 ll~~~d~~~~~~~l~~l~~ll~~~ 388 (434)
T d1q1sc_ 365 LLSAKDTKIIQVILDAISNIFQAA 388 (434)
T ss_dssp HTTSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 865999899999999999999988
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.38 E-value=2e-06 Score=60.43 Aligned_cols=148 Identities=15% Similarity=0.228 Sum_probs=96.8
Q ss_pred HCCHHHHHHHHHHHHHHHHHHHHHHHCCCHHH---HHHHHHCCC-CHHHHHHHHCCCCHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 02213588765336699999998420492378---998431179-91588742103502331122345788734889999
Q 000535 1130 AQADTTVKSYMCSQSLLSRLFQMFNRIEPPIL---LKCVNHLST-DPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSE 1205 (1437)
Q Consensus 1130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---lk~~~~~s~-~~~~l~~~~~~~ai~~l~~~l~~~~~~~~~~~~~~ 1205 (1437)
++.+......+....++..+.++++.-++++. ++++.+++. +...-..+-..+.++.|+.+|+-. -.++...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~Lv~ll~~~~~~~~~~al~~l~~l~~~~~~~~~~~~~~~~~~~l~~ll~~~----~~~v~~~ 291 (434)
T d1q1sc_ 216 TDGPNERIEMVVKKGVVPQLVKLLGATELPIVTPALRAIGNIVTGTDEQTQKVIDAGALAVFPSLLTNP----KTNIQKE 291 (434)
T ss_dssp TSSCHHHHHHHHTTTCHHHHHHHHTCSCHHHHHHHHHHHHHHTTSCHHHHHHHHHTTGGGGHHHHTTCS----SHHHHHH
T ss_pred CHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHHCHHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHCCC----CHHHHHH
T ss_conf 012345677776315420100002343065540212213567766667789998525640577761364----1466688
Q ss_pred HHHHHHHHHHCCHHHHHHHHHCCCCHHHHHHHCCCCC-CCCCCHHHHHHHCCCCH-HHHHHHHHCCCCEEEECCCCCC
Q ss_conf 9999986530360458999962970121221014896-53220235621001351-2499998708900000102455
Q 000535 1206 VLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASR-NSREQLRAHGGLDVYLNLLENE 1281 (1437)
Q Consensus 1206 ~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~~p-~~~~~lp~l~~~a~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1281 (1437)
...++.|+|.-+....+.....|++|.+.....+..+ .+.-|.-.++.++..+. .....+...|++...+++|+..
T Consensus 292 a~~~L~~l~~~~~~~~~~i~~~~~i~~li~~l~~~~~~v~~~a~~~l~nl~~~~~~~~~~~l~~~~~i~~L~~ll~~~ 369 (434)
T d1q1sc_ 292 ATWTMSNITAGRQDQIQQVVNHGLVPFLVGVLSKADFKTQKEAAWAITNYTSGGTVEQIVYLVHCGIIEPLMNLLSAK 369 (434)
T ss_dssp HHHHHHHHTTSCHHHHHHHHHTTCHHHHHHHHHSSCHHHHHHHHHHHHHHHHHSCHHHHHHHHHTTCHHHHHHHTTSS
T ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf 887886520045045777766546899998775158688999999999998349999999999897699999986599
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=1.4e-06 Score=61.50 Aligned_cols=143 Identities=15% Similarity=0.135 Sum_probs=97.0
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEEE
Q ss_conf 2398567984842259579999999679909999993056348888999999999998179-998214889998189699
Q 000535 15 TLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-HKNIVKYLGSLKTRSHLH 93 (1437)
Q Consensus 15 tLgnRYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLk-HPNIVKLlGVfeddd~LY 93 (1437)
.+-..|++.+..+.++.+.||+.. ..+..+.+|+...... .....+.+|..++..|. +--+.+++.+..+++..|
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHCEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCC--CCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 751352799767899877189999--0898699998488765--325569999999998760699872899975089649
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q ss_conf 99961489998898611999999999999999999999999998------------------------------------
Q 000535 94 IILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHE------------------------------------ 137 (1437)
Q Consensus 94 LVMEYieGGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLHS------------------------------------ 137 (1437)
+||++++|.++.+..... .. ...+..++...+..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEECCCCCCCCCCCCC----CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 999860433435433440----26---99999989999999855684214357644656555778998776555543033
Q ss_pred -----------------------CCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -----------------------8932111258836864599199972066312
Q 000535 138 -----------------------QGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 138 -----------------------kGIVHRDIKPENILIssDG~VKLiDFGLAr~ 168 (1437)
..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 232005799999999844986781789860047642364996599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.86 E-value=4.6e-05 Score=50.59 Aligned_cols=81 Identities=17% Similarity=0.135 Sum_probs=53.2
Q ss_pred EEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCC-C----HHHHHHHHHHHHHHHHCC--CCC-CCEEEEEEEECCEEE
Q ss_conf 98484225957999999967990999999305634-8----888999999999998179--998-214889998189699
Q 000535 22 LGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENI-A----QEDLNIIMQEIDLLKNLN--HKN-IVKYLGSLKTRSHLH 93 (1437)
Q Consensus 22 IlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~l-S----eEeieeLlREIkILKrLk--HPN-IVKLlGVfeddd~LY 93 (1437)
..+.||.|....||++.+...++.|++|.-..... . .....+...|+..|+.+. .|. +.+++.+ +....+
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCE
T ss_conf 699807985276899995799848999617713034677788877899999999998650579885528998--598877
Q ss_pred EEEEECCCCCH
Q ss_conf 99961489998
Q 000535 94 IILEYVENGSL 104 (1437)
Q Consensus 94 LVMEYieGGSL 104 (1437)
+|||++.+..+
T Consensus 108 lvmE~L~~~~~ 118 (392)
T d2pula1 108 TVMEDLSHLKI 118 (392)
T ss_dssp EEECCCTTSEE
T ss_pred EEEECCCCCCC
T ss_conf 98713577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=9.6e-05 Score=48.30 Aligned_cols=129 Identities=16% Similarity=0.120 Sum_probs=83.0
Q ss_pred EEECCCC-CEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEECCEEEEEEEECC
Q ss_conf 4842259-579999999679909999993056348888999999999998179--9982148899981896999996148
Q 000535 24 DEIGKGA-YGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN--HKNIVKYLGSLKTRSHLHIILEYVE 100 (1437)
Q Consensus 24 EkLGkGS-FGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLk--HPNIVKLlGVfeddd~LYLVMEYie 100 (1437)
+.+..|. -+.||++.. ..+..+.+|....... ..+..|+..++.|. .-.+.+++.+..+++..++||++++
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EECCCCCCCCEEEEEEE-CCCCEEEEEECCCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEE
T ss_conf 87678654775899993-8987899995896677-----68999999999998659998861322245661599987441
Q ss_pred CCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q ss_conf 999889861199999999999999999999999999--------------------------------------------
Q 000535 101 NGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLH-------------------------------------------- 136 (1437)
Q Consensus 101 GGSLsDLLKssk~GpLSEkeIlqILrQILsALeYLH-------------------------------------------- 136 (1437)
|.++.+.. .... .+..++...|..||
T Consensus 90 G~~~~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 90 GQDLLSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp SEETTTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCCCCCCC-------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHH
T ss_conf 35543221-------2689---9999999999987368854488755412468899999987541101134011213799
Q ss_pred -------H-------CCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -------8-------8932111258836864599199972066312
Q 000535 137 -------E-------QGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 137 -------S-------kGIVHRDIKPENILIssDG~VKLiDFGLAr~ 168 (1437)
. ..++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9999998718765795678678887635773796589998533265
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.60 E-value=0.00017 Score=46.60 Aligned_cols=139 Identities=12% Similarity=0.105 Sum_probs=74.8
Q ss_pred HHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEECCCC-HHHHHHHHCCC-HHHHHHHHHHHHHHHCCCCHHHCCC
Q ss_conf 461367999723589999999999983299971799932670-34798630661-3789899999999842880000111
Q 000535 596 RLVGSLRPDESEDAIVSACQKLIAIFHQRPGQKQFFVTQHGL-LPLMELLELPQ-TRVICSILQLINQIVKDNSDFQENA 673 (1437)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (1437)
.|+.-|+ +++..+...++.-+-.+-...+..+ .++-..|. -+++.+|..+. ..+--.....+-.+. .+.+.....
T Consensus 21 ~L~~lL~-~~~~~v~~~A~~~l~~l~~~~~~~~-~~~~~~~~v~~l~~~L~~~~~~~~~~~a~~~L~~l~-~~~~~~~~i 97 (529)
T d1jdha_ 21 ELTKLLN-DEDQVVVNKAAVMVHQLSKKEASRH-AIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLS-HHREGLLAI 97 (529)
T ss_dssp HHHHHHT-CSCHHHHHHHHHHHHHHHTSHHHHH-HHHTCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHT-TSHHHHHHH
T ss_pred HHHHHHC-CCCHHHHHHHHHHHHHHHHCCHHHH-HHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHH-CCCHHHHHH
T ss_conf 9999872-9999999999999999984557789-998713399999999847999999999999999995-891669999
Q ss_pred EEECCCCEEECCCCCCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHH
Q ss_conf 21046010003478898502231199999998310531344666427930435323655874453
Q 000535 674 CLVGLIPVVMGFAVPDRPREVRMEAAYFLQQLCQSSSLTLQMFIACRGIPVLVGFLEADYAKYRE 738 (1437)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (1437)
.-.|+||.+..+-. ....+++..|+..+..+|..+...-++|..++|||.|+++|..+..+-++
T Consensus 98 ~~~g~i~~Li~lL~-~~~~~v~~~a~~aL~~l~~~~~~~~~~~~~~g~i~~Lv~lL~~~~~~~~~ 161 (529)
T d1jdha_ 98 FKSGGIPALVKMLG-SPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLA 161 (529)
T ss_dssp HHTTHHHHHHHHTT-CSCHHHHHHHHHHHHHHHHHCTTHHHHHHHHTHHHHHHHGGGCCCHHHHH
T ss_pred HHCCCHHHHHHHHC-CCCHHHHHHHHHHHHHHHCCCCHHHHHHHHCCCCHHHHHHHHCCCHHHHH
T ss_conf 98798999999857-97989999999999986513201136787658814899988705768888
|
| >d1xqra1 a.118.1.21 (A:87-350) Hsp70-binding protein 1 (HspBP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HspBP1 domain domain: Hsp70-binding protein 1 (HspBP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.45 E-value=0.00035 Score=44.25 Aligned_cols=199 Identities=14% Similarity=0.155 Sum_probs=112.5
Q ss_pred HHHHHCCCCHHHHHHHHCCCCHHHHCC-CCCCCCCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCCHHHHHHHCCCC
Q ss_conf 984311799158874210350233112-2345788734889999999998653036045899996297012122101489
Q 000535 1163 KCVNHLSTDPNCLENLQRADAIKYLIP-NLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDS 1241 (1437)
Q Consensus 1163 k~~~~~s~~~~~l~~~~~~~ai~~l~~-~l~~~~~~~~~~~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~~ 1241 (1437)
..+.+|.-+.+.-..+....++..|+. .|.- ...++--+...++.|+|+-|..-|+...+.|+||.|.+.+.++.
T Consensus 39 ~~L~~L~~~~d~a~~l~~~gg~~~ll~~ll~s----~~~~vr~~A~~~L~~l~~~~~~~~~~~~~~~~i~~Lv~lL~~~~ 114 (264)
T d1xqra1 39 ELLADLCENMDNAADFCQLSGMHLLVGRYLEA----GAAGLRWRAAQLIGTCSQNVAAIQEQVLGLGALRKLLRLLDRDA 114 (264)
T ss_dssp HHHHHHHTSHHHHHHHHHTTHHHHHHHTTTTC----SSHHHHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHHHHHHHHCS
T ss_pred HHHHHHHCCHHHHHHHHHCCCHHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHCCC
T ss_conf 99999976978899999869999999998379----99999999999999999888888899997276379999960499
Q ss_pred C--CCCCCHHHHHHHCCCCHHHHHHHHHCCCCEEEECCCCCCCCEEEEHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 6--53220235621001351249999870890000010245530243001356666135731699998632799999987
Q 000535 1242 P--LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENEVWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVK 1319 (1437)
Q Consensus 1242 p--~~~~~lp~l~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1319 (1437)
. .+..|+-.|.-++....+.+..+...||+.+-+++|..+. .++ ...+...|.
T Consensus 115 ~~~v~~~a~~aL~~l~~~~~~~~~~~~~~~gi~~L~~lL~~~~-------------------~~~-----~~~a~~~L~- 169 (264)
T d1xqra1 115 CDTVRVKALFAISCLVREQEAGLLQFLRLDGFSVLMRAMQQQV-------------------QKL-----KVKSAFLLQ- 169 (264)
T ss_dssp CHHHHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHHHHHHHSSC-------------------HHH-----HHHHHHHHH-
T ss_pred CHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCCC-------------------HHH-----HHHHHHHHH-
T ss_conf 8999999999999874244026789987201268899880586-------------------578-----899999999-
Q ss_pred HHCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC--CCCCH
Q ss_conf 4025898412343699999850154210000025941799963053014789879999999984099986520--02681
Q 000535 1320 FFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAVYEHHPRPKQLI--VENDL 1397 (1437)
Q Consensus 1320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~ll~~~~~~~~~~~~~~~~~--~~~~~ 1397 (1437)
.++..++.....+...|..+.++.-|.+.++-+|-.-+..+.++.+.++....-. .+.++
T Consensus 170 ------------------~l~~~~~~~~~~~~~~~~v~~L~~lL~~~~~~~~~~a~~aL~~L~~~~~~~~~~~~~~~l~~ 231 (264)
T d1xqra1 170 ------------------NLLVGHPEHKGTLCSMGMVQQLVALVRTEHSPFHEHVLGALCSLVTDFPQGVRECREPELGL 231 (264)
T ss_dssp ------------------HHHHHCGGGHHHHHHTTHHHHHHHHHTSCCSTHHHHHHHHHHHHHTTCHHHHHHHHCGGGCH
T ss_pred ------------------HHHHCCHHHHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_conf ------------------98744577888888764689999997399989999999999999864889999998744459
Q ss_pred HHHHHHHHHHH
Q ss_conf 59999999997
Q 000535 1398 PQKLQNLIEER 1408 (1437)
Q Consensus 1398 ~~~~~~~~~~~ 1408 (1437)
.+.|+..+...
T Consensus 232 ~~~L~~~~~~~ 242 (264)
T d1xqra1 232 EELLRHRCQLL 242 (264)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHC
T ss_conf 99999999763
|
| >d1xqra1 a.118.1.21 (A:87-350) Hsp70-binding protein 1 (HspBP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HspBP1 domain domain: Hsp70-binding protein 1 (HspBP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.85 E-value=0.014 Score=32.86 Aligned_cols=117 Identities=17% Similarity=0.144 Sum_probs=67.8
Q ss_pred HHHHHHCCC-CHHHHHHHHCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCCHHHHHHHCCC
Q ss_conf 998431179-9158874210350233112234578873488999999999865303604589999629701212210148
Q 000535 1162 LKCVNHLST-DPNCLENLQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSD 1240 (1437)
Q Consensus 1162 lk~~~~~s~-~~~~l~~~~~~~ai~~l~~~l~~~~~~~~~~~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~ 1240 (1437)
+.++.+++. ++.+-+.+-..++|..|+.+|.-. . ..++-...+.++.|+|+-+...+..-...|.||.|.+.+.+.
T Consensus 80 ~~~L~~l~~~~~~~~~~~~~~~~i~~Lv~lL~~~-~--~~~v~~~a~~aL~~l~~~~~~~~~~~~~~~gi~~L~~lL~~~ 156 (264)
T d1xqra1 80 AQLIGTCSQNVAAIQEQVLGLGALRKLLRLLDRD-A--CDTVRVKALFAISCLVREQEAGLLQFLRLDGFSVLMRAMQQQ 156 (264)
T ss_dssp HHHHHHHHTTCHHHHHHHHHTTHHHHHHHHHHHC-S--CHHHHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHCC-C--CHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 9999999988888889999727637999996049-9--899999999999987424402678998720126889988058
Q ss_pred CC-CCCCCHHHHHHHCCCCHHHHHHHHHCCCCEEEECCCCCC
Q ss_conf 96-532202356210013512499998708900000102455
Q 000535 1241 SP-LKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLENE 1281 (1437)
Q Consensus 1241 ~p-~~~~~lp~l~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 1281 (1437)
.+ ++..++-+|+.++......+.++...|++..-+.||.++
T Consensus 157 ~~~~~~~a~~~L~~l~~~~~~~~~~~~~~~~v~~L~~lL~~~ 198 (264)
T d1xqra1 157 VQKLKVKSAFLLQNLLVGHPEHKGTLCSMGMVQQLVALVRTE 198 (264)
T ss_dssp CHHHHHHHHHHHHHHHHHCGGGHHHHHHTTHHHHHHHHHTSC
T ss_pred CHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 657889999999998744577888888764689999997399
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.017 Score=32.19 Aligned_cols=134 Identities=16% Similarity=0.163 Sum_probs=75.4
Q ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC---CC--CCCEEE--EEEEECCEEEEEEEECCC
Q ss_conf 59579999999679909999993056348888999999999998179---99--821488--999818969999961489
Q 000535 29 GAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN---HK--NIVKYL--GSLKTRSHLHIILEYVEN 101 (1437)
Q Consensus 29 GSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLk---HP--NIVKLl--GVfeddd~LYLVMEYieG 101 (1437)
+.-..||++.. .+|..|++|+.+....+. +.+..|...+..|. -| ..+..- ..+...+..+.+++++.|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred CCCCEEEEEEC-CCCCEEEEEEECCCCCCH---HHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCC
T ss_conf 61202699983-899979999847877889---99999999999998559987875206898056653479999865277
Q ss_pred CCHH-----HHH-------------CCCC---CCC-------------------CCHH---HHHHHHHHHHHHHHHHH--
Q ss_conf 9988-----986-------------1199---999-------------------9999---99999999999999999--
Q 000535 102 GSLA-----NII-------------KPNK---FGP-------------------FPES---LVAVYIAQVLEGLVYLH-- 136 (1437)
Q Consensus 102 GSLs-----DLL-------------Kssk---~Gp-------------------LSEk---eIlqILrQILsALeYLH-- 136 (1437)
..+. .+. .... ... ++.. .....+.++...+...-
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 68899999999998999999886303578655677897887665689998747699889899999999999999984545
Q ss_pred --HCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf --88932111258836864599199972066312
Q 000535 137 --EQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 137 --SkGIVHRDIKPENILIssDG~VKLiDFGLAr~ 168 (1437)
..+++|+|+.+.|||++. + ..++||+.|..
T Consensus 189 ~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCCCEEECCCCCCCCEEEEC-C-CEEEECHHCCC
T ss_conf 68712024788804287838-9-35886520146
|
| >d1b3ua_ a.118.1.2 (A:) Constant regulatory domain of protein phosphatase 2a, pr65alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Constant regulatory domain of protein phosphatase 2a, pr65alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.46 E-value=0.02 Score=31.67 Aligned_cols=181 Identities=13% Similarity=0.151 Sum_probs=92.5
Q ss_pred CCCCHHHHHHHCCCCC-CCCCCHHHHHHHCCCCH--HHHHHHHHCCCCEEEECCCCCCCCEE--EEHHHHHHHHHCCCCH
Q ss_conf 2970121221014896-53220235621001351--24999987089000001024553024--3001356666135731
Q 000535 1227 NGIIPHLMHFIMSDSP-LKQYALPLLCDMAHASR--NSREQLRAHGGLDVYLNLLENEVWSV--TALDSIAVCLAHDNDN 1301 (1437)
Q Consensus 1227 ~giip~~~~~~~~~~p-~~~~~lp~l~~~a~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~--~a~~~~~~~~~~~~~~ 1301 (1437)
..++|.+...+.++.+ .++.++..+..+++.-. .-.+.+ ....+.++.|++|.| .|..++.....+-..
T Consensus 401 ~~ll~~l~~~~~d~~~~~r~~~~~~l~~l~~~~~~~~~~~~l-----~~~l~~~l~D~~~~VR~~A~~~L~~l~~~~~~- 474 (588)
T d1b3ua_ 401 QSLLPAIVELAEDAKWRVRLAIIEYMPLLAGQLGVEFFDEKL-----NSLCMAWLVDHVYAIREAATSNLKKLVEKFGK- 474 (588)
T ss_dssp HHHHHHHHHHHTCSSHHHHHHHHHHHHHHHHHHCGGGCCHHH-----HHHHHHGGGCSSHHHHHHHHHHHHHHHHHHCH-
T ss_pred HHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHCCHHHHHHHH-----HHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCC-
T ss_conf 677899999984335889999999999999771847677888-----88877635687416899999999999998393-
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCCHHHHHHHHHHHHHHH
Q ss_conf 69999863279999998740258984123436999998501542100000259417999630530147898799999999
Q 000535 1302 RKVEQALLKKDAVQKLVKFFQSCPEPHFVHILEPFLKIITKSSRINTTLAVNGLTPLLIARLDHQDAIARLNLLKLIKAV 1381 (1437)
Q Consensus 1302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~ll~~~~~~ 1381 (1437)
+ ...+..+..++.+++......-...+..+-++....++ ......+.|.+..-+....+-||.+..+.+..+
T Consensus 475 ---~--~~~~~i~~~l~~~~~~~~~~~R~~~~~~l~~l~~~~~~---~~~~~~ilp~ll~~~~D~v~nVR~~a~~~l~~i 546 (588)
T d1b3ua_ 475 ---E--WAHATIIPKVLAMSGDPNYLHRMTTLFCINVLSEVCGQ---DITTKHMLPTVLRMAGDPVANVRFNVAKSLQKI 546 (588)
T ss_dssp ---H--HHHHHTHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---HHHHHHTHHHHHHGGGCSCHHHHHHHHHHHHHH
T ss_pred ---H--HHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHCCH---HHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHH
T ss_conf ---8--78999999999986599878999999999999998696---878999999999885999879999999999999
Q ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 840999865200268159999999997303567852358899999999831
Q 000535 1382 YEHHPRPKQLIVENDLPQKLQNLIEERRDGQRSGGQVLVKQMATSLLKALH 1432 (1437)
Q Consensus 1382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vlv~~~a~~l~~~~~ 1432 (1437)
+...+. ..+-+++..+++.++ +|+-.-||..|.+-+..+-
T Consensus 547 ~~~~~~-------~~~~~~i~~~l~~L~----~D~d~dVr~~A~~al~~l~ 586 (588)
T d1b3ua_ 547 GPILDN-------STLQSEVKPILEKLT----QDQDVDVKYFAQEALTVLS 586 (588)
T ss_dssp GGGSCH-------HHHHHHHHHHHHHHT----TCSSHHHHHHHHHHHHHTT
T ss_pred HHHCCC-------HHHHHHHHHHHHHHC----CCCCHHHHHHHHHHHHHHH
T ss_conf 987080-------757999999999975----7998779999999999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.43 E-value=0.014 Score=32.77 Aligned_cols=76 Identities=14% Similarity=0.096 Sum_probs=50.0
Q ss_pred EEEEEECCCCCEEEEEEEECC-------CCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCC-CCEEEEEEEECCEE
Q ss_conf 798484225957999999967-------9909999993056348888999999999998179998-21488999818969
Q 000535 21 MLGDEIGKGAYGRVYKGLDLE-------NGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKN-IVKYLGSLKTRSHL 92 (1437)
Q Consensus 21 kIlEkLGkGSFGtVYKArDkk-------TGk~VAIKVIkke~lSeEeieeLlREIkILKrLkHPN-IVKLlGVfeddd~L 92 (1437)
...++|+.|-.-.+|++.... ....|.+++... ... .-...+|..+++.+.-.+ ..++++++.+
T Consensus 45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-CCH---HHHHHHHHHHHHHHHHCCCCCEEEEECCC----
T ss_conf 6999917853343489996887754457898179996599-611---65899999999999757999808998189----
Q ss_pred EEEEEECCCCCH
Q ss_conf 999961489998
Q 000535 93 HIILEYVENGSL 104 (1437)
Q Consensus 93 YLVMEYieGGSL 104 (1437)
.+|+||++|..+
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEECCCCC
T ss_conf 569997345548
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.04 E-value=0.05 Score=28.80 Aligned_cols=148 Identities=11% Similarity=0.061 Sum_probs=100.4
Q ss_pred HCCCHHHHHHHHHHHHHHHHHH-HCCHHHHHHHHHHHHHHHHHHHHHHHCCCHHH---HHHHHHCCCCHHHHHHHHCCCC
Q ss_conf 1012799999999988886753-02213588765336699999998420492378---9984311799158874210350
Q 000535 1108 STLNADVAREYLEKVADLLLEF-AQADTTVKSYMCSQSLLSRLFQMFNRIEPPIL---LKCVNHLSTDPNCLENLQRADA 1183 (1437)
Q Consensus 1108 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---lk~~~~~s~~~~~l~~~~~~~a 1183 (1437)
+..+.++.......+..+.... .......+..+.....+.-++++++.-.+++. +.++.+|+.++.+-+.+. ..+
T Consensus 294 ~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~l~~L~~~l~~~~~~v~~~a~~~l~~La~~~~~~~~i~-~~~ 372 (457)
T d1xm9a1 294 KSKKDATLEACAGALQNLTASKGLMSSGMSQLIGLKEKGLPQIARLLQSGNSDVVRSGASLLSNMSRHPLLHRVMG-NQV 372 (457)
T ss_dssp HCCCHHHHHHHHHHHHHHTTCSSSHHHHHHHHHHTTSCCHHHHHHHTTCSCHHHHHHHHHHHHHHHTSGGGHHHHH-HHT
T ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHHCHHHHHHHH-HHH
T ss_conf 3663578899999988886144000488999999983976889754037508999999999999860766799999-965
Q ss_pred HHHHCCCCCC--CCCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCCHHHHHHHCCCCCC--CCCCHHHHHHHCC
Q ss_conf 2331122345--78873488999999999865303604589999629701212210148965--3220235621001
Q 000535 1184 IKYLIPNLDL--KDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSPL--KQYALPLLCDMAH 1256 (1437)
Q Consensus 1184 i~~l~~~l~~--~~~~~~~~~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~~p~--~~~~lp~l~~~a~ 1256 (1437)
|..|+..|.. .......++...++.++.||+.-+....+.-.+.|.|+.|.+++++..+. .+-|.-+||.|+.
T Consensus 373 i~~li~~L~~~~~~~~~~~~v~~~a~~~L~~l~~~~~~~~~~l~~~g~i~~L~~l~~~~~~~~~~~aA~~~L~~L~~ 449 (457)
T d1xm9a1 373 FPEVTRLLTSHTGNTSNSEDILSSACYTVRNLMASQPQLAKQYFSSSMLNNIINLCRSSASPKAAEAARLLLSDMWS 449 (457)
T ss_dssp HHHHHHTTTSCCSCSTTHHHHHHHHHHHHHHHHTTCTHHHHHHCCHHHHHHHHHHHHCTTCHHHHHHHHHHHHTTSS
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHC
T ss_conf 99999998553667678599999999999998617999999999888899999998689989999999999999974
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.96 E-value=0.091 Score=26.94 Aligned_cols=144 Identities=15% Similarity=0.081 Sum_probs=77.1
Q ss_pred CEEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----CCCCCEEEE---EEEECC
Q ss_conf 567984842259579999999679909999993056348888999999999998179-----998214889---998189
Q 000535 19 KYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLN-----HKNIVKYLG---SLKTRS 90 (1437)
Q Consensus 19 RYkIlEkLGkGSFGtVYKArDkkTGk~VAIKVIkke~lSeEeieeLlREIkILKrLk-----HPNIVKLlG---Vfeddd 90 (1437)
...-.+.|..|---..|++.. ++..|++|++.... ..+.+..|+.++..|. .|..+...+ +.....
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~ 92 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHT--TKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 92 (316)
T ss_dssp CEEEEEEECC---EEEEEEEE--SSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred CCEEEECCCCCCCCCEEEEEE--CCCCEEEEECCCCC----CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEEC
T ss_conf 856852378885267389997--89728999807899----988999999998754302555455641048976213412
Q ss_pred EEEEEEEECCCCCHHH--------------HHC----CCC---CCCCCH------------------HHHHHHHHHHHHH
Q ss_conf 6999996148999889--------------861----199---999999------------------9999999999999
Q 000535 91 HLHIILEYVENGSLAN--------------IIK----PNK---FGPFPE------------------SLVAVYIAQVLEG 131 (1437)
Q Consensus 91 ~LYLVMEYieGGSLsD--------------LLK----ssk---~GpLSE------------------keIlqILrQILsA 131 (1437)
....++.+..|..... .+. ... ...... ......+......
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (316)
T d2ppqa1 93 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 172 (316)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred CCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_conf 55024531146553332046788888998764544432024531011101200245677776531141279999999876
Q ss_pred HHHHH----HCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99999----88932111258836864599199972066312
Q 000535 132 LVYLH----EQGVIHRDIKGANILTTKEGLVKLADFGVATK 168 (1437)
Q Consensus 132 LeYLH----SkGIVHRDIKPENILIssDG~VKLiDFGLAr~ 168 (1437)
+.... ..|++|+|+.++||+++.+...-++||+.|..
T Consensus 173 ~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 173 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 42048554545033378636564020454126742221236
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.13 E-value=0.062 Score=28.13 Aligned_cols=95 Identities=12% Similarity=0.077 Sum_probs=49.1
Q ss_pred HHCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCHHHHHHHHHCCCCHHHHHHHCCCCC-------CCCCCHHH
Q ss_conf 21035023311223457887348899999999986530360458999962970121221014896-------53220235
Q 000535 1178 LQRADAIKYLIPNLDLKDGHLVSLIHSEVLHALFNLCKINKRRQEQAAENGIIPHLMHFIMSDSP-------LKQYALPL 1250 (1437)
Q Consensus 1178 ~~~~~ai~~l~~~l~~~~~~~~~~~~~~~~~~~~n~c~~~k~rqe~aa~~giip~~~~~~~~~~p-------~~~~~lp~ 1250 (1437)
+..+++|..|+..|.-. ...+....+.++.||++-..-+. .-++ +.||.+...+..... .+..|+-.
T Consensus 327 ~~~~~~l~~L~~~l~~~----~~~v~~~a~~~l~~La~~~~~~~-~i~~-~~i~~li~~L~~~~~~~~~~~~v~~~a~~~ 400 (457)
T d1xm9a1 327 GLKEKGLPQIARLLQSG----NSDVVRSGASLLSNMSRHPLLHR-VMGN-QVFPEVTRLLTSHTGNTSNSEDILSSACYT 400 (457)
T ss_dssp HTTSCCHHHHHHHTTCS----CHHHHHHHHHHHHHHHTSGGGHH-HHHH-HTHHHHHHTTTSCCSCSTTHHHHHHHHHHH
T ss_pred HHHCCCHHHHHHHHCCC----CHHHHHHHHHHHHHHHHCHHHHH-HHHH-HHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 99839768897540375----08999999999999860766799-9999-659999999855366767859999999999
Q ss_pred HHHHCCCCHHHHHHHHHCCCCEEEECCC
Q ss_conf 6210013512499998708900000102
Q 000535 1251 LCDMAHASRNSREQLRAHGGLDVYLNLL 1278 (1437)
Q Consensus 1251 l~~~a~~~~~~~~~~~~~~~~~~~~~~~ 1278 (1437)
|+.|+......|++++..||+..-++++
T Consensus 401 L~~l~~~~~~~~~~l~~~g~i~~L~~l~ 428 (457)
T d1xm9a1 401 VRNLMASQPQLAKQYFSSSMLNNIINLC 428 (457)
T ss_dssp HHHHHTTCTHHHHHHCCHHHHHHHHHHH
T ss_pred HHHHHCCCHHHHHHHHHCCCHHHHHHHH
T ss_conf 9998617999999999888899999998
|